Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,eosinophil chemotaxis (GO:0048245),0.9145873497354161,2.0663105907248145,0.0,0.0,0.0,3/14,0.31%,CCL3;CCL4;CCL2
prerank,eosinophil migration (GO:0072677),0.9145873497354161,2.0663105907248145,0.0,0.0,0.0,3/14,0.31%,CCL3;CCL4;CCL2
prerank,lymphocyte migration (GO:0072676),0.7438180445088207,1.9429980434352434,0.0,0.030727607628160496,0.073,4/32,1.52%,CCL3;CCL4;CCL2;ADAM8
prerank,positive regulation of calcium ion import (GO:0090280),0.8867065779577215,1.930393999289136,0.0,0.033521026503447814,0.104,4/12,6.44%,CCL3;CCL2;PDGFRB;PDGFB
prerank,chemokine-mediated signaling pathway (GO:0070098),0.6937507572628988,1.9212579045254532,0.0012239902080783353,0.03310201367215472,0.128,3/42,0.31%,CCL3;CCL4;CCL2
prerank,regulation of platelet activation (GO:0010543),0.7915328152682521,1.9059101010314263,0.0,0.042075871809015224,0.19,6/21,6.44%,SELP;PLEK;PDGFA;PLA2G4A;APOE;PDGFB
prerank,zinc ion homeostasis (GO:0055069),0.745602335279829,1.894499034329443,0.0,0.04594176400249321,0.238,12/28,6.62%,TMC8;SLC39A14;ATP13A2;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B;SLC39A8
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.6729152848223622,1.8924727288349643,0.0,0.04163940010975159,0.242,8/53,8.17%,MC2R;NPY;LPAR3;CCL2;HRH2;MTNR1A;AGT;HTR2C
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.8355456134362862,1.8884160452502594,0.0,0.0401553963322552,0.257,3/14,1.61%,CCL3;CCL4;ADAM17
prerank,regulation of acute inflammatory response (GO:0002673),0.8058342961727454,1.8791004211831566,0.0,0.044834372948361456,0.297,3/18,3.22%,OSM;ADAM8;NLRP3
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.8969703847656606,1.8739709940196032,0.0,0.046281871820101246,0.333,2/11,0.19%,CCL3;CCL4
prerank,fibrinolysis (GO:0042730),0.8451407798924703,1.8718976907880047,0.0,0.04417093596548072,0.346,3/13,2.70%,SERPINF2;PLAUR;SERPINE1
prerank,monocyte chemotaxis (GO:0002548),0.7081977501768155,1.8653140277008988,0.0,0.047058364129840206,0.386,4/32,0.82%,CCL3;CCL4;CCL2;CALCA
prerank,lymphocyte chemotaxis (GO:0048247),0.7049025344818726,1.8542426466054802,0.0012787723785166241,0.054696139227724004,0.448,4/34,1.52%,CCL3;CCL4;CCL2;ADAM8
prerank,negative regulation by host of viral transcription (GO:0043922),0.8451587519602272,1.8491030816060015,0.0,0.05642706128080383,0.488,5/12,3.85%,CCL3;CCL4;JUN;INPP5K;TARDBP
prerank,positive regulation of calcium ion transport (GO:0051928),0.6934951247838147,1.8457500088784429,0.0,0.05689408599901593,0.512,5/36,0.63%,CCL3;CCL4;CRACR2A;CCL2;PDGFRB
prerank,heme catabolic process (GO:0042167),-0.6874105599677762,-1.8434799859836268,0.0,0.7909240025359436,0.794,4/14,7.80%,SLCO2B1;ABCG2;BLVRA;BLVRB
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.6874105599677762,-1.8434799859836268,0.0,0.7909240025359436,0.794,4/14,7.80%,SLCO2B1;ABCG2;BLVRA;BLVRB
prerank,mRNA stabilization (GO:0048255),0.6775662861610738,1.831702720145193,0.0012330456226880395,0.07227971339805934,0.618,12/40,12.60%,GDNF;MAPKAPK2;ZFP36;TENT5C;FUS;HNRNPU;TARDBP;TAF15;DHX9;YBX1;ANGEL2;YBX3
prerank,protein heterooligomerization (GO:0051291),-0.6372908113771136,-1.82440962412443,0.009287925696594427,0.6578887276739809,0.858,13/17,24.42%,GRIN2B;PKD1;KCNC2;NUDT21;CPSF7;FARSB;GRIN1;TMEM120B;PKD2;MAT2A;CBR4;HSD17B8;TMEM120A
prerank,peripheral nervous system development (GO:0007422),0.7530045075508475,1.8232160583397619,0.0,0.08100914738333223,0.68,6/23,10.45%,GDNF;EGR2;SOX10;SCN8A;ARTN;BDNF
prerank,anterior/posterior axis specification (GO:0009948),0.7943465283158406,1.801917111090842,0.001564945226917058,0.11815059177119847,0.832,2/15,2.20%,HOXD8;FZD5
prerank,sensory perception of pain (GO:0019233),0.750408548789632,1.7998955013998084,0.0,0.11679982672295099,0.843,3/21,0.70%,KCNK4;CCL2;ALOXE3
prerank,regulation of calcium-mediated signaling (GO:0050848),0.7167447475094876,1.7991753493710194,0.0,0.11258475717006208,0.845,4/25,6.29%,CCL3;CCL4;PLEK;CMKLR1
prerank,modulation by host of symbiont process (GO:0051851),0.6842128419663946,1.7988232656848138,0.0,0.10827672481369366,0.846,13/31,12.03%,CCL3;CCL4;JUN;INPP5K;TARDBP;SAP30BP;RRP1B;CARD9;HDAC1;CHD1;CTDP1;HPN;SMARCB1
prerank,cellular zinc ion homeostasis (GO:0006882),0.7227933946068379,1.7969215863848427,0.0,0.10725817583643969,0.858,11/26,6.62%,SLC39A14;ATP13A2;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B;SLC39A8
prerank,macrophage chemotaxis (GO:0048246),0.877496410056498,1.7966111150188127,0.0,0.10335649838563077,0.858,3/10,6.40%,CCL3;CCL2;CXCL17
prerank,response to interleukin-1 (GO:0070555),0.6071440469225977,1.793121887844432,0.0,0.10626165401592957,0.872,17/73,13.42%,CCL3;CCL4;CCL2;ADAMTS12;IL1R1;ACOD1;SOX9;RELA;SIRPA;TANK;SMPD1;PYCARD;RC3H1;IRAK2;APP;CCL25;CCL13
prerank,integrated stress response signaling (GO:0140467),0.7963520295382996,1.7829239111023802,0.002932551319648094,0.12103024473119862,0.902,8/14,11.58%,CCL2;NFE2L2;EIF2AK1;ATF4;EIF2S1;QRICH1;EIF2AK3;HSPA5
prerank,cellular response to zinc ion (GO:0071294),0.7889485640027211,1.7805752978894562,0.002849002849002849,0.12100935377807144,0.907,9/15,4.64%,ATP13A2;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B
prerank,response to copper ion (GO:0046688),0.7485143138202781,1.7792773982202188,0.0028653295128939827,0.11990501109771234,0.912,10/20,9.29%,MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B;IL1A;PRNP
prerank,cellular response to copper ion (GO:0071280),0.7788425320009994,1.7681324057803425,0.0,0.13928564460915385,0.938,9/16,9.29%,MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B;PRNP
prerank,regulation of calcium ion import (GO:0090279),0.7250920381330532,1.7678292567211524,0.0,0.135515733187376,0.939,6/21,9.75%,CCL3;CCL2;PDGFRB;PDGFB;PRNP;CTNNB1
prerank,neutrophil chemotaxis (GO:0030593),0.6274690382392978,1.766538797878514,0.0,0.1339827319417042,0.944,4/53,2.09%,CCL3;CCL4;CCL2;CXADR
prerank,gas transport (GO:0015669),0.8515264054152475,1.7633125094360387,0.0,0.13775046828760587,0.951,2/10,7.33%,MYC;IPCEF1
prerank,granulocyte chemotaxis (GO:0071621),0.6214643552114646,1.7618902279440427,0.0,0.13659183432228783,0.953,4/55,2.09%,CCL3;CCL4;CCL2;CXADR
prerank,neural crest cell development (GO:0014032),0.6476248765624025,1.759488336981787,0.0012135922330097086,0.13855152222978384,0.955,12/44,10.36%,GDNF;SEMA3G;SOX10;CORO1C;SEMA4G;SEMA6D;KLHL12;SEMA6A;ANXA6;TAPT1;SEMA4C;PEF1
prerank,embryonic digestive tract development (GO:0048566),-0.6171182363420643,-1.7583796791785198,0.003205128205128205,1.0,0.978,9/18,24.70%,SALL1;NIPBL;FGFR2;RARB;ID2;PDGFRA;TGFB2;PKDCC;SOX11
prerank,muscle filament sliding (GO:0030049),0.652876533013075,1.7533822126886442,0.0012515644555694619,0.14400656264371808,0.962,5/38,6.79%,TNNI2;TPM3;TPM4;MYH2;MYL6
prerank,actin-myosin filament sliding (GO:0033275),0.652876533013075,1.7533822126886442,0.0012515644555694619,0.14400656264371808,0.962,5/38,6.79%,TNNI2;TPM3;TPM4;MYH2;MYL6
prerank,positive regulation of interleukin-17 production (GO:0032740),0.7022782128840882,1.7494062388543488,0.0013966480446927375,0.1490892952425306,0.967,6/22,10.93%,OSM;SLC7A5;CARD9;ZBTB7B;IL18;LY9
prerank,neural crest cell migration (GO:0001755),0.6635138066167617,1.7342406184254282,0.0025188916876574307,0.18552344438174656,0.99,9/36,9.93%,GDNF;SEMA3G;SOX10;CORO1C;SEMA4G;SEMA6D;SEMA6A;ANXA6;SEMA4C
prerank,positive regulation of ion transport (GO:0043270),0.6216974615828762,1.733724821938996,0.0,0.18216314242498646,0.99,4/48,0.25%,CCL3;GDNF;CCL4;CRACR2A
prerank,PERK-mediated unfolded protein response (GO:0036499),0.8383668806063174,1.7334405862341016,0.006557377049180328,0.17831614801716889,0.99,7/10,11.58%,CCL2;NFE2L2;ATF4;EIF2S1;QRICH1;EIF2AK3;HSPA5
prerank,positive regulation of lipid transport (GO:0032370),0.7953901161057224,1.732069997322818,0.003115264797507788,0.17751836291612455,0.99,4/12,7.87%,PRELID1;APOE;SPP1;LRP1
prerank,regulation of neuron apoptotic process (GO:0043523),0.5761294249601447,1.7316290919207271,0.0010905125408942203,0.17478820962512073,0.99,23/96,14.27%,CCL3;GDNF;CCL2;AGAP2;TFAP2B;ADAM8;NUPR1;SNX6;ATF4;APOE;EGLN2;FAIM2;LANCL1;PTK2B;SET;PPT1;PRNP;CTNNB1;BDNF;SRPK2;FOXO3;NAE1;WFS1
prerank,neutrophil migration (GO:1990266),0.6079146781261171,1.7252640298537243,0.0,0.1882634395484337,0.993,4/58,2.09%,CCL3;CCL4;CCL2;CXADR
prerank,ureteric bud morphogenesis (GO:0060675),0.7419798348052002,1.7250824093662225,0.007407407407407408,0.18450849105235836,0.993,2/16,0.09%,GDNF;MYC
prerank,mesonephric tubule development (GO:0072164),-0.6483024436606357,-1.719542112176578,0.005494505494505495,1.0,0.994,7/15,18.64%,SALL1;PKD1;NPNT;FGFR2;ROBO2;PKD2;SLIT2
prerank,negative regulation of bone mineralization (GO:0030502),0.7795643091006725,1.7187932290218693,0.0046439628482972135,0.19851896807041872,0.996,4/13,7.92%,CCL3;SRGN;TRPM4;PTK2B
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.7439231351008726,1.7177906100143838,0.007518796992481203,0.19670830634292272,0.996,2/16,0.09%,GDNF;MYC
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.697094202509702,1.7153013395178285,0.008064516129032258,0.19936541361259355,0.998,9/24,13.41%,CCL3;TFAP2B;TYROBP;NUPR1;ATF4;PRNP;CTNNB1;SRPK2;FOXO3
prerank,cellular response to chemokine (GO:1990869),0.6129213853917626,1.7136735851407336,0.0048250904704463205,0.19962033165822732,0.998,3/46,0.31%,CCL3;CCL4;CCL2
prerank,response to tumor necrosis factor (GO:0034612),0.5796405135245335,1.7122073522536356,0.0,0.19984346667999375,0.999,25/91,14.11%,CCL3;CCL4;CCL2;ADAMTS12;NFE2L2;ZFP36;INPP5K;ACOD1;IKBKB;ADAM9;RELA;MAP2K7;TANK;ERBIN;GSDME;DHX9;SMPD1;SIRT1;PYCARD;GCH1;YBX3;MAP4K3;CCL25;CCL13;CXCL16
prerank,positive regulation of interleukin-1 production (GO:0032732),0.611103921396607,1.7095921068779092,0.0011862396204033216,0.20244604943926017,0.999,13/51,12.57%,CCL3;EGR1;STAT3;LPL;FZD5;TYROBP;HMGB1;NLRP3;TMED10;PYCARD;RIPK2;PYDC1;APP
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.695448757368447,1.7016814762624088,0.0013774104683195593,0.22191248182797194,1.0,6/24,3.91%,ATF3;SESN2;NFE2L2;CREB3L1;ATF4;CHD6
prerank,regulation of membrane repolarization (GO:0060306),0.7652341912006648,1.6979200913879067,0.004291845493562232,0.22957068391423757,1.0,5/13,9.42%,KCNH2;CACNA2D1;AKAP6;KCNJ2;AKAP9
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.6622970266118553,1.6964323264869319,0.005555555555555556,0.22974552598825318,1.0,5/26,9.03%,CCL3;MYC;CDK6;TMEM178A;C1QC
prerank,macrophage migration (GO:1905517),0.7777407486654777,1.6963136240603236,0.009146341463414634,0.22589835279667234,1.0,3/13,6.40%,CCL3;CCL2;CXCL17
prerank,regulation of monocyte differentiation (GO:0045655),0.7561829971389171,1.6952107221268025,0.01078582434514638,0.22539081116011447,1.0,5/14,8.25%,MYC;CSF1;IL34;FOXP1;CDK6
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.6520477599059086,-1.6935761658552115,0.003194888178913738,1.0,0.999,4/13,4.33%,TPST2;ENPP1;TPST1;BPNT2
prerank,positive regulation of acute inflammatory response (GO:0002675),0.7656242463454237,1.692213104509497,0.004524886877828055,0.23083117581057258,1.0,2/14,1.52%,OSM;ADAM8
prerank,positive regulation of neuron death (GO:1901216),0.6111749004687211,1.6922006069429412,0.0023781212841854932,0.22683663932678527,1.0,13/46,13.41%,CCL3;EGR1;TFAP2B;TYROBP;PICALM;NUPR1;ATF4;EIF2S1;PRNP;CTNNB1;CLU;SRPK2;FOXO3
prerank,cellular response to cadmium ion (GO:0071276),0.6903612430163284,1.690586418741293,0.001364256480218281,0.22758537444501398,1.0,11/24,9.77%,JUN;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B;MAPK8;SUMO1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.7861990616223892,1.687061508730373,0.00949367088607595,0.23461167596216073,1.0,3/11,7.64%,NFKBIZ;NFKBID;CARD9
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.6329742926679126,1.6865422016170633,0.0037313432835820895,0.23242990929187543,1.0,9/34,7.83%,EGR3;MAPKAPK2;NR4A1;PRKD2;MAP2K3;RELA;MT1G;SEMA6A;VEGFC
prerank,carboxylic acid transport (GO:0046942),0.5915170482724577,1.6790297324849819,0.0023612750885478157,0.25348559027530393,1.0,18/55,17.64%,SLC7A5;SLC7A1;SLC16A3;SLC23A2;SLC23A1;SLC16A14;SLC16A1;SLC6A11;SLC3A2;SLC6A6;SLC36A1;SLC1A1;PSAP;SLC38A1;SLC16A6;SLC36A4;SLC16A7;SLC15A4
prerank,regulation of interleukin-1 beta production (GO:0032651),0.5771173607739652,1.6785375313460371,0.0022624434389140274,0.25093461977278575,1.0,16/66,12.57%,CCL3;EGR1;STAT3;LPL;FZD5;TYROBP;NLRP3;SIRPA;FOXP1;PYCARD;RIPK2;CARD16;CD33;PYDC1;IGF1;APP
prerank,positive regulation of response to external stimulus (GO:0032103),0.5487290844908616,1.676571642099247,0.0,0.2538020578118192,1.0,29/128,12.75%,CCL3;OSM;SERPINF2;PDGFRB;CD180;LPL;ADAM8;SERPINE1;ACOD1;GPSM3;NFKBIZ;NINJ1;LY86;PDGFB;AGT;POLR3B;DHX9;TLR7;IL17RA;BMP6;AKIRIN2;STX3;PPM1F;PUM2;IL18;POLR3F;APP;OPTN;TNIP1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.585224448800122,1.6764259235055285,0.0,0.25026196056529154,1.0,17/65,13.83%,BAMBI;ADAM17;SKIL;PIN1;SNX6;TGFBR1;TGFBR2;RPS27A;UBC;PEG10;NRROS;ZBTB7A;SMURF1;SIRT1;STUB1;LEMD3;SKOR2
prerank,regulation of sensory perception of pain (GO:0051930),0.7943075862750287,1.6755575072857694,0.0032520325203252032,0.24940932988815306,1.0,1/11,0.01%,CCL3
prerank,mRNA methylation (GO:0080009),-0.6016258395815466,-1.6742716913271138,0.025236593059936908,1.0,1.0,10/15,21.25%,METTL16;WTAP;PCIF1;TRMT6;ZC3H13;VIRMA;TRMT61B;METTL14;CMTR1;NSUN2
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.6314572286191726,-1.6739963407341092,0.020172910662824207,1.0,1.0,5/14,11.00%,LONP2;IRS2;IRS1;ABCD2;AKT2
prerank,autonomic nervous system development (GO:0048483),0.7370370281143181,1.6738757954907564,0.01171303074670571,0.2510902648127578,1.0,3/17,1.02%,GDNF;SOX10;TFAP2B
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.605419582344516,1.6713355501736507,0.004842615012106538,0.2557385403530298,1.0,7/45,3.22%,CCL3;EGR1;STAT3;LPL;FZD5;TYROBP;NLRP3
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.6005553731611963,1.6706741592914562,0.007518796992481203,0.2543192217580055,1.0,10/43,13.41%,EGR1;STAT3;JUN;SOX9;NFATC3;RELA;PDGFB;SPI1;DDX5;FOXO3
prerank,response to cadmium ion (GO:0046686),0.6760879224815322,1.6703200850865558,0.0013477088948787063,0.2516961496379807,1.0,11/26,9.77%,JUN;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B;MAPK8;SUMO1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.726536404780222,1.6690706311082066,0.0077279752704791345,0.25190153532702547,1.0,3/15,6.66%,GDNF;SOX9;AGT
prerank,negative regulation of ossification (GO:0030279),0.6715544639980003,1.6672201885969289,0.0014204545454545455,0.25472734268575115,1.0,7/23,10.92%,CCL3;SRGN;SOX9;TRPM4;PTK2B;LRP4;RBPJ
prerank,regulation of hormone secretion (GO:0046883),0.7275675296378371,1.6669338634775748,0.011834319526627219,0.25197511198490136,1.0,2/15,3.59%,OSM;SNX6
prerank,amino acid import (GO:0043090),0.6865921187084384,1.6645986344486123,0.004166666666666667,0.2564014133405846,1.0,8/21,12.37%,SLC7A5;SLC7A1;SLC22A4;SFXN2;SLC1A3;SLC6A6;SLC36A1;SLC1A1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.6946304306347282,1.658466731457823,0.010279001468428781,0.2733775607409562,1.0,2/20,0.31%,CCL3;CCL2
prerank,regulation of urine volume (GO:0035809),0.7827876443617385,1.6552948693272738,0.014018691588785047,0.28009611062505935,1.0,2/10,2.61%,TFAP2B;INPP5K
prerank,reticulophagy (GO:0061709),-0.660050124032267,-1.6533339095134572,0.019444444444444445,1.0,1.0,10/12,21.45%,ULK2;UBA5;RB1CC1;DDRGK1;ATG2B;ULK1;ATG2A;UFC1;TEX264;UFM1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.6960658620177185,1.650718669510485,0.01366120218579235,0.2927989991828709,1.0,4/18,7.11%,GDNF;ABL2;AGT;POR
prerank,phasic smooth muscle contraction (GO:0014821),0.7831783671293177,1.650124255583654,0.014084507042253521,0.29105066599625107,1.0,1/10,0.04%,GDNF
prerank,retinoid metabolic process (GO:0001523),0.5684449920060757,1.648079175315029,0.0011061946902654867,0.29470569134281205,1.0,10/71,11.77%,PLB1;ALDH8A1;LPL;SDC4;APOE;SCPEP1;LRP1;DHRS13;ALDH1A1;GPC5
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.6205069056209331,-1.6465750784275786,0.024324324324324326,1.0,1.0,6/13,16.55%,CALM2;CALM1;SLC8A1;SRI;PDE4D;CALM3
prerank,glial cell differentiation (GO:0010001),0.6446726240690555,1.6461180190727698,0.008152173913043478,0.29772452851341524,1.0,5/28,3.29%,EGR2;SOX10;STAT3;METRN;SOX9
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.5214808618948652,-1.6443312709279914,0.007874015748031496,1.0,1.0,10/26,14.91%,CAB39;CACNA1D;WWP2;ATP1B3;ANK2;DLG1;KCNAB1;ATP1B2;VAMP2;ITGB1
prerank,cyclooxygenase pathway (GO:0019371),0.7759907655235319,1.6424071781447187,0.013996889580093312,0.306795957412415,1.0,6/10,11.44%,CBR1;PTGES2;HPGDS;PTGDS;PTGES3;TBXAS1
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.6081862685586619,-1.6416268878383071,0.029850746268656716,1.0,1.0,6/15,11.00%,IRS2;IRS1;PPARG;PRKCE;LDLRAP1;AKT2
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.6337003516219845,1.6372922539740702,0.015915119363395226,0.32373914215308996,1.0,9/29,14.69%,GDNF;TENT5C;FUS;HNRNPU;TAF15;DHX34;YBX1;FMR1;SLC11A1
prerank,negative regulation of cartilage development (GO:0061037),0.7377147018311506,1.6366703533286922,0.015527950310559006,0.32184784364628977,1.0,4/13,10.24%,ADAMTS12;SOX9;TGFBR1;EFEMP1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.5524559340799734,-1.6365191206123932,0.01730103806228374,0.9679049957237864,1.0,5/19,5.11%,TPST2;ENPP1;TPST1;BPNT2;SLC35B3
prerank,carboxylic acid metabolic process (GO:0019752),0.6396322862591411,1.6357064717663201,0.008917197452229299,0.3215671062806276,1.0,11/33,13.45%,SLC23A2;SLC23A1;CARNMT1;LIAS;PLA2G4A;AGXT;GLUD1;GSTO2;TBXAS1;CSGALNACT1;SLC2A1
prerank,platelet degranulation (GO:0002576),0.532952679169072,1.6343116083340739,0.001075268817204301,0.3231012930349068,1.0,28/118,15.04%,SELENOP;SELP;SERPINF2;WDR1;CD9;PLEK;SRGN;SERPINE1;PDGFA;HABP4;TAGLN2;MANF;ITGB3;SPARC;PDGFB;VEGFC;CYRIB;ENDOD1;TMSB4X;CLU;IGF1;APP;PSAP;CYB5R1;PROS1;OLA1;FLNA;HGF
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.7273182188161141,1.6337011566052169,0.01461038961038961,0.3216539675514662,1.0,4/13,6.44%,SOX9;NFATC3;RELA;PDGFB
prerank,blood vessel endothelial cell migration (GO:0043534),0.6685298120448908,1.6332579497830513,0.015341701534170154,0.31946074204430447,1.0,4/22,2.65%,EGR3;NR4A1;MYH9;PIK3R3
prerank,amino acid import across plasma membrane (GO:0089718),0.654347365712574,1.6318867954137166,0.013477088948787063,0.3203642069602141,1.0,9/24,14.23%,SLC7A5;SLC7A1;SLC22A4;SLC3A2;SLC1A3;SLC6A6;SLC36A1;SLC1A1;SLC6A5
prerank,protein kinase B signaling (GO:0043491),0.6632698877486941,1.631688306721886,0.01098901098901099,0.31731889328920754,1.0,4/23,2.65%,CCL3;CCL2;EPHA2;PIK3R3
prerank,actin filament bundle organization (GO:0061572),0.6153358584088047,1.63115661866792,0.013801756587202008,0.31577795648209317,1.0,6/33,5.08%,MICAL1;LCP1;ADD1;LIMA1;FAM107A;BAIAP2L1
prerank,osteoclast differentiation (GO:0030316),0.6674446962017503,1.6304113466331869,0.01366120218579235,0.31524895932148755,1.0,6/22,7.48%,CSF1;EPHA2;TYROBP;SBNO2;GPR183;FOXP1
prerank,skin development (GO:0043588),0.5715924252392545,1.6257681209086554,0.006726457399103139,0.32948912829951477,1.0,10/65,7.26%,SPRR1A;ALOXE3;EPHA2;LSR;PDGFA;COL1A2;ADAM9;CLIC4;COL1A1;JAG1
prerank,aorta morphogenesis (GO:0035909),0.6930850228408646,1.625550425986519,0.019461077844311378,0.3267161462261996,1.0,6/17,10.92%,PDGFRB;TFAP2B;JAG1;LRP1;ENG;RBPJ
prerank,cellular response to interleukin-1 (GO:0071347),0.5256829737086389,1.6241169060282685,0.0,0.3285871589914582,1.0,36/143,13.42%,CCL3;CCL4;CCL2;EGR1;ADAMTS12;IL1R1;SQSTM1;ACOD1;PSMD2;SOX9;PSMC4;FBXW11;IKBKB;RELA;PSMD4;SIRPA;TANK;PSMD1;RPS27A;UBC;PSME3;PSMB6;IL1A;PSMD10;PELI3;PYCARD;RIPK2;PSMB1;RC3H1;PSMD11;PSMA2;PSMD13;IRAK2;CCL25;PSMB10;CCL13
prerank,regulation of striated muscle contraction (GO:0006942),-0.5012446019757278,-1.6234759486186336,0.007722007722007722,1.0,1.0,8/27,16.55%,CALM2;ANK2;CALM1;PRKACA;SLC8A3;SRI;ATP1A2;CALM3
prerank,response to sterol (GO:0036314),0.7673647902065501,1.62235105753273,0.017684887459807074,0.33205652484150083,1.0,5/11,13.72%,CCL3;TGFBR1;TGFBR2;CCR5;RORA
prerank,digestive tract morphogenesis (GO:0048546),-0.6224947825758146,-1.6189043431412133,0.02318840579710145,0.9722577982393065,1.0,6/14,24.70%,NIPBL;FGFR2;BBS7;ID2;PDGFRA;SOX11
prerank,positive regulation of inflammatory response (GO:0050729),0.5420756634654498,1.6179708807119815,0.0011086474501108647,0.3449798799956804,1.0,17/86,12.75%,CCL3;OSM;LPL;ADAM8;KARS1;SERPINE1;GPSM3;NFKBIZ;NUPR1;NINJ1;AGT;DHX9;TLR7;IL17RA;IL18;APP;TNIP1
prerank,positive regulation of macrophage migration (GO:1905523),0.6760432048778506,1.6165999802985695,0.017467248908296942,0.3467985886499279,1.0,5/19,6.40%,CCL3;CSF1;IL34;CMKLR1;CXCL17
prerank,protein heterotetramerization (GO:0051290),-0.6323243092682485,-1.6160173549012937,0.022988505747126436,0.9330331119346782,1.0,9/13,21.46%,GRIN2B;PKD1;NUDT21;CPSF7;FARSB;GRIN1;PKD2;CBR4;HSD17B8
prerank,inflammatory response (GO:0006954),0.5151388933928768,1.6156245233054352,0.001026694045174538,0.34722988568471574,1.0,35/195,13.83%,CCL3;CCL4;RELB;CCL2;MAPKAPK2;STAT3;ADORA1;ADAM8;CXCR4;HMGB1;LIAS;NLRP3;NFATC3;CDO1;IKBKB;RELA;TBK1;CYBB;PRDX5;NRROS;CMKLR1;ITGAL;PARP4;IL1A;RIPK2;HDAC5;IL18;BLNK;SCUBE1;CCR5;ADCY8;C5AR2;CCL25;CCL13;IL10RB
prerank,positive regulation of macrophage activation (GO:0043032),0.6985695475109959,1.6147083963211764,0.022321428571428572,0.3470217236716943,1.0,2/17,2.45%,CCL3;KARS1
prerank,regulation of potassium ion transport (GO:0043266),-0.47633641739381105,-1.6143632824251948,0.01556420233463035,0.889193756653035,1.0,10/31,10.72%,DPP6;KCNIP4;CACNA1D;DPP10;KCNN2;KCNIP1;ANK2;KCNIP3;DLG1;KCNAB1
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.6484672459862879,-1.6142272104890945,0.016172506738544475,0.8406991053754536,1.0,5/12,11.00%,IRS2;IRS1;ABCD2;PPARGC1A;AKT2
prerank,regulation of cation transmembrane transport (GO:1904062),-0.489664674048478,-1.611572804134124,0.01171875,0.8143663085874298,1.0,12/29,13.52%,DPP6;KCNIP4;CACNA1D;DPP10;FGF12;KCNN2;KCNIP1;SNTA1;KCNIP3;DLG1;KCNAB1;WNK3
prerank,sympathetic nervous system development (GO:0048485),0.7224413290581356,1.6085132404275548,0.02467343976777939,0.36798003115858735,1.0,4/15,11.10%,GDNF;TFAP2B;CTNNB1;NRP2
prerank,myeloid cell activation involved in immune response (GO:0002275),0.6875572164804143,1.6077390845894692,0.02109704641350211,0.3673275985530941,1.0,6/18,12.28%,SLAMF1;TYROBP;KARS1;SBNO2;PYCARD;DOCK2
prerank,regulation of axon extension (GO:0030516),0.598762872623814,1.6068104595719273,0.010230179028132993,0.36763190143601837,1.0,16/37,17.48%,SEMA3G;CDKL3;RUFY3;DNM2;RTN4;APOE;GOLGA4;CDKL5;LIMK1;PTPRS;DBNL;MAG;SIN3A;ZFYVE27;SEMA3A;NRCAM
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.7191760921503905,1.6032793587989376,0.020061728395061727,0.3791244529415685,1.0,4/14,10.24%,ADAMTS12;SOX9;TGFBR1;EFEMP1
prerank,embryonic axis specification (GO:0000578),0.7035475743433606,1.6025160177658049,0.01524390243902439,0.37857605903044345,1.0,2/15,2.20%,HOXD8;FZD5
prerank,negative regulation of blood coagulation (GO:0030195),0.6014310544917458,1.602031335818068,0.008997429305912597,0.37680937544891313,1.0,7/38,9.27%,SERPINF2;PLAUR;SERPINE1;PDGFA;APOE;PDGFB;F3
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.7671871482379267,1.6018467007307993,0.029556650246305417,0.373929045945157,1.0,4/10,5.39%,MYC;PDGFA;SOX9;TGFBR2
prerank,keratinocyte differentiation (GO:0030216),0.6352948054142736,1.6017005498864088,0.016709511568123392,0.3709943561220326,1.0,5/29,7.26%,SPRR1A;EPHA2;ADAM9;CLIC4;JAG1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.5554020707997757,1.6012154404593695,0.0057670126874279125,0.36947533301405394,1.0,22/60,16.77%,MYC;PDGFRB;NEK7;PRKD2;ACD;HSP90AB1;MAP2K7;PCNA;PDGFB;XRCC5;PTGES3;CCT8;POLG2;NVL;SMOC2;CTNNB1;CCT7;HMBOX1;HGF;FBXO4;CCT6A;HNRNPA1
prerank,regulation of fibrinolysis (GO:0051917),0.7336612528875466,1.6000911461373295,0.02009273570324575,0.37082635569439143,1.0,2/13,2.70%,SERPINF2;SERPINE1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.6001541004917971,1.5998199209722794,0.013681592039800995,0.36842375918468334,1.0,9/37,9.96%,SELP;CXADR;NECTIN3;CADM3;CADM1;ITGAL;ALCAM;TENM2;PTPRD
prerank,ameboidal-type cell migration (GO:0001667),0.5771553123938297,1.599534778802636,0.013126491646778043,0.36614103039902324,1.0,9/51,9.93%,GDNF;SEMA3G;SOX10;CORO1C;SEMA4G;SEMA6D;SEMA6A;ANXA6;SEMA4C
prerank,actin filament bundle assembly (GO:0051017),0.6053601664779872,1.5994939809427877,0.010230179028132993,0.363031207076191,1.0,6/33,5.08%,MICAL1;LCP1;ADD1;LIMA1;FAM107A;BAIAP2L1
prerank,embryonic limb morphogenesis (GO:0030326),-0.46469065142044075,-1.5990969440595646,0.013953488372093023,0.8545408708157994,1.0,9/34,8.75%,LRP6;SALL1;NIPBL;WDPCP;PTCH1;CACNA1C;MBNL1;HDAC2;MEGF8
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.7366533900916291,1.5982134122904557,0.02037617554858934,0.36467210473477407,1.0,3/12,6.66%,GDNF;SOX9;AGT
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.5370998194633052,-1.5932407698632396,0.021806853582554516,0.8541040202891698,1.0,5/19,11.00%,PRKCD;IRS2;IRS1;ABCD2;AKT2
prerank,arachidonic acid metabolic process (GO:0019369),0.6009224453653866,1.592879459373226,0.02127659574468085,0.3832947684839759,1.0,11/35,15.23%,ALOXE3;CBR1;PTGES2;PLA2G4A;HPGDS;PTGDS;PTGES3;GPX4;TBXAS1;CYP2A6;PNPLA8
prerank,negative regulation of biomineral tissue development (GO:0070168),0.6576565534340434,1.5905514304609467,0.01925925925925926,0.3893695112546869,1.0,5/21,7.92%,CCL3;SRGN;SOX9;TRPM4;PTK2B
prerank,skeletal muscle tissue development (GO:0007519),0.6140097357403058,1.5896361062154585,0.013175230566534914,0.38955440745827424,1.0,6/32,12.46%,EGR2;LEMD2;POPDC3;MYL6;IGSF8;CFLAR
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.7518927311054923,1.5878046607547185,0.029556650246305417,0.3934476303148486,1.0,4/11,5.39%,MYC;PDGFA;SOX9;TGFBR2
prerank,negative regulation of platelet activation (GO:0010544),0.6708332741627651,1.5869213115134129,0.032448377581120944,0.39386310814988595,1.0,4/16,6.44%,CD9;PDGFA;APOE;PDGFB
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.6542436487806592,1.5869175749716204,0.024079320113314446,0.3872875740666203,1.0,4/21,12.16%,GDNF;BCL2L1;IL1A;EYA2
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.6542436487806592,1.5869175749716204,0.024079320113314446,0.3872875740666203,1.0,4/21,12.16%,GDNF;BCL2L1;IL1A;EYA2
prerank,response to growth factor (GO:0070848),0.5859513327131427,1.586893348917019,0.011056511056511056,0.3841125542199768,1.0,14/41,17.49%,MYC;EPHA2;HDAC6;TGFBR1;TGFBR2;PDGFB;ACVR1B;CTNNB1;ACVR2B;SOX2;TBC1D7;HTRA2;ACVR1;CPNE3
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.7407350345225836,1.5850080513781388,0.020602218700475437,0.3882275083989189,1.0,5/12,11.76%,BASP1;MYO1E;KLF15;JAG1;PTPRO
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.6910953192223487,1.584398013514009,0.028875379939209727,0.3874151423759133,1.0,11/15,21.54%,ZFP36;TOB1;BTG2;CNOT7;POLR2G;TNRC6C;CNOT1;TENT4A;AGO2;TNRC6A;CPEB3
prerank,positive regulation of defense response (GO:0031349),0.5301750913947534,1.5826499904743032,0.0045045045045045045,0.39148743554636417,1.0,19/89,12.75%,CCL3;OSM;LPL;ADAM8;SERPINE1;GPSM3;NFKBIZ;NINJ1;AGT;POLR3B;DHX9;TLR7;IL17RA;AKIRIN2;IL18;POLR3F;APP;OPTN;TNIP1
prerank,autophagy of nucleus (GO:0044804),-0.5553788922419899,-1.5804585687626747,0.025889967637540454,0.9006673871696571,1.0,10/16,24.18%,ULK2;WDR45B;ATG5;RB1CC1;ATG12;ATG2B;ULK1;ATG2A;ATG7;ATG9A
prerank,regulation of DNA biosynthetic process (GO:2000278),0.6264202515494851,1.5796621364145125,0.01881720430107527,0.40073170696006816,1.0,8/27,9.57%,MYC;PDGFRB;PRKD2;PDGFA;PDGFB;PARP4;SMOC2;TOM1L1
prerank,regulation of T cell activation (GO:0050863),0.5665166360483609,1.5789012673642049,0.02132701421800948,0.4008360546716031,1.0,15/42,20.63%,CCL2;PRELID1;SIRPA;CYRIB;PYCARD;TNFAIP8L2;TNFRSF1B;PAG1;HSPD1;KAT2A;GPNMB;DUSP3;CCDC88B;THY1;METTL3
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.6359596816368516,1.5780277132530705,0.019662921348314606,0.4009720010568672,1.0,4/23,6.66%,GDNF;WNT5B;SOX9;AGT
prerank,import into cell (GO:0098657),0.5784148504803668,1.5759879197965292,0.01373283395755306,0.40554338338952234,1.0,13/41,15.43%,SLC7A5;SLC7A1;SLC39A14;SLC22A4;LRRC8D;SLC29A1;SLC1A3;SLC6A6;SLC12A6;SLC36A1;SLC38A1;SLC5A3;NEURL1B
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.657285213969428,1.575477076918756,0.017341040462427744,0.4045519783068691,1.0,8/20,10.92%,SESN2;NFE2L2;ATF4;CHD6;RELA;CREB3;RUNX2;RBPJ
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.5258661933147879,1.5745507617790298,0.0043859649122807015,0.40520002458709853,1.0,22/95,13.83%,LTBP4;BAMBI;ADAM17;SKIL;HSP90AB1;PIN1;SNX6;TGFBR1;TGFBR2;RPS27A;UBC;PEG10;SDCBP;ZBTB7A;SMURF1;LATS1;SIRT1;ENG;CREBBP;STUB1;LEMD3;SKOR2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.681585888970366,1.5738354484371992,0.025373134328358207,0.40498395938384224,1.0,7/16,15.71%,BCKDK;ADIPOR1;SIRT1;SCARB2;PDK3;RORA;FOXK2
prerank,negative regulation of neuron death (GO:1901215),0.519024425256082,1.5730700431716216,0.003260869565217391,0.40502707858447884,1.0,31/93,20.18%,GDNF;CCL2;AGAP2;CSF1;ADAM8;ATP13A2;SNX6;ATF4;APOE;CD200R1;PTK2B;SET;PPT1;SORL1;BDNF;CD200;VPS35;WFS1;TNFRSF1B;MAG;BTBD10;SOD2;HTRA2;GPNMB;INPP5A;MEF2C;KDM2B;NTRK2;NRBP2;SNCA;FBXO7
prerank,epidermal cell differentiation (GO:0009913),0.5915165790026545,1.5729192627135027,0.013079667063020214,0.4025380086081645,1.0,8/41,10.23%,SPRR1A;EPHA2;ADAM9;CLIC4;JAG1;CTNNB1;HDAC1;ERCC2
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.6264050601285176,-1.571866493704703,0.023255813953488372,0.9185044148691246,1.0,5/12,16.55%,CALM2;CALM1;SRI;PDE4D;CALM3
prerank,skeletal muscle contraction (GO:0003009),0.6655899531155665,1.5718121021141926,0.02556818181818182,0.4040874682235409,1.0,3/19,10.68%,TNNI2;STAC;STAC2
prerank,necroptotic process (GO:0070266),-0.5761775899661984,-1.5711815403551292,0.03757225433526012,0.8845559723031842,1.0,9/16,20.26%,CYLD;ITPK1;LY96;RIPK1;TLR3;IPMK;DNM1L;TLR4;PGAM5
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.6063575930950849,-1.5697263878585472,0.028720626631853787,0.859050638028091,1.0,5/13,14.80%,KCNN2;KCNJ3;CACNA1C;ANK2;CACNB2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.7615911331533203,1.5689806952054128,0.02090032154340836,0.41286053468437256,1.0,7/11,18.21%,ATF3;CREB3L1;ATF4;HSPA5;ATF6;DDIT3;CEBPB
prerank,carbohydrate transport (GO:0008643),0.728391759678465,1.5671187525652441,0.03814262023217247,0.4172126280179126,1.0,2/11,2.29%,SLC23A2;SLC23A1
prerank,response to zinc ion (GO:0010043),0.6244276737643037,1.566259324323246,0.026881720430107527,0.4175724746855276,1.0,10/25,7.54%,ATP13A2;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B;CRIP1
prerank,prostaglandin biosynthetic process (GO:0001516),0.6699305535670261,1.5644118080351401,0.03115727002967359,0.42199485691726385,1.0,8/18,15.23%,CBR1;PTGES2;PLA2G4A;HPGDS;PTGDS;PTGES3;TBXAS1;PNPLA8
prerank,regulation of defense response to virus (GO:0050688),0.7000749460328879,1.5615852993903039,0.03162650602409638,0.43061159227526896,1.0,10/14,19.69%,C1QBP;DHX9;PCBP2;TRAF3IP1;ILRUN;TRAF3;TNFAIP3;PPM1B;RNF216;ITCH
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.7519789682962918,1.5611934322261907,0.025210084033613446,0.42914902298534974,1.0,5/10,17.55%,NFKBIZ;NFKBID;RC3H1;RC3H2;ZC3H12A
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.6958927215615524,1.5601157560301144,0.03278688524590164,0.4304533780617968,1.0,3/14,10.94%,CSF1;TYROBP;ATP6AP1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.6068747504071166,1.559554527544738,0.030013642564802184,0.4298299001293167,1.0,8/27,12.34%,MYC;PDGFA;PDGFB;AGT;DHX9;CDK6;DDR2;IGF1
prerank,myeloid dendritic cell activation (GO:0001773),0.7307530817934869,1.558627245809828,0.03343465045592705,0.43035125949199715,1.0,5/12,12.28%,SLAMF1;HMGB1;TGFBR2;PYCARD;DOCK2
prerank,regulation of mRNA stability (GO:0043488),0.49834690534040005,1.5572201785985242,0.003134796238244514,0.43305562146073523,1.0,35/145,11.81%,GDNF;MAPKAPK2;DIS3;DCP1A;ZFP36;TENT5C;FUS;HNRNPD;PSMD2;HNRNPU;PSMC4;RIDA;FXR2;PSMD4;PSMD1;HSPA8;RPS27A;UBC;TAF15;PCID2;PSME3;SET;PSMB6;PSMD10;SAMD4B;EXOSC8;PUM2;PSMB1;RC3H1;YBX1;GIGYF2;PSMD11;RC3H2;PSMA2;PSMD13
prerank,regulation of integrin activation (GO:0033623),0.6891145382300912,1.5571860076831407,0.028358208955223882,0.430186506794247,1.0,3/15,3.36%,SELP;PLEK;FBLIM1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.4974741850553664,1.554239684180615,0.0010416666666666667,0.440136857477598,1.0,29/151,13.91%,CCL3;CCL4;CCL2;SERPINF2;PDGFRB;SLAMF1;PRKD2;PDGFA;HMGB1;MAP2K7;MAP2K1;APOE;GLIPR2;PDGFB;GPR183;CARD9;PTK2B;HTR2C;P2RY1;PRKCZ;PTPRC;PYCARD;ARRB1;ATP6AP1;APP;CCL25;CCL13;ROR1;GCNT2
prerank,C21-steroid hormone metabolic process (GO:0008207),0.6480891282668675,1.5538821908809004,0.027932960893854747,0.43867916983033023,1.0,3/20,10.65%,FDX1;STARD3;STARD3NL
prerank,cellular response to tumor necrosis factor (GO:0071356),0.49584865861949656,1.5512265474076035,0.0,0.44721068458266894,1.0,44/175,15.39%,CCL3;CCL4;CCL2;ADAMTS12;NFE2L2;LTBR;ADAM17;ZFP36;INPP5K;ACOD1;PSMD2;TNFSF13B;PSMC4;IKBKB;RELA;PSMD4;TANK;PSMD1;ERBIN;PSME3;GSDME;DHX9;PTK2B;PSMB6;PSMD10;SIRT1;PYCARD;PSMB1;TMSB4X;PSMD11;PYDC1;TXNDC17;PSMA2;PSMD13;YBX3;CCL25;PSMB10;FOXO3;CCL13;TRAF3;LIMS1;SMPD4;PSMB3;TNFRSF1B
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5875131624322898,1.5510116173446844,0.03580901856763926,0.4451303540544412,1.0,6/33,8.74%,EGR1;STAT3;JUN;RELA;PDGFB;SPI1
prerank,RNA stabilization (GO:0043489),0.5892240211854363,1.5502111881277247,0.02937420178799489,0.44567920157992186,1.0,5/33,5.55%,GDNF;TENT5C;FUS;HNRNPU;TAF15
prerank,regulation of steroid biosynthetic process (GO:0050810),0.7304478657522301,1.549649645959635,0.04051863857374392,0.4450544787579637,1.0,4/11,12.62%,BMP5;EGR1;SIRT1;DGKQ
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.6117466794734849,1.5464034778841647,0.022099447513812154,0.4556278929415244,1.0,10/27,16.12%,SLC7A5;SLC7A1;ARL6IP5;SLC3A2;SLC25A13;SLC1A3;SLC1A1;SLC38A1;SLC6A5;SLC36A4
prerank,T cell migration (GO:0072678),0.708921401299903,1.5449794738860194,0.04134762633996937,0.4585985171968403,1.0,6/13,17.87%,CCL3;GPR183;MSN;CXCL16;S1PR1;PIK3CG
prerank,rRNA pseudouridine synthesis (GO:0031118),0.7428416672319222,1.5448385950198689,0.032362459546925564,0.4561077907693396,1.0,1/10,0.08%,RPUSD2
prerank,regulation of osteoclast differentiation (GO:0045670),0.5913878944599,1.5435176217667865,0.02099737532808399,0.45855376616820775,1.0,2/33,0.59%,CCL3;CSF1
prerank,regulation of biosynthetic process (GO:0009889),0.7267546113183821,1.5419963603037925,0.026604068857589983,0.46201571267242,1.0,3/11,8.91%,THRSP;MID1IP1;SLC25A33
prerank,modulation by symbiont of host process (GO:0044003),0.7265152372561232,1.5394969713859437,0.03594771241830065,0.47048963200932986,1.0,3/10,5.42%,PGK1;RPS27A;UBC
prerank,positive regulation of phosphatase activity (GO:0010922),0.6300625457909296,1.5379426895818382,0.05182072829131653,0.4739782405955267,1.0,4/21,2.96%,PDGFRB;PPP1R15B;PLEK;HSP90AB1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.6960991517315671,1.5377586942261274,0.03492063492063492,0.4716281133997753,1.0,10/13,21.54%,ZFP36;TOB1;BTG2;CNOT7;POLR2G;TNRC6C;CNOT1;AGO2;TNRC6A;CPEB3
prerank,regulation of oxidative phosphorylation (GO:0002082),0.6733724929928919,1.5369834401179174,0.04105571847507331,0.47204167215910625,1.0,5/16,10.62%,SHMT2;NUPR1;COX7A2;SLC25A33;COX7A2L
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.7140101879943598,1.5366709708147552,0.03852080123266564,0.4707216335048615,1.0,3/12,10.65%,FDX1;STARD3;STARD3NL
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.6358871277640417,1.5343543653904061,0.03156384505021521,0.47880023667744975,1.0,6/21,4.76%,CHST11;BCAN;CHPF;NCAN;CHST12;CSPG4
prerank,regulation of water loss via skin (GO:0033561),0.6872318463855382,1.5339170595831255,0.03193033381712627,0.47482765398911847,1.0,2/15,2.47%,ALOXE3;LSR
prerank,establishment of skin barrier (GO:0061436),0.6872318463855382,1.5339170595831255,0.03193033381712627,0.47482765398911847,1.0,2/15,2.47%,ALOXE3;LSR
prerank,dendritic cell chemotaxis (GO:0002407),0.6973178075125809,1.5328848579605967,0.04035874439461883,0.4762821764969683,1.0,6/14,11.95%,CXCR4;HMGB1;TRPM4;GPR183;CCR5;TRPM2
prerank,anion transmembrane transport (GO:0098656),0.5307198331654202,1.5321506344593796,0.012716763005780347,0.47698262163457156,1.0,21/67,17.61%,SLC7A5;SLC6A8;SLC7A1;ARL6IP5;SLC23A2;SLC23A1;LRRC8D;ABCC5;SFXN2;SLC3A2;SLC39A8;SLC25A13;SLC1A3;SLC25A21;SLC1A1;SLC25A5;SLC6A5;SLC36A4;SLC16A7;MFSD12;SLC25A14
prerank,positive regulation of bone resorption (GO:0045780),0.7147602349218365,1.5314653800663585,0.040257648953301126,0.4770814468587466,1.0,4/11,15.80%,ADAM8;SPP1;ATP6AP1;PLEKHM1
prerank,regulation of interleukin-17 production (GO:0032660),0.5833139429004619,1.5310248530550439,0.026143790849673203,0.4762193735295206,1.0,7/31,10.93%,OSM;SLC7A5;CARD9;ZBTB7B;PRNP;IL18;LY9
prerank,response to organic cyclic compound (GO:0014070),0.5530426519554404,1.530895088569856,0.013002364066193853,0.4739770888503694,1.0,9/52,12.37%,CCL3;CCL2;STAT3;ARL6IP5;SPP1;CTNNB1;IL18;TRPM2;SLC1A1
prerank,oligosaccharide metabolic process (GO:0009311),-0.4167482564872178,-1.5298116394794448,0.018292682926829267,1.0,1.0,20/46,24.72%,FUT9;ST3GAL2;MANBA;ST6GALNAC3;ST6GALNAC4;NEU1;B4GALT1;ST6GAL2;ST8SIA1;ST3GAL4;IDUA;MAN2B2;B3GALT5;AMY1A;AMY1C;AMY1B;ST8SIA5;B3GALT1;GLA;ST8SIA3
prerank,epithelial cell migration (GO:0010631),-0.43662511260627135,-1.5295692053420291,0.028037383177570093,1.0,1.0,20/37,32.45%,RHOA;STAT1;LPXN;PXN;ANLN;KANK1;FSTL1;STARD13;NRP1;PKN2;KANK2;KIT;TESK1;TNFSF12;ABL1;DPP4;ROCK1;ZEB2;PLEKHG5;FAP
prerank,vasculogenesis (GO:0001570),0.5817416017399943,1.5283624350976508,0.02313624678663239,0.4824102164775031,1.0,5/32,8.66%,CCM2;PDGFRB;TGFBR2;GLMN;ENG
prerank,cellular response to alkaloid (GO:0071312),-0.5484702761148575,-1.5271555020539114,0.04516129032258064,1.0,1.0,8/17,27.93%,SPIDR;BLM;SLC8A1;CASP7;TGM2;CASP3;RYR3;CASP6
prerank,regulation of epithelial cell proliferation (GO:0050678),0.5109918209865846,1.5257138366640737,0.007641921397379912,0.49110768608911604,1.0,19/85,16.54%,MYC;BMP5;NR4A1;ZFP36;SGPP2;SOX9;NUPR1;NLRC3;CDK6;TCF7L2;BMP6;SOX2;BAD;HPN;IGF1;LIMS1;EPB41L4B;PAX2;FGF9
prerank,regulation of mononuclear cell migration (GO:0071675),0.6162052310669457,1.5251152785814224,0.04160887656033287,0.4907963452856784,1.0,6/23,9.52%,BMP5;CSF1;IL34;CMKLR1;CXCL17;MSN
prerank,signal peptide processing (GO:0006465),0.7192147714132172,1.524368705788196,0.029641185647425898,0.4913169059022787,1.0,5/11,8.78%,CLN5;SEC11A;SPPL3;HM13;FURIN
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.713421953294049,1.5243253282389602,0.04134762633996937,0.4886949073410886,1.0,2/12,3.49%,CCL3;NUPR1
prerank,negative regulation of cell division (GO:0051782),0.7303205398380265,1.523947753901103,0.03064516129032258,0.48747567493483773,1.0,2/11,1.71%,MYC;VPS4A
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.6911740979067791,1.5234176310233765,0.03656597774244833,0.4870964304806362,1.0,5/13,14.37%,TM9SF4;BRSK2;SORL1;SAR1B;TMEM30A
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.6283797577001015,1.522803359798267,0.029411764705882353,0.4870309937365284,1.0,6/22,16.23%,RAB7B;ACOD1;NINJ1;WDFY1;FLOT1;TNFAIP3
prerank,regulation of monooxygenase activity (GO:0032768),0.6154525009787857,1.5222716223851873,0.02997275204359673,0.48661711903124816,1.0,7/23,12.02%,GDNF;NOSIP;DNM2;POR;IL1A;ZDHHC21;DDAH2
prerank,negative regulation of defense response to virus (GO:0050687),0.7405111862109892,1.522268393612409,0.03902439024390244,0.4838892000034222,1.0,7/10,19.69%,C1QBP;TARBP2;PCBP2;TRAF3IP1;ILRUN;PPM1B;ITCH
prerank,programmed necrotic cell death (GO:0097300),-0.5358998344263873,-1.5219140806924603,0.03614457831325301,1.0,1.0,9/18,20.26%,CYLD;ITPK1;LY96;RIPK1;TLR3;IPMK;DNM1L;TLR4;PGAM5
prerank,cellular transition metal ion homeostasis (GO:0046916),0.5130828966790338,1.521712961034512,0.007518796992481203,0.4836028399380966,1.0,31/91,15.96%,MYC;SLC39A14;ATP6V1A;ATP6V0D1;ATP13A2;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B;SLC39A8;SLC22A17;CAND1;BMP6;PRNP;GLRX3;NEDD8;ATP6AP1;FBXL5;SLC31A1;SLC30A5;APP;ABCB7;COX19;SLC11A1;SKP1;MT2A;TMPRSS6
prerank,amyloid-beta metabolic process (GO:0050435),-0.5437786291434673,-1.5214977238216083,0.0627062706270627,1.0,1.0,11/16,25.30%,PSEN1;NCSTN;PSEN2;ABCA7;BACE1;MME;MGAT3;APH1A;APEH;PSENEN;BACE2
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5166661837882487,1.5196737322326241,0.013729977116704805,0.4894186261956518,1.0,21/74,17.44%,GDNF;BMP5;BCL2L1;SIAH2;SERPINE1;RELA;TGFBR1;FAIM2;PSME3;IL1A;TCF7L2;PELI3;BIRC6;EYA2;IGF1;CFLAR;RNF34;TNFAIP3;ARHGEF2;ICAM1;ACVR1
prerank,fat cell differentiation (GO:0045444),0.5321986871466822,1.518332931211239,0.01875732708089097,0.49254263822098177,1.0,13/57,10.29%,EGR2;ALOXE3;TFAP2B;NR4A1;CTBP2;WNT5B;CLIP3;ZBTB7A;BBS4;METRNL;TCF7L2;SIRT1;OSBPL8
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.5570441274723019,1.516619985922907,0.03245942571785269,0.49719210721966567,1.0,12/40,15.13%,MYC;WRNIP1;PARG;KMT5A;RADX;FXR2;IER3;CASP9;RFWD3;FMR1;NSMCE1;ETAA1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.4397387701106686,-1.5165062264663611,0.02586206896551724,1.0,1.0,13/32,19.49%,RHOA;PIK3C2A;PDCD10;NOTCH1;AKT3;STARD13;MAP3K3;HMOX1;HDAC7;HDAC9;ITGB1BP1;FGF2;VEGFA
prerank,protein targeting to lysosome (GO:0006622),0.642589585583439,1.5146308116834943,0.02442528735632184,0.5033363014813302,1.0,9/20,14.11%,GNPTAB;NCOA4;VPS4A;HSPA8;SORL1;ZFYVE16;SCARB2;CLU;NAGPA
prerank,water-soluble vitamin metabolic process (GO:0006767),0.5161298540963051,1.5143511008328363,0.018411967779056387,0.501784944800847,1.0,14/68,13.45%,SLC52A2;MMACHC;SHMT2;PDZD11;SLC23A2;SLC23A1;MTHFD1L;MTHFD2;PDXK;GSTO2;TCN2;FPGS;PCCA;SLC2A1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.47756450317235405,-1.5139770981195562,0.05078125,0.9986487244756852,1.0,16/25,24.51%,ARHGAP44;ODF2L;ABI3;PRKCD;CCP110;CDK10;KANK1;EVL;STAP1;SLIT2;LIMK2;RAP1GAP;TCHP;PFN2;TESK1;PLXNB3
prerank,embryonic appendage morphogenesis (GO:0035113),-0.6085700977948963,-1.5119573463633316,0.04032258064516129,0.9821305459099529,1.0,4/12,8.75%,LRP6;PTCH1;MBNL1;MEGF8
prerank,platelet aggregation (GO:0070527),0.5869857862266924,1.5116763304578908,0.02368421052631579,0.5106011089439876,1.0,13/33,17.87%,MYL12A;MYH9;PLEK;FIBP;GNAS;ITGB3;ACTG1;STXBP3;FLNA;ACTB;METAP1;ILK;PIK3CG
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.5177613763971493,1.51100885232431,0.02508551881413911,0.5108070535679121,1.0,19/69,19.26%,GDNF;CCL2;AGAP2;ADAM8;SNX6;APOE;PTK2B;SET;PPT1;BDNF;ZPR1;WFS1;MAG;NONO;SOD2;MEF2C;KDM2B;NTRK2;NRBP2
prerank,proteoglycan metabolic process (GO:0006029),0.6093267494654478,1.5109165116843581,0.03230148048452221,0.5084731911293381,1.0,10/26,16.46%,ADAMTS12;CHST11;CHST12;FAM20B;XYLT1;IGF1;CSGALNACT1;SULF2;B4GALT7;HS3ST4
prerank,L-amino acid transport (GO:0015807),0.5955917318184099,1.5107295389578657,0.02680965147453083,0.5065820554500435,1.0,8/28,12.37%,SLC7A5;SLC7A1;ARL6IP5;SLC3A2;SLC25A13;SLC1A3;SLC36A1;SLC1A1
prerank,regulation of microglial cell activation (GO:1903978),0.6658820465742504,1.5088769010269216,0.037091988130563795,0.5119882313584643,1.0,4/15,15.03%,CCL3;PTPRC;CST7;IL6
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.6348997409992315,1.5084365378218687,0.05007153075822604,0.5114823471674114,1.0,5/18,16.42%,MYC;NLRC3;PARP10;MED25;B4GALT7
prerank,regulation of tumor necrosis factor production (GO:0032680),0.49668800664515705,1.5075921046718295,0.004333694474539545,0.5126929120695035,1.0,24/112,13.68%,CCL3;MAPKAPK2;STAT3;SLAMF1;LPL;ZFP36;FZD5;TYROBP;HMGB1;ARFGEF2;SIRPA;NLRC3;FOXP1;DHX9;IL1A;PTPRC;PYCARD;PTPN6;CD33;CLU;IGF1;APP;C5AR2;ILRUN
prerank,regulation of calcium ion transport (GO:0051924),0.5282509042235138,1.5032407192769492,0.018779342723004695,0.5295220096504114,1.0,11/54,14.27%,CCL3;CCL4;CRACR2A;CD84;INPP5K;CACNA2D1;CAMK2G;CTNNB1;CD33;SARAF;WFS1
prerank,ureteric bud development (GO:0001657),-0.5323371663217288,-1.5006135176181978,0.06336088154269973,1.0,1.0,6/17,18.64%,SALL1;NPNT;FGFR2;ROBO2;PKD2;SLIT2
prerank,response to interferon-gamma (GO:0034341),0.5158356453486571,1.4999025201727594,0.013745704467353952,0.5419920117521523,1.0,14/67,15.84%,CCL3;CCL4;CCL2;ACOD1;RPL13A;SIRPA;IFITM3;GCH1;IRF8;CCL25;CCL13;CXCL16;SLC11A1;DAPK1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.4968173767957097,1.4993494997728654,0.00755939524838013,0.5416982763937481,1.0,29/101,18.76%,CCL3;CCL2;CD180;ZFP36;SERPINE1;ACOD1;HMGB1;NLRP3;ADAM9;RELA;SBNO2;SIRPA;IL1A;MAPK8;PYCARD;CARD16;IL18;CCR5;MTDH;IL6;TNFRSF1B;CD86;TNFAIP3;NFKB1;ZC3H12A;CTR9;UPF1;MEF2C;HCK
prerank,negative regulation of axonogenesis (GO:0050771),0.5852099290089661,1.4985394652330053,0.04183535762483131,0.5427183117933215,1.0,7/27,8.29%,SEMA3G;ARHGDIA;CDKL3;FGF13;RUFY3;RTN4;LRP4
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.51040744715648,1.4979422632130341,0.02252252252252252,0.5424986918419118,1.0,22/74,18.20%,BMP5;BAMBI;TGFBR1;TGFBR2;ADIPOR1;COL1A1;GLIPR2;USF3;SDCBP;PHLDB1;CTNNB1;HPN;EPHA3;GCNT2;MTOR;IL6;WWTR1;SMAD3;DAG1;EZH2;TIAM1;LDLRAD4
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.5724081511751572,-1.4974310950148924,0.04597701149425287,1.0,1.0,6/13,12.28%,CBL;TSG101;SOCS5;ZFYVE28;ERRFI1;ZGPAT
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5895577600087932,1.4964132046821177,0.055782312925170066,0.5470138068627354,1.0,2/26,1.33%,GDNF;BCL2L1
prerank,blood circulation (GO:0008015),-0.4047261224627148,-1.495642321600952,0.0457516339869281,1.0,1.0,17/49,28.96%,SGCZ;STAT1;ROCK2;SGCD;TBC1D8;GCLM;GUCY1B1;SOD1;ITGB1BP1;ACVRL1;MYOF;GPX1;CYB5R3;OLR1;ADCY6;ROCK1;GUCY1A1
prerank,retinoic acid metabolic process (GO:0042573),0.6777768339606943,1.4946205553593341,0.060431654676258995,0.5527583410795814,1.0,2/14,6.22%,ALDH8A1;SCPEP1
prerank,regulation of fibroblast proliferation (GO:0048145),0.5415436594996307,1.4943176899192414,0.0343980343980344,0.5513229759482737,1.0,13/45,16.42%,MYC;PDGFA;PDGFB;AGT;NLRC3;DHX9;CDK6;PARP10;CTNNB1;DDR2;IGF1;MED25;B4GALT7
prerank,positive regulation of T cell cytokine production (GO:0002726),0.6261768476095542,1.4934295886227222,0.06318681318681318,0.5527407764002898,1.0,8/20,15.03%,IL1R1;FZD5;NLRP3;CD55;PRKCZ;IL18;DENND1B;IL6
prerank,positive regulation of exosomal secretion (GO:1903543),0.6589471626378215,1.4917605101791118,0.055964653902798235,0.5578707650862978,1.0,7/15,9.05%,VPS4A;ATP13A2;PDCD6IP;SDC4;SDCBP;SMPD3;STAM
prerank,ethanol metabolic process (GO:0006067),0.6796420150102396,1.4913637484958173,0.05451713395638629,0.5570848193274879,1.0,4/12,12.71%,ALDH1B1;ALDH2;ALDH1A1;ADH5
prerank,response to endoplasmic reticulum stress (GO:0034976),0.49087450308245,1.491183755200524,0.010672358591248666,0.5551558796675534,1.0,30/107,15.62%,ATF3;BAG6;PPP1R15B;CREB3L1;TMEM33;JUN;NCK1;ERLEC1;MBTPS1;ATF4;ERP27;SEL1L;EIF2S1;RASGRF1;PIK3R1;QRICH1;CASP4;BRSK2;EIF2AK3;USP19;UFL1;HSPA5;DERL1;P4HB;GORASP2;WFS1;CCDC47;ATF6;HYOU1;FLOT1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.49445682733054314,1.4903089973491337,0.010752688172043012,0.5564757417553063,1.0,22/104,13.83%,BAMBI;ADAM17;SKIL;LEMD2;PIN1;SNX6;TGFBR1;TGFBR2;RPS27A;UBC;PEG10;ZBTB7A;CRIM1;SMURF1;UBE2D1;SORL1;SIRT1;UBE2D3;ACVR2B;STUB1;LEMD3;SKOR2
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.6576789236751054,1.490254664734477,0.05368098159509203,0.554016721570703,1.0,5/15,10.68%,CSF1;LPL;PRKCH;AGT;IL18
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5508144630668749,1.489649434444434,0.03015075376884422,0.5542309162071117,1.0,16/40,17.86%,BAMBI;TGFBR1;TGFBR2;COL1A1;GLIPR2;SDCBP;JAG1;TCF7L2;CTNNB1;GCNT2;MTOR;IL6;WWTR1;SMAD3;EZH2;TIAM1
prerank,T-helper cell differentiation (GO:0042093),0.6579588142255401,1.4894008262194787,0.05598755832037325,0.5526870334501891,1.0,4/14,7.48%,TMEM98;HMGB1;GPR183;FOXP1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.5092915427910275,1.4880856325720546,0.026696329254727477,0.556279823236904,1.0,21/71,13.52%,BAG6;ADAMTS12;CTSB;CTSL;VPS4A;HDAC6;SOCS6;PDCD6IP;RPS27A;UBC;LONP1;HM13;OTUD7B;RSPRY1;ZRANB1;CHFR;NEDD8;FBXL17;DDB1;STUB1;IDE
prerank,negative regulation of myoblast differentiation (GO:0045662),0.6713607464152793,1.4876873400481607,0.057003257328990226,0.5553523891499738,1.0,3/13,4.82%,SOX9;PRICKLE1;EID2B
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.5207151191959445,-1.4875721811724534,0.05214723926380368,1.0,1.0,10/18,14.99%,DENND10;SNX12;MTMR2;MAP2K2;RDX;MAPK1;CHMP3;MAPK3;SRC;DAB2
prerank,artery morphogenesis (GO:0048844),0.572915321353338,1.4859278219526595,0.036734693877551024,0.5606890507500805,1.0,6/30,8.66%,PDGFRB;TFAP2B;TGFBR1;JAG1;LRP1;ENG
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.6809068470966345,1.4846805349730474,0.04675716440422323,0.564058789575789,1.0,6/12,15.46%,LAMA3;ZDHHC7;TRAF3IP1;ACTG1;SCRIB;ACTB
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.6891507000222946,1.4844628462538163,0.04953560371517028,0.5623567255833425,1.0,6/13,14.96%,DDX20;PRPF31;AAR2;SRSF10;SRSF12;SART3
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.6487563746946412,1.4839052791748857,0.060514372163388806,0.5622394825342818,1.0,3/13,5.51%,BMP5;PLEK;APOE
prerank,regulation of cytoplasmic transport (GO:1903649),-0.5988990047096394,-1.483801904693723,0.055710306406685235,1.0,1.0,8/11,13.42%,DENND10;MAP2K2;MAPK1;LRRK2;CHMP3;MAPK3;SRC;USP7
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.6363802978116748,1.4834358707055921,0.04899135446685879,0.5618002645737012,1.0,3/16,4.54%,SERPINF2;CREB3L1;LARP6
prerank,glycine metabolic process (GO:0006544),0.69256500088499,1.4830230600156873,0.055031446540880505,0.5610484366170091,1.0,2/12,3.61%,SHMT2;RIDA
prerank,sensory perception (GO:0007600),0.5379878691187987,1.482557163361017,0.03708133971291866,0.560662446760792,1.0,8/45,12.09%,KCNK4;CCL2;ALOXE3;PENK;GNAS;BBS4;TTC8;TRPV2
prerank,negative regulation of interferon-beta production (GO:0032688),0.7108658873595084,1.4803557618584933,0.06935483870967742,0.5680568539448764,1.0,4/10,9.33%,RELB;SIRPA;NLRC3;PYCARD
prerank,peptide cross-linking (GO:0018149),0.6011548721182672,1.4795452975765804,0.046052631578947366,0.5689300483058655,1.0,1/25,0.07%,SPRR1A
prerank,xenobiotic transport (GO:0042908),0.629224264876662,1.4771325580703873,0.06593406593406594,0.577190175106242,1.0,3/17,4.44%,SLC7A5;SLC22A4;ABCC5
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.6365454383748701,1.4766815484723093,0.0680786686838124,0.5765188022742839,1.0,6/15,15.04%,PRELID1;BCL2L1;PSMD10;CLU;IGF1;HGF
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.632993428388226,1.4763303497470077,0.060294117647058824,0.5755074878312528,1.0,3/17,2.65%,EGR3;NR4A1;PIK3R3
prerank,cellular response to fatty acid (GO:0071398),0.6613208448800488,1.4763285590825967,0.06366459627329192,0.5729198303729058,1.0,2/12,1.49%,KCNK4;LPL
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.5163965191640346,1.4757229933623057,0.026936026936026935,0.5730611136857642,1.0,18/62,17.28%,RTKN2;BCL2L1;NFE2L2;CREB3L1;PLAUR;PTTG1IP;CREB3;BCL2L2;SIRT1;DNAJA1;TMBIM6;CLU;YBX3;NDUFA13;HYOU1;SOD2;ARHGEF2;HTRA2
prerank,negative regulation of neuron differentiation (GO:0045665),0.6041327675319527,1.4748009689466612,0.04447632711621234,0.574898698685108,1.0,7/22,17.96%,DISP3;SOX9;SOX2;NEPRO;MED1;CNTN4;CALR
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.6084323337725407,-1.4744916934172936,0.07065217391304347,1.0,1.0,7/11,30.66%,MERTK;GAS6;SELENOS;LILRB1;NOD2;IRF7;HCLS1
prerank,metanephros development (GO:0001656),0.5896786746591949,1.4736186939114408,0.05563093622795115,0.5780887248444595,1.0,2/26,0.53%,GDNF;BASP1
prerank,intermediate filament organization (GO:0045109),0.6252966868705364,1.473476119600363,0.05611510791366906,0.5762121694933788,1.0,2/17,6.07%,GFAP;MTM1
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.7021681104354652,1.473182836468129,0.05124223602484472,0.5749751293020495,1.0,1/12,0.13%,BMP5
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.5646600507022665,-1.4729129446472047,0.055865921787709494,1.0,1.0,7/13,28.27%,NAGK;RENBP;MGAT3;PGM3;EXTL2;CHST7;CHST3
prerank,positive regulation of telomerase activity (GO:0051973),0.5537019217076324,1.4723681688291421,0.041343669250646,0.5764780370706014,1.0,9/33,9.75%,MYC;NEK7;ACD;HSP90AB1;MAP2K7;XRCC5;PTGES3;NVL;CTNNB1
prerank,negative chemotaxis (GO:0050919),0.5701660785828697,1.4721812462354464,0.036458333333333336,0.5746285246092537,1.0,8/33,9.93%,SEMA3G;SEMA4G;PDGFA;SEMA6D;ITGB3;SEMA6A;UNC5C;SEMA4C
prerank,negative regulation of axon extension (GO:0030517),0.5723609083047523,1.4717981292841678,0.047058823529411764,0.5739610436129072,1.0,11/30,17.82%,SEMA3G;SEMA4G;CDKL3;SEMA6D;RTN4;SEMA6A;SEMA4C;PTPRS;MAG;SEMA3A;SEMA3D
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.4810007355823077,1.4711383392273523,0.00851063829787234,0.5744783821071806,1.0,21/113,12.34%,MYC;BMP5;EGR3;NR4A1;PRKD2;SOX9;EMC10;TGFBR1;RTN4;ITGB3;PDGFB;NRAS;VEGFC;TCF7L2;SIRT1;BMP6;F3;NRP2;BAD;HPN;IGF1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.6680691683010017,1.4703874738466711,0.05909090909090909,0.5751357479700528,1.0,5/14,12.60%,MAPKAPK2;ZFP36;TARDBP;ANGEL2;YBX3
prerank,negative regulation of cell activation (GO:0050866),0.6497014145222841,1.4699369136083777,0.06359300476947535,0.574685988979308,1.0,4/14,11.37%,PDGFA;APOE;PDGFB;CD200
prerank,regulation of glycogen metabolic process (GO:0070873),0.694109968070504,1.4693785640925907,0.05819295558958652,0.5748220363481861,1.0,2/12,2.61%,PPP1R3E;INPP5K
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5079608597828839,1.469064412969566,0.017142857142857144,0.5738826482890136,1.0,12/73,9.33%,CCL3;STAT3;LPL;ADAM8;FZD5;TYROBP;HMGB1;ARFGEF2;DHX9;IL1A;PTPRC;PYCARD
prerank,positive regulation of dendrite development (GO:1900006),0.705217547523497,1.4683944407726794,0.07086614173228346,0.5746956283775692,1.0,7/10,21.99%,BMP5;VLDLR;COBL;PTN;LRP8;DAB2IP;PACSIN1
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.5246856098668775,1.468326725621837,0.04042806183115339,0.57253153033638,1.0,19/52,15.34%,HDGF;ADD1;ATP6V0D1;TPP1;TATDN2;CXXC1;PPP2R5B;CTDSP2;TSPYL2;KLHDC3;GFPT1;PDIA6;ZBTB17;HSPA5;SSR1;WFS1;WIPI1;HYOU1;EDEM1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.6859864782147002,1.4681478069299656,0.057971014492753624,0.5709577993802859,1.0,5/11,13.60%,STAT3;ZFP36;DHX9;PUM2;FMR1
prerank,epithelial cell differentiation (GO:0030855),0.49053176335976056,1.4674969594143605,0.018162393162393164,0.5717070678682957,1.0,15/88,14.01%,KDM6B;BASP1;PGK1;CBR1;CTSB;TPP1;TAGLN2;PCNA;ZDHHC7;JAG1;LATS1;HDAC1;SCUBE1;SCRIB;ANXA7
prerank,response to molecule of bacterial origin (GO:0002237),0.5060237631516253,1.4673894347523317,0.02870264064293915,0.5698181681056792,1.0,13/69,11.25%,SELP;MAPKAPK2;ADAM17;FZD5;ACOD1;LIAS;C4B;ERBIN;FOXP1;IFNAR1;CYRIB;GCH1;SIRT2
prerank,myofibril assembly (GO:0030239),0.5381695684049241,1.4673123048305665,0.03615960099750624,0.5677754262205487,1.0,3/42,3.02%,WDR1;PDGFRB;FLII
prerank,epidermis development (GO:0008544),0.5205833958503229,1.4661911245278556,0.03428571428571429,0.5704980900114164,1.0,5/56,10.69%,SPRR1A;LAMA3;FLOT2;HDAC1;YBX1
prerank,positive regulation of intracellular transport (GO:0032388),-0.4099756345099157,-1.464475396886574,0.024154589371980676,1.0,1.0,24/38,32.52%,ICE1;NUMA1;PDCD10;TPR;TBC1D20;PRR5L;OAZ2;B3GAT3;PCNT;VAMP2;OAZ1;ZFAND1;BCAS3;STK11;CEP290;EHD1;ACTN2;CAPN10;RIPOR1;RAB29;PLA2G4E;NEDD4;MLC1;STX18
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.48430046750505895,-1.46293222373506,0.047619047619047616,1.0,1.0,7/24,11.08%,HSP90AA1;STAT1;TOMM70;PARP9;ZDHHC1;DTX3L;EIF2AK4
prerank,positive regulation of interleukin-4 production (GO:0032753),0.6370153724587226,1.462925529869316,0.06811594202898551,0.5827295937092424,1.0,5/17,18.21%,SLC7A5;NLRP3;PRKCZ;CD86;CEBPB
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.6141532297567619,1.4620251397338986,0.06461086637298091,0.584170860184957,1.0,9/19,12.34%,PIN1;PICALM;FLOT2;RTN4;APOE;SORL1;PRNP;CLU;IGF1
prerank,regulation of inflammatory response (GO:0050727),0.46094008757920985,1.4612014659815,0.0030737704918032786,0.5856473932725456,1.0,42/190,15.39%,CCL3;OSM;ADAMTS12;IL1R1;LPL;SERPINE1;ACOD1;GPSM3;NLRP3;NR1D2;NFKBIZ;SNX6;NINJ1;RELA;SBNO2;SIRPA;APOE;CASP4;CXCL17;AGT;NLRC3;FOXP1;DHX9;CD200R1;METRNL;TLR7;IL17RA;TNFAIP8L2;IL18;TMSB4X;UFL1;CD200;VPS35;APP;TNIP1;GPS2;BCL6;RORA;BRD4;IL6;AKNA;TNFRSF1B
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.45293619521082756,-1.4583652519821058,0.042801556420233464,1.0,1.0,16/25,28.39%,DENND10;TMEM50A;VPS4B;LAPTM4B;CHMP3;CHMP2B;LEPROTL1;MVB12A;CHMP1A;UBXN6;CHMP4B;CHMP4A;CHMP1B;CHMP7;LEPROT;CHMP2A
prerank,regulation of proteolysis (GO:0030162),0.5287907957126742,1.4583330252291162,0.04018912529550828,0.5960500107749122,1.0,17/48,19.69%,LTBP4;BAG6;PLAUR;FBXW11;HDAC6;DNAJC1;CLN8;ASPH;NEDD8;BAD;STUB1;TRAF3;IST1;TBC1D10A;SERPINE2;GSAP;ITCH
prerank,ribosomal small subunit assembly (GO:0000028),0.640789281559681,1.457470644995299,0.06607929515418502,0.5975470737925465,1.0,7/16,17.21%,RPS15;RRP7A;XRCC5;RPSA;MRPS7;RPS14;ERAL1
prerank,blood vessel morphogenesis (GO:0048514),0.5096651659480869,1.455183123238593,0.0407185628742515,0.6056805132823705,1.0,8/54,12.37%,CCM2;SERPINF2;TGFBR1;TGFBR2;GLMN;ENG;RBPJ;SLC1A1
prerank,serine family amino acid metabolic process (GO:0009069),0.6266752690222149,1.45406814108007,0.06821480406386067,0.6084899287691,1.0,3/16,3.87%,SHMT2;CDO1;SARS1
prerank,pseudouridine synthesis (GO:0001522),0.6610391564589764,1.4539207920989246,0.05365853658536585,0.6066300166328951,1.0,1/13,0.08%,RPUSD2
prerank,response to lipopolysaccharide (GO:0032496),0.4712262879221395,1.4537723891439185,0.007352941176470588,0.6049602087658464,1.0,23/138,10.16%,SELP;CCL2;MAPKAPK2;CD180;ADAM17;ZFP36;SERPINE1;ACOD1;HMGB1;LIAS;NLRP3;ADAM9;RELA;SBNO2;SIRPA;ERBIN;FOXP1;IFNAR1;IL1A;MAPK8;PYCARD;GCH1;CARD16
prerank,glucose metabolic process (GO:0006006),0.5101305272152524,1.45346422775181,0.03349282296650718,0.6038191056346507,1.0,9/58,6.77%,G6PC3;PGK1;TFAP2B;PGM1;SLC39A14;ATF4;APOD;MDH1;SLC25A13
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.5149315980567055,1.4532162160521753,0.04800936768149883,0.6025296862476823,1.0,16/52,11.80%,PNLDC1;LSM5;DIS3;DCP1A;ZFP36;EDC3;TUT7;CNOT8;CNOT6;SAMD4B;EXOSC8;DCP1B;RC3H1;CNOT4;RC3H2;CNOT7
prerank,diterpenoid metabolic process (GO:0016101),0.5148754916328026,1.4524239781777137,0.03248259860788863,0.6037620222718073,1.0,7/55,11.77%,PLB1;LPL;SDC4;APOE;LRP1;ALDH1A1;GPC5
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.6015975833808174,1.452135254132377,0.06611570247933884,0.6026595824985677,1.0,5/20,14.29%,CREB3L1;PRKD2;SMOC2;NPTN;SULF2
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.6700516111700806,1.45210364074303,0.08012820512820513,0.6004527527029341,1.0,4/12,4.76%,BCAN;NCAN;CHST12;CSPG4
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.5821793791339712,1.4510166042789858,0.058333333333333334,0.6028893570255317,1.0,5/24,7.72%,MYC;COQ10B;SLC25A13;MRAP2;GFPT1
prerank,cellular response to glucose starvation (GO:0042149),0.532680712592198,1.4508497493511454,0.04369538077403246,0.6014904832001297,1.0,16/41,18.47%,SESN2;BRSK1;ATF4;ITFG2;PIK3R4;PIK3C3;BRSK2;EIF2AK3;MTMR3;PRKAG1;HSPA5;FOXO3;HNRNPA1;PICK1;ZC3H12A;PRKAA1
prerank,monosaccharide transmembrane transport (GO:0015749),0.6388222249367264,1.4504501735313406,0.08284023668639054,0.6009800735007016,1.0,2/16,2.29%,SLC23A2;SLC23A1
prerank,regulation of neuroinflammatory response (GO:0150077),0.6194016920289931,1.449627898311306,0.06456241032998565,0.6022060469283463,1.0,8/19,18.19%,NUPR1;CD200R1;IL18;CD200;IGF1;IL6;TNFRSF1B;DAGLA
prerank,vasoconstriction (GO:0042310),-0.5927647473236735,-1.4495562631014227,0.09016393442622951,1.0,1.0,5/11,26.86%,PIK3C2A;SLC8A1;HTR2B;EDNRB;EDNRA
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.4313040945015423,-1.448718173868429,0.035555555555555556,1.0,1.0,10/34,16.55%,CALM2;ATP2A2;ANK2;CALM1;PRKACA;SLC8A1;SRI;PDE4D;ADRA1A;CALM3
prerank,regulation of stem cell population maintenance (GO:2000036),0.6179943693052614,1.4476946208499963,0.08625730994152046,0.6087084487091606,1.0,10/18,21.67%,MYC;TAF5L;WDR43;NCOA3;CNOT2;KAT2A;ELAVL1;CNOT1;PTN;REST
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.4738419900953421,-1.4468846851895785,0.066006600660066,1.0,1.0,8/20,16.15%,PSEN1;BCAP31;ATP2A2;PML;TMCO1;BAX;FIS1;TGM2
prerank,regulation of activated T cell proliferation (GO:0046006),0.5553983933788962,1.446642640035635,0.05394736842105263,0.6111030265855174,1.0,8/30,13.41%,HMGB1;PRNP;PYCARD;IL27RA;RC3H1;IL18;IGF1;SCRIB
prerank,positive regulation of glial cell differentiation (GO:0045687),0.6216880612139555,1.4462051540852732,0.0704647676161919,0.6108625560544535,1.0,3/17,2.92%,EGR2;CXCR4;IL34
prerank,striated muscle contraction (GO:0006941),0.5162711430795832,1.4447451940123388,0.043942992874109264,0.6153497053955008,1.0,7/53,10.68%,TNNI2;KCNH2;STAC;DTNA;ATP1B1;SCN1B;STAC2
prerank,response to fatty acid (GO:0070542),0.6104630267841819,1.444394807572647,0.08345534407027819,0.6146957764582129,1.0,3/17,3.29%,KCNK4;LPL;SOX9
prerank,smooth muscle contraction (GO:0006939),-0.5475690632211843,-1.443853039663266,0.08379888268156424,1.0,1.0,7/14,27.76%,PIK3C2A;ROCK2;SLC8A1;ADRA1A;TPCN2;EDNRA;ROCK1
prerank,positive regulation of collagen metabolic process (GO:0010714),0.6114158631056386,1.4437457440941792,0.0754985754985755,0.6153187675177061,1.0,3/17,4.54%,SERPINF2;CREB3L1;LARP6
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.6106764298100693,1.4432379521068177,0.06940509915014165,0.6153211274221374,1.0,5/20,9.93%,SEMA3G;SEMA4G;SEMA6D;SEMA6A;SEMA4C
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.49480125076089787,1.441459649229201,0.026726057906458798,0.6209168219688903,1.0,21/78,11.88%,EPHA2;BCL2L1;SQSTM1;VPS4A;AKAP5;CLIP3;PICALM;RHOG;PIK3R1;ZDHHC7;PRKCH;STAC;PPP2R5A;MRAP2;ZDHHC8;LRP1;STX3;CLTC;RHOQ;STAC2;EPHA3
prerank,cellular response to hydrogen peroxide (GO:0070301),0.5499125349305707,1.4403243608355267,0.05006587615283267,0.6237294162473556,1.0,13/33,16.23%,NFE2L2;HDAC6;OSER1;RELA;SIRPA;RHOB;SIRT1;TRPM2;RNF112;SETX;IL6;PAX2;TNFAIP3
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.41858052091841946,-1.4392822598968025,0.05855855855855856,1.0,1.0,13/34,20.38%,GRIN2B;GABRG3;GABRG2;GLRA1;LRRK2;GABRA5;GSK3B;GRIN1;GSK3A;GABRG1;INSYN2A;GABRA1;ARRB2
prerank,cellular response to growth factor stimulus (GO:0071363),0.46259727154416885,1.4377091303928597,0.006153846153846154,0.6331051095932433,1.0,38/151,18.98%,EGR3;CCL2;MAPKAPK2;ADAMTS12;NR4A1;ZFP36;PRKD2;KIDINS220;INPP5K;SOX9;MAP2K3;RELA;PTPN12;MT1G;TGFBR1;TGFBR2;PDGFB;SEMA6A;ACVR1B;BMP6;CTNNB1;RUNX2;ACVR2B;SIRT2;SETX;ZPR1;LIMS1;HGF;MED1;SYAP1;HTRA2;ACVR1;SMAD3;CPNE3;MEF2C;DUSP3;EEF1A1;NTRK2
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.529241162483793,1.4374153605901174,0.04310344827586207,0.6322416579777946,1.0,6/39,9.75%,GDNF;MYC;EPHA2;TGFBR2;ENG;CTNNB1
prerank,autophagy of peroxisome (GO:0030242),0.660137037857709,1.4370726458948133,0.08346456692913386,0.6314654309096761,1.0,4/12,8.73%,SQSTM1;PIK3R4;PIK3C3;MAP1LC3B
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5015869475712483,1.436880547193643,0.02088167053364269,0.6300847893862361,1.0,13/69,12.57%,CCL3;STAT3;LPL;FZD5;TYROBP;HMGB1;ARFGEF2;DHX9;IL1A;PTPRC;PYCARD;CLU;APP
prerank,striated muscle cell differentiation (GO:0051146),0.624918197791208,1.436696517730128,0.08558558558558559,0.6286377633426583,1.0,4/16,10.57%,KDM6B;PLD3;POPDC3;MYEF2
prerank,morphogenesis of an epithelium (GO:0002009),0.5688201241173778,1.4366685392667393,0.05737704918032787,0.6265384590098974,1.0,11/25,20.82%,SOX10;LAMA3;SOX9;LIN7C;TRAF3IP1;ACTG1;ACTB;DAG1;KDM2B;PRKX;VCL
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.6266813410812582,1.4360382023633285,0.08208955223880597,0.6271718777810501,1.0,4/15,11.29%,ZFP36;HNRNPU;FAM107A;UBE2L3
prerank,negative regulation of hormone secretion (GO:0046888),0.6956233543549221,1.434558594118646,0.07425742574257425,0.6316429346530771,1.0,1/10,0.18%,OSM
prerank,transepithelial transport (GO:0070633),0.6351300910069566,1.4338885717924794,0.0899390243902439,0.632189377314462,1.0,5/15,12.37%,CXADR;SLC23A2;SLC23A1;SLC1A3;SLC1A1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.6171177519021692,1.4337659608074789,0.08982035928143713,0.6304303359282504,1.0,4/17,5.26%,BAG6;EMC4;GET1;EMC10
prerank,gliogenesis (GO:0042063),0.6356472501880526,1.4317806581522852,0.07578008915304606,0.6370154803313128,1.0,3/15,8.25%,CD9;METRN;CDK6
prerank,response to glucocorticoid (GO:0051384),0.5636419047045687,1.4302738088351823,0.07171853856562922,0.6414996978165377,1.0,7/26,15.03%,ZFP36;HNRNPU;ADAM9;FAM107A;UBE2L3;GOT1;IL6
prerank,positive regulation of chemokine production (GO:0032722),0.5239813309891148,1.4296698679477857,0.05289052890528905,0.6420071511100831,1.0,10/44,12.57%,EGR1;LPL;ADAM17;HMGB1;EIF2AK2;TLR7;IL17RA;PYCARD;IL18;APP
prerank,negative regulation of protein localization to membrane (GO:1905476),0.5686122828367959,1.4288311805675646,0.07544581618655692,0.6435770578733949,1.0,8/24,9.86%,BCL2L1;INPP5K;PICALM;PPP2R5A;MRAP2;LZTFL1;CLTC;RHOQ
prerank,translational termination (GO:0006415),0.4841993514202692,1.4282923310787736,0.01847826086956522,0.6437305930334206,1.0,24/95,13.39%,GSPT2;MRPL40;MRPL18;MRPL51;ETF1;MRPL47;MRPS26;GFM2;MRPL50;MRPS6;MRPS35;MRPS28;MRPL28;MRPL30;MRPS31;MRPL46;MRPS34;MRPS12;MRPS7;MRPL37;MRPL2;MRPL41;MRPL27;MRPS27
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.5407986111321701,1.4282727549592078,0.06675062972292191,0.6415784801816148,1.0,12/35,17.82%,SEMA3G;ARHGDIA;SEMA4G;SEMA6D;SEMA6A;SH3BP1;SEMA4C;NRP2;FLNA;RAC1;SEMA3A;SEMA3D
prerank,regulation of chemokine production (GO:0032642),0.5392526140419759,1.4280334238815986,0.06844106463878327,0.6404962745474125,1.0,10/36,15.03%,EGR1;LPL;ADAM17;EIF2AK2;FOXP1;TLR7;PYCARD;IL18;APP;IL6
prerank,regulation of interleukin-6 production (GO:0032675),0.4751627799334281,1.4280260378451335,0.03618421052631579,0.6383010795865587,1.0,27/96,17.55%,MAPKAPK2;STAT3;SLAMF1;RAB7B;LPL;TYROBP;HMGB1;SIRPA;NLRC3;CARD9;DHX9;CD200R1;IL1A;TLR7;IL17RA;PYCARD;ARRB1;PTPN6;CD200;APP;C5AR2;POU2F2;IL6;HSPD1;TNFAIP3;ARHGEF2;ZC3H12A
prerank,regulation of DNA metabolic process (GO:0051052),0.525422457117178,1.427978290331983,0.057571964956195244,0.6363284530923052,1.0,11/44,11.69%,MYC;WRNIP1;WDR18;HNRNPD;PDGFA;PARG;RADX;XRCC5;TOM1L1;NBN;KPNA2
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5897339523320443,1.4278364281887947,0.09224011713030747,0.6347174471257296,1.0,7/20,12.34%,PDGFRB;SERPINE1;PDGFA;PDGFB;LRP1;SORL1;IGF1
prerank,regulation of telomerase activity (GO:0051972),0.5118239138983348,1.4269526054448316,0.05454545454545454,0.6366972215090222,1.0,10/45,9.75%,MYC;NEK7;ACD;HSP90AB1;MAP2K7;PARP4;XRCC5;PTGES3;NVL;CTNNB1
prerank,regulation of interleukin-4 production (GO:0032673),0.600004681465511,1.4263458187868459,0.07593123209169055,0.6372846785908381,1.0,6/21,18.21%,SLC7A5;NLRP3;PRKCZ;CD86;DDIT3;CEBPB
prerank,regulation of cellular respiration (GO:0043457),0.6160650476713179,1.4261226848250081,0.09259259259259259,0.63595241976875,1.0,5/17,13.83%,PRELID1;SHMT2;IFNAR1;IDE;IL10RB
prerank,negative regulation of protein metabolic process (GO:0051248),0.516005524163981,1.4260667732239787,0.046341463414634146,0.6340107461620544,1.0,14/48,11.94%,MAD2L1;AGAP2;CD84;HSP90AB1;PIN1;EIF2AK1;FLOT2;MDM4;APOE;ITGB3;PRNP;SIRT2;PFDN1;CLU
prerank,stabilization of membrane potential (GO:0030322),0.6242927627099534,1.4260475219411384,0.0746705710102489,0.6319611380538399,1.0,2/16,5.23%,KCNK4;KCNK9
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.5579846601081901,1.4256276671608092,0.05128205128205128,0.6316050278751864,1.0,10/29,14.27%,MYC;KAT5;TRRAP;TCF7L2;CTNNB1;HDAC1;CREBBP;TCF7L1;KMT2D;TLE3
prerank,establishment of spindle orientation (GO:0051294),0.5539678265696489,1.424900289513323,0.0685640362225097,0.6327412258900914,1.0,7/28,11.61%,MAD2L1;NDEL1;LLGL1;FBXW11;MAP4;NDC80;PAFAH1B1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.6172490182796448,1.424600677672576,0.08761329305135952,0.6319969123576179,1.0,1/16,0.13%,BMP5
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.5946840152966769,1.4232091236787188,0.07386363636363637,0.636066399194565,1.0,1/18,0.01%,CCL3
prerank,histone H3-K36 demethylation (GO:0070544),-0.5970188811899867,-1.4231567403367689,0.09090909090909091,1.0,1.0,6/10,16.92%,KDM4C;KDM4B;PHF8;RIOX2;KDM7A;KDM4A
prerank,positive regulation of cellular respiration (GO:1901857),0.6865599139012445,1.4231119240146504,0.07469512195121951,0.6344891287500433,1.0,4/11,13.83%,PRELID1;NUPR1;IFNAR1;IL10RB
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.4777631219060822,1.4220840552729508,0.035754189944134075,0.6369658472637966,1.0,22/77,15.04%,PRELID1;RTKN2;BCL2L1;PLAUR;SIAH2;RELA;SLC35F6;TGFBR1;BCL2L2;PSME3;TCF7L2;PSMD10;PELI3;BDNF;BIRC6;TMBIM6;CLU;IGF1;CFLAR;SLC25A5;NDUFA13;HGF
prerank,gluconeogenesis (GO:0006094),0.5297146176103845,1.4213246150792118,0.0606826801517067,0.6384203391741056,1.0,7/39,6.77%,G6PC3;PGK1;PGM1;SLC39A14;ATF4;MDH1;SLC25A13
prerank,pinocytosis (GO:0006907),0.6807437191895367,1.420221692360779,0.09120521172638436,0.6414052789616157,1.0,5/10,12.28%,MAPKAPK2;SNX33;PPT1;PYCARD;DOCK2
prerank,positive regulation of MAPK cascade (GO:0043410),0.4469105539519537,1.4200723418101635,0.0030425963488843813,0.6399210977449653,1.0,44/245,13.91%,CCL3;OSM;CCL4;CCL2;SERPINF2;PDGFRB;SLAMF1;ADAM8;ARL6IP5;PRKD2;PDGFA;IL34;HMGB1;DUSP19;EIF2AK2;MAP2K7;MAP2K1;APOE;JCAD;GLIPR2;PDGFB;GPR183;GSDME;CARD9;PTK2B;RYK;HTR2C;P2RY1;PRKCZ;PTPRC;PYCARD;SEMA4C;ARRB1;MID1;ATP6AP1;SOX2;TAOK2;IGF1;APP;CCL25;CCL13;LPAR1;ROR1;GCNT2
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.5229188162415721,1.4197332215577987,0.05759803921568627,0.6393081381796029,1.0,7/41,7.25%,ALOXE3;SCD5;ELOVL1;PLA2G4A;FADS1;DEGS1;GPX4
prerank,regulation of glucose import (GO:0046324),-0.4247054409044711,-1.4197044552231335,0.06896551724137931,1.0,1.0,11/30,16.42%,PID1;ENPP1;INSR;PRKCI;IRS2;IRS1;AKT2;PTPN11;SORBS1;GSK3A;SELENOS
prerank,regulated exocytosis (GO:0045055),0.45561861594320824,1.4192978333954596,0.009297520661157025,0.6389980022533781,1.0,35/173,15.33%,SELENOP;SELP;SERPINF2;WDR1;CD9;MYH9;PLEK;SRGN;SERPINE1;PDGFA;HABP4;TAGLN2;RIMS1;RIMS3;MANF;ITGB3;SPARC;PDGFB;RAB31;TMED10;VEGFC;CYRIB;ENDOD1;TMSB4X;CLU;IGF1;APP;PSAP;CYB5R1;PROS1;OLA1;FLNA;SYT1;HGF;ARHGAP17
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.4722501872253589,1.4186453320048358,0.02282608695652174,0.6398948975800629,1.0,28/95,18.17%,CCL2;CD180;ZFP36;FZD5;SERPINE1;ACOD1;HMGB1;NLRP3;ADAM9;RELA;SBNO2;SIRPA;IL1A;CYRIB;MAPK8;PYCARD;CARD16;SIRT2;CCR5;IL6;TNFRSF1B;CD86;TNFAIP3;NFKB1;ZC3H12A;CTR9;UPF1;MEF2C
prerank,negative regulation of cell cycle (GO:0045786),0.48531069096043367,1.4186355440760106,0.04308390022675737,0.6378549074153624,1.0,17/73,13.41%,MAD2L1;NPPC;NR4A1;IPO5;INCA1;NUPR1;NUDT6;RHOB;TSPYL2;CDK6;LATS1;RNF167;BTG2;ZBTB17;TAF6;ANGEL2;SCRIB
prerank,linoleic acid metabolic process (GO:0043651),0.6124359599827633,1.4171819098820801,0.08714285714285715,0.6424568653052238,1.0,3/17,5.82%,ALOXE3;ELOVL1;FADS1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.5061860164012268,1.416270104830091,0.06064209274673008,0.6444763132575804,1.0,10/51,7.83%,CSF1;ADAM17;C1QBP;SERPINE1;IL34;HMGB1;CREB3;CMKLR1;CXCL17;VEGFC
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.5647128724819799,1.4156563146232546,0.07598371777476255,0.6449722588393731,1.0,13/26,19.69%,C1QBP;ACOD1;NLRC3;PCBP2;TRAF3IP1;CARD16;SIRT2;ILRUN;TNFAIP3;TRAFD1;PPM1B;TRIB1;ITCH
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.5188662706358027,-1.412852806266311,0.08059701492537313,1.0,1.0,7/15,32.01%,IRAK3;CUEDC2;TGFB2;LILRB1;JAK3;HFE;TNF
prerank,hexose biosynthetic process (GO:0019319),0.5158314658499955,1.4113504454040982,0.06483790523690773,0.6619257522512619,1.0,7/42,6.77%,G6PC3;PGK1;PGM1;SLC39A14;ATF4;MDH1;SLC25A13
prerank,positive regulation of GTPase activity (GO:0043547),0.45118588012892236,1.410851954364242,0.011270491803278689,0.6620436309177041,1.0,59/188,19.22%,CCL3;CCL4;CORO1C;CCL2;EPHA1;RGS1;EPHA2;TBC1D10B;NDEL1;TBC1D17;PIN1;PICALM;ALS2;USP6NL;RHOG;ARHGEF26;SNX13;RABGAP1;RASGRF1;SGSM2;SH3BP1;RGS7;ZC3H15;GMIP;RAP1GAP2;LARS1;TBC1D30;ARHGAP22;RANGAP1;CDKL5;DOCK10;RIC1;SRGAP2;EVI5L;DOCK9;CCL25;SCRIB;CCL13;LIMS1;TBC1D7;TBC1D4;RALBP1;RUNDC1;ARHGEF10;RALGAPA2;FLCN;PKP4;RASGRP2;GPR65;TBC1D22A;TBC1D10A;TBC1D15;EZH2;TIAM1;ARHGAP25;ASAP3;ARHGAP24;BCAR3;RAB3GAP1
prerank,transition metal ion homeostasis (GO:0055076),0.5475233072332925,1.4104214486644628,0.07133243606998654,0.6619231372682122,1.0,11/28,17.39%,TMC8;SLC39A14;ATP13A2;PICALM;NEO1;FBXL5;CUTC;ABCB7;SLC11A1;TMPRSS6;IREB2
prerank,dermatan sulfate metabolic process (GO:0030205),0.6384312325035627,1.409397672662161,0.10172143974960876,0.6644789548099356,1.0,4/13,4.76%,BCAN;NCAN;CHST12;CSPG4
prerank,regulation of protein transport (GO:0051223),0.5556854651436344,1.4073724287159128,0.07712765957446809,0.6713915756779848,1.0,10/27,11.46%,NDEL1;LCP1;LLGL1;RHBDF2;ATP13A2;HSPA8;DNAJC1;DNAJA1;PPM1F;STXBP5L
prerank,regulation of mitochondrial fusion (GO:0010635),-0.5561110007628749,-1.40729625326143,0.12181303116147309,1.0,1.0,4/11,9.06%,PID1;HUWE1;ZDHHC6;BNIP3
prerank,nucleic acid-templated transcription (GO:0097659),0.5087341534788344,1.4069812528317807,0.07673267326732673,0.6711000999298351,1.0,15/42,19.89%,NKX2-8;THAP1;RRAGC;POLR2J;FUBP3;BAZ2A;PWP1;POLR2E;POLR2B;POLR2G;MEF2A;PPP5C;MED20;POLR2K;THRB
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.45371979246492344,-1.40685153583232,0.0694980694980695,1.0,1.0,9/23,16.55%,CAB39;CALM2;UBE2K;AXIN1;CALM1;MAPK1;IRGM;WNK3;CALM3
prerank,regulation of mRNA catabolic process (GO:0061013),0.46016802466387874,1.4066265294902647,0.023579849946409433,0.6705890604664008,1.0,39/121,17.81%,MAPKAPK2;DIS3;DCP1A;ZFP36;HNRNPD;PSMD2;PSMC4;FXR2;PSMD4;PSMD1;HSPA8;RPS27A;UBC;PCID2;CNOT8;PSME3;SET;PSMB6;PSMD10;SAMD4B;EXOSC8;PUM2;PSMB1;RC3H1;PSMD11;RC3H2;PSMA2;CNOT7;PSMD13;PSMB10;FMR1;ZC3H14;PSMB3;YTHDF2;YWHAZ;PSMC1;ZC3H12A;ELAVL1;UPF1
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.5886721153687039,1.4065373766699685,0.09037900874635568,0.6688755849598647,1.0,5/18,12.34%,HMGB1;PYCARD;IL27RA;IL18;IGF1
prerank,positive regulation of developmental process (GO:0051094),0.44843734811778535,1.4064907208078152,0.00819672131147541,0.6669561214716663,1.0,22/164,9.00%,GDNF;BMP5;CORO1C;SERPINF2;BASP1;DLG5;SHANK1;DVL2;C1QBP;HSP90AB1;SOX9;KMT5B;RTN4;APOE;PDGFB;PHLDB1;TRPM4;SORL1;ACVR1B;SIRT1;TAPT1;SLC6A6
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.6851237492432645,1.4064020000177073,0.10284810126582279,0.6653203582630607,1.0,5/10,10.88%,RPS27A;UBC;TUT7;CHFR;NEDD8
prerank,acidic amino acid transport (GO:0015800),0.6041100843803081,1.4063933249150897,0.08600583090379009,0.6632770792301667,1.0,6/17,12.37%,ARL6IP5;LRRC8D;SLC25A13;SLC1A3;SLC6A6;SLC1A1
prerank,regulation of exosomal secretion (GO:1903541),0.5956328939277153,1.4061910308627052,0.08591549295774648,0.6621996804984777,1.0,7/19,9.05%,VPS4A;ATP13A2;PDCD6IP;SDC4;SDCBP;SMPD3;STAM
prerank,synaptic vesicle recycling (GO:0036465),-0.4135378745188603,-1.4059077586399635,0.05752212389380531,1.0,1.0,17/31,28.15%,NLGN1;RAB5A;FCHO2;PLD2;SYT2;STON2;TBC1D24;VAMP2;SYT7;CDK5;STX1A;NLGN2;NLGN3;SYNJ2;RAB3A;OPHN1;CANX
prerank,aorta development (GO:0035904),0.6286092562922623,1.4056480961829696,0.08490566037735849,0.6626661981833388,1.0,4/14,7.87%,PDGFRB;TFAP2B;JAG1;LRP1
prerank,mitochondrial fusion (GO:0008053),-0.4818446239642884,-1.4028639106792997,0.10631229235880399,1.0,1.0,11/18,22.75%,MFN1;CHCHD3;USP30;MFN2;BAX;FIS1;MIGA2;SPG7;MIGA1;OPA1;STOML2
prerank,regulation of actin filament depolymerization (GO:0030834),0.6478250158699196,1.4025756509494407,0.09822866344605476,0.6747723145667998,1.0,4/12,7.30%,WDR1;PLEK;LIMA1;SH3BP1
prerank,protein localization to lysosome (GO:0061462),0.5479128698552056,1.4023400562960044,0.0701058201058201,0.673753293665549,1.0,12/28,17.56%,NCOA4;VPS4A;ATP13A2;RTN4;SORL1;MFSD1;GLMP;ZFYVE16;SCARB2;NAGPA;LMBRD1;RAB7A
prerank,cellular response to organic substance (GO:0071310),0.4560824218233607,1.4020976660703595,0.028361344537815126,0.6727630174463541,1.0,21/116,11.00%,CCL3;CCL2;STAT3;CXCR4;ARL6IP5;INPP5K;HDAC6;PTPN12;TBK1;PTPN14;TGFBR1;TGFBR2;PDGFB;AKAP6;ACVR1B;MAPK8;CTNNB1;PTPN4;IL18;ACVR2B;PTPN6
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.47460097146500346,-1.4016839953845788,0.06293706293706294,1.0,1.0,8/20,22.00%,NIBAN2;TRAF6;EP300;GTF2B;DDRGK1;RB1;LAMTOR5;PARK7
prerank,regulation of stem cell differentiation (GO:2000736),0.47087181009235896,1.4015498325028264,0.03634361233480176,0.673194728172166,1.0,27/89,17.14%,GDNF;OSM;PSMD2;HNRNPU;PSMC4;EIF2AK2;PSMD4;PSMD1;JAG1;PSME3;PSMB6;PSMD10;PSMB1;PSMD11;PSMA2;PSMD13;TCF3;PSMB10;PSMB3;LDB1;KMT2A;RUNX1;PUS7;SMYD5;YTHDF2;PSMC1;TCF12
prerank,pharyngeal system development (GO:0060037),0.6141245030496599,1.4012685742693358,0.0950965824665676,0.6724293644506891,1.0,2/15,5.29%,BMP5;TGFBR1
prerank,cation transmembrane transport (GO:0098655),0.5195229859005094,1.4011758796063152,0.06403940886699508,0.6708471844716408,1.0,11/44,17.06%,SLC7A5;SLC7A1;ATP13A2;SFXN2;SLC3A2;TRPM4;ATP1B1;TRPM2;SLC6A5;SLC36A4;MFSD12
prerank,protein export from nucleus (GO:0006611),0.5461131864114911,1.400310007880728,0.08536585365853659,0.6726774855466032,1.0,3/27,2.07%,EGR2;RANBP3;DUSP16
prerank,regulation of BMP signaling pathway (GO:0030510),0.4770994889712636,1.4001213975298323,0.04880817253121453,0.6715060391409617,1.0,15/73,13.83%,BAMBI;FBXL15;TFAP2B;SKIL;LEMD2;CRIM1;SMURF1;UBE2D1;SORL1;ENG;UBE2D3;ACVR2B;RBPJ;LEMD3;SKOR2
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.5732436776354212,1.399608542753572,0.09028727770177838,0.671865619502181,1.0,6/24,9.93%,SEMA3G;SEMA4G;SEMA6D;SEMA6A;DSCAM;SEMA4C
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.46288361964728586,1.3994268793824356,0.03728070175438596,0.6706533149752303,1.0,30/88,19.23%,BAG6;ILF3;MALSU1;RPL13A;RIDA;TOB1;EIF2AK2;HDAC6;FXR2;APOE;DNAJC1;CNOT8;EIF2AK3;CLN8;SAMD4B;YBX1;BTG2;GIGYF2;RIC1;CNOT7;FMR1;EIF4E2;DAPK1;PUS7;CNOT10;NFKB1;CALR;ENC1;CNOT1;SERPINE2
prerank,cellular response to drug (GO:0035690),0.56292351381602,1.3994134482400498,0.08776595744680851,0.6687080973901686,1.0,2/25,0.87%,MYC;KCNH2
prerank,cardiac muscle cell differentiation (GO:0055007),0.5797941407290046,1.3993688304368148,0.09343065693430656,0.6668995715015233,1.0,2/21,2.09%,KDM6B;CXADR
prerank,triglyceride metabolic process (GO:0006641),0.5077346411545565,1.3990830765264022,0.07032181168057211,0.6661056955562358,1.0,7/48,10.06%,LPL;APOBR;SEL1L;APOC1;APOE;SIRT1;GPAT4
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4929890573395076,1.3982620726713761,0.0611764705882353,0.667797037267685,1.0,7/56,8.92%,BMP5;PIN1;RBPMS;TGFBR1;SDCBP;ENG;BMP6
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5992245105304246,1.3982498806519839,0.10556348074179743,0.6658646952908435,1.0,4/17,9.70%,KCNH2;CACNA2D1;AKAP9;SCN1B
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.670748429357667,1.3978673447035848,0.09032258064516129,0.6656432893817946,1.0,3/10,7.87%,APOD;PTPN12;LRP1
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.5727002777001351,-1.397721720974231,0.11764705882352941,1.0,1.0,4/10,17.60%,LRRK2;MLLT11;SRC;DCN
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.635211734067689,1.3975431651182677,0.1021671826625387,0.6650534686563638,1.0,7/14,19.30%,PPP1R15B;NCK1;PPP2R2D;PPM1F;PPP2CB;PPP5C;PPP2R2A
prerank,regulation of sequestering of calcium ion (GO:0051282),0.6478633183509824,1.3971011150700032,0.0976,0.6650630639562352,1.0,4/12,12.36%,FKBP1B;PTK2B;ANXA6;DIAPH1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.5129760249808493,1.3969095322031861,0.06781750924784218,0.6639423711640959,1.0,6/45,8.92%,BMP5;RBPMS;TGFBR1;SDCBP;ENG;BMP6
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.6412212593388548,1.3964026730643813,0.1088,0.6641170134232643,1.0,3/12,14.69%,IL1R1;IL18;SLC11A1
prerank,nuclear membrane disassembly (GO:0051081),0.614563322264167,1.3961192629169394,0.09465648854961832,0.6634501785367622,1.0,6/14,18.12%,NEK6;CTDNEP1;CNEP1R1;AKAP8L;PRKCB;DCTN1
prerank,negative regulation of T cell proliferation (GO:0042130),0.5522220801133623,1.3958400034397607,0.09126466753585398,0.6626475384159829,1.0,9/28,18.21%,DLG5;SDC4;GLMN;PRNP;RC3H1;SCRIB;CD86;GPNMB;CEBPB
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4575942844099222,1.395723703641452,0.028481012658227847,0.6612258626655088,1.0,29/128,13.91%,BMP5;BAMBI;ZYX;JUN;COL1A2;ADAM9;ZMIZ1;TGFBR1;TGFBR2;RPS27A;UBC;NRROS;FNTA;SMURF1;LTBP2;ACVR1B;HIVEP1;SIRT1;ENG;FURIN;PRKCZ;BMP6;RUNX2;ACVR2B;ZFYVE16;COL3A1;DDX5;STUB1;GCNT2
prerank,homotypic cell-cell adhesion (GO:0034109),0.5193829096549849,1.3954059916633152,0.07653701380175659,0.6606425577306397,1.0,13/39,17.87%,MYL12A;MYH9;PLEK;FIBP;GNAS;ITGB3;ACTG1;STXBP3;FLNA;ACTB;METAP1;ILK;PIK3CG
prerank,negative regulation of vascular permeability (GO:0043116),-0.5522760202298519,-1.395266896357495,0.10511363636363637,1.0,1.0,5/12,19.49%,SH3GL2;FERMT2;ANGPT1;SLIT2;VEGFA
prerank,regulation of collagen biosynthetic process (GO:0032965),0.5771123218462992,1.394991524888386,0.09859154929577464,0.6605773407131486,1.0,3/19,4.54%,SERPINF2;CREB3L1;LARP6
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.6193867671891621,1.3949100590985952,0.09649122807017543,0.6590177381915747,1.0,5/15,8.78%,ADAM8;ADAM9;APOE;SNX33;FURIN
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.5458364493235542,1.3947996067146717,0.08157894736842106,0.6576615893560814,1.0,9/29,11.80%,LSM5;DIS3;DCP1A;EDC3;CNOT8;CNOT6;EXOSC8;DCP1B;CNOT7
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5811337294432003,1.3947157390447544,0.10260115606936417,0.65611619602061,1.0,3/18,2.99%,CCL2;ADAM17;HMGB1
prerank,bone morphogenesis (GO:0060349),-0.5287069224413631,-1.394651285280586,0.10526315789473684,1.0,1.0,3/14,10.71%,LRP6;BMPR2;FGFR2
prerank,negative regulation of TORC1 signaling (GO:1904262),0.6435789222078081,1.3944800908845052,0.11235955056179775,0.6553295210669159,1.0,3/13,3.81%,SESN2;CASTOR1;ITFG2
prerank,acyl-CoA biosynthetic process (GO:0071616),0.599550981265595,1.394236315990137,0.1099554234769688,0.6546096209674718,1.0,6/16,12.91%,SCD5;ACLY;PPT1;PPCS;ACACA;ACAT1
prerank,negative regulation of immune response (GO:0050777),0.44857724066332927,1.393213464827219,0.018691588785046728,0.6572139321447961,1.0,30/154,15.03%,MC2R;CALCA;MYH9;SAMSN1;ADAM17;PDCD1;RHBDF2;C1QBP;ACOD1;HRH2;ADCY5;NLRC3;PCBP2;SPI1;FURIN;TRAF3IP1;RC3H1;SIRT2;GNB1;PRKAR2A;GPR176;COL3A1;DPEP1;ADCY8;ADCY3;ILRUN;FCGR1A;ADRB2;CREB1;IL6
prerank,negative regulation of leukocyte migration (GO:0002686),0.6727811081117441,1.3924406588011426,0.10891089108910891,0.6587589898628273,1.0,3/10,11.37%,BMP5;CD200R1;CD200
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.44164262130734255,-1.391315275055881,0.08365019011406843,1.0,1.0,8/25,12.28%,CBL;TSG101;SOCS5;ZFYVE28;ERRFI1;PPARG;EPHB2;ZGPAT
prerank,response to light stimulus (GO:0009416),0.4944993733990121,1.3910621385551483,0.06315789473684211,0.6631584256614327,1.0,9/55,10.23%,UVSSA;DDB2;BRSK1;MAPK10;MAP2K7;CRY2;MAPK8;COPS3;ERCC2
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.6451280999783783,1.390836943858343,0.11411411411411411,0.6622339348357088,1.0,5/13,16.22%,MAD2L1;PCID2;NDC80;LCMT1;DYNC1LI1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.4846646586127994,1.3903283657095546,0.07482185273159145,0.6626488954326821,1.0,12/54,10.87%,EPHA2;ADAM17;PRKD2;HMGB1;MAP2K3;ANGPT2;APOE;JUP;PDGFB;SH3BP1;SIRT1;TMSB4X
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.6397908322785728,1.3897457542984788,0.10062893081761007,0.6632833059370419,1.0,5/12,15.03%,GPR183;PTK2B;DOCK10;LFNG;IL6
prerank,positive regulation of monooxygenase activity (GO:0032770),0.5567471205661437,1.3896953025469607,0.08969210174029452,0.6616910960836834,1.0,4/26,9.43%,GDNF;APOE;POR;GCH1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.5534505364872951,1.3890994736807818,0.0891891891891892,0.6624813395812977,1.0,7/27,8.38%,CHST11;BCAN;CHPF;NCAN;CHST12;CSPG4;XYLT1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.5931142594090546,1.389002331826984,0.11624441132637854,0.6610650847404301,1.0,3/18,6.29%,BAG6;SH2B2;CMKLR1
prerank,positive regulation of DNA metabolic process (GO:0051054),0.47767653828257534,1.3888819992682115,0.06343713956170703,0.6598066926481848,1.0,14/61,12.16%,MYC;PDGFRB;PRKD2;PPP1R10;HMGB1;PCNA;PDGFB;TRIM28;DHX9;SIRT1;SMOC2;NBN;TOX;EYA2
prerank,stress-activated MAPK cascade (GO:0051403),0.49158218613784477,1.3887265747526003,0.054022988505747126,0.6587019844025724,1.0,17/61,13.07%,CCM2;ZFP36;MAPK10;MAP2K3;FBXW11;IKBKB;MAP2K7;RPS27A;UBC;ARHGEF6;MAP4K2;MAPK8;RIPK2;TAOK2;IRAK2;MAP4K3;GPS2
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.5025014066790013,-1.388041713801528,0.08116883116883117,1.0,1.0,7/16,25.58%,KLK2;BMPR2;PLCB3;GSK3A;GPR37L1;SLC2A5;KLK1
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5912873195132171,-1.387892382489534,0.08064516129032258,1.0,1.0,4/10,21.58%,IRF1;LAG3;ZC3H8;MDK
prerank,regulation of transport (GO:0051049),0.5202507408574871,1.3873919455125625,0.0697084917617237,0.6625109453905743,1.0,8/36,9.95%,DISP3;ARL6IP5;POFUT2;MBTPS1;ICA1;YRDC;DNAJA1;ACTG1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.5471633444186149,1.3870284920506468,0.09498680738786279,0.6621891031372694,1.0,4/29,11.43%,BMP5;ADIPOR1;USF3;HPN
prerank,ncRNA metabolic process (GO:0034660),0.5214001513346261,1.3867460404051601,0.08290816326530612,0.6614237423016822,1.0,6/37,6.97%,EXD1;TARBP2;NIFK;TUT7;DGCR8;ZCCHC8
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.5460546301939275,-1.3852981166595342,0.11764705882352941,1.0,1.0,7/12,27.92%,DPYD;CTPS2;DPYSL5;CTPS1;UMPS;CRMP1;DPYSL2
prerank,membrane repolarization during action potential (GO:0086011),0.6295613586149056,1.3852759380406663,0.11937984496124031,0.6658774289905338,1.0,3/13,9.67%,KCNH2;KCNJ2;ATP1B1
prerank,glutamine family amino acid metabolic process (GO:0009064),0.5281335644025703,1.3850325425380936,0.09009009009009009,0.665137448232666,1.0,16/33,21.69%,SLC39A8;GLS2;GLS;ALDH18A1;GLUD1;DGLUCY;FPGS;GOT2;DDAH2;PYCR2;GOT1;ART4;NIT2;RIMKLB;GCLC;MTHFS
prerank,regulation of DNA binding (GO:0051101),0.5026383724114599,1.3849108386314921,0.06854345165238677,0.663809753304974,1.0,13/44,13.68%,PLAUR;JUN;HMGB1;HABP4;DOT1L;ZBTB7A;MAPK8;SUMO1;KDM1A;SIRT2;HJURP;IGF1;ILRUN
prerank,regulation of dopamine secretion (GO:0014059),0.5548994667938526,1.3847738200994049,0.11156462585034013,0.6626416867386835,1.0,1/25,0.04%,GDNF
prerank,cellular response to organic cyclic compound (GO:0071407),0.4474064159261699,1.3843301316649275,0.016597510373443983,0.6627836833050659,1.0,36/141,18.39%,CCL3;CCL2;EGR1;NCOA4;ARL6IP5;INPP5K;KAT5;GABRB2;SPP1;TAF1;ADCY5;JUP;PDGFB;AKAP6;P2RY1;AKAP9;MSN;CTNNB1;IL18;UBE2L3;GNB1;TRPM2;DIAPH1;SLC1A1;ADCY8;ADCY3;RORA;NCOA3;MED1;ACTB;ATP1A3;RIOK3;ZC3H12A;RAP1B;MEF2C;HSP90B1
prerank,cellular response to lipid (GO:0071396),0.44296265793268025,1.3833812276600916,0.009193054136874362,0.6651800612808,1.0,50/191,18.17%,KCNK4;CCL2;CD180;NCOA4;LPL;ZFP36;WNT5B;SERPINE1;ACOD1;HMGB1;NLRP3;SOX9;ADAM9;KAT5;RELA;SBNO2;SIRPA;ABL2;SPP1;ADCY5;PTK2B;IL1A;MAPK8;PYCARD;MSN;CARD16;UBE2L3;CCR5;EPHA3;PDK3;ADCY8;ADCY3;RORA;SETX;NDUFA13;NCOA3;CREB1;IL6;MED1;TNFRSF1B;CD86;PAX2;TNFAIP3;ATP1A3;NFKB1;HTRA2;ZC3H12A;CTR9;UPF1;MEF2C
prerank,positive regulation of cellular metabolic process (GO:0031325),0.4573430381359872,1.3830654242830707,0.046908315565031986,0.6647543338276065,1.0,22/98,13.83%,PRELID1;CSF1;PDGFRB;CBR1;ACOD1;DHRS4;TGFBR2;APOC1;APOE;ACLY;PDGFB;AGT;IFNAR1;ARRB1;ACACA;HPN;ANXA2;NSF;INPP5F;SCRIB;FMR1;IL10RB
prerank,negative regulation of interleukin-12 production (GO:0032695),0.6229020992384323,1.3823799390073601,0.12269938650306748,0.6657974218303558,1.0,3/14,6.29%,SLAMF1;C1QBP;CMKLR1
prerank,glutamate metabolic process (GO:0006536),0.5786714250719717,1.3822004493667088,0.1239193083573487,0.6647733292110367,1.0,8/19,14.48%,GLS2;GLS;ALDH18A1;GLUD1;DGLUCY;FPGS;GOT2;GOT1
prerank,protein-containing complex disassembly (GO:0032984),0.49296083656566075,1.382029212917764,0.07838479809976247,0.6637574480434866,1.0,12/54,10.79%,MYC;LIX1;DVL2;VPS4A;FZD5;GABARAP;GABARAPL1;HSPA8;MAP1LC3A;MAP1LC3B;CTNNB1;TECPR1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.5463687731114136,1.3820077865879594,0.09517426273458444,0.6620956984207786,1.0,9/26,18.92%,ZFP36;INPP5K;SOX9;PTPN12;ZPR1;MED1;SYAP1;DUSP3;EEF1A1
prerank,positive regulation of hydrolase activity (GO:0051345),0.44803712347481633,1.3813166767068958,0.025,0.6632260023654211,1.0,33/137,15.07%,CCL3;CCL4;CCL2;RGS1;NDEL1;PIN1;PICALM;ALS2;USP6NL;SNX13;RASGRF1;FNTA;SGSM2;SH3BP1;RGS7;ZC3H15;LARS1;MAPK8;TBC1D30;CDKL5;DOCK10;CD200;RIC1;SRGAP2;EVI5L;PSAP;DOCK9;CCL25;CCL13;NDUFA13;LIMS1;TBC1D7;RALBP1
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.5358939207799672,1.3806332628198725,0.09948320413436693,0.6643420873518427,1.0,12/32,15.02%,PDGFRB;PPP1R15B;HSP90AB1;PIN1;SPPL3;PPP2R5A;SMPD1;CNEP1R1;PTBP1;PPP1R16B;MTOR;SYMPK
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.6416749081512868,1.3806069573143573,0.11077389984825493,0.6627276304498088,1.0,5/13,9.10%,TYROBP;TM9SF4;HSP90AB1;SNX33;STX3
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.4848464881640596,1.380310701137158,0.0675990675990676,0.6622596518887975,1.0,18/57,18.02%,MYC;CTSD;ARL6IP5;HMGB1;NLRP3;CARD9;SIRT1;PYCARD;PPM1F;RIPK2;ASPH;BAD;GRIN2A;NDUFA13;DAPK1;HTRA2;TBC1D10A;PDCD6
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.577004591350426,-1.3798253504176223,0.09560723514211886,1.0,1.0,7/10,24.06%,SNW1;PPARG;RARB;RXRB;RXRG;RARA;RARG
prerank,potassium ion export across plasma membrane (GO:0097623),0.6269759366434211,1.3786530287867764,0.13292117465224113,0.6673299001775647,1.0,1/13,0.87%,KCNH2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.4612669661896385,1.37828498698643,0.04525386313465784,0.6672697499898969,1.0,18/87,8.90%,BAMBI;ZYX;JUN;COL1A2;ADAM9;ZMIZ1;TGFBR1;TGFBR2;RPS27A;UBC;NRROS;FNTA;SMURF1;LTBP2;SIRT1;ENG;FURIN;PRKCZ
prerank,axonemal dynein complex assembly (GO:0070286),-0.42306525807595563,-1.378255954127793,0.06779661016949153,1.0,1.0,23/28,54.41%,DNAL1;DNAI4;TTC12;DNAAF5;SPAG1;CCDC39;ODAD1;DNAH8;LRRC49;DNAAF3;DNAH5;ODAD2;CCDC40;ODAD4;DNAI3;DRC1;ODAD3;DNAAF2;DNAH17;DNAAF1;CCDC65;DNAH1;CFAP100
prerank,synaptonemal complex assembly (GO:0007130),0.6210796328866593,1.3776066374016094,0.10906298003072197,0.6669142828019183,1.0,1/15,0.41%,BAG6
prerank,synaptonemal complex organization (GO:0070193),0.6210796328866593,1.3776066374016094,0.10906298003072197,0.6669142828019183,1.0,1/15,0.41%,BAG6
prerank,positive regulation of cell motility (GO:2000147),0.43908347086006233,1.3774628172257783,0.0163098878695209,0.6657973135583064,1.0,29/205,9.97%,CCL3;SEMA3G;CSF1;STAT3;PDGFRB;EPHA1;SEMA4G;ADAM17;WNT5B;PIK3R3;PDGFA;RUFY3;ADAM9;FAM107A;SEMA6D;TGFBR1;ELP3;COL1A1;SDCBP;PDGFB;SEMA6A;MYO1C;MGAT5;PTK2B;F3;SUN2;SEMA4C;ACTG1;PPM1F
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.538290290582142,1.3773874475651753,0.09959623149394348,0.664370222369679,1.0,9/27,15.03%,STAT3;ZFP36;MAP2K1;DHX9;PUM2;DDX5;FMR1;EIF4E2;IL6
prerank,indolalkylamine catabolic process (GO:0046218),-0.5867744903563715,-1.3755861627949728,0.13279132791327913,1.0,1.0,5/10,34.01%,KYNU;KYAT1;HAAO;KMO;IL4I1
prerank,amino acid transmembrane transport (GO:0003333),0.500540515351695,1.3747061694679763,0.07821901323706378,0.6743494485834591,1.0,12/45,17.06%,SLC7A5;SLC7A1;SLC22A4;LRRC8D;SFXN2;SLC3A2;SLC25A13;SLC6A6;SLC36A1;SLC38A1;SLC36A4;MFSD12
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.4443621925608716,1.3744703797277125,0.0196078431372549,0.673557754344279,1.0,21/140,13.81%,LPAR3;CALCA;CXCR4;HMGB1;ABL2;CACNA1A;ADCY5;CMKLR1;CACNA2D1;CD55;SPPL3;TRPM4;HTR2C;P2RY1;TRPC3;CCR5;GNA15;ADCY8;C5AR2;LPAR1;NPTN
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.4856616952500429,-1.3743062416748428,0.1262135922330097,1.0,1.0,5/16,6.34%,DAZAP1;CELF4;RBM3;NCL;SNW1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.410907973520139,-1.373908540686879,0.0944206008583691,1.0,1.0,12/30,19.23%,JAK2;GRB2;ITGAV;IRS2;NOTCH1;SRC;VAV1;RASGEF1A;TGM2;MMD2;LRRC59;FGF10
prerank,fatty acid biosynthetic process (GO:0006633),0.47801010454380793,1.373714097795974,0.06096131301289566,0.675020562238587,1.0,9/63,7.25%,SCD5;LPL;ELOVL1;ACSF3;LIAS;FADS1;DEGS1;ACLY;GPX4
prerank,negative regulation of catabolic process (GO:0009895),0.5003791096248553,1.3729131056361061,0.07646356033452807,0.676654949299867,1.0,14/47,18.47%,MAD2L1;AGAP2;PIN1;NUPR1;MDM4;APOC1;ZDHHC7;SIRT2;NCOR1;FLNA;AZIN1;SF3B3;PDE3B;PRKAA1
prerank,positive regulation of lipid localization (GO:1905954),0.6458326197919216,1.3728012582853601,0.1288244766505636,0.6753596571452039,1.0,5/11,17.55%,LPL;LRP1;IKBKE;NFKB1;ZC3H12A
prerank,Golgi localization (GO:0051645),-0.5604738706842967,-1.372434739795022,0.10966057441253264,1.0,1.0,4/11,6.01%,ARCN1;PDCD10;ARHGAP21;COPG1
prerank,cochlea morphogenesis (GO:0090103),0.6553771385920149,1.372402062126434,0.11147011308562198,0.6753790258199819,1.0,4/10,21.47%,SOX9;HPN;PAX2;TIFAB
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.5092586437566694,1.3716391755984456,0.09090909090909091,0.6770637398309134,1.0,10/38,11.13%,CD180;ADAM8;ACOD1;LY86;POLR3B;DHX9;BMP6;AKIRIN2;PUM2;POLR3F
prerank,positive regulation of binding (GO:0051099),0.4585997944279466,1.3701811305556573,0.05901639344262295,0.6814672319848653,1.0,25/84,15.62%,BAMBI;PLAUR;ADD1;CLN5;HMGB1;PIN1;APOE;TAF1;SPPL3;RALB;DHX9;LRP1;TCF7L2;NVL;CAPRIN2;RIPK2;NCBP1;SIRT2;IGF1;DERL1;APP;HMBOX1;IDE;MED25;FLOT1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.537838026643454,1.3701504986520867,0.09986684420772303,0.6799037297897836,1.0,8/27,11.13%,CCM2;FBXW11;IKBKB;MAP2K7;RPS27A;UBC;MAPK8;TAOK2
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.460274286086563,1.369984085083567,0.052805280528052806,0.6789323862021339,1.0,21/86,14.10%,ATF3;NFE2L2;HIGD1A;PSMD2;PSMC4;ATF4;PSMD4;PSMD1;RPS27A;UBC;EGLN2;PSME3;PSMB6;PSMD10;CREBBP;PSMB1;PSMD11;PSMA2;PSMD13;PSMB10;CUL2
prerank,mesoderm formation (GO:0001707),0.5866185229255054,1.369735960281997,0.12081513828238719,0.6782573302031035,1.0,2/17,5.62%,KDM6B;ITGB3
prerank,manganese ion transport (GO:0006828),0.6140179218573857,1.3694509448961292,0.11160714285714286,0.6777872994091282,1.0,7/14,18.56%,SLC39A14;SLC39A8;TRPC4;TRPC1;TRPC3;SLC11A1;TRPC5
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.46493869593798304,1.368886254540628,0.05351170568561873,0.6786936824174927,1.0,15/75,11.10%,EGR3;NR4A1;ADAM17;PRKD2;HMGB1;EMC10;TGFBR1;ITGB3;JCAD;PDGFB;NRAS;VEGFC;SIRT1;F3;NRP2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.53541885271512,-1.3684912371265212,0.13068181818181818,1.0,1.0,10/11,44.44%,RIN3;STAP1;SLIT2;SLAMF8;MIF;PADI2;NBL1;CCN3;GREM1;DUSP1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.49615739081143057,1.3682712698448343,0.06880189798339265,0.6798535303754303,1.0,14/52,11.88%,EPHA2;SQSTM1;AKAP5;CLIP3;RHOG;PIK3R1;PRKCH;STAC;ZDHHC8;LRP1;CNST;STX3;STAC2;EPHA3
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.5309656138479241,1.3678926098379538,0.09125964010282776,0.6797781367231445,1.0,9/31,11.80%,LSM5;DIS3;DCP1A;EDC3;CNOT8;CNOT6;EXOSC8;DCP1B;CNOT7
prerank,mitochondrial translational elongation (GO:0070125),0.4685151826240256,1.3678887322018831,0.046460176991150445,0.678113667881126,1.0,23/88,13.39%,MRPL40;MRPL18;MRPL51;MRPL47;MRPS26;GFM2;MRPL50;MRPS6;MRPS35;MRPS28;MRPL28;MRPL30;MRPS31;MRPL46;MRPS34;MRPS12;MRPS7;MRPL37;MRPL2;TSFM;MRPL41;MRPL27;MRPS27
prerank,regulation of ERAD pathway (GO:1904292),0.6382158995989494,1.3672009046784896,0.12324492979719189,0.6793801624615445,1.0,4/11,11.31%,BAG6;USP19;USP25;UBXN1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.6104654352808042,1.3668425019315156,0.12884333821376281,0.6791413636266574,1.0,2/14,4.12%,PISD;SELENOI
prerank,protein-DNA complex disassembly (GO:0032986),0.6024745322084242,1.366503464336758,0.11566617862371889,0.6788728527837384,1.0,5/16,12.03%,MYC;SMARCC1;SMARCD2;SET;SMARCB1
prerank,response to cytokine (GO:0034097),0.4448303179336964,1.365131891947813,0.02182952182952183,0.6829934824883331,1.0,31/141,14.69%,SELP;RELB;MAPKAPK2;STAT3;SHMT2;BCL2L1;IL1R1;CXCR4;EIF2AK2;ADAM9;RELA;DDOST;MAP2K7;PTPN12;TBK1;PTPN14;IFITM3;TRIM56;AKAP6;SMPD1;MAPK8;GCH1;PTPN4;PTPN6;IRAK2;APP;MAP4K3;COL3A1;CXCL16;IKBKE;SLC11A1
prerank,positive regulation of RNA metabolic process (GO:0051254),0.48823924856475287,1.36496837436183,0.08733087330873308,0.6820842491014059,1.0,15/45,16.56%,RIOK1;UTP15;HABP4;RELA;MAP2K1;PIK3R1;U2AF2;WDR43;DDX5;SETX;ZPR1;IL6;DYRK1A;HNRNPLL;NFKB1
prerank,cobalamin metabolic process (GO:0009235),0.5779476311089595,1.3646291873571186,0.11890243902439024,0.6817032170384095,1.0,4/17,16.64%,MMACHC;TCN2;MMAA;LMBRD1
prerank,cardiac muscle cell development (GO:0055013),0.5674698909491654,1.3645787052657545,0.1289855072463768,0.6803019944663002,1.0,2/20,2.09%,PDGFRB;CXADR
prerank,myeloid leukocyte differentiation (GO:0002573),0.46990928178233515,1.3641846468226013,0.09018264840182648,0.6804737869556851,1.0,11/65,8.74%,CSF1;MYH9;EPHA2;TYROBP;SBNO2;MT1G;TGFBR2;GPR183;FOXP1;SIRT1;SPI1
prerank,glycogen biosynthetic process (GO:0005978),0.6341252612174851,1.3638308645966473,0.11384615384615385,0.6785831834128665,1.0,3/12,13.46%,PGM1;GYS1;PGM2L1
prerank,glucan biosynthetic process (GO:0009250),0.6341252612174851,1.3638308645966473,0.11384615384615385,0.6785831834128665,1.0,3/12,13.46%,PGM1;GYS1;PGM2L1
prerank,positive regulation of interleukin-8 production (GO:0032757),0.4877432276655545,1.3637716656855496,0.08487084870848709,0.677202984753803,1.0,8/49,9.33%,STAT3;PRKD2;SERPINE1;HMGB1;RELA;TLR7;F3;PYCARD
prerank,endothelial tube morphogenesis (GO:0061154),0.6738210420393617,1.3631094163521695,0.12748344370860928,0.6783097560331467,1.0,5/10,10.92%,CCM2;PRKD2;RHOB;CTNNB1;RBPJ
prerank,positive regulation of cell population proliferation (GO:0008284),0.42249452196269327,1.3624810590011593,0.0,0.6793986587202845,1.0,64/423,12.34%,GDNF;MYC;BMP5;OSM;SERPINF2;BAMBI;DISP3;CSF1;PDGFRB;RTKN2;CHTOP;EPHA1;TFAP2B;SLAMF1;COPS9;DERL2;ADAM17;CUL3;PDGFA;IL34;HNRNPU;SOX9;RELA;CDC123;NOP2;SLC35F6;DOT1L;TGFBR1;TGFBR2;RHOG;SDCBP;PDGFB;PRKCH;AGT;TRPM4;CNOT8;FOXP1;DHX9;CNOT6;VEGFC;PTK2B;CDK6;TCF7L2;SIRT1;CNBP;SLC25A33;BMP6;PTPRC;STX3;TET1;FAM98B;DDR2;POU3F2;HDAC1;IL18;RBPJ;KDM1A;PTPN6;UFL1;BAD;CNOT7;DNAJA2;TOX;IGF1
prerank,integrin-mediated signaling pathway (GO:0007229),0.4595219346083581,1.3623968850099595,0.07519640852974187,0.6781567298907374,1.0,12/73,8.97%,CCM2;ADAMTS1;MYH9;ZYX;PLEK;LAMA3;CUL3;ADAM9;ITGB3;ERBIN;PTK2B;COL16A1
prerank,positive regulation of cytokine production (GO:0001819),0.42427227174455656,1.3621491360931703,0.007056451612903226,0.6776782523198146,1.0,62/292,15.68%,OSM;SERPINF2;EGR1;SLC7A5;STAT3;RAB7B;IL1R1;LPL;ADAM17;PRKD2;FZD5;TYROBP;SERPINE1;HMGB1;NLRP3;EIF2AK2;ATF4;RELA;PNP;TBK1;DDX41;CADM1;CXCL17;AGT;GLMN;XRCC5;POLR3B;FOXP1;STAT6;CARD9;EIF2AK3;TMED10;DHX9;ZBTB7B;IL1A;SORL1;CYRIB;CRCP;TLR7;IL17RA;PRKCZ;PTPRC;F3;PYCARD;CTNNB1;RIPK2;CREBBP;IL18;LY9;POLR3F;CD200;APP;POLR2E;SCRIB;RORA;SULF2;SLC11A1;POU2F2;IL6;CD86;FLOT1;RUNX1
prerank,dendritic cell migration (GO:0036336),0.6005622927183634,1.362070279969041,0.113997113997114,0.6764288747748198,1.0,6/16,11.95%,CXCR4;HMGB1;TRPM4;GPR183;CCR5;TRPM2
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.597279774797995,1.3613288684172222,0.13224368499257058,0.6765344435966513,1.0,7/15,21.54%,ZFP36;TOB1;CNOT7;TNRC6C;CNOT1;AGO2;CPEB3
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.597279774797995,1.3613288684172222,0.13224368499257058,0.6765344435966513,1.0,7/15,21.54%,ZFP36;TOB1;CNOT7;TNRC6C;CNOT1;AGO2;CPEB3
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.4307056981310374,1.3612881681780613,0.014285714285714285,0.6751059454165127,1.0,37/214,13.91%,CCL3;CCL4;CCL2;SERPINF2;PDGFRB;SLAMF1;EPHA2;PRKD2;PDGFA;HMGB1;PIN1;SIRPA;MAP2K7;MAP2K1;APOE;GLIPR2;PDGFB;GPR183;SEMA6A;CARD9;PTK2B;HTR2C;P2RY1;PRKCZ;PTPRC;PYCARD;PTPRR;ARRB1;ATP6AP1;PTPN6;APP;TNIP1;SYNJ2BP;CCL25;CCL13;ROR1;GCNT2
prerank,negative regulation of type I interferon production (GO:0032480),0.5067547578262438,1.360509964609387,0.08930817610062892,0.6766958401602563,1.0,18/40,19.69%,RELB;ACOD1;PIN1;SIRPA;TBK1;NLRC3;PCBP2;PYCARD;TRAF3IP1;ILRUN;IKBKE;PTPRS;TNFAIP3;NLRC5;NLRX1;PPM1B;RNF216;ITCH
prerank,steroid hormone biosynthetic process (GO:0120178),0.5320664659976433,1.3603221473508815,0.1062992125984252,0.6759120629402564,1.0,5/29,15.17%,FDX1;HSD17B1;STARD3;STARD3NL;MED1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5627188843413312,1.3602680496857977,0.11470588235294117,0.6745442655036894,1.0,5/20,6.05%,EGR1;HSP90AB1;ZMIZ1;TGFBR1;DCUN1D1
prerank,regulation of aerobic respiration (GO:1903715),0.6034430767982751,1.360109501618514,0.12351190476190477,0.6735533133567859,1.0,5/15,13.52%,SHMT2;COX7A2;SLC25A33;COX7A2L;IDE
prerank,positive regulation of blood coagulation (GO:0030194),0.5849254489652651,1.3596419702352105,0.11846153846153847,0.6739840971388322,1.0,3/17,9.27%,SERPINF2;SERPINE1;F3
prerank,regulation of interleukin-1 production (GO:0032652),0.6108511677466746,1.3591322018928402,0.11649016641452345,0.6744934519955117,1.0,4/15,7.72%,HMGB1;SIRPA;FOXP1;TMED10
prerank,translational elongation (GO:0006414),0.45840829953391293,1.3588362230242423,0.043478260869565216,0.6741356147650143,1.0,24/101,13.39%,EEF1B2;MRPL40;MRPL18;MRPL51;MRPL47;MRPS26;GFM2;MRPL50;MRPS6;MRPS35;MRPS28;MRPL28;MRPL30;MRPS31;MRPL46;MRPS34;MRPS12;MRPS7;MRPL37;MRPL2;TSFM;MRPL41;MRPL27;MRPS27
prerank,tetrapyrrole metabolic process (GO:0033013),0.569507567532362,1.358468896320203,0.12556732223903178,0.6741026903903544,1.0,4/18,16.64%,MMACHC;TCN2;MMAA;LMBRD1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.48250033961819816,1.358091110854683,0.08139534883720931,0.6741232649843761,1.0,16/55,15.90%,PDGFRB;CBR1;ACOD1;DHRS4;TGFBR2;PDGFB;AGT;EIF6;NOXO1;SLC25A33;SIRT5;SIRT2;PDK3;ARF4;PAX2;RAC1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.5669707471435291,1.3576874282188247,0.1295774647887324,0.6741921293991293,1.0,7/19,17.55%,NLRP3;CARD16;CD33;PYDC1;IGF1;TNFAIP3;ZC3H12A
prerank,negative regulation of fat cell differentiation (GO:0045599),0.5113983054036246,1.3566851595567848,0.10371318822023047,0.6767829599266096,1.0,13/34,17.82%,CCDC85B;BBS12;TRIB2;SIRT1;SIRT2;TRIO;GPS2;RORA;IL6;WWTR1;FLCN;SMAD3;RUNX1T1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.582935925236891,1.3564708413940605,0.11671469740634005,0.6761061007280541,1.0,6/17,14.89%,PDGFRB;PPP1R15B;HSP90AB1;PTPRC;CD33;MTOR
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.43927671604580937,-1.3563145518325805,0.11228070175438597,1.0,1.0,8/23,11.29%,MOSMO;SUFU;ENPP1;PTCH1;MGRN1;HERC4;MEGF8;BTRC
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.5224713425923806,1.35559139081459,0.11895424836601307,0.6781929297778622,1.0,6/28,5.51%,SQSTM1;AKAP5;TYROBP;FAM107A;CALB1;APOE
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.5579622436336072,1.3554070543654964,0.12622720897615708,0.6774368376043962,1.0,3/21,5.58%,UCHL5;DLG5;ULK3
prerank,regulation of interleukin-8 production (GO:0032677),0.46030934062817735,1.3552142728140102,0.06526806526806526,0.6766913727838564,1.0,15/69,15.03%,STAT3;PRKD2;SERPINE1;HMGB1;RELA;OTUD7B;TLR7;PTPRC;F3;PYCARD;ARRB1;TMSB4X;CD33;C5AR2;IL6
prerank,regulation of small molecule metabolic process (GO:0062012),0.5208526273429157,1.3552091397047423,0.11096256684491979,0.6751690239998974,1.0,8/28,15.71%,BCKDK;ADIPOR1;APOE;SIRT1;PDK3;DGKQ;RORA;FOXK2
prerank,camera-type eye morphogenesis (GO:0048593),-0.5646910994201242,-1.3549278944085053,0.144,1.0,1.0,3/10,19.49%,LRP6;TENM3;VEGFA
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6174477645989782,1.3546047618717292,0.12538699690402477,0.6760533957441806,1.0,3/12,7.48%,LPL;HMGB1;FOXP1
prerank,negative regulation of TOR signaling (GO:0032007),0.508444199329784,1.3542554840502294,0.10327455919395466,0.6759289810653776,1.0,14/36,19.27%,SESN2;CASTOR1;NPRL2;ITFG2;TMEM127;SIRT1;UBR1;NPRL3;TBC1D7;FLCN;UBR2;PDCD6;PRKAA1;TSC2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.5604082640783518,1.3536281279404279,0.12962962962962962,0.6769356107998654,1.0,5/19,11.95%,SELP;FKBP1B;PTPRC;PRNP;TRPM2
prerank,positive regulation of nuclear division (GO:0051785),0.5437645268306871,1.3536196082832024,0.10555555555555556,0.6754453735593503,1.0,6/25,15.26%,PDGFRB;PDGFB;IL1A;SIRT2;IGF1;LRP5
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.45327238769612366,-1.3535796436055905,0.08666666666666667,1.0,1.0,11/20,28.10%,SLC8B1;SLC8A3;LETM1;MCUB;MICU3;SPG7;PHB2;STOML2;MAIP1;PMPCA;SMDT1
prerank,vesicle coating (GO:0006901),0.4667601229279226,1.3533449930034593,0.08515535097813579,0.6720622899852897,1.0,20/61,15.58%,NAPA;CUL3;TRAPPC5;TRAPPC2L;PPP6R1;KLHL12;TMED10;TRAPPC10;TRAPPC4;PPP6R3;TRAPPC3;PEF1;NSF;SEC24C;TRAPPC9;SEC24A;SAR1B;STX5;USO1;ANKRD28
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.4667601229279226,1.3533449930034593,0.08515535097813579,0.6720622899852897,1.0,20/61,15.58%,NAPA;CUL3;TRAPPC5;TRAPPC2L;PPP6R1;KLHL12;TMED10;TRAPPC10;TRAPPC4;PPP6R3;TRAPPC3;PEF1;NSF;SEC24C;TRAPPC9;SEC24A;SAR1B;STX5;USO1;ANKRD28
prerank,COPII vesicle coating (GO:0048208),0.4667601229279226,1.3533449930034593,0.08515535097813579,0.6720622899852897,1.0,20/61,15.58%,NAPA;CUL3;TRAPPC5;TRAPPC2L;PPP6R1;KLHL12;TMED10;TRAPPC10;TRAPPC4;PPP6R3;TRAPPC3;PEF1;NSF;SEC24C;TRAPPC9;SEC24A;SAR1B;STX5;USO1;ANKRD28
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.5476429722423283,-1.3533337675108599,0.12342569269521411,1.0,1.0,6/11,13.20%,FBH1;SMARCAL1;BLM;ZRANB3;LIG3;TIPIN
prerank,mitochondrial translational termination (GO:0070126),0.4625505185566807,1.3530831971487773,0.04955947136563876,0.671618044368681,1.0,22/88,13.39%,MRPL40;MRPL18;MRPL51;MRPL47;MRPS26;GFM2;MRPL50;MRPS6;MRPS35;MRPS28;MRPL28;MRPL30;MRPS31;MRPL46;MRPS34;MRPS12;MRPS7;MRPL37;MRPL2;MRPL41;MRPL27;MRPS27
prerank,positive regulation of cell killing (GO:0031343),0.6155174690331456,1.3530034079411493,0.13636363636363635,0.6704415742401708,1.0,4/13,15.90%,DVL2;NOXO1;MAPK8;RAC1
prerank,maturation of 5.8S rRNA (GO:0000460),0.5799862726092426,1.3527688769858095,0.12650602409638553,0.6699305930167762,1.0,7/17,13.70%,RRP15;PES1;URB1;EIF6;C1D;EXOSC10;MPHOSPH6
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.46595786710921144,1.3527058800493748,0.075,0.6687188724040938,1.0,24/70,17.14%,OSM;PSMD2;PSMC4;EIF2AK2;PSMD4;PSMD1;PSME3;PSMB6;PSMD10;N4BP2L2;PSMB1;PSMD11;PSMA2;PSMD13;TCF3;PSMB10;PSMB3;LDB1;KMT2A;RUNX1;PUS7;YTHDF2;PSMC1;TCF12
prerank,response to hydrogen peroxide (GO:0042542),0.4893137690896267,1.3523984106633362,0.08880778588807786,0.6684857313523979,1.0,15/45,16.23%,NFE2L2;ADAM9;HDAC6;OSER1;RELA;SIRPA;GLRX2;RHOB;APTX;SIRT1;TRPM2;SETX;IL6;PAX2;TNFAIP3
prerank,peptide metabolic process (GO:0006518),0.4599150697239895,1.3520930703916447,0.0703125,0.66830460797288,1.0,15/75,13.52%,CPXM1;MMACHC;CLN5;CARNMT1;TPP1;GLRX2;SEC11A;HPGDS;SPPL3;HM13;FURIN;PCSK1;NPEPPS;DPEP1;IDE
prerank,oligodendrocyte development (GO:0014003),0.589600592043218,1.3515197528660667,0.1225114854517611,0.669146379572033,1.0,7/15,16.99%,SOX10;EIF2B2;CNTNAP1;B4GALT5;NSUN5;PLP1;EIF2B3
prerank,production of siRNA involved in RNA interference (GO:0030422),0.649154636794896,1.351404201068204,0.1390728476821192,0.6680901172957954,1.0,5/10,20.13%,TARBP2;DROSHA;TSN;TSNAX;AGO2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.45546877810673014,1.35126623028766,0.07432432432432433,0.6672710270293466,1.0,28/76,19.69%,PRMT2;ACOD1;NLRP3;RBCK1;CMKLR1;ERBIN;NLRC3;PSMD10;SIRT1;SPI1;PYCARD;PARP10;ARRB1;TMSB4X;COMMD6;UFL1;CD200;PYDC1;IRAK2;TRAF3;TNFAIP3;NLRC5;OTULIN;ZC3H12A;DDIT3;NWD1;AIM2;ITCH
prerank,response to UV (GO:0009411),0.44912687361091114,1.3506775623858838,0.05194805194805195,0.6682680354257456,1.0,17/95,10.92%,MYC;UVSSA;DDB2;BRSK1;COPS9;ATF4;RELA;EIF2S1;MAP2K7;PCNA;TAF1;SMPD1;MAPK8;CREBBP;ERCC2;CASP9;KDM1A
prerank,membrane protein proteolysis (GO:0033619),0.5130559174968925,1.350509420744002,0.09535759096612297,0.6674933999510062,1.0,9/37,7.65%,NAPSA;MYH9;ADAM17;MBTPS1;ADAM9;RELA;SPPL3;HM13;ADAM19
prerank,ERK1 and ERK2 cascade (GO:0070371),0.5550876351735167,1.3502431927635947,0.11283497884344147,0.6670995331746464,1.0,4/21,4.92%,MYC;KARS1;SOX9;MAP2K1
prerank,ATP synthesis coupled proton transport (GO:0015986),0.5874869289941499,1.349661694180122,0.12265512265512266,0.6680607301367284,1.0,9/17,18.30%,ATP5MF;ATP5PF;ATP5F1E;ATP5PD;ATP5MC2;ATP5F1C;ATP5F1D;ATP5MC3;ATP5MG
prerank,cellular response to pH (GO:0071467),0.5867110848508196,1.3483845539394872,0.14488636363636365,0.6716593506136489,1.0,1/17,0.11%,KCNK4
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.4768713135168354,1.348329239491517,0.09810874704491726,0.6704432531075296,1.0,13/49,13.92%,RTKN2;BCL2L1;PLAUR;BID;NUPR1;BCL2L2;GSDME;SGMS1;EIF2AK3;PYCARD;BAD;P4HB;NDUFA13
prerank,regulation of cell differentiation (GO:0045595),0.4352187015958489,1.3472204075432748,0.03941908713692946,0.6734746982710764,1.0,35/148,18.21%,GDNF;LTBP4;SERPINF2;CSF1;TFAP2B;HSP90AB1;TAF8;NR1D2;EIF2AK2;ATF4;CASZ1;FLOT2;TGFBR1;FADS1;PHLDB1;CDK6;SLC6A6;RUNX2;CREBBP;PA2G4;BDNF;EPHA3;GPS2;DDX5;BCL6;PTBP1;ST7;RUNX1;RAF1;SMYD5;APC;PRKCB;DAG1;TIAM1;CEBPB
prerank,primary alcohol metabolic process (GO:0034308),-0.42108401594633826,-1.3471143330613085,0.0989010989010989,1.0,1.0,7/25,18.96%,GPD2;PECR;ALDH3A2;GDPD1;RDH10;NAPEPLD;NAAA
prerank,cortical actin cytoskeleton organization (GO:0030866),0.5602586964262506,1.3465569275074798,0.1267605633802817,0.6748798944883877,1.0,7/20,9.86%,LCP1;LLGL1;PLEK;FMNL3;IKBKB;NCKAP1;RHOQ
prerank,cellular response to amino acid starvation (GO:0034198),0.4645466853916496,1.346453039190123,0.07692307692307693,0.6738295245476879,1.0,17/71,10.66%,SESN2;CASTOR1;RRAGC;ATP6V1D;ATP6V1A;ATP6V0D1;NPRL2;EIF2AK2;ATF4;ITFG2;EIF2S1;ATP6V0E1;EIF2AK3;LARS1;MAPK8;ATP6V0C;RHEB
prerank,positive regulation of protein binding (GO:0032092),0.47391000796982446,1.3464515957664038,0.09389671361502347,0.6723916925817599,1.0,17/56,13.52%,BAMBI;ADD1;PIN1;APOE;TAF1;SPPL3;RALB;LRP1;TCF7L2;NVL;CAPRIN2;RIPK2;BDNF;DERL1;APP;PPP2CB;IDE
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.5188818008492581,1.346184155136959,0.10785619174434088,0.6719850844175614,1.0,9/29,20.61%,TYROBP;CADM1;CYRIB;SPI1;RAET1E;AP1G1;SLAMF6;NECTIN2;LAMP1
prerank,ether lipid metabolic process (GO:0046485),-0.4911321709716577,-1.3461434364664315,0.12538226299694188,1.0,1.0,5/14,6.30%,NCEH1;DHRS7B;PLAAT3;PLA2G7;AGPS
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.6461109798220155,1.3459906584552628,0.14119601328903655,0.6712729116315439,1.0,2/10,1.62%,WDR1;PLEK
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.5943316955056022,1.3455147011958435,0.14652567975830816,0.671756804963625,1.0,6/14,15.39%,CD200R1;PTPRC;CD200;IGF1;CST7;TNFRSF1B
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.5214854133194493,-1.3452487244525544,0.14689265536723164,1.0,1.0,7/13,19.48%,TGFBR3;ERBB4;NOTCH1;FGFR2;ZFPM2;BMPR1A;FGF2
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.597486735767109,1.3440832212987683,0.14485981308411214,0.6763282536231687,1.0,4/14,6.40%,CSF1;IL34;CMKLR1;CXCL17
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.5688446703565005,1.3433282359321537,0.12320916905444126,0.677940473115674,1.0,8/19,16.34%,CDKL3;SS18L2;CAPRIN2;PTPRD;CDKL5;SS18L1;DBNL;CUX1
prerank,sarcomere organization (GO:0045214),0.5246467604337873,1.3433112511331227,0.11748998664886515,0.676547814305753,1.0,1/27,0.45%,WDR1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.4434377027009718,1.343304209657844,0.06309148264984227,0.675136643768627,1.0,20/107,14.69%,CCL3;SLC39A14;ATP13A2;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B;ATP13A1;SLC39A8;HTR2C;ATP1B1;ATP13A3;SLC30A5;CCL13;NPTN;SLC11A1
prerank,cytoplasmic translation (GO:0002181),0.45020990000773786,1.3431481306313207,0.06188925081433225,0.6743515436817747,1.0,37/91,20.80%,GSPT2;RPL31;ETF1;EIF3I;RPS15;RPL3;TMA7;RPL13A;RPL15;RPL10;RPS8;RPL22L1;EIF4A1;RPS27A;RPL9;RPL22;EIF4A2;ZC3H15;RPS21;RPL23A;RPL34;RPSA;RPS14;RWDD1;RPL27;RPL8;EIF2B3;RPS24;RPL38;DRG2;RPL27A;RPLP1;RPL17;RPL23;RPS11;RPS26;RPL36
prerank,positive regulation of phospholipid transport (GO:2001140),0.6443319109022883,1.3430792285367632,0.13884297520661157,0.673156489378771,1.0,2/10,5.51%,PRELID1;APOE
prerank,protein catabolic process (GO:0030163),0.461178679421345,1.3416776816748281,0.08826945412311266,0.6773695270763487,1.0,16/59,14.89%,BAG6;CTSD;DENND3;SIAH2;CLN5;TPP1;SOCS6;HSPA8;APOE;CLN8;PPT1;MAGEC2;DDB1;USE1;IDE;MTOR
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.577247307554401,1.3406113612284558,0.14122681883024252,0.6802774548135035,1.0,5/17,10.16%,CD180;LY86;CD55;BMP6;CARD16
prerank,N-glycan processing (GO:0006491),0.5659703871400737,1.3402177207913117,0.1225071225071225,0.6805115361475296,1.0,6/18,11.08%,GNPTAB;MAN2A2;PRKCSH;ST8SIA6;MGAT4A;MAN1C1
prerank,response to alcohol (GO:0097305),0.5189123423483168,1.339826693753139,0.13770053475935828,0.6807314891235275,1.0,7/27,16.14%,CCL3;TGFBR1;TGFBR2;GOT2;CCR5;GRIN2A;SDF4
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.647368030388447,1.3397756422656646,0.14814814814814814,0.6795071601003907,1.0,1/10,0.41%,BAG6
prerank,acylglycerol homeostasis (GO:0055090),0.5551117144359304,1.3394534308958002,0.14385474860335196,0.6793354645264164,1.0,5/20,15.23%,LPL;APOE;IL18;RORA;PNPLA8
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.4879837072655281,1.3393799753657065,0.10327455919395466,0.678221486210806,1.0,13/43,18.76%,SERPINF2;ADAMTS1;PDGFRB;JUN;PDGFB;FOXP1;IL18;IGF1;IL6;FGF9;FOXJ2;CDH13;GJA1
prerank,long-term memory (GO:0007616),0.5516707595178422,1.3391740568499961,0.1471004243281471,0.6775793903712357,1.0,5/19,9.29%,SHANK1;CALB1;APOE;RASGRF1;PRNP
prerank,ribosomal small subunit biogenesis (GO:0042274),0.496281849922488,1.3389363160830723,0.10467980295566502,0.6772023785340366,1.0,14/39,18.84%,RIOK1;NOP14;RPS15;NOB1;RRP7A;UTP4;RPSA;RRP36;MRPS7;RPS14;RIOK3;ERAL1;RPS24;SRFBP1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5629143762047487,1.3382345775057658,0.13314840499306518,0.6785821901247738,1.0,7/19,15.62%,SERPINF2;ADAM19;BMP6;PPM1F;PTPRU;NEXMIF;FLOT1
prerank,neural tube development (GO:0021915),-0.4907028773479776,-1.337456720424916,0.1457142857142857,1.0,1.0,7/15,25.44%,PKD1;PTCH1;DVL1;PKD2;SOX4;SOX11;PROX1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.5663736978125238,1.3371658526259949,0.13112391930835735,0.6814984517787619,1.0,7/20,9.86%,BCL2L1;PICALM;PPP2R5A;MRAP2;LZTFL1;CLTC;RHOQ
prerank,cardiac muscle contraction (GO:0060048),0.5099418627965534,1.3370935559262107,0.11969111969111969,0.680415193128144,1.0,4/34,9.70%,TNNI2;KCNH2;ATP1B1;SCN1B
prerank,positive regulation of protein sumoylation (GO:0033235),-0.5676650874394685,-1.336720372203841,0.1335149863760218,1.0,1.0,5/10,27.14%,SAE1;PIAS1;PIAS4;PIAS3;RWDD3
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.46107225315916617,-1.3362419270032435,0.08191126279863481,1.0,1.0,6/20,23.61%,FUT9;ST3GAL2;B4GALT1;ST3GAL4;B3GALT5;B3GALT1
prerank,positive regulation of cellular process (GO:0048522),0.4129407181795182,1.3355217297760051,0.0,0.6852386994466676,1.0,104/565,15.91%,GDNF;EGR2;MYC;BMP5;OSM;SERPINF2;BAMBI;CSF1;PDGFRB;RTKN2;CHTOP;EPHA1;TFAP2B;SLAMF1;COPS9;DERL2;DVL2;ADAM8;ADAM17;ZFP36;CUL3;C1QBP;PRKD2;POFUT2;DDX49;PDGFA;IL34;HSP90AB1;SOX9;FKBP1B;NUPR1;RELA;CDC123;NOP2;FXR2;SIRPA;SLC35F6;DOT1L;TGFBR1;TGFBR2;RHOG;ADGRG1;ACLY;SDCBP;PDGFB;TRPM4;CNOT8;COLEC12;AKAP6;CNOT6;VEGFC;LRP1;PTK2B;PSMD10;NOXO1;SIRT1;CNBP;SLC25A33;BMP6;SLC6A6;STX3;MAPK8;PYCARD;TET1;FAM98B;POU3F2;HDAC1;IER5;RIPK2;NCBP1;PA2G4;ACACA;PTPN6;UFL1;SIRT2;HPN;TRPC3;CNOT7;DNAJA2;EIF4G2;DOCK2;IGF1;P4HB;SLC25A5;SSR1;SRPK2;FMR1;KMT2D;GCNT2;CXCL16;CST7;MCTS1;SLC11A1;EPB41L4B;NSMCE1;IL6;WWTR1;LRP5;TNFRSF1B;CD86;FLOT1;PGF;RAC1;FLCN
prerank,positive regulation of cell migration (GO:0030335),0.4211461598655142,1.3354256582557378,0.019114688128772636,0.6841543625208685,1.0,38/253,9.97%,CCL3;SEMA3G;CSF1;STAT3;PDGFRB;EPHA1;SEMA4G;ADAM17;WNT5B;C1QBP;PIK3R3;PDGFA;SOX9;PFN1;RUFY3;ADAM9;HDAC6;FAM107A;SEMA6D;TGFBR1;RTN4;ELP3;COL1A1;GLIPR2;SDCBP;PDGFB;SEMA6A;MYO1C;MGAT5;PTK2B;ACVR1B;PTPRC;F3;SUN2;DDR2;SEMA4C;ACTG1;PPM1F
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.5766635564242161,1.3344178378973028,0.12719298245614036,0.6866819124940376,1.0,4/17,6.40%,SERPINE1;HMGB1;CREB3;CXCL17
prerank,regulation of macromolecule metabolic process (GO:0060255),0.42725533322616827,1.333830401944559,0.032989690721649485,0.6874888894824466,1.0,33/170,12.60%,GDNF;MYC;KDM6B;ZNF513;HNRNPK;HNRNPD;PIN1;NFKBIZ;NFKBID;TOB1;FUBP3;TARDBP;ZUP1;SIRPA;APOE;AFF2;FOXP1;CRIP1;UBAP2;C1D;PCBP2;MTMR3;CDK6;PTPRC;ATP1B1;YBX1;TRIM17;NPAT;SOX2;SCARB2;IGF1;APP;YBX3
prerank,lipoxygenase pathway (GO:0019372),0.5962267920425226,1.333424484001388,0.1338235294117647,0.6877890812886972,1.0,3/14,12.22%,ALOXE3;GPX4;PON2
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.6105168602546673,1.3332234581561972,0.15895061728395063,0.6871980763626028,1.0,5/12,9.29%,PICALM;FLOT2;APOE;TMED10;PRNP
prerank,response to amino acid starvation (GO:1990928),0.4578203512742714,1.3327191562556986,0.08641975308641975,0.6876633755352012,1.0,17/72,10.66%,SESN2;CASTOR1;RRAGC;ATP6V1D;ATP6V1A;ATP6V0D1;NPRL2;EIF2AK2;ATF4;ITFG2;EIF2S1;ATP6V0E1;EIF2AK3;LARS1;MAPK8;ATP6V0C;RHEB
prerank,heart trabecula morphogenesis (GO:0061384),0.5659705751719376,1.3326440016369052,0.12663755458515283,0.6865851799320499,1.0,5/18,14.96%,BMP5;TGFBR1;ENG;RBPJ;S1PR1
prerank,negative regulation of mitochondrion organization (GO:0010823),0.5059570094164179,1.3324702520122629,0.12163892445582586,0.6859642131287936,1.0,11/33,16.31%,PRELID1;BCL2L1;SLC35F6;PSMD10;ADCK1;CLU;IGF1;SLC25A5;HGF;FLCN;VAT1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.6251048630571432,1.3324062211857979,0.15867768595041323,0.6848367679036674,1.0,1/11,0.26%,CORO1C
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.44420445727907537,1.3317495179387782,0.06805708013172337,0.6862979126551279,1.0,30/84,19.02%,ILF3;MALSU1;PIN1;RPL13A;RIDA;TOB1;EIF2AK2;FXR2;RTN4;APOE;CNOT8;EIF2AK3;SORL1;SAMD4B;PRNP;YBX1;BTG2;GIGYF2;CNOT7;CLU;IGF1;FMR1;EIF4E2;DAPK1;PUS7;CNOT10;CALR;ENC1;NTRK2;CNOT1
prerank,negative regulation of lipid metabolic process (GO:0045833),0.5455795902640633,1.3314046682204033,0.14611260053619302,0.6862155468871284,1.0,6/22,18.47%,APOD;APOC1;PPP2R5A;NCOR1;PDE3B;PRKAA1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.34434509125098994,-1.3314011859337025,0.05161290322580645,1.0,1.0,15/54,10.72%,DPP6;KCNIP4;CAB39;CACNA1D;DPP10;WWP2;KCNN2;KCNIP1;GNG2;KCNJ3;BIN1;KCNIP3;DLG1;KCNJ10;KCNAB1
prerank,MAPK cascade (GO:0000165),0.4202841769410367,1.331390081869496,0.01706827309236948,0.6849033433108956,1.0,52/295,12.34%,CCL3;GDNF;MYC;CCM2;CCL2;MAPKAPK2;PDGFRB;DUSP5;BCL2L1;ZFP36;CUL3;PEBP1;KARS1;PSMD2;PDGFA;SOX9;FGF13;PSMC4;FBXW11;IKBKB;PSMD4;MAP2K7;CSF2RA;PSMD1;MAP2K1;RPS27A;UBC;ZDHHC9;PPP1CB;RASGRF1;PIK3R1;FNTA;PDGFB;KBTBD7;PSME3;NRAS;PSMB6;PSMD10;MAPK8;RASGRP3;ARTN;SYNGAP1;PSMB1;IL18;TAOK2;PSMD11;PSMA2;PSMD13;CCR5;PTPRA;TNIK;IGF1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.43728633348698837,1.3313473369920887,0.04909284951974386,0.6836927615001652,1.0,19/117,15.03%,MC2R;CALCA;MYH9;ADAM17;RHBDF2;KARS1;HRH2;ADCY5;FURIN;GNB1;PRKAR2A;GPR176;DPEP1;ADCY8;ADCY3;FCGR1A;ADRB2;CREB1;IL6
prerank,defense response to Gram-negative bacterium (GO:0050829),0.48826216600342354,1.3312119009596501,0.09912170639899624,0.6828508258875066,1.0,8/42,15.77%,SELP;SERPINE1;PYCARD;OPTN;DROSHA;SLC11A1;IL6;RNASE3
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.5341778941198247,1.330915536447318,0.14627659574468085,0.6826299129170436,1.0,3/23,7.25%,ALOXE3;FADS1;GPX4
prerank,cell chemotaxis (GO:0060326),0.4587032225568535,1.3308889154696337,0.09427609427609428,0.6813623462499401,1.0,12/60,15.04%,EGR3;PDGFRB;NR4A1;EPHA2;CXCR4;RHOG;PDGFB;ELMO2;CCR5;CCL25;LPAR1;HGF
prerank,negative regulation of immune system process (GO:0002683),0.5729944601020566,1.330887592909936,0.15950920245398773,0.6800145937061038,1.0,4/16,12.97%,PDCD1;SOX9;CD200;COL3A1
prerank,actin filament depolymerization (GO:0030042),0.622803280079827,1.3307412781649026,0.15396578538102643,0.6792778805126273,1.0,2/11,0.45%,MICAL1;WDR1
prerank,positive regulation of immune system process (GO:0002684),-0.4819114526678726,-1.3305617069574767,0.12732919254658384,1.0,1.0,7/16,33.48%,NCKAP1L;VEGFA;TGFB2;PIK3CB;IL15;RSAD2;ANXA1
prerank,central nervous system neuron differentiation (GO:0021953),0.5082678729722693,1.3290178732382254,0.11037234042553191,0.6849120805583421,1.0,7/33,12.11%,NPY;CHD5;FAIM2;RYK;CTNNB1;ZC4H2;TOX
prerank,regulation of protein-containing complex assembly (GO:0043254),0.43816006923977463,1.328898758310663,0.06673842841765339,0.6840673730210811,1.0,22/110,11.94%,SELP;NAPA;GFAP;TMC8;WARS1;BID;FBLIM1;EIF2AK2;FNIP2;HDAC6;HSPA8;APOE;GNL3L;RALB;SORL1;LATS1;PRKCZ;TRAF3IP1;SUMO1;HJURP;HSPA5;CLU
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.5884084485975032,1.328329544300895,0.12354651162790697,0.6848756479201601,1.0,9/16,18.30%,ATP5MF;ATP5PF;ATP5F1E;ATP5PD;ATP5MC2;ATP5F1C;ATP5F1D;ATP5MC3;ATP5MG
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.49924705696628935,-1.3280512392171449,0.13920454545454544,1.0,1.0,5/14,15.53%,TRAF6;TRAF2;MAP3K7;TLR3;COPS8
prerank,cellular response to BMP stimulus (GO:0071773),0.45991198025737984,1.3278534148662118,0.09360730593607305,0.6854070302530247,1.0,11/66,13.08%,BMP5;ADAMTS12;SOX9;SMURF1;HIVEP1;ENG;BMP6;RUNX2;ACVR2B;ZFYVE16;DDX5
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.5258729718564237,1.3276690854229394,0.13164893617021275,0.6847819894630807,1.0,11/27,14.52%,BAG6;KAT5;ATAT1;TRRAP;BRD8;CREBBP;TAF6;NAA50;MORF4L2;MORF4L1;PHF20L1
prerank,neurotransmitter transport (GO:0006836),0.4523171138518961,1.3276443116647512,0.08304891922639362,0.6835444055383223,1.0,20/73,14.82%,BRSK1;PDZD11;RIMS1;HSPA8;LIN7C;SLC32A1;SLC29A1;SLC1A3;GLS2;GLS;PPFIA4;STXBP3;SYN3;SLC1A1;GAD2;PTPRN2;SNPH;SLC38A1;SLC6A2;SYT1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.5914224863062622,1.3271606844116153,0.154434250764526,0.684134607257226,1.0,1/15,0.08%,ATF3
prerank,heart process (GO:0003015),-0.5081993212605114,-1.3269526528276903,0.15501519756838905,1.0,1.0,5/14,22.53%,SGCZ;SGCD;SOD1;NOX4;GPX1
prerank,anterior/posterior pattern specification (GO:0009952),0.4665578952829899,1.3269027221102851,0.09210526315789473,0.6838158720440183,1.0,11/53,18.07%,HOXD9;BASP1;HOXB7;CELSR2;TGFBR1;ACVR2B;ATP6AP2;HOXC6;LRP5;HOXB3;DDIT3
prerank,activin receptor signaling pathway (GO:0032924),0.5742550403910558,1.3265981485955614,0.15781710914454278,0.6837347850633037,1.0,5/15,17.45%,TGFBR1;ACVR1B;ACVR2B;ACVR1;SMAD3
prerank,central nervous system neuron development (GO:0021954),0.5856793682106952,1.3265836250646275,0.13943028485757122,0.6824864723759012,1.0,2/15,2.96%,NPY;HSP90AB1
prerank,energy reserve metabolic process (GO:0006112),0.5564062266898344,1.326560561170765,0.1463768115942029,0.6812693894218165,1.0,3/19,7.72%,MYC;MRAP2;GFPT1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.44736513954334683,1.3264753597924537,0.0752453653217012,0.6802636844907255,1.0,13/86,10.92%,BMP5;FBXL15;ADAM17;HSP90AB1;RBPMS;TGFBR1;SDCBP;ACVR1B;ENG;BMP6;CREBBP;ACVR2B;RBPJ
prerank,phosphate-containing compound metabolic process (GO:0006796),0.41948922331713084,1.3256750078334945,0.027635619242579325,0.6822325664955151,1.0,32/198,12.60%,PLB1;PLCD4;G6PC3;STAT3;PGK1;DUSP5;PFKM;PI4KA;PLCH1;LPL;DUSP16;XYLB;INPP5K;BCKDK;PFKFB3;PLPPR4;NUDT5;PLA2G4A;ITPKC;GPX4;ACYP1;GFPT1;CLN8;PTPRC;ITPKB;PTPRD;IP6K2;PPA2;IPPK;PANK3;INPP4A;OCRL
prerank,cilium-dependent cell motility (GO:0060285),0.541025467496107,1.3254003262013427,0.15164520743919885,0.6820301726778094,1.0,3/22,6.69%,EFHC1;EFHC2;RSPH9
prerank,tryptophan metabolic process (GO:0006568),-0.5427204138363576,-1.324751801566245,0.17415730337078653,1.0,1.0,6/11,39.13%,KYNU;KYAT1;HAAO;KMO;IL4I1;ATP7A
prerank,regulation of tau-protein kinase activity (GO:1902947),0.6448232621204608,1.324721175582259,0.16097560975609757,0.6834079133542765,1.0,4/10,11.94%,EGR1;HSP90AB1;SORL1;CLU
prerank,L-glutamate transmembrane transport (GO:0015813),0.6274078173016552,1.3244583771919067,0.15822784810126583,0.6831014990083305,1.0,4/10,12.37%,ARL6IP5;SLC25A13;SLC1A3;SLC1A1
prerank,import into nucleus (GO:0051170),0.45132609231087384,1.3239945891773353,0.09728506787330317,0.6836391005657362,1.0,14/73,9.34%,SPRN;STAT3;DDX20;IPO5;PPP1R10;NUP153;TNPO2;PTTG1IP;PRICKLE1;RPAIN;IPO13;NUP88;FAM53C;GEMIN7
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.5832092144611034,1.32352908811794,0.13402061855670103,0.6841005378975025,1.0,4/15,5.48%,REEP2;TMEM33;RAB18;RTN4
prerank,regulation of cytoplasmic translation (GO:2000765),0.5933091142883722,1.3234761192135815,0.1523076923076923,0.6829949132217883,1.0,5/14,13.60%,DHX9;CNBP;CPEB1;YBX3;FMR1
prerank,negative regulation of protein processing (GO:0010955),0.6055829462268695,1.323388377688399,0.1633587786259542,0.6820172089997919,1.0,3/12,9.29%,SERPINF2;SERPINE1;PRNP
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.5899861224695381,1.3225297703077523,0.16424418604651161,0.6840623451562078,1.0,6/14,15.46%,NLRP3;NFKBIZ;NFKBID;PRKCZ;IL18;CD86
prerank,regulation of plasminogen activation (GO:0010755),0.6163796734281198,1.3221626479021047,0.13643659711075443,0.6842451706839635,1.0,6/12,21.48%,SERPINF2;SERPINE1;HPN;RUNX1;SERPINE2;CTSZ
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.4230662775397423,-1.3220782746462003,0.10526315789473684,1.0,1.0,8/23,12.89%,CBL;TSG101;SOCS5;ZFYVE28;MVP;ERRFI1;ZGPAT;SH3BP5
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.5154128778145254,-1.3220052544871497,0.16056338028169015,1.0,1.0,6/12,19.18%,SERINC3;MTHFD1;SEPHS1;PSAT1;SRR;SERINC5
prerank,protein localization to cell junction (GO:1902414),-0.42915368804017745,-1.321537947998135,0.10600706713780919,1.0,1.0,7/22,8.27%,NLGN1;TJP2;KIF3A;JAM3;PAK2;FERMT2;PCLO
prerank,divalent inorganic cation homeostasis (GO:0072507),0.5313497990292853,1.321521028788837,0.13831258644536654,0.6855164989766703,1.0,6/25,15.82%,TMC8;TFAP2B;ATP13A2;CNNM2;WFS1;SELENON
prerank,serine family amino acid catabolic process (GO:0009071),0.6341711320653413,1.3212196237912563,0.14802631578947367,0.6854226151817943,1.0,1/10,0.79%,SHMT2
prerank,icosanoid metabolic process (GO:0006690),0.48736236428238505,1.3210386813124588,0.11878787878787879,0.6848290373337048,1.0,9/40,15.23%,MAPKAPK2;ALOXE3;PLA2G4A;FADS1;GPX4;TBXAS1;PON2;DPEP1;PNPLA8
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5470308737314088,1.320924875891131,0.1581196581196581,0.683989128249907,1.0,6/21,11.84%,BCL2L1;CREB3L1;NCK1;CREB3;EIF2AK3;TMBIM6
prerank,leukocyte cell-cell adhesion (GO:0007159),0.5314517751334478,1.320582547281164,0.14685314685314685,0.6840305709049426,1.0,4/24,12.75%,SELP;ITGAL;MSN;TNIP1
prerank,negative regulation of chemotaxis (GO:0050922),0.5105927983625086,1.3204378792982758,0.14701986754966886,0.6833093018683003,1.0,6/31,9.93%,SEMA3G;SEMA4G;ANGPT2;SEMA6D;SEMA6A;SEMA4C
prerank,regulation of interferon-gamma production (GO:0032649),0.4496065540188409,1.3202197636622943,0.10336817653890824,0.6829673749610474,1.0,16/71,18.07%,SLC7A5;IL1R1;C1QBP;FZD5;HMGB1;SIRPA;CYRIB;TLR7;PRNP;PYCARD;IL18;SCRIB;SLC11A1;HSPD1;ZC3H12A;DDIT3
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.4796718388486697,1.3201815051963945,0.11262376237623763,0.681816112677021,1.0,9/40,12.34%,PRELID1;BCL2L1;PLAUR;BID;PSMD10;PYCARD;BAD;CLU;IGF1
prerank,translation (GO:0006412),0.42243684359819766,1.319596323570687,0.025510204081632654,0.6828072060238801,1.0,47/208,12.80%,EEF1B2;GSPT2;MRPL18;MRPL51;RPL31;WARS1;ETF1;MRPL47;KARS1;IARS2;RPS15;RPL3;TMA7;GFM2;RPL13A;RPL15;RPL10;SARS1;SARS2;IARS1;RPS8;MRPS6;MRPS28;MRPL28;RPL22L1;RPS27A;RPL9;RPL22;ZC3H15;RPS21;RPL23A;LARS1;MRPS34;MRPS12;PPA2;RPL34;RRBP1;RPSA;MRPS7;MRPL37;MRPL2;RPS14;TSFM;MRPL41;MRPL27;TNIP1;RWDD1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.4293156747133379,1.319196516015041,0.04855371900826446,0.6830357813723663,1.0,23/142,13.81%,LPAR3;CALCA;CXCR4;HMGB1;FKBP1B;ABL2;CALB1;CACNA1A;ADCY5;CMKLR1;CD55;SPPL3;TRPM4;P2RY1;TMEM178A;TRPC4;TRPC1;TRPC3;CCR5;ADCY8;C5AR2;LPAR1;NPTN
prerank,glial cell development (GO:0021782),0.5295443294376421,1.319036740929868,0.1388888888888889,0.6824379426839238,1.0,8/25,17.26%,SOX10;EIF2B2;NRROS;CDK6;NSUN5;APP;EIF2B3;PICK1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.44861095250057603,-1.318774650573616,0.09830508474576272,1.0,1.0,10/21,16.55%,CALM2;CACNA1C;ANK2;CALM1;PRKACA;SLC8A1;SRI;ATP1A2;PDE4D;CALM3
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.507445990727029,1.3187101082086565,0.12634408602150538,0.6824486859728199,1.0,11/31,13.41%,WDR1;PDZD11;PDCD6IP;LIN7C;ERBIN;SH3BP1;ANK1;MSN;MYO9A;SYNJ2BP;SCRIB
prerank,methylguanosine-cap decapping (GO:0110156),0.6315298624328264,1.3184123429364283,0.15656565656565657,0.6823332976475254,1.0,5/10,15.04%,DCP1A;EDC3;PNRC2;DCP1B;PATL1
prerank,positive regulation of transferase activity (GO:0051347),0.42364484392378055,1.3178916082228231,0.05219206680584551,0.6831961615886968,1.0,30/142,13.73%,MYC;PDGFRB;EPHA1;EPHA2;NEK7;HNRNPD;ACD;HSP90AB1;PIN1;MAP2K7;SERINC1;PCNA;DCUN1D1;XRCC5;PTGES3;RYK;POLG2;SORL1;NVL;NBN;CTNNB1;DDR2;EPM2AIP1;UBE2L3;CD200;EPHA3;MAGEC2;UBE2I;HMBOX1;ROR1
prerank,cellular response to light stimulus (GO:0071482),0.4556585074334657,1.3178572098801304,0.09307604994324631,0.6820690094702639,1.0,11/66,11.35%,MYC;COPS9;ATF4;EIF2S1;PCNA;TAF1;SMPD1;CREBBP;CASP9;KDM1A;GNB1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.48243078956548757,-1.317692502796984,0.11708860759493671,1.0,1.0,8/16,16.55%,CALM2;CACNA1C;ANK2;CALM1;PRKACA;SLC8A1;ATP1A2;CALM3
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.4328265125501333,1.3171523916074697,0.05931321540062435,0.6835098581551611,1.0,29/124,16.74%,GDNF;NPY;IQCG;PLEK;BLOC1S6;CATIP;LIMA1;HMGB1;LRP12;MANF;APOE;MAP4;RASGRF1;ATXN10;RYK;CYFIP1;STX3;TTC17;BTG2;APP;PLP1;ARMC2;IL6;GPM6A;CNTN4;RAC1;MICALL1;ZFYVE27;GPM6B
prerank,central nervous system myelination (GO:0022010),0.6192157334898941,1.3156675671635212,0.15650741350906094,0.6879243289497202,1.0,5/11,13.56%,SOX10;CNTNAP1;B4GALT5;CLU;PLP1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.49256017396447455,1.315024341203268,0.12830188679245283,0.6890646789842914,1.0,12/37,17.55%,STAT3;APOD;PLD3;SIRPA;NLRC3;CARD9;IL17RA;PYCARD;IL6;PER1;ADCY7;ZC3H12A
prerank,regulation of protein metabolic process (GO:0051246),0.4807146078325686,1.3150147024118444,0.11138310893512852,0.6878371897872656,1.0,13/44,14.27%,LTBP4;PLAUR;HSP90AB1;TMEM9;APOE;CENATAC;FURIN;MAPK8;NEDD8;VPS35;APP;TRAF3;WFS1
prerank,response to cholesterol (GO:0070723),0.5718409960767405,1.3148537445355868,0.12684365781710916,0.6872078540137245,1.0,5/17,11.82%,CCL3;TGFBR1;TGFBR2;GRAMD1A;CCR5
prerank,protein import (GO:0017038),0.4421449260756582,1.3143956166096906,0.07891770011273957,0.6876780475913745,1.0,18/84,10.09%,SPRN;STAT3;HSPA4;IPO5;PPP1R10;NUP153;TNPO2;PTTG1IP;PRICKLE1;RAB8B;APOE;RPAIN;SNX33;PEX3;IPO13;NUP88;FAM53C;GDAP1
prerank,iron ion transport (GO:0006826),0.4783841522791029,1.3142225631989801,0.10735826296743065,0.6871371576416285,1.0,16/47,17.75%,SLC39A14;ATP6V1D;ATP6V1A;ATP6V0D1;DNM2;ATP6V0E1;ATP6V0A1;CLTC;ATP6V0C;ATP6AP1;ABCB7;SLC11A1;ARHGAP1;ATP6V0B;IREB2;ATP6V1G2
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5713088536202454,1.3140112603870617,0.15886524822695036,0.6867201292062578,1.0,3/17,8.78%,LPL;APOC1;FURIN
prerank,positive regulation of leukocyte migration (GO:0002687),0.5205631125347409,1.3134029941028673,0.14092140921409213,0.6879928331526319,1.0,3/27,1.61%,CSF1;ADAM8;ADAM17
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.44586849225615804,1.3131689816570309,0.08004509582863585,0.6876289012381857,1.0,15/79,14.29%,BAMBI;ADAMTS12;CREB3L1;SKIL;LEMD2;CRIM1;AGT;SMURF1;UBE2D1;SORL1;UBE2D3;ACVR2B;LEMD3;SKOR2;SULF2
prerank,vacuolar acidification (GO:0007035),0.5401350125522603,1.3130342181679864,0.14344827586206896,0.6868381801992334,1.0,10/21,19.42%,CLN5;ATP6V0D1;TMEM9;ATP6V0E1;PPT1;ATP6V0A1;ATP6AP2;SLC11A1;DMXL2;DMXL1
prerank,positive regulation of ERAD pathway (GO:1904294),0.5946815935335553,1.3127578980982582,0.14414414414414414,0.68670643943686,1.0,2/13,1.39%,BAG6;NFE2L2
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.43554819762507996,1.312689784749354,0.06796116504854369,0.6857597970956184,1.0,24/110,12.43%,MAGOH;MAGOHB;GSPT2;DCP1A;RPL31;ETF1;RPS15;RPL3;RPL13A;RPL15;RPL10;RPS8;RPS27A;RPL9;DHX34;RPL22;PNRC2;SMG7;RPS21;RPL23A;NCBP1;RPL34;RPSA;RPS14
prerank,positive regulation of interferon-gamma production (GO:0032729),0.46676743893244566,1.3126825972558762,0.10184049079754601,0.6845490247715954,1.0,10/48,16.07%,SLC7A5;IL1R1;FZD5;CYRIB;TLR7;PYCARD;IL18;SCRIB;SLC11A1;HSPD1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.556160921871081,1.3122369832941234,0.14905933429811866,0.6850671724841747,1.0,3/18,2.92%,CXCR4;TMEM98;IL34
prerank,positive regulation of lamellipodium organization (GO:1902745),0.49368087290655743,1.3118594629220568,0.13082901554404144,0.6853337824515385,1.0,6/32,8.66%,CORO1C;ABI2;ARPC2;PIK3R1;NCKAP1;CYFIP1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.6288590511688297,1.311733204846236,0.16065573770491803,0.6846118725170003,1.0,4/10,15.21%,DERL2;ERLEC1;UBAC2;UBE2J1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.4323683730951213,1.311717558273499,0.0861504907306434,0.6834435985129855,1.0,35/100,19.93%,BAG6;ARIH2;UCHL5;GABARAP;HSP90AB1;RYBP;PRICKLE1;USP5;TAF1;TRIB2;SDCBP;GLMN;CSNK1E;PSMD10;SUMO1;COP1;UFL1;SIRT2;UBXN1;CLU;DNAJB2;RNF144A;RNF19B;STUB1;EIF3H;ARIH1;MAP1A;CSNK1D;CEBPA;ARAF;ANKIB1;HECTD1;FHIT;TRIB1;VCP
prerank,somite development (GO:0061053),-0.5379903023591162,-1.3111194963139092,0.1356382978723404,1.0,1.0,3/11,6.98%,PTCH1;PPP2R3A;MTHFD1
prerank,presynapse organization (GO:0099172),-0.5341176177272258,-1.3109895013057717,0.15485564304461943,1.0,1.0,5/10,24.11%,NLGN1;DVL1;C5AR1;NLGN2;NLGN3
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.4174579969745021,1.3104082225187528,0.041109969167523124,0.6874424595255868,1.0,58/190,19.30%,RTKN2;DLG5;EPHA2;BCL2L1;PLEK;PLAUR;PEBP1;INPP5K;OTUD3;NPRL2;NLRP3;MAP2K3;RELA;TANK;TMEM127;ADIPOR1;BCL2L2;PPP2R5B;NLRC3;OTUD7B;SH3BP1;CD2AP;DGKD;PSMD10;CYRIB;SIRT1;UBR1;SPI1;PYCARD;PHLPP1;PIK3IP1;TMSB4X;WWC2;TNIP1;RORA;NDUFA13;NPRL3;TBC1D7;CIT;VGLL4;FLCN;RNF34;TNFAIP3;RIOK3;PER1;UBR2;ZC3H12A;DAG1;PDCD6;DDIT3;PDE3B;PRKAA1;DUSP3;ARHGAP25;NLRX1;PDE11A;TSC2;PPM1B
prerank,transferrin transport (GO:0033572),0.5028075951116903,1.3104069223627,0.13584905660377358,0.6862248441104785,1.0,12/33,17.75%,ATP6V1D;ATP6V1A;ATP6V0D1;DNM2;ATP6V0E1;ATP6V0A1;CLTC;ATP6V0C;ATP6AP1;ARHGAP1;ATP6V0B;ATP6V1G2
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.6097460475022827,1.3103972343259196,0.184,0.6850376029048293,1.0,5/12,14.44%,ZBTB7A;FOXP1;SIRT1;HDAC1;NCOR1
prerank,regulation of protein kinase activity (GO:0045859),0.436049929166377,1.3100099009690718,0.07462686567164178,0.6853237169408349,1.0,22/106,12.52%,AGAP2;CSF1;EPHA1;WARS1;INPP5K;TARBP2;DUSP19;MAP2K3;DBNDD2;ALS2;CAMKK1;TRIB2;TSPYL2;XRCC5;PTK2B;SIRT1;PTPRC;DDR2;PPM1F;PRKAG1;PYDC1;ANKRD54
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.4495715911716869,1.3095540724810453,0.09954751131221719,0.6858961942406532,1.0,24/73,17.14%,OSM;PSMD2;PSMC4;EIF2AK2;PSMD4;PSMD1;PSME3;PSMB6;PSMD10;SPI1;PSMB1;PSMD11;PSMA2;PSMD13;TCF3;PSMB10;PSMB3;LDB1;KMT2A;RUNX1;PUS7;YTHDF2;PSMC1;TCF12
prerank,negative regulation of developmental growth (GO:0048640),0.49795469727289465,1.309452168349301,0.14986737400530503,0.6850452623696545,1.0,4/30,5.48%,SEMA3G;CDKL3;FGF13;RTN4
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.5583624301058981,1.3093222164161982,0.18143459915611815,0.6843802344483684,1.0,4/18,5.42%,DERL2;SEL1L;RPS27A;UBC
prerank,ERBB signaling pathway (GO:0038127),-0.32706692428958706,-1.3089940992092652,0.04697986577181208,1.0,1.0,17/64,8.81%,KIF16B;CBL;HSP90AA1;GRB2;PIK3C2A;NRG2;GAB1;PTK2;BRAF;MVP;SHC3;RPS6KA5;PLCG1;ERBB4;MAPK1;CUL5;PTPN18
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.3910532306926842,-1.3085224655619763,0.09691629955947137,1.0,1.0,16/31,26.10%,NLGN1;ARHGAP44;ABI3;SIPA1L1;PDLIM5;LRRK2;CAPRIN1;PTEN;PPFIA2;CUX2;CDK5;CAMK2B;EPHA4;SHANK3;TANC2;ZDHHC15
prerank,regulation of protein modification process (GO:0031399),0.46937500953751826,1.3082082680822322,0.1166077738515901,0.6873396485297084,1.0,7/50,3.98%,CORO1C;SESN2;HPF1;WARS1;PARG;PIN1;FNIP2
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.4941721494654874,1.3081667583163994,0.13478818998716302,0.6862973607239286,1.0,8/36,11.31%,BAG6;UCHL5;HSP90AB1;RYBP;PSME3IP1;SDCBP;USP25;UBXN1
prerank,mitochondrial translation (GO:0032543),0.43770150142442127,1.3071853992613118,0.07303974221267455,0.6888846612794903,1.0,25/104,13.39%,MRPL40;MRPL18;MRPL51;MRPL47;IARS2;MRPS26;GFM2;MRPL50;MRPS6;MRPS35;MRPS28;MRPL28;MRPL30;MRPS31;MRPL46;MRPS34;MRPS12;EARS2;MRPS7;MRPL37;MRPL2;TSFM;MRPL41;MRPL27;MRPS27
prerank,proton transmembrane transport (GO:1902600),0.49773699387179904,1.3068486187747794,0.1267427122940431,0.6889935856907221,1.0,10/36,19.39%,ATP5MF;ATP6V1A;ATP6V0D1;ATP6V0E1;ATP6V0C;SLC36A1;ATP1A3;HVCN1;SLC25A14;SLC9A1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.6143893727606313,1.3068133724660753,0.15146579804560262,0.6879172459351026,1.0,5/11,12.34%,PIK3R1;EIF2AK3;GIGYF2;GIGYF1;IGF1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.6002073953755549,1.3067642575547531,0.16271186440677965,0.6857082935173112,1.0,1/12,0.26%,CORO1C
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.6002073953755549,1.3067642575547531,0.16271186440677965,0.6857082935173112,1.0,1/12,0.26%,CORO1C
prerank,cellular response to hypoxia (GO:0071456),0.42739714550228336,1.30631025635168,0.06468716861081654,0.6862391753477302,1.0,34/126,15.27%,MYC;PGK1;ADAM8;HIGD1A;PSMD2;PSMC4;PSMD4;PSMD1;MDM4;RPS27A;UBC;EGLN2;PSME3;PSMB6;PSMD10;SIRT1;CPEB1;CARD16;CREBBP;PSMB1;NPEPPS;SIRT2;BAD;PSMD11;PSMA2;PSMD13;P4HB;STUB1;PSMB10;RORA;CUL2;MTOR;PSMB3;HYOU1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.42083601914860486,1.306177720334892,0.05641025641025641,0.6855424558163614,1.0,56/168,19.44%,PNLDC1;MAGOH;MAGOHB;GSPT2;DCP1A;ZFP36;RPL31;ETF1;RPS15;RPL3;RPL13A;RPL15;RPL10;RPS8;RPS27A;RPL9;TUT7;DHX34;RPL22;PNRC2;CNOT8;SMG7;CNOT6;RPS21;SAMD4B;RPL23A;EXOSC8;NCBP1;RPL34;DCP1B;RC3H1;CNOT4;EXOSC10;TUT1;RC3H2;RPSA;CNOT7;RPS14;DDX5;RPL27;PATL1;RBM8A;RPL8;CNOT10;POLR2G;CNOT2;ZC3H12A;RPS24;UPF1;RPL38;RPL27A;CNOT1;RPLP1;PPP2R2A;RPL17;RPL23
prerank,second-messenger-mediated signaling (GO:0019932),0.44385344783600783,1.3051139084968373,0.08231368186874305,0.6884028614985843,1.0,10/82,12.02%,CCL3;CXCR4;APOE;AGT;TRPM4;EIF2AK3;DGKD;KSR2;CCR5;DDAH2
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.6438265565200808,1.3050915840472148,0.17721518987341772,0.6873097194064147,1.0,3/10,8.78%,TYROBP;HSP90AB1;FURIN
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.550022958309903,1.3048809196811677,0.1673469387755102,0.6869711750632104,1.0,4/20,11.71%,BMP5;APOC1;WDTC1;PRMT3
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.40378453286740323,1.3043353756908374,0.0,0.6879215401346035,1.0,206/834,18.71%,GDNF;ATF3;EGR2;MYC;NKX2-8;BMP5;OSM;KDM6B;SERPINF2;EGR1;HOXD8;LITAF;STAT3;ZNF513;PFKM;GLIS1;TFAP2B;DRAP1;NR4A1;HOXB7;NFE2L2;BEX1;DVL2;SQSTM1;CTBP2;NFATC2IP;JUN;PRKD2;FZD5;MED19;SERPINE1;NCK1;HMGB1;HNRNPU;PIN1;NLRP3;MAML3;SOX9;NR1D2;KLF15;NFATC3;KANSL3;FUBP3;IKBKB;ATF4;KAT5;IER2;RELA;SBNO2;ECD;SS18L2;CASZ1;ZMIZ1;CREB3L4;CREB3;TBK1;CSRNP2;DOT1L;DPF2;LARP7;RPS27A;UBC;JUP;PIK3R1;CRTC1;PDGFB;SMARCD2;TET2;RRP1B;JAG1;PAXBP1;STAT6;DHX9;ATAD2B;E2F5;TCF7L2;ELL;CCNK;HIVEP1;SMARCA1;SIRT1;TBL1X;ENG;SPI1;KLF10;CNBP;BMP6;AKIRIN2;BRD8;MICAL2;TET1;GABPB1;GABPB2;CAPRIN2;CTNNB1;RUNX2;RHOQ;POU3F2;PPRC1;ARRB1;HDAC1;IER5;RIPK2;DLGAP5;CREBBP;KLF7;IRF8;HDAC5;IL18;YBX1;SFPQ;NPAT;RBPJ;KDM1A;MITF;SOX2;ZBTB17;SIRT2;DR1;GLMP;MAML1;SS18;TAF6;SMARCB1;PHF10;PHOX2A;IGF1;TCF3;APP;SS18L1;TNIP1;CDK8;GPS2;CDK12;FOXO3;MRTFB;KMT2D;RORA;AKAP8L;SETX;LMX1B;JUND;ARF4;BRD4;MYSM1;NCOA3;SLC11A1;POU2F2;ATF1;CREB1;ATF6;MED25;IL6;HGF;MED1;WWTR1;CCNT1;LRP5;AKNA;MED13;LDB2;LDB1;KMT2A;RUNX1;FOXK2;PAX2;FLCN;TMPRSS6;SIN3A;IRF2BPL;RXRA;NFKB1;HOXB3;TET3;PER1;RPRD1B;MEF2A;KAT2A;ARHGEF2;POGZ;NLRC5;MEF2B;TCF12;FOXJ2;ZBTB49;MPND;ACVR1;SMAD3;ATMIN;ZC3H12A;RBM14;ETS1;RLF;ZBED3;TCEA1;CEBPZ;DDIT3;MEF2C;CEBPB;CDH13;CEBPA;MED4;EPAS1;HLF;TFCP2;CDK9
prerank,cardiocyte differentiation (GO:0035051),0.638495568981843,1.3039284963531412,0.16097560975609757,0.6881997276996845,1.0,1/10,0.29%,KDM6B
prerank,ruffle organization (GO:0031529),0.577487616596318,1.303837220240683,0.1567489114658926,0.6873610316502736,1.0,4/16,8.66%,PLEK;INPP5K;LIMA1;CYFIP1
prerank,cellular response to starvation (GO:0009267),0.4219923526554651,1.3026129168965594,0.065625,0.6908554911765739,1.0,33/147,11.58%,SESN2;CASTOR1;BRSK1;RRAGC;GABARAP;ATP6V1D;ATP6V1A;ATP6V0D1;NPRL2;GABARAPL1;EIF2AK2;ATF4;ITFG2;EIF2S1;PIK3R4;HSPA8;ATP6V0E1;FADS1;PIK3C3;MAP1LC3A;BRSK2;RALB;EIF2AK3;MTMR3;SIRT1;MAP1LC3B;KLF10;LARS1;MAPK8;ATP6V0C;RHEB;PRKAG1;HSPA5
prerank,potassium ion homeostasis (GO:0055075),0.5254957170085635,1.3023584149634997,0.1695827725437416,0.6906375404349858,1.0,7/23,16.47%,KCNH2;TFAP2B;KCNJ2;SLC12A6;ATP1B1;KCNMA1;ATP1A3
prerank,acylglycerol metabolic process (GO:0006639),0.4857870255879957,1.302300656982222,0.15031055900621118,0.689668260511561,1.0,7/37,8.21%,LPL;APOBR;SEL1L;DGKZ;APOC1;APOE;DGKD
prerank,tetrahydrofolate metabolic process (GO:0046653),0.6166229947495856,1.3022962809438632,0.17757009345794392,0.6885038653989947,1.0,3/10,8.34%,SHMT2;MTHFD1L;MTHFD2
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4675001308089068,1.3021294550712184,0.12412177985948478,0.6879412625120382,1.0,13/52,11.88%,EPHA2;SQSTM1;AKAP5;CLIP3;RHOG;PIK3R1;PRKCH;STAC;ZDHHC8;LRP1;STX3;STAC2;EPHA3
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.43567208727916207,1.3017843893105105,0.0929451287793953,0.6881412810590603,1.0,20/80,15.84%,MYC;CTSD;ARL6IP5;SIAH2;HMGB1;NLRP3;CARD9;DELE1;SIRT1;PYCARD;PPM1F;CARD16;SOX2;BAD;DPEP1;NDUFA13;HGF;PAX2;RAF1;DAPK1
prerank,negative regulation of inflammatory response (GO:0050728),0.41448852479439363,1.3017410768128967,0.038974358974358976,0.6871579229182745,1.0,41/182,19.03%,MC2R;CALCA;MYH9;ADAM17;RHBDF2;ACOD1;NLRP3;HRH2;SIRPA;APOE;ADCY5;CXCL17;NLRC3;CD200R1;METRNL;FURIN;TNFAIP8L2;GNB1;CD200;PRKAR2A;VPS35;IGF1;GPR176;GPS2;DPEP1;ADCY8;ADCY3;RORA;FCGR1A;ADRB2;CREB1;IL6;TNFRSF1B;TNFAIP3;PROC;ADCY7;OTULIN;INSL3;ADCY9;HCK;LRFN5
prerank,peptidyl-lysine acetylation (GO:0018394),0.6329297898331072,1.3011404367225303,0.17990275526742303,0.6882960435666636,1.0,4/10,10.23%,BAG6;KAT5;SIRT1;CREBBP
prerank,positive regulation of type 2 immune response (GO:0002830),0.5906107415768043,1.300984567717306,0.17673716012084592,0.6877641872356355,1.0,6/14,15.46%,NLRP3;PRKCZ;IL18;DENND1B;IL6;CD86
prerank,regulation of brown fat cell differentiation (GO:0090335),0.5702382244542689,1.3009639374587594,0.1696165191740413,0.6866838194794921,1.0,8/16,21.29%,HNRNPU;METRNL;ZBTB7B;SIRT1;FLCN;FTO;TFE3;RREB1
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.4974019279763615,-1.3008607970023567,0.13802816901408452,1.0,1.0,6/12,9.55%,HSP90AA1;B4GALT6;EPHB1;MYCBP2;PTEN;EPHB2
prerank,cGMP biosynthetic process (GO:0006182),0.6323976703870009,1.3006405571950268,0.15855572998430142,0.6867906477232275,1.0,1/10,1.07%,NPPC
prerank,skeletal muscle organ development (GO:0060538),0.5209174685157677,1.2999330137318375,0.13648648648648648,0.68831322445574,1.0,5/26,12.46%,BASP1;POPDC3;MYL6;IGSF8;CFLAR
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.5742198369563178,1.298911305254822,0.1705790297339593,0.6909556799185474,1.0,4/14,12.68%,ENTPD1;NUDT5;ENTPD7;ENTPD5
prerank,regulation of chemotaxis (GO:0050920),0.5059233673443959,1.298847222154677,0.16971279373368145,0.6900318772651325,1.0,8/30,12.15%,PDGFRB;CXCR4;PDGFB;GPR183;CYRIB;STX3;PPM1F;ZSWIM6
prerank,early endosome to late endosome transport (GO:0045022),-0.43684847078154115,-1.2977174086849343,0.1232876712328767,1.0,1.0,7/20,10.70%,KIF16B;RAB5A;BECN1;WDR91;SNF8;ANKRD27;HOOK1
prerank,positive regulation of cell growth (GO:0030307),0.4329122687839871,1.2976247478728833,0.08198489751887811,0.693560987435344,1.0,28/96,18.89%,CPNE9;DERL2;ADAM17;DDX49;RIMS1;RUFY3;TGFBR1;SDCBP;SMURF1;AKAP6;PSMD10;SLC25A33;NCBP1;BDNF;GOLGA4;CDKL5;HPN;LIMK1;EIF4G2;IGF1;CXCL16;SYT1;DBNL;ZFYVE27;SYT4;HDGFL2;RPTOR;MMP14
prerank,mitochondrial gene expression (GO:0140053),0.4820467023288496,1.2975118749285248,0.1368547418967587,0.6928216006650105,1.0,13/42,14.25%,MRPL51;MRPL47;IARS2;GFM2;MRPS6;MRPS28;SLC25A33;MRPS34;MRPS12;MRPS7;MRPL2;FOXO3;TFB2M
prerank,regulation of cholesterol esterification (GO:0010872),0.6331475634584638,1.2973189418135962,0.1712121212121212,0.6924029644986485,1.0,3/10,6.66%,APOC1;APOE;AGT
prerank,epithelial structure maintenance (GO:0010669),0.613339196693497,1.2969584250961037,0.15764331210191082,0.6926037677123318,1.0,1/11,2.09%,CXADR
prerank,B cell proliferation (GO:0042100),0.5627252558023286,1.2964864720171523,0.16840536512667661,0.693223961316076,1.0,4/17,18.17%,CD180;PTPRC;HSPD1;MEF2C
prerank,positive regulation of macrophage differentiation (GO:0045651),0.6113251090551413,1.2963493885332105,0.18681318681318682,0.6926257740063783,1.0,2/11,2.92%,CSF1;IL34
prerank,carnitine shuttle (GO:0006853),0.6086055242124587,1.296122481361863,0.1791277258566978,0.6923665876880513,1.0,3/11,11.00%,THRSP;MID1IP1;ACACA
prerank,chondroitin sulfate metabolic process (GO:0030204),0.503387918726883,1.2961072457817129,0.14678899082568808,0.6912827210773366,1.0,6/30,4.76%,CHST11;BCAN;CHPF;NCAN;CHST12;CSPG4
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.43276238197868705,1.2960443262958412,0.0860566448801743,0.6903669260048922,1.0,21/93,14.03%,SERPINF2;SLAMF1;LTBR;ARL6IP5;ANKRD6;HMGB1;DUSP19;EIF2AK2;EMC10;SDCBP;CARD9;PTK2B;MAP4K2;SPI1;PYCARD;SEMA4C;MID1;TAOK2;APP;TRAF3;MBIP
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.5152958785391706,1.2960233228997777,0.1547945205479452,0.6893262369000315,1.0,8/26,15.03%,ATF4;SARS1;CXCL17;EIF2AK3;IL1A;RORA;SULF2;IL6
prerank,vesicle transport along microtubule (GO:0047496),0.5335492192627337,1.2958264669826107,0.1601615074024226,0.6888981675675362,1.0,6/23,11.61%,NDEL1;FBXW11;FYCO1;KIF5A;TRAK1;PAFAH1B1
prerank,endothelial cell differentiation (GO:0045446),0.6082335831699163,1.2957410898238442,0.16716867469879518,0.6880993568037361,1.0,4/12,11.68%,KDM6B;JAG1;ACVR2B;SCUBE1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.5909878315678836,1.2956480194176898,0.19135802469135801,0.6873100497342557,1.0,2/12,7.23%,ADAMTS12;SEMA6A
prerank,regulation of myelination (GO:0031641),0.5064475047496021,1.2955150609975767,0.16098226466575716,0.6866521254844579,1.0,8/25,15.39%,EGR2;TMEM98;EIF2AK3;SIRT2;NSUN5;ZPR1;CST7;TNFRSF1B
prerank,hepaticobiliary system development (GO:0061008),0.5367163205691846,1.2949872197569166,0.1589310829817159,0.687412494761861,1.0,3/20,5.50%,NKX2-8;LSR;PRKCSH
prerank,muscle tissue morphogenesis (GO:0060415),-0.46351976954612983,-1.2948697589833844,0.1452991452991453,1.0,1.0,9/16,48.46%,TGFBR3;NOTCH1;PROX1;ZFPM1;EFEMP2;BMP2;BMP4;HEY2;MYLK
prerank,cellular response to UV (GO:0034644),0.44368369066255037,1.2945780532834146,0.10484780157835401,0.6878177785054883,1.0,16/76,13.60%,MYC;DDB2;COPS9;ATF4;EIF2S1;PCNA;TAF1;CRIP1;SMPD1;SIRT1;CARD16;CREBBP;CASP9;KDM1A;DDB1;FMR1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.5650433895194793,1.2943921333176516,0.1618075801749271,0.6873331319910924,1.0,8/17,21.63%,NEIL2;ACD;MPG;TDG;MBD4;NEIL3;TERF2IP;TERF2
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.5264577457687334,1.2940019070991764,0.14840499306518723,0.68769116073337,1.0,3/23,9.16%,KCNH2;TFAP2B;SLC12A6
prerank,positive regulation of lymphocyte activation (GO:0051251),0.5016812056761907,1.2935638156733706,0.15454545454545454,0.6882149489653749,1.0,5/28,9.33%,CCL2;TYROBP;SIRPA;CYRIB;PYCARD
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.4836157459421231,1.2926721098057252,0.15501905972045743,0.690560014488616,1.0,2/35,0.78%,SELP;PCDHB14
prerank,neurogenesis (GO:0022008),0.4754624760960545,1.2922580828935726,0.14407814407814407,0.6909857749046666,1.0,15/43,21.89%,CXCR4;BTBD6;CLN5;TRAK1;RYK;CDK6;LPAR1;BTBD3;CIT;DCHS1;BTBD2;DAGLA;METTL3;FAT4;BTBD1
prerank,ncRNA processing (GO:0034470),0.41147231726842864,1.2922326455451656,0.049029622063329927,0.6899575118387146,1.0,47/200,12.56%,DIS3;NOP14;RPL31;UTP15;WDR18;KARS1;DDX49;RPS15;PES1;RPL3;NOB1;TARBP2;RPL13A;RPL15;RPL10;SARS1;RRP7A;UTP11;DDX54;UTP18;NOP56;INTS9;INTS6;RPL9;TUT7;ESF1;INTS10;RPL22;DGCR8;RRP1B;RRP1;ZCCHC8;C1D;SENP3;RPL23A;NVL;UTP4;EXOSC8;RPP30;RPL34;EXOSC10;TUT1;POP1;INTS8;RRP36;RPS14;WDR43
prerank,positive regulation of interleukin-6 production (GO:0032755),0.4473280824439981,1.2921378684864389,0.1152073732718894,0.689216877068845,1.0,16/68,17.01%,STAT3;RAB7B;LPL;TYROBP;HMGB1;CARD9;DHX9;IL1A;TLR7;IL17RA;PYCARD;APP;POU2F2;IL6;HSPD1;ARHGEF2
prerank,phagosome maturation (GO:0090382),0.480304411212772,1.2920124302454417,0.15006150061500614,0.6885969011941625,1.0,12/35,17.75%,ATP6V1D;ATP6V1A;ATP6V0D1;ATP6V0E1;RAB31;ATP6V0A1;ATP6V0C;RAB32;CORO1A;ATP6V0B;RAB7A;ATP6V1G2
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5723662422762126,1.291583643458002,0.1746268656716418,0.6891597150240087,1.0,4/15,4.76%,BCAN;NCAN;CHST12;CSPG4
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.4642382795933105,1.2912628640745056,0.12848484848484848,0.6892238992867515,1.0,12/46,16.23%,SERPINF2;PDGFRB;APOD;PDGFB;XRCC5;FOXP1;TCF7L2;CTNNB1;IL18;IGF1;IL6;TNFAIP3
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.5626185077715107,1.2909203398175892,0.19083969465648856,0.689461064986946,1.0,2/16,4.14%,SELP;RELA
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.5421116683140003,1.290761135881343,0.173974540311174,0.6889638623384418,1.0,7/20,12.68%,HSP90AB1;NLRP3;ENTPD1;PYCARD;IL18;APP;ENTPD5
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.4967915007340301,-1.2906886895089167,0.16986301369863013,1.0,1.0,9/12,28.72%,SEC61A1;SEC62;SGTA;SEC61G;SGTB;GET3;CHMP4B;CHMP4A;SEC61B
prerank,tryptophan catabolic process (GO:0006569),-0.5295293362303968,-1.290585795538926,0.19618528610354224,1.0,1.0,6/11,40.41%,KYNU;KYAT1;HAAO;KMO;IL4I1;AFMID
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.4542554076485487,1.2900175854977547,0.13716295427901523,0.6906018640753571,1.0,12/56,13.85%,CLEC4E;MAPKAPK2;CTSB;CTSL;HMGB1;RPS27A;UBC;TLR7;IRAK2;SFTPA1;SFTPA2;TRAF3
prerank,cellular response to cytokine stimulus (GO:0071345),0.4023159184261456,1.2894540480811947,0.007,0.6916506250794017,1.0,105/416,19.84%,CCL3;MYC;OSM;CCL4;CCL2;EGR1;CSF1;STAT3;ADAMTS12;BCL2L1;NFE2L2;IL1R1;CXCR4;ZFP36;NDN;INPP5K;ACOD1;IL34;HNRNPU;SOX9;RPL13A;COL1A2;IKBKB;RELA;SBNO2;SIRPA;ABL2;SOCS6;CSF2RA;PTPN12;MT1X;TANK;TBK1;PTPN14;HSPA8;RPS27A;UBC;PIK3R1;ERBIN;RHOU;GSDME;AKAP6;STAT6;DHX9;IFNAR1;IL1A;SIRT1;STX3;F3;MAPK8;PYCARD;PTPN4;IL27RA;IRF8;RC3H1;IL18;PTPN6;SOX2;CCR5;IRAK2;YBX3;CCL25;FOXO3;CCL13;CRK;BCL6;RORA;IL4R;IL10RB;NDUFA13;S1PR1;SMPD4;SOS1;IL6;HGF;TNFRSF1B;CD86;DAPK1;MT2A;ST3GAL6;CSF2RB;NFKB1;IFNAR2;TEC;YWHAZ;ARHGEF2;ICAM1;HTRA2;SMAD3;ZC3H12A;UPF1;CEBPA;HSP90B1;CDK9;HCK;IRAK4;JAK1;JUNB;ITGB2;CSF1R;TLR2;CCND1;AIM2;IL6ST;ASAH2
prerank,cellular protein catabolic process (GO:0044257),0.4597723898430808,1.2883934655240667,0.12096774193548387,0.6945120971632405,1.0,18/59,17.56%,PISD;ADAMTS12;CTSB;CTSL;DENND3;SIAH2;LONP1;RSPRY1;AP2A1;CLTC;MAGEC2;MYLIP;IDE;VLDLR;YME1L1;AP2M1;HTRA2;RAB7A
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.4302564841804987,1.2879232010602135,0.0935483870967742,0.6951743135736919,1.0,24/94,13.37%,EGR1;IL1R1;SQSTM1;PSMD2;PSMC4;FBXW11;IKBKB;RELA;PSMD4;PSMD1;RPS27A;UBC;PSME3;PSMB6;IL1A;PSMD10;PELI3;RIPK2;PSMB1;PSMD11;PSMA2;PSMD13;IRAK2;PSMB10
prerank,chromatin organization (GO:0006325),0.4158488462541191,1.2875645837003145,0.0875,0.6954463878425707,1.0,38/132,18.44%,MYC;KDM6B;ACTL6B;HMGN3;HMGN1;SOX9;SMARCC1;NUDT5;ACTL6A;ZBTB7A;SMARCD2;BAZ2A;CHRAC1;BAZ1A;BAZ1B;SMARCA1;SIRT1;TADA2A;SPI1;HDAC1;CHD1;CHD1L;HDAC5;SOX2;DR1;SETDB1;SMARCB1;TCF7L1;SETD7;MYSM1;PBRM1;HDAC11;KAT2A;MPND;SAFB;EZH2;RBBP4;PIH1D1
prerank,negative regulation of growth (GO:0045926),0.4256038363287245,1.2873404632068004,0.08088235294117647,0.6952104598378007,1.0,30/121,16.57%,SESN2;NAIF1;SERTAD3;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B;CCDC85B;RTN4;TSPYL2;JADE1;PPT1;ACVR1B;SIRT1;CAPRIN2;IP6K2;ING1;DNAJB2;BCL6;NDUFA13;NME6;VGLL4;ING4;FLCN;MT2A;PRDM11
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.5861213546431631,1.2871266850571392,0.19195046439628483,0.6949221559685396,1.0,2/12,2.92%,CSF1;IL34
prerank,nitrogen compound transport (GO:0071705),0.41497971929058197,1.2867300577771559,0.07240293809024134,0.6953159918016396,1.0,30/141,17.64%,SLC52A2;SLC7A5;SLC6A8;MYH9;SLC7A1;ARL6IP5;ARRDC2;SLC23A1;SLC22A4;NDC1;LRRC8D;SLC3A2;SLC15A3;PPT1;SLC6A6;TCN2;SLC36A1;CMTM6;SCARB2;TOM1;SLC38A1;SLC6A2;TMEM30A;SLC11A1;RALBP1;SEC14L1;SLC18A1;PICK1;RAB7A;SLC15A4
prerank,secretion (GO:0046903),0.5854535749216218,1.2865241920851198,0.1794071762870515,0.6950367064729248,1.0,3/14,11.93%,SLC22A4;RIMS1;TPD52
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.500526152758312,1.2862665880406225,0.15203145478374835,0.6948524809219968,1.0,2/29,4.37%,PLB1;PLA2G4A
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.5147465832190966,1.2862146495030837,0.17615176151761516,0.6939495852371983,1.0,7/24,12.96%,LIG1;RPS27A;UBC;PCNA;XRCC1;POLB;POLD4
prerank,chromatin remodeling (GO:0006338),0.42408208309806444,1.2859349992285232,0.09482758620689655,0.6938895309852117,1.0,22/100,12.03%,MYC;KDM6B;ACTL6B;SOX9;SMARCC1;NUDT5;ACTL6A;ZBTB7A;SMARCD2;BAZ2A;CHD4;CHRAC1;BAZ1A;BAZ1B;SMARCA1;SIRT1;TADA2A;HDAC1;CHD1L;HDAC5;DR1;SMARCB1
prerank,regulation of bone mineralization (GO:0030500),0.4528070121890977,1.285639259733649,0.13048635824436536,0.6939447787017967,1.0,9/55,10.78%,CCL3;SRGN;BMP2K;TRPM4;PTK2B;ANKH;BMP6;DDR2;ACVR2B
prerank,response to X-ray (GO:0010165),-0.47686081552835524,-1.2855492864959328,0.18028169014084508,1.0,1.0,5/14,12.90%,NIPBL;NUCKS1;BLM;XRCC4;IKBIP
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.4562827414811321,1.2854466836338798,0.12455089820359282,0.6935072832853052,1.0,11/51,13.83%,BAMBI;SKIL;LEMD2;CRIM1;SMURF1;UBE2D1;SORL1;UBE2D3;ACVR2B;LEMD3;SKOR2
prerank,actin cytoskeleton reorganization (GO:0031532),-0.3227028557127002,-1.2851837813927363,0.08450704225352113,1.0,1.0,16/63,8.54%,RHOA;AUTS2;CDC42BPA;NEDD9;GRB2;FER;THSD7B;MINK1;GAB1;GSN;SIPA1L1;CDC42BPB;PARVG;THSD7A;RALA;PTPN1
prerank,positive regulation of stem cell proliferation (GO:2000648),0.5495889894914943,1.2851696759439917,0.16371681415929204,0.6934334491835592,1.0,5/17,10.92%,HNRNPU;LTBP3;PTPRC;N4BP2L2;KDM1A
prerank,cellular response to organonitrogen compound (GO:0071417),0.4231311744928203,1.2847578455965283,0.10967741935483871,0.6938950692346033,1.0,18/99,12.36%,SESN2;EGR1;IPO5;RRAGC;INPP5K;SOX9;RELA;GABRB2;TAF1;JUP;AKAP6;P2RY1;LARS1;AKAP9;CPEB1;CTNNB1;TRPM2;DIAPH1
prerank,replication fork processing (GO:0031297),-0.36599208405320016,-1.284547204175964,0.1320754716981132,1.0,1.0,14/38,19.05%,THOC1;NUCKS1;MRE11;FBH1;SMARCAL1;BLM;DNA2;BOD1L1;MMS22L;ZRANB3;ZGRF1;WRN;BRCA2;ATR
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3973754452235204,1.2844370301935926,0.0,0.6939940873677197,1.0,264/1082,18.63%,GDNF;ATF3;EGR2;MYC;NKX2-8;BMP5;OSM;TNNI2;SOX10;KDM6B;SERPINF2;BAMBI;EGR1;HOXD8;LITAF;STAT3;ZNF513;KCNH2;PFKM;ZIC1;GLIS1;TFAP2B;DRAP1;NR4A1;HOXB7;NFE2L2;BEX1;DVL2;SEC14L2;SQSTM1;CTBP2;NFATC2IP;JUN;PRKD2;PRMT2;UTP15;SERTAD3;FZD5;HMGN1;KARS1;ILF3;INPP5K;MED19;HNRNPD;SERPINE1;FOXE1;NCK1;NFYA;HMGB1;HNRNPU;RNF20;PIN1;NLRP3;MAML3;SOX9;NR1D2;KLF15;PICALM;NFATC3;MAP2K3;KANSL3;FBXW11;FUBP3;HIVEP3;IKBKB;NDP;ATF4;RYBP;KAT5;IER2;SMARCC1;RELA;SBNO2;ECD;SS18L2;CASZ1;MAP2K7;ZMIZ1;ZBTB48;CREB3L4;CREB3;MAP2K1;TBK1;CSRNP2;DOT1L;DPF2;TGFBR1;DNM2;RPS27A;UBC;RHOG;APOE;TAF15;ICE2;CXXC1;SPP1;PCID2;COL1A1;JUP;PIK3R1;QRICH1;TRIM56;CRTC1;PDGFB;SMARCD2;AGT;TET2;RRP1B;TRIM28;JAG1;PAXBP1;STAT6;EIF2AK3;DHX9;ATAD2B;E2F5;TCF7L2;ELL;CCNK;HIVEP1;SMARCA1;SIRT1;TBL1X;ENG;SPI1;KLF10;PBX4;CNBP;BMP6;AKIRIN2;BRD8;TET1;GABPB1;GABPB2;CAPRIN2;CTNNB1;USP21;RUNX2;RHOQ;POU3F2;PPRC1;ARRB1;HDAC1;IER5;RIPK2;CREBBP;KLF7;IRF8;HDAC5;IL18;YBX1;SFPQ;NPAT;RBPJ;KDM1A;MITF;ING1;SOX2;ZBTB17;SIRT2;DR1;ELF2;GLMP;MAML1;ZNF496;SS18;TAF6;SMARCB1;PHF10;PHOX2A;IGF1;TCF3;WDR43;APP;KMT2B;CREB5;SS18L1;TNIP1;CDK8;GPS2;FOXO3;MRTFB;KMT2D;RORA;AKAP8L;SETX;LMX1B;JUND;ZPR1;ARF4;BRD4;MYSM1;NCOA3;SLC11A1;CAMKK2;POU2F2;ATF1;CREB1;ATF6;MTOR;MED25;IL6;HGF;MED1;WWTR1;CCNT1;LRP5;AKNA;MED13;CTCF;CD86;LDB2;LDB1;KMT2A;RUNX1;FOXK2;PAX2;CDCA4;FLCN;TMPRSS6;DYRK1A;SIN3A;IRF2BPL;RXRA;NFKB1;PRDM11;HOXB3;ILK;TET3;PER1;RPRD1B;MEF2A;KAT2A;ARHGEF2;POGZ;NLRC5;MEF2B;TCF12;FOXJ2;ZBTB49;ENY2;MPND;ACVR1;SMAD3;ATMIN;ZC3H12A;RBM14;ETS1;RLF;ZBED3;ZXDC;TCEA1;CEBPZ;DDIT3;MDFIC;MEF2C;CEBPB;CDH13;CEBPA;MED4;RPTOR;EPAS1;HLF;TFCP2
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.513545630715703,-1.2837394972184415,0.17195767195767195,1.0,1.0,6/11,25.61%,TJP2;RAP2C;AFDN;RAPGEF6;F11R;RAB1B
prerank,tRNA aminoacylation (GO:0043039),0.48295942807058506,1.2835404131998178,0.14194373401534527,0.6962759713644019,1.0,8/37,10.41%,WARS1;KARS1;IARS2;SARS1;SARS2;IARS1;LARS1;PPA2
prerank,negative regulation of cell differentiation (GO:0045596),0.4106349247345262,1.2832953283734079,0.04815573770491803,0.6960353774500659,1.0,41/181,18.20%,BMP5;BAMBI;DISP3;ADAMTS12;HNRNPU;SOX9;EID2B;TGFBR1;CCDC85B;ADIPOR1;ITGB3;BBS12;TRIB2;USF3;CRIM1;TRPM4;JAG1;PTK2B;CDK6;SIRT1;EFEMP1;HOXB8;SOX2;SIRT2;NEPRO;HPN;TRIO;GPS2;RORA;PTBP1;IL6;MED1;WWTR1;LRP5;CNTN4;YTHDF2;SMAD3;CTR9;RUNX1T1;CALR;LDLRAD4
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.46834883670351757,-1.2832521911970103,0.17696629213483145,1.0,1.0,6/14,23.68%,RHOA;PDCD10;NOTCH1;STARD13;ITGB1BP1;THBS1
prerank,regulation of feeding behavior (GO:0060259),0.6024530916348723,1.2831717758046326,0.18325434439178515,0.6953693608390398,1.0,1/11,0.61%,STAT3
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.5045420918919755,1.282643232383182,0.16925064599483206,0.6963635958328166,1.0,5/29,17.19%,BAG6;TERB1;MEI4;SYCE2;RAD21
prerank,axon extension (GO:0048675),-0.41180377759587294,-1.2823585371259814,0.1434108527131783,1.0,1.0,12/23,18.64%,AUTS2;SEMA5A;SPG11;HSP90AA1;ULK2;MAP1B;SLC9A6;PPP3CB;ULK1;NRP1;CDK5;SLIT2
prerank,cellular response to decreased oxygen levels (GO:0036294),0.44441153368371095,1.2822099630604036,0.12797281993204984,0.6969039571613669,1.0,16/65,15.27%,MYC;PGK1;ADAM8;MDM4;EGLN2;SIRT1;CPEB1;CARD16;NPEPPS;SIRT2;BAD;P4HB;STUB1;RORA;MTOR;HYOU1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.5092097193729496,1.281801314927482,0.16172506738544473,0.6973746475935603,1.0,5/27,7.92%,AGAP2;PDGFRB;PIK3R4;PDGFB;PTK2B
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.48437352296242403,-1.2815641377652531,0.17784256559766765,1.0,1.0,5/14,11.74%,SEC23A;SCAP;TBC1D20;SEC24D;SEC31A
prerank,mitotic DNA replication (GO:1902969),0.6274327971386602,1.2814619267346876,0.1952,0.6975917016290426,1.0,3/10,5.07%,GINS3;MCM2;LIG1
prerank,negative regulation of cytokine production (GO:0001818),0.4078893868213764,1.2812419785923752,0.06494845360824743,0.6972931981282737,1.0,47/163,19.69%,SLAMF1;ZFP36;C1QBP;SRGN;TYROBP;CD84;ACOD1;HMGB1;PIN1;APOD;SARS1;KAT5;SIRPA;TBK1;CMKLR1;TRIB2;NLRC3;OTUD7B;CD200R1;PCBP2;PTPRC;PRNP;PYCARD;TRAF3IP1;ARRB1;TMSB4X;PTPN6;CD33;CD200;C5AR2;ILRUN;NPTN;IKBKE;SLC11A1;LGR4;IL6;RAC1;TNFAIP3;NLRC5;ADCY7;GPNMB;ZC3H12A;DDIT3;HOMER2;NLRX1;RNF216;ITCH
prerank,COPII-coated vesicle budding (GO:0090114),0.4364996324534242,1.2809936935937036,0.11885714285714286,0.6971309864760786,1.0,20/68,15.58%,NAPA;CUL3;TRAPPC5;TRAPPC2L;PPP6R1;KLHL12;TMED10;TRAPPC10;TRAPPC4;PPP6R3;TRAPPC3;PEF1;NSF;SEC24C;TRAPPC9;SEC24A;SAR1B;STX5;USO1;ANKRD28
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.5824437932561531,1.2809075697855592,0.1921259842519685,0.6964221750031544,1.0,3/14,10.68%,TGFBR2;CD55;IL18
prerank,negative regulation of MAPK cascade (GO:0043409),0.4304828287714125,1.2808188442956576,0.09726775956284153,0.6957010779999261,1.0,14/87,9.35%,MYC;PEBP1;INPP5K;PIN1;UCHL1;SIRPA;APOE;AGT;SEMA6A;SORL1;PSMD10;SMPD1;PTPRC;PTPRR
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5048364517334529,1.2795490741640287,0.17105263157894737,0.6993487781038278,1.0,5/29,6.40%,C1QBP;SERPINE1;HMGB1;CREB3;CXCL17
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.43176425947447994,1.2795074672030429,0.10044150110375276,0.6984652382612762,1.0,20/84,11.81%,MAD2L1;CUL3;UBE2S;PSMD2;PSMC4;PSMD4;PSMD1;RPS27A;UBC;UBE2D1;PSME3;PSMB6;PSMD10;ANAPC5;UBE2E1;PSMB1;PSMD11;ANAPC10;PSMA2;PSMD13
prerank,iron ion transmembrane transport (GO:0034755),0.6112040645959513,1.2793998970225384,0.1890145395799677,0.6977795090954105,1.0,4/10,14.43%,SLC39A14;ABCC5;SLC39A8;ABCB7
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.4228179254729431,1.2793352542086858,0.09458023379383634,0.6969441700376238,1.0,27/105,17.13%,RELB;CLEC4E;TYROBP;PSMD2;PSMC4;FBXW11;IKBKB;RELA;PSMD4;PSMD1;PSME3;CARD9;NRAS;PSMB6;PSMD10;CREBBP;PSMB1;PSMD11;PSMA2;PSMD13;PSMB10;PSMB3;SKP1;RAF1;NFKB1;KRAS;PSMC1
prerank,phospholipid metabolic process (GO:0006644),0.4395652295371004,1.2792980212575158,0.13101903695408734,0.6960220865075913,1.0,10/71,8.49%,PLB1;LPL;AGPAT4;PLPPR4;PLA2G4A;FADS1;SMPD3;GPX4;CLN8;SMPD1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.4342377035970525,-1.279248730672567,0.15034965034965034,1.0,1.0,9/19,14.57%,DLG2;LRRC7;PATJ;PRKCI;DLG1;PARD3B;DLG3;MTCL1;PARD3
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.4228287071986137,1.2791588701731476,0.09904153354632587,0.6944422368462754,1.0,27/104,17.13%,RELB;CLEC4E;TYROBP;PSMD2;PSMC4;FBXW11;IKBKB;RELA;PSMD4;PSMD1;PSME3;CARD9;NRAS;PSMB6;PSMD10;CREBBP;PSMB1;PSMD11;PSMA2;PSMD13;PSMB10;PSMB3;SKP1;RAF1;NFKB1;KRAS;PSMC1
prerank,cellular response to lectin (GO:1990858),0.4228287071986137,1.2791588701731476,0.09904153354632587,0.6944422368462754,1.0,27/104,17.13%,RELB;CLEC4E;TYROBP;PSMD2;PSMC4;FBXW11;IKBKB;RELA;PSMD4;PSMD1;PSME3;CARD9;NRAS;PSMB6;PSMD10;CREBBP;PSMB1;PSMD11;PSMA2;PSMD13;PSMB10;PSMB3;SKP1;RAF1;NFKB1;KRAS;PSMC1
prerank,calcium-mediated signaling (GO:0019722),0.4273448554780077,1.2787926789404458,0.09750812567713976,0.6946343927742878,1.0,12/93,11.95%,CCL3;SELP;CXCR4;FKBP1B;TRPM4;EIF2AK3;PTPRC;PRNP;KSR2;ATP1B1;CCR5;TRPM2
prerank,eye photoreceptor cell differentiation (GO:0001754),0.5876235752779464,1.2784766321157026,0.20124804992199688,0.6947705003897523,1.0,3/12,9.39%,STAT3;SDK2;DSCAM
prerank,regulation of translational initiation (GO:0006446),0.44759462061582095,1.278435145883681,0.13073394495412843,0.6938697413489125,1.0,21/63,18.21%,ATF3;PPP1R15B;EIF2B2;NCK1;HABP4;ATF4;EIF1;CDC123;EIF4A2;EIF2AK3;NCBP1;EIF3B;EIF4G2;FMR1;EIF5B;MIF4GD;EIF3H;POLR2G;YTHDF2;KLHL25;CEBPB
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.5292918822038487,-1.2782165475531928,0.16886543535620052,1.0,1.0,5/10,39.13%,THAP4;KYNU;KYAT1;IL4I1;ATP7A
prerank,T cell homeostasis (GO:0043029),-0.550492185747277,-1.2779625563753712,0.16266666666666665,1.0,1.0,3/10,14.05%,NCKAP1L;PPP2R3C;ZC3H8
prerank,ribosome assembly (GO:0042255),0.46262538589650487,1.2779498283786432,0.15320665083135393,0.6946543868049048,1.0,11/47,12.43%,C1QBP;RPS15;RPL3;RPL10;NOP2;RRP7A;EIF6;RPL23A;RPSA;MRPS7;RPS14
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.41732491186122006,1.277778585924422,0.0924548352816153,0.6942518848487512,1.0,19/112,8.90%,BAMBI;ZYX;JUN;SOX9;COL1A2;ADAM9;ZMIZ1;TGFBR1;TGFBR2;RPS27A;UBC;NRROS;FNTA;SMURF1;LTBP2;SIRT1;ENG;FURIN;PRKCZ
prerank,phosphate ion homeostasis (GO:0055062),0.6258587545380283,1.2777002591177247,0.18181818181818182,0.6934615100814531,1.0,1/10,1.02%,TFAP2B
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.521763971754036,1.277686755106359,0.1871508379888268,0.692465889841494,1.0,6/22,11.07%,NOP14;PES1;URB1;RPS21;EXOSC8;EXOSC10
prerank,regulation of B cell differentiation (GO:0045577),-0.4511761879632395,-1.2773809212085359,0.17421602787456447,1.0,1.0,10/17,37.25%,NCKAP1L;PPP2R3C;XBP1;ZFP36L1;ID2;CD27;SLAMF8;IKZF3;IL4I1;INHBA
prerank,nuclear export (GO:0051168),0.43228039463915313,1.2772908591513052,0.11817168338907469,0.6929432550073907,1.0,12/80,10.12%,EGR2;RANBP3;MAGOH;MAGOHB;CHTOP;NUP153;SMURF1;U2AF2;NXF1;SRSF2;U2AF1;NCBP1
prerank,muscle cell differentiation (GO:0042692),0.4893124484379954,1.2767002931545939,0.16050955414012738,0.6939084574159173,1.0,9/32,13.72%,TMEM204;WNT5B;NINJ1;POPDC3;GLMN;SEMA4C;KDM1A;MRTFB;RORA
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.4945069068086257,1.2766588154051242,0.17516339869281045,0.6930293726363743,1.0,5/28,8.39%,WDR1;PFN1;SH3BP1;COTL1;LATS1
prerank,carboxylic acid transmembrane transport (GO:1905039),0.4729629088944483,1.2763881062782472,0.14538558786346398,0.6929862472109463,1.0,11/40,17.61%,SLC7A5;SLC23A2;SLC23A1;SLC16A1;ABCC5;SLC25A21;SLC36A1;SLC38A1;SLC36A4;SLC16A7;SLC25A14
prerank,regulation of lipid biosynthetic process (GO:0046890),0.4869455549874774,1.274983412940076,0.1482444733420026,0.69709903332517,1.0,8/32,15.58%,THRSP;MID1IP1;ADIPOR1;APOE;EIF6;CREB1;MTOR;ADIPOR2
prerank,regulation of DNA recombination at telomere (GO:0072695),0.5292039408975715,1.2746792195814702,0.1752873563218391,0.696082731218768,1.0,8/19,21.63%,POLR2J;ACD;POLR2E;POLR2B;POLR2G;POLR2K;TERF2IP;TERF2
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.5292039408975715,1.2746792195814702,0.1752873563218391,0.696082731218768,1.0,8/19,21.63%,POLR2J;ACD;POLR2E;POLR2B;POLR2G;POLR2K;TERF2IP;TERF2
prerank,cellular response to alcohol (GO:0097306),-0.34422239171052926,-1.2744759708703097,0.09523809523809523,1.0,1.0,15/42,15.17%,LRP6;GRAMD1B;ADCY2;GNG2;SPIDR;PTCH1;KLF9;GLRA1;BLM;LARP1;GOLPH3;PTGER4;GNAI1;GLRA2;ADCY1
prerank,iron ion homeostasis (GO:0055072),0.4478391217348344,1.2738516109716884,0.1310734463276836,0.6980728902112665,1.0,17/58,15.96%,MYC;ATP6V1A;ATP6V0D1;ATP13A2;PICALM;SLC22A17;NEO1;CAND1;BMP6;GLRX3;NEDD8;ATP6AP1;FBXL5;ABCB7;SLC11A1;SKP1;TMPRSS6
prerank,negative regulation of kinase activity (GO:0033673),0.451591465740713,1.2734286746164512,0.13200934579439252,0.6985983670237296,1.0,13/62,11.53%,EPHA1;WARS1;INPP5K;NPRL2;HNRNPU;TARBP2;DUSP19;DBNDD2;TRIB2;PPP2R5A;PTPRC;PPM1F;PYDC1
prerank,ion homeostasis (GO:0050801),-0.38882518644146025,-1.2731462687365085,0.14522821576763487,1.0,1.0,9/30,23.20%,UNC80;SLC4A7;AP3D1;WNK2;KLHL3;WNK3;SLC30A4;SLC4A8;SLC12A5
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.5011693037673595,1.2730780578260525,0.1601615074024226,0.6988294140781884,1.0,6/29,11.00%,SCD5;ELOVL1;ACSF3;ACLY;PPT1;ACACA
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.5451938490129298,1.2728660753384147,0.1952662721893491,0.6985723744284342,1.0,7/17,12.34%,PIN1;RTN4;APOE;SORL1;PRNP;CLU;IGF1
prerank,positive regulation of receptor internalization (GO:0002092),-0.4143038165222073,-1.2727125931743422,0.1368421052631579,1.0,1.0,9/22,20.63%,INSR;MAGI2;TBC1D5;ANGPT1;ATAD1;AHI1;VEGFA;ARRB2;SCYL2
prerank,regulation of macrophage differentiation (GO:0045649),0.5547510687125294,1.272606675614514,0.19213973799126638,0.6984845015571857,1.0,3/15,9.03%,CSF1;IL34;C1QC
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.46601950759166955,1.272321543599281,0.1407766990291262,0.6985264791134985,1.0,8/47,6.66%,PDGFRB;CBR1;TYROBP;ACOD1;DHRS4;TGFBR2;PDGFB;AGT
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.4749011131694973,1.2721905232697328,0.164366373902133,0.6979860286099809,1.0,5/38,6.77%,BMP5;TMC8;BCL2L1;SERPINE1;FAIM2
prerank,neuron remodeling (GO:0016322),-0.5367693178386569,-1.2719750735449882,0.18933333333333333,1.0,1.0,2/10,0.91%,ANKS1A;ADGRB3
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.5316822784624446,1.2719019688388278,0.1763085399449036,0.6980439971187413,1.0,6/21,7.65%,MYH9;ADAM17;ADAM9;SPPL3;HM13;ADAM19
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.4268946607940881,-1.2719008690756275,0.15636363636363637,1.0,1.0,8/21,16.15%,SLC8B1;BCAP31;SLC8A3;LETM1;MCUB;MICU3;FIS1;TGM2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.4331145343773242,1.271892227715581,0.12614678899082568,0.6970511916120639,1.0,12/72,12.34%,SELP;OSM;PDGFRB;PDGFA;SOX9;PIK3R1;PDGFB;AGT;SIRT1;IL18;PTPN6;IGF1
prerank,nuclear envelope organization (GO:0006998),0.5300480244268613,1.2717460484601584,0.1875,0.6965413482598521,1.0,6/20,13.54%,VPS4A;LEMD2;NEMP1;SUN2;CTDNEP1;LEMD3
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.5177671927187113,1.2717169194630267,0.1781767955801105,0.6956317480102829,1.0,7/23,12.61%,MTMR10;INPP5K;MTM1;MTMR3;MTMR12;OCRL;INPP5F
prerank,protein polyglutamylation (GO:0018095),-0.5295569183115816,-1.2713045860260146,0.18406593406593408,1.0,1.0,4/11,13.31%,CFAP20;TTLL11;TTLL4;TTLL7
prerank,mesoderm development (GO:0007498),-0.44334920918430176,-1.2709474960102358,0.19205298013245034,1.0,1.0,7/18,32.18%,JAK2;IKZF1;MESD;VEGFA;TBX6;MEST;IKZF3
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.5332566244793188,1.2706060305920834,0.17857142857142858,0.6985081529607823,1.0,7/22,19.30%,DUSP5;DUSP16;PPM1F;PPM1G;PPP2CB;PPP5C;PPM1B
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.35855532934323464,-1.2703274858917506,0.1187214611872146,1.0,1.0,20/36,32.43%,CHEK2;CLOCK;DNA2;TIPRL;ERCC6;TIPIN;CDC5L;RAD9B;ATRIP;RHNO1;ATR;CEP63;USP28;RAD9A;DONSON;HUS1;CLSPN;TIMELESS;E2F1;RAD1
prerank,vitamin transport (GO:0051180),0.4869902579342873,1.2694557078671211,0.16711229946524064,0.7017380743728563,1.0,2/29,2.29%,SLC52A2;SLC23A1
prerank,rRNA processing (GO:0006364),0.4050677149334589,1.2685463779854194,0.09397344228804903,0.7041214820239784,1.0,38/172,12.56%,DIS3;RIOK1;NOP14;RPL31;UTP15;WDR18;RRP15;DDX49;RPS15;PES1;RPL3;NOB1;RPL13A;RPL15;RPL10;NOP2;RRP7A;UTP11;DDX54;UTP18;NOP56;RPL9;ESF1;RPL22;EIF6;RRP1B;RRP1;C1D;SENP3;RPL23A;NVL;UTP4;EXOSC8;RPL34;EXOSC10;RRP36;RPS14;WDR43
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.4698863246327824,1.2683313413074946,0.16160388821385177,0.7038654277876488,1.0,10/41,14.70%,KCNH2;KCNJ6;STAC;AKAP6;KCNMB2;KCNMB3;KCNJ2;GNB1;KCNMA1;FLNA
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.48800704162000375,1.2678026851636979,0.15891472868217055,0.7048537760890075,1.0,8/31,18.21%,DLG5;TYROBP;SDC4;GLMN;RC3H1;CD86;GPNMB;CEBPB
prerank,retinal metabolic process (GO:0042574),0.581354739367136,1.2677664302584501,0.19939577039274925,0.7039810287956418,1.0,2/12,8.85%,ALDH8A1;DHRS13
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.5382388381262262,1.2670825753910298,0.18876080691642652,0.7055484798762054,1.0,6/17,17.28%,NFE2L2;SIRT1;SFPQ;P4HB;SOD2;HTRA2
prerank,positive regulation of protein depolymerization (GO:1901881),0.5959584099052102,1.2668653867585729,0.2064,0.705273678290388,1.0,2/11,1.62%,WDR1;PLEK
prerank,endocardial cushion morphogenesis (GO:0003203),0.535017698384924,1.2666947041306476,0.19311377245508982,0.7049089743647114,1.0,4/18,8.66%,SOX9;MDM4;TGFBR2;ENG
prerank,positive regulation of viral life cycle (GO:1903902),0.5211405804330552,1.2666101546420594,0.18679775280898878,0.7042313637179671,1.0,7/22,13.60%,VPS4A;LGALS1;VPS37B;KPNA2;DDB1;P4HB;FMR1
prerank,regulation of stem cell proliferation (GO:0072091),0.541138790836667,1.266417446588564,0.17287630402384502,0.7039566289764074,1.0,6/17,18.76%,HNRNPU;EIF2AK2;PTPRC;KDM1A;AGO3;GJA1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.5924234239065616,1.265990695702158,0.18740399385560677,0.7045345560534727,1.0,7/12,17.39%,IDH1;ACO2;ACLY;IDH3B;GLUD1;IDH2;IREB2
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.5834545833291283,1.2653361246021444,0.20352564102564102,0.705920896238161,1.0,3/12,3.58%,CLCN2;SEC14L2;MBTPS1
prerank,positive regulation of rRNA processing (GO:2000234),0.6007226265082255,1.2647669174645515,0.2222222222222222,0.706964091823924,1.0,2/10,2.06%,RIOK1;UTP15
prerank,triglyceride catabolic process (GO:0019433),0.5283857992873188,1.2643090769652903,0.2,0.7076776044565732,1.0,1/19,1.49%,LPL
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.42494245597022146,-1.264261911125083,0.15932203389830507,1.0,1.0,9/20,16.55%,CALM2;ATP2A2;CACNA1C;ANK2;CALM1;PRKACA;SLC8A1;ATP1A2;CALM3
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.4242968523647383,1.2640162963266084,0.13691128148959475,0.7077680416067486,1.0,21/85,11.81%,DVL2;FZD5;CELSR2;PSMD2;FZD6;PSMC4;PFN1;PSMD4;PRICKLE1;PSMD1;SMURF1;PSME3;PSMB6;RYK;PSMD10;AP2A1;CLTC;PSMB1;PSMD11;PSMA2;PSMD13
prerank,cellular copper ion homeostasis (GO:0006878),0.5745711812591642,1.2638364248868377,0.19692307692307692,0.7074472773363614,1.0,5/14,15.95%,PRNP;SLC31A1;APP;COX19;MT2A
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.5318103250998879,1.2636900974407668,0.18044077134986225,0.7069841746742795,1.0,5/20,11.00%,SCD5;ACLY;PPT1;FAR1;ACACA
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5529233563110889,1.2636615959924629,0.20278637770897834,0.705079854924461,1.0,3/16,4.10%,CORO1C;APOD;FAM107A
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5529233563110889,1.2636615959924629,0.20278637770897834,0.705079854924461,1.0,3/16,4.10%,CORO1C;APOD;FAM107A
prerank,protein localization to nucleus (GO:0034504),0.4190393027141767,1.2634248775810715,0.11517761033369214,0.7049147955954431,1.0,20/102,10.51%,SPRN;STAT3;TBRG1;IPO5;PPP1R10;NUP153;TAF8;HNRNPU;TNPO2;PTTG1IP;PRICKLE1;RPAIN;COL1A1;ZBTB7A;BBS4;IPO13;NUP88;FAM53C;CTDNEP1;CNEP1R1
prerank,inositol lipid-mediated signaling (GO:0048017),0.45104659311837547,1.2633906947242344,0.1467455621301775,0.704060257091184,1.0,9/50,12.61%,PLCD4;PDGFRB;PI4KA;PLCH1;PIK3C3;PIK3R1;PI4KB;IGF1;INPP5F
prerank,superoxide anion generation (GO:0042554),0.5797268277889052,1.2633206432931536,0.2108345534407028,0.7032911087897391,1.0,3/13,9.74%,NCF4;CYBB;NCF2
prerank,regulation of cell killing (GO:0031341),0.5587670693907574,1.262837151022732,0.19797687861271676,0.7041324204680144,1.0,6/16,17.24%,DVL2;CD55;NOXO1;MAPK8;RAC1;ICAM1
prerank,extracellular transport (GO:0006858),-0.49098064775763856,-1.2623462463295687,0.18983957219251338,1.0,1.0,2/13,1.88%,WWP2;TSG101
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.4962905308917093,1.2618384092266097,0.1830238726790451,0.7066261345500471,1.0,9/30,17.24%,BMP5;BCL2L1;SERPINE1;FAIM2;CFLAR;RNF34;TNFAIP3;ARHGEF2;ICAM1
prerank,modulation by host of viral genome replication (GO:0044827),-0.4952770137372723,-1.2617970662162135,0.20277777777777778,1.0,1.0,7/13,15.14%,NUCKS1;YTHDC2;TBC1D20;EIF2AK4;PPIB;VAPA;IFI27
prerank,maturation of LSU-rRNA (GO:0000470),0.4988824722458867,1.2616491991062717,0.18144611186903137,0.7063095692281275,1.0,6/26,6.87%,RRP15;PES1;URB1;NOP2;NIFK;EIF6
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.42195371386088276,1.2614667054907238,0.13600891861761427,0.7058951817984753,1.0,26/80,18.12%,RAB7B;TBC1D10B;CLN5;TBC1D17;SNX6;VPS50;PHETA1;GGA1;SGSM2;VPS52;TRAPPC10;VPS29;CLTC;SPAG9;RIC1;VPS35;ERC1;GBF1;DENND5A;PREPL;PLEKHJ1;STX5;ARL1;TBC1D10A;RAB7A;DCTN1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.5794512399268228,1.261202141280973,0.19169329073482427,0.7059468743008188,1.0,4/12,17.32%,NEK6;CTDNEP1;CNEP1R1;PRKCB
prerank,snRNA metabolic process (GO:0016073),0.5360450736133828,1.2611302296712212,0.1967930029154519,0.705191836794811,1.0,6/17,12.05%,INTS9;INTS6;INTS10;ZCCHC8;TUT1;INTS8
prerank,positive regulation of JNK cascade (GO:0046330),0.4340753420849388,1.2610541039329792,0.14076576576576577,0.7044785267973805,1.0,15/70,14.03%,SERPINF2;SLAMF1;LTBR;ANKRD6;HMGB1;DUSP19;SDCBP;CARD9;PTK2B;MAP4K2;PYCARD;TAOK2;APP;TRAF3;MBIP
prerank,positive regulation of secretion (GO:0051047),-0.5095872027822659,-1.260506346564323,0.18994413407821228,1.0,1.0,3/11,23.45%,ACSL3;XBP1;GPLD1
prerank,regulation of telomere maintenance (GO:0032204),0.5050565876896963,1.2602536461271687,0.19559228650137742,0.7063897049678264,1.0,5/26,9.60%,MYC;PPP1R10;HNRNPD;XRCC5;NBN
prerank,rRNA catabolic process (GO:0016075),0.5488376724301727,1.2599546079023396,0.20444444444444446,0.706569164969759,1.0,4/16,11.20%,DIS3;EXOSC8;EXOSC10;DEDD2
prerank,regulation of protein binding (GO:0043393),0.40806387903713004,1.259784464436409,0.11571125265392782,0.7061944079875155,1.0,30/114,15.62%,BAMBI;TMC8;ADD1;PIN1;PSME3IP1;TAF1;GNL3L;PDGFB;SPPL3;CSNK1E;RALB;LRP1;SORL1;TCF7L2;NVL;MAPK8;CAPRIN2;RIPK2;CARD16;HDAC5;KDM1A;TMBIM6;DNAJB2;DERL1;APP;IDE;CRK;SYMPK;ACTB;FLOT1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.49459428138334394,1.2594841685415807,0.17328042328042328,0.7062977742692647,1.0,5/28,7.50%,BAG6;ATF4;QRICH1;CASP4;BRSK2
prerank,regulation of exit from mitosis (GO:0007096),0.4665978794040996,1.259353793739835,0.16625,0.7057903996979638,1.0,9/38,11.44%,MAD2L1;UBE2S;RPS27A;UBC;UBE2D1;ANAPC5;UBE2E1;SIRT2;ANAPC10
prerank,respiratory system development (GO:0060541),0.4864830656354908,1.2592576034143932,0.1566579634464752,0.7051083909151022,1.0,2/32,0.53%,BAG6;BASP1
prerank,regulation of neurotransmitter transport (GO:0051588),0.545040257513222,1.2591155940368857,0.21099554234769688,0.704625866709502,1.0,5/16,18.17%,RIMS1;SNCAIP;FMR1;FLOT1;MEF2C
prerank,thymus development (GO:0048538),0.5666358459307871,1.2589082402141378,0.1984375,0.7043115298133312,1.0,2/13,5.29%,FOXE1;TGFBR1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.4283924504432158,1.258440947876062,0.13472706155632985,0.7049659067512569,1.0,29/69,19.37%,POLR2J;TAF8;ELL2;GTF2A1;INTS9;INTS6;ICE2;INTS10;TBP;INTS14;ELL;CCNK;RPAP2;NCBP1;GTF2F2;TAF6;INTS8;NABP1;POLR2E;RPRD1A;POLR2B;POU2F2;CCNT1;SNAPC1;POLR2G;RPRD1B;CDK9;POLR2K;INTS3
prerank,sphingosine biosynthetic process (GO:0046512),-0.5214438540336549,-1.2583370289104212,0.18786127167630057,1.0,1.0,6/11,31.05%,SPTLC2;ASAH1;ACER3;SPHK2;SPTLC1;ACER2
prerank,sphingoid biosynthetic process (GO:0046520),-0.5214438540336549,-1.2583370289104212,0.18786127167630057,1.0,1.0,6/11,31.05%,SPTLC2;ASAH1;ACER3;SPHK2;SPTLC1;ACER2
prerank,positive regulation of cellular protein localization (GO:1903829),0.43661694949642943,1.258253031352693,0.1443661971830986,0.704650521652976,1.0,19/69,16.72%,SESN2;VPS28;TYROBP;TM9SF4;HSP90AB1;RTN4;SNX33;GNL3L;CROCC;EIF2AK3;STX3;NDC80;CEP250;SLC5A3;WWTR1;MAP1A;CCDC88A;APC;GPR137B
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.5237210485222797,1.2582006090400737,0.20396600566572237,0.7038606437498096,1.0,8/21,11.80%,PNLDC1;ZFP36;TUT7;CNOT8;CNOT6;SAMD4B;CNOT4;CNOT7
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5191510294504956,1.257800134320953,0.172821270310192,0.7042315757841463,1.0,7/21,18.76%,ADAMTS1;JUN;PDGFB;IGF1;FGF9;FOXJ2;GJA1
prerank,positive regulation of T cell activation (GO:0050870),0.44577298076146327,1.2577280272310754,0.15179606025492468,0.703507846592283,1.0,10/62,9.33%,CCL2;SLC7A1;NCK1;SIRPA;ZMIZ1;PNP;FLOT2;CYRIB;PTPRC;PYCARD
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3921082713503554,1.2576787509754754,0.03009027081243731,0.7027098430298668,1.0,71/308,18.76%,GDNF;KDM6B;BAMBI;CXCR4;C1QBP;INPP5K;SERPINE1;SOX9;KMT5B;EIF2AK2;GATM;GNAS;TGFBR1;TGFBR2;ADIPOR1;RTN4;APOE;CADM1;COL1A1;GLIPR2;CMKLR1;SDCBP;PDGFB;PRKCH;AGT;GLMN;TRPM4;EBF2;STAT6;CARD9;LRP1;ZBTB7B;IL1A;SORL1;ACVR1B;SIRT1;TAPT1;KSR2;CTNNB1;IL18;KDM1A;B4GALT5;BAD;TRPV2;IL4R;GCNT2;PRKAB1;ADRB2;NCOA3;SLC11A1;MTOR;IL6;MED1;WWTR1;ADIPOR2;FLOT1;PAX2;APC;HMCES;KAT2A;SMO;ACVR1;SMAD3;EZH2;TIAM1;PIK3CG;ZBED3;CEBPB;ELOVL6;EPAS1;GJA1
prerank,regulation of GTPase activity (GO:0043087),0.40186083569155095,1.2576450172598335,0.0744138634046891,0.7018723574055247,1.0,51/177,19.36%,CCL3;CCL4;CCL2;EPHA1;RGS1;PLXNA1;TBC1D10B;NDEL1;PIN1;PICALM;ALS2;USP6NL;SNX13;RABGAP1;RASGRF1;SGSM2;RRP1B;SH3BP1;RGS7;ZC3H15;GMIP;LARS1;TBC1D30;FGD1;CDKL5;DOCK10;RIC1;EPHA3;SRGAP2;EVI5L;OCRL;DOCK9;CCL25;CCL13;CRK;LIMS1;TBC1D7;RALBP1;FLCN;GPR137B;PKP4;RASGRP2;TBC1D15;EZH2;PRKG1;NTRK2;ASAP3;BCAR3;RAB3GAP1;TMED2;PLXND1
prerank,regulation of endopeptidase activity (GO:0052548),0.4422226801186002,1.2572435497071326,0.1742690058479532,0.7023028146089223,1.0,9/59,10.01%,SERPINF2;PRELID1;SERPINE1;ATP13A2;PICALM;AGT;PSME3;FURIN;HDAC1
prerank,cellular response to sterol (GO:0036315),-0.4771776792766949,-1.257222614214482,0.19197707736389685,1.0,1.0,4/13,6.12%,LRP6;GRAMD1B;PTCH1;INSIG2
prerank,leukocyte tethering or rolling (GO:0050901),0.5289544094073941,1.257090435575688,0.21460506706408347,0.7019238750865604,1.0,1/17,0.05%,SELP
prerank,cellular response to inorganic substance (GO:0071241),-0.4082041996287788,-1.256611216181904,0.17567567567567569,1.0,1.0,11/21,31.74%,SPIDR;KCNC2;BLM;RTF2;GUCY1B1;CDK2;DDI2;MTR;DDX11;MT3;TIMELESS
prerank,snRNA transcription (GO:0009301),0.4269761071798536,1.256358822114727,0.1351039260969977,0.7036038276510066,1.0,29/70,19.37%,POLR2J;TAF8;ELL2;GTF2A1;INTS9;INTS6;ICE2;INTS10;TBP;INTS14;ELL;CCNK;RPAP2;NCBP1;GTF2F2;TAF6;INTS8;NABP1;POLR2E;RPRD1A;POLR2B;POU2F2;CCNT1;SNAPC1;POLR2G;RPRD1B;CDK9;POLR2K;INTS3
prerank,protein dephosphorylation (GO:0006470),0.4061243107600061,1.2561846083656256,0.09844559585492228,0.7032641620224965,1.0,36/135,14.31%,DUSP5;PPP1R15B;DUSP16;NCK1;FBXW11;PPP4R1;PTPN12;PTPN14;PPP2R5B;CTDSP2;PPP1CB;MTM1;PPP2R5A;MTMR3;PPP2R2D;PTPRC;PTPRR;CTDNEP1;PTPRD;PPM1F;PTPN4;RPAP2;CTDP1;PTPN6;PTPRU;PTPRO;PTPRA;PPM1G;EYA2;CTDSP1;PPM1H;PTPRN2;CTTNBP2NL;PPP2CB;PTPRE;RPRD1A
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.41290676734479154,1.2557688375055853,0.10980810234541578,0.7038045496520904,1.0,18/116,15.03%,MC2R;CALCA;MYH9;ADAM17;RHBDF2;HRH2;ADCY5;FURIN;GNB1;PRKAR2A;GPR176;DPEP1;ADCY8;ADCY3;FCGR1A;ADRB2;CREB1;IL6
prerank,regulation of macrophage chemotaxis (GO:0010758),0.5183685361895357,1.2556236441706237,0.20584144645340752,0.703367195446516,1.0,5/21,7.92%,CSF1;IL34;CMKLR1;CXCL17;PTK2B
prerank,regulation of protein phosphorylation (GO:0001932),0.3921135919788114,1.2555540478437535,0.047474747474747475,0.7026349880291737,1.0,68/256,19.34%,ATF3;CORO1C;SESN2;PPP1R15B;DVL2;ADAM17;PLAUR;WARS1;CLIP3;INPP5K;PIK3R3;PDGFA;IL34;PIN1;SOX9;ATF4;TARDBP;FNIP2;FXR2;SIRPA;ITGB3;PPP2R5B;TSPYL2;MOB1B;PPP2R5A;RALB;EIF2AK3;VEGFC;P2RY1;SIRT1;ENG;PRNP;TRAF3IP1;ARRB1;TNIK;LIMCH1;ANKRD54;APP;FMR1;AKAP8L;NPTN;BRD4;CAMKK2;FKBP8;HGF;RALBP1;WWTR1;FLOT1;PGF;RAC1;FLCN;FGF9;CCDC88A;ILK;KRAS;AKTIP;CSNK1D;GPNMB;ZC3H12A;ZBED3;CEBPB;PDCL3;VEGFB;NTRK2;ITGB2;IBTK;CSF1R;TERF2IP
prerank,protein import into nucleus (GO:0006606),0.4351242997100775,1.255313936678704,0.1478463329452852,0.702521631815071,1.0,12/66,8.73%,SPRN;STAT3;IPO5;PPP1R10;NUP153;TNPO2;PTTG1IP;PRICKLE1;RPAIN;IPO13;NUP88;FAM53C
prerank,gland development (GO:0048732),0.43833897300507624,1.2553085333925793,0.12603062426383982,0.7015966744677422,1.0,8/59,11.10%,NKX2-8;LSR;FOXE1;SOX9;TGFBR1;PRKCSH;MSN;SOX2
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.47605605534954265,1.2550045378789527,0.18434343434343434,0.701691984978148,1.0,7/35,8.65%,PDGFRB;PPP1R15B;HSP90AB1;PPP6R1;FKBP1B;CRY2;PPP6R3
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.4426371941866116,1.2549990425120539,0.15250291036088476,0.7007564928210208,1.0,15/59,12.45%,RELB;NKIRAS1;IKBKB;RELA;TANK;TBK1;RPS27A;UBC;RBCK1;NLRC3;TLR7;RIPK2;RNF31;IRAK2;ERC1
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.5502777186386693,1.254528131508982,0.2033898305084746,0.7014761099537296,1.0,5/15,12.68%,ENTPD1;AK8;CMPK1;ENTPD7;ENTPD5
prerank,rRNA metabolic process (GO:0016072),0.4034826415998455,1.254386075757995,0.09400826446280992,0.7010573139365153,1.0,36/160,12.56%,DIS3;NOP14;RPL31;UTP15;WDR18;DDX49;RPS15;PES1;RPL3;NOB1;RPL13A;RPL15;RPL10;RRP7A;NIFK;UTP11;DDX54;UTP18;NOP56;RPL9;ESF1;RPL22;RRP1B;RRP1;C1D;SENP3;RPL23A;NVL;UTP4;EXOSC8;RPL34;EXOSC10;DEDD2;RRP36;RPS14;WDR43
prerank,regulation of neutrophil migration (GO:1902622),-0.5180956481724925,-1.2542237793777267,0.18610421836228289,1.0,1.0,3/10,4.30%,NCKAP1L;RHOH;JAM3
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.5298881841157854,1.2539713430342476,0.2140845070422535,0.7015729779836679,1.0,6/20,11.94%,HSPA4;HSP90AB1;BBS12;LONP1;PTGES3;CLU
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.5360345560801381,1.2536479815827342,0.2077922077922078,0.7017915814602248,1.0,5/18,8.46%,LLGL1;RUFY3;KRIT1;PTK2B;CYRIB
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.49379537835123744,1.2532237795690262,0.17092866756393002,0.7023681493300652,1.0,5/27,17.24%,CALCA;HTR2C;GNA15;LPAR1;GPR65
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5305680123292035,1.2529780653445155,0.2040520984081042,0.7023084737212182,1.0,4/18,11.29%,ZFP36;HNRNPU;FAM107A;UBE2L3
prerank,protein insertion into ER membrane (GO:0045048),0.47459527333283086,1.252138717575025,0.17548387096774193,0.7044491959463267,1.0,13/37,18.67%,WDR83OS;BAG6;EMC4;GET1;EMC10;PRNP;APP;CCDC47;TRAM1;STX5;EMC7;EMC1;MMGT1
prerank,inhibitory synapse assembly (GO:1904862),0.5978067821754183,1.2514337488013165,0.2168284789644013,0.7059932069662691,1.0,3/11,5.99%,FGF13;GABRB2;LGI2
prerank,triglyceride homeostasis (GO:0070328),0.49977410762607044,1.2511910874496992,0.19257221458046767,0.7059289305152195,1.0,6/26,15.23%,LPL;APOE;SIRT1;IL18;RORA;PNPLA8
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.4168588558485225,1.2509573940859784,0.13160733549083065,0.7058676188869147,1.0,27/86,19.49%,OSM;SAMSN1;PDGFA;CSPG4;ITGB3;PDGFB;AGT;PTK2B;PRKCZ;BMP6;PTPRC;PRNP;RIPK2;PTPN6;CNOT7;IGF1;APP;DGKQ;IL6;HGF;ITGA5;TEC;ARHGEF2;ACVR1;PDCL3;ITGB2;RAP2B
prerank,negative regulation of MAP kinase activity (GO:0043407),0.45897955670769325,1.2507753142162523,0.1668711656441718,0.7055944533935837,1.0,8/44,8.75%,INPP5K;DUSP19;UCHL1;APOE;AGT;SORL1;SMPD1;DNAJA1
prerank,sensory perception of smell (GO:0007608),0.5952530408396531,1.2504772122676453,0.21935483870967742,0.7057385198449045,1.0,3/11,20.86%,BBS4;ADCY3;SYT10
prerank,ribosome biogenesis (GO:0042254),0.398030186999532,1.2503655403103746,0.09183673469387756,0.7051908046550774,1.0,40/187,12.56%,DIS3;RIOK1;NOP14;RPL31;UTP15;GTF3A;WDR18;DDX49;RPS15;PES1;RPL3;MALSU1;NOB1;RPL13A;RPL15;RPL10;RRP7A;UTP11;DDX54;UTP18;NOP56;RPL9;LTO1;ESF1;RPL22;DDX31;EIF6;RRP1B;RRP1;C1D;SENP3;RPL23A;NVL;UTP4;EXOSC8;RPL34;EXOSC10;RRP36;RPS14;WDR43
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.4257074892084839,1.2502432821939957,0.14752252252252251,0.7046931677850353,1.0,22/74,15.15%,NFE2L2;HIGD1A;PSMD2;PSMC4;PSMD4;PSMD1;RPS27A;UBC;EGLN2;PSME3;PSMB6;PSMD10;CREBBP;PSMB1;RBPJ;SIRT2;PSMD11;PSMA2;PSMD13;PSMB10;CUL2;PSMB3
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.40225575661484536,-1.2501396689807955,0.17164179104477612,1.0,1.0,7/23,25.44%,TGFBR3;TPM1;FGFR2;ID2;ADAMTS9;PKP2;PROX1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.4292430964456413,-1.248836767195001,0.18885448916408668,1.0,1.0,8/18,19.49%,PIK3C2A;AKT3;MAP3K3;HMOX1;HDAC7;HDAC9;FGF2;VEGFA
prerank,protein glycosylation (GO:0006486),0.4069605542846119,1.2483585575940477,0.1074468085106383,0.7103835319886089,1.0,38/125,18.68%,ST6GALNAC2;ALG11;DDOST;RPN2;ST8SIA6;GALNT6;TUSC3;SLC39A8;TRAK1;TET2;POFUT1;ALG12;GFPT1;MGAT5;POMGNT1;DPM1;GALNT10;TET1;MGAT5B;SERP2;ALG10B;B3GALNT2;GALNT1;PMM1;MGAT4A;MAN1C1;B4GALT5;GALNT7;ENTPD5;GCNT2;ST3GAL6;PMM2;B4GALT7;TET3;NPC1;ALG9;C1GALT1C1;ALG8
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.4533057261159275,-1.248142335335596,0.1661631419939577,1.0,1.0,10/15,34.43%,MRE11;CHEK2;TIPIN;RAD9B;RAD9A;ATF2;HUS1;FANCD2;EME2;NEK11
prerank,toll-like receptor signaling pathway (GO:0002224),0.422696119892251,1.2474769017392802,0.14174972314507198,0.7126030949600137,1.0,27/84,19.71%,MAPKAPK2;CTSB;CTSL;HMGB1;IKBKB;PIK3R4;RPS27A;UBC;PIK3C3;UBE2D1;COLEC12;TLR7;UBE2D3;RIPK2;IRAK2;TNIP1;SFTPA1;SFTPA2;TRAF3;HSPD1;MAPKAPK3;HSP90B1;IRAK4;ITGB2;PIK3AP1;TLR2;RFTN1
prerank,neutral amino acid transport (GO:0015804),0.48968611757590036,1.2472572821659058,0.18381344307270234,0.7124532736308051,1.0,7/28,16.12%,SLC7A5;SLC3A2;SLC6A6;SLC36A1;SLC1A1;SLC38A1;SLC36A4
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.48966225816048653,1.2472121207213858,0.20261437908496732,0.7116418847253234,1.0,8/27,12.51%,USP2;RBM4B;FBXL3;PPP1CB;CRTC1;CRY2;FBXL8;FBXL17
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.45538141629462714,1.2469537271664763,0.17034313725490197,0.7116151775934502,1.0,9/47,11.13%,MYC;ARL6IP5;EIF2AK2;MAP2K1;CARD9;PHLPP1;SEMA4C;MID1;TAOK2
prerank,positive regulation of telomere capping (GO:1904355),0.5273052806595835,1.2467201868178122,0.19732937685459942,0.7114879225307256,1.0,3/17,4.53%,NEK7;HNRNPD;MAP2K7
prerank,regulation of ion transmembrane transport (GO:0034765),0.47543953096297475,1.2464503692974858,0.18627450980392157,0.7115234313252373,1.0,5/33,9.42%,KCNH2;KCNJ6;AKAP6;KCNJ2;AKAP9
prerank,chromosome organization (GO:0051276),0.41343954474748235,1.245673961927075,0.12747252747252746,0.7133432257102438,1.0,27/99,17.83%,MYC;DDB2;ACTL6B;HMGN3;HMGN1;DOT1L;RPS27A;UBC;ZBTB7A;TCF7L2;LATS1;SIRT1;COPS3;HDAC1;MSH3;NDC80;HDAC5;SOX2;RFWD3;TCF7L1;DDB1;SETD7;LDB1;CUL4A;HDAC11;SAFB;EZH2
prerank,negative regulation of response to external stimulus (GO:0032102),0.4091075663072077,1.2456185210849906,0.1346153846153846,0.7125963956565184,1.0,34/105,20.77%,C1QBP;SERPINE1;ACOD1;NLRP3;SIRPA;APOE;CXCL17;NLRC3;METRNL;PCBP2;TRAF3IP1;CARD16;TNFAIP8L2;SIRT2;VPS35;INPP5F;GPS2;CRK;ILRUN;RORA;PTPRS;TNFAIP3;PROC;OTULIN;CERS2;CTNNA2;TRAFD1;DUSP3;LRFN5;PPM1B;TRIB1;ITCH;AOAH;RTN4RL1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.40543087051507326,1.244765951807241,0.11691022964509394,0.7147719962137136,1.0,38/149,17.63%,STAT3;RTKN2;RAB7B;ADAM8;PRKD2;NLRP3;IKBKB;EIF2AK2;RELA;FLOT2;RPS27A;UBC;RBCK1;ZBTB7A;PRKCH;AGT;CARD9;DHX9;PRKCZ;PYCARD;RNF25;RIPK2;CARD16;IL18;RNF31;CLU;IRAK2;ERC1;CFLAR;APP;ROR1;MTDH;IL6;FLOT1;NFKB1;ARHGEF2;PRKCB;TRIM5
prerank,actin filament capping (GO:0051693),0.5320582017841491,1.2430323220237247,0.19622093023255813,0.7190514546564688,1.0,3/18,3.02%,TRIOBP;ADD1;FLII
prerank,barbed-end actin filament capping (GO:0051016),0.5320582017841491,1.2430323220237247,0.19622093023255813,0.7190514546564688,1.0,3/18,3.02%,TRIOBP;ADD1;FLII
prerank,signal release from synapse (GO:0099643),0.45438334400054936,1.2426666028040507,0.19053398058252427,0.7193663639929525,1.0,12/43,14.82%,BRSK1;PDZD11;RIMS1;HSPA8;LIN7C;SLC32A1;STXBP3;SYN3;GAD2;PTPRN2;SNPH;SYT1
prerank,protein autoprocessing (GO:0016540),0.5234062338895303,1.242322876841548,0.21565731166912852,0.7196067986537883,1.0,5/17,17.28%,CTSL;CASP4;FAM111A;AFG3L2;HTRA2
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.5283768365426617,-1.2422890788927197,0.21715817694369974,1.0,1.0,4/10,11.00%,IRS2;IRS1;PRKCE;AKT2
prerank,regulation of actin filament-based movement (GO:1903115),-0.5183280034732392,-1.241851440463534,0.18811881188118812,1.0,1.0,3/10,16.30%,ANK2;SRI;PDE4D
prerank,cellular iron ion homeostasis (GO:0006879),0.44047069837463915,1.2415989754979515,0.15963511972633979,0.7212905403804304,1.0,16/55,15.96%,MYC;SLC39A14;ATP6V1A;ATP6V0D1;ATP13A2;SLC22A17;CAND1;BMP6;GLRX3;NEDD8;ATP6AP1;FBXL5;ABCB7;SLC11A1;SKP1;TMPRSS6
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.5052125970366848,1.241451179740504,0.21309192200557103,0.7208694028703911,1.0,6/23,10.87%,NLRP3;RELA;ADIPOR1;NLRC3;SPI1;TMSB4X
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.4164604380526562,-1.2414154605791954,0.15358361774744028,1.0,1.0,11/20,42.16%,CAB39;GOPC;PRKCE;ACTN2;YWHAE;NEDD4;HECW1;ADRA2A;STK39;OSR1;NEDD4L
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.5993718018070319,1.2413026780666006,0.23832528180354268,0.7204683791400086,1.0,6/10,18.30%,ATP5PD;ATP5MC2;ATP5F1C;ATP5F1D;ATP5MC3;ATP5MG
prerank,zinc ion transport (GO:0006829),0.5165198956228281,1.241267881303295,0.20784883720930233,0.7196721775347775,1.0,5/21,11.95%,SLC39A14;SLC39A3;SLC39A8;SLC30A5;TRPM2
prerank,negative regulation of secretion by cell (GO:1903531),0.461614104411365,1.2410992898414175,0.16117216117216118,0.7193645353335515,1.0,5/38,9.83%,OSM;RHBDF2;PNKD;APOE;SERGEF
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.4617467623492411,1.2409247079695283,0.1891891891891892,0.7190522744709424,1.0,10/42,15.90%,CSF1;EPHA1;JUP;PTK2B;CDK6;COL16A1;PPM1F;CCL25;LIMS1;RAC1
prerank,chondrocyte differentiation (GO:0002062),0.4809695493778639,1.2406141411464595,0.19921363040629095,0.7192071401744179,1.0,9/32,18.17%,WNT5B;SLC39A14;SOX9;EIF2AK3;RUNX2;SNX19;SULF2;RUNX1;MEF2C
prerank,regulation of neuron death (GO:1901214),0.4161832843787642,1.2405724760975865,0.14046822742474915,0.7184409664336128,1.0,23/82,18.17%,EGR1;CSF1;TYROBP;ATP13A2;PICALM;EIF2S1;TBK1;EGLN2;FAIM2;LANCL1;CD200R1;SORL1;PRNP;CD200;CLU;VPS35;NAE1;TNFRSF1B;BTBD10;HTRA2;GPNMB;INPP5A;MEF2C
prerank,intestinal absorption (GO:0050892),-0.482216543261083,-1.2404707283256178,0.18624641833810887,1.0,1.0,8/13,42.48%,TJP2;CD36;SLC2A5;F11R;SLC26A6;SLC46A1;ADRA2A;UGCG
prerank,regulation of viral transcription (GO:0046782),0.45821005147951654,1.24034741608545,0.17997465145754118,0.7183616377934819,1.0,15/39,18.93%,ZFP36;POLR2J;TARBP2;LARP7;IFITM3;DHX9;CTDP1;GTF2F2;POLR2E;POLR2B;CCNT1;POLR2G;MDFIC;CDK9;POLR2K
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.5192680570560637,1.2398661755169738,0.21664275466284075,0.7191119215151397,1.0,6/20,9.86%,BCL2L1;PICALM;PPP2R5A;MRAP2;CLTC;RHOQ
prerank,kidney development (GO:0001822),0.43149177976590475,1.2397292755565184,0.15560640732265446,0.7186997909223455,1.0,8/65,9.57%,GDNF;BAG6;TFAP2B;TGFBR1;AGT;ARL3;LRP4;TRAF3IP1
prerank,regulation of cellular protein localization (GO:1903827),0.4524658790026499,1.239549469653886,0.17023809523809524,0.718384069353577,1.0,13/45,13.40%,NDEL1;LCP1;HSP90AB1;ATP13A2;PIN1;CSNK1E;RALB;CTNNB1;PPM1F;BDNF;KDM1A;GPC5;GBF1
prerank,positive regulation of growth (GO:0045927),0.42644397092700226,1.2394156048804164,0.15807174887892378,0.7179135689398183,1.0,22/64,21.46%,DERL2;ADAM17;DDX49;TGFBR1;SDCBP;AKAP6;PSMD10;SLC25A33;PPM1F;NCBP1;HPN;EIF4G2;CXCL16;ZPR1;WFS1;HDGFL2;RPTOR;MMP14;RFTN1;ADAM10;CDC42;INO80
prerank,positive regulation of protein secretion (GO:0050714),0.4221857878029218,1.2392805952879153,0.16493656286043828,0.7174616860680602,1.0,14/69,12.34%,MYRIP;ADAM8;ATP13A2;ADAM9;TMED10;CD2AP;IL1A;TCF7L2;BMP6;GLUD1;CD33;BAD;APBB3;IGF1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.47232615837172076,1.239099224851447,0.1925545571245186,0.717152768925595,1.0,8/34,9.69%,PDGFRB;PIK3R3;PIK3R4;RUBCN;PIK3R1;PDGFB;PTK2B;PIK3IP1
prerank,regulation of chromatin organization (GO:1902275),0.5596990743021749,1.2388390291999611,0.2295839753466872,0.7171893634036257,1.0,4/14,3.80%,HPF1;PARG;HNRNPU;TLK1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5547434196341445,1.2384558440745022,0.22522522522522523,0.7175928344836411,1.0,3/14,4.86%,BCL2L1;CREB3L1;CREB3
prerank,negative regulation of cell junction assembly (GO:1901889),0.4930097413204901,1.238107051229262,0.2274618585298197,0.7178700015464632,1.0,4/25,4.10%,CORO1C;IKBKB;APOD;FAM107A
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.3083281432566166,-1.2379551851575303,0.08860759493670886,1.0,1.0,34/91,19.33%,PLD1;SCFD1;HIP1;DENND10;RAB5A;ITGAV;RAB5B;RUFY2;SNX12;RINT1;MAP2K2;ARFGAP1;SCARB1;RALA;MAPK1;LRRK2;RIT2;PTPN1;STON2;CHMP3;MAPK3;SRC;RIMS2;USP7;RAB11B;RAB8A;VAMP2;SYT7;LGI3;NRP1;AP2S1;RAB33B;RAB5C;RNF139
prerank,nucleic acid metabolic process (GO:0090304),0.4216722876374129,1.2374811041380402,0.1506849315068493,0.7192166240816786,1.0,28/69,21.19%,POLR2J;HNRNPK;HNRNPD;HNRNPU;HNRNPM;DDX54;HNRNPH2;PCBP2;NCBP1;GTF2F2;KPNA2;HNRNPL;POLR2E;HNRNPH1;PTBP1;POLR2B;DNASE1L1;POLR2G;HNRNPA1;ATXN2;HNRNPR;TOPBP1;POLR2K;RAN;DNASE2;POLG;METTL3;HNRNPA2B1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.5004126942339677,1.237267590480063,0.19920844327176782,0.7190483516701667,1.0,6/24,8.39%,UCHL5;APOE;UBE3A;PSME3;PTK2B;LATS1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3827470376230105,1.237219557746224,0.015,0.718313590472112,1.0,129/572,17.01%,ATF3;MYC;SOX10;HOXD9;STAT3;DDX20;ZNF436;GLIS1;TFAP2B;DRAP1;THAP1;ZFP36;CTBP2;HSF4;PHF6;SKIL;ZMYM5;NR2F6;C1QBP;JUN;HDGF;USP2;FOXE1;HMGB1;ZNF177;HNRNPU;SOX9;KLF11;NR1D2;NFATC3;KMT5A;RPL10;ATF4;SARS1;FNIP2;KAT5;RELA;ARID5A;MYPOP;DPF2;MDM4;LARP7;RPS27A;UBC;UXT;TAF1;TGIF1;SDCBP;PDGFB;ZBTB7A;UBE2D1;OTUD7B;FOXP1;BCL11A;DNAJA3;CRY2;ZBTB7B;TCF7L2;PSMD10;HIVEP1;SIRT1;TBL1X;SPI1;KLF10;CNBP;BMP6;NCOA5;ZBTB2;TENM2;N4BP2L2;UBE2D3;SUMO1;HDAC1;CREBBP;KLF7;IRF8;HDAC5;SFPQ;ACVR2B;RBPJ;KDM1A;MITF;ZNF148;SOX2;TCF25;SIRT2;DR1;PCGF2;CBX4;WWC2;LIN37;UBE2I;TCF3;RPS14;MIER1;DNMT3A;GPS2;DDX5;FOXO3;HMBOX1;BCL6;SKOR2;CBX5;ZFP69;WFS1;NCOR1;MTDH;MED25;ARID5B;MED1;CTCF;LDB2;LDB1;RUNX1;FLCN;TMPRSS6;SIN3A;IRF2BPL;GATAD2A;CUX1;RXRA;NFKB1;ZBTB4;IRF2BP2;ETV6;CNOT2;PER1;MEF2A;EID1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.49948092202662103,1.2368448002039938,0.1934156378600823,0.7187144108554308,1.0,5/23,11.61%,MAD2L1;NDEL1;FBXW11;NDC80;PAFAH1B1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.4258460386066929,-1.2366300780130761,0.20723684210526316,1.0,1.0,4/19,8.32%,NCKAP1L;RHOH;GAS6;PPP2R3C
prerank,phosphate ion transport (GO:0006817),0.5474084088438026,1.2355826784989108,0.22475106685633,0.7222276791213772,1.0,6/16,17.61%,SLC37A1;SLC25A3;SLC20A2;SLC37A3;SLC20A1;SLC25A14
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.56725253589587,1.2353045243975787,0.22652757078986588,0.7222072358658311,1.0,5/13,14.27%,PPP1R15B;NCK1;UFL1;HSPA5;WFS1
prerank,RNA interference (GO:0016246),0.5292581879813422,1.2352176066618388,0.225,0.721612220646199,1.0,7/17,20.13%,TARBP2;DHX9;DROSHA;TSN;AGO3;TSNAX;AGO2
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3874211251554607,1.2346895884440279,0.07931726907630522,0.7226137499014066,1.0,72/241,18.05%,MAGOH;MAGOHB;LSM5;BCAS2;DHX35;DDX42;PRPF31;POLR2J;FUS;HNRNPK;HNRNPD;RBM4B;HNRNPU;HNRNPM;ESS2;PRPF40A;HSPA8;DDX41;SNRPA1;SNRPA;HNRNPH2;ZCCHC8;U2AF2;DHX9;PCBP2;GEMIN7;SRSF2;GCFC2;U2AF1;SRSF10;NCBP1;SRSF12;CWC15;YBX1;SFPQ;FIP1L1;GTF2F2;ELAVL2;HNRNPL;PRPF40B;SF3A2;DDX5;DNAJC8;POLR2E;HNRNPH1;CWC25;SF3A1;SNRNP27;PTBP1;SNRNP48;SNRPG;POLR2B;BUD13;U2SURP;SART3;SYMPK;RBM10;RBM8A;ZRSR2;SNRNP40;POLR2G;PPIL3;GPATCH1;PSPC1;HNRNPA1;NONO;ELAVL1;HNRNPR;PRPF4;RBM14;SF3B3;SNRNP70
prerank,intracellular protein transport (GO:0006886),0.38668730821715025,1.234501112393888,0.0482897384305835,0.7223623093443461,1.0,83/304,18.30%,EGR2;RANBP3;NAPA;SPRN;STAT3;ARFGAP3;IPO5;TBC1D10B;PPP1R10;VPS28;CLIP3;NUP153;VPS26C;GABARAP;TBC1D17;ACD;RAB18;SNX6;TLK1;TNPO2;HDAC6;PTTG1IP;TMED5;PRICKLE1;ARL6;TMED4;USP6NL;SNX13;RPAIN;RABGAP1;GGA1;TRAK1;SGSM2;SMURF1;MYO1C;RAB31;CTSA;AKAP6;TMED10;LTBP2;SCFD2;IPO13;SORL1;NUP88;AP2A1;FAM53C;STAM;STX3;VPS29;TBC1D30;CLTC;STXBP3;RIC1;VPS35;NSF;RAB32;EVI5L;HERC2;SAR1B;IPO4;ARF4;HEATR3;TBC1D4;CDC37;RUNDC1;STX5;USO1;ARL1;VPS45;ARHGEF2;PICK1;DNAJC27;TBC1D22A;TBC1D10A;TBC1D15;RAB7A;RANBP17;CALR;ARL5B;PDCD6;STRADA;SYNDIG1;STX8
prerank,endoderm development (GO:0007492),0.5632121527369325,1.2340230550177145,0.22938530734632684,0.7231129727981511,1.0,1/13,0.83%,DUSP5
prerank,mononuclear cell differentiation (GO:1903131),0.4945453585173038,1.2337067404583502,0.23024523160762944,0.72333338628664,1.0,5/24,11.95%,RELB;MYH9;MT1G;IRF8;TRPM2
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.40845621050950304,1.2336500716962795,0.1468682505399568,0.722623857997728,1.0,25/94,18.21%,BAG6;EPHA2;BCL2L1;CUL3;ARL6IP5;C1QBP;ATF4;FNIP2;BCL2L2;QRICH1;CASP4;BRSK2;CRIP1;PYCARD;PPM1F;CASP9;BAD;DDX5;CUL2;IKBKE;TNFRSF1B;CUL4A;HTRA2;DDIT3;CEBPB
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.5337706220400245,1.233313982538651,0.20600858369098712,0.7229387278034336,1.0,4/18,12.90%,NAIF1;BCL2L1;BAD;SLC25A5
prerank,negative regulation of RNA splicing (GO:0033119),0.5264987828346243,1.2325622534528995,0.23002754820936638,0.7246499563439677,1.0,7/19,14.15%,C1QBP;PTBP2;U2AF2;SRSF10;SRSF12;TMBIM6;PTBP1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.5609000506732791,1.2324515186557885,0.21712538226299694,0.7241428399837165,1.0,6/13,15.34%,DERL2;ERLEC1;BRSK2;UBAC2;UBE2J1;EDEM1
prerank,positive regulation of viral transcription (GO:0050434),0.48488839017692403,1.2316156633827913,0.2114047287899861,0.7262584307478214,1.0,11/25,18.93%,POLR2J;DHX9;CTDP1;GTF2F2;POLR2E;POLR2B;CCNT1;POLR2G;MDFIC;CDK9;POLR2K
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.3756865674505578,-1.2316151044579575,0.17551020408163265,1.0,1.0,22/30,35.93%,INSIG2;FDFT1;LBR;ARV1;NSDHL;GGPS1;CYP51A1;ACAA2;INSIG1;PMVK;SQLE;LSS;EBP;IDI1;DHCR24;DHCR7;PLPP6;HSD17B7;ACAT2;MVK;FDPS;TM7SF2
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.3982697848203489,1.2311041769251578,0.11216931216931217,0.7271438050698481,1.0,38/122,20.63%,MYC;CCL2;PPP1R3E;PDGFRB;PRKD2;HNRNPD;FXR2;LARP6;PCNA;LARP4B;PDGFB;EIF6;DHX9;SIRT1;SMOC2;STN1;EPM2AIP1;NSUN5;ATAD5;IGF1;FMR1;ABCB10;MTOR;IL6;HGF;LDB1;NFKB1;NLRC5;BRPF3;ELAVL1;SLC6A9;BCAR3;PRMT1;TLR2;DYRK2;TMEM106A;LARP4;METTL3
prerank,cGMP metabolic process (GO:0046068),0.565986345731254,1.2310494924750772,0.24127465857359637,0.7264374382425117,1.0,1/12,1.07%,NPPC
prerank,neuron projection extension (GO:1990138),-0.3511622835959676,-1.2304039936618674,0.12442396313364056,1.0,1.0,14/32,17.51%,AUTS2;SEMA5A;SPG11;HSP90AA1;ULK2;SH3GL2;MAP1B;SLC9A6;EIF2AK4;PPP3CB;ULK1;NRP1;CDK5;LLPH
prerank,monocarboxylic acid transport (GO:0015718),0.4392332112863239,1.230071621427896,0.1981020166073547,0.7289222687535644,1.0,6/51,4.57%,SLC6A8;ATP8B1;SLC16A3;SLC16A14;SLC16A1;SLC6A11
prerank,actin polymerization or depolymerization (GO:0008154),0.4430904215598432,1.2300676886276432,0.18007202881152462,0.7280360940393481,1.0,11/50,12.36%,MICAL1;WDR1;CATIP;FLII;ABI2;ENAH;FAM107A;WASHC3;MICAL2;TTC17;DIAPH1
prerank,positive regulation of kinase activity (GO:0033674),0.41147545531424573,1.2290205403564174,0.1532690246516613,0.7306893211375393,1.0,17/107,11.88%,AGAP2;CSF1;PDGFRB;EPHA1;EPHA2;DUSP19;MAP2K3;ALS2;CAMKK1;XRCC5;PTK2B;RYK;PTPRC;NBN;DDR2;PRKAG1;EPHA3
prerank,negative regulation of cell growth (GO:0030308),0.40336575840316735,1.2289551701358843,0.13836477987421383,0.7300015099196274,1.0,25/121,16.57%,SEMA3G;SESN2;NAIF1;SERTAD3;CDKL3;FGF13;CCDC85B;RTN4;TSPYL2;JADE1;PPT1;ACVR1B;SIRT1;CAPRIN2;IP6K2;ING1;DNAJB2;BCL6;NDUFA13;NME6;VGLL4;PTPRS;FLCN;MAG;PRDM11
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.43556623403789974,1.228919696155312,0.17249417249417248,0.7292467721532478,1.0,12/54,11.71%,COPS9;SQSTM1;VPS28;GNL3L;U2AF2;DNAJA1;CTNNB1;ARRB1;GTPBP4;UFL1;UBXN1;PRMT3
prerank,apoptotic mitochondrial changes (GO:0008637),0.46891342324086116,1.2282502678383613,0.2120451693851945,0.7307027680475525,1.0,7/32,12.01%,NAIF1;BCL2L1;AIFM2;BID;BAD;CLU;VPS35
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.5202446764043156,-1.228160280860273,0.23697916666666666,1.0,1.0,9/10,44.34%,ACAD11;ACADM;ETFDH;ACADS;GCDH;ACADL;ETFA;ACADVL;ETFB
prerank,regulation of protein localization to cell surface (GO:2000008),0.4768775292458842,1.2279503201926993,0.20654911838790932,0.7308338104180339,1.0,11/33,16.74%,TYROBP;TM9SF4;HSP90AB1;PICALM;SNX33;STX3;CTNNB1;BDNF;GBF1;MAP1A;GPM6B
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.5009925988319746,-1.2278514925236153,0.226775956284153,1.0,1.0,3/10,23.93%,IFT88;SOD1;ADGRV1
prerank,regulation of cellular biosynthetic process (GO:0031326),0.47210413051150757,1.2277644992029213,0.20127388535031848,0.7306020220019089,1.0,11/28,17.06%,SIRPA;ADIPOR1;EIF6;SIRT1;SIRT5;MITF;MED1;TNFRSF1B;ADIPOR2;RAC1;MFSD12
prerank,regulation of establishment of planar polarity (GO:0090175),0.41190378345510104,1.2276416462098039,0.16593406593406593,0.7301543395977017,1.0,26/88,17.86%,DVL2;FZD5;CELSR2;PSMD2;FZD6;PSMC4;PFN1;PSMD4;PRICKLE1;PSMD1;SMURF1;PSME3;PSMB6;PSMD10;AP2A1;CLTC;PSMB1;PSMD11;PSMA2;PSMD13;PSMB10;PSMB3;RAC1;AP2M1;PSMC1;TIAM1
prerank,gonad development (GO:0008406),0.4603689396096518,1.2276113276888052,0.19709794437726724,0.7293705908056707,1.0,3/41,3.29%,BASP1;NCOA4;SOX9
prerank,cellular response to nitrogen compound (GO:1901699),-0.4225807030117031,-1.2272913334237796,0.17288135593220338,1.0,1.0,8/20,24.68%,ROCK2;SPIDR;BLM;RTF2;HSF1;EPG5;DDI2;DDX11
prerank,lung epithelium development (GO:0060428),-0.5137145733673207,-1.2272764469856672,0.22606382978723405,1.0,1.0,3/10,19.23%,PKD1;ERRFI1;FGF10
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.45463409791775883,1.2269631627674074,0.215,0.7308175022850995,1.0,3/36,4.33%,MYC;DUSP19;SIRPA
prerank,lipoprotein catabolic process (GO:0042159),0.5626324268949776,1.2269241118147671,0.2128935532233883,0.7300643877733332,1.0,3/11,8.10%,CTSD;APOE;PPT1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.4118724942454049,1.226875870167193,0.1547085201793722,0.729336195913258,1.0,31/85,21.97%,BAG6;ARIH2;GABARAP;NUPR1;PRICKLE1;USP5;TAF1;TRIB2;CSNK1E;PSMD10;SUMO1;COP1;SIRT2;CLU;DNAJB2;RNF144A;RNF19B;STUB1;FMR1;ARIH1;CSNK1D;CEBPA;ANKIB1;HECTD1;TRIB1;VCP;CSNK1A1;DAB2IP;RNF185;HSPBP1;RNF19A
prerank,negative regulation of defense response (GO:0031348),0.4138002667788696,1.226678661028406,0.1638981173864895,0.7291783715671873,1.0,24/77,20.15%,C1QBP;ACOD1;NLRP3;SIRPA;APOE;CXCL17;NLRC3;METRNL;PCBP2;TRAF3IP1;TNFAIP8L2;SIRT2;VPS35;GPS2;ILRUN;RORA;TNFAIP3;PROC;OTULIN;TRAFD1;LRFN5;PPM1B;ITCH;AOAH
prerank,aggrephagy (GO:0035973),0.4844217753162762,1.2263998560697957,0.2197070572569907,0.7292639498384016,1.0,5/27,7.05%,SQSTM1;HDAC6;RPS27A;UBC;WDFY3
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.4033414348665545,-1.2258842897872015,0.19655172413793104,1.0,1.0,7/23,9.05%,JAK2;IFNGR2;STAT1;PARP9;PIAS1;IRGM;PPARG
prerank,negative regulation of chemokine production (GO:0032682),0.5509689872625387,1.2256318485647277,0.24085365853658536,0.7311428986965625,1.0,3/14,15.03%,APOD;SIRPA;IL6
prerank,glycosaminoglycan metabolic process (GO:0030203),0.4377765738046518,1.2253148604750743,0.19239904988123516,0.7313521919398512,1.0,23/54,21.91%,HS3ST3A1;HS3ST3B1;GLB1;GUSB;SDC4;XYLT1;SLC35D2;NDST2;GPC5;IDS;GCNT2;HS3ST6;HS3ST5;B4GALT7;HS6ST2;FUCA1;B3GAT1;EXT2;GPC6;SDC3;HS6ST1;AGRN;GPC3
prerank,organonitrogen compound catabolic process (GO:1901565),0.4303859375327012,1.2249802832289343,0.19047619047619047,0.7315915608320341,1.0,14/57,15.23%,AMDHD2;CLN5;BCKDK;TPP1;RIDA;PLA2G4A;CLN8;PPT1;NPEPPS;USE1;IDE;NPL;MTOR;PNPLA8
prerank,peptide hormone secretion (GO:0030072),0.48538872194375643,1.2245428788271013,0.2359249329758713,0.7322427421854115,1.0,4/26,15.03%,LTBP4;CAMK2G;SNX19;IL6
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.49301973039027863,1.2244814607845211,0.22159887798036465,0.731558773644647,1.0,7/24,15.03%,ATF4;CXCL17;EIF2AK3;IL1A;RORA;SULF2;IL6
prerank,histone H3-K4 trimethylation (GO:0080182),0.5855554375830077,1.2242079203077745,0.24165341812400637,0.7315887850226341,1.0,6/11,17.70%,TET2;WDR82;KMT2D;KMT2A;TET3;CTR9
prerank,positive regulation of response to stimulus (GO:0048584),0.45610794328518584,1.223998348786454,0.19543147208121828,0.7313460610258319,1.0,10/40,16.86%,MYC;FXR2;DHX9;SIRT1;IER5;FMR1;NSMCE1;SELENON;ILK;YPEL3
prerank,establishment of protein localization to organelle (GO:0072594),0.41826276603071005,1.222703063384255,0.18489289740698986,0.7349799193837888,1.0,12/72,8.73%,SPRN;STAT3;IPO5;PPP1R10;NUP153;TNPO2;PTTG1IP;PRICKLE1;RPAIN;IPO13;NUP88;FAM53C
prerank,negative regulation of DNA replication (GO:0008156),0.5561929121197687,1.2219755112574089,0.2350230414746544,0.7366857899646987,1.0,4/13,15.92%,PDS5A;TSPYL2;GTPBP4;WAPL
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.48883076340413256,1.2218283701873722,0.2214484679665738,0.7362747903695326,1.0,12/27,21.27%,CCL2;RELA;SIRPA;CYRIB;PYCARD;IL6;HSPD1;ETS1;ITGB2;CCDC88B;THY1;CD44
prerank,aminoglycan catabolic process (GO:0006026),0.47809045577962483,1.2215349261554695,0.20052770448548812,0.7363948576081594,1.0,12/28,21.91%,GLB1;GUSB;OVGP1;SDC4;CTBS;GPC5;IDS;FUCA1;GPC6;SDC3;AGRN;GPC3
prerank,cellular response to metal ion (GO:0071248),0.40357849849260213,1.2211564037897464,0.12341772151898735,0.7368096088080728,1.0,33/123,18.47%,CPNE9;JUN;ADD1;ATP13A2;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B;CPNE8;CLIC4;SMPD1;BMP6;PRNP;MAPK8;SUMO1;ITPKB;TRPM2;DPEP1;ADCY8;SYT1;MT2A;RASGRP2;MEF2A;ADCY7;HVCN1;CPNE3;SYT4;MEF2C;PRKAA1
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.4561379488793806,1.2210741560651908,0.21265822784810126,0.7361934576733777,1.0,11/37,19.11%,HNRNPD;ENTPD1;NUDT5;NCBP1;ENTPD7;ENTPD5;SND1;RNASE3;DNASE1L1;RNASEH1;RNASEH2A
prerank,renal absorption (GO:0070293),-0.5255956521842458,-1.220524076696674,0.225,1.0,1.0,3/10,10.88%,GSN;SLC15A2;KLHL3
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.3813257553109711,-1.2205196407148529,0.17894736842105263,1.0,1.0,11/25,29.70%,GRIN2B;GLRA1;LRRK2;GSK3B;GRIN1;GSK3A;INSYN2A;ARRB2;NLGN3;GRIN2D;MPP2
prerank,regulation of cell population proliferation (GO:0042127),0.37819106232974053,1.2204067770251064,0.02,0.7375581562306487,1.0,116/691,15.78%,GDNF;MYC;BMP5;OSM;BAMBI;ADAMTS1;CSF1;STAT3;PDGFRB;RTKN2;CHTOP;EPHA1;TFAP2B;TBRG1;DLG5;SLAMF1;COPS9;DERL2;ADAM17;CTBP2;CUL3;JUN;WARS1;PDGFA;IL34;SOX9;INCA1;KLF11;NUPR1;TOB1;EIF2AK2;CHD5;RELA;CDC123;NOP2;NUDT6;SLC35F6;MAP2K1;PTPN14;DOT1L;MDM4;TGFBR1;TMEM127;TGFBR2;RHOG;ADGRG1;JUP;SDCBP;PDGFB;AGT;GLMN;TRAPPC14;XRCC5;TRPM4;CNOT8;JAG1;GSDME;DNAJA3;STAT6;CNOT6;VEGFC;PTK2B;IL1A;CDK6;TCF7L2;SIRT1;ENG;KLF10;CNBP;SLC25A33;BMP6;STX3;TET1;FAM98B;CTNNB1;POU3F2;HDAC1;IER5;BIRC6;PTPN6;GTPBP4;BTG2;ZBTB17;UFL1;CD33;SIRT2;CD200;PTPRU;CNOT7;DNAJA2;CLU;DNAJB2;IGF1;APP;SLC25A5;SSR1;SRPK2;BCL6;KMT2D;GCNT2;JUND;LIMS1;MCTS1;ABI1;IL6;PLPP1;WWTR1;ING4;LRP5;ADARB1;CTCF;CD86;PBRM1;RUNX1;PGF;RAF1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.5634245493911839,1.2201776317517936,0.24060150375939848,0.737463839109519,1.0,6/12,21.55%,COLEC12;RALB;DHX9;FLOT1;CGAS;MAVS
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.6000891707351104,1.220148123416602,0.26812816188870153,0.7366998291793664,1.0,2/10,8.85%,NINJ1;WDFY1
prerank,phospholipid dephosphorylation (GO:0046839),0.4581350243177472,1.2198312340508748,0.20947630922693267,0.736897467086279,1.0,10/37,15.11%,SGPP2;MTMR10;INPP5K;PLPPR4;MTM1;MTMR3;MTMR12;OCRL;INPP5F;PLPP1
prerank,positive regulation of mRNA processing (GO:0050685),-0.4056979903208348,-1.2198156779254736,0.20863309352517986,1.0,1.0,5/21,6.34%,DAZAP1;CELF4;RBM3;NCL;SNW1
prerank,membrane lipid catabolic process (GO:0046466),0.5871193782316229,1.2197897848397172,0.2358642972536349,0.7361659961785412,1.0,4/10,17.60%,NAGA;PPT1;FUCA1;SGPL1
prerank,cellular response to UV-A (GO:0071492),-0.4936526112258556,-1.2195862678325595,0.2359249329758713,1.0,1.0,3/11,14.22%,PPID;MMP1;MME
prerank,response to lipid (GO:0033993),0.4091642108718793,1.2195292935756195,0.14208826695371368,0.7362675464806365,1.0,12/105,9.75%,SELP;MAPKAPK2;STAT3;ADAM17;LIAS;SOX9;SPP1;ERBIN;FOXP1;IFNAR1;GCH1;CTNNB1
prerank,supramolecular fiber organization (GO:0097435),0.38150655736757433,1.2189263036269926,0.06820461384152457,0.7375062822686268,1.0,44/334,9.86%,CCDC13;CORO1C;SERPINF2;GFAP;TRIOBP;MYO1E;CALCA;CRTAP;TPM3;LAMA3;CLIP3;CEP126;SIAH2;HSP90AB1;FLII;PIN1;FGF13;TPM4;COL1A2;RUFY3;RHOB;CALB1;TGFBR1;RPS27A;UBC;RHOG;COL1A1;CLIP2;MTM1;GGA1;TSPAN14;SH3BP1;MYO1C;LTBP2;LTBP3;CD2AP;SORL1;COLGALT1;TUBGCP5;FURIN;COL16A1;TUBGCP6;COL24A1;DDR2
prerank,histone H2A acetylation (GO:0043968),0.5296621980794902,1.21850025281955,0.2694610778443114,0.7380861140748,1.0,6/16,13.51%,ACTL6A;EP400;TRRAP;BRD8;MORF4L2;MORF4L1
prerank,cellular protein metabolic process (GO:0044267),0.3845992018496752,1.2182981252043357,0.041082164328657314,0.7378711330421542,1.0,86/396,16.42%,NAPSA;GSPT2;CSF1;FDX1;MRPL18;FAM20C;PENK;ADAM17;DENND3;MRPL51;RPL31;WARS1;SIAH2;CLN5;LGALS1;RPS15;UBE2S;CDKL3;RPL3;GGCX;RPL13A;MBTPS1;RPL15;RPL10;SARS1;RPS8;ABL2;MRPS6;CSF2RA;RPN2;MRPL28;SEC11A;RPS27A;PRKCSH;APOE;SPP1;RPL9;GOLM1;SPPL3;RPL22;PARP4;HM13;CHGB;RPS21;FURIN;RPL23A;PDIA6;UBE2D3;USP25;MRPS12;RPL34;MGAT4A;NEDD8;RRBP1;UBE2L3;RPSA;MAGEC2;MRPS7;UBE2I;MRPL37;IGF1;RPS14;APP;RABGGTB;MRPL41;MRPL27;TNIP1;P4HB;CSNK1G3;SFTPA1;SFTPA2;IDE;NAGPA;RPL27;WFS1;AFG3L2;PAPPA;IL6;PHKA2;YME1L1;RPL8;LCMT1;ST3GAL6;CSF2RB;EVA1A;B4GALT7
prerank,activation of GTPase activity (GO:0090630),0.40904639499713996,1.2176862983408674,0.16775599128540306,0.7390799128878504,1.0,31/89,19.57%,CORO1C;EPHA1;EPHA2;TBC1D10B;TBC1D17;USP6NL;RHOG;ARHGEF26;RABGAP1;RASGRF1;SGSM2;GMIP;RAP1GAP2;TBC1D30;ARHGAP22;RANGAP1;EVI5L;SCRIB;TBC1D7;TBC1D4;RUNDC1;ARHGEF10;RALGAPA2;GPR65;TBC1D22A;TBC1D10A;TBC1D15;TIAM1;ARHGAP25;ARHGAP24;ARHGAP42
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.5911369669195587,1.2174387516826595,0.2442622950819672,0.7390506566179416,1.0,3/10,11.25%,JUN;NCK1;SIRT2
prerank,photoreceptor cell development (GO:0042461),-0.45713816475834135,-1.217389234654948,0.23076923076923078,1.0,1.0,6/14,21.78%,RORB;DCX;TOPORS;AHI1;VEGFA;CEP290
prerank,pre-replicative complex assembly (GO:0036388),0.4218802027141048,1.2164466426140468,0.1965909090909091,0.7415981007117187,1.0,16/64,13.37%,PSMD2;PSMC4;PSMD4;PSMD1;MCM2;RPS27A;UBC;PSME3;PSMB6;ORC5;PSMD10;PSMB1;PSMD11;PSMA2;PSMD13;PSMB10
prerank,receptor recycling (GO:0001881),0.5795268815189297,1.2162111977751162,0.2661290322580645,0.7414828748269866,1.0,4/10,14.30%,ARFGEF2;PHETA1;SORL1;PLEKHJ1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.48946630354838044,1.2162084554738735,0.21739130434782608,0.7406163232688293,1.0,3/25,6.43%,SLC7A5;FZD5;CD55
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.45178151157010393,1.2161851934473789,0.20933165195460277,0.7398371540206062,1.0,9/42,11.34%,WARS1;KARS1;IARS2;SARS1;SARS2;IARS1;LARS1;PPA2;EARS2
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.4019895554753157,1.2158987565691215,0.1744186046511628,0.7399628247342754,1.0,15/110,14.96%,MC2R;LPAR3;CALCA;S1PR5;GNAS;ADGRG1;ADCY5;ADGRL2;GNB1;ADCY8;ADCY3;LPAR1;ADRB2;LGR4;S1PR1
prerank,embryonic organ development (GO:0048568),0.4290766825229753,1.2157486639751203,0.19675925925925927,0.7396181055030282,1.0,8/61,10.92%,GDNF;FOXE1;PDGFA;RPL10;ATF4;TGFBR2;PBX4;RBPJ
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.5221733484448837,1.215528916043062,0.25146198830409355,0.7395835274366032,1.0,6/16,17.55%,APOD;SIRPA;NLRC3;PYCARD;ADCY7;ZC3H12A
prerank,establishment of protein localization to extracellular region (GO:0035592),0.4476279336973695,1.2155081190118096,0.2141982864137087,0.7387895391044477,1.0,7/39,7.80%,ARFGAP3;TANGO2;SEL1L;TVP23A;PPY;RAB8B;LTBP2
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.5081555564477447,1.2151007004113945,0.2404692082111437,0.7393228131631361,1.0,4/19,6.40%,CSF1;IL34;CMKLR1;CXCL17
prerank,ncRNA catabolic process (GO:0034661),0.4773351762128554,1.214991423499239,0.233201581027668,0.7388416903722825,1.0,7/28,13.78%,DIS3;ZCCHC8;EXOSC8;EXOSC10;DEDD2;POP1;SND1
prerank,regulation of RNA splicing (GO:0043484),0.4199274690530092,1.2148427894088036,0.1850613154960981,0.7385285144294635,1.0,30/69,20.66%,FUS;HNRNPK;HABP4;FASTK;LARP7;PIK3R1;AFF2;HNRNPH2;RRP1B;PTBP2;U2AF2;RBM39;RBM38;CLK4;SRSF10;TMBIM6;HNRNPL;SRPK2;HNRNPH1;SETX;ZPR1;PTBP1;DYRK1A;HNRNPLL;SNRNP70;QKI;KHDRBS3;SF1;YTHDC1;RPS26
prerank,RNA catabolic process (GO:0006401),0.4399168822751567,1.2147000212475214,0.19614921780986763,0.7381339837528947,1.0,13/46,19.11%,LSM5;ZFP36;HNRNPD;RIDA;NCBP1;SND1;ZPR1;RNASE3;CNOT10;AGO3;YTHDF2;RNASEH1;RNASEH2A
prerank,secondary alcohol metabolic process (GO:1902652),0.4407722994617356,1.2146493865578336,0.2014475271411339,0.7374124092263105,1.0,7/42,9.22%,FDX1;IDH1;APOE;STARD3;CLN8;OSBPL1A;IDH3B
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.481368479781059,1.2145835147038053,0.226775956284153,0.7367927492615328,1.0,6/27,10.68%,CSF1;LPL;ITGB3;PRKCH;AGT;IL18
prerank,histone acetylation (GO:0016573),0.4169475819092736,1.2145059226322354,0.20044052863436124,0.7362245906197588,1.0,26/69,17.46%,TADA1;ACTL6B;CHD5;KAT5;ACTL6A;EP400;NAA60;TAF12;TRRAP;TAF5L;JADE1;TADA2A;SPI1;BRD8;CREBBP;DR1;TAF6;NAA50;MORF4L2;MORF4L1;MBIP;PHF20L1;ING4;PER1;KAT2A;BRPF3
prerank,cellular response to oxygen-containing compound (GO:1901701),0.381990320396598,1.2143968728731276,0.06934673366834171,0.7357479962283604,1.0,66/291,18.46%,KCNK4;CCL2;SESN2;EGR1;CD180;IPO5;LPL;RRAGC;ZFP36;WNT5B;JUN;INPP5K;SERPINE1;ACOD1;HMGB1;NLRP3;SOX9;ADAM9;KAT5;RELA;SBNO2;SIRPA;ABL2;PRDX5;TAF1;PDGFB;AKAP6;PTK2B;IL1A;P2RY1;ERCC6L2;LARS1;MAPK8;PYCARD;AKAP9;CPEB1;IP6K2;CARD16;GNB1;CCR5;EPHA3;PDK3;DPEP1;RORA;SETX;NDUFA13;NCOA3;CAMKK2;CREB1;MTOR;IL6;TNFRSF1B;ACTB;CD86;PAX2;DAPK1;TNFAIP3;NFKB1;HTRA2;ZC3H12A;CTR9;UPF1;RAP1B;MEF2C;HSP90B1;RPTOR
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.4268001273855124,1.2142194640295403,0.2116279069767442,0.7354406025527516,1.0,10/57,9.01%,RIOK1;NOP14;GTF3A;RPS15;TGS1;PES1;MALSU1;LTO1;DDX31;NVL
prerank,epithelial to mesenchymal transition (GO:0001837),0.43907216351629447,1.2141469857780784,0.20024570024570024,0.7348139450569058,1.0,11/47,15.31%,DLG5;SOX9;TGFBR1;TRIM28;ENG;CTNNB1;RBPJ;DDX5;LIMS1;HGF;AKNA
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.5150221943940521,1.2136332954159539,0.2321167883211679,0.7356992779186412,1.0,3/17,6.44%,ADAMTS1;PDGFRB;PDGFB
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.37950065981897907,1.2134487243587886,0.0853413654618474,0.7354791909369964,1.0,77/264,18.25%,MAGOH;MAGOHB;LSM5;DDX20;BCAS2;DHX35;DDX42;PRPF31;POLR2J;FUS;HNRNPK;HNRNPD;TGS1;RBM4B;HNRNPU;HNRNPM;ESS2;PRPF40A;HSPA8;DDX41;SNRPA1;SNRPA;HNRNPH2;ZCCHC8;U2AF2;DHX9;PCBP2;GEMIN7;SRSF2;GCFC2;U2AF1;SRSF10;NCBP1;SRSF12;CWC15;YBX1;SFPQ;FIP1L1;GTF2F2;SCAF11;ELAVL2;HNRNPL;PRPF40B;SF3A2;DDX5;DNAJC8;SRPK2;POLR2E;HNRNPH1;CWC25;SF3A1;SNRNP27;PTBP1;SNRNP48;SNRPG;POLR2B;BUD13;U2SURP;SART3;SYMPK;RBM10;RBM8A;ZRSR2;SNRNP40;POLR2G;PPIL3;GPATCH1;PSPC1;HNRNPA1;NONO;ELAVL1;HNRNPR;PRPF4;RBM14;SF3B3;SNRNP70;SNUPN
prerank,regulation of mitotic cell cycle (GO:0007346),0.3890826357128732,1.2132539398063589,0.12589559877175024,0.735316597221139,1.0,39/171,13.41%,MAD2L1;THAP1;NEK7;USP2;UBE2S;PSMD2;HNRNPU;RNF20;PIN1;PSMC4;PSMD4;NEK6;TTL;PSMD1;SDCBP;UBE2D1;PSME3;PSMB6;PSMD10;SIRT1;ANAPC5;SMOC2;UBE2E1;PIM3;DLGAP5;ERCC2;PSMB1;RCC1;BTG2;PSMD11;ANAPC10;PSMA2;PSMD13;ANGEL2;APP;DDB1;PSMB10;GBF1;SCRIB
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.49833221009956546,1.2131397171560723,0.21927374301675978,0.7348770559232196,1.0,8/24,14.27%,BCL2L1;CREB3L1;CREB3;USP25;UBXN1;TMBIM6;CLU;WFS1
prerank,cellular response to amino acid stimulus (GO:0071230),0.46165326767993914,1.2130730831936898,0.2236503856041131,0.7342679731236433,1.0,7/33,9.68%,SESN2;CASTOR1;IPO5;RRAGC;UBR1;LARS1;CPEB1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3872070796489709,1.2121687969083688,0.12422997946611909,0.7364561306869618,1.0,34/166,15.60%,MYC;PPP1R3E;EGR1;PDGFRB;PRKD2;HNRNPD;HSP90AB1;MID1IP1;FXR2;LARP6;PCNA;LARP4B;PDGFB;EIF6;DHX9;SIRT1;SMOC2;STN1;PAOX;CTDNEP1;EPM2AIP1;CNEP1R1;NSUN5;CLU;DDAH2;ATAD5;IGF1;DDB1;FMR1;ABCB10;MTOR;IL6;HGF;LDB1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.5434422935986293,1.211807693063807,0.24246987951807228,0.7368567523117128,1.0,6/13,14.27%,NUPR1;MANF;EIF2AK3;USP19;CLU;WFS1
prerank,regulation of response to interferon-gamma (GO:0060330),-0.45801897852136286,-1.2113882747727316,0.22033898305084745,1.0,1.0,5/14,5.75%,JAK2;IFNGR2;STAT1;PARP9;PIAS1
prerank,regulation of T cell mediated immunity (GO:0002709),0.5794090660288885,1.2111552379058987,0.26156299840510366,0.7382883131950573,1.0,4/10,18.93%,HMGB1;TRPM4;TNFRSF1B;ZBTB1
prerank,myelination (GO:0042552),0.44201935227451805,1.210648224559429,0.20074812967581046,0.7391446547003245,1.0,13/46,16.40%,SOX10;CXCR4;EIF2B2;DEGS1;SCN8A;CNTNAP1;B4GALT5;SIRT2;MPZ;PLP1;ARHGEF10;PMP22;PLLP
prerank,positive regulation of chemotaxis (GO:0050921),0.4517247419913731,1.2105228352212591,0.2376237623762376,0.7387458399386239,1.0,10/43,10.87%,PDGFRB;ADAM17;PRKD2;PDGFB;STX3;SMOC2;F3;DSCAM;PPM1F;TMSB4X
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.5864949536102352,1.2102423054948515,0.2558139534883721,0.7388705046305409,1.0,5/10,18.67%,EMC4;EMC10;EMC7;EMC1;MMGT1
prerank,protein N-linked glycosylation (GO:0006487),0.4158096333278103,1.2100227414439566,0.1856492027334852,0.7387560992045288,1.0,24/66,21.12%,ALG11;DDOST;RPN2;TUSC3;SLC39A8;ALG12;GFPT1;MGAT5;DPM1;MGAT5B;ALG10B;PMM1;MGAT4A;MAN1C1;ENTPD5;DPM2;UBE2J1;PMM2;B4GALT7;ALG9;ALG8;DOLPP1;MGAT1;STT3B
prerank,cellular response to reactive oxygen species (GO:0034614),0.42311278802858976,1.2100145246722944,0.19792865362485615,0.7379324143969815,1.0,17/59,16.23%,NFE2L2;JUN;HDAC6;OSER1;RELA;SIRPA;RHOB;PRDX5;SIRT1;ERCC6L2;MAPK8;TRPM2;SETX;CAMKK2;IL6;PAX2;TNFAIP3
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.503712632513257,1.209895576671021,0.23652694610778444,0.7374925125638014,1.0,4/19,7.33%,EPHA2;IKBKB;PRKCH;MYO1C
prerank,positive regulation of potassium ion transport (GO:0043268),0.4512889980701024,1.2096391679368852,0.21253071253071254,0.7375546606672034,1.0,9/38,14.70%,KCNH2;KCNJ6;AKAP6;KCNMB2;KCNMB3;KCNJ2;GNB1;KCNMA1;FLNA
prerank,positive regulation of reproductive process (GO:2000243),0.4645865271662163,1.2096354699824083,0.2286096256684492,0.73672560782811,1.0,5/31,15.44%,C1QBP;CFAP69;ACVR1B;SIRT2;PGAM4
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.37252500786523113,1.2089506526321652,0.0,0.7382834282578841,1.0,380/1667,18.63%,GDNF;ATF3;EGR2;MYC;NKX2-8;BMP5;ZFP82;OSM;RELB;SOX10;EGR3;KDM6B;SERPINF2;HOXD9;EGR1;ZNF319;HOXD8;LITAF;STAT3;DDX20;ZNF513;IFRD1;ZNF83;ZNF436;PFKM;ZIC1;GLIS1;TFAP2B;DRAP1;NR4A1;HOXB7;THAP1;NFE2L2;BEX1;DVL2;CREB3L1;SQSTM1;ZFP36;TADA1;CTBP2;ACTL6B;HSF4;PHF6;ZBTB8A;SKIL;ZMYM5;ZNF471;NR2F6;C1QBP;NFATC2IP;JUN;PRKD2;HDGF;FUS;FZD5;USP2;HNRNPK;MED19;SERPINE1;LIN9;FOXE1;NCK1;NFYA;HMGB1;ZNF177;HNRNPU;PRRX1;PIN1;NLRP3;MAML3;SOX9;KLF11;NR1D2;KLF15;NFATC3;KANSL3;ZBTB25;FUBP3;KMT5A;HIVEP3;IKBKB;RPL10;ZBTB6;ATF4;SARS1;CHD5;FNIP2;KAT5;IER2;SMARCC1;RELA;NOP2;SBNO2;ECD;SS18L2;CASZ1;ZMIZ1;ZBTB48;ARID5A;CCNL1;CREB3L4;CREB3;ACTL6A;MYPOP;TBK1;CSRNP2;DOT1L;DPF2;MDM4;LARP7;RPS27A;UBC;UXT;APOE;GTF2H4;ELP3;ZKSCAN5;TAF1;ZNF691;SALL3;JUP;PIK3R1;TGIF1;SDCBP;CRTC1;ZBTB7A;SMARCD2;TRAK1;TET2;TOX4;RRP1B;MAFG;UBE2D1;CHD4;OTUD7B;TRIM28;JAG1;ELOA;EBF2;PAXBP1;FOXP1;BCL11A;DNAJA3;BAZ1A;STAT6;ZBTB22;DHX9;CRY2;REPIN1;ATAD2B;ZBTB7B;BAZ1B;E2F5;TCF7L2;PSMD10;CCNK;HIVEP1;SMARCA1;SIRT1;TBL1X;ENG;MED8;TADA2A;SPI1;KLF10;PBX4;CNBP;BMP6;NCOA5;AKIRIN2;HR;BRD8;ZBTB2;TENM2;ZNF467;CHD2;N4BP2L2;UBE2D3;TET1;GABPB1;GABPB2;ZFX;CAPRIN2;CTNNB1;SUMO1;RUNX2;RHOQ;POU3F2;PPRC1;ARRB1;HDAC1;RPAP2;CHD1;IER5;RIPK2;CREBBP;KLF7;CTDP1;IRF8;HOXB8;HDAC5;IL18;YBX1;SFPQ;ACVR2B;NPAT;RBPJ;KDM1A;MITF;ZNF148;SOX2;ZBTB17;TCF25;SIRT2;DR1;ELF2;GLMP;PCGF2;MAML1;ZNF496;SS18;CBX4;SLTM;TAF6;WWC2;LIN37;SMARCB1;TOX;UBE2I;PHF10;PHOX2A;IGF1;TCF7L1;TCF3;RPS14;CTDSP1;APP;DGKQ;MIER1;CREB5;SS18L1;TNIP1;ZBTB40;DNMT3A;ASCL4;CDK8;AEBP2;GPS2;DDX5;CDK12;FOXO3;HMBOX1;MRTFB;CRK;BCL6;ZNF292;KMT2D;RORA;AKAP8L;POU6F2;SKOR2;SETX;CBX5;LMX1B;JUND;ARF4;ZFP69;WFS1;RPRD1A;EBF4;NCOR1;HOXC6;MTDH;BRD4;PHF20L1;MYSM1;NCOA3;SLC11A1;ZSCAN26;POU2F2;ATF1;CREB1;HOXC8;ATF6;MED12L;MED25;IL6;HGF;ARID5B;MED1;WWTR1;CCNT1;LRP5;TSHZ2;AKNA;MED13;CTCF;LDB2;LDB1;KMT2A;JMJD1C;CCNL2;RUNX1;FOXK2;PAX2;FLCN;TMPRSS6;IRF9;SIN3A;HSPD1;IRF2BPL;GATAD2A;ZFP91;CUX1;AGO3;RXRA;BACH2;NFKB1;RBAK;ZBTB4;IRF2BP2;HOXB3;TET3;ETV6;ELP2;CNOT2;SOD2;TEF;PER1;RPRD1B;MEF2A;KAT2A;ZFHX4;ARHGEF2;EID1;POGZ;NLRC5;MEF2B;CC2D1B;TCF12;BRD2;RAD21;FOXJ2;ZBTB49;ENY2;NFYC;PRKCB;MPND;ACVR1;SMAD3;ATMIN;ZC3H12A;SAFB;HDGFL2;RBM14;CTR9;ETS1;EZH2;RLF;ZBED3;CALR;ZXDC;TCEA1;MED20;CEBPZ;DDIT3;TNRC6C;MEF2C;CEBPB;CDH13;PATZ1;GMEB2;CEBPA;PLK3;MED4;KDM2B;EPAS1;HLF;PHF21A;TFCP2
prerank,regulation of translation (GO:0006417),0.3853081196323347,1.2089134570048872,0.11692307692307692,0.7375507712144064,1.0,53/173,18.18%,SHMT2;ETF1;EIF2B2;ILF3;HNRNPD;RBM4B;MALSU1;RPL13A;RIDA;TOB1;RPL10;EIF2AK2;EIF1;FXR2;LARP6;LARP4B;EIF6;CNOT8;EIF4A2;EIF2AK3;DHX9;SAMD4B;CYFIP1;NCBP1;YBX1;BTG2;GIGYF2;NSUN5;EIF3B;CNOT7;EIF4G2;TSFM;APP;FOXO3;FMR1;EIF5B;MIF4GD;EIF4E2;MTOR;EIF3H;IL6;EIF4E;DAPK1;LTN1;PUS7;CNOT10;METAP1;ATXN2;ELAVL1;KLHL25;UPF1;CALR;ENC1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.4323120785424815,1.2086739331947265,0.19928400954653938,0.7375078174155939,1.0,14/49,16.57%,TMC8;HMGB1;RPL13A;HDAC6;NLRC3;SORL1;PRKCZ;TRAF3IP1;PYDC1;HSPA5;CLU;RAF1;LCMT1;RIOK3
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3838419422639398,1.2085007255305458,0.10488798370672098,0.7373294121419562,1.0,65/234,19.69%,STAT3;RTKN2;RAB7B;BEX1;DVL2;ADAM8;PRKD2;NLRP3;IKBKB;EIF2AK2;RELA;FLOT2;RPS27A;UBC;ANXA3;TAF1;RBCK1;JUP;CRTC1;ZBTB7A;TAF12;PRKCH;AGT;CARD9;DHX9;PRKCZ;PYCARD;CTNNB1;DDR2;RNF25;PPRC1;RIPK2;CARD16;HDAC5;IL18;KDM1A;RNF31;CD200;CLU;SMARCB1;IRAK2;TCF3;ERC1;CFLAR;APP;ADCY8;ROR1;IKBKE;MTDH;IL6;ARID5B;FLOT1;NFKB1;ARHGEF2;SMO;PRKCB;SMAD3;TRIM5;DDIT3;COPS5;TERF2IP;TLR2;TRIM8;AIM2;TRIM26
prerank,T cell receptor signaling pathway (GO:0050852),0.39308138685696226,1.2083548975655076,0.13883089770354906,0.736997013263304,1.0,38/138,17.55%,PRKD2;EIF2B2;PSMD2;NCK1;NFKBIZ;NFKBID;PSMC4;FBXW11;IKBKB;RELA;PSMD4;PSMD1;RBCK1;PIK3R1;SPPL3;PSME3;PSMB6;PSMD10;PTPRC;RIPK2;PSMB1;RC3H1;RNF31;PSMD11;RC3H2;MOG;PSMA2;PSMD13;PSMB10;DENND1B;PSMB3;PAG1;SKP1;NFKB1;TEC;EIF2B3;PSMC1;ZC3H12A
prerank,cellular response to dsRNA (GO:0071359),0.5384035706606088,1.2080419712649386,0.24076809453471196,0.7372051488052104,1.0,7/15,21.55%,COLEC12;RALB;DHX9;FLOT1;RIOK3;CGAS;MAVS
prerank,regulation of chondrocyte differentiation (GO:0032330),0.4877131075173437,1.2078630667954706,0.2373806275579809,0.7369613318664713,1.0,4/24,10.24%,ADAMTS12;SOX9;TGFBR1;EFEMP1
prerank,phagosome acidification (GO:0090383),0.4787779364394622,1.207375914474704,0.23404255319148937,0.7377218028782622,1.0,9/26,17.75%,ATP6V1D;ATP6V1A;ATP6V0D1;ATP6V0E1;ATP6V0A1;ATP6V0C;ATP6V0B;RAB7A;ATP6V1G2
prerank,limb morphogenesis (GO:0035108),-0.41071045179395543,-1.2066679722762172,0.20333333333333334,1.0,1.0,5/20,8.75%,LRP6;NIPBL;PTCH1;MBNL1;MEGF8
prerank,neuromuscular process (GO:0050905),0.5215172010961984,1.2060924009972878,0.2582496413199426,0.7411987020004743,1.0,4/16,11.61%,SHANK1;TPP1;GCH1;PAFAH1B1
prerank,phosphorylation (GO:0016310),0.37482592676207765,1.2054063820890861,0.056056056056056056,0.7427144152651428,1.0,106/385,19.08%,CCL2;STK38L;MAPKAPK2;STAT3;PGK1;PI4KA;BRSK1;MAPK6;FAM20C;GNPTAB;TKFC;NEK7;PRKD2;XYLB;MAPK10;ILF3;CDKL3;BCKDK;IKBKB;EIF2AK2;TLK1;PPP4R1;FAM20B;FNIP2;FASTK;NEK6;CDK18;DGKZ;PIK3R4;MAP2K1;TBK1;BMP2K;TGFBR1;TGFBR2;TAF1;SNRK;TRIB2;PDGFB;PRKCH;MAP4K5;CSNK1E;BRSK2;EIF2AK3;PTK2B;TP53RK;RYK;DGKD;CDK6;MAP4K2;LATS1;ACVR1B;PRKCZ;MAPK8;PIM3;GNPTG;BIRC6;ACVR2B;PRKAG1;TAOK2;CSNK1G2;CDKL5;MAML1;GMFB;TNIK;LIMK1;MKNK1;STK17B;PANK3;PDK3;APP;DGKQ;MAP4K3;HUNK;CDK8;CDK12;SRPK2;PRKAB1;IKBKE;CDK19;CAMKK2;CREB1;MTOR;CCNT1;PEAK1;DAPK1;DYRK1A;MAST2;TEC;ILK;YWHAZ;CSNK1D;BRD2;PICK1;PRKCB;ACVR1;PIK3CG;GRK2;STRADA;SGK1;PRKAA1;CDK9;HCK;AATK;STK38;PRKG1;JAK1
prerank,cardiac muscle tissue development (GO:0048738),0.43176244629595617,1.2053956989303478,0.2111506524317912,0.7419134147550999,1.0,2/50,0.29%,BMP5;KDM6B
prerank,glycerophospholipid metabolic process (GO:0006650),0.41256171379503004,1.2049384938009724,0.1915367483296214,0.7425765192058071,1.0,23/75,20.21%,PDGFRB;PLEK;PIGX;PLA2G4A;PIGQ;SERINC1;ENPP6;FAR1;PAFAH1B1;PIGN;PIGM;PIGP;SMPD4;DPM2;GPCPD1;PIGF;PIGC;CPNE3;CRLS1;PLA2G6;CSF1R;ABHD3;DGKH
prerank,regulation of protein ubiquitination (GO:0031396),0.3950637141693128,1.2048366054648947,0.1631130063965885,0.7420870252504322,1.0,28/108,15.10%,SQSTM1;CUL3;VPS28;HSP90AB1;FAM107A;PTTG1IP;PRICKLE1;TGFBR1;UBE3A;DCUN1D1;GNL3L;UBE2D1;U2AF2;PSMD10;DNAJA1;ARRB1;RIPK2;GTPBP4;UFL1;UBE2L3;UBXN1;PRMT3;DNAJB2;DERL1;STUB1;WFS1;TBC1D7;FBXO4
prerank,liver development (GO:0001889),0.46353872099603965,1.2048110000515553,0.23037323037323038,0.7413399801510614,1.0,3/32,5.50%,NKX2-8;LSR;PRKCSH
prerank,RNA transport (GO:0050658),0.41851123023598924,1.2041280733064204,0.18212669683257918,0.7428998852308044,1.0,20/71,16.81%,MAGOH;MAGOHB;CHTOP;SLBP;ZFP36;NUP153;TGFBR2;U2AF2;NXF1;SRSF2;U2AF1;NCBP1;YBX1;SIDT1;FMR1;EIF4E;FLOT1;RBM8A;HNRNPA1;ATXN2
prerank,regulation of phagocytosis (GO:0050764),-0.31394154768984217,-1.2039853890478769,0.12280701754385964,1.0,1.0,13/53,16.15%,MERTK;GAS6;RAB27A;ITGAV;CAMK1D;SCARB1;FCGR2B;LMAN2;ABCA7;CD47;PIP4P2;SYT7;TGM2
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.44205830318994166,-1.2039424809691472,0.24233128834355827,1.0,1.0,6/15,34.01%,KYNU;KYAT1;HAAO;KMO;FAH;IL4I1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.46636911634285494,1.203904691988838,0.25066666666666665,0.7428069908568468,1.0,11/28,19.01%,ZIC1;IPO5;JUP;PIK3R1;TRIM28;ZPR1;FLNA;UBR5;SMAD3;ZC3H12A;RAN
prerank,neurotransmitter secretion (GO:0007269),0.44154218174973414,1.2035932977240331,0.212636695018226,0.7430166122154752,1.0,12/44,14.82%,BRSK1;PDZD11;RIMS1;HSPA8;LIN7C;SLC32A1;STXBP3;SYN3;GAD2;PTPRN2;SNPH;SYT1
prerank,regulation of mitotic nuclear division (GO:0007088),0.4247663795033879,1.2033070705355668,0.2186761229314421,0.7431508578246913,1.0,10/55,15.86%,PDGFRB;PIN1;PDGFB;IL1A;TOM1L1;RCC1;IGF1;NME6;LRP5;LCMT1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.4655401933517155,1.2030931671350529,0.22883597883597884,0.743012398673364,1.0,4/30,8.66%,LTBP4;TFAP2B;LATS1;ENG
prerank,mRNA polyadenylation (GO:0006378),-0.3754452233055545,-1.202905377646559,0.17672413793103448,1.0,1.0,10/26,18.14%,CPSF3;PAPOLG;CPSF2;MTPAP;TENT2;PAPOLA;WDR33;PNPT1;PAF1;CPSF1
prerank,RNA polyadenylation (GO:0043631),-0.3754452233055545,-1.202905377646559,0.17672413793103448,1.0,1.0,10/26,18.14%,CPSF3;PAPOLG;CPSF2;MTPAP;TENT2;PAPOLA;WDR33;PNPT1;PAF1;CPSF1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.41857560796939647,1.2027856345946737,0.19190751445086704,0.7432444463081043,1.0,24/59,19.63%,JUN;SOX9;RELA;TRIM28;TCF7L2;MED8;CTNNB1;RUNX2;MITF;CDK8;SETX;MED25;IL6;MED1;MED13;AGO3;NFKB1;MED20;TNRC6C;CEBPB;MED4;MED23;CSF1R;CCND1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.49113813431783404,1.202686700710163,0.24661246612466126,0.7427597358233518,1.0,5/22,8.78%,ADAM8;ADAM9;APOE;SNX33;FURIN
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3749509232900796,1.2021069582139428,0.04,0.743800210410121,1.0,106/476,18.21%,EGR2;MYC;TNNI2;SOX10;BAMBI;EGR1;STAT3;KCNH2;ZIC1;TFAP2B;SEC14L2;JUN;PRMT2;SERTAD3;KARS1;ILF3;INPP5K;HNRNPD;FOXE1;NFYA;RNF20;SOX9;NR1D2;PICALM;MAP2K3;FBXW11;FUBP3;HIVEP3;IKBKB;NDP;ATF4;RYBP;KAT5;SMARCC1;RELA;CASZ1;MAP2K7;ZMIZ1;ZBTB48;MAP2K1;TGFBR1;DNM2;RHOG;APOE;TAF15;CXXC1;SPP1;PCID2;COL1A1;QRICH1;TRIM56;PDGFB;AGT;TRIM28;SMARCA1;TBL1X;PBX4;CNBP;CTNNB1;USP21;RUNX2;HDAC1;CREBBP;NPAT;MITF;ING1;SOX2;ELF2;ZNF496;IGF1;TCF3;KMT2B;CREB5;SS18L1;FOXO3;RORA;BRD4;CAMKK2;CREB1;IL6;MED1;LRP5;MED13;CTCF;CD86;KMT2A;RUNX1;FOXK2;PAX2;DYRK1A;RXRA;NFKB1;PRDM11;ILK;KAT2A;ENY2;ACVR1;SMAD3;ATMIN;ETS1;RLF;ZXDC;DDIT3;MDFIC;MEF2C;CEBPB
prerank,fatty acid catabolic process (GO:0009062),-0.29233623909925216,-1.2018808523936655,0.10526315789473684,1.0,1.0,26/67,24.23%,SLC25A17;ABCD3;ECHS1;PCCB;AUH;CROT;HADHB;AIG1;ABCD2;LPIN2;PECR;ALDH3A2;ECHDC1;PEX13;PHYH;DECR1;NUDT7;MCEE;ACAD11;ACOT8;ACADM;HADH;ACOX1;ACAA2;SLC27A4;ECI1
prerank,organelle disassembly (GO:1903008),-0.3526848323216589,-1.2017961522975624,0.18807339449541285,1.0,1.0,18/33,21.45%,ULK2;UBA5;GOLGA2;RB1CC1;MTIF2;DDRGK1;MRRF;ATG2B;ULK1;VRK1;ATG2A;ZFAND1;EIF2D;UFC1;KIF9;TEX264;MTIF3;UFM1
prerank,regulation of protein localization (GO:0032880),0.41949547156714234,1.2015901318952091,0.21176470588235294,0.7446032600758051,1.0,14/58,11.19%,CTSD;VPS4A;HSP90AB1;PICALM;PLEKHM2;ITGB3;ZDHHC7;CSNK1E;MAPK8;SUMO1;PPM1F;TRIM17;KDM1A;UFL1
prerank,zinc ion transmembrane transport (GO:0071577),0.48757722378563306,1.2013135581911847,0.24444444444444444,0.7446430027375229,1.0,5/22,11.95%,SLC39A14;SLC39A3;SLC39A8;SLC30A5;TRPM2
prerank,regulation of acrosome reaction (GO:0060046),-0.49966463184952137,-1.201136413459691,0.26430517711171664,1.0,1.0,1/10,5.36%,GLRA1
prerank,regulation of immune response (GO:0050776),0.38909669511833667,1.2010623027327272,0.16996871741397288,0.7446443329337138,1.0,23/135,14.94%,PILRA;TKFC;PDCD1;TREML2;CXADR;TYROBP;COL1A2;COL1A1;ITGAL;COLEC12;FOXP1;CD200R1;PIANP;CD33;CD200;RAET1E;COL3A1;DENND1B;BCL6;TRAF3;FCGR1A;SPPL2A;GPR108
prerank,intracellular pH reduction (GO:0051452),0.4537404615017033,1.2006112290781898,0.23027989821882952,0.7454124583052307,1.0,13/33,19.42%,ATP6V1D;ATP6V1A;ATP6V0D1;TMEM9;ATP6V0E1;ATP6V0A1;ATP6V0C;SLC11A1;ATP6V0B;RAB7A;ATP6V1G2;DMXL2;DMXL1
prerank,regulation of cell-matrix adhesion (GO:0001952),0.41875563325589416,1.2005609571495053,0.19696969696969696,0.7447628619396421,1.0,22/64,20.82%,CORO1C;CSF1;EPHA1;JUP;JAG1;PTK2B;CDK6;ACTG1;PTPRA;EPHA3;LIMCH1;CCL25;NEXMIF;LDB1;PEAK1;GPM6B;CDH13;DUSP3;SLC9A1;MAP4K4;THY1;VCL
prerank,ATP transport (GO:0015867),-0.5005888719504342,-1.2004395845604579,0.2602739726027397,1.0,1.0,4/10,13.09%,SLC25A17;SLC17A9;SLC25A4;CD47
prerank,Wnt signaling pathway (GO:0016055),0.4064977342628954,1.2002558553499925,0.19315673289183222,0.7449805066649366,1.0,19/92,12.82%,DVL2;WNT5B;FZD5;CELSR2;FZD6;ARL6;RPS27A;UBC;KLHL12;CSNK1E;RYK;TCF7L2;ZRANB1;VPS29;CTNNB1;CSNK1G2;VPS35;TCF7L1;CSNK1G3
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.5175270243941588,1.2001632351998825,0.2342606149341142,0.7444623172939767,1.0,4/17,10.68%,STAT3;CD55;JAG1;IL18
prerank,negative regulation of transferase activity (GO:0051348),0.4734487946160091,1.1997669558930264,0.21964529331514324,0.7449292808550964,1.0,5/28,7.40%,ZFP36;INPP5K;NPRL2;HNRNPU;EIF4A2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.4705215902389227,-1.1996467213459014,0.23641304347826086,1.0,1.0,5/12,15.14%,KHDRBS1;NUP214;TPR;RBM4;IFI27
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.41357760680395544,1.1994918515507174,0.20398593200468934,0.7450571906430393,1.0,15/63,12.46%,TMC8;LTBR;SIAH2;BID;RELA;TGFBR1;AGT;PSME3;TCF7L2;PELI3;PYCARD;BIRC6;DEDD2;IGF1;CFLAR
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.30261517702151436,-1.1994430646100216,0.14285714285714285,1.0,1.0,22/57,21.15%,GRIA3;GRIN2B;DLG2;NLGN1;MINK1;SHISA6;LRRC7;GRIA1;OPRM1;DLG1;DLGAP2;DLG3;CACNG7;GRIN1;CACNG3;CAMK2A;DLGAP4;CAPN1;DLGAP1;CACNG4;NLGN2;CAMK2B
prerank,regulation of fat cell differentiation (GO:0045598),0.4079670948535929,1.1992263638793201,0.1938073394495413,0.7451329609776309,1.0,23/74,18.21%,LPL;ZFP36;TAF8;CCDC85B;BBS12;CMKLR1;TRIB2;TRPM4;SIRT1;SIRT2;TRIO;GPS2;RORA;CREB1;IL6;WWTR1;LRP5;SYAP1;SMAD3;ZC3H12A;FTO;RUNX1T1;CEBPB
prerank,cell junction organization (GO:0034330),0.406659989634624,1.1991495167230914,0.21283783783783783,0.7445811966712269,1.0,28/71,22.35%,MARVELD2;CXADR;RAB39B;PIN1;FBLIM1;RAB8B;PPFIBP2;SDK2;SH3BP1;LRP4;ELFN1;PPFIA4;ACTG1;MYO9A;APP;LIMS1;FLNA;ACTB;ILK;SMAD3;PPFIBP1;SNCA;TJP1;CDC42;C1QA;AGRN;CAPZA1;VMP1
prerank,nuclear pore complex assembly (GO:0051292),0.5841749296623665,1.1990149904208942,0.26366559485530544,0.744228421438444,1.0,3/10,5.48%,NUP153;NDC1;RTN4
prerank,regulation of endothelial cell proliferation (GO:0001936),0.40165515148376535,1.198861294754966,0.1737704918032787,0.743872974006353,1.0,14/88,9.27%,EGR3;NR4A1;PRKD2;KRIT1;EMC10;TGFBR1;APOE;ITGB3;SPARC;PDGFB;NRAS;VEGFC;SIRT1;F3
prerank,2-oxoglutarate metabolic process (GO:0006103),0.5431200222409367,1.198714044624483,0.270516717325228,0.7436020618826684,1.0,6/13,15.63%,IDH1;GOT2;GPT2;OGDH;GOT1;IDH2
prerank,proteoglycan biosynthetic process (GO:0030166),0.4698651627942617,1.1986755984389215,0.24124513618677043,0.7429237322583235,1.0,11/31,18.91%,CHST11;CHST12;HS3ST3B1;FAM20B;XYLT1;IGF1;CSGALNACT1;B4GALT7;GLCE;B3GAT1;EXT2
prerank,negative regulation of programmed cell death (GO:0043069),0.37521451797849376,1.1985762549034773,0.07336683417085427,0.7424449432993152,1.0,66/355,15.78%,GDNF;MYC;EGR3;MAD2L1;PRELID1;TFAP2B;ARHGDIA;BCL2L1;SQSTM1;PLAUR;AIFM2;HIGD1A;HNRNPK;SIAH2;BID;SOX9;NUPR1;IKBKB;RPL10;RELA;RPS27A;UBC;PCID2;PRDX5;BCL2L2;PIK3R1;TXNDC5;FAIM2;GPX4;PTK2B;PPT1;PSMD10;TCIM;SIRT1;DNAJA1;MAPK8;PIM3;CTNNB1;HDAC1;RIPK2;PA2G4;BIRC6;BAG1;HPN;BNIP1;HSPA5;CBX4;TMBIM6;DDAH2;IGF1;ERC1;CFLAR;DPEP1;UBE2Z;SETX;ARF4;WFS1;MTDH;TMBIM4;FLNA;IL6;HGF;MED1;YME1L1;PAX2;RAF1
prerank,sulfur compound catabolic process (GO:0044273),0.4474484767676376,1.198532330825236,0.22249690976514216,0.7417910862593792,1.0,9/38,13.11%,BCAN;NCAN;GLB1;CSPG4;GALNS;CHAC2;IDS;ACAT1;DPEP1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.47760661042566166,1.1982553798471398,0.2503276539973788,0.7419120241278875,1.0,5/26,7.82%,MID1IP1;APOC1;ADIPOR1;EIF6;WDTC1
prerank,regulation of MAP kinase activity (GO:0043405),0.4022124394661342,1.198242291850851,0.18859649122807018,0.7411426385794474,1.0,13/92,8.49%,PDGFRB;ADAM8;INPP5K;PDGFA;IL34;DUSP19;UCHL1;APOE;TRIB2;PDGFB;AGT;SORL1;SMPD1
prerank,glutamate receptor signaling pathway (GO:0007215),-0.34306654840535544,-1.1981839610050768,0.18316831683168316,1.0,1.0,5/37,3.34%,GRIA3;GRIN2B;GRIN3A;GRM5;GRIK4
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.48475082934558184,1.1979397526821527,0.25,0.741367746187958,1.0,3/23,8.66%,LTBP4;LATS1;ENG
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.33519831231549396,-1.1977112127070781,0.15873015873015872,1.0,1.0,9/39,8.84%,CBL;GRB2;SH3GL2;TSG101;ZFYVE28;MVP;ERRFI1;PTPN18;LGMN
prerank,cellular response to interferon-gamma (GO:0071346),0.4017335579831873,1.1976978327333796,0.1982475355969332,0.7413817193946314,1.0,22/88,19.69%,CCL3;CCL4;CCL2;ACOD1;RPL13A;SIRPA;CAMK2G;IRF8;MID1;CCL25;CCL13;FCGR1A;DAPK1;MT2A;IRF9;ICAM1;TRIM5;HCK;JAK1;TLR2;TRIM8;TRIM26
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.5057653716238536,1.1975880861295627,0.25292397660818716,0.740981653922814,1.0,3/18,6.09%,BAG6;NCK1;PIK3R1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.5327518576534036,1.1973489714633174,0.2716236722306525,0.7409698840796529,1.0,2/13,1.49%,CD9;LPL
prerank,brain development (GO:0007420),0.38861106796558476,1.1972971634356904,0.1755485893416928,0.7403203141408465,1.0,19/136,8.88%,EGR2;BAG6;ZIC1;CXCR4;SLC23A1;CLN5;MAP1S;RAB18;FBXW11;APOD;TGFBR2;ADGRG1;UBE3A;AFF2;ADGRL2;BBS4;PPT1;SMARCA1;PBX4
prerank,sterol biosynthetic process (GO:0016126),-0.35136888119011817,-1.1969372100091837,0.17886178861788618,1.0,1.0,23/33,35.93%,INSIG2;FDFT1;LBR;ARV1;NSDHL;CH25H;GGPS1;CYP51A1;ACAA2;INSIG1;PMVK;SQLE;LSS;EBP;IDI1;DHCR24;DHCR7;PLPP6;HSD17B7;ACAT2;MVK;FDPS;TM7SF2
prerank,folic acid metabolic process (GO:0046655),0.49927979433823216,1.1967441353169628,0.2619047619047619,0.7413896946764994,1.0,4/18,11.67%,SHMT2;MTHFD1L;MTHFD2;FPGS
prerank,regulation of protein localization to nucleus (GO:1900180),0.43137836950460645,1.1966981051226975,0.2229064039408867,0.7407388104297195,1.0,11/43,16.05%,SESN2;ATP13A2;PIN1;OTUD7B;EIF2AK3;LATS1;NVL;ILRUN;WWTR1;FLCN;SIN3A
prerank,histone H2A ubiquitination (GO:0033522),0.5123272599450435,1.1964947124385197,0.25217391304347825,0.7406379853907541,1.0,6/17,18.52%,DDB2;RYBP;DDB1;SKP1;UBR2;KDM2B
prerank,regulation of protein sumoylation (GO:0033233),0.5258618957954798,1.1962877927679365,0.2601744186046512,0.740557718310242,1.0,4/17,9.75%,EGR1;ZMIZ1;GNL3L;CTNNB1
prerank,carboxylic acid catabolic process (GO:0046395),0.562291720614347,1.1962633760520254,0.2515432098765432,0.7398240454763508,1.0,2/12,2.79%,AMDHD2;BCKDK
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.5003835752074521,1.1960213108537308,0.2679640718562874,0.7398124828078617,1.0,2/18,6.62%,SELP;SLC39A8
prerank,negative regulation of interleukin-6 production (GO:0032715),0.4689090496145239,1.1954851908009683,0.2557200538358008,0.7407088061397947,1.0,10/27,17.55%,SLAMF1;SIRPA;NLRC3;CD200R1;ARRB1;PTPN6;CD200;C5AR2;TNFAIP3;ZC3H12A
prerank,response to hydroxyurea (GO:0072710),-0.49386613054213174,-1.1953857404673152,0.2554945054945055,1.0,1.0,6/11,24.68%,SPIDR;BLM;RTF2;KAT7;DDI2;DDX11
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.5792231612328277,1.1952597799934999,0.2740619902120718,0.7406378092034275,1.0,1/10,1.61%,ADAM17
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.573345590922653,1.1952421239586164,0.2694214876033058,0.7399150669757487,1.0,2/10,5.56%,BMP5;LIN7C
prerank,dopaminergic neuron differentiation (GO:0071542),0.49475489634426467,1.1951138866701652,0.2565982404692082,0.7395441741509253,1.0,5/19,14.01%,MANF;RYK;CTNNB1;PHOX2A;LMX1B
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.5263420902980342,1.1945889360561102,0.2671641791044776,0.7405019962792895,1.0,7/15,21.91%,WNT5B;CSNK1E;ZNRF3;CSNK1D;TIAM1;DAAM2;GPC3
prerank,regulation of lipid storage (GO:0010883),0.4889891860613976,1.1941326748058647,0.25140449438202245,0.7412124118093759,1.0,8/22,17.77%,LPL;ITGB3;SIRT1;IKBKE;IL6;NFKB1;ZC3H12A;FTO
prerank,oligodendrocyte differentiation (GO:0048709),0.5011501578986621,1.1934124742969656,0.25370919881305637,0.7428625214064856,1.0,3/19,3.29%,SOX10;EIF2B2;SOX9
prerank,pore complex assembly (GO:0046931),0.5064277013354402,1.192739138845931,0.2664756446991404,0.7443347065389221,1.0,6/19,14.05%,PDZD11;NUP153;NDC1;RTN4;BAD;NUP98
prerank,regulation of amyloid-beta formation (GO:1902003),0.4538759872074383,1.1927181842940904,0.22409326424870465,0.743611529368762,1.0,10/34,12.34%,PIN1;PICALM;RELA;RTN4;APOE;TMED10;SORL1;PRNP;CLU;IGF1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5268583856282661,1.1924422416368567,0.2762345679012346,0.7437020366579135,1.0,3/14,10.68%,CD84;CARD9;IL18
prerank,response to thyroid hormone (GO:0097066),0.5451320514176059,1.192412255017962,0.26498422712933756,0.7430100455071739,1.0,7/13,20.75%,CTSB;CTSL;BRD8;HPN;MED1;THRB;LMO2
prerank,regulation of G0 to G1 transition (GO:0070316),-0.340823159974417,-1.1923732308258845,0.208955223880597,1.0,1.0,19/38,26.62%,PHC3;EED;CBX3;SUZ12;RBBP8;RBBP7;TFDP2;EPC1;PCGF6;MAX;E2F6;BMI1;PHC1;RHNO1;EHMT2;RING1;EHMT1;BRCA1;CDC7
prerank,cellular response to leucine (GO:0071233),0.5817559532169855,1.1922160791893466,0.272572402044293,0.7421253240567753,1.0,6/10,18.46%,SESN2;UBR1;LARS1;MTOR;UBR2;RPTOR
prerank,response to leucine (GO:0043201),0.5817559532169855,1.1922160791893466,0.272572402044293,0.7421253240567753,1.0,6/10,18.46%,SESN2;UBR1;LARS1;MTOR;UBR2;RPTOR
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.5699752384934552,1.1921803649804814,0.28429752066115704,0.7414671993452359,1.0,3/11,9.67%,KCNH2;KCNJ2;ATP1B1
prerank,ceramide biosynthetic process (GO:0046513),0.4476420465168509,1.1921351493604828,0.212636695018226,0.7408448688538746,1.0,8/40,8.49%,ALOXE3;B4GALNT1;SPTSSA;ST8SIA6;DEGS1;SGMS1;CLN8;SMPD1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.4462359081900794,1.1920066028784395,0.21662468513853905,0.740517607845809,1.0,8/38,9.70%,KCNH2;JUP;CACNA2D1;TRPM4;CACNA1G;KCNJ2;AKAP9;SCN1B
prerank,regulation of T cell proliferation (GO:0042129),0.42083470760038877,1.1919344163072367,0.2226027397260274,0.7399640365269384,1.0,14/61,19.75%,DLG5;SLC7A1;NCK1;PNP;SDC4;GLMN;PTPRC;IL6;TNFRSF1B;CD86;GPNMB;CEBPB;CCDC88B;IL6ST
prerank,vitamin D metabolic process (GO:0042359),-0.4550489892142855,-1.1918789392077513,0.2534435261707989,1.0,1.0,3/13,24.98%,LGMN;PIAS4;CYP2R1
prerank,spliceosomal snRNP assembly (GO:0000387),0.44651393550009605,1.1917466483342278,0.24265644955300128,0.7397788789278259,1.0,14/38,20.29%,DDX20;PRPF31;TGS1;GEMIN7;AAR2;SRSF10;SRSF12;SNRPG;SART3;SNUPN;STRAP;SNRPD2;SNRPD1;PRPF6
prerank,smooth muscle cell differentiation (GO:0051145),0.5545499408508456,1.191578096971546,0.2724458204334365,0.7395399673660182,1.0,3/12,18.17%,TMEM204;MRTFB;MEF2C
prerank,thyroid hormone generation (GO:0006590),0.5799028741409713,1.1912117726579206,0.2824074074074074,0.7399627518400218,1.0,1/10,2.80%,FOXE1
prerank,erythrocyte differentiation (GO:0030218),-0.32594611593812783,-1.1911615721537738,0.21195652173913043,1.0,1.0,14/44,22.33%,NCKAP1L;JAK2;IKZF1;FLVCR1;UBA5;TGFBR3;ALAS1;SLC25A38;CASP3;VEGFA;ID2;DMTN;CDK5RAP3;KIT
prerank,regulation of T cell chemotaxis (GO:0010819),0.5631254043505014,1.1902750380818534,0.271875,0.7422966679505598,1.0,1/11,1.61%,ADAM17
prerank,photoperiodism (GO:0009648),0.4656680189359119,1.1902011577971014,0.25392670157068065,0.7417320198111097,1.0,7/28,8.44%,USP2;RBM4B;FBXL3;PPP1CB;CRTC1;CRY2;FBXL8
prerank,regulation of cellular protein metabolic process (GO:0032268),0.43280720380046916,1.1899067957993092,0.22168087697929353,0.7419993212676099,1.0,13/47,16.81%,CSF1;RBM4B;RPL10;APOE;AGT;CYFIP1;VPS35;APP;FOXO3;EIF4E;METAP1;NFKB1;ATXN2
prerank,glutamine family amino acid catabolic process (GO:0009065),0.5439334466851606,1.189888721474682,0.2702702702702703,0.7412877789124206,1.0,3/13,9.62%,GLS2;GLS;GLUD1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.5606270777734803,1.1897185625733164,0.2764612954186414,0.7410224352746261,1.0,7/11,25.00%,LANCL1;P4HB;REST;PINK1;UBQLN1;FYN;PRKN
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.5557286013513973,1.1895788785741666,0.2765273311897106,0.7407247405634584,1.0,3/12,9.60%,WRNIP1;WDR18;NBN
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.4781370242419082,1.1890691815087624,0.23848238482384823,0.7416702433064103,1.0,8/25,15.36%,BAG6;CUL3;HDAC6;LONP1;DERL1;FBXL17;STUB1;YME1L1
prerank,positive regulation of apoptotic process (GO:0043065),0.3743881257017017,1.1877411022815014,0.09375,0.7451193091858185,1.0,71/293,18.19%,CCL3;DDX20;TFAP2B;SQSTM1;CTSD;ARL6IP5;C1QBP;JUN;PRMT2;AIFM2;CLIP3;BID;HMGB1;KLF11;NUPR1;ATF4;KALRN;RYBP;UTP11;RHOB;TGFBR1;DNM2;RPS27A;UBC;ARHGEF26;QRICH1;RRP1B;ARHGEF4;ARHGEF6;LATS1;SMPD1;SIRT1;DNAJA1;PRNP;MAPK8;PYCARD;CTNNB1;FGD1;IP6K2;CASP9;SIRT2;BAD;ADAMTSL4;CLU;STK17B;TRIO;PTRH2;MTCH1;UBE2Z;SRPK2;SCRIB;FOXO3;BCL6;KCNMA1;ATF6;SOS1;IL6;ING4;DAPK1;FLCN;HSPD1;PRDM11;APC;ARHGEF3;ARHGEF2;HTRA2;UNC13B;ZC3H12A;TIAM1;DDIT3;ITSN1
prerank,regulation of cellular response to stress (GO:0080135),0.39154474352039426,1.1873798492331342,0.1900739176346357,0.7455465127777043,1.0,22/115,11.17%,ATF3;MAPKAPK2;AIFM2;NUP153;HSP90AB1;NDC1;NUPR1;ATF4;NEK6;MANF;HSPA8;PTGES3;IER3;CAMK2G;USP19;NUP88;SIRT1;CREBBP;BAG1;NUP210;CASP9;NUP37
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.52237358449197,1.1871033216482585,0.2777777777777778,0.7456789921399465,1.0,4/15,15.03%,STAT3;CARD9;IL17RA;IL6
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.4499968588933962,1.18632961575491,0.2613195342820181,0.7474414173002671,1.0,9/34,17.19%,PDGFRB;CUL3;PDGFB;IL1A;ANAPC5;DLGAP5;IGF1;LRP5;ANAPC7
prerank,inner ear morphogenesis (GO:0042472),0.47861061270192506,1.1862326877073663,0.26367461430575034,0.7469961060271773,1.0,4/22,15.75%,ZIC1;SOX9;HPN;PAX2
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.537789653334189,1.1862176371591016,0.26604068857589985,0.7462544479403542,1.0,5/13,16.00%,PTTG1IP;PSMD10;SIRT1;KDM1A;DYRK1A
prerank,piRNA metabolic process (GO:0034587),0.49139534302413257,1.1858771714070853,0.28062678062678065,0.7466608502134803,1.0,2/19,12.08%,EXD1;TEX15
prerank,negative regulation of anoikis (GO:2000811),-0.43997263684026827,-1.1858247022571224,0.23692307692307693,1.0,1.0,5/14,14.91%,PTK2;NOTCH1;TLE1;SRC;ITGB1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.5352871628199917,1.1857354268634077,0.2727272727272727,0.7463481326647619,1.0,5/14,13.15%,NMNAT1;PNP;AK8;CMPK1;NMNAT2
prerank,positive regulation of myelination (GO:0031643),0.5579336439337557,1.1856775498132806,0.293354943273906,0.7457874779027607,1.0,1/11,0.09%,EGR2
prerank,negative regulation of protein ubiquitination (GO:0031397),0.4209570261551536,1.1851811145423867,0.23696682464454977,0.7466962638689698,1.0,12/50,12.04%,SQSTM1;VPS28;TAF1;GNL3L;U2AF2;DNAJA1;ARRB1;GTPBP4;UFL1;UBXN1;PRMT3;LIMK1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.42936051201670494,1.184881742470627,0.2407185628742515,0.7469423692357431,1.0,11/44,14.70%,KCNH2;KCNJ6;AKAP6;KCNMB2;KCNMB3;KCNJ2;AKAP9;ATP1B1;GNB1;KCNMA1;FLNA
prerank,regulation of chromosome organization (GO:0033044),0.48688868743996644,1.1840701755147438,0.266304347826087,0.7488490836204438,1.0,3/22,7.01%,MYC;HNRNPD;XRCC5
prerank,regulation of macrophage migration (GO:1905521),0.5769881467427486,1.183482899211089,0.27821939586645467,0.7499432413247652,1.0,4/10,11.37%,CSF1;CD200R1;PTK2B;CD200
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.3957893218248951,1.1831919387980974,0.2157079646017699,0.7501150426929394,1.0,23/95,16.83%,HS3ST3A1;CHST11;BCAN;CHPF;NCAN;CHST12;HS3ST3B1;ABCC5;CSPG4;SDC4;XYLT1;SLC35D2;B4GALT5;NDST2;GPC5;CSGALNACT1;GCNT2;ST3GAL6;HS3ST6;HS3ST5;B4GALT7;GLCE;HS6ST2
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.562966830043396,1.183116750429391,0.292259083728278,0.7488248574593992,1.0,6/11,21.37%,ZFP36;EIF6;AGO3;TNRC6C;AGO2;TNRC6A
prerank,miRNA mediated inhibition of translation (GO:0035278),0.562966830043396,1.183116750429391,0.292259083728278,0.7488248574593992,1.0,6/11,21.37%,ZFP36;EIF6;AGO3;TNRC6C;AGO2;TNRC6A
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.4630624952175397,1.1830091740693502,0.25444596443228457,0.7484094547834271,1.0,4/27,6.09%,SHANK1;INPP5K;PFN1;PIK3R1
prerank,regulation of Rac protein signal transduction (GO:0035020),0.5152196341087507,1.182742993502045,0.27794117647058825,0.7485498604829376,1.0,5/16,7.30%,GABARAP;ALS2;RASGRF1;KBTBD7;SH3BP1
prerank,heterocycle biosynthetic process (GO:0018130),0.5298895905974184,1.182048903207756,0.29429429429429427,0.7499824715965147,1.0,4/14,12.83%,MOCS1;LIAS;GCH1;PYCR2
prerank,mRNA processing (GO:0006397),0.36988228312478866,1.1818013434958015,0.11646586345381527,0.7500758996571953,1.0,84/287,18.05%,MAGOH;MAGOHB;LSM5;CHTOP;BCAS2;DHX35;DDX42;PRPF31;POLR2J;FUS;HNRNPK;HNRNPD;RBM4B;HNRNPU;HNRNPM;PRPF18;ESS2;PRPF40A;HSPA8;DDX41;RAMAC;GTF2H4;SNRPA1;SNRPA;HNRNPH2;ZCCHC8;U2AF2;DHX9;PCBP2;CPSF6;GEMIN7;SRSF2;GCFC2;U2AF1;SRSF10;NCBP1;ERCC2;SRSF12;CWC15;YBX1;SFPQ;FIP1L1;GTF2F2;SCAF11;ELAVL2;HNRNPL;PRPF40B;SF3A2;DDX5;DNAJC8;POLR2E;HNRNPH1;CWC25;AKAP8L;SF3A1;SNRNP27;PTBP1;RPRD1A;SNRNP48;SNRPG;POLR2B;BUD13;U2SURP;SART3;SYMPK;CMTR2;RBM10;RBM8A;ZRSR2;SNRNP40;POLR2G;PPIL3;GPATCH1;PSPC1;HNRNPA1;NONO;RPRD1B;ELAVL1;HNRNPR;PRPF4;RBM14;ALKBH5;SF3B3;SNRNP70
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.4069627322691213,1.1817312641702744,0.22869955156950672,0.7494850776441465,1.0,11/69,12.61%,PLCD4;PDGFRB;PI4KA;PLCH1;C1QBP;PIK3C3;PIK3R1;PI4KB;SIRT2;IGF1;INPP5F
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.4242311599269645,1.1817009284854587,0.23401688781664656,0.7488258426034299,1.0,9/48,10.90%,BAG6;EPHA2;BCL2L1;FNIP2;BCL2L2;CRIP1;SIRT1;PYCARD;CASP9
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.5036535257979107,1.1813027903905493,0.25301204819277107,0.7493652866900103,1.0,2/17,1.19%,TFAP2B;TMEM204
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.4753659981067834,1.18119952995326,0.25787965616045844,0.7489811602952765,1.0,5/21,9.03%,PRKD2;RELA;PRKCH;FOXP1;PTPRC
prerank,inner mitochondrial membrane organization (GO:0007007),0.43207623209799684,1.181052253234054,0.2360774818401937,0.7486843105071954,1.0,15/47,16.87%,TIMM8B;MTX1;ATP5MF;ATP5PF;ATP5F1E;ATP5PD;CHCHD6;TMEM11;TIMM9;NDUFA13;ATP5MC2;AFG3L2;ATP5F1C;ATP5F1D;ATP5MC3
prerank,T cell differentiation in thymus (GO:0033077),0.5373239891732702,1.1810435050015675,0.3005952380952381,0.7479528381240604,1.0,2/14,9.03%,ADAM17;PTPRC
prerank,regulation of mitochondrial translation (GO:0070129),0.4925350791647197,1.180714384625792,0.2539454806312769,0.7483012898588685,1.0,6/21,14.75%,SHMT2;C1QBP;MALSU1;TSFM;MRPS27;RMND1
prerank,regulation of spindle organization (GO:0090224),-0.40975413508095193,-1.1807081425230532,0.22508038585209003,1.0,1.0,10/18,32.05%,SENP6;NUMA1;RAE1;GNAI1;GPSM2;BORA;MAP9;TACC3;PARP3;TPX2
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.5390639915009178,1.1804268501356037,0.28419452887537994,0.7484669927228966,1.0,3/13,8.12%,HNRNPU;METRNL;ZBTB7B
prerank,positive regulation of nervous system process (GO:0031646),0.5076959025197192,1.1803079188555656,0.27941176470588236,0.74808891863494,1.0,2/18,3.71%,EGR2;RIMS1
prerank,response to nitric oxide (GO:0071731),-0.4435431047681779,-1.1801527942535115,0.2521246458923513,1.0,1.0,7/13,29.13%,KCNC2;EGLN1;GUCY1B1;CDK2;MTR;TXN;MT3
prerank,acute-phase response (GO:0006953),-0.46682636378484116,-1.1799377890820255,0.26869806094182824,1.0,1.0,2/12,5.39%,IL6R;IL22
prerank,positive regulation of protein import (GO:1904591),0.4491111875097178,1.1795774624198772,0.26848249027237353,0.7497588673288599,1.0,11/30,19.01%,ZIC1;IPO5;JUP;PIK3R1;TRIM28;ZPR1;FLNA;UBR5;SMAD3;ZC3H12A;RAN
prerank,amide transport (GO:0042886),-0.3653493091468423,-1.1792793568313422,0.2230769230769231,1.0,1.0,13/26,38.82%,DISP1;ABCG2;GLTP;SLC25A32;SLC14A1;PLEKHA8;ABCB9;SLC27A1;PDPN;ABCA13;SLC46A1;SLC5A6;SLC19A1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.4531775785078174,1.1788125969719256,0.2720306513409962,0.75153368772956,1.0,5/30,6.41%,BAG6;UCHL5;HSP90AB1;RYBP;SDCBP
prerank,glycolytic process (GO:0006096),0.4694612548742535,1.1782913586182113,0.2683578104138852,0.7524938201943799,1.0,3/28,2.16%,PGK1;PFKM;PGM1
prerank,cellular response to osmotic stress (GO:0071470),-0.3759265613058319,-1.1781593667136425,0.2109090909090909,1.0,1.0,9/21,21.53%,CAB39;RCSD1;SCN2A;WNK3;CAPN3;PKD2;ZFAND1;ZFP36L1;TRPV4
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.4785205338094484,1.178117030349555,0.2541899441340782,0.7523059749306079,1.0,10/22,19.48%,UTP15;ATF4;EIF2AK3;PWP1;IPPK;SMARCB1;WDR43;MTOR;PIH1D1;WDR75
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.45954573422634964,1.1780724368049762,0.26174496644295303,0.7517217166983413,1.0,6/28,11.20%,GABARAP;BID;ZDHHC3;DELE1;SPI1;DEDD2
prerank,negative regulation of binding (GO:0051100),0.3915749336808775,1.178003987166268,0.22135706340378197,0.7511682348683502,1.0,22/81,15.92%,TMC8;JUN;PIN1;HABP4;PSME3IP1;GNL3L;PDGFB;CSNK1E;RALB;SORL1;MAPK8;SUMO1;CARD16;BTAF1;KDM1A;GTPBP4;TMBIM6;DNAJB2;ILRUN;SYMPK;ACTB;WAPL
prerank,regulation of interleukin-10 production (GO:0032653),0.43733514179962857,1.1776767322792632,0.25953259532595324,0.7514638208029567,1.0,6/44,9.33%,STAT3;TYROBP;HMGB1;TRIB2;PRKCZ;PYCARD
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.45877604129000826,1.1770836444494166,0.2592087312414734,0.7526818633302967,1.0,5/32,7.26%,CORO1C;SERPINE1;APOD;FAM107A;JAG1
prerank,phosphate ion transmembrane transport (GO:0035435),0.547452576580678,1.1769158015865555,0.27341389728096677,0.7524547272860521,1.0,6/12,17.61%,SLC37A1;SLC25A3;SLC20A2;SLC37A3;SLC20A1;SLC25A14
prerank,RNA splicing (GO:0008380),0.3904510816093292,1.1765574638262954,0.23034330011074197,0.7528870981293072,1.0,31/95,20.29%,MAGOH;MAGOHB;BCAS2;RRAGC;FUS;PRPF18;TARDBP;SNRPA1;SRSF2;U2AF1;SRSF10;NCBP1;SFPQ;SCAF11;PPIG;CDK12;SRPK2;PTBP1;SNRNP48;SNRPG;RBM8A;ZRSR2;SNRNP40;NONO;PRPF4;SF3B3;SNRPD2;SNRPD1;USP39;SRSF7;PRPF6
prerank,regulation of cation channel activity (GO:2001257),-0.2781364326231498,-1.1763782316677742,0.15584415584415584,1.0,1.0,31/89,21.15%,GRIA3;GRIN2B;DLG2;NLGN1;FGF12;MINK1;SHISA6;CALM2;AHNAK;LRRC7;ANK2;CALM1;GRIA1;OPRM1;PRKACA;DLG1;KCNAB1;DLG3;CACNG7;VAMP2;GRIN1;CACNB2;ITGB1;CACNG3;PDE4D;CAMK2A;CAPN1;CACNG4;JPH4;NLGN2;CAMK2B
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.5719959460150948,1.176114985617674,0.28225806451612906,0.7535920529069539,1.0,2/10,1.92%,TKFC;C1QBP
prerank,positive regulation of endopeptidase activity (GO:0010950),0.4671131904438272,1.1760851767193192,0.26728723404255317,0.7529349575834301,1.0,5/26,9.33%,PRELID1;STAT3;PICALM;PSME3;PYCARD
prerank,regulation of complement activation (GO:0030449),0.4357838772807837,1.175870031365315,0.273955773955774,0.7528858659992507,1.0,7/40,13.34%,C1QBP;C4B;CD55;C1QC;CLU;PROS1;C5AR2
prerank,response to ethanol (GO:0045471),-0.45236571079964727,-1.175336336765001,0.26900584795321636,1.0,1.0,6/14,16.10%,GRIN2B;GRIN3A;GLRA1;GLRA2;GRIN1;SOD1
prerank,negative regulation of cellular component organization (GO:0051129),0.39931468274985515,1.1750802643742702,0.229490022172949,0.7547505323989984,1.0,16/74,12.18%,TMC8;HDAC6;RUBCN;HSPA8;DNM2;DNAJA4;SNX33;XRCC5;SORL1;PRKCZ;BMP6;TRAF3IP1;HSPA5;EPHA3;CLU;DNAJB2
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3680639158343599,1.174535093377125,0.10230692076228685,0.7557703012071256,1.0,77/348,17.44%,BMP5;OSM;AGAP2;CSF1;DVL2;ADAM17;PLAUR;PRKD2;CLIP3;PIK3R3;PDGFA;IL34;HSP90AB1;PIN1;SOX9;DUSP19;MAP2K3;FNIP2;HDAC6;ALS2;FXR2;CSPG4;TBK1;RBPMS;TGFBR1;CAMKK1;ITGB3;SDCBP;PDGFB;AGT;XRCC5;RALB;VEGFC;PTK2B;P2RY1;LATS1;SIRT1;ENG;BMP6;PTPRC;PRNP;AKAP9;TOM1L1;NBN;CAPRIN2;DDR2;ARRB1;RIPK2;BDNF;PRKAG1;TAOK2;TNIK;LIMCH1;IGF1;APP;DGKQ;FMR1;NPTN;CAMKK2;IL6;HGF;RALBP1;FLOT1;PGF;RAF1;RAC1;FLCN;ITGA5;FGF9;TEC;ILK;KRAS;ARHGEF2;AKTIP;CSNK1D;GPNMB;ACVR1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.48696448704851103,1.174338257854055,0.28175182481751826,0.7556452702479738,1.0,7/18,19.48%,UTP15;ATF4;EIF2AK3;WDR43;FLNA;POLR2K;WDR75
prerank,regulation of protein kinase B signaling (GO:0051896),0.37454122999165274,1.174334312060363,0.164969450101833,0.7548984513400891,1.0,24/193,10.68%,CCL3;OSM;PDGFRB;EPHA2;ADAM8;C1QBP;RICTOR;INPP5K;OTUD3;PDGFA;HSP90AB1;TGFBR1;RHOG;RTN4;PPP2R5B;PIK3R1;PDGFB;TCF7L2;SIRT1;ENG;F3;PHLPP1;OSBPL8;IL18
prerank,amyloid fibril formation (GO:1990000),0.4159784672543914,1.173945943494403,0.24553039332538737,0.7553667131029148,1.0,11/51,12.57%,CALCA;SIAH2;CALB1;RPS27A;UBC;GGA1;TSPAN14;SORL1;FURIN;SNCAIP;APP
prerank,positive regulation of chromatin organization (GO:1905269),0.5438962439299383,1.173884421104166,0.29448818897637796,0.7548188541131046,1.0,6/12,21.63%,ACD;MIER1;SIN3A;TERF2IP;TAL1;TERF2
prerank,protein-containing complex assembly (GO:0065003),0.36651540830372265,1.1737572977533086,0.1385237613751264,0.7545128614198631,1.0,70/259,18.24%,MYC;NAPA;SHANK1;LLGL1;PDZD11;CUL3;TRAPPC5;TRAPPC2L;WDR19;PPP6R1;SOX9;PICALM;RIMS1;KAT5;CDC123;NIFK;MDM4;KLHL12;TRRAP;RSPH9;SKAP2;TMED10;DHX9;PTK2B;PDE4DIP;CD2AP;TRAPPC10;TCF7L2;CAND1;TRAPPC4;PPP6R3;COL16A1;TRAPPC3;CTNNB1;ST13;HDAC1;CREBBP;PEF1;TSPAN4;MITF;BAD;NSF;TCF7L1;SEC24C;ADCY8;TRAPPC9;SLC2A1;SEC24A;KMT2D;SAR1B;TLE3;AFG3L2;TUBGCP4;DBNL;WIPF1;STX5;USO1;ANKRD28;SKP1;KMT2A;MAGI1;FANCC;AP2M1;APC;CSNK1D;ZC3H12A;MDN1;TIAM1;PDCD6;DMD
prerank,gene expression (GO:0010467),0.36793556808028105,1.1736198412175627,0.1091091091091091,0.7542074770619958,1.0,107/348,20.31%,NKX2-8;MAGOH;MAGOHB;GSPT2;DDX20;CHTOP;SLBP;MRPL18;THAP1;RRAGC;MRPL51;RPL31;POLR2J;WARS1;NUP153;HNRNPK;HNRNPD;RPS15;RPL3;HNRNPU;NDC1;RPL13A;FUBP3;RPL15;RPL10;ANGPT2;SARS1;RPS8;DDX54;MRPS6;MRPL28;RBPMS;RPS27A;RPL9;TSPAN14;RPL22;BAZ2A;SMG7;U2AF2;RBM39;SORL1;NUP88;RPS21;RPL23A;NXF1;SRSF2;U2AF1;PWP1;NCBP1;MRPS12;RPL34;NUP210;FIP1L1;NUP37;DEDD2;RRBP1;RPSA;HNRNPL;MRPS7;MRPL37;RPS14;MRPL41;MRPL27;TNIP1;STUB1;POLR2E;DROSHA;HNRNPH1;SETX;NUP98;RPL27;POLR2B;SYMPK;EIF4E;ADARB1;NUP54;RBM8A;RPL8;HSPD1;SNRNP40;POLR2G;MEF2A;RPS24;PRPF4;UPF1;ALKBH5;PPP5C;MED20;RPL38;TSPAN32;RPL27A;EEF1A1;POLR2K;RPLP1;COPS5;RPL17;RPL23;MRPL23;RANBP2;THRB;HARS2;MRPL3;RPS11;AGO2;SRSF7;YTHDC1;MRPS18A
prerank,prostanoid biosynthetic process (GO:0046457),0.5129714498663771,1.1736145226959538,0.28205128205128205,0.7534741160928912,1.0,5/15,15.23%,PLA2G4A;PTGDS;PTGES3;TBXAS1;PNPLA8
prerank,macrophage activation involved in immune response (GO:0002281),0.5405093986646584,1.1736125925920378,0.2826747720364742,0.7527297395850953,1.0,2/13,4.18%,TYROBP;SBNO2
prerank,monocyte differentiation (GO:0030224),0.5571690589427559,1.1732188312076697,0.31092436974789917,0.7532243591033341,1.0,2/10,4.61%,MYH9;MT1G
prerank,regulation of lipid metabolic process (GO:0019216),0.397004349025734,1.1731554771016879,0.218851570964247,0.7526818758639582,1.0,26/88,17.42%,DISP3;THRSP;TGS1;NFYA;MID1IP1;NR1D2;APOC1;ADIPOR1;BBS4;TBL1X;CREBBP;ACACA;PSAP;GPS2;HMGCS1;RORA;ZFP69;NCOR1;PLPP1;MED1;SC5D;SIN3A;OPA3;RXRA;NFYC;CERS2
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3856249220956868,1.1731128218700178,0.21274298056155508,0.7520648279606531,1.0,20/100,15.04%,SELP;OSM;PDGFRB;PDGFA;SOX9;PPP2R5B;PIK3R1;PDGFB;AGT;NLRC3;IER3;SIRT1;PIK3IP1;IL18;PTPN6;IGF1;ENTPD5;ROR1;PPP1R16B;HGF
prerank,glycolipid metabolic process (GO:0006664),0.4161351589988256,1.1729410781338034,0.25060827250608275,0.7518816758127908,1.0,14/47,17.54%,B4GALNT1;ARSA;GLB1;GBGT1;ST8SIA6;NAGA;SMPD3;CTSA;SMPD1;SUMF1;PSAP;SMPD4;ST3GAL6;FUCA1
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.4475218801832244,1.1728973112229932,0.27413127413127414,0.7512593974764257,1.0,5/31,8.25%,BAMBI;SOX9;CRIM1;TRPM4;CDK6
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.4717477685289686,1.1728859985024847,0.2832214765100671,0.7505484695008758,1.0,6/22,9.57%,VPS4A;VPS28;RNF115;VPS37B;STAM;TOM1L1
prerank,regulation of monocyte chemotaxis (GO:0090025),0.4815437664915443,1.172872947323579,0.2868741542625169,0.749860615446108,1.0,4/24,6.40%,SERPINE1;HMGB1;CREB3;CXCL17
prerank,negative regulation of bone remodeling (GO:0046851),0.5432297319856773,1.1727069685801383,0.3073322932917317,0.7496710745506098,1.0,4/11,16.72%,CALCA;IL6;TNFAIP3;GPR137B
prerank,tRNA metabolic process (GO:0006399),0.510918745968862,1.1724626212455107,0.3039647577092511,0.7497239615018918,1.0,4/17,11.52%,KARS1;SARS1;RPP30;POP1
prerank,kinetochore organization (GO:0051383),0.5405368092129889,1.1724463751102985,0.31504702194357365,0.7490554086096143,1.0,5/13,17.04%,MIS12;DLGAP5;NDC80;CENPC;POGZ
prerank,histone monoubiquitination (GO:0010390),0.4731402979848627,1.1724061533061223,0.28897849462365593,0.7484467638961826,1.0,9/24,20.46%,DDB2;RNF20;RYBP;UBE2E1;DDB1;SKP1;CTR9;KDM2B;RNF40
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.4349833433867006,1.171964781495512,0.2537688442211055,0.7491456467248477,1.0,10/39,9.99%,PI4KA;PIK3R3;SOCS6;ITPKC;PIK3C3;PIK3R1;EFR3B;ITPKB;PI4KB;IP6K2
prerank,regulation of cell growth (GO:0001558),0.37386529166888155,1.1712635264031348,0.16194331983805668,0.7506516377924846,1.0,37/204,14.89%,LTBP4;SESN2;NAIF1;TMC8;DERL2;ADAM17;SERTAD3;DDX49;FAM107A;TGFBR1;CCDC85B;RTN4;EGLN2;SDCBP;TSPYL2;AGT;JADE1;AKAP6;PPT1;PSMD10;ACVR1B;SIRT1;SLC25A33;CAPRIN2;IP6K2;NCBP1;ING1;TAOK2;HPN;DNAJB2;EIF4G2;BCL6;NDUFA13;CXCL16;NME6;VGLL4;MTOR
prerank,ribonucleoprotein complex assembly (GO:0022618),0.3812239377722895,1.1706158746209057,0.1886993603411514,0.7520101591877475,1.0,47/132,20.49%,DDX20;KHDC4;RPS15;TGS1;RPL3;HSP90AB1;TARBP2;PRPF18;RPL10;NOP2;RRP7A;RAMAC;EIF6;EIF3A;XRCC5;PTGES3;DHX9;RPL23A;CPSF6;GEMIN7;GCFC2;SRSF10;NCBP1;RPSA;SCAF11;DENR;MRPS7;RPS14;SF3A2;SRPK2;SETX;SNRPG;MCTS1;SART3;ZRSR2;ERAL1;MDN1;RPL38;SNUPN;STRAP;SNRPD2;SNRPD1;USP39;SF1;YTHDC1;PRPF6;BOP1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.5178258818348142,1.170483552474493,0.29185185185185186,0.7516887445253999,1.0,1/15,0.11%,KCNK4
prerank,regulation of TORC1 signaling (GO:1903432),0.44498888887484295,1.1704567918743363,0.26605504587155965,0.7510406038516168,1.0,9/33,16.72%,SESN2;CASTOR1;RRAGC;ITFG2;LARS1;GPR137C;DGKQ;FLCN;GPR137B
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.46726738086248054,-1.1699526323412277,0.25925925925925924,1.0,1.0,6/12,21.29%,ABCA1;ITGAV;PPARG;ABCA5;ABCG1;NR1H2
prerank,monocarboxylic acid metabolic process (GO:0032787),0.3875635754454383,1.169860062037115,0.20718816067653276,0.7522179666324612,1.0,18/117,12.78%,ALDH8A1;SLC6A8;LPL;PDZD11;SLC16A3;ACSF3;MTHFD1L;SLC16A1;GATM;SCPEP1;AGXT;PDHA1;HAGH;MSMO1;GOT2;ABAT;IGF1;PCCA
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.5035452451710437,1.169562521306469,0.27177177177177175,0.7524710836119352,1.0,6/17,11.13%,ARL6IP5;EIF2AK2;CARD9;SEMA4C;MID1;TAOK2
prerank,protein sumoylation (GO:0016925),0.41693736772485257,1.1692139482885007,0.2581032412965186,0.7528012270801985,1.0,12/49,12.23%,EGR2;NUP153;NDC1;TRPM4;TRIM28;BCL11A;NUP88;SUMO1;RANGAP1;NUP210;NUP37;UBE2I
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.3450807391810231,-1.169144548643356,0.21171171171171171,1.0,1.0,12/33,10.68%,NCOA2;KLK2;UFSP2;KDM4C;CARM1;AXIN1;UBA5;SAFB2;H3-3A;RNF6;EP300;DDRGK1
prerank,regulation of amyloid-beta clearance (GO:1900221),0.510986743263207,1.1690070897117102,0.28193832599118945,0.7527261852157822,1.0,4/16,11.94%,APOE;LRP1;HDAC1;CLU
prerank,regulation of cytokine production (GO:0001817),0.38053309309907796,1.1688810166393164,0.1946808510638298,0.752404930835133,1.0,30/126,17.87%,MAPKAPK2;SRGN;EIF2AK2;PLD3;SIRPA;TBK1;CADM1;TRIM56;AGT;GLMN;FOXP1;CARD9;IL1A;PTPRC;IRF8;MOG;C5AR2;BCL6;NPTN;TRAF3;SLC11A1;LGR4;IL6;TNFRSF1B;FLOT1;MAST2;PER1;KAT2A;GPNMB;PIK3CG
prerank,metanephric mesenchyme development (GO:0072075),0.567940735734776,1.168479419155878,0.28731942215088285,0.7530057216696684,1.0,1/10,0.53%,BASP1
prerank,phagolysosome assembly (GO:0001845),0.5236681648692193,1.1683700316002565,0.3080495356037152,0.7526543382977103,1.0,4/12,17.56%,RAB7B;ARL8B;CORO1A;RAB7A
prerank,cellular component assembly (GO:0022607),0.365305956419363,1.1680190189536248,0.140973630831643,0.7531116160701486,1.0,58/253,17.19%,MICAL1;BAG6;SHANK1;LCP1;TLCD2;LLGL1;ADD1;LIMA1;ACD;PDGFA;WDR19;SOX9;FBLIM1;PICALM;RIMS1;FAM107A;NIFK;BAIAP2L1;MDM4;RHOG;RTN4;RSPH9;NCKAP1;CFAP46;RHOU;SH3BP1;SKAP2;PTK2B;CD2AP;CYFIP1;RHOQ;ACTG1;ST13;CREBBP;BAIAP2;TSPAN4;MITF;MYO9A;GORASP2;SLC2A1;LIMS1;FLNA;AFG3L2;TUBGCP4;WIPF1;ACTB;KMT2A;MAGI1;RAC1;FANCC;ZFYVE27;YTHDF2;APC;GPM6B;ILK;SYCE2;YWHAZ;RAD21
prerank,regulation of cell migration (GO:0030334),0.36344340406329206,1.1678168923664956,0.11022044088176353,0.7530508339050812,1.0,87/382,19.49%,CCL3;SEMA3G;CORO1C;CSF1;STAT3;PDGFRB;EPHA1;DLG5;SEMA4G;PLXNA1;ADAM17;WNT5B;PIK3R3;SERPINE1;PDGFA;TCAF1;RNF20;RUFY3;ADAM9;FAM107A;SEMA6D;RHOB;CLIC4;TGFBR1;ELP3;COL1A1;SDCBP;PDGFB;SEMA6A;JAG1;MYO1C;MGAT5;PTK2B;SORL1;CYRIB;ENG;F3;SUN2;SEMA4C;ACTG1;PPM1F;TMSB4X;SPAG9;MITF;GTPBP4;DOCK10;HSPA5;PTPRU;LIMCH1;IGF1;SRGAP2;SRGAP3;DPEP1;FOXO3;GCNT2;CXCL16;FLNA;HGF;ADARB1;LDB2;LDB1;RAC1;FLCN;SEMA3A;FGF9;APC;SOD2;SMO;GPNMB;TBCCD1;CTNNA2;ACVR1;CPNE3;NUMB;DAG1;SEMA3D;TIAM1;TTBK2;LDLRAD4;CDH13;SGK1;DUSP3;MMP14;SERPINE2;CSF1R;PLXND1;RAP2B
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.5211365542026658,1.1677189537970463,0.3010590015128593,0.7526457196875291,1.0,1/14,0.31%,CCL2
prerank,glycoprotein catabolic process (GO:0006516),0.5017265467156183,1.1668610883088382,0.28720238095238093,0.7547028356561578,1.0,2/17,1.61%,ADAMTS12;CTSL
prerank,peptide biosynthetic process (GO:0043043),0.3798316575514343,1.1667122219710009,0.20062047569803515,0.754481945953085,1.0,50/153,20.80%,GSPT2;MRPL18;MRPL51;RPL31;WARS1;RPS15;RPL3;RPL13A;RPL15;RPL10;SARS1;RPS8;MRPS6;MRPL28;RPS27A;RPL9;RPL22;RPS21;FURIN;RPL23A;PCSK1;MRPS12;RPL34;RRBP1;RPSA;MRPS7;MRPL37;RPS14;MRPL41;MRPL27;TNIP1;RPL27;RPL8;RPS24;RPL38;DMD;RPL27A;EEF1A1;RPLP1;COPS5;RPL17;RPL23;MRPL23;HARS2;MRPL3;RPS11;AGO2;MRPS18A;RPS26;RPL36
prerank,regulation of secretion by cell (GO:1903530),0.41007145249565663,1.1665345835784298,0.2540792540792541,0.7543342135200596,1.0,12/54,15.93%,LLGL1;RHBDF2;RIMS1;RAB8B;DNAJC1;RIC1;STXBP5L;SNCAIP;NSF;FMR1;SYT1;STXBP5
prerank,protein targeting to peroxisome (GO:0006625),-0.35116984685555513,-1.166521320807477,0.21755725190839695,1.0,1.0,11/29,17.42%,LONP2;SLC25A17;ABCD3;ABCD2;PEX6;ALDH3A2;PEX13;ATAD1;PEX19;FIS1;PXMP4
prerank,blood vessel diameter maintenance (GO:0097746),0.445731881033156,1.1661699479488699,0.2748091603053435,0.7546863113795113,1.0,4/34,8.07%,SERPINF2;SCPEP1;AGT;KCNMB2
prerank,potassium ion import across plasma membrane (GO:1990573),0.43903392954416703,1.1660917228270242,0.27625,0.754212005997585,1.0,6/41,9.67%,KCNH2;KCNJ6;KCNK9;KCNJ2;SLC12A6;ATP1B1
prerank,defense response to fungus (GO:0050832),0.49055993515386126,1.1657676329273459,0.2888243831640058,0.7545051241947922,1.0,2/17,7.64%,CLEC4E;CARD9
prerank,regulation of interferon-beta production (GO:0032648),0.42541132329887554,1.1654825442077976,0.26431181485992694,0.7546940329391156,1.0,18/46,19.58%,RELB;SIRPA;TBK1;TRIM56;NLRC3;POLR3B;DHX9;TLR7;PYCARD;RIPK2;POLR3F;TRAF3;PTPRS;FLOT1;RIOK3;PPM1B;TLR2;RNF216
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.4387544259559471,1.1654307028434734,0.26282051282051283,0.75412960258163,1.0,4/36,6.25%,CSF1;ADAM17;CXCR4;CASP4
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.4424394117174703,1.1654006017717273,0.2828282828282828,0.7534989634144351,1.0,4/39,5.25%,CCL2;NFE2L2;SERPINE1;KRIT1
prerank,natural killer cell mediated immunity (GO:0002228),0.522716747614766,1.1651877477232988,0.2947813822284908,0.7534795893640027,1.0,4/15,14.80%,PLEKHM2;TUBB;RAET1E;ARL8B
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.44573541574192566,-1.1650862957379515,0.258160237388724,1.0,1.0,6/13,15.05%,PKD1;SUFU;GOPC;YWHAB;KEAP1;PKD2
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5102022636209231,1.1648563659752877,0.291981845688351,0.7538421755718548,1.0,8/16,17.27%,PIGX;PIGQ;PIGN;PIGM;PIGP;DPM2;PIGF;PIGC
prerank,plasma membrane invagination (GO:0099024),-0.348575884391365,-1.1643974386608744,0.23236514522821577,1.0,1.0,9/29,10.54%,RHOA;DOCK1;SNX9;MSR1;GSN;BIN2;FCGR2B;SNX18;VAMP7
prerank,response to nutrient levels (GO:0031667),0.5126285191549905,1.1643329392812427,0.28634361233480177,0.7548700425250313,1.0,5/17,18.47%,ATF4;FAM107A;MTOR;RPTOR;PRKAA1
prerank,regulation of phospholipase C activity (GO:1900274),0.5126698105461633,1.1641535756966401,0.3073463268365817,0.754690333653779,1.0,2/15,4.45%,PDGFRB;ABL2
prerank,establishment of protein localization to membrane (GO:0090150),0.40250830714588737,1.163873692685465,0.25838926174496646,0.7548478172711783,1.0,15/66,13.22%,NACAD;BID;NECTIN3;ARL6;RABGEF1;ZDHHC9;VPS37B;SDCBP;ZDHHC7;MYO1C;ZDHHC3;ZDHHC21;TAOK2;CHM;GORASP2
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.504556578959081,1.1637955499447867,0.2948148148148148,0.7543868668336102,1.0,5/16,17.81%,ZFP36;TARDBP;RC3H1;ZC3H12A;UPF1
prerank,positive regulation of organelle assembly (GO:1902117),0.42616108622031323,1.163582083516266,0.265281173594132,0.7543537884249554,1.0,10/44,8.68%,LCP1;PDCD6IP;SDC4;ASAP1;SDCBP;CROCC;BBS4;RALB;CNOT6;TAPT1
prerank,positive regulation of positive chemotaxis (GO:0050927),0.5150205694934141,1.163537228924197,0.3026706231454006,0.7537805613677897,1.0,5/15,18.78%,VEGFC;F3;PGF;CDH13;VEGFB
prerank,endothelial cell proliferation (GO:0001935),-0.4005824000545677,-1.1634086023882915,0.23076923076923078,1.0,1.0,8/17,20.92%,SEMA5A;BMPR2;CD34;BMPER;DLG1;HMOX1;ITGB1BP1;ACVRL1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.41994306424850725,1.1632838794023805,0.26181818181818184,0.7538835445797837,1.0,16/48,17.96%,TRIOBP;C1QBP;CDKL3;SS18L2;CAPRIN2;PTPRD;CDKL5;SS18L1;P4HB;CRK;LIMS1;FLNA;RAC1;CUX1;ILK;CALR
prerank,outer dynein arm assembly (GO:0036158),-0.43092278121746586,-1.1630487630744668,0.2636103151862464,1.0,1.0,11/15,52.37%,DNAL1;DNAAF5;ODAD1;DNAH8;LRRC49;DNAH5;ODAD2;ODAD4;ODAD3;DNAH17;DNAAF1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.48523645739205934,1.1627052259884785,0.3028571428571429,0.7549940719786968,1.0,5/19,11.07%,ACD;HNRNPU;GNL3L;STN1;EXOSC10
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.512179871235309,1.162630885044598,0.2939346811819596,0.7545162860458668,1.0,3/14,7.01%,TPP1;ACD;XRCC5
prerank,lipid droplet formation (GO:0140042),-0.4949916082100241,-1.1623883029079403,0.2918918918918919,1.0,1.0,5/10,42.31%,CDS1;SQLE;AUP1;FITM2;PLA2G4C
prerank,folic acid-containing compound metabolic process (GO:0006760),0.4816686096788678,1.1622974325620368,0.2949438202247191,0.75487246692394,1.0,4/19,11.67%,SHMT2;MTHFD1L;MTHFD2;FPGS
prerank,protein O-linked glycosylation (GO:0006493),0.38820086331578596,1.161962593384832,0.2326086956521739,0.7552378930283639,1.0,19/96,11.64%,ST6GALNAC2;POFUT2;FKRP;ST8SIA6;GALNT6;TRAK1;TET2;POFUT1;POMGNT1;DPM1;GALNT10;TET1;MGAT5B;B3GALNT2;GALNT1;XXYLT1;B4GALT5;GALNT15;GALNT7
prerank,positive regulation of metabolic process (GO:0009893),0.38124675977792294,1.1619342211025803,0.2297872340425532,0.7546205044291571,1.0,25/103,18.76%,KDM6B;DISP3;CXCR4;GATM;GNAS;ADIPOR1;ACLY;CMKLR1;EBF2;STAT6;ZBTB7B;KSR2;IL18;KDM1A;ACACA;TRPV2;IL4R;PRKAB1;ADRB2;ADIPOR2;APC;CEBPB;ELOVL6;EPAS1;GJA1
prerank,cytoplasmic translational initiation (GO:0002183),0.4987377832313393,1.161674523499671,0.28717201166180756,0.7547498326844944,1.0,7/17,16.99%,EIF3I;EIF4A1;EIF3A;EIF4A2;DENR;MCTS1;EIF2B3
prerank,covalent chromatin modification (GO:0016569),0.5119390190025181,1.161379467530663,0.30568356374807987,0.7549461803211435,1.0,5/14,11.19%,SIRT1;HDAC1;CHD1;PARP2;UFL1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.37984874979817074,1.161327017030693,0.22727272727272727,0.7544148144626487,1.0,27/114,15.39%,LTBR;ADAM17;PSMD2;TNFSF13B;PSMC4;IKBKB;RELA;PSMD4;PSMD1;PSME3;PTK2B;PSMB6;PSMD10;PYCARD;PSMB1;TMSB4X;PSMD11;PYDC1;TXNDC17;PSMA2;PSMD13;PSMB10;FOXO3;TRAF3;LIMS1;PSMB3;TNFRSF1B
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.565963601734292,1.161165687719115,0.3300813008130081,0.754254690132009,1.0,3/11,13.96%,SERPINF2;CD200;ATP6AP2
prerank,protein monoubiquitination (GO:0006513),0.43162857524048187,1.160967269895147,0.2844155844155844,0.7541846276354374,1.0,7/36,9.49%,CUL3;RNF20;UBE2T;UBE3D;KLHL12;UBE2E1;UBE2D3
prerank,cytokine-mediated signaling pathway (GO:0019221),0.36121190854442503,1.1607290139337916,0.081,0.754285179602203,1.0,106/532,17.24%,CCL3;MYC;OSM;CCL4;CCL2;EGR1;CSF1;STAT3;LMNB1;BCL2L1;IL1R1;LTBR;LCP1;SQSTM1;ADAM17;NDN;PSMD2;IL34;TNFSF13B;COL1A2;PSMC4;FBXW11;IKBKB;RELA;PSMD4;ABL2;SOCS6;CSF2RA;PSMD1;HSPA8;RPS27A;UBC;ADIPOR1;IFITM3;PIK3R1;SNRPA1;PDGFB;RHOU;PSME3;STAT6;IFNAR1;PTK2B;CAMK2G;PSMB6;IL1A;PSMD10;SIRT1;SPI1;IL17RA;STX3;PELI3;F3;PYCARD;MSN;IP6K2;IL27RA;RIPK2;PSMB1;IRF8;MID1;IL18;TMSB4X;PTPN6;SOX2;PSMD11;PYDC1;TXNDC17;PSMA2;PSMD13;CCR5;ANXA2;IRAK2;P4HB;CCL25;PSMB10;FOXO3;CCL13;CRK;BCL6;RORA;IL4R;IL10RB;TRAF3;FCGR1A;LIMS1;PITPNA;S1PR1;SOS1;IL6;HGF;PSMB3;TNFRSF1B;CD86;ADIPOR2;SKP1;MT2A;IRF9;CSF2RB;NFKB1;IFNAR2;TEC;ILK;SOD2;YWHAZ;PSMC1;ICAM1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.3942105759537346,1.1604742626927884,0.2332955832389581,0.7543717592446935,1.0,29/78,22.21%,ARIH2;NFE2L2;GABARAP;PRICKLE1;USP5;TAF1;TRIB2;CSNK1E;PSMD10;SUMO1;COP1;SIRT2;CLU;DNAJB2;RNF144A;RNF19B;STUB1;ARIH1;CSNK1D;CEBPA;PLK3;ANKIB1;HECTD1;TRIB1;VCP;CSNK1A1;HSPBP1;RNF19A;HERPUD1
prerank,actin crosslink formation (GO:0051764),0.544415233069679,1.1603144220278654,0.30577223088923555,0.7541571952484757,1.0,4/12,14.70%,LCP1;BAIAP2L1;BAIAP2;FLNA
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.2742654864607227,-1.1600017962967348,0.11666666666666667,1.0,1.0,20/104,9.74%,RHOA;LRP6;CCNT2;CAB39;GTF2H1;CCND3;TSG101;CDK7;PDCD10;CALM2;MAP2K2;CALM1;SNF8;MNAT1;BLM;CDKN1B;SLC8A3;IRGM;CCNG2;SLC8A1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.44650959806965385,1.159915493894675,0.2763496143958869,0.7546869191614651,1.0,12/32,18.69%,NEK7;ACD;MAP2K7;XRCC5;CCT8;CTNNB1;CCT7;HMBOX1;FBXO4;CCT6A;HNRNPA1;MAP3K4
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.5249862951242901,1.1596804854524474,0.2839313572542902,0.7547159370991531,1.0,6/12,22.98%,STAT3;NCOR1;IL6;ZC3H12A;ESR1;TGFB1
prerank,ribosomal large subunit biogenesis (GO:0042273),0.4100249480004657,1.1595966547789114,0.2543757292882147,0.7542790039384928,1.0,11/54,9.01%,GTF3A;RRP15;PES1;RPL3;MALSU1;RPL10;NOP2;LTO1;EIF6;RPL23A;NVL
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.3770962352639763,-1.1595584349056414,0.23430962343096234,1.0,1.0,8/23,9.85%,PPP1R13B;CASP8;NMT1;YWHAH;YWHAQ;TFDP2;PPP3CC;YWHAB
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.3770962352639763,-1.1595584349056414,0.23430962343096234,1.0,1.0,8/23,9.85%,PPP1R13B;CASP8;NMT1;YWHAH;YWHAQ;TFDP2;PPP3CC;YWHAB
prerank,regulation of heart contraction (GO:0008016),-0.2769543107865137,-1.1591422870126558,0.14942528735632185,1.0,1.0,25/90,22.11%,CELF2;TMEM65;ITPR2;CALM2;ATP1B3;ATP2A2;ANK2;CALM1;STIM1;PRKACA;SLC8A3;SLC8A1;TPM1;SRI;ITPR1;ATP1A2;ATP1B2;GSK3A;PDE4D;CALM3;ATP2B1;ADORA3;ATP2B3;TGFB2;ITPR3
prerank,cellular amino acid catabolic process (GO:0009063),0.38460108984428565,1.1591011599429322,0.2372697724810401,0.7551853755612752,1.0,15/87,14.48%,BCAT2;SHMT2;CARNMT1;BCKDK;HMGCL;GLS2;GLS;SLC25A21;GLUD1;GOT2;ACAD8;ABAT;ACAT1;OGDH;GOT1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.3339199195310968,-1.158962693604401,0.21,1.0,1.0,10/39,14.66%,CACNA1D;WWP2;FGF12;ANK2;YWHAH;UTRN;RIPK1;WNK3;GPD1L;FXYD5
prerank,cellular response to interleukin-6 (GO:0071354),-0.36171683948077477,-1.1587802086707446,0.1791044776119403,1.0,1.0,7/26,3.17%,PID1;JAK2;IL6R;CBL;FER;STAT1;SELPLG
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.526042354033572,1.1586241135324447,0.29673590504451036,0.7559960688450335,1.0,5/14,14.15%,C1QBP;U2AF2;SRSF10;SRSF12;PTBP1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.4940858257727126,1.1584791848365996,0.2916666666666667,0.7557185926372098,1.0,6/17,20.06%,BCL2L1;BID;BAD;CLU;SOD2;MFF
prerank,negative regulation of hippo signaling (GO:0035331),0.5319092874582727,1.1581156128727377,0.3090062111801242,0.7561500863073101,1.0,5/12,14.77%,DLG5;MAP2K3;WWC2;CIT;VGLL4
prerank,negative regulation of interleukin-2 production (GO:0032703),0.4954633298069595,1.158078082159461,0.29300291545189505,0.7555576502427148,1.0,4/18,9.29%,ZFP36;KAT5;PTPRC;PRNP
prerank,snRNA processing (GO:0016180),0.5023401225639781,1.1580392258740477,0.30335365853658536,0.7549780216800454,1.0,6/16,12.05%,INTS9;INTS6;INTS10;INTS14;TUT1;INTS8
prerank,hematopoietic stem cell proliferation (GO:0071425),0.5487558691196541,1.1574773968452388,0.32018927444794953,0.7560862417541627,1.0,4/11,16.80%,ARIH2;RUNX1;YTHDF2;ETV6
prerank,aerobic respiration (GO:0009060),0.48168427127669716,1.1571037547358165,0.28854314002828857,0.756565440361245,1.0,6/20,17.61%,SURF1;UQCRC1;UQCRB;ATP5F1D;MTFR1L;SLC25A14
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.43345641260207346,1.1569927231748913,0.2685069008782936,0.7562014438179429,1.0,5/39,7.33%,MYO1E;NDEL1;FBXW11;TRAK1;MYO1C
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.37470278657862643,1.1563445457102037,0.23979057591623038,0.7574667531709349,1.0,36/129,17.34%,BAMBI;JRK;PSMD2;PIN1;PSMC4;PSMD4;PSMD1;TMEM9;COL1A1;JUP;TRPM4;PSME3;CSNK1E;PSMB6;PSMD10;TBL1X;CAPRIN2;PSMB1;DKK2;CSNK1G2;PSMD11;PSMA2;GPC5;PSMD13;CSNK1G3;PSMB10;ATP6AP2;USP8;LGR4;PSMB3;NFKB1;ILK;LRRK1;CSNK1D;PSMC1;UBR5
prerank,regulation of epidermal cell differentiation (GO:0045604),0.4818307089923728,1.1562825574544497,0.2916666666666667,0.7569812414937105,1.0,4/21,10.29%,CTSL;ZFP36;MAFG;KLF7
prerank,JNK cascade (GO:0007254),0.4307290698137841,1.156278790698855,0.27305825242718446,0.756291002244976,1.0,11/40,13.07%,MAPK10;MAP2K7;RPS27A;UBC;ARHGEF6;MAP4K2;MAPK8;RIPK2;IRAK2;MAP4K3;GPS2
prerank,regulation of RNA metabolic process (GO:0051252),0.4022591155070758,1.156141345912857,0.2600229095074456,0.7560390770071393,1.0,19/59,16.59%,FUS;FASTK;AFF2;HNRNPH2;RRP1B;PTBP2;PCBP2;RBM38;CLK4;RC3H1;MITF;RC3H2;HNRNPL;HNRNPH1;PTBP1;MED1;TNFRSF1B;HNRNPLL;YTHDF2
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.3606206459997867,-1.1557175639203363,0.23550724637681159,1.0,1.0,7/26,14.52%,ST3GAL2;B4GALT6;B3GNT2;B4GALT1;ST3GAL4;B4GALT4;B4GALT3
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.5361358424610113,1.155683161087272,0.3108320251177394,0.7567867423009218,1.0,2/11,10.09%,AKAP6;ALG10B
prerank,embryonic digit morphogenesis (GO:0042733),-0.40144468588744675,-1.15549424913776,0.2572463768115942,1.0,1.0,5/18,16.75%,SALL1;WDPCP;HDAC2;ECE1;INTU
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.5225644260031632,1.1553946400281487,0.2898550724637681,0.7569874976937709,1.0,3/13,13.17%,ADAM8;TOX;CLPTM1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.48197302899661165,1.1552528458024849,0.2750352609308886,0.7567472234385942,1.0,2/21,2.74%,MAD2L1;UBE2S
prerank,peptidyl-proline hydroxylation (GO:0019511),0.541732008990313,1.1551211259125722,0.3192868719611021,0.7564668424564357,1.0,5/11,21.31%,CRTAP;EGLN2;P4HB;OGFOD1;P4HA1
prerank,DNA damage checkpoint signaling (GO:0000077),-0.3489055940529615,-1.1551169844149705,0.23673469387755103,1.0,1.0,17/28,32.43%,CHEK2;CLOCK;TIPRL;ERCC6;CDC5L;ATRIP;RHNO1;ATR;CEP63;USP28;RAD9A;DONSON;HUS1;CLSPN;E2F1;STK33;RAD1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.4522187367302279,-1.1549559594144265,0.28362573099415206,1.0,1.0,5/12,21.55%,EPHB1;MYCBP2;EPHB2;SZT2;EPHA4
prerank,protein deacylation (GO:0035601),0.4613090337245262,1.154763152912589,0.28779840848806365,0.7568891908618625,1.0,7/23,11.25%,HDAC6;PPT1;SIRT1;HDAC1;SIRT5;HDAC5;SIRT2
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.47679096169823565,1.1545876664903092,0.2918395573997234,0.7567123100884545,1.0,5/21,14.70%,KCNH2;CACNA2D1;AKAP9;SCN1B;FLNA
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.4368135751165858,1.1545090187780211,0.2801556420233463,0.7562584665604655,1.0,6/37,6.41%,BAG6;UCHL5;HSP90AB1;RYBP;TAF1;SDCBP
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.37005972160351264,1.1544251577671034,0.2303719008264463,0.7558468191448917,1.0,41/152,17.34%,BAMBI;JRK;WNT5B;PSMD2;PIN1;PSMC4;PSMD4;PSMD1;TMEM9;COL1A1;JUP;TRPM4;PSME3;CSNK1E;PSMB6;PSMD10;ZRANB1;TBL1X;CAPRIN2;ATP6V0C;PSMB1;DKK2;CSNK1G2;PSMD11;PSMA2;GPC5;PSMD13;CSNK1G3;PSMB10;ATP6AP2;USP8;SULF2;LGR4;PSMB3;TNFAIP3;NFKB1;ILK;LRRK1;CSNK1D;PSMC1;UBR5
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.37238456808554926,1.1543932138609572,0.2121524201853759,0.7552590959425621,1.0,18/150,10.68%,CCL3;OSM;PDGFRB;ADAM8;C1QBP;RICTOR;PDGFA;HSP90AB1;TGFBR1;RHOG;RTN4;PIK3R1;PDGFB;TCF7L2;ENG;F3;OSBPL8;IL18
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.4319242420221828,1.1540326965324543,0.2770780856423174,0.755691177489462,1.0,10/39,11.47%,STAT3;MAML3;ZMIZ1;BMP2K;TSPAN14;JAG1;CREBBP;RBPJ;NEPRO;MAML1
prerank,leukotriene metabolic process (GO:0006691),0.484395969640539,1.1540261875883882,0.26788218793828894,0.7550221752846893,1.0,2/19,4.37%,MAPKAPK2;PLA2G4A
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.431317780795163,1.1532252128165807,0.27365728900255754,0.756851031330791,1.0,11/38,19.27%,EPHA2;INPP5K;OTUD3;PPP2R5B;SIRT1;PHLPP1;FLCN;DAG1;PDCD6;DDIT3;TSC2
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.4225151408055685,1.1529200567416509,0.29936305732484075,0.7571090759288496,1.0,7/40,11.28%,PRELID1;BCL2L1;ARL6IP5;SLC25A33;SLC25A36;PPA2;BAD
prerank,regulation of spindle assembly (GO:0090169),-0.3688695070287848,-1.152815234037098,0.22813688212927757,1.0,1.0,12/25,23.91%,SENP6;DRG1;NUMA1;TPR;VPS4B;CHMP3;CHMP2B;EML3;CHMP1A;GPSM2;CHMP4B;CHMP1B
prerank,substantia nigra development (GO:0021762),0.42626791756068305,1.1520774222859964,0.25710754017305315,0.7591326256659233,1.0,11/37,16.54%,BASP1;CNP;ATP5PF;GLUD1;ZNF148;SIRT2;NDRG2;HSPA5;PLP1;ACTB;FGF9
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.5488044479981697,1.152061655842284,0.3275862068965517,0.7584935099457729,1.0,2/10,3.54%,HMGB1;PSMC4
prerank,negative regulation of cellular protein localization (GO:1903828),0.43333221664980504,1.1520287305777404,0.3,0.7578947105853743,1.0,13/34,18.14%,PICALM;SNX33;OTUD7B;LATS1;SPI1;DNAJA1;LZTFL1;ILRUN;FLCN;SIN3A;MAP1A;GPM6B;TTBK2
prerank,plasma membrane repair (GO:0001778),0.5233284296015671,1.1513012418720727,0.30895522388059704,0.7594531244267305,1.0,4/13,14.80%,MYH9;ANXA6;SMPD1;ARL8B
prerank,regulation of protein import into nucleus (GO:0042306),0.42832273419741707,1.1509833218328813,0.28717948717948716,0.7596961893150302,1.0,13/36,19.01%,ZIC1;IPO5;APOD;JUP;PIK3R1;TRIM28;ZPR1;FLNA;UBR5;SMAD3;ZC3H12A;MDFIC;RAN
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.3969593272430504,-1.1506585581629412,0.25705329153605017,1.0,1.0,5/18,1.71%,JAK2;IL6R;CBL;FER;STAT1
prerank,apoptotic cell clearance (GO:0043277),0.4526563968961376,1.150545614625636,0.2751592356687898,0.7603797280419164,1.0,7/30,7.87%,TYROBP;HMGB1;RHOG;ITGB3;XKR8;TXNDC5;LRP1
prerank,positive regulation of innate immune response (GO:0045089),0.4394847462363917,1.1500872950839485,0.29649595687331537,0.7611286256861711,1.0,9/30,17.64%,ADAM8;POLR3B;DHX9;SPI1;AKIRIN2;POLR3F;RIOK3;NLRC5;SLC15A4
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.48889294786978443,-1.1500469377004126,0.3076923076923077,1.0,1.0,4/10,16.42%,SDHAF3;ZNF692;USP7;SELENOS
prerank,endothelial cell migration (GO:0043542),0.4426271740807254,1.1500305252675134,0.2883116883116883,0.7606290116408341,1.0,3/37,1.13%,EGR3;NR4A1;MYH9
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.4411762864485018,1.14941374358796,0.29831387808041504,0.7619176610581668,1.0,8/33,17.24%,NFE2L2;SERPINE1;NUPR1;KRIT1;TCF7L2;WFS1;TNFAIP3;ICAM1
prerank,carbohydrate homeostasis (GO:0033500),0.393215573328039,1.1490837008235915,0.270996640537514,0.7622731526244296,1.0,15/67,18.47%,STAT3;TFAP2B;INPP5K;ADIPOR1;CRY2;TCF7L2;KLF7;BAD;ADCY8;WFS1;IL6;ADIPOR2;MTNR1B;CEBPA;PRKAA1
prerank,negative regulation of protein kinase activity (GO:0006469),0.3884099414353524,1.148706139091319,0.24315443592552027,0.7627313319856202,1.0,18/88,15.28%,CORO1C;EPHA1;WARS1;INPP5K;TARBP2;DUSP19;DBNDD2;TRIB2;SORL1;PTPRC;PYCARD;PPM1F;PYDC1;PTPRO;SH3BP5L;WWTR1;LRP5;ADARB1
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.43632092517514465,-1.1485668167973395,0.2985507246376812,1.0,1.0,5/13,10.71%,SENP6;SAE1;ATG10;UBA5;UBA7
prerank,positive regulation of endocytosis (GO:0045807),0.41271354623920686,1.1485090917780092,0.27195121951219514,0.7626526040095573,1.0,9/45,8.49%,VPS28;CLIP3;HNRNPK;SERPINE1;APOE;RAB31;LRP1;PPT1;SMPD1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.541174855659472,1.1484325691266053,0.3126984126984127,0.7622409276725317,1.0,1/10,0.55%,CD9
prerank,glycoprotein metabolic process (GO:0009100),-0.2962985544805273,-1.1480169078569342,0.2549019607843137,1.0,1.0,15/53,15.35%,GCNT1;NGLY1;ST3GAL2;MANBA;GANC;ST6GALNAC3;ERP44;GOLPH3;HIF1A;ST8SIA1;ST3GAL4;MGAT4B;ENGASE;AGA;MAN1A2
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.478690172846014,1.1480021711901793,0.30080213903743314,0.7629295249453063,1.0,7/21,18.51%,NPPC;ADCY5;AMPD2;ADCY8;ADCY3;ADCY7;ADCY9
prerank,NIK/NF-kappaB signaling (GO:0038061),0.39076128256331083,1.1479646868569529,0.27474972191323693,0.7623662649898342,1.0,19/72,17.13%,RELB;PSMD2;PSMC4;FBXW11;RELA;PSMD4;PSMD1;PSME3;PSMB6;PSMD10;PSMB1;PSMD11;PSMA2;PSMD13;PSMB10;PSMB3;SKP1;ZFP91;PSMC1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.3872819251085929,1.1479249046366584,0.2549450549450549,0.7618125134205017,1.0,26/88,17.13%,FBXL15;PSMD2;PSMC4;FBXW11;PSMD4;PSMD1;FBXL3;PSME3;PSMB6;PSMD10;FBXL8;FBXW4;FBXW5;PSMB1;PSMD11;FBXL5;PSMA2;PSMD13;FBXL17;PSMB10;CUL2;FBXO4;PSMB3;SKP1;CUL4A;PSMC1
prerank,dephosphorylation (GO:0016311),0.3677926244470777,1.1474712144557342,0.22530864197530864,0.7625769525050216,1.0,33/147,13.57%,DUSP5;SGPP2;DUSP16;INPP5K;FBXW11;PPP4R1;PLPPR4;PTPN12;PTPN14;PPP2R5B;CTDSP2;PPP1CB;MTM1;PPP2R5A;MTMR3;PTPRC;PTPRR;CTDNEP1;PTPRD;PPM1F;PTPN4;CTDP1;PTPN6;PTPRU;PTPRO;PTPRA;PPM1G;CTDSP1;PPM1H;PTPRN2;CTTNBP2NL;PPP2CB;PTPRE
prerank,positive regulation by host of viral transcription (GO:0043923),0.5047234481643613,1.1469929809812187,0.30460624071322434,0.763391828087863,1.0,7/15,15.19%,JUN;RRP1B;CHD1;CTDP1;HPN;SMARCB1;CCNT1
prerank,body fluid secretion (GO:0007589),0.502353801926867,1.1468658127016085,0.29508196721311475,0.7630814718175368,1.0,3/15,10.06%,SLC22A4;ZBTB7B;GPAT4
prerank,positive regulation of cell differentiation (GO:0045597),0.36205534125921035,1.1467475587043834,0.17831813576494426,0.7627791954118126,1.0,54/237,18.21%,GDNF;SERPINF2;BAMBI;CSF1;LPL;ZFP36;BLOC1S6;HSP90AB1;SOX9;TGFBR1;TGFBR2;COL1A1;XKR8;GLIPR2;CMKLR1;SDCBP;PRKCH;AGT;TRPM4;BMP6;SLC6A6;CTNNB1;RUNX2;DDR2;PA2G4;IL18;ACVR2B;SPAG9;ATP6AP1;ZC4H2;IGF1;TCF3;GCNT2;CREB1;MTOR;IL6;HGF;WWTR1;LRP5;SYAP1;PAX2;SIN3A;NFKB1;MEF2A;ARHGEF2;CTNNA2;ACVR1;SMAD3;NRCAM;ZC3H12A;EZH2;TIAM1;MEF2C;CEBPB
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.4180464795447425,-1.1465315501676785,0.2785923753665689,1.0,1.0,8/16,31.11%,PARP1;SMG5;NAF1;TNKS;SLX4;RTEL1;PINX1;TINF2
prerank,chondroitin sulfate catabolic process (GO:0030207),0.5261546420505556,1.1465084000855847,0.3194444444444444,0.7628015854812469,1.0,3/13,4.76%,BCAN;NCAN;CSPG4
prerank,negative regulation of cell population proliferation (GO:0008285),0.3588167472394515,1.1463298980492114,0.14543630892678033,0.76268219945395,1.0,69/351,18.68%,MYC;BMP5;OSM;ADAMTS1;TFAP2B;TBRG1;DLG5;CTBP2;WARS1;SOX9;INCA1;KLF11;NUPR1;TOB1;EIF2AK2;APOD;CHD5;NUDT6;MAP2K1;PTPN14;MDM4;TMEM127;ADGRG1;GLMN;NLRC3;GSDME;DNAJA3;PTK2B;IL1A;CDK6;KLF10;PARP10;CTNNB1;PTPN6;GTPBP4;BTG2;SOX2;ZBTB17;CD33;SIRT2;CD200;HPN;PTPRU;CNOT7;DNAJB2;APP;ABI1;VGLL4;MED25;IL6;PLPP1;ING4;ADARB1;CTCF;PBRM1;RAF1;FLCN;TNFAIP3;B4GALT7;APC;SOD2;ZBTB49;GPNMB;ETS1;CDH13;RBBP4;CEBPA;KDM2B;CLMN
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.4604274940911415,1.1457839450628262,0.312,0.7637052779238258,1.0,2/26,1.61%,ADAMTS1;ADAM17
prerank,regulation of lymphocyte migration (GO:2000401),-0.4781220094993462,-1.1457040874390731,0.29736842105263156,1.0,1.0,3/10,6.76%,SLC8B1;STK10;JAM2
prerank,establishment of spindle localization (GO:0051293),0.5172985743262373,1.1455573557134875,0.332824427480916,0.763699607453914,1.0,2/14,5.77%,LLGL1;MAP4
prerank,positive regulation of T cell proliferation (GO:0042102),0.4092005593302324,1.1447514009185442,0.2817229336437718,0.7655325110166998,1.0,11/55,15.46%,SLC7A1;NCK1;HMGB1;PNP;PTPRC;PYCARD;IL27RA;IL18;IGF1;IL6;CD86
prerank,RNA processing (GO:0006396),0.36546502820379984,1.1445396565366237,0.22016460905349794,0.7655074485810384,1.0,49/176,17.95%,MAGOH;MAGOHB;LSM5;DDX20;BCAS2;RRAGC;FUS;HNRNPK;HNRNPD;HNRNPU;PRPF18;TARDBP;DDX54;RBPMS;SNRPA1;TUT7;ZCCHC8;U2AF2;RBM39;CPSF6;SRSF2;U2AF1;NCBP1;SFPQ;DEDD2;TUT1;SCAF11;HNRNPL;PPIG;SF3A2;CDK12;SRPK2;DROSHA;HNRNPH1;AKAP8L;SF3A1;SETX;PTBP1;SNRNP48;SNRPG;ADARB1;RBM8A;ZRSR2;SNRNP40;NONO;HNRNPR;PRPF4;ALKBH5;SF3B3
prerank,negative regulation of interleukin-1 production (GO:0032692),0.4608489344139685,1.1444929543083495,0.3142857142857143,0.7649703455976514,1.0,7/23,17.55%,NLRP3;CARD16;CD33;PYDC1;IGF1;TNFAIP3;ZC3H12A
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.382492749349908,1.1443714094943045,0.26885245901639343,0.7646750763773222,1.0,17/87,16.77%,EGR3;CCL2;NR4A1;ZFP36;POLR2J;HNRNPM;FIBP;NCBP1;GTF2F2;POLR2E;HNRNPH1;SETX;PTBP1;POLR2B;POLR2G;FGF9;HNRNPA1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.4213410373395659,1.1440967951661105,0.28695652173913044,0.7648579255563661,1.0,19/44,21.54%,ZFP36;RIDA;TOB1;CNOT8;RC3H1;BTG2;GIGYF2;CNOT7;POLR2G;YTHDF2;ZC3H12A;FTO;UPF1;TNRC6C;CNOT1;AGO2;METTL3;TNRC6A;CPEB3
prerank,mesenchymal to epithelial transition (GO:0060231),0.5513776941218177,1.143613340527488,0.3028391167192429,0.7656648679685575,1.0,1/10,0.53%,BASP1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.40597965136411396,-1.1435515233266815,0.26851851851851855,1.0,1.0,5/17,15.25%,CDKN1B;PPARG;PTEN;TPM1;TAFA5
prerank,transcription by RNA polymerase I (GO:0006360),-0.3286358101391774,-1.1434659974857861,0.23529411764705882,1.0,1.0,15/34,19.89%,GTF2H1;GTF2H2;CDK7;TAF1D;MNAT1;UBTF;TCOF1;RRN3;TAF1A;MAPK3;POLR1F;GTF2H5;TAF1B;ERCC3;CCNH
prerank,lipid biosynthetic process (GO:0008610),0.3869506479214057,1.1432973340578576,0.2755905511811024,0.765967560418909,1.0,12/77,11.00%,SCD5;LPL;PDSS2;ACSF3;AGPAT4;HSD17B1;FADS1;ACLY;CLN8;GPAT4;LPCAT1;ACACA
prerank,cardiac cell development (GO:0055006),0.5366928330601914,1.1430770008607907,0.3322884012539185,0.7659831789216612,1.0,2/11,7.26%,CXADR;JAG1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.4410252899021622,-1.142780258771008,0.3058823529411765,1.0,1.0,10/14,49.02%,ZEB1;SPRED1;SPRED3;CAV1;NOTCH4;SPRY2;OSR1;SPRY1;SPRED2;GDF3
prerank,regulation of protein catabolic process (GO:0042176),0.37697442757764443,1.142198313282273,0.25327510917030566,0.7680436415549429,1.0,33/99,21.40%,GFAP;MAD2L1;AGAP2;VPS28;ATP13A2;PIN1;MDM4;TMEM9;EGLN2;SMURF1;CTSA;CENATAC;SORL1;FURIN;SIRT2;NSF;DDB1;IDE;NDUFA13;FLNA;STX5;AZIN1;TNFAIP3;APC;RAB7A;SF3B3;EEF1A1;ITCH;VCP;ADGRB1;FOXO1;DAB2IP;AREL1
prerank,negative regulation of stem cell differentiation (GO:2000737),0.5281173460667932,1.1421118063199158,0.319047619047619,0.7676580666961869,1.0,4/12,16.59%,HNRNPU;JAG1;N4BP2L2;YTHDF2
prerank,regulation of vasculogenesis (GO:2001212),-0.41942229558354127,-1.1420865137447072,0.2781065088757396,1.0,1.0,12/14,51.55%,CD34;HIF1AN;TMEM100;CEACAM1;KDR;EMP2;ASB4;HEY1;HEY2;RAPGEF2;RRAS;RIN2
prerank,heterotypic cell-cell adhesion (GO:0034113),0.453465718032393,1.142050215001502,0.30707610146862485,0.7671562669551102,1.0,6/25,11.37%,CXADR;NINJ1;ITGB3;JUP;CD200R1;CD200
prerank,regulation of humoral immune response (GO:0002920),0.41776392589183087,1.1415338183466457,0.3047158403869408,0.7680560818774776,1.0,7/44,13.34%,C1QBP;C4B;CD55;C1QC;CLU;PROS1;C5AR2
prerank,sphingolipid metabolic process (GO:0006665),0.37906814307998893,1.1414117361300966,0.24167561761546724,0.7677696959528917,1.0,27/108,18.41%,ALOXE3;B4GALNT1;SGPP2;PRKD2;ARSA;ELOVL1;SPTSSA;GLB1;SERINC1;DEGS1;SMPD3;CTSA;SGMS1;CLN8;PPT1;SMPD1;SUMF1;CSNK1G2;PSAP;SMPD4;PLPP1;TEX2;SPNS2;CERS2;SGPL1;ELOVL7;ELOVL6
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.33099938245773625,-1.140893067660509,0.24761904761904763,1.0,1.0,18/36,26.62%,PHC3;EED;CBX3;SUZ12;RBBP8;RBBP7;TFDP2;EPC1;PCGF6;MAX;E2F6;BMI1;PHC1;EHMT2;RING1;EHMT1;BRCA1;CDC7
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.38729183563257247,1.140730059854242,0.2541436464088398,0.7691818914200071,1.0,24/87,17.07%,PDGFRB;ARHGDIA;IQGAP3;RICTOR;PDGFA;FAM107A;ABL2;RHOB;RHOG;SH3BP1;LRP1;PTK2B;RHOQ;BAIAP2;TAOK2;EPHA3;TRPM2;CRK;MTOR;ARHGAP17;RAC1;CCDC88A;GPM6B;CORO1A
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.45278238212290123,-1.1407121046013113,0.31496062992125984,1.0,1.0,4/12,5.26%,PARP6;PARP12;PARP1;TIPARP
prerank,regulation of execution phase of apoptosis (GO:1900117),0.5358697650730211,1.1404975562417368,0.31736526946107785,0.7692176905418553,1.0,3/11,17.55%,BCL2L1;SIRT2;ZC3H12A
prerank,negative regulation of mRNA processing (GO:0050686),0.5070001046397106,1.1400597498319165,0.33187134502923976,0.7699129837603652,1.0,5/15,14.15%,C1QBP;U2AF2;SRSF10;SRSF12;PTBP1
prerank,epithelial tube morphogenesis (GO:0060562),0.4380567282644585,1.1399896808963315,0.3155080213903743,0.7694441527453858,1.0,9/32,20.51%,CCM2;PRKD2;RHOB;CTNNB1;SCRIB;ACVR1;MEF2C;CSF1R;PRKX
prerank,positive regulation of endothelial cell migration (GO:0010595),0.3846597398577121,1.1398606212961788,0.2641509433962264,0.7691633381687087,1.0,17/84,11.10%,ADAM17;PRKD2;HMGB1;MAP2K3;RHOB;EMC10;ITGB3;ANXA3;SPARC;PDGFB;AGT;FOXP1;PTK2B;SIRT1;SMOC2;TMSB4X;NRP2
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3932506375021682,1.1398188060904,0.28634850166481685,0.7686149156715281,1.0,12/75,12.09%,KCNH2;KCNJ6;SLC39A14;KCNK9;CACNA2D1;SLC39A8;TRPM4;KCNJ2;SLC12A6;ATP1B1;TRPM2;TRPV2
prerank,negative regulation of B cell proliferation (GO:0030889),0.5323599409511461,1.1394205327466091,0.33124018838304553,0.769169298747844,1.0,2/11,10.61%,TYROBP;RC3H1
prerank,muscle contraction (GO:0006936),0.3691278776719479,1.1393769515196066,0.24552160168598525,0.768616315839729,1.0,10/126,11.40%,TNNI2;MYL12A;SLC6A8;TPM3;TPM4;MYH2;MYL6;DTNA;ASPH;GNAO1
prerank,positive regulation of nervous system development (GO:0051962),-0.31695188626000625,-1.1387307706779273,0.2708333333333333,1.0,1.0,22/42,28.44%,IL1RAP;NLGN1;NRXN1;EPHB1;SNW1;OPRM1;EPHB2;MME;LRRC4B;TGM2;CUX2;CLSTN2;FAIM;RGS14;CX3CR1;NLGN2;NLGN3;SOX11;NUMBL;TRIM32;SPEN;NAP1L1
prerank,organelle fusion (GO:0048284),-0.3772193380885469,-1.138687906457666,0.2427536231884058,1.0,1.0,10/22,22.15%,MFN1;CHCHD3;USP30;MFN2;BAX;FIS1;MIGA2;SPG7;MIGA1;OPA1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.4309071260836703,1.1384833903225235,0.2862547288776797,0.7707888053682601,1.0,10/35,15.16%,PARG;LIG1;PCNA;XRCC1;POLB;MPG;POLD4;ADPRS;TDG;MBD4
prerank,extracellular matrix organization (GO:0030198),0.35760852916884084,1.138168725198844,0.19195979899497487,0.7710240052072072,1.0,33/276,9.86%,SERPINF2;ADAMTS1;ADAMTS12;BCAN;CRTAP;CREB3L1;LCP1;ADAM8;CTSL;LAMA3;LAMA4;NID1;SERPINE1;NCAN;PDGFA;COL1A2;TNR;TGFBR1;ITGB3;SPP1;COL1A1;SPARC;PDGFB;ITGAL;SLC39A8;ADAM19;NOXO1;COLGALT1;FURIN;COL16A1;SMOC2;COL24A1;DDR2
prerank,positive regulation of interleukin-10 production (GO:0032733),0.45298837562903416,1.1373512481536487,0.31158455392809586,0.7728759551812212,1.0,6/30,16.07%,STAT3;HMGB1;PRKCZ;PYCARD;IL6;HSPD1
prerank,regulation of platelet aggregation (GO:0090330),0.4800770386946395,1.137221733950498,0.3073394495412844,0.772600273259092,1.0,1/17,0.55%,CD9
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.5149008650346031,1.1371082833806636,0.3443396226415094,0.772259144706029,1.0,4/12,13.75%,MIS12;NDC80;CENPC;MAD1L1
prerank,neuropeptide signaling pathway (GO:0007218),0.40100597925411224,1.1368269978624084,0.28891509433962265,0.7724949833725229,1.0,4/58,8.32%,NPY;PENK;PPY;SORL1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.525592973798386,1.1366131853543018,0.3201267828843106,0.7724635000109392,1.0,6/12,20.75%,CTSB;CTSL;BRD8;MED1;THRB;LMO2
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.439598227595961,-1.1360809522299018,0.3045822102425876,1.0,1.0,2/13,9.41%,PID1;PPARGC1A
prerank,protein localization to mitochondrion (GO:0070585),-0.46151854922236973,-1.1359135502014606,0.30376344086021506,1.0,1.0,4/11,8.24%,HK2;HK1;RALA;LRRK2
prerank,regulation of cellular metabolic process (GO:0031323),-0.30860066875431436,-1.13590100916773,0.26436781609195403,1.0,1.0,9/45,10.86%,PID1;KIF16B;TBC1D16;NPC2;LAMTOR1;RNF41;BCO2;MPV17;MBOAT7
prerank,regulation of axon guidance (GO:1902667),-0.48759684498478084,-1.1357825379667965,0.32987012987012987,1.0,1.0,5/10,19.49%,MYCBP2;ZSWIM5;ZSWIM4;NRP1;VEGFA
prerank,positive regulation of signal transduction (GO:0009967),0.35793503236239643,1.1357698839851047,0.2150101419878296,0.7743216477187422,1.0,55/238,17.32%,STAT3;CD180;UCHL5;DLG5;SHANK1;CTBP2;PRKD2;SLC39A14;MAML3;RIMS1;ZMIZ1;BMP2K;TGFBR1;ULK3;ITGB3;JCAD;LY86;PIK3R1;TSPAN14;JAG1;MYO1C;MGAT5;PTK2B;ZBTB7B;SORL1;SIRT1;ZRANB1;PRKCZ;BMP6;PTPRC;SMOC2;F3;CREBBP;ATP6V0C;BDNF;RBPJ;NEPRO;MAML1;VPS35;SMARCB1;IGF1;GPS2;NPTN;ATP6AP2;SULF2;LIMS1;ZDHHC5;FLNA;IL6;TUBD1;TNFAIP3;ITGA5;ILK;SMO;PRKCB
prerank,modification-dependent protein catabolic process (GO:0019941),0.3609086638706679,1.1352658698741829,0.24382716049382716,0.775262248877935,1.0,44/193,13.44%,BAG6;MAD2L1;ARIH2;RNF7;SQSTM1;UBR4;CUL3;SIAH2;UBE2S;RNF20;RPS27A;UBC;LONP1;TAF1;SMURF1;UBE2D1;ANAPC5;UBA6;UBE2E1;UBA1;COPS3;ARRB1;FBXW4;BIRC6;RC3H1;CHFR;RNF167;NEDD8;CNOT4;UBE2L3;PSMD11;ANAPC10;RC3H2;PSMD13;MYLIP;RNF43;UBE2I;DDB1;RNF144A;RNF19B;UBE4A;RNF215;STUB1;ZNRF3
prerank,regulation of cell cycle phase transition (GO:1901987),0.38257322547443545,1.1352425659617673,0.2685589519650655,0.7746558978396318,1.0,26/91,17.19%,MAD2L1;UBE2S;PSMD2;PSMC4;PSMD4;PSMD1;TAF1;UBE2D1;PSME3;PSMB6;PSMD10;TCIM;ANAPC5;UBE2E1;ERCC2;PSMB1;PSMD11;ANAPC10;PSMA2;PSMD13;DDB1;PSMB10;PSMB3;SKP1;PSMC1;ANAPC7
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.5040625198040445,1.1350323814167822,0.3220858895705521,0.7746208231344158,1.0,3/15,5.39%,MTHFD1L;TGFBR1;TGFBR2
prerank,negative regulation of cellular process (GO:0048523),0.35284074817725075,1.1350092388793473,0.126,0.7740097122379652,1.0,98/521,17.45%,MYC;BMP5;OSM;SESN2;ADAMTS1;CD9;NAIF1;TFAP2B;TBRG1;ARHGDIA;DLG5;NR4A1;MYH9;PLXNA1;TMEM98;CTBP2;SERTAD3;WARS1;NCK1;MALSU1;INCA1;KLF11;NUPR1;TOB1;EIF2AK2;CHD5;SIRPA;NUDT6;RHOB;MAP2K1;PTPN14;MDM4;TMEM127;CCDC85B;ADGRG1;RTN4;TSPYL2;GLMN;JADE1;GSDME;DNAJA3;EIF2AK3;PTK2B;ANXA6;PPT1;IL1A;CDK6;ACVR1B;SIRT1;KLF10;DSCAM;CAPRIN2;CTNNB1;IP6K2;RNF167;PTPN6;GTPBP4;ING1;BTG2;ZBTB17;CD33;SIRT2;CD200;PTPRU;CNOT7;TMBIM6;TAF6;CLU;VPS35;TEX15;DNAJB2;SRGAP2;APP;CTTNBP2NL;BCL6;NDUFA13;WFS1;ABI1;NME6;VGLL4;IL6;PLPP1;ING4;ADARB1;TNFRSF1B;CTCF;PBRM1;RAF1;FLCN;PRDM11;SMYD5;APC;SOD2;UBR2;ZBTB49;HTRA2;GPNMB;SMAD3
prerank,dicarboxylic acid metabolic process (GO:0043648),0.40576053502670756,1.1347184921293547,0.283704572098476,0.7742080442576099,1.0,14/52,15.63%,SHMT2;IDH1;MTHFD1L;ACLY;MDH1;MTHFD2;ALDH18A1;DGLUCY;FPGS;GOT2;GPT2;OGDH;GOT1;IDH2
prerank,positive regulation of synaptic transmission (GO:0050806),0.3880006960318305,1.1345788616713521,0.3063063063063063,0.7739862925962636,1.0,18/72,15.62%,CCL2;SQSTM1;AKAP5;RIMS1;RIMS3;CACNG8;ZDHHC3;PTK2B;CLSTN1;PRKCZ;CACNG2;APP;ADCY8;FMR1;GRIN2A;NPTN;SYT1;FLOT1
prerank,cholesterol biosynthetic process (GO:0006695),-0.3410806188250211,-1.1345334632315767,0.2581967213114754,1.0,1.0,22/31,35.93%,INSIG2;FDFT1;LBR;ARV1;NSDHL;GGPS1;CYP51A1;ACAA2;INSIG1;PMVK;SQLE;LSS;EBP;IDI1;DHCR24;DHCR7;PLPP6;HSD17B7;ACAT2;MVK;FDPS;TM7SF2
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5077482908033739,1.134286244941616,0.3156297420333839,0.7742124411237312,1.0,5/13,20.61%,TYROBP;IL18;AP1G1;ZBTB1;LAMP1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.4787827591402228,1.134187200261277,0.32215743440233235,0.7738368874304861,1.0,9/18,23.54%,NAPA;GRID1;GRIK5;UNC13B;SLC17A6;GRIK1;NAPB;GRIA2;CDH8
prerank,regulation of cell death (GO:0010941),-0.2627406477529419,-1.1341501200099595,0.17346938775510204,1.0,1.0,37/94,29.13%,FAF1;RILPL1;ATG5;BECN1;EPHB1;FERMT2;PRKD1;VPS4B;CDKN1B;LRRK2;BNIP3;ADNP2;RRAS2;DUS2;HTR2B;CHRNA7;DCC;BNIP3L;SRSF6;ACER3;PARP16;CRYAB;FGF2;NOA1;SOX4;TRIM13;CD36;PARK7;NPAS2;CHMP4B;SOX11;SLC25A24;TMEM109;RAB29;CHMP2A;DHCR24;MT3
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.539625258355164,1.1340765631444067,0.33914421553090335,0.7734964179295933,1.0,3/10,8.12%,TGFBR2;CD55;ZBTB7B
prerank,positive regulation of proteolysis (GO:0045862),0.406829542518031,1.1336882204255683,0.28870779976717115,0.774028424081544,1.0,16/55,17.55%,ADAM8;FBXW11;ADAM9;TANK;APOE;SNX33;FURIN;ASPH;BAD;TNIP1;STUB1;NDUFA13;IST1;TNFRSF1B;TBC1D10A;ZC3H12A
prerank,pulmonary valve development (GO:0003177),-0.39481582493201395,-1.1335313125150295,0.2672955974842767,1.0,1.0,7/18,21.68%,ROBO1;BMPR2;NOTCH1;ROBO2;TNFRSF1A;SLIT2;TGFB2
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.3647297891952326,1.1324976501733701,0.2381443298969072,0.7770643614185748,1.0,41/163,17.55%,PRKD2;EIF2B2;PSMD2;SH2B2;NCK1;NFKBIZ;NFKBID;PSMC4;FBXW11;IKBKB;RELA;PSMD4;PSMD1;RBCK1;PIK3R1;SPPL3;PSME3;PSMB6;PSMD10;PTPRC;RIPK2;PSMB1;RC3H1;BLNK;RNF31;PSMD11;RC3H2;MOG;PSMA2;PSMD13;PSMB10;DENND1B;PSMB3;PAG1;SKP1;NFKB1;TEC;EIF2B3;PSMC1;PRKCB;ZC3H12A
prerank,protein prenylation (GO:0018342),0.5392460450072746,1.132400198293847,0.319672131147541,0.7766758934694721,1.0,4/10,12.59%,CHML;FNTA;CHM;RABGGTB
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.39265588283762887,1.1322697837009614,0.2895927601809955,0.7764100063535244,1.0,8/66,8.25%,CCL2;ADAMTS1;ADAM17;PRMT2;FAM107A;JADE1;PSME3;CDK6
prerank,negative regulation of apoptotic process (GO:0043066),0.3521306267368353,1.1316999853649932,0.14314314314314314,0.7774564736010412,1.0,82/444,16.98%,GDNF;MYC;EGR3;CCL2;MAD2L1;PRELID1;AGAP2;TFAP2B;ARHGDIA;BCL2L1;SQSTM1;ADAM8;PLAUR;HIGD1A;HNRNPK;SIAH2;BID;SOX9;NUPR1;SNX6;IKBKB;RPL10;RELA;RPS27A;UBC;APOE;PCID2;PRDX5;BCL2L2;PIK3R1;TXNDC5;PRKCH;FAIM2;PTK2B;SET;PPT1;PSMD10;TCIM;SIRT1;DNAJA1;MAPK8;PIM3;CTNNB1;HDAC1;RIPK2;CARD16;PA2G4;BDNF;BIRC6;SFPQ;BAG1;HPN;BNIP1;HSPA5;CBX4;TMBIM6;DDAH2;PTRH2;IGF1;ERC1;CFLAR;DPEP1;UBE2Z;SETX;ARF4;WFS1;MTDH;TMBIM4;FLNA;IL6;HGF;MED1;YME1L1;PAX2;RAF1;MAG;HSPD1;ITGA5;NFKB1;PROC;SOD2;YWHAZ
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.5343339944885883,1.1309651167160681,0.3406408094435076,0.7790826011376845,1.0,4/10,17.32%,PRKD2;ITGB3;ITGA5;PRKCB
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.4931509667582081,1.1307031955042468,0.3125,0.7792710925129365,1.0,6/16,20.61%,CADM1;RAET1E;AP1G1;SLAMF6;NECTIN2;LAMP1
prerank,positive regulation of immune response (GO:0050778),0.39155146131270147,1.1303542007088994,0.27816901408450706,0.7796554472991029,1.0,10/64,11.13%,ADAM8;KARS1;NLRP3;POLR3B;DHX9;SIRT1;PTPRC;AKIRIN2;PYCARD;POLR3F
prerank,membrane repolarization (GO:0086009),0.49850319730003423,1.1293235988841406,0.3333333333333333,0.7822439050434274,1.0,3/15,9.67%,KCNH2;KCNJ2;ATP1B1
prerank,regulation of presynapse assembly (GO:1905606),0.48488214878374364,1.1290835899807117,0.3352192362093352,0.7816061413820472,1.0,9/18,23.84%,SLITRK3;PTPRD;VPS35;APP;LRFN5;GPC6;SNCA;EIF4G1;IL1RAPL1
prerank,regulation of presynapse organization (GO:0099174),0.48488214878374364,1.1290835899807117,0.3352192362093352,0.7816061413820472,1.0,9/18,23.84%,SLITRK3;PTPRD;VPS35;APP;LRFN5;GPC6;SNCA;EIF4G1;IL1RAPL1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.36386025273990524,1.1289239879757085,0.25077399380804954,0.7814347151509147,1.0,20/152,14.96%,MC2R;LPAR3;CALCA;RGS1;S1PR5;AKAP5;MTNR1A;GNAS;ADGRG1;ADCY5;ADGRL2;GNAO1;GNA15;PSAP;ADCY8;ADCY3;LPAR1;ADRB2;LGR4;S1PR1
prerank,lipid catabolic process (GO:0016042),0.47871633705045835,1.1285811146258184,0.33579881656804733,0.781829016544955,1.0,4/18,16.78%,LPL;PPT1;SIRT2;CEL
prerank,regulation of macrophage cytokine production (GO:0010935),-0.44289291274606046,-1.1278694260290105,0.29850746268656714,1.0,1.0,8/13,26.12%,IRAK3;CUEDC2;CD74;PLCG2;GPRC5B;TGFB2;LILRB1;SEMA7A
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3482871734415405,1.1274520999120967,0.089,0.7847313489479012,1.0,170/807,17.01%,ATF3;MYC;SOX10;HOXD9;BASP1;STAT3;DDX20;CALCA;ZNF436;GLIS1;TFAP2B;DRAP1;THAP1;CREB3L1;ATP8B1;ZFP36;CTBP2;HSF4;PHF6;SKIL;ZMYM5;NR2F6;C1QBP;JUN;HDGF;PRMT2;USP2;ILF3;INPP5K;FOXE1;HMGB1;ZNF177;HNRNPU;SOX9;KLF11;NR1D2;SNX6;FBXW11;KMT5A;RPL10;ATF4;SARS1;FNIP2;HDAC6;KAT5;RELA;SBNO2;PRICKLE1;ARID5A;EID2B;MYPOP;DPF2;MDM4;HSPA8;LARP7;CCDC85B;RPS27A;UBC;UXT;PRDX5;TAF1;TGIF1;SDCBP;PDGFB;ZBTB7A;XRCC5;UBE2D1;OTUD7B;TRIM28;FOXP1;BCL11A;DNAJA3;CRY2;SET;ZBTB7B;TCF7L2;PSMD10;HIVEP1;SIRT1;TBL1X;SPI1;KLF10;CNBP;BMP6;NCOA5;ZBTB2;TENM2;N4BP2L2;UBE2D3;GCFC2;CTNNB1;SUMO1;RUNX2;PPM1F;HDAC1;CREBBP;KLF7;PA2G4;IRF8;HDAC5;SFPQ;ACVR2B;BTAF1;RBPJ;KDM1A;MITF;ZNF148;SOX2;DEDD2;TCF25;SIRT2;DR1;PCGF2;CBX4;CNOT7;WWC2;LIN37;UBE2I;PHF10;TCF3;RPS14;MIER1;DNMT3A;GPS2;DDX5;MBD1;FOXO3;SAMD1;HMBOX1;BCL6;SKOR2;NDUFA13;CBX5;ZFP69;WFS1;LIMS1;NCOR1;MTDH;FLNA;VGLL4;CREB1;MED25;ARID5B;MED1;ING4;CTCF;LDB2;LDB1;RUNX1;FOXK2;PAX2;FLCN;TMPRSS6;SIN3A;IRF2BPL;GATAD2A;CUX1;RXRA;NFKB1;PRDM11;RBAK;ZBTB4;IRF2BP2;PSPC1;NONO;ETV6;CNOT2;PER1;MEF2A;EID1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.40412925124342497,1.1272894052360185,0.3055885850178359,0.7845433800676447,1.0,15/51,16.77%,NEK7;ACD;HNRNPU;MAP2K7;GNL3L;XRCC5;CCT8;STN1;CTNNB1;EXOSC10;CCT7;HMBOX1;FBXO4;CCT6A;HNRNPA1
prerank,nerve growth factor signaling pathway (GO:0038180),0.5513771242985098,1.1269262210258555,0.3453689167974882,0.7850260809795684,1.0,2/10,10.45%,KIDINS220;BDNF
prerank,cAMP metabolic process (GO:0046058),0.5174276214338338,1.126886257008155,0.329803328290469,0.7844809666384726,1.0,6/13,18.51%,EPHA2;ADCY5;ADCY8;ADCY3;ADCY7;ADCY9
prerank,protein homotetramerization (GO:0051289),0.4050740018584606,1.1267444332467111,0.2843016069221261,0.7842446161778475,1.0,13/49,22.21%,SHMT2;SSBP1;TRPM4;GLS;KCNJ2;ACACA;TRPM2;SOD2;ALDH9A1;ACOT13;USP16;ALDOA;MCOLN1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.39028925704553186,1.1265994287198573,0.28312570781426954,0.7840024273992426,1.0,20/73,20.09%,OSM;PRKD2;HSP90AB1;FNIP2;HDAC6;TBK1;LATS1;AKAP9;CAPRIN2;RIPK2;BDNF;APP;IL6;RAF1;RPTOR;ARAF;BCAR3;TERF2IP;SNCA;ATP2B4
prerank,O-glycan processing (GO:0016266),0.4003461311758636,1.12637797715217,0.28708133971291866,0.784006499871615,1.0,10/54,11.64%,ST6GALNAC2;GALNT6;POFUT1;POMGNT1;GALNT10;GALNT1;XXYLT1;B4GALT5;GALNT15;GALNT7
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.5461600302898035,1.126356565115266,0.34281200631911535,0.7834071442267516,1.0,1/10,1.61%,ADAM17
prerank,positive regulation of epithelial cell migration (GO:0010634),0.3782812767675075,1.126237377365597,0.29053318824809576,0.7830871402387445,1.0,27/92,18.02%,PRKD2;SOX9;PFN1;ADAM9;HDAC6;RHOB;EMC10;RTN4;ITGB3;ANXA3;SPARC;GLIPR2;AGT;FOXP1;PTK2B;SMOC2;PPM1F;NRP2;EPB41L4B;MTOR;RAC1;ZC3H12A;ETS1;INSL3;PIK3CG;CALR;PDCD6
prerank,heart contraction (GO:0060047),0.4185593430706551,1.1261404549723215,0.327970297029703,0.7826868263176218,1.0,4/41,9.70%,TNNI2;KCNH2;ATP1B1;SCN1B
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.3918634002996239,1.1257844520046758,0.2948571428571429,0.7831678280316255,1.0,18/67,18.25%,CSF1;TRIOBP;EPHA1;C1QBP;JUP;PDGFB;PTK2B;CDK6;PPM1F;P4HB;CCL25;CRK;LIMS1;FLNA;RAC1;ILK;CALR;CDH13
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.4836634368717629,1.1255195331872685,0.31008902077151335,0.7833526483862053,1.0,6/17,20.61%,CADM1;RAET1E;AP1G1;SLAMF6;NECTIN2;LAMP1
prerank,epithelium development (GO:0060429),0.36993356776310954,1.1254177837473989,0.28038379530916846,0.7829930065269578,1.0,8/107,5.81%,SOX10;PGK1;CBR1;CTSB;TPP1;SOX9;TAGLN2;PCNA
prerank,cytoskeleton organization (GO:0007010),0.37195717884683177,1.125409573991975,0.28450106157112526,0.7823532730488757,1.0,22/114,12.36%,CCL3;CCL2;MICAL1;FMNL3;ABI2;RHOB;PRPF40A;RHOG;APOE;RHOU;SEMA6A;PACSIN2;CNTNAP1;LRCH3;ANK1;ZRANB1;RANBP10;MICAL2;FGD1;ZMYM4;TNIK;DIAPH1
prerank,neuron differentiation (GO:0030182),0.36162475995830917,1.1253779025108102,0.2623456790123457,0.7817995552350391,1.0,28/165,15.68%,BRSK1;WNT5B;FZD5;PIN1;IER2;MAP2K1;MANF;TGFBR1;BRSK2;PPT1;RYK;ITM2C;SMARCA1;PBX4;DTNB;TENM2;CTNNB1;RUNX2;POU3F2;PTPRD;ERCC2;MYEF2;PHOX2A;RNF112;SNPH;LMX1B;LDB1;RUNX1
prerank,intracellular cholesterol transport (GO:0032367),-0.4170949372347089,-1.1250835311386747,0.30745341614906835,1.0,1.0,6/15,11.56%,LRP6;ABCA1;RELCH;NPC2;LDLRAP1;LDLR
prerank,receptor metabolic process (GO:0043112),0.40086226355927945,1.1250059857319608,0.30552291421856637,0.7822368444787959,1.0,10/53,9.79%,CD9;PICALM;ARFGEF2;PIK3R4;PHETA1;DNM2;SMURF1;RAB31;LRP1;CLTC
prerank,glycosaminoglycan catabolic process (GO:0006027),0.397323506855119,1.124684728531438,0.30930232558139537,0.7825629903091743,1.0,10/55,12.13%,BCAN;NCAN;GLB1;GUSB;CSPG4;SDC4;GALNS;CEMIP2;GPC5;IDS
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.34708736033418885,1.1243170943510867,0.024,0.7830403772733316,1.0,328/1645,17.32%,ATF3;EGR2;MYC;NKX2-8;ZFP82;RELB;TNNI2;SOX10;EGR3;BAMBI;SPIN4;HOXD9;EGR1;BASP1;ZNF319;HOXD8;LITAF;STAT3;CALCA;IFRD1;KCNH2;ZNF83;ZNF436;ZBTB11;ZIC1;GLIS1;TFAP2B;DRAP1;NR4A1;HOXB7;THAP1;NFE2L2;DVL2;SEC14L2;CREB3L1;ATP8B1;TADA1;CTBP2;ACTL6B;HSF4;PHF6;ZBTB8A;ZNF471;NR2F6;JUN;HDGF;PRMT2;SERTAD3;FUS;CELSR2;KARS1;HNRNPK;ILF3;INPP5K;HNRNPD;LIN9;FOXE1;NFYA;HMGB1;ZNF177;RNF20;PRRX1;SOX9;KLF11;NR1D2;KLF15;PICALM;NFATC3;MAP2K3;SNX6;ZBTB25;FBXW11;FUBP3;KMT5A;HIVEP3;IKBKB;NDP;ZBTB6;ATF4;CHD5;RYBP;HDAC6;KAT5;SMARCC1;RELA;NOP2;SBNO2;GLRX2;PRICKLE1;CASZ1;MAP2K7;CDK18;ZMIZ1;ZBTB48;ARID5A;CCNL1;EID2B;CREB3L4;CREB3;ACTL6A;MAP2K1;MYPOP;CSRNP2;DPF2;MDM4;TGFBR1;HSPA8;CCDC85B;DNM2;RHOG;UXT;APOE;TAF15;CXXC1;SPP1;PCID2;ELP3;ZKSCAN5;PCNA;FADS1;COL1A1;ZNF691;SALL3;QRICH1;TRIM56;TGIF1;PDGFB;ZBTB7A;TRRAP;SMARCD2;SLC39A8;AGT;TRAK1;TOX4;TAF5L;BAZ2A;XRCC5;MAFG;POFUT1;CHD4;TRIM28;ELOA;EBF2;FOXP1;BCL11A;BAZ1A;STAT6;ZBTB22;DHX9;CRY2;SET;REPIN1;ZBTB7B;BAZ1B;E2F5;TCF7L2;TCIM;ACVR1B;CCNK;HIVEP1;SMARCA1;SIRT1;TBL1X;ENG;MED8;TADA2A;SPI1;KLF10;PBX4;CNBP;HR;ZBTB2;UTP4;ZNF467;CHD2;ZFX;GCFC2;CTNNB1;SUMO1;USP21;RUNX2;SRSF10;POU3F2;PPM1F;ARRB1;HDAC1;CHD1;CREBBP;EFEMP1;KLF7;PA2G4;IRF8;HOXB8;HDAC5;YBX1;SFPQ;ACVR2B;BTAF1;NPAT;RBPJ;KDM1A;MITF;ZNF148;ING1;SOX2;ZBTB17;POLR3F;DEDD2;SIRT2;UBE2L3;ELF2;ZNF496;CBX4;CNOT7;SLTM;ELAVL2;WWC2;PTP4A3;APBB3;SMARCB1;TOX;UBE2I;PHF10;PHOX2A;IGF1;TCF7L1;TCF3;CTDSP1;ERC1;TSFM;DGKQ;KMT2B;CREB5;SS18L1;ZBTB40;ASCL4;AEBP2;DDX5;MBD1;FOXO3;SAMD1;HMBOX1;CRK;BCL6;ZNF292;KMT2D;RORA;POU6F2;SKOR2;NDUFA13;CBX5;LMX1B;JUND;ZFP69;LIMS1;EBF4;NCOR1;HOXC6;MTDH;BRD4;PHF20L1;ZSCAN26;CAMKK2;POU2F2;VGLL4;ATF1;CREB1;HOXC8;ATF6;MED12L;IL6;ARID5B;MED1;WWTR1;CCNT1;ING4;LRP5;TSHZ2;MED13;CTCF;CD86;LDB1;KMT2A;JMJD1C;CCNL2;RUNX1;FOXK2;PAX2;TMPRSS6;IRF9;DYRK1A;SIN3A;HSPD1;IRF2BPL;GATAD2A;ZFP91;CUX1;RXRA;BACH2;NFKB1;PRDM11;RBAK;ZBTB4;IRF2BP2;HOXB3;ILK;PSPC1;NONO;ETV6;ELP2;CNOT2;SOD2;TEF;PER1;MEF2A;KAT2A;ZFHX4;EID1;MEF2B;CC2D1B;TCF12;BRD2;RAD21;FOXJ2;ZBTB49;ENY2;NFYC;PRKCB
prerank,regulation of ATP metabolic process (GO:1903578),0.3991640888143229,1.123576944387254,0.29634002361275086,0.7845927089862393,1.0,15/54,15.64%,SHMT2;NUP153;NDC1;ZBTB7A;EIF6;NUP88;COX7A2;SLC25A33;COX7A2L;NUP210;PRKAG1;NUP37;NUP98;PGAM1;NUP54
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3590308362489728,1.1232747421897389,0.25622406639004147,0.7848394018369671,1.0,37/161,15.18%,DVL2;CUL3;ANKRD6;SIAH2;PSMD2;FZD6;SOX9;PSMC4;PSMD4;PRICKLE1;PSMD1;APOE;CTNND1;KLHL12;JADE1;PSME3;PSMB6;LRP4;TCF7L2;PSMD10;LATS1;HDAC1;PSMB1;DKK2;SOX2;PSMD11;PSMA2;PTPRU;PTPRO;PSMD13;INVS;PSMB10;ZNRF3;UBAC2;TLE3;PSMB3;WWTR1
prerank,positive regulation of lipid kinase activity (GO:0090218),0.442145737162291,1.1232520755755953,0.322237017310253,0.7842608586011354,1.0,5/29,7.92%,PDGFRB;DGKZ;PIK3R4;PDGFB;PTK2B
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.3596497609397829,-1.1230175443520272,0.26907630522088355,1.0,1.0,7/24,16.81%,JAK2;OCIAD1;ERBB4;NOTCH1;PRLR;CENPJ;IL10RA
prerank,negative regulation of phosphorylation (GO:0042326),0.37594194000812686,1.1226536694214764,0.303670745272525,0.78544500540659,1.0,12/85,9.57%,CORO1C;PPP1R15B;WARS1;INPP5K;NPRL2;HNRNPU;NUPR1;TARDBP;SIRPA;SIRT1;PRNP;TRAF3IP1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.4024627174678576,1.12248477486743,0.32432432432432434,0.7852790829992763,1.0,13/51,17.24%,SERPINF2;EPHA1;PLEK;PFN1;TGFBR1;PPM1F;LIMK1;LIMCH1;LPAR1;ARHGEF10;RAC1;CCDC88A;GPR65
prerank,epithelial cell morphogenesis (GO:0003382),-0.40937196303069984,-1.1223652988631534,0.31626506024096385,1.0,1.0,13/17,57.92%,RILPL1;CCDC88C;MET;COL22A1;COL18A1;SIPA1L3;DACT2;STC1;PKHD1;GRHL2;TNMD;CNMD;POF1B
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.3677908486424847,-1.1220134756810785,0.27099236641221375,1.0,1.0,8/22,21.58%,CD46;IRF1;LAG3;DUSP10;CBFB;VSIR;NFATC2;MDK
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.5007151547702247,1.1218683450193885,0.33588957055214724,0.7865200995979503,1.0,3/14,4.24%,PES1;URB1;NIFK
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.3332102535292545,-1.1218118514392676,0.24,1.0,1.0,11/31,16.07%,PPP1R13B;CASP8;NMT1;YWHAH;YWHAQ;TFDP2;PPP3CC;YWHAB;BAX;GSK3B;GSK3A
prerank,nucleotide metabolic process (GO:0009117),0.4579461991964964,1.1212207155512952,0.35195530726256985,0.7877871120034134,1.0,6/23,13.15%,NMNAT1;NUDT5;PNP;AK8;CMPK1;NMNAT2
prerank,brain morphogenesis (GO:0048854),0.5182345295516431,1.1211460875919836,0.345565749235474,0.7873540376638157,1.0,6/12,17.77%,FBXW11;BBS4;PAFAH1B1;PAX2;CTNNA2;SPEF2
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.42364891937386956,1.1208062221562853,0.32051282051282054,0.7877055848615905,1.0,11/35,16.77%,NEK7;ACD;MAP2K7;XRCC5;CCT8;CTNNB1;CCT7;HMBOX1;FBXO4;CCT6A;HNRNPA1
prerank,positive regulation of protein acetylation (GO:1901985),0.5186812740999845,1.1207452345291804,0.3442367601246106,0.7872470482943185,1.0,7/12,24.32%,KAT5;PRKAA1;TERF2IP;DIP2A;TAOK1;CAMK1;DDX3X
prerank,neutrophil mediated immunity (GO:0002446),0.34915420919252216,1.1206707708930777,0.1871871871871872,0.7868155092524901,1.0,98/432,16.31%,CRACR2A;PLEKHO2;GLIPR1;CTSB;PTGES2;CTSD;ADAM8;UBR4;ADAM17;PLAUR;PGM1;ARSA;TYROBP;IDH1;ATP6V1D;PSMD2;HSP90AB1;HMGB1;GLB1;RAB18;GUSB;SIRPA;DDOST;PSMD1;PNP;STK11IP;HSPA8;CYBB;RHOG;FRMPD3;ANXA3;DEGS1;JUP;TXNDC5;ACLY;GALNS;GCA;SDCBP;CD55;ITGAL;TSPAN14;XRCC5;RAB31;CCT8;CTSA;CARD9;NRAS;COTL1;BRI3;PDXK;CAND1;CYFIP1;DPP7;TUBB;PTPRC;ATP6V0A1;PYCARD;CYSTM1;STXBP3;ATP6V0C;PA2G4;PSMB1;ACTR1B;DERA;LPCAT1;PTPN6;AP1M1;CD33;PSMD11;CMTM6;PSMA2;PSMD13;TRPM2;ANXA2;DOCK2;DIAPH1;PSAP;CPPED1;PTPRN2;TOM1;SPTAN1;CAP1;ATP6AP2;PGRMC1;TMEM30A;SLC11A1;IL6;IST1;ARPC5;MOSPD2;DBNL;TNFRSF1B;PGAM1;RNASE3;RAC1;DYNC1LI1;DNASE1L1;VAT1
prerank,protein secretion (GO:0009306),0.39278994302485093,1.1201055033057008,0.319672131147541,0.7878961416647289,1.0,11/56,14.11%,ARFGAP3;TANGO2;SEL1L;TVP23A;PPY;RAB8B;LTBP2;CAMK2G;SNX19;OLFM2;NAGPA
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.40054865290265346,1.1200348284377173,0.3044496487119438,0.7874508138491185,1.0,15/53,15.38%,PSMD2;BCKDK;PSMC4;PSMD4;PSMD1;PSME3;PSMB6;PSMD10;PSMB1;PSMD11;PSMA2;PSMD13;PSMB10;PSMB3;AZIN1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.3897102431634463,1.1195640148249026,0.30439814814814814,0.7882282030170513,1.0,7/66,6.44%,PDGFRB;DVL2;ADAM8;PDGFA;IL34;DUSP19;PDGFB
prerank,regulation of histone methylation (GO:0031060),0.5114079040066355,1.1191086182207548,0.3490427098674521,0.7889929693103145,1.0,4/13,18.44%,CHTOP;TET1;CTR9;PIH1D1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.43294817131597546,1.1190975810559691,0.3377837116154873,0.7883693331653305,1.0,7/27,16.00%,KMT5A;PTTG1IP;PSMD10;SIRT1;KDM1A;DDX5;DYRK1A
prerank,regulation of leukocyte migration (GO:0002685),-0.39694257708613223,-1.1184261841790892,0.2936046511627907,1.0,1.0,2/16,0.29%,NCKAP1L;RHOH
prerank,negative regulation of protein catabolic process (GO:0042177),0.41599639258510934,1.118261946986088,0.3233458177278402,0.7901880743324821,1.0,14/40,21.20%,MAD2L1;AGAP2;PIN1;MDM4;CTSA;SIRT2;RIC1;FLNA;AZIN1;SF3B3;SNRNP70;SNCA;ADGRB1;DAB2IP
prerank,ubiquinone metabolic process (GO:0006743),0.49154096636869804,1.118174901652472,0.3303834808259587,0.7898218005629541,1.0,3/15,4.84%,PDSS2;AIFM2;COQ10B
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.43632470716997385,1.1180920883708592,0.31290743155149936,0.78942920760032,1.0,5/31,8.25%,CCL2;PRMT2;FAM107A;JADE1;CDK6
prerank,regulation of Notch signaling pathway (GO:0008593),0.3826975050144957,1.1180592422311137,0.2956810631229236,0.7888680284162031,1.0,17/76,14.32%,STAT3;LLGL1;MAML3;ZMIZ1;BMP2K;ZBTB7A;TSPAN14;POFUT1;JAG1;TCIM;ARRB1;CREBBP;RBPJ;NEPRO;MAML1;SYNJ2BP;LFNG
prerank,T cell activation involved in immune response (GO:0002286),0.5132668435293538,1.1177910100268635,0.34290271132376393,0.7890318588709041,1.0,4/12,17.24%,LCP1;ITGAL;SLC11A1;ICAM1
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.44165570095401485,-1.117766268312225,0.323943661971831,1.0,1.0,8/12,45.69%,SMS;OAZ2;HNMT;ODC1;DDC;ATP7A;SRM;AMD1
prerank,negative regulation of proteolysis (GO:0045861),0.42511700101094047,1.1173350048061679,0.336734693877551,0.7898062620751874,1.0,5/34,9.29%,BAG6;HDAC6;DNAJC1;CLN8;PRNP
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.44118130434074376,1.1171739189074714,0.34274193548387094,0.7896340092167939,1.0,11/26,24.53%,HMGB1;NINJ1;RTN4;WDFY1;FLOT1;SLC15A4;TLR2;CYBA;TIRAP;DDX3X;MFHAS1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.30600227583963685,-1.117058461962405,0.265,1.0,1.0,10/45,7.23%,KIF16B;CBL;GRB2;PIK3C2A;GAB1;PTK2;BRAF;SHC3;RPS6KA5;PLCG1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.4094622860709364,1.1164156152699203,0.3333333333333333,0.7913149010465025,1.0,11/41,21.27%,SERPINF2;PLAUR;ADAM19;PTPRU;GCNT2;FLOT1;MAGI1;JAK1;TJP1;THY1;CD44
prerank,dicarboxylic acid catabolic process (GO:0043649),0.5109414667841757,1.1164000340831635,0.32819722650231126,0.7907008944808869,1.0,4/13,14.48%,ACSF3;GLUD1;GOT2;GOT1
prerank,positive regulation of ATPase activity (GO:0032781),0.4081934852691425,1.1160209208613654,0.32082324455205813,0.7911682487091711,1.0,8/41,12.18%,CHTOP;HNRNPU;PFN1;SSBP1;DHX9;ATP1B1;MSH3;DNAJB2
prerank,myoblast differentiation (GO:0045445),0.4916067547725335,1.1158489527117972,0.32370820668693007,0.7910549799843836,1.0,7/14,21.71%,JAG1;TCF7L2;IGF1;DDX5;EPAS1;REST;DDX17
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.5354659442924453,1.115640107807892,0.3627760252365931,0.7910315630074035,1.0,5/11,22.84%,TYROBP;SPI1;ITGB2;MAVS;ITGAM
prerank,regulation of macroautophagy (GO:0016241),0.3669263659273326,1.1155728539562053,0.3078579117330463,0.7906101912720437,1.0,20/105,12.01%,SESN2;RRAGC;ATP6V1D;ATP6V1A;ATP6V0D1;ATP13A2;SNX6;HDAC6;UCHL1;LZTS1;TBK1;ATP6V0E1;SIRT1;ATP6V0A1;MAPK8;EXOC7;ATP6V0C;RHEB;PRKAG1;VPS35
prerank,miRNA metabolic process (GO:0010586),0.4716579878803358,1.1153700797124642,0.3263009845288326,0.7905432800359643,1.0,8/20,21.71%,TARBP2;TUT7;DGCR8;DROSHA;SND1;RAN;AGO2;DDX17
prerank,regulation of T cell cytokine production (GO:0002724),0.4864560135850755,1.1152679558588017,0.34433285509325684,0.7902107254585864,1.0,3/15,7.04%,FZD5;CD55;TRPM4
prerank,regulation of gene expression (GO:0010468),0.3446128666823611,1.115078745610871,0.097,0.7901605791099331,1.0,202/903,18.53%,CCL3;GDNF;MYC;KDM6B;SPIN4;EGR1;SLC7A5;CSF1;STAT3;ZNF513;ZBTB11;DRAP1;HOXB7;THAP1;NFE2L2;DVL2;CREB3L1;SERTAD3;FUS;WARS1;CELSR2;TYROBP;HNRNPK;PIK3R3;HNRNPD;NFYA;RNF20;ATP13A2;PIN1;SOX9;MATR3;NR1D2;NFKBIZ;NFKBID;PICALM;TOB1;FUBP3;RIMS1;ATF4;TARDBP;RYBP;ZUP1;HDAC6;FASTK;RELA;SBNO2;SIRPA;GLRX2;CASZ1;MAP2K1;FLOT2;TGFBR1;DNM2;APOE;CXXC1;ZKSCAN5;FADS1;TAF1;DNAJA4;PDGFB;AFF2;TRRAP;HNRNPH2;SLC39A8;GLMN;TAF5L;BAZ2A;RRP1B;POFUT1;PTBP2;FOXP1;CRIP1;ADAM19;EIF2AK3;UBAP2;C1D;PCBP2;ZBTB7B;IL1A;CDK6;ACVR1B;SIRT1;ENG;SPI1;CNBP;BMP6;PTPRC;UTP4;F3;MAPK8;RBM38;PARP10;MSN;GCFC2;ATP1B1;FAM98B;CLK4;SRSF10;ACTG1;PPM1F;HDAC1;PUM2;CREBBP;EFEMP1;HDAC5;RC3H1;YBX1;TRIM17;SFPQ;ACVR2B;NPAT;RBPJ;PRKAG1;MITF;ZNF148;SOX2;UBE2L3;HPN;MOG;SETDB1;CNOT7;ELAVL2;WWC2;PTP4A3;CLU;APBB3;HNRNPL;VPS35;PTRH2;IGF1;TCF7L1;TCF3;ERC1;APP;YBX3;DGKQ;SRPK2;BCL6;KMT2D;RORA;HNRNPH1;POU6F2;SKOR2;TRAF3;GCNT2;ANXA7;LMX1B;MBIP;TDG;ZPR1;PTBP1;PRKAB1;LIMS1;SLC11A1;ZSCAN26;EPB41L4B;MTOR;SART3;IL6;MED1;WWTR1;CTCF;LDB1;JMJD1C;RUNX1;FOXK2;FLCN;HNRNPLL;AGO3;FGF9;NFKB1;PRDM11;YTHDF2;RBAK;ZBTB4;PSPC1;NONO;PER1;KRAS;POGZ;SMO;NFYC;UBR5;SMAD3;ZC3H12A;TRIM5;CTR9;ETS1;SORT1;EZH2;CALR;SNRNP70;DDIT3;NWD1;TNRC6C;MEF2C;CEBPB;PATZ1;CEBPA;GON4L;PRKAA1;PDCL3
prerank,protein transport (GO:0015031),0.35024610890499885,1.1150424519043185,0.21184738955823293,0.7896202356104816,1.0,90/332,18.39%,NAPA;ARFGAP3;MYH9;TBC1D10B;ARL6IP5;ARRDC2;TANGO2;VPS26C;ATP6V1D;ATP6V1A;TBC1D17;ATP6V0D1;ACD;NDC1;RAB18;SNX6;TLK1;HDAC6;SEL1L;TMED5;ARL6;TVP23A;PPY;TMED4;USP6NL;RAB8B;DNM2;ATP6V0E1;APOE;SNX13;RABGAP1;SNX33;GGA1;SGSM2;RAB31;CTSA;TMED10;LTBP2;SCFD2;LRP1;PPT1;AP2A1;STX3;ATP6V0A1;VPS29;TBC1D30;CLTC;STXBP3;ATP6V0C;GOLGA4;ATP6AP1;RIC1;CMTM6;CLU;VPS35;NSF;RAB32;OLFM2;EVI5L;OPTN;TOM1;HERC2;SAR1B;VLDLR;PREPL;ARF4;TBC1D4;RUNDC1;STX5;USO1;NEURL1B;ARL1;KIF3B;ARHGAP1;VPS45;ARHGEF2;PICK1;DNAJC27;PRKCB;ATP6V0B;TBC1D22A;TBC1D10A;TBC1D15;RAB7A;ATP6V1G2;ARL5B;PDCD6;SYNDIG1;STX8;HSP90B1
prerank,ganglion development (GO:0061548),0.5316825687777238,1.114273119917579,0.35429447852760737,0.7912401860732828,1.0,4/11,16.48%,UNC5C;CTNNB1;NRP2;SEMA3A
prerank,B cell activation involved in immune response (GO:0002312),0.5046763862682715,1.1141127152986783,0.35358255451713394,0.7910290188406701,1.0,2/13,7.13%,CD180;GPR183
prerank,regulation of actin filament-based process (GO:0032970),0.38508525928169607,1.1138474682416557,0.3178733031674208,0.7911830772824583,1.0,20/70,17.07%,PDGFRB;IQGAP3;RICTOR;PDGFA;FAM107A;RHOB;RHOG;SH3BP1;LRP1;RHOQ;BAIAP2;TAOK2;EPHA3;CRK;MTOR;ARHGAP17;RAC1;CCDC88A;GPM6B;CORO1A
prerank,regulation of cell cycle (GO:0051726),0.35080358970941544,1.1136927928320273,0.243680485338726,0.790980860020465,1.0,72/271,20.90%,MYC;STAT3;TBRG1;NR4A1;THAP1;BEX2;NEK7;JUN;LIN9;PES1;HSP90AB1;HNRNPU;RNF20;SOX9;NUPR1;TARDBP;CDC123;NEK6;NUDT6;RHOB;MAP2K1;FBXL3;TGFBR1;SDCBP;TSPYL2;CDK6;TCF7L2;FBXL8;SIRT1;PTPRC;PIM3;NBN;DLGAP5;RNF167;SOX2;ZBTB17;SIRT2;TAF6;LIN37;EIF4G2;FBXL17;RNF112;SRPK2;GBF1;SND1;JUND;WHAMM;MED25;ING4;ADARB1;PRDM11;APC;RPRD1B;ZBTB49;HTRA2;SMAD3;CALR;RBBP4;TBRG4;CDK9;JUNB;TSC2;RPL23;CCND1;ASAH2;ANKRD17;RNF40;BOP1;METTL3;CRLF3;MLXIPL;ADAM10
prerank,regulation of immune effector process (GO:0002697),0.41104294209235515,1.1136475873123801,0.3321078431372549,0.7904548793110219,1.0,7/41,13.34%,C1QBP;C4B;CD55;C1QC;CLU;PROS1;C5AR2
prerank,receptor signaling pathway via STAT (GO:0097696),0.4488031480185861,1.1132489151840288,0.33787465940054495,0.7909414026326117,1.0,5/25,7.90%,CCL2;STAT3;SOCS6;STAT6;IFNAR1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.5163114420296125,1.1129410958268549,0.3590551181102362,0.7911923559720033,1.0,5/13,15.34%,TM9SF4;SORL1;SAR1B;TMEM30A;EDEM1
prerank,cellular response to estrogen stimulus (GO:0071391),0.49514873483829347,1.1129045048468602,0.3425655976676385,0.7906649288862915,1.0,2/14,4.76%,NCOA4;ARID5A
prerank,response to exogenous dsRNA (GO:0043330),0.47348541732040966,1.1128549768482572,0.3448275862068966,0.7901673398354302,1.0,8/18,21.55%,SLC3A2;COLEC12;RALB;DHX9;FLOT1;CGAS;RFTN1;MAVS
prerank,regulation of trophoblast cell migration (GO:1901163),0.5039055751957505,1.1125339364334774,0.3667180277349769,0.7904728161470055,1.0,5/14,20.13%,C1QBP;ACVR1B;CALR;GJA1;AGO2
prerank,aminoglycan biosynthetic process (GO:0006023),0.403800681755413,1.1125247763239976,0.33170731707317075,0.7898613119542106,1.0,18/49,21.91%,HS3ST3A1;HS3ST3B1;SDC4;XYLT1;SLC35D2;NDST2;GPC5;GCNT2;HS3ST6;HS3ST5;B4GALT7;HS6ST2;EXT2;GPC6;SDC3;HS6ST1;AGRN;GPC3
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.45761875962949494,1.1124637468033052,0.3323943661971831,0.7893970468245989,1.0,4/21,12.11%,DISP3;CTNNB1;KDM1A;TOX
prerank,protein neddylation (GO:0045116),0.5081773460380857,1.1124237254739466,0.3497615262321145,0.788892754923295,1.0,5/13,15.90%,RNF7;DCUN1D1;NEDD8;NAE1;UBE2F
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.4450699522055432,1.112400707976472,0.3445491251682369,0.7883290090562283,1.0,10/26,20.84%,CUL3;PPP1R10;USP2;TTL;SMOC2;APP;EIF4E;DUSP3;TAL1;EIF4EBP1
prerank,protein targeting (GO:0006605),0.36373005148818705,1.1123110387247739,0.28541448058761804,0.7879748343494685,1.0,22/118,11.51%,TIMM8B;NACAD;GABARAP;ARL6;RABGEF1;ZDHHC9;VPS37B;DNAJC19;SDCBP;ZDHHC7;TRAK1;MYO1C;AKAP6;TOMM20;LTBP2;ZDHHC3;SORL1;GDAP1;TIMM44;ZDHHC21;TAOK2;CHM
prerank,regulation of histone modification (GO:0031056),0.5107371883544668,1.1121797527594375,0.36976047904191617,0.787714459705831,1.0,5/13,18.71%,HPF1;PARG;AKAP8L;FLCN;CDK9
prerank,cellular response to hormone stimulus (GO:0032870),0.38185629733766074,1.1121484552627898,0.3116438356164384,0.7871767449066777,1.0,6/69,4.76%,STAT3;CTSB;NCOA4;CTSL;INPP5K;ARID5A
prerank,regulation of intracellular protein transport (GO:0033157),0.4234914408446332,1.1121415342325027,0.331151832460733,0.7865645915571494,1.0,5/32,5.11%,NDEL1;LCP1;ATP13A2;RUFY3;PTPN14
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.4358725436616239,1.1118808002119738,0.3337628865979381,0.7866855996978943,1.0,14/27,23.84%,BRSK1;NDEL1;EFHC2;BRSK2;CAMK2G;VPS35;CCDC88A;CTNNA2;FBXO7;NTNG2;NTNG1;HOMER1;ULK4;IL1RAPL1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.3735479661124545,1.111863264152252,0.32004429678848284,0.7860967941596092,1.0,16/88,12.04%,PLEK;VPS4A;WARS1;BID;ATP13A2;PFN1;FNIP2;PDCD6IP;SDC4;SDCBP;GNL3L;SMPD3;STAM;SUMO1;CLU;LIMK1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.4123128639042726,1.1118484563742137,0.33709273182957394,0.7855148462648571,1.0,4/35,6.15%,CCL2;KRIT1;APOE;SPARC
prerank,neuron development (GO:0048666),0.3624334214736604,1.1116397017538142,0.28911917098445594,0.7855276056799805,1.0,30/141,16.74%,GDNF;NPY;ACTL6B;BLOC1S6;CLN5;HMGB1;LRP12;MANF;APOE;MAP4;RASGRF1;ATXN10;ARL3;PPT1;RYK;PBX4;STX3;TENM2;POU3F2;BTG2;B4GALT5;APP;PLP1;IL6;GPM6A;CNTN4;RUNX1;MICALL1;ZFYVE27;GPM6B
prerank,positive regulation of signaling receptor activity (GO:2000273),0.42208439973639594,1.1116092220516456,0.3312577833125778,0.7849807618619769,1.0,7/36,14.63%,CCL2;ADAM17;HDAC6;TAF1;HDAC1;ADRB2;NCOA3
prerank,glucose homeostasis (GO:0042593),0.3751787594588865,1.1115912840658233,0.3088888888888889,0.7844044827809665,1.0,17/83,15.95%,STAT3;TFAP2B;INPP5K;LRRC8D;ADIPOR1;PIK3R1;CRY2;TCF7L2;SIRT1;KLF7;BAD;ADCY8;WFS1;IL6;ADIPOR2;FOXK2;MTNR1B
prerank,acetyl-CoA metabolic process (GO:0006084),0.491595697656502,1.1115737898037379,0.33229813664596275,0.7838266052758015,1.0,5/15,13.51%,ACLY;PPCS;ACACA;ACAT1;HMGCS1
prerank,cellular response to ionizing radiation (GO:0071479),-0.2940005734347985,-1.1114475579409362,0.23976608187134502,1.0,1.0,30/47,35.10%,NIPBL;GRB2;TLK2;NUCKS1;SPIDR;CLOCK;BLM;HSF1;RPL26;MAPK14;WRN;RAD9B;RHNO1;ATR;CRYAB;EEF1D;RAD9A;KDM4D;TMEM109;TNKS1BP1;HUS1;GADD45A;CDKN1A;HRAS;RAD1;YAP1;NET1;ECT2;MDM2;RAD51AP1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.30844945932265816,-1.1112031557033808,0.25280898876404495,1.0,1.0,8/43,6.85%,CBL;GRB2;SH3GL2;TSG101;SOCS5;ZFYVE28;MVP;ERRFI1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.5240313823972705,1.111170184669471,0.3640699523052464,0.7843736925728897,1.0,6/11,22.68%,SIRT2;HPN;HGF;RAC1;BCAR1;PAK1
prerank,neuron projection development (GO:0031175),0.3596775732170634,1.1111154851132679,0.2731006160164271,0.7838942114320336,1.0,35/168,16.74%,GDNF;NPY;SHANK1;BLOC1S6;MAP1S;HMGB1;LRP12;ALS2;MANF;DNM2;APOE;MAP4;RASGRF1;NCKAP1;ATXN10;CNTNAP1;RYK;STX3;BDNF;BTG2;TAOK2;DOCK10;TNIK;TRIO;SRGAP2;APP;PLP1;ZPR1;IL6;GPM6A;DBNL;CNTN4;MICALL1;ZFYVE27;GPM6B
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.348860102894135,1.1110350515272134,0.2515151515151515,0.7835195804033431,1.0,62/248,17.38%,BAMBI;JRK;DVL2;CUL3;ANKRD6;SIAH2;PSMD2;FZD6;PIN1;SOX9;PSMC4;PSMD4;PRICKLE1;PSMD1;TMEM9;APOE;CTNND1;COL1A1;JUP;KLHL12;TRPM4;JADE1;PSME3;CSNK1E;PSMB6;LRP4;TCF7L2;PSMD10;LATS1;TBL1X;CAPRIN2;CTNNB1;HDAC1;PSMB1;DKK2;SOX2;CSNK1G2;PSMD11;PSMA2;PTPRU;PTPRO;GPC5;PSMD13;CSNK1G3;INVS;PSMB10;ZNRF3;UBAC2;ATP6AP2;USP8;TLE3;LGR4;PSMB3;WWTR1;NFKB1;APC;ILK;LRRK1;CSNK1D;PSMC1;UBR5;OTULIN
prerank,cellular response to hydroxyurea (GO:0072711),-0.466265062164503,-1.1105393683549114,0.34946236559139787,1.0,1.0,7/10,36.99%,SPIDR;BLM;RTF2;DDI2;DDX11;TIMELESS;ATRX
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.35836625677635336,1.1098949155286526,0.3051742344244984,0.7862940163752475,1.0,20/125,11.61%,MAD2L1;NDEL1;CEP126;NUDC;CENPP;EFHC1;EFHC2;MIS12;NEK6;MAP4;SUN2;TBCE;RANGAP1;DLGAP5;NDC80;RCC1;NUP37;EML4;CENPC;PAFAH1B1
prerank,V(D)J recombination (GO:0033151),0.5302747424407246,1.1093477082256424,0.35834609494640124,0.7873192438200924,1.0,3/11,12.39%,HMGB1;LIG1;TCF3
prerank,endosome organization (GO:0007032),0.4135500830640784,1.1093184035300443,0.32923832923832924,0.7867769769074755,1.0,7/41,6.19%,CORO1C;SQSTM1;ARFGEF2;ALS2;PHETA1;TMEM9;SNX33
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.5006447786445342,1.1083153199407314,0.34545454545454546,0.7891087592684018,1.0,3/13,9.75%,TGFBR2;ENG;CTNNB1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.4895717927799294,1.1078975216086389,0.3589001447178003,0.7896552627598664,1.0,2/15,3.93%,TYROBP;ADAM9
prerank,DNA packaging (GO:0006323),-0.4006264554684255,-1.1078773346513178,0.32792207792207795,1.0,1.0,3/16,6.74%,HAT1;AIFM1;NOC2L
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.35960502103894315,1.1077317935342903,0.310740354535975,0.7895359540174746,1.0,25/124,11.81%,DVL2;FZD5;CELSR2;PSMD2;FZD6;PSMC4;PFN1;PSMD4;PRICKLE1;PSMD1;SMURF1;PSME3;PSMB6;RYK;TCF7L2;PSMD10;AP2A1;CTNNB1;CLTC;PSMB1;GNB1;PSMD11;GNAO1;PSMA2;PSMD13
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.4187606513601248,1.1077272499516169,0.3337730870712401,0.7889235354418148,1.0,5/33,10.61%,PRKD2;RELA;DGKZ;PRNP;RC3H1
prerank,negative regulation of B cell activation (GO:0050869),0.4544104322806638,1.107623183011552,0.36439499304589706,0.7886381947958848,1.0,3/21,10.61%,SAMSN1;TYROBP;RC3H1
prerank,BMP signaling pathway (GO:0030509),0.38567786431255974,1.1076164453760236,0.3451025056947608,0.7880291315587529,1.0,9/62,13.08%,BMP5;SMURF1;HIVEP1;ENG;BMP6;RUNX2;ACVR2B;ZFYVE16;DDX5
prerank,cardiac muscle cell contraction (GO:0086003),-0.38779431957353744,-1.1075451402779541,0.30670926517571884,1.0,1.0,5/19,4.59%,CACNA1D;FGF12;SCN1A;GSN;CACNA1C
prerank,DNA modification (GO:0006304),0.4559305842174155,1.1074443421557632,0.334716459197787,0.7879248179510369,1.0,8/22,19.34%,NEIL2;ACD;MPG;PARP2;TDG;MBD4;NEIL3;TERF2IP
prerank,positive regulation of protein localization to membrane (GO:1905477),0.37238213020502126,1.1074419750213578,0.3146551724137931,0.787303144275453,1.0,19/98,11.88%,EPHA2;SQSTM1;AKAP5;CLIP3;BID;TCAF1;RHOG;PIK3R1;PRKCH;STAC;MYO1C;ZDHHC8;LRP1;STX3;PRNP;MAPK8;STAC2;BAD;EPHA3
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.4562115128020762,1.1073755357017612,0.3603851444291609,0.7868686853085005,1.0,5/22,11.08%,DERL2;SEL1L;RPS27A;UBC;MAN1C1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.39087658785645996,-1.1064692152895028,0.3303834808259587,1.0,1.0,8/15,30.89%,SEC61A1;RAB3GAP2;SEC61G;SRPRB;SRP14;SPCS2;ZFAND2B;SPCS1
prerank,cellular protein modification process (GO:0006464),0.3420611668348314,1.1063693052875339,0.107,0.7891845832780147,1.0,222/983,17.32%,SPRR1A;CCL2;STK38L;MAPKAPK2;CSF1;FBXL15;TRIOBP;DUSP5;ST6GALNAC2;DDB2;BRSK1;MAPK6;RNF7;FAM20C;PENK;CUL3;OARD1;NEK7;BTBD6;PRKD2;DUSP16;DCAF10;MAPK10;ILF3;LGALS1;UBE2S;CDKL3;PSMD2;BCKDK;CHML;GGCX;MAN2A2;PSMC4;MBTPS1;FBXW11;IKBKB;EIF2AK2;TLK1;PPP4R1;FAM20B;FNIP2;FASTK;PSMD4;NEK6;ABL2;DDOST;SOCS6;PTPN12;RPN2;PSMD1;CDK18;PIK3R4;MAP2K1;FBXL3;TBK1;PTPN14;BMP2K;TGFBR1;TGFBR2;PRKCSH;APOE;SPP1;ST8SIA6;PPP2R5B;TAF1;CTDSP2;GOLM1;PPP1CB;PIK3C3;DCUN1D1;MTM1;SNRK;TRIB2;PDGFB;PRKCH;MAP4K5;PPP2R5A;KBTBD7;PARP4;DCAF5;PSME3;CSNK1E;CHGB;BRSK2;EIF2AK3;WDTC1;PTK2B;TP53RK;PSMB6;MTMR3;RYK;CDK6;MAP4K2;PSMD10;LATS1;FBXL8;ACVR1B;CAND1;SIRT1;PRKCZ;TULP4;PTPRC;UBE2E1;MAPK8;PTPRR;PDIA6;PARP10;UBE2D3;PIM3;USP25;CTDNEP1;COPS3;SERP2;PTPRD;PPM1F;PTPN4;ALG10B;COP1;SUMF1;FBXW4;CTDP1;ASB6;FBXW5;SIRT5;B3GALNT2;BIRC6;PSMB1;ACVR2B;MGAT4A;NEDD8;PRKAG1;PARP2;PTPN6;B4GALT5;TAOK2;CSNK1G2;CDKL5;UFL1;SIRT2;UBE2L3;PSMD11;MAML1;CHM;FBXL5;PSMA2;GMFB;PTPRU;PTPRO;PSMD13;PTPRA;TNIK;PPM1G;LIMK1;MKNK1;STK17B;UBE2I;CTDSP1;PDK3;APP;RABGGTB;DDB1;MAP4K3;P4HB;CSNK1G3;PPM1H;HUNK;COL3A1;CDK8;CDK12;PTPRN2;CTTNBP2NL;PPP2CB;SRPK2;PSMB10;PTPRE;NAE1;GCNT2;CUL2;NAGPA;PRKAB1;ARF4;WFS1;WIPI1;IKBKE;ATG4B;CDK19;CAMKK2;ART4;CREB1;MTOR;IL6;FBXO4;PTPRS;PSMB3;CCNT1;PHKA2;SKP1;PEAK1;DAPK1;LCMT1;UBE2F;DYRK1A;ST3GAL6;PMM2;HS3ST5;CUL4A;EVA1A;B4GALT7;METAP1;MAST2;PROC;TEC;ILK;CEL;FBXW9;YWHAZ;NPC1;CSNK1D;PSMC1;BRD2;PICK1;PRKCB
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.4430010522002747,1.105986504593005,0.3512064343163539,0.7897138483632314,1.0,5/25,9.42%,CXADR;FGF13;JUP;TRPM4;AKAP9
prerank,protein localization to cilium (GO:0061512),0.4241780502110796,1.1058165464130585,0.335978835978836,0.7895936846160267,1.0,6/32,7.81%,ATP6V1D;WDR19;ARL6;TULP2;BBS4;ARL3
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.37307579220752596,1.1056863957437992,0.3092896174863388,0.789322050898235,1.0,26/93,20.70%,OSM;PRKD2;INPP5K;NCK1;HSP90AB1;FNIP2;HDAC6;TBK1;LATS1;AKAP9;CAPRIN2;PPM1F;RIPK2;BDNF;APP;IL6;RAF1;CNKSR3;DMD;RPTOR;ARAF;BCAR3;TERF2IP;SNCA;ATP2B4;MLXIPL
prerank,establishment of mitotic spindle localization (GO:0040001),0.4327963149487879,1.1055430576268483,0.3445491251682369,0.7890988757796314,1.0,5/28,11.61%,MAD2L1;NDEL1;FBXW11;NDC80;PAFAH1B1
prerank,positive regulation of viral process (GO:0048524),0.37863373347842827,1.1052403809428224,0.31338028169014087,0.7893369342453981,1.0,19/60,18.93%,VPS4A;POLR2J;TARBP2;DHX9;CTDP1;GTF2F2;KPNA2;CNOT7;DDB1;SRPK2;POLR2E;POLR2B;CCNT1;ADARB1;POLR2G;RAB7A;MDFIC;CDK9;POLR2K
prerank,regulation of NMDA receptor activity (GO:2000310),-0.32237353059229573,-1.1051965711294165,0.3008849557522124,1.0,1.0,14/32,18.57%,GRIA3;GRIN2B;DLG2;NLGN1;LRRC7;GRIA1;OPRM1;DLG1;EPHB2;DLG3;GRIN1;CAMK2A;CCR2;CAPN1
prerank,histone H4 acetylation (GO:0043967),0.39756412139455305,1.1049778300998307,0.3281807372175981,0.789501860161981,1.0,15/47,16.90%,ACTL6B;KANSL3;CHD5;ACTL6A;EP400;NAA60;TRRAP;JADE1;BRD8;KANSL1;MORF4L2;MORF4L1;ING4;KMT2A;PER1
prerank,positive regulation of developmental growth (GO:0048639),0.40033491967229085,1.104957068355426,0.33608490566037735,0.7889387059423206,1.0,17/49,22.85%,CPNE9;RIMS1;RUFY3;SMURF1;BDNF;GOLGA4;CDKL5;LIMK1;SYT1;DBNL;ZFYVE27;SYT4;PLAA;AGRN;ITSN2;GHR;SHTN1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.3448771569622932,1.1047671975297846,0.2457200402819738,0.788882457532271,1.0,77/341,13.44%,BAG6;MAD2L1;ARIH2;RNF7;NFE2L2;SQSTM1;UBR4;CUL3;VPS4A;VPS28;SIAH2;UBE2S;PSMD2;RNF20;PSMC4;FBXW11;RNF115;UCHL1;KAT5;UBE3D;PSMD4;PSMD1;VPS37B;TAF1;RBCK1;KBTBD7;SMURF1;UBE2D1;OTUD7B;PSME3;PCBP2;PSMB6;PSMD10;SIRT1;ZRANB1;TBL1X;KCTD5;ANAPC5;UBA6;UBE2E1;UBA1;UBE2D3;TOM1L1;KCTD2;CTNNB1;COPS3;ARRB1;COP1;FBXW4;FBXW5;BIRC6;PSMB1;RC3H1;CHFR;RNF167;NEDD8;CNOT4;SIRT2;UBE2L3;UBXN1;PSMD11;ANAPC10;RC3H2;PSMA2;PSMD13;MYLIP;RNF43;UBE2I;FBXL17;DDB1;RNF144A;RNF19B;UBE4A;RNF215;STUB1;PSMB10;ZNRF3
prerank,positive regulation of cholesterol efflux (GO:0010875),0.44933206952203325,1.1046528973319407,0.35714285714285715,0.7885945209197308,1.0,6/21,16.45%,APOE;ZDHHC8;LRP1;SIRT1;GPS2;RXRA
prerank,mRNA modification (GO:0016556),0.4483843381384058,1.1046059225666363,0.34492350486787204,0.7881290146331753,1.0,1/22,0.08%,RPUSD2
prerank,extracellular structure organization (GO:0043062),0.3514798003895263,1.1044525876207258,0.2791411042944785,0.7879845940313728,1.0,25/204,9.86%,ADAMTS1;ADAMTS12;BCAN;LAMA3;LAMA4;NID1;SERPINE1;NCAN;PDGFA;COL1A2;TNR;TGFBR1;ITGB3;SPP1;COL1A1;SPARC;PDGFB;ITGAL;SLC39A8;ADAM19;FURIN;COL16A1;SMOC2;COL24A1;DDR2
prerank,negative regulation of protein modification process (GO:0031400),0.3726811376540685,1.1034945274462133,0.3118756936736959,0.7901963188979001,1.0,11/79,9.57%,CORO1C;PPP1R15B;CRTAP;WARS1;INPP5K;TARDBP;SIRPA;XRCC1;SIRT1;PRNP;TRAF3IP1
prerank,regulation of receptor internalization (GO:0002090),-0.321398439616019,-1.1033172589610318,0.2638888888888889,1.0,1.0,12/35,20.78%,RIN3;MTMR2;INSR;MAGI2;TBC1D5;ANGPT1;ATAD1;AHI1;VEGFA;ARRB2;SCYL2;ANKRD13D
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3672203097148524,1.1031377252722236,0.30618892508143325,0.7906170247787043,1.0,22/90,18.76%,KDM6B;CXCR4;GATM;GNAS;ADIPOR1;CMKLR1;EBF2;STAT6;ZBTB7B;KSR2;IL18;KDM1A;TRPV2;IL4R;PRKAB1;ADRB2;ADIPOR2;APC;CEBPB;ELOVL6;EPAS1;GJA1
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.37688887591420905,-1.1025216414723298,0.3053691275167785,1.0,1.0,4/18,3.14%,IL6R;SLC8B1;CAMK1D;MTUS1
prerank,hexose metabolic process (GO:0019318),0.40540578304173014,1.102401893567288,0.3367088607594937,0.7921306120590116,1.0,9/39,18.83%,TFAP2B;PGM1;APOD;GALK2;PMM1;PMM2;GALM;FUCA1;FUCA2
prerank,regulation of wound healing (GO:0061041),-0.3100563362836464,-1.1022828435588492,0.26288659793814434,1.0,1.0,14/42,20.42%,PTK2;PLAU;ARFGEF1;CASK;EPHB2;PRKCE;KANK1;ALOX5;ITGB1;CADM4;AJAP1;SRSF6;FGF2;DMTN
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.4639319205828673,1.102102788690266,0.35714285714285715,0.7923578612947134,1.0,9/21,21.20%,HS3ST3B1;XYLT1;SULF2;HS3ST5;HS3ST4;GLCE;HS6ST2;EXT2;HS6ST1
prerank,Golgi organization (GO:0007030),-0.24903725198835724,-1.1020001008469773,0.1935483870967742,1.0,1.0,28/112,11.79%,HACE1;SYNE1;VCPIP1;STX17;PDCD10;STX16;ATL2;HUWE1;GOLPH3L;ARHGAP21;TRAPPC12;UBXN2A;PRKD1;GOLGA2;TBC1D20;TMED7;COG7;CLASP2;LRRK2;ARFGEF1;TMED9;LMAN2;ATP8B4;PI4K2A;NSFL1C;GOLPH3;UBXN2B;LMAN1
prerank,response to unfolded protein (GO:0006986),0.3950383534114411,1.1016116158750968,0.3085234093637455,0.7931622507689463,1.0,18/48,22.82%,HSPA4;HSP90AB1;HSPA8;HSPB3;DNAJA1;HSPA5;TMBIM6;DNAJB2;DERL1;OPTN;HSPD1;TOR1B;DDIT3;HSPA4L;STT3B;DAB2IP;HERPUD1;BAG3
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.3371901049256928,-1.1015204191600634,0.2702702702702703,1.0,1.0,14/29,25.77%,UFSP2;CARM1;AXIN1;UBA5;STRN3;DDRGK1;CNOT9;CBFB;GPAM;KANK2;UFM1;KCTD6;BRCA1;VPS11
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.4471386255519286,1.1014085558598512,0.3516949152542373,0.7931153886437461,1.0,3/22,8.55%,PLEK;INPP5K;SIRT1
prerank,axonogenesis (GO:0007409),0.3489574129951862,1.1012935681625036,0.2862903225806452,0.7928237115325089,1.0,56/237,17.82%,GDNF;SEMA3G;EPHA1;BRSK1;EPHA2;SEMA4G;LLGL1;CXCR4;LAMA3;MAP1S;HSP90AB1;TNR;PLPPR4;ENAH;SLITRK3;SEMA6D;PIK3R1;KIF5A;SEMA6A;BRSK2;RYK;CYFIP1;NRXN3;UNC5C;DSCAM;ARTN;SCN1B;SEMA4C;KLF7;BDNF;BAIAP2;NRP2;B4GALT5;TAOK2;PTPRO;PTPRA;EPHA3;APP;SPTAN1;NPTN;VLDLR;AFG3L2;DOK1;SOS1;EPHA6;ACTB;CNTN4;PAX2;MAP1A;SEMA3A;FEZ2;PALLD;CTNNA2;NRCAM;DAG1;SEMA3D
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.4297348961143562,1.101259417604658,0.35286284953395475,0.7923049792935167,1.0,9/29,14.43%,IKBKB;TANK;TBK1;RPS27A;UBC;UBE2D1;UBE2D3;TRAF3;IKBKE
prerank,positive regulation of cyclase activity (GO:0031281),-0.4075388721899038,-1.1010537755860854,0.336283185840708,1.0,1.0,6/14,14.45%,CACNA1D;CACNA1C;STIM1;ORAI1;MAPK3;MAPK14
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.4545273260343957,1.1010316977743235,0.340941512125535,0.7923300400009918,1.0,11/21,20.82%,CORO1C;ACTG1;PTPRA;EPHA3;LIMCH1;LDB1;PEAK1;GPM6B;DUSP3;SLC9A1;VCL
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.35516377183680586,1.1007617492053876,0.29015544041450775,0.792487433060463,1.0,44/159,21.95%,SELP;PCDHB14;CXADR;CELSR2;CD84;NECTIN3;CADM3;SLITRK3;TGFBR2;CADM1;SDK2;ITGAL;ALCAM;TENM2;DSCAM;PTPRD;CLDN11;MPZ;PCDHGB4;CDH12;NPTN;IGSF11;PTPRS;DCHS1;CDH19;CNTN4;LRRC4;MAG;ICAM1;PALLD;ACVR1;CDH13;LRFN5;NECTIN4;ITGB2;GPC6;CDH20;NECTIN2;KIRREL3;FAT4;PTPRF;CD164;NTNG1;CDH2
prerank,meiosis I (GO:0007127),-0.3603832375574244,-1.100676462910023,0.29615384615384616,1.0,1.0,12/23,47.07%,BCL2L11;ZSCAN21;ING2;ZCWPW1;PTTG1;MYBL1;FOXJ3;DDX4;SYCP3;BRDT;SGO1;HSF2BP
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.4729396247712119,1.1004313526843656,0.3652173913043478,0.792843799651477,1.0,2/18,5.15%,SURF1;SMIM20
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.48029000795358867,1.100066064735303,0.35285285285285284,0.7933015905233302,1.0,3/17,17.67%,PLA2G4A;LPCAT1;CRLS1
prerank,cell-cell junction organization (GO:0045216),0.37475745856406656,1.0999814821049951,0.31201764057331866,0.7929328712185345,1.0,22/79,20.39%,MARVELD2;CXADR;NECTIN3;CADM3;CADM1;CTNND1;JUP;SDK2;ARVCF;CDH12;LIMS1;DCHS1;CDH19;FLCN;PKP4;SMAD3;CDH13;NECTIN4;CSF1R;CDH20;TJP1;NECTIN2
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.38369660608135836,1.0997101109370846,0.32828870779976715,0.7931308488289655,1.0,16/61,15.38%,PSMD2;PSMC4;PSMD4;PSMD1;PSME3;PSMB6;PSMD10;SIRT1;SIRT5;PSMB1;PSMD11;PSMA2;PSMD13;PSMB10;PSMB3;AZIN1
prerank,regulation of rRNA processing (GO:2000232),0.47104893410416543,1.0993352587682674,0.36890243902439024,0.7936190929481052,1.0,7/16,22.75%,RIOK1;UTP15;WDR43;YTHDF2;WDR75;USP36;RIOK2
prerank,regulation of type I interferon production (GO:0032479),0.3696833840605425,1.0989161048746787,0.3348164627363737,0.7942773721978277,1.0,30/84,19.69%,ACOD1;PIN1;RELA;TBK1;DDX41;TRIM56;XRCC5;POLR3B;STAT6;DHX9;PCBP2;CRCP;TRAF3IP1;CTNNB1;CREBBP;IRF8;POLR3F;POLR2E;ILRUN;TRAF3;IKBKE;TNFAIP3;NFKB1;NLRC5;CGAS;POLR2K;NLRX1;POLR3E;RNF216;ITCH
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.5285552799843736,1.098796796460206,0.3674418604651163,0.7940276899597246,1.0,3/10,13.41%,PRNP;RC3H1;SCRIB
prerank,regulation of fatty acid metabolic process (GO:0019217),0.4723406636624883,1.0985155759643432,0.3668188736681887,0.7942250170297644,1.0,4/17,15.58%,ADIPOR1;EIF6;NCOR1;ADIPOR2
prerank,regulation of phosphorylation (GO:0042325),0.3560424009861718,1.0982721041084624,0.30655391120507397,0.7943327831526735,1.0,31/120,17.08%,CORO1C;SESN2;NUP153;PIN1;NDC1;IKBKB;FNIP2;SDCBP;ZBTB7A;GLMN;EIF6;PTGES3;NUP88;SIRT1;DSCAM;KCTD20;NUP210;PRKAG1;NUP37;SIRT2;APP;NUP98;PGAM1;LDB2;LDB1;NUP54;FLCN;BTBD10;CCDC88A;ILK;NLRC5
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.3753778767058282,1.0978487658889142,0.33144796380090497,0.7949268524603301,1.0,23/75,18.17%,BRSK1;LLGL1;CELSR2;MAP1S;PLPPR4;SLITRK3;BRSK2;RYK;LRP4;KLF7;BAIAP2;TAOK2;APP;BTBD3;AFG3L2;ACTB;CNTN4;PAX2;MAP1A;MEF2A;CTNNA2;NRCAM;MEF2C
prerank,Notch signaling pathway (GO:0007219),0.38479522389333015,1.097592500758807,0.3356562137049942,0.7950922403480932,1.0,11/59,11.47%,MYC;ADAM17;MAML3;POFUT1;JAG1;DLGAP5;CREBBP;DTX3;YBX1;RBPJ;MAML1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.33913953688065823,-1.097349868212312,0.288,1.0,1.0,7/27,8.54%,PID1;PIP4K2A;PIP4K2B;ENPP1;PRKCD;IRS1;PTPN1
prerank,regulation of sequestering of triglyceride (GO:0010889),0.4822517297619948,1.0969008351186451,0.37462235649546827,0.7965008109996817,1.0,3/15,12.04%,LPL;OSBPL8;PLIN2
prerank,negative regulation of cell communication (GO:0010648),0.44819767835889596,1.0967700107341827,0.35082872928176795,0.7962716001813941,1.0,1/21,0.18%,OSM
prerank,DNA conformation change (GO:0071103),-0.37572823770707076,-1.0967537213303422,0.2972972972972973,1.0,1.0,12/17,34.80%,TOP1;HAT1;TOP3B;TOP3A;HHEX;ERCC3;HMGB2;ABL1;TOP2A;TOP1MT;NAA10;KAT6A
prerank,glutathione derivative metabolic process (GO:1901685),0.4491921455707688,1.0965464645649818,0.37965616045845274,0.7957447803229077,1.0,3/20,9.84%,HPGDS;ESD;GSTO2
prerank,glutathione derivative biosynthetic process (GO:1901687),0.4491921455707688,1.0965464645649818,0.37965616045845274,0.7957447803229077,1.0,3/20,9.84%,HPGDS;ESD;GSTO2
prerank,cation transport (GO:0006812),0.35470544327153875,1.0964444845007666,0.3077720207253886,0.7954432414953845,1.0,21/167,13.65%,KCNK4;KCNJ6;SLC7A1;SLC23A1;SLC22A4;FGF13;KCNK9;SCN8A;SLC3A2;TRPM4;KCNMB2;KCNMB3;KCNJ2;SLC6A6;ATP1B1;ANO10;SLC36A1;TRPM2;SLC1A1;KCNC1;KCNMA1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3395153337616971,1.0963221152058358,0.2602602602602603,0.7951929710270481,1.0,81/348,20.13%,CCL3;MYC;EGR1;CSF1;STAT3;NFE2L2;WARS1;TYROBP;PIK3R3;ATP13A2;SOX9;FUBP3;RIMS1;ATF4;MAP2K1;TGFBR1;DNAJA4;PDGFB;TRIM28;ADAM19;EIF2AK3;ZBTB7B;IL1A;BMP6;F3;MAPK8;MSN;FAM98B;ACTG1;PPM1F;ARRB1;RBPJ;PRKAG1;MITF;HPN;SETDB1;CLU;VPS35;ANXA2;NSF;IGF1;APP;INPP5F;DGKQ;SRPK2;SCRIB;FMR1;MBIP;ZPR1;PRKAB1;WFS1;LIMS1;SLC11A1;EPB41L4B;MTOR;IL6;MED1;CTCF;AGO3;FGF9;KRAS;SMO;PICK1;UBR5;SMAD3;ZC3H12A;ETS1;NWD1;TNRC6C;MEF2C;PRKAA1;PDCL3;GJA1;MED23;NTRK2;RPL23;TLR2;ITCH;SNCA;NR5A1;AGO2
prerank,inositol phosphate biosynthetic process (GO:0032958),0.5125006894664208,1.0961558069918877,0.3739967897271268,0.7950470330041186,1.0,5/11,16.55%,ITPKC;ITPKB;IP6K2;IPPK;PPIP5K1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.5222993714382703,1.0960537069882255,0.3682539682539683,0.794708077438737,1.0,5/10,21.09%,KLF15;SIRT1;FLCN;PRKAA1;DIP2A
prerank,renal system development (GO:0072001),0.39155752414799055,1.0959104808232667,0.342042755344418,0.7944718211706414,1.0,10/52,15.75%,BAG6;TFAP2B;TGFBR1;AGT;ARL3;LRP4;TRAF3IP1;WFS1;SULF2;PAX2
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.44505975355964567,1.0953649128740623,0.35437589670014347,0.7954386197771216,1.0,4/20,8.37%,ADAM17;HSP90AB1;PDGFB;PSMD10
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.4404820285024194,-1.0953508912990448,0.37270341207349084,1.0,1.0,4/11,7.74%,VCPIP1;LPCAT3;ATL2;ARL6IP1
prerank,mismatch repair (GO:0006298),0.4305654002772191,1.095331567251453,0.33902759526938236,0.7949210028823515,1.0,9/27,19.11%,MSH5;LIG1;PCNA;MLH3;MSH3;POLD4;TDG;POLD3;RNASEH2A
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.4506954523707942,1.0952726618235744,0.3665283540802213,0.7944563551974468,1.0,2/22,7.04%,SLC7A5;TRPM4
prerank,negative regulation of GTPase activity (GO:0034260),-0.35418009471471745,-1.0952665894420863,0.33079847908745247,1.0,1.0,11/22,24.51%,RDX;LRRK2;ARFGEF1;CPEB2;LRCH1;GPSM1;BCAS3;ARL2;F11R;SH3BP4;PLXNB3
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.4501798075820126,1.0951197125151888,0.35027472527472525,0.7943108495725945,1.0,7/20,19.39%,TFAP2B;KCNJ2;ATP1B1;ATP6AP1;KCNMA1;ATP1A3;SLC9A1
prerank,neutrophil degranulation (GO:0043312),0.3414872412197738,1.0949848074977562,0.23847695390781562,0.7940966394737726,1.0,95/425,16.31%,CRACR2A;PLEKHO2;GLIPR1;CTSB;PTGES2;CTSD;ADAM8;UBR4;PLAUR;PGM1;ARSA;TYROBP;IDH1;ATP6V1D;PSMD2;HSP90AB1;HMGB1;GLB1;RAB18;GUSB;SIRPA;DDOST;PSMD1;PNP;STK11IP;HSPA8;CYBB;RHOG;FRMPD3;ANXA3;DEGS1;JUP;TXNDC5;ACLY;GALNS;GCA;SDCBP;CD55;ITGAL;TSPAN14;XRCC5;RAB31;CCT8;CTSA;NRAS;COTL1;BRI3;PDXK;CAND1;CYFIP1;DPP7;TUBB;PTPRC;ATP6V0A1;PYCARD;CYSTM1;STXBP3;ATP6V0C;PA2G4;PSMB1;ACTR1B;DERA;LPCAT1;PTPN6;AP1M1;CD33;PSMD11;CMTM6;PSMA2;PSMD13;TRPM2;ANXA2;DOCK2;DIAPH1;PSAP;CPPED1;PTPRN2;TOM1;SPTAN1;CAP1;ATP6AP2;PGRMC1;TMEM30A;SLC11A1;IST1;ARPC5;MOSPD2;DBNL;TNFRSF1B;PGAM1;RNASE3;RAC1;DYNC1LI1;DNASE1L1;VAT1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.46328748005391196,1.0949313532639242,0.35878962536023057,0.793659315437925,1.0,4/18,9.07%,CCL2;CACNG8;PTK2B;CACNG2
prerank,positive regulation of keratinocyte migration (GO:0051549),0.5288013006958577,1.094835378076799,0.3987138263665595,0.7933034852049602,1.0,4/10,20.05%,ADAM9;EPB41L4B;MTOR;MAP4K4
prerank,regulation of actin filament bundle assembly (GO:0032231),0.4321587628364869,1.0943384028748495,0.34084880636604775,0.7940988842246997,1.0,9/26,20.99%,SHANK1;PLEK;PFN1;ACTG1;LIMK1;RAC1;ASAP3;SLC9A1;CDC42
prerank,neutrophil activation involved in immune response (GO:0002283),0.3411113866015435,1.0940562838621688,0.24348697394789579,0.7943273545568509,1.0,95/428,16.31%,CRACR2A;PLEKHO2;GLIPR1;CTSB;PTGES2;CTSD;ADAM8;UBR4;PLAUR;PGM1;ARSA;TYROBP;IDH1;ATP6V1D;PSMD2;HSP90AB1;HMGB1;GLB1;RAB18;GUSB;SIRPA;DDOST;PSMD1;PNP;STK11IP;HSPA8;CYBB;RHOG;FRMPD3;ANXA3;DEGS1;JUP;TXNDC5;ACLY;GALNS;GCA;SDCBP;CD55;ITGAL;TSPAN14;XRCC5;RAB31;CCT8;CTSA;NRAS;COTL1;BRI3;PDXK;CAND1;CYFIP1;DPP7;TUBB;PTPRC;ATP6V0A1;PYCARD;CYSTM1;STXBP3;ATP6V0C;PA2G4;PSMB1;ACTR1B;DERA;LPCAT1;PTPN6;AP1M1;CD33;PSMD11;CMTM6;PSMA2;PSMD13;TRPM2;ANXA2;DOCK2;DIAPH1;PSAP;CPPED1;PTPRN2;TOM1;SPTAN1;CAP1;ATP6AP2;PGRMC1;TMEM30A;SLC11A1;IST1;ARPC5;MOSPD2;DBNL;TNFRSF1B;PGAM1;RNASE3;RAC1;DYNC1LI1;DNASE1L1;VAT1
prerank,cellular response to acid chemical (GO:0071229),0.42882774661898554,1.0939482369585556,0.3604806408544726,0.7940452837772224,1.0,5/27,9.68%,SESN2;IPO5;RRAGC;LARS1;CPEB1
prerank,regulation of apoptotic process (GO:0042981),0.33967684231929224,1.0937348208274615,0.159,0.794046069431146,1.0,126/676,15.91%,GDNF;MYC;EGR3;MAD2L1;PRELID1;DDX20;TFAP2B;ARHGDIA;CTSB;BCL2L1;BEX2;SQSTM1;CTSD;DDX42;ARL6IP5;C1QBP;PLAUR;JUN;PRMT2;AIFM2;HIGD1A;CLIP3;HNRNPK;SIAH2;LGALS1;BID;HMGB1;SOX9;KLF11;NUPR1;IKBKB;RPL10;ATF4;TARDBP;KALRN;RYBP;RELA;UTP11;RHOB;DNM2;RPS27A;UBC;RTN4;ARHGEF26;EGLN2;PCID2;PRDX5;BCL2L2;PIK3R1;QRICH1;TXNDC5;ZBTB7A;AGT;FAIM2;RRP1B;LANCL1;ARHGEF4;GLS2;ARHGEF6;DNAJA3;PTK2B;PPT1;PSMD10;LATS1;TCIM;SMPD1;SIRT1;DNAJA1;MAPK8;PYCARD;PHLPP1;PIM3;CTNNB1;FGD1;ANKRD13C;IP6K2;HDAC1;RIPK2;CREBBP;PA2G4;BIRC6;BAG1;CASP9;PTPN6;BAD;HPN;BNIP1;CHM;ADAMTSL4;HSPA5;CBX4;TMBIM6;CLU;DDAH2;STK17B;TRIO;IGF1;ERC1;CFLAR;RABGGTB;MTCH1;DPEP1;UBE2Z;SCRIB;FOXO3;BCL6;NAE1;KCNMA1;SETX;ARF4;WFS1;MTDH;TMBIM4;FLNA;ATF6;SOS1;IL6;HGF;MED1;ING4;YME1L1;PAX2;RAF1;DAPK1;LCMT1;FLCN
prerank,positive regulation of neuron differentiation (GO:0045666),-0.296007546349345,-1.0934771069466842,0.25396825396825395,1.0,1.0,17/40,34.90%,RHOA;TCF4;ZEB1;BRINP3;MMD2;GPRC5B;VWC2;SOX11;PROX1;TRIM32;BEND6;PCP4;BRINP1;HOXD3;BRINP2;ECT2;NBL1
prerank,synaptic membrane adhesion (GO:0099560),0.4932816082814704,1.0933099589631543,0.36786786786786785,0.7947268728106589,1.0,8/14,21.73%,SLITRK3;PTPRD;PTPRS;LRRC4;LRFN5;GPC6;PTPRF;NTNG1
prerank,positive regulation of lipid metabolic process (GO:0045834),0.44235549352892206,1.0932663510144014,0.34716459197787,0.7942507707511797,1.0,4/22,14.89%,DISP3;APOE;CREB1;MTOR
prerank,negative regulation of lymphocyte activation (GO:0051250),0.4470095660873161,1.093177354262967,0.3610719322990127,0.7939242436937889,1.0,6/21,18.69%,SAMSN1;TNFAIP8L2;PAG1;TNFAIP3;GPNMB;DUSP3
prerank,regulation of JNK cascade (GO:0046328),0.3624698018199323,1.0925976683593297,0.33225458468176916,0.7949821956570814,1.0,19/101,14.44%,SERPINF2;SLAMF1;LTBR;ANKRD6;HMGB1;DUSP19;SIRPA;SDCBP;CARD9;PTK2B;MAP4K2;PYCARD;PHLPP1;TAOK2;APP;GPS2;TRAF3;MBIP;NCOR1
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.4487942510614569,-1.092169936600969,0.35038363171355497,1.0,1.0,4/11,5.26%,PARP6;PARP12;PARP9;TIPARP
prerank,mRNA catabolic process (GO:0006402),0.40354780676400176,1.0917731593313948,0.3584905660377358,0.7968245886836861,1.0,12/44,17.81%,LSM5;ZFP36;RIDA;TUT7;DHX34;RC3H1;EXOSC10;DDX5;CNOT10;AGO3;YTHDF2;UPF1
prerank,mitochondrion organization (GO:0007005),0.3492359035508009,1.091678865263294,0.3145491803278688,0.796515913433056,1.0,39/165,17.16%,TIMM8B;MTX1;PISD;BCL2L1;AIFM2;CXADR;HIGD1A;BID;SSBP1;DNM2;LONP1;MTM1;DNAJC19;MTFP1;TRAK1;DNAJA3;TOMM20;POLG2;COX7A2;ADCK1;SLC25A33;SLC25A36;GABPB1;PPRC1;GDAP1;TIMM44;SIRT5;COX7A2L;RAB32;RAB5IF;TMEM11;TIMM9;TFB2M;AFG3L2;YME1L1;HSPD1;ATP5F1D;MEF2A;MTFR1L
prerank,positive regulation of dendritic spine development (GO:0060999),0.4575527574448738,1.0910143719770218,0.373134328358209,0.7978599496501394,1.0,6/20,15.29%,DLG5;SHANK1;APOE;CAPRIN2;FMR1;DBNL
prerank,response to calcium ion (GO:0051592),0.36364979737864994,1.0909439784384487,0.3272921108742004,0.79746055777015,1.0,35/102,22.96%,CPNE9;ADD1;ADAM9;ANXA11;CPNE8;CLIC4;SLC25A13;KCNMB2;KCNMB3;SMPD1;TRPC1;ITPKB;PEF1;TRPC3;TRPM2;DPEP1;ADCY8;KCNMA1;SYT1;RASGRP2;MEF2A;CPNE3;SYT4;PDCD6;MEF2C;PRKAA1;AHCYL1;CARF;SYT10;CAMK2D;CPNE4;MCOLN1;SYT9;HOMER1;ALOX5AP
prerank,positive regulation of organelle organization (GO:0010638),-0.3223655774800026,-1.0908325881245928,0.31512605042016806,1.0,1.0,11/32,14.11%,C2CD5;RAB3GAP2;PFDN2;IRGM;TMED9;PPARGC1A;AKT2;LMAN1;SMCR8;GSK3B;KATNBL1
prerank,sensory perception of sound (GO:0007605),0.3686418141165891,1.0906783813970313,0.3355408388520971,0.7976536812049864,1.0,10/88,14.27%,WDR1;MARVELD2;TIMM8B;COL1A1;GSDME;TBL1X;HPN;TIMM9;ROR1;WFS1
prerank,neuron migration (GO:0001764),-0.29603875745074915,-1.0905608191027927,0.2654320987654321,1.0,1.0,15/48,17.31%,AUTS2;NAV1;DISC1;ASTN1;ADGRL3;DNER;SH3RF1;DCX;MAP1B;SPOCK1;CEP85L;PEX13;MARK1;NRP1;CDK5
prerank,striated muscle tissue development (GO:0014706),0.4275343576272523,1.090450152563057,0.3836898395721925,0.7977150763164241,1.0,5/29,12.46%,BMP5;POPDC3;MYL6;IGSF8;CFLAR
prerank,glutathione metabolic process (GO:0006749),0.4064335339903924,1.0903045946178742,0.34045226130653267,0.7975413960370328,1.0,6/38,13.11%,MMACHC;GLRX2;HPGDS;CHAC2;HAGH;DPEP1
prerank,nervous system development (GO:0007399),0.34006774263087103,1.0902230028891535,0.23223223223223224,0.7971655868131367,1.0,80/429,17.48%,GDNF;EGR2;SOX10;STAT3;PCDHB14;ADORA1;BCAN;ZIC1;SCD5;CXCR4;ACTL6B;BTBD6;FZD5;EIF2B2;CLN5;MAP1S;NCAN;TPP1;FGF13;NDP;NINJ1;KALRN;ESS2;UTP11;ACTL6A;DPF2;TGFBR1;NRSN2;ELP3;SDK2;SCN8A;CRIM1;RAPGEFL1;NCKAP1;TRAK1;SEMA6A;JAG1;ATXN10;CLN8;PPT1;RYK;SMPD1;ACVR1B;DSCAM;ARTN;POU3F2;BDNF;ZC4H2;MPZ;SNTG2;MOG;GMFB;LIMK1;MYLIP;IGSF8;FBXL17;SLC2A1;LPAR1;BTBD3;POU6F2;VLDLR;GPM6A;WWTR1;DBNL;MARCKSL1;DCHS1;CNTN4;LDB2;LDB1;ADAM23;DYRK1A;IRF2BPL;PMP22;NDUFV2;APC;GPM6B;SMO;FEZ2;BTBD2;NRCAM
prerank,response to prostaglandin E (GO:0034695),-0.4467487907637532,-1.0901842547155,0.34554973821989526,1.0,1.0,3/10,11.63%,GNG2;TGFBR3;PTGER4
prerank,regulation of erythrocyte differentiation (GO:0045646),0.40235338721202885,1.0899338302504764,0.34777070063694265,0.7974010098026052,1.0,13/35,20.39%,STAT3;ZFP36;CDK6;ACVR1B;SPI1;ANKRD54;FOXO3;ABCB10;MED1;LDB1;ETS1;PRMT1;TAL1
prerank,limb development (GO:0060173),-0.33029146223423084,-1.0890732505514924,0.34710743801652894,1.0,1.0,10/28,27.28%,SALL1;PTCH1;MEGF8;KREMEN1;KAT2B;INTU;FGF10;SMOC1;COMP;RSPO2
prerank,regulation of telomere capping (GO:1904353),0.43605159481330424,1.0885743879727554,0.35195530726256985,0.8007818318017035,1.0,4/23,9.60%,NEK7;HNRNPD;MAP2K7;NBN
prerank,regulation of cellular component biogenesis (GO:0044087),0.4049628833182693,1.0884932460118923,0.3470661672908864,0.800394965805946,1.0,9/39,11.62%,GFAP;HSPA8;APOE;AGT;LATS1;PARP10;MSN;HJURP;SNCAIP
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.37318064176711463,1.0884166092832843,0.3669724770642202,0.8000189287409699,1.0,17/66,17.55%,SESN2;ZIC1;IPO5;LARP7;JUP;PIK3R1;TRIM28;CCT8;EIF2AK3;CCT7;ZPR1;FLNA;WWTR1;CCT6A;UBR5;SMAD3;ZC3H12A
prerank,positive regulation of heart rate (GO:0010460),-0.3790285349018077,-1.0883758240006487,0.3092105263157895,1.0,1.0,7/17,27.82%,ATP2A2;TPM1;PDE4D;ADRA1A;ADRA1B;ADRB1;SCN3B
prerank,regulation of axonogenesis (GO:0050770),0.3839532388417731,1.0881336089502853,0.35093896713615025,0.8002286573964877,1.0,8/51,8.29%,ARHGDIA;BRSK1;METRN;PLXNA1;RUFY3;RTN4;BRSK2;LRP4
prerank,cardiac myofibril assembly (GO:0055003),0.48025060772476585,1.0875914260440183,0.36186186186186187,0.8011873199972848,1.0,1/15,0.63%,PDGFRB
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.48009150502977915,1.0871389441836792,0.36661698956780925,0.8018763686612357,1.0,3/15,9.67%,KCNH2;KCNJ2;ATP1B1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.5178374799258383,1.0871026726893929,0.38323353293413176,0.8007628891916089,1.0,5/10,16.52%,AP2A1;CLTC;MYLIP;VLDLR;AP2M1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.5178374799258383,1.0871026726893929,0.38323353293413176,0.8007628891916089,1.0,5/10,16.52%,AP2A1;CLTC;MYLIP;VLDLR;AP2M1
prerank,negative regulation of lymphocyte migration (GO:2000402),0.532344312557066,1.0869491336562604,0.3684210526315789,0.8006346524049619,1.0,3/10,11.37%,APOD;CD200R1;CD200
prerank,mitochondrial transport (GO:0006839),0.38802593077372444,1.086863629235403,0.3595238095238095,0.8002949057473945,1.0,13/53,14.50%,TIMM8B;BCL2L1;STARD3;DNAJC19;SLC25A13;TOMM20;GDAP1;TIMM44;BAD;SLC25A5;TIMM9;ABCB10;TMEM14C
prerank,mesenchyme morphogenesis (GO:0072132),0.4604438749551586,1.0867720692046146,0.3895522388059702,0.79997212069563,1.0,3/17,8.66%,SOX9;MDM4;ENG
prerank,regulation of microtubule-based movement (GO:0060632),0.5031851171771136,1.0867589334051848,0.373015873015873,0.7994094651073076,1.0,2/11,5.28%,HDAC6;DYNLT2B
prerank,peptidyl-tyrosine modification (GO:0018212),0.38820980396865495,1.0863922507772412,0.3684820393974508,0.7998341607227406,1.0,11/56,11.88%,PDGFRB;EPHA1;ABI2;TTL;ABL2;PDGFB;PTK2B;DDR2;EFEMP1;PTPN6;EPHA3
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.42215906859597674,1.0860272969005245,0.3745072273324573,0.8003019999241063,1.0,9/30,14.43%,IKBKB;TANK;TBK1;RPS27A;UBC;UBE2D1;UBE2D3;TRAF3;IKBKE
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.3929034758851162,-1.085998819644739,0.33226837060702874,1.0,1.0,3/17,7.94%,NCKAP1L;P2RY12;PIEZO1
prerank,negative regulation of cell adhesion (GO:0007162),-0.2602384780462711,-1.0855269022410285,0.26,1.0,1.0,15/72,9.55%,RHOA;SEMA5A;SIPA1;TBCD;ADAM22;PLXNC1;LPXN;PLXNB2;PTK2;JAM3;ARHGDIB;TGFBI;NOTCH1;SPOCK1;EPHB2
prerank,oogenesis (GO:0048477),-0.4030852269186163,-1.0851914012072437,0.35294117647058826,1.0,1.0,2/15,0.93%,FMN2;MARF1
prerank,sulfur compound biosynthetic process (GO:0044272),0.3587433864988056,1.0850071375324337,0.3311827956989247,0.8026462626195741,1.0,15/104,11.12%,CHST11;BCAN;CHPF;NCAN;CHST12;LIAS;CDO1;CSPG4;HPGDS;CHAC2;ESD;GSTO2;HAGH;SLC35D2;B4GALT5
prerank,cellular response to retinoic acid (GO:0071300),0.40530923455556156,1.0848348156251058,0.364190012180268,0.8025289999501044,1.0,10/42,17.28%,WNT5B;SOX9;ABL2;PTK2B;EPHA3;SETX;NDUFA13;CREB1;PAX2;HTRA2
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.44711220010207386,1.0845166248915645,0.3789173789173789,0.802844808634885,1.0,5/20,11.67%,GATM;CHAC2;PTDSS2;HAGH;FPGS
prerank,positive regulation of gene expression (GO:0010628),0.3345310311466098,1.0842953837390017,0.26452905811623245,0.8028811172442366,1.0,95/442,18.98%,CCL3;MYC;EGR1;CSF1;STAT3;NFE2L2;WARS1;TYROBP;PIK3R3;HNRNPD;ATP13A2;HABP4;SOX9;FUBP3;RIMS1;EIF2AK2;ATF4;FXR2;LARP6;MAP2K1;TGFBR1;CADM1;PIK3R1;DNAJA4;LARP4B;PDGFB;AGT;GLMN;EIF6;MYO1C;U2AF2;CARD9;ADAM19;EIF2AK3;TBP;ZBTB7B;IL1A;BAZ1B;DDX21;BMP6;F3;MAPK8;MSN;FAM98B;ACTG1;PPM1F;RBPJ;PRKAG1;MITF;NSUN5;HPN;CLU;VPS35;IGF1;APP;DGKQ;DDX5;SRPK2;POLR2E;FMR1;SETX;MBIP;ZPR1;PRKAB1;LIMS1;SLC11A1;EPB41L4B;MTOR;IL6;MED1;CTCF;ACTB;FLOT1;DYRK1A;HNRNPLL;AGO3;FGF9;KRAS;KAT2A;SMO;UBR5;SMAD3;ZC3H12A;ELAVL1;ETS1;PIK3CG;NWD1;TNRC6C;MEF2C;PRKAA1;PDCL3;GJA1;MED23;POLR2K;NTRK2
prerank,mesenchymal cell differentiation (GO:0048762),0.38368355761390777,1.0842532212925569,0.3609112709832134,0.8023830915614791,1.0,12/51,15.31%,DLG5;SOX9;TGFBR1;TRIM28;ENG;CTNNB1;RBPJ;FBXL17;DDX5;LIMS1;HGF;AKNA
prerank,positive regulation of telomere maintenance (GO:0032206),0.4126358228447087,1.084124649865496,0.36495388669301715,0.802135625944456,1.0,5/31,9.60%,NEK7;PPP1R10;HNRNPD;MAP2K7;NBN
prerank,negative regulation of viral genome replication (GO:0045071),0.4039899462942304,1.0840375363507182,0.3745271122320303,0.8018239804972477,1.0,9/40,14.26%,ILF3;INPP5K;EIF2AK2;IFITM3;PARP10;SETDB1;TNIP1;SRPK2;FAM111A
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.5105850810327648,1.083913605478348,0.3993759750390016,0.8016044953439014,1.0,1/11,0.41%,BAG6
prerank,amide biosynthetic process (GO:0043604),0.3949185402510529,1.0838369577423532,0.35697399527186763,0.8012424550148042,1.0,8/47,9.33%,ALOXE3;SPTSSA;DEGS1;SGMS1;CLN8;SMPD1;FURIN;PCSK1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.38051138227512254,-1.0836741125204268,0.3277591973244147,1.0,1.0,7/18,16.07%,SOX6;TMEM119;BHLHE41;NOTCH1;HDAC3;XBP1;GSK3A
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.33349025161182755,-1.0833420569840724,0.29707112970711297,1.0,1.0,7/28,8.54%,PID1;PIP4K2A;PIP4K2B;ENPP1;PRKCD;IRS1;PTPN1
prerank,organelle transport along microtubule (GO:0072384),0.41877159241315254,1.08318073662673,0.35917312661498707,0.8025275162787943,1.0,5/31,6.74%,NDEL1;MAP1S;FBXW11;UXT;TRAK1
prerank,peptidyl-threonine modification (GO:0018210),-0.27248350686868383,-1.0829265037072209,0.2923076923076923,1.0,1.0,23/66,18.02%,CDC42BPA;NLK;GALNT13;ROCK2;HIPK1;CDC42BPB;GALNT3;PRKCD;CSNK2A1;CSNK2A2;PRKD1;MAPK1;LRRK2;CDK10;GALNT16;WNK3;ULK1;GSK3B;GSK3A;MAP3K10;MAP3K12;CDK5;TNKS
prerank,positive regulation of ossification (GO:0045778),-0.3019408966943419,-1.0827648026094039,0.325,1.0,1.0,16/39,26.29%,ZBTB16;BMPR2;TMEM119;ATRAID;SLC8A1;ALOX5;PTPN11;NELL1;BMPR1A;ATP2B1;TGFB2;PKDCC;ADGRV1;SOX11;ACVR2A;P2RX7
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.4558054211662141,1.082502055226841,0.3845070422535211,0.8038579730529577,1.0,5/20,7.15%,ADAM17;MBTPS1;ADAM9;RELA;HM13
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.29078006218016617,-1.0823481115135727,0.31176470588235294,1.0,1.0,8/45,8.14%,JAK2;SP100;IRF5;IFNGR2;STAT1;PRKCD;PML;IRF3
prerank,mitotic spindle assembly (GO:0090307),-0.30785811239745536,-1.0820946264937372,0.30939226519337015,1.0,1.0,26/42,38.80%,RHOA;SMC3;CHEK2;OFD1;GOLGA2;CLASP2;LSM14A;ABRAXAS1;SMC1A;BCCIP;AAAS;KPNB1;RACGAP1;CLASP1;MAP9;SPICE1;KIF23;KIF11;TPX2;PRC1;KIFC2;KIF2A;STAG2;KIF4A;KIFC1;TOGARAM2
prerank,fatty acid transmembrane transport (GO:1902001),0.4554820867621906,1.0815312012365776,0.37517433751743373,0.8061262963192425,1.0,4/19,13.45%,THRSP;MID1IP1;ACACA;SLC2A1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.39953261050085687,-1.0814765141155738,0.34916201117318435,1.0,1.0,3/15,13.99%,LRP6;HDAC2;ROGDI
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.44175967147645745,1.0809099370568391,0.3787878787878788,0.8073592190631201,1.0,7/22,12.63%,DDB2;RPS27A;UBC;GTF2H4;CHD1L;ERCC2;DDB1
prerank,transcription preinitiation complex assembly (GO:0070897),0.5044376061204977,1.0807889236343824,0.3902439024390244,0.8071373921109795,1.0,4/12,11.29%,TAF1;TAF12;TBP;DR1
prerank,DNA-dependent DNA replication (GO:0006261),0.34865380988394534,1.0805719970778902,0.35287958115183243,0.8072119846716561,1.0,26/128,13.37%,WRNIP1;PSMD2;PSMC4;SSBP1;GINS3;PSMD4;PSMD1;MCM2;RPS27A;UBC;RPAIN;PSME3;BAZ1A;PSMB6;ORC5;POLG2;POLB;PSMD10;DDX21;PSMB1;PSMD11;PSMA2;PSMD13;POLD4;SRPK2;PSMB10
prerank,regulation of gene silencing by miRNA (GO:0060964),0.3734350323665961,1.0804172997150345,0.347010550996483,0.8070477596827049,1.0,20/62,20.13%,STAT3;ZFP36;POLR2J;NUP153;NDC1;DHX9;NUP88;PUM2;NUP210;NUP37;POLR2E;FMR1;NUP98;POLR2B;NUP54;POLR2G;ELAVL1;POLR2K;RANBP2;AGO2
prerank,cellular respiration (GO:0045333),0.3990262195582544,1.0803866602786962,0.3655514250309789,0.8065340847442611,1.0,10/41,17.61%,SURF1;COQ10B;SLC25A13;UQCRC1;UQCRB;UQCRFS1;NDUFA5;ATP5F1D;MTFR1L;SLC25A14
prerank,cytosolic calcium ion transport (GO:0060401),-0.33470196443522465,-1.0803547278446566,0.3387096774193548,1.0,1.0,11/28,24.01%,ATP2A2;CACNA1C;SLC8A1;MCUB;MICU3;ADRA1A;ATP2B1;ATP2B3;JPH4;ITPR3;MAIP1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.44103760414658566,-1.0803433841261636,0.3821138211382114,1.0,1.0,5/11,23.85%,JAK2;HDAC2;XBP1;TAF7;CIITA
prerank,myelin assembly (GO:0032288),0.5191685650312,1.0798702808972487,0.3863275039745628,0.8074235325363799,1.0,2/10,8.12%,CD9;CNTNAP1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.4922940466951147,1.0797774101570834,0.37025796661608495,0.8070907068130425,1.0,4/12,15.68%,PTPRC;RC3H1;ELF2;RUNX1
prerank,alpha-amino acid metabolic process (GO:1901605),0.3990909747826779,1.0797752906817197,0.38228155339805825,0.8065018792289663,1.0,12/45,14.48%,SLC25A13;GLS2;GLS;ALDH18A1;GLUD1;GOT2;DDAH2;GPT2;PYCR2;DPEP1;FOLH1;GOT1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.29756661234549453,-1.0790932399929118,0.30601092896174864,1.0,1.0,13/43,16.07%,PID1;PIP4K2A;PIP4K2B;NUCKS1;ENPP1;SNX5;PRKCD;IRS1;PTPN1;KANK1;PTPN11;SORBS1;GSK3A
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.4754920091312035,1.0784789617228752,0.3964757709251101,0.8095922092180293,1.0,2/16,6.86%,SLC39A14;MRAP2
prerank,regulation of neurogenesis (GO:0050767),-0.2852862005176172,-1.0781303345230946,0.29411764705882354,1.0,1.0,24/55,34.06%,DOCK7;SNW1;OPRM1;BHLHE41;NOTCH1;PRUNE1;MME;TGM2;FAIM;RGS14;CX3CR1;HMGB2;BHLHE40;CX3CL1;PER2;SOX11;NUMBL;TRIM32;SPEN;NAP1L1;TNF;YAP1;HES6;PCM1
prerank,alanine transport (GO:0032328),0.5293051257141079,1.0780259314204,0.39933444259567386,0.8104321909483422,1.0,4/10,21.64%,SLC6A6;SLC36A1;SLC36A4;SLC6A17
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.41086395238684736,-1.0779512389106984,0.3514285714285714,1.0,1.0,6/13,17.18%,RHOT1;BCL2L11;BNIP3;BAX;BLOC1S2;BNIP3L
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.3190532171669792,-1.0775583808245481,0.3292181069958848,1.0,1.0,12/30,19.89%,GTF2H1;GTF2H2;CDK7;TAF1D;MNAT1;UBTF;TAF1A;POLR1F;GTF2H5;TAF1B;ERCC3;CCNH
prerank,chemical synaptic transmission (GO:0007268),0.3397874470459211,1.077556861673376,0.3185929648241206,0.8112117618690552,1.0,49/284,15.07%,NPY;LPAR3;NAPA;PCDHB14;CNP;BRSK1;PENK;PDZD11;AKAP5;GABARAP;RIMS1;HRH2;GABRB2;HSPA8;CAMKK1;CACNA1A;APOE;LIN7C;SLC32A1;SDCBP;KIF5A;SLC1A3;HTR2C;SYPL1;SLC12A6;DTNA;AKAP9;KCNQ3;GRID1;STXBP3;SYN3;MPZ;PAFAH1B1;PRKAR2A;SLC1A1;ERC1;GPR176;SYNJ2BP;GAD2;PTPRN2;SNPH;PLP1;GRIN2A;SLC6A2;SLC6A5;GRIK5;CAMKK2;SYT1;GABRA4
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3352735068260197,1.0772512006522574,0.3096192384769539,0.8115278625163534,1.0,79/336,18.07%,MYC;CCDC13;MAPKAPK2;HPF1;DDB2;BRSK1;EPHA2;BCL2L1;OARD1;BID;SUSD6;UBE2T;KMT5B;FNIP2;TANK;APTX;LIG1;DOT1L;GTF2H4;RPAIN;BCL2L2;TAF1;USP3;PDS5A;TRRAP;PARP4;XRCC5;RAD52;TRIM28;CSNK1E;FOXP1;CRIP1;BAZ1B;POLB;TDP1;CCNK;SIRT1;UBA6;UBA1;NBN;SUMO1;CHD1L;MSH3;ENDOV;CASP9;PARP2;BTG2;TAOK2;UFL1;RFWD3;DDB1;ZBTB40;NABP1;CHCHD6;ADPRS;HERC2;FMR1;BCL6;SETX;CBX5;SETD7;FAM111A;IKBKE;ETAA1;MBD4;TNFRSF1B;OTUB1;FANCC;CUL4A;ZBTB4;APC;HMCES;AKTIP;HTRA2;UBR5;ZC3H12A;UPF1;TOPBP1;DDIT3
prerank,response to peptide (GO:1901652),0.41196956596795675,1.076941597871834,0.3745072273324573,0.8118089659879631,1.0,6/33,9.29%,STAT3;EIF2B2;CACNA1A;ERBIN;STAT6;PRNP
prerank,axon guidance (GO:0007411),0.34317279578884563,1.07677099605328,0.3384301732925586,0.811718497180797,1.0,44/201,17.82%,GDNF;SEMA3G;EPHA1;EPHA2;SEMA4G;PLXNA1;CXCR4;LAMA3;TNR;ENAH;SEMA6D;RHOG;PIK3R1;KIF5A;SEMA6A;RYK;ALCAM;CYFIP1;NRXN3;UNC5C;DSCAM;ARTN;SCN1B;SEMA4C;KLF7;BDNF;NRP2;PTPRO;PTPRA;EPHA3;SPTAN1;NPTN;VLDLR;DOK1;SOS1;EPHA6;CNTN4;RAC1;SEMA3A;SMO;FEZ2;PALLD;DAG1;SEMA3D
prerank,central nervous system development (GO:0007417),0.3379557351299494,1.0766737661100154,0.3282828282828283,0.8114013359394372,1.0,27/250,8.88%,EGR2;SOX10;BAG6;STAT3;BCAN;ZIC1;CXCR4;SLC23A1;LSR;EIF2B2;CLN5;MAP1S;NCAN;TPP1;SOX9;RAB18;APOD;TGFBR2;ADGRG1;UBE3A;ELP3;AFF2;NCKAP1;ADGRL2;PPT1;SMARCA1;PBX4
prerank,positive regulation of behavior (GO:0048520),-0.46364381793764586,-1.0765715949994503,0.37404580152671757,1.0,1.0,2/10,6.17%,NLGN1;CFAP20
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.40912559677701993,-1.0762995883874407,0.3495440729483283,1.0,1.0,5/14,15.05%,FAF1;PKD1;SUFU;KEAP1;PKD2
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.4056727978746832,1.076278280456442,0.36835443037974686,0.8118886651985359,1.0,9/35,15.90%,HNRNPK;SERPINE1;PICALM;BMP2K;APOC1;PPT1;CLU;FLOT1;RAC1
prerank,regulation of multicellular organism growth (GO:0040014),-0.4028330231757049,-1.0762574840806982,0.3205882352941177,1.0,1.0,5/15,16.10%,MBD5;PTCH1;PPIB;BBS2;SOD1
prerank,positive regulation of exocytosis (GO:0045921),0.40956602312804913,1.0759424357289964,0.382051282051282,0.8122681572410744,1.0,8/35,10.94%,VPS4A;ATP13A2;PDCD6IP;SDC4;SDCBP;SMPD3;STAM;ATP6AP1
prerank,external encapsulating structure organization (GO:0045229),0.34311847576646226,1.0758539231231328,0.3254861821903787,0.8119650524968475,1.0,24/205,9.86%,ADAMTS1;ADAMTS12;BCAN;LAMA3;LAMA4;NID1;SERPINE1;NCAN;PDGFA;COL1A2;TNR;ITGB3;SPP1;COL1A1;SPARC;PDGFB;ITGAL;SLC39A8;ADAM19;FURIN;COL16A1;SMOC2;COL24A1;DDR2
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.4836486481472221,1.0757690277341014,0.3924050632911392,0.811613489806947,1.0,2/13,2.99%,ADAM17;HMGB1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.4619318695207665,1.075469913483078,0.3943452380952381,0.8118793535343877,1.0,3/16,6.44%,PDGFRB;PDGFA;PDGFB
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.42965349842462996,1.0753263894560658,0.4088397790055249,0.8116771408660441,1.0,5/24,8.66%,ABI2;ARPC2;PIK3R1;NCKAP1;CYFIP1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.4127034702093751,1.0753120706806936,0.38144329896907214,0.8111199460120239,1.0,11/32,16.81%,RBM4B;PICALM;RPL10;TMED10;CYFIP1;APP;FOXO3;EIF4E;PGAM1;METAP1;ATXN2
prerank,protein localization to chromosome (GO:0034502),0.40808429777193717,1.0748396523081765,0.3854033290653009,0.8118183145925908,1.0,13/34,22.85%,LEMD2;TPP1;ACD;XRCC5;CTCF;WAPL;RAD21;TERF2IP;IFFO1;ESR1;RPA1;TERF2;SLF2
prerank,modified amino acid transport (GO:0072337),0.46878437237002263,1.0747229373262104,0.4080370942812983,0.8115488325361543,1.0,1/15,0.87%,SLC6A8
prerank,regulation of endothelial cell migration (GO:0010594),0.3611050156850898,1.0747022660187773,0.367032967032967,0.8110203312534545,1.0,23/85,18.02%,EPHA2;PRKD2;RHOB;KRIT1;EMC10;APOE;ITGB3;ANXA3;SPARC;DNAJA4;AGT;SH3BP1;FOXP1;PTK2B;SMOC2;NRP2;SYNJ2BP;RAC1;ZC3H12A;ETS1;PIK3CG;CALR;PDCD6
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.3760942275631095,1.0743921053772485,0.3668571428571429,0.8113470426402025,1.0,21/67,17.96%,PSMD2;PSMC4;IKBKB;PSMD4;NCF4;PSMD1;CYBB;PSME3;PSMB6;PSMD10;NCF2;PSMB1;PSMD11;PSMA2;PSMD13;PSMB10;FCGR1A;PSMB3;PSMC1;TAP2;CALR
prerank,regulation of mRNA polyadenylation (GO:1900363),0.46659934026790645,1.0741613274490343,0.36793893129770994,0.8114256402631526,1.0,11/17,23.15%,RNF20;CPSF6;CPEB1;NCBP1;ZC3H14;CCNT1;CTR9;CDK9;RNF40;CPEB3;NCBP2
prerank,positive regulation of phosphorylation (GO:0042327),0.33868729195001623,1.0741244430061336,0.32896064581231077,0.8109431629577983,1.0,54/240,17.36%,PDGFRB;EPHA1;EPHA2;DVL2;ADAM17;PLAUR;CLIP3;PIK3R3;IL34;PIN1;SOX9;PFKFB3;FXR2;ITGB3;SDCBP;GLMN;PTGES3;RALB;VEGFC;RYK;P2RY1;SIRT1;ENG;DSCAM;NBN;DDR2;ARRB1;KCTD20;EPHA3;TNIK;LIMCH1;IGF1;APP;ENTPD5;FMR1;ROR1;NPTN;CAMKK2;HGF;RALBP1;EPHA6;FLOT1;PGF;RAC1;FLCN;BTBD10;VAC14;FGF9;ILK;KRAS;AKTIP;CSNK1D;PFKFB2;GPNMB
prerank,collagen fibril organization (GO:0030199),0.36114085464455253,1.0740413805724671,0.3737596471885336,0.8105736470588085,1.0,12/88,12.97%,SERPINF2;CRTAP;LAMA3;COL1A2;TGFBR1;COL1A1;COLGALT1;COL16A1;COL24A1;DDR2;P4HB;COL3A1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.44978700325631815,1.0740210756883624,0.3924581005586592,0.8100409416539573,1.0,2/18,2.61%,CLIP3;INPP5K
prerank,cellular response to misfolded protein (GO:0071218),0.4454593067727617,1.072839285919183,0.3877266387726639,0.8128735311893228,1.0,2/20,1.71%,BAG6;CUL3
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.3885930459276994,-1.0726974986554225,0.35843373493975905,1.0,1.0,3/16,9.41%,PID1;PARP1;PPARGC1A
prerank,calcium ion import (GO:0070509),-0.33236572127727126,-1.072327563903537,0.2931726907630522,1.0,1.0,9/28,14.80%,CACNA1D;ATP2A2;CACNA1C;CACNA1B;SLC8A1;CACNA1E;MCUB;MICU3;CACNB2
prerank,neuromuscular process controlling balance (GO:0050885),0.48889568059217126,1.0722452456311253,0.3984126984126984,0.8140187099435754,1.0,3/12,11.61%,SHANK1;TPP1;PAFAH1B1
prerank,regulation of extracellular matrix organization (GO:1903053),0.4856879753153167,1.072173395486294,0.40795287187039764,0.8136344264916627,1.0,5/15,15.68%,AGT;LRP1;DDR2;RIC1;RUNX1
prerank,positive regulation of programmed cell death (GO:0043068),0.33896367132157446,1.072148694794207,0.3148335015136226,0.8131252355663859,1.0,59/272,17.30%,DDX20;SQSTM1;CTSD;ARL6IP5;C1QBP;JUN;PRMT2;AIFM2;CLIP3;BID;HMGB1;KLF11;ATF4;KALRN;RYBP;HDAC6;UTP11;RHOB;DNM2;RPS27A;UBC;ARHGEF26;QRICH1;RRP1B;ARHGEF4;ARHGEF6;LATS1;SMPD1;SIRT1;DNAJA1;MAPK8;PYCARD;CTNNB1;FGD1;IP6K2;CASP9;BAD;ADAMTSL4;CLU;STK17B;TRIO;MTCH1;UBE2Z;SCRIB;FOXO3;BCL6;KCNMA1;ATF6;SOS1;IL6;ING4;DAPK1;FLCN;HSPD1;APC;ARHGEF3;ARHGEF2;HTRA2;UNC13B
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.31413889362146785,-1.071695875485885,0.33620689655172414,1.0,1.0,14/32,19.89%,GTF2H1;GTF2H2;CDK7;TAF1D;MNAT1;UBTF;RRN3;TAF1A;MAPK3;POLR1F;GTF2H5;TAF1B;ERCC3;CCNH
prerank,macromolecule catabolic process (GO:0009057),0.4233762068845764,1.0716436052231513,0.40054127198917455,0.8139535717934685,1.0,9/26,14.89%,CLN5;TPP1;PIK3R4;SMURF1;CLN8;PPT1;USE1;IDE;MTOR
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.39311528632401976,-1.0715362430570783,0.3601190476190476,1.0,1.0,11/15,38.47%,GAS6;TPR;ANP32B;GSK3B;RBM22;YWHAE;EMD;RAPGEF3;TP53;IL1B;XPO4
prerank,regulation of interleukin-12 production (GO:0032655),0.39179541259261863,1.0709982724142335,0.36904761904761907,0.8152433492968497,1.0,6/47,10.11%,SLAMF1;C1QBP;HMGB1;CMKLR1;FOXP1;RIPK2
prerank,regulation of mRNA metabolic process (GO:1903311),0.5032469435490119,1.0709633241809875,0.4012841091492777,0.8147627579892427,1.0,7/11,17.78%,DHX9;IWS1;NCBP1;SLTM;SRPK2;SAFB;PTCD2
prerank,positive regulation of protein processing (GO:0010954),0.45371362337046683,1.0709484557276816,0.3803418803418803,0.814223322184107,1.0,2/19,1.52%,MYH9;ADAM8
prerank,response to metal ion (GO:0010038),0.36702938287755876,1.0708743071593259,0.37672811059907835,0.8138646477293002,1.0,19/67,18.81%,ADAM9;ANXA11;MT1X;MT1A;SLC25A13;CRIP1;IL1A;TRPC1;PEF1;TRPC3;SLC30A5;PPP2CB;KCNMA1;MT2A;ATP5F1D;HVCN1;PPP5C;PDCD6;AHCYL1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.38103454495431893,1.0705481851634386,0.37777777777777777,0.8141709791466122,1.0,8/48,10.87%,ADAM17;PRKD2;HMGB1;MAP2K3;JCAD;PDGFB;SIRT1;TMSB4X
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.42813021696365516,1.0702327096144857,0.40053763440860213,0.8144595748132896,1.0,11/26,19.02%,ZBTB7A;FOXP1;CRY2;SIRT1;HDAC1;NCOR1;VPS18;CNOT2;PER1;CALR;CNOT1
prerank,cellular response to interleukin-15 (GO:0071350),0.4913363610035399,1.0701254029113534,0.4,0.8135907566179563,1.0,1/13,0.61%,STAT3
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.4913363610035399,1.0701254029113534,0.4,0.8135907566179563,1.0,1/13,0.61%,STAT3
prerank,negative regulation of endopeptidase activity (GO:0010951),0.38908956777756887,1.0699954312629394,0.37982565379825656,0.8133771427396416,1.0,5/47,8.32%,SERPINF2;SERPINE1;PCID2;AGT;SORL1
prerank,zymogen activation (GO:0031638),0.4038608426686868,1.0698451946739074,0.37892095357590966,0.8132493168961694,1.0,7/39,13.74%,PGK1;CTSL;FURIN;RIPK2;ASPH;BAD;GRIN2A
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3450443144934314,1.0697207797151411,0.370020964360587,0.8130362528515301,1.0,22/150,11.53%,CORO1C;EPHA1;PPP1R15B;SAMSN1;WARS1;INPP5K;NCK1;TARBP2;DUSP19;TARDBP;DBNDD2;SIRPA;TRIB2;ENG;PRKCZ;PTPRC;PRNP;TRAF3IP1;PPM1F;PTPN6;SIRT2;PYDC1
prerank,negative regulation of epithelial cell migration (GO:0010633),0.40539958362486583,1.0696499171567573,0.36967418546365916,0.8126550196935864,1.0,6/33,9.35%,CORO1C;KRIT1;ADIPOR1;APOE;DNAJA4;PTPRR
prerank,prostaglandin metabolic process (GO:0006693),0.4242801707913053,1.0694649583065103,0.4191374663072776,0.8126185202658589,1.0,6/26,15.23%,PLA2G4A;HPGDS;PTGDS;PTGES3;TBXAS1;PNPLA8
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3636153233123202,1.069287826079937,0.3580387685290764,0.8125267429116977,1.0,24/76,19.93%,ARIH2;GABARAP;PRICKLE1;USP5;TAF1;TRIB2;SMURF1;CSNK1E;PSMD10;SUMO1;COP1;SIRT2;CLU;DNAJB2;RNF144A;RNF19B;STUB1;ARIH1;CSNK1D;CEBPA;ANKIB1;HECTD1;TRIB1;VCP
prerank,glycine transport (GO:0015816),0.5023768672633233,1.0692858304940018,0.4113821138211382,0.8119546662910634,1.0,5/10,23.52%,SLC36A1;SLC6A5;SLC6A9;SLC6A17;SLC7A8
prerank,chromatin assembly or disassembly (GO:0006333),-0.4215892002862547,-1.0691254553665712,0.3699731903485255,1.0,1.0,9/11,45.25%,HDAC8;NOC2L;MTA2;CDAN1;HIRIP3;SUV39H2;TP53;CHAF1B;CHAF1A
prerank,membrane depolarization (GO:0051899),0.411579534808044,1.0691041987514573,0.3856041131105398,0.8118926117877461,1.0,6/32,9.70%,KCNH2;CACNA1A;SCN8A;CACNA1G;CACNG2;SCN1B
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.3834078250535264,1.068598976625048,0.3806060606060606,0.8127610392007842,1.0,2/49,0.61%,OSM;STAT3
prerank,neuron projection morphogenesis (GO:0048812),0.344365504158828,1.0681233566300845,0.3715170278637771,0.8135275778697744,1.0,36/137,17.48%,BRSK1;SHANK1;LLGL1;CELSR2;MAP1S;PLPPR4;SLITRK3;ALS2;DNM2;NCKAP1;BRSK2;CNTNAP1;RYK;ALCAM;LRP4;CTNNB1;KLF7;BDNF;BAIAP2;TAOK2;DOCK10;TNIK;TRIO;SRGAP2;APP;BTBD3;AFG3L2;GPM6A;DBNL;ACTB;CNTN4;PAX2;MAP1A;MEF2A;CTNNA2;NRCAM
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.3326899070033279,1.0678790678714145,0.3263263263263263,0.8136455827881797,1.0,77/327,18.46%,SPIN4;STAT3;ZBTB11;DRAP1;HOXB7;THAP1;DVL2;SERTAD3;FUS;CELSR2;HNRNPD;NFYA;RNF20;NR1D2;ATF4;RYBP;RELA;SBNO2;GLRX2;CASZ1;ZMIZ1;TGFBR1;DNM2;CXXC1;ZKSCAN5;FADS1;TRRAP;SLC39A8;TAF5L;BAZ2A;POFUT1;ACVR1B;ENG;SPI1;CNBP;UTP4;GCFC2;SRSF10;CREBBP;EFEMP1;YBX1;SFPQ;ACVR2B;MITF;SOX2;UBE2L3;ELAVL2;WWC2;PTP4A3;APBB3;TCF7L1;TCF3;ERC1;KMT2D;RORA;POU6F2;SKOR2;LMX1B;ZSCAN26;WWTR1;LDB1;JMJD1C;FOXK2;RBAK;ZBTB4;PSPC1;NONO;NFYC;CTR9;EZH2;CALR;DDIT3;MEF2C;CEBPB;PATZ1;CEBPA;GON4L
prerank,chordate embryonic development (GO:0043009),0.3778415007038985,1.067483690107261,0.36091954022988504,0.81422278549083,1.0,9/55,15.91%,BMP5;TGFBR1;COL1A1;XYLT1;PTPRR;KIAA1217;LMX1B;SULF2;FLCN
prerank,actin filament organization (GO:0007015),0.34501171776751693,1.0674363224152095,0.36373056994818653,0.8137754437722775,1.0,40/151,21.37%,CORO1C;TRIOBP;MYO1E;LCP1;TPM3;FLII;TPM4;ABI2;RUFY3;ENAH;RHOB;BAIAP2L1;RHOG;SH3BP1;MYO1C;CD2AP;BAIAP2;ELMO2;MPRIP;WHAMM;ABI1;FLNA;ARHGAP17;MARCKSL1;RAC1;MYO15A;ARHGEF2;CORO1A;SHROOM3;ZBED3;COBL;MYO1B;ARHGAP25;ELMO1;BIN3;WASL;CDC42;BCAR1;ALDOA;RHOBTB1
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.2693854503465892,-1.0671728076881857,0.2971014492753623,1.0,1.0,29/68,21.72%,GTF2H1;GTF2H2;CDK7;CPSF3;PABPN1;TAF1D;MNAT1;CPSF2;UBTF;NUDT21;CPSF7;SNRPB;MAZ;PAPOLA;TAF1A;POLR1F;CPSF4;SMN1;WDR33;SNRPD3;GTF2H5;TAF1B;CPSF1;ERCC3;CCNH;CSTF1;POLR3K;PRMT5;SNRPE
prerank,regulation of cell division (GO:0051302),0.3665140923949155,1.06713951567736,0.3699885452462772,0.8140268439308703,1.0,10/72,11.25%,MYC;BCL2L1;EFHC1;PIN1;PIK3R4;PRPF40A;PIK3C3;BBS4;BIRC6;SIRT2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.4577813625642524,1.0671127407910028,0.4054441260744986,0.8135327281498995,1.0,4/17,20.62%,DGKZ;PRNP;DUSP3;THY1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.4552198842616816,-1.066764108838869,0.3984375,1.0,1.0,6/10,41.20%,PIEZO1;SKAP1;DPP4;FERMT3;CCL5;PODXL
prerank,protein polyubiquitination (GO:0000209),0.3360467993194801,1.06637406129632,0.3453815261044177,0.81504528841921,1.0,79/297,17.74%,FBXL15;TRIM69;ARIH2;DDB2;CUL3;HECTD2;SIAH2;UBE2S;PSMD2;RNF20;UBE2T;PSMC4;FBXW11;RNF115;UBE3D;PSMD4;PSMD1;FBXL3;RPS27A;UBC;UBE3A;TAF1;RBCK1;TRIM56;KBTBD7;SMURF1;UBE2D1;PSME3;PSMB6;PSMD10;FBXL8;ANAPC5;PELI3;UBE2E1;UBE2D3;CTNNB1;ANKRD39;FBXW4;FBXW5;PSMB1;RC3H1;CHFR;NPEPPS;RNF167;RNF31;UBE2L3;PSMD11;ANAPC10;RC3H2;FBXL5;PSMA2;PSMD13;MYLIP;FBXL17;RNF144A;RNF19B;UBE4A;STUB1;PSMB10;TRAF3;FBXO4;PSMB3;UBE2J1;SKP1;TPP2;TRIM36;ARIH1;RNF34;TNFAIP3;ZFP91;UNKL;FBXW9;UBR2;AKTIP;PSMC1;ANAPC7;UBR5;TRIM5;TTC3
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.4394092879136372,-1.0662229346834637,0.3879310344827586,1.0,1.0,4/11,28.86%,EP300;CLK2;SIK1;PGP
prerank,inorganic cation transmembrane transport (GO:0098662),0.3379722268783399,1.0662153961566816,0.33804238143289606,0.8149109621885342,1.0,38/268,14.69%,KCNK4;ABCB8;SLC6A8;KCNH2;ATP5MF;SLC39A14;SLC39A3;ATP6V1A;ATP6V0D1;MCOLN3;SLC6A11;KCNK9;CACNA1A;ATP6V0E1;SCN8A;SLC39A8;SLC1A3;TRPM4;CACNA1G;KCNJ2;TRPC4;SLC6A6;KCNQ3;ATP1B1;SCN1B;TRPC1;ATP6V0C;SLC36A1;HPN;TRPC3;SLC30A5;TRPM2;TRPV2;KCNC1;SLC6A2;SLC6A5;ABCB7;SLC11A1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.34901005187196055,-1.066187222951695,0.33070866141732286,1.0,1.0,12/24,25.91%,EED;SUZ12;CREBZF;H3-3A;RBBP7;TRIM27;EPC1;BMI1;JARID2;MTF2;DNMT3B;DNMT1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.4537149518581039,1.0661304654069275,0.4045584045584046,0.8145662817768557,1.0,9/20,15.62%,NUPR1;PDCD6IP;FLOT2;SDCBP;CFLAR;MLKL;STUB1;CDC37;FLOT1
prerank,axon development (GO:0061564),0.3671588681946631,1.0661003093880579,0.3783482142857143,0.814075404766403,1.0,21/78,17.48%,BRSK1;LLGL1;MAP1S;PLPPR4;SLITRK3;RTN4;BRSK2;RYK;KLF7;BAIAP2;TAOK2;APP;PLP1;ZPR1;AFG3L2;ACTB;CNTN4;PAX2;MAP1A;CTNNA2;NRCAM
prerank,regulation of lysosomal lumen pH (GO:0035751),0.4938589137035038,1.0660518601030469,0.4009433962264151,0.8136496281409872,1.0,4/12,13.96%,CLN5;TMEM9;PPT1;ATP6AP2
prerank,cellular glucan metabolic process (GO:0006073),-0.4316220928711658,-1.0655287105571705,0.3790322580645161,1.0,1.0,3/11,17.06%,PYGL;GSK3B;PHKA1
prerank,negative regulation of cell migration (GO:0030336),0.34215075190527305,1.0653631884979804,0.38784067085953877,0.815057634031893,1.0,38/137,21.20%,CORO1C;EPHA1;DLG5;SERPINE1;TCAF1;RNF20;RHOB;CLIC4;ADGRG1;ADIPOR1;JAG1;LRP1;ENG;PTPRR;MITF;GTPBP4;PTPRU;LIMCH1;SRGAP2;SRGAP3;COL3A1;DPEP1;FOXO3;NEXMIF;ADARB1;RAC1;FLCN;DAG1;CALR;LDLRAD4;DUSP3;GJA1;RAP2B;TRIB1;ARID2;THY1;VCL;DAB2IP
prerank,regulation of epithelial cell differentiation (GO:0030856),0.4577843466662736,1.0652308577421363,0.38205499276411,0.8148528040651766,1.0,5/17,20.51%,SOX9;MAFG;KLF7;CEBPB;PRKX
prerank,polyol metabolic process (GO:0019751),0.3855187773599009,1.0651835386555382,0.4026602176541717,0.8144140826958746,1.0,11/46,17.57%,PLCD4;PLCH1;ITPKC;ITPKB;IP6K2;IPPK;INPP4A;OCRL;SLC5A3;PPIP5K1;INPP5A
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.33194804484787604,1.0650271201058772,0.3216432865731463,0.8142882461129228,1.0,88/366,18.46%,SPIN4;STAT3;ZBTB11;DRAP1;HOXB7;THAP1;DVL2;SERTAD3;FUS;CELSR2;HNRNPD;RBM4B;PDGFA;NFYA;RNF20;NR1D2;RPL10;ATF4;RYBP;RELA;SBNO2;GLRX2;CASZ1;TGFBR1;DNM2;CXXC1;ZKSCAN5;FADS1;TRRAP;SLC39A8;TAF5L;BAZ2A;POFUT1;ORC5;ACVR1B;ENG;CYFIP1;SPI1;CNBP;UTP4;TOM1L1;GCFC2;SRSF10;CREBBP;EFEMP1;YBX1;SFPQ;ACVR2B;MITF;SOX2;UBE2L3;ELAVL2;WWC2;PTP4A3;APBB3;TCF7L1;TCF3;ERC1;APP;FOXO3;KMT2D;RORA;POU6F2;SKOR2;LMX1B;ZSCAN26;WWTR1;EIF4E;LDB1;JMJD1C;FOXK2;METAP1;RBAK;ZBTB4;CCDC88A;PSPC1;NONO;ATXN2;NFYC;CTR9;EZH2;CALR;DDIT3;MEF2C;CEBPB;PATZ1;CEBPA;GON4L
prerank,glucose catabolic process to pyruvate (GO:0061718),0.4298109580077516,1.0648649075866135,0.39389736477115117,0.8136294440098165,1.0,2/24,0.93%,PGK1;PFKM
prerank,canonical glycolysis (GO:0061621),0.4298109580077516,1.0648649075866135,0.39389736477115117,0.8136294440098165,1.0,2/24,0.93%,PGK1;PFKM
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.34149261320765945,1.0646820426298957,0.3730407523510972,0.813528734506342,1.0,35/136,18.10%,PRMT2;ACOD1;FZD6;NLRP3;NUPR1;TAF1;RBCK1;CMKLR1;ERBIN;NLRC3;TCF7L2;PSMD10;SIRT1;SPI1;PRNP;PYCARD;PARP10;SUMO1;ARRB1;TMSB4X;KDM1A;COMMD6;UFL1;CD200;PYDC1;IRAK2;TRAF3;WFS1;FLNA;TNFAIP3;NLRC5;OTULIN;ZC3H12A;DDIT3;NWD1
prerank,cellular calcium ion homeostasis (GO:0006874),0.3455466749142575,1.0644129306636347,0.3724066390041494,0.8136710938748447,1.0,20/133,14.79%,CCL3;CALCA;ATP13A2;FKBP1B;CALB1;ATP13A1;ANXA6;HTR2C;TMEM178A;TRPC4;ATP1B1;TRPC1;ATP13A3;TRPC3;ADCY8;CCL13;NPTN;WFS1;CCDC47;AFG3L2
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.40927838323377175,-1.0642767864921667,0.3649425287356322,1.0,1.0,4/13,17.68%,NIBAN2;PTPN1;CADM4;HHEX
prerank,phagosome-lysosome fusion (GO:0090385),0.5053986049499531,1.0638275416441505,0.38971807628524047,0.8147107175809225,1.0,3/10,17.56%,RAB7B;ARL8B;RAB7A
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.3367824978067851,-1.0636811360975655,0.36186770428015563,1.0,1.0,12/24,28.93%,ABCG2;FLVCR1;CPOX;ALAS1;SLC25A38;SUCLA2;PPOX;COX15;RSAD1;FECH;UROS;FXN
prerank,negative regulation of inclusion body assembly (GO:0090084),0.5041078629870779,1.0635773132878332,0.41091492776886035,0.8148072059609454,1.0,3/10,12.18%,DNAJA4;SORL1;DNAJB2
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.37156095510541937,-1.063442732135345,0.36038961038961037,1.0,1.0,4/19,11.78%,RAB11FIP2;LY96;PRKCE;NMI
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.32852831757913714,-1.0629297869306953,0.3574468085106383,1.0,1.0,12/26,34.72%,DRG1;NUMA1;NAV3;STMN2;RPS3;SLAIN2;TRPV4;ARL2;CLASP1;MET;MAPRE1;FES
prerank,water transport (GO:0006833),-0.42086759997488865,-1.0627577386024798,0.42565597667638483,1.0,1.0,6/12,57.91%,PDPN;CFTR;AQP11;AQP4;AQP1;SLC5A1
prerank,negative regulation of translation (GO:0017148),0.3530639935424008,1.0620032792530443,0.36824696802646084,0.8186499921125159,1.0,31/87,22.05%,ILF3;MALSU1;RPL13A;RIDA;TOB1;EIF2AK2;FXR2;CNOT8;EIF2AK3;SAMD4B;CPEB1;YBX1;BTG2;GIGYF2;CNOT7;FMR1;EIF4E2;DAPK1;PUS7;CNOT10;YTHDF2;FTO;CALR;ENC1;CNOT1;AGO2;METTL3;EIF4EBP1;EIF4A3;CPEB3;EIF4EBP2
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3340460903008633,1.0619219105181432,0.34510595358224017,0.8182987322860212,1.0,73/314,16.26%,BAG6;MAD2L1;FBXL15;DERL2;JKAMP;NFE2L2;CUL3;SIAH2;UBE2S;PSMD2;PSMC4;FBXW11;UCHL1;KAT5;UBE3D;SEL1L;PSMD4;PSMD1;FBXL3;RPS27A;UBC;UBXN4;TAF1;RBCK1;KBTBD7;SMURF1;UBE2D1;PSME3;PCBP2;PSMB6;USP19;PSMD10;FBXL8;SIRT1;TBL1X;UBR1;KCTD5;ANAPC5;UBE2E1;UBE2D3;KCTD2;CTNNB1;ARRB1;COP1;FBXW4;FBXW5;PSMB1;SIRT2;UBXN1;PSMD11;ANAPC10;HSPA5;FBXL5;PSMA2;PSMD13;DNAJB2;DERL1;FBXL17;DDB1;UBE4A;STUB1;PSMB10;CUL2;WFS1;FBXO4;PSMB3;UBE2J1;GID4;EDEM1;SKP1;LTN1;RNF34;CUL4A
prerank,protein localization to vacuole (GO:0072665),0.4841975687781707,1.0618869949506908,0.40217391304347827,0.8178217910885159,1.0,5/13,16.64%,ATP13A2;RTN4;MFSD1;GLMP;LMBRD1
prerank,regulation of lamellipodium assembly (GO:0010591),0.39969182826787697,1.0617820316222777,0.3979328165374677,0.8175265813855652,1.0,6/34,8.66%,EPHA2;ABI2;ARPC2;PIK3R1;NCKAP1;CYFIP1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.3044877087327542,-1.0617746805199226,0.31221719457013575,1.0,1.0,12/37,16.55%,CAB39;CALM2;UBE2K;AXIN1;CALM1;MAPK1;IRGM;SPRED1;WNK3;PARD3;CADM4;CALM3
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3375836058187429,1.06177211211476,0.3816872427983539,0.8169841860720993,1.0,41/186,15.18%,DVL2;CUL3;ANKRD6;SIAH2;PSMD2;FZD6;SOX9;PSMC4;PSMD4;PRICKLE1;PSMD1;APOE;CTNND1;KLHL12;JADE1;PSME3;LRP1;PSMB6;LRP4;TCF7L2;PSMD10;LATS1;HDAC1;PSMB1;DKK2;SOX2;PSMD11;PSMA2;PTPRU;PTPRO;PSMD13;RNF43;INVS;PSMB10;ZNRF3;UBAC2;TLE3;VGLL4;TRABD2B;PSMB3;WWTR1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.43920181271726955,-1.061217052486313,0.3994910941475827,1.0,1.0,4/10,11.79%,RNF13;MAP2K2;MAPK1;MAPK3
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.4342101608843505,1.061195026188561,0.4156378600823045,0.8180295855428652,1.0,3/24,5.25%,NFE2L2;SERPINE1;KRIT1
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.26863954162920517,-1.0605552984156978,0.3087248322147651,1.0,1.0,21/59,18.02%,CDC42BPA;NLK;ROCK2;HIPK1;CDC42BPB;PRKCD;CSNK2A1;CSNK2A2;PRKD1;MAPK1;LRRK2;CDK10;WNK3;ULK1;GSK3B;GSK3A;MAP3K10;MAP3K12;CAMK2A;CDK5;TNKS
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.46487199835012655,1.0605134354372345,0.399702823179792,0.8193712523019684,1.0,2/15,6.43%,PNP;CD55
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3600721870636445,1.0603092646670924,0.40160183066361554,0.8193696499074948,1.0,21/72,19.26%,UVSSA;POLR2J;HMGN1;LIG1;RPS27A;UBC;GTF2H4;PCNA;XRCC1;COPS3;ERCC2;DDB1;POLD4;POLR2E;POLR2B;CUL4A;POLR2G;POLD3;TCEA1;POLR2K;COPS5
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.500534448517379,1.060303574350939,0.3909657320872274,0.8188179858323239,1.0,5/11,20.81%,CREB3L1;SEMA6A;SYNJ2BP;EPN1;E2F2
prerank,lipid phosphorylation (GO:0046834),0.5084671635057488,1.0600258601820622,0.41068447412353926,0.8189759085000897,1.0,5/10,20.36%,DGKZ;DGKD;DGKQ;DGKH;DGKG
prerank,proteasomal protein catabolic process (GO:0010498),0.3353806508304126,1.0599715153270712,0.3670756646216769,0.8185682648684364,1.0,43/201,13.37%,BAG6;NFE2L2;CUL3;SIAH2;PSMD2;ERLEC1;PSMC4;FBXW11;UCHL1;KAT5;UBE3D;SEL1L;PSMD4;SOCS6;PSMD1;RBCK1;KBTBD7;SMURF1;PSME3;BRSK2;PCBP2;PSMB6;PSMD10;SIRT1;TBL1X;KCTD5;UBE2D3;KCTD2;CTNNB1;ARRB1;COP1;FBXW5;PSMB1;SIRT2;UBXN1;PSMD11;PSMA2;PSMD13;DERL1;FBXL17;DDB1;STUB1;PSMB10
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.4546878754082677,1.059840100280643,0.4096209912536443,0.8183784221042685,1.0,6/17,16.21%,PTTG1IP;PSMD10;SIRT1;KDM1A;DYRK1A;RNF34
prerank,polarized epithelial cell differentiation (GO:0030859),0.46725006493470567,1.05905654004131,0.39553429027113235,0.8199830516587485,1.0,5/13,13.41%,ZDHHC7;SH3BP1;MSN;MYO9A;SCRIB
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.4227294037703025,1.0589945182465033,0.42323651452282157,0.8195806536923377,1.0,3/24,5.62%,TMEM204;PRKD2;ITGB3
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.44921060276951325,1.0587903666203473,0.4013888888888889,0.8195614548016791,1.0,9/19,21.20%,HS3ST3B1;XYLT1;NDST2;CSGALNACT1;HS3ST5;GLCE;HS6ST2;EXT2;HS6ST1
prerank,cortical cytoskeleton organization (GO:0030865),0.3912767614111957,1.0586252934268985,0.39975550122249387,0.8194688608089246,1.0,8/41,6.72%,LCP1;LLGL1;PLEK;FMNL3;IKBKB;RHOB;RHOG;NCKAP1
prerank,glycoprotein biosynthetic process (GO:0009101),0.3589997042254527,1.0585924956001762,0.38333333333333336,0.818995012202379,1.0,19/79,17.03%,CHST11;ST6GALNAC2;CHST12;FAM20B;DDOST;ST8SIA6;XYLT1;SERP2;ALG10B;B3GALNT2;B4GALT5;IGF1;TNIP1;CSGALNACT1;GCNT2;ST3GAL6;PMM2;B4GALT7;NPC1
prerank,response to estradiol (GO:0032355),0.40886914825429727,1.0584969004674518,0.3982521847690387,0.8187018535837856,1.0,4/31,14.63%,STAT3;KAT5;CTNNB1;NCOA3
prerank,protein depolymerization (GO:0051261),0.41681877018792657,1.0582255414396895,0.4,0.8188733811475372,1.0,2/27,0.45%,MICAL1;WDR1
prerank,respiratory chain complex IV assembly (GO:0008535),0.444493303249578,1.0578329359246554,0.4231843575418994,0.8194165633140608,1.0,2/21,5.15%,SURF1;SMIM20
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.3807211374563395,-1.0577235078057345,0.3843843843843844,1.0,1.0,4/15,7.31%,CDC27;TPR;ANAPC1;CDC16
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.41572158718720814,-1.0576895781836695,0.3971830985915493,1.0,1.0,5/13,29.62%,B3GNT2;B3GALT5;B3GALT1;B3GALNT1;B3GALT2
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.4437808637960492,-1.0576843506983546,0.37464788732394366,1.0,1.0,3/10,6.85%,ENPP1;MVP;ERRFI1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.3839361325847106,1.0576211192499658,0.39880239520958083,0.8194395747582982,1.0,14/48,18.52%,NPPC;ADSS2;ADCY5;PPCS;PANK3;AMPD2;ACAT1;ADCY8;ADCY3;ADCY7;DCAKD;ADSL;ADCY9;PANK1
prerank,proteolysis (GO:0006508),0.336517567269682,1.057487689424771,0.3569261880687563,0.8192374110130272,1.0,41/252,15.36%,NAPSA;CPXM1;ADAMTS12;CTSB;ATG4D;CTSD;ADAM17;CTSL;SRGN;TPP1;PSMC4;MBTPS1;UBE3A;LONP1;CASP4;SPPL3;HM13;CTSA;ADAM19;RSPRY1;TBL1X;FURIN;DPP7;F3;PCSK1;USP25;NPEPPS;NEDD8;RNPEPL1;HPN;LAP3;FOLH1;IDE;FAM111A;SPPL2A;ATG4B;AFG3L2;CPA6;HGF;TRABD2B;YME1L1
prerank,cellular response to leucine starvation (GO:1990253),0.5025747861967114,1.0573551257548266,0.4025764895330113,0.8190608466808974,1.0,3/10,14.89%,SESN2;LARS1;MTOR
prerank,protein phosphorylation (GO:0006468),0.32890340984640887,1.0566543095259338,0.343687374749499,0.8204677525903095,1.0,122/479,19.68%,CCL2;STK38L;MAPKAPK2;PDGFRB;EPHA1;BRSK1;MAPK6;FAM20C;NEK7;PRKD2;MAPK10;RICTOR;ILF3;CDKL3;BCKDK;ATP13A2;ABI2;IKBKB;EIF2AK2;EIF2AK1;TLK1;PPP4R1;FAM20B;FNIP2;FASTK;NEK6;ABL2;CDK18;PIK3R4;MAP2K1;TBK1;BMP2K;TGFBR1;TGFBR2;ULK3;GTF2H4;TAF1;SNRK;TRIB2;PDGFB;PRKCH;MAP4K5;CSNK1E;BRSK2;EIF2AK3;PTK2B;TP53RK;RYK;BAZ1B;CDK6;MAP4K2;LATS1;ACVR1B;TLR7;PRKCZ;MAPK8;PIM3;DDR2;EFEMP1;BIRC6;ACVR2B;PRKAG1;PTPN6;TAOK2;CSNK1G2;CDKL5;MAML1;GMFB;EPHA3;TNIK;LIMK1;MKNK1;STK17B;ERC1;PDK3;APP;DGKQ;MAP4K3;CSNK1G3;HUNK;CDK8;CDK12;SRPK2;PRKAB1;IKBKE;CIT;CDK19;ABI1;CAMKK2;CREB1;MTOR;CCNT1;PEAK1;DAPK1;DYRK1A;MAST2;TEC;ILK;YWHAZ;CSNK1D;BRD2;PICK1;PRKCB;ACVR1;GRK2;STRADA;MAPKAPK3;TTBK2;SGK1;PRKAA1;CDK9;HCK;AATK;STK38;PRKG1;NTRK2;JAK1;NRBP2;CSF1R;STK16;TLR2;TRIB1
prerank,response to gamma radiation (GO:0010332),0.43059100859403854,1.0566314461902584,0.40716180371352784,0.8199611525060507,1.0,3/24,10.92%,MYC;XRCC5;KDM1A
prerank,"transcription, DNA-templated (GO:0006351)",0.3335181583047799,1.056433804507722,0.38109756097560976,0.8199505001859795,1.0,56/207,18.93%,NKX2-8;DRAP1;THAP1;RRAGC;POLR2J;GTF3A;TTF2;NFYA;FUBP3;ATF4;GTF2A1;TAF15;GTF2H4;TAF1;TAF12;GTF3C2;TAF5L;BAZ2A;TRIP11;ELOA;TBP;ZBTB7B;ELL;DDX21;CCNK;CRCP;SLC25A33;IWS1;PWP1;NCBP1;ERCC2;CTDP1;GTF2F2;TAF6;GTF3C5;DDX5;MBD1;POLR2E;FOXO3;SETX;TFB2M;POLR2B;CCNT1;IRF9;POLR2G;NFKB1;MEF2A;CTR9;PPP5C;TCEA1;MED20;GMEB2;RPAP1;MED4;CDK9;POLR2K
prerank,microtubule anchoring (GO:0034453),-0.42548039531783655,-1.055820202915527,0.39276485788113696,1.0,1.0,3/12,8.21%,BICD2;BICD1;CLASP2
prerank,positive regulation of cell death (GO:0010942),0.36823802222193824,1.0556705173471668,0.3870967741935484,0.8215429040521847,1.0,9/59,11.94%,EGR1;TYROBP;PICALM;EIF2S1;LRP1;SLC6A6;PRNP;RIPK2;CLU
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.39660939590324795,1.0555478502308437,0.40488431876606684,0.82133291809934,1.0,9/37,12.96%,DDB2;RPS27A;UBC;GTF2H4;PCNA;CHD1L;ERCC2;DDB1;POLD4
prerank,protein processing (GO:0016485),0.3479160589163992,1.05550359592487,0.4029692470837752,0.8208912365775233,1.0,13/102,9.33%,CPXM1;ADAM17;CTSL;SRGN;CLN5;SEC11A;CASP4;SPPL3;HM13;ADAM19;FURIN;F3;PCSK1
prerank,cellular response to amyloid-beta (GO:1904646),0.3977565510823826,1.0550906571717407,0.405440414507772,0.8214645764036609,1.0,13/35,18.76%,SNX6;CACNA1A;CASP4;CACNA2D1;LRP1;PRNP;IGF1;APP;GRIN2A;ADRB2;ATP1A3;ICAM1;GJA1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.35664793883360696,1.0550013707650623,0.4024390243902439,0.8211406829542969,1.0,22/87,17.36%,CCL2;PRMT2;PSMD2;PSMC4;FAM107A;PSMD4;PSMD1;JADE1;PSME3;PSMB6;CDK6;PSMD10;PSMB1;PSMD11;PSMA2;PSMD13;PSMB10;PSMB3;SKP1;APC;PSMC1;GPNMB
prerank,proteasome assembly (GO:0043248),0.4978026229605616,1.054788039630881,0.41721854304635764,0.8211630562973342,1.0,5/11,14.62%,PSMD4;PSMD10;PSMD11;PSMD13;POMP
prerank,negative regulation of centrosome duplication (GO:0010826),0.5028232258082675,1.0546250049744155,0.4142857142857143,0.821038830675594,1.0,5/11,18.88%,MDM1;CENATAC;KAT2A;RBM14;TMEM67
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.3982628607772495,-1.054510955332457,0.36716417910447763,1.0,1.0,8/14,26.86%,CD74;BCL10;PLCG2;GPRC5B;KIT;LILRB1;SEMA7A;TICAM1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.4860399169257632,1.0544826079422998,0.40993788819875776,0.8208767224295203,1.0,4/12,8.90%,ZBTB7B;SORL1;SIRT1;PRKCZ
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.4403900345631674,1.0544527167990485,0.40446304044630405,0.8203718771170745,1.0,3/20,8.39%,IPO5;INCA1;LATS1
prerank,presynaptic endocytosis (GO:0140238),-0.33265332540252335,-1.0543750996886416,0.3415492957746479,1.0,1.0,12/24,28.15%,NLGN1;FCHO2;SYT2;STON2;VAMP2;CDK5;STX1A;NLGN2;NLGN3;SYNJ2;OPHN1;CANX
prerank,regulation of dendrite extension (GO:1903859),0.4493427428863213,1.0543030524523258,0.4206128133704735,0.8202434291349632,1.0,7/18,21.83%,CPNE9;RIMS1;SMURF1;SYT1;SYT4;PLAA;ITSN2
prerank,positive regulation of double-strand break repair (GO:2000781),-0.3004140901118339,-1.0542489613656092,0.3592814371257485,1.0,1.0,16/39,26.31%,FMN2;PARP1;SPIDR;WDR48;PARP9;KMT5C;DTX3L;ERCC6;RIF1;ZCWPW1;SMCHD1;WRAP53;DDX11;MRNIP;MMS19;KDM4D
prerank,negative regulation of cellular metabolic process (GO:0031324),0.3936250775991469,1.0541429990050706,0.42098609355246525,0.8200915121633735,1.0,10/37,16.81%,APOE;ITGB3;SDCBP;SIRT5;SIRT2;OPTN;NCOR1;PAX2;NFKB1;ATXN2
prerank,insulin receptor signaling pathway (GO:0008286),0.3630798242313182,1.0536162718727373,0.3886363636363636,0.8209429419283165,1.0,24/69,21.18%,SLC39A14;ATP6V1D;PIK3R3;ATP6V1A;ATP6V0D1;SH2B2;ATP6V0E1;PIK3R1;ATP6V0A1;RHOQ;ATP6V0C;BAIAP2;ATP6AP1;IDE;SOS1;APC;ATP6V0B;ATP6V1G2;BCAR3;AP3S1;PHIP;ATP6V1C1;FOXO1;BCAR1
prerank,ephrin receptor signaling pathway (GO:0048013),-0.2520448207973473,-1.0535423171579226,0.3522727272727273,1.0,1.0,13/82,4.89%,RHOA;ANKS1A;EPHA5;GRIN2B;PSEN1;AP2A2;ROCK2;VAV3;PTK2;NCSTN;SIPA1L1;EPHB1;CHN1
prerank,mRNA transport (GO:0051028),0.3503644605515738,1.053520177702242,0.3995656894679696,0.8206254678604687,1.0,23/101,15.69%,MAGOH;MAGOHB;CHTOP;SLBP;ZFP36;NUP153;NDC1;SMG7;U2AF2;NUP88;NXF1;SRSF2;U2AF1;NCBP1;NUP210;FIP1L1;NUP37;FMR1;NUP98;SYMPK;EIF4E;NUP54;RBM8A
prerank,inositol phosphate metabolic process (GO:0043647),0.38107213045774413,1.053229901260354,0.4077669902912621,0.8208725929447446,1.0,8/46,12.60%,PLCD4;PLCH1;ITPKC;ITPKB;IP6K2;IPPK;INPP4A;OCRL
prerank,regulation of peptidase activity (GO:0052547),0.43603247405405987,1.0527686377728478,0.4220055710306407,0.8215859828291009,1.0,5/19,14.16%,ATP13A2;FURIN;HDAC1;NDUFA13;CST7
prerank,regulation of defense response (GO:0031347),0.3592247668530663,1.0527219855932175,0.40250855188141393,0.8211487568813346,1.0,15/76,15.31%,ADAMTS12;IL1R1;TKFC;NR1D2;RELA;SBNO2;APOE;CASP4;FOXP1;TMSB4X;UFL1;BCL6;TRAF3;BRD4;AKNA
prerank,cell projection organization (GO:0030030),0.4042229143760982,1.0522020898155007,0.4056987788331072,0.8219387666926812,1.0,8/30,9.86%,PLEK;PDGFA;RHOG;NCKAP1;RHOU;PACSIN2;CYFIP1;RHOQ
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.35748835438813165,1.0517483148316091,0.4041095890410959,0.8226278680557123,1.0,19/72,17.97%,DDB2;DCP1A;EDC3;RPS27A;UBC;GTF2H4;PCNA;PNRC2;CHD1L;ERCC2;DCP1B;DDB1;POLD4;MEI4;RNASE1;CUL4A;DNASE1L1;ZC3H12A;POLD3
prerank,protein polymerization (GO:0051258),0.37505988797964585,1.0517089906837804,0.3986013986013986,0.8221687348278042,1.0,9/56,7.25%,CATIP;UBE2S;MID1IP1;PIN1;FGF13;FAM107A;ARL6;WASHC3;GPX4
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.41189092826057355,1.0515690689586437,0.40784313725490196,0.8220107415070818,1.0,5/29,7.90%,CCL2;STAT3;SOCS6;STAT6;IFNAR1
prerank,negative regulation of viral transcription (GO:0032897),0.4860052792819531,1.0515145659463305,0.4298642533936652,0.8215996194953202,1.0,3/13,5.89%,ZFP36;LARP7;IFITM3
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.4417914795846749,1.0514920797787672,0.42045454545454547,0.8211079839649608,1.0,3/19,3.98%,FZD5;ATP13A2;HDAC6
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.31261448696527794,-1.0512591754786194,0.3776824034334764,1.0,1.0,13/33,24.11%,NLGN1;IQSEC2;GRIK4;ABR;LRRC4C;BCR;CACNA1B;GRIK3;CX3CR1;NLGN2;PSMC5;SLC4A8;NLGN3
prerank,hemopoiesis (GO:0030097),0.35314702497978523,1.0512367829321636,0.3929747530186608,0.8212367224124028,1.0,18/87,16.80%,RTKN2;ARIH2;PLEK;ATF4;TGFBR2;SNRK;PDGFB;TET2;GLRX5;JAG1;PTPRC;RUNX2;TOX;KMT2A;RUNX1;FLCN;YTHDF2;ETV6
prerank,negative regulation of endocytosis (GO:0045806),0.4258020993431229,1.0507776270275078,0.40970350404312667,0.8219582959842038,1.0,6/24,15.90%,PICALM;RUBCN;APOC1;SNX33;EPHA3;RAC1
prerank,protein deubiquitination (GO:0016579),0.3340093304209872,1.0507102373200392,0.36730575176589303,0.8215852285805981,1.0,62/242,17.55%,MYC;SHMT2;UCHL5;DDB2;USP2;SIAH2;USP32;OTUD3;PSMD2;NLRP3;PSMC4;UCHL1;PSMD4;PSMD1;ACTL6A;MDM4;TGFBR1;RPS27A;UBC;USP5;USP3;TRRAP;UBE2D1;OTUD7B;PSME3;TOMM20;PSMB6;USP19;POLB;PSMD10;ZRANB1;WDR20;STAM;USP25;USP21;JOSD1;PSMB1;NEDD8;PSMD11;PSMA2;PSMD13;TNIP1;PSMB10;TRAF3;USP8;ADRB2;MYSM1;ABRAXAS2;PSMB3;OTUD4;ACTB;FOXK2;OTUB1;TNFAIP3;USP40;APC;KAT2A;PSMC1;ENY2;OTULIN;SMAD3;ZC3H12A
prerank,mRNA metabolic process (GO:0016071),0.35480886446930526,1.050612236885349,0.39867109634551495,0.8212906815990729,1.0,26/90,18.54%,LSM5;SLBP;ZFP36;RIDA;PRPF18;U2AF2;PCBP2;CPSF6;SRSF2;U2AF1;NCBP1;SFPQ;SCAF11;SF3A2;DDX5;AKAP8L;SF3A1;PTBP1;SNRPG;CNOT10;AGO3;YTHDF2;NONO;HNRNPR;ALKBH5;TBRG4
prerank,nucleotide-sugar metabolic process (GO:0009225),0.4948395067164847,1.0505718634024817,0.4296875,0.8208434432542628,1.0,3/12,12.89%,PARG;GFPT1;CSGALNACT1
prerank,regulation of hippo signaling (GO:0035330),0.45242990443140885,1.0504982626202264,0.42255639097744363,0.8204803856139292,1.0,6/17,14.77%,DLG5;MAP2K3;SCHIP1;WWC2;CIT;VGLL4
prerank,regulation of ion transport (GO:0043269),0.36073223235491814,1.050473049985506,0.4024390243902439,0.8199996173372551,1.0,5/76,8.68%,GDNF;KCNJ6;SNX6;ITGB3;KCNJ2
prerank,stem cell development (GO:0048864),0.45647831927039817,1.0501425701967089,0.4050073637702504,0.8203923238216158,1.0,4/16,10.36%,KLHL12;TAPT1;PTPRC;PEF1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.40144638781950753,1.049605206248564,0.4098573281452659,0.8212665630079915,1.0,3/31,5.39%,HOXD9;TGFBR1;TGFBR2
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3560936536567385,1.0493999956494189,0.4077777777777778,0.8212764510966102,1.0,6/85,8.58%,WDR1;MARVELD2;TIMM8B;COL1A1;GSDME;TBL1X
prerank,transcription by RNA polymerase II (GO:0006366),0.3256729675917618,1.0490337232223295,0.3816717019133938,0.8217035033914678,1.0,84/305,18.93%,NKX2-8;SLBP;DRAP1;NR4A1;NR2F6;POLR2J;TTF2;NFYA;TAF8;PRRX1;MAML3;NR1D2;ATF4;ELL2;NRBF2;GTF2A1;INTS9;INTS6;TAF15;ICE2;PCID2;GTF2H4;TAF1;TAF12;INTS10;TAF5L;TRIP11;ELOA;TBP;INTS14;ZBTB7B;ELL;DDX21;CCNK;TBL1X;IWS1;HDAC1;RPAP2;NCBP1;CREBBP;ERCC2;CTDP1;HDAC5;RBPJ;FIP1L1;GTF2F2;MAML1;TAF6;INTS8;NABP1;DDX5;MBD1;CDK12;POLR2E;NR2C2AP;RORA;SETX;RPRD1A;SNRPG;POLR2B;NCOR1;POU2F2;SYMPK;MED1;WWTR1;CCNT1;IRF9;SNAPC1;RXRA;POLR2G;NFKB1;ELP2;RPRD1B;CTR9;TCEA1;MED20;GMEB2;RPAP1;MED4;TFCP2;CDK9;MED23;ZBTB1;POLR2K
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.3350303007968619,-1.0489082395376734,0.3712121212121212,1.0,1.0,12/25,18.83%,CCNT2;THOC1;DDX39B;SETD5;HTATSF1;ZMYND11;ERCC6;EAF2;ZNF326;SUPT4H1;KAT7;CCAR2
prerank,fatty acid beta-oxidation (GO:0006635),-0.2806772074621983,-1.0488922435292996,0.39204545454545453,1.0,1.0,23/51,30.96%,ACOX3;SLC25A17;ABCD3;ECHS1;AUH;CROT;HADHB;ABCD2;ECHDC1;DECR1;ACAD11;ACOT8;ACADM;HADH;ACOX1;ACAA2;ETFDH;ECI1;CPT2;ACADS;AMACR;MCAT;GCDH
prerank,nuclear body organization (GO:0030575),0.4861808504602907,1.048847724790339,0.4421553090332805,0.8216488917254201,1.0,5/12,17.73%,HABP4;AFF2;SRPK2;ZPR1;ETS1
prerank,ribosomal subunit export from nucleus (GO:0000054),0.48255692020181273,1.0487294451953513,0.4205607476635514,0.8214301039147585,1.0,3/13,8.50%,RPS15;EIF6;NUP88
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.3843913008583973,1.0485225488822096,0.40616966580976865,0.8214321063637527,1.0,10/37,18.94%,ADAMTS1;JUN;PDGFB;IGF1;FGF9;SOD2;FOXJ2;MEF2C;GJA1;PRKG1
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.3297511711937656,1.0483893679955498,0.3877755511022044,0.8212581094683543,1.0,78/306,20.31%,NKX2-8;EEF1B2;GSPT2;TBRG1;MRPL18;THAP1;RRAGC;MRPL51;RPL31;POLR2J;WARS1;RPS15;RPL3;RPL13A;FUBP3;RPL15;RPL10;SARS1;KAT5;RPS8;MRPS6;MCM2;MRPL28;RPS27A;APOE;RPL9;RPL22;BAZ2A;SET;ORC5;RPS21;RPL23A;NBN;PWP1;MRPS12;RPL34;B4GALT5;RRBP1;RPSA;MRPS7;EIF4G2;MRPL37;RPS14;TSFM;MRPL41;MRPL27;TNIP1;POLR2E;RPL27;FAM111A;POLR2B;ING4;RPL8;POLR2G;MEF2A;RPS24;UPF1;PPP5C;TOPBP1;POLD3;MED20;RPL38;RPL27A;EXT2;EEF1A1;POLR2K;RPLP1;RNASEH2A;COPS5;RPL17;RPL23;MRPL23;THRB;HARS2;MRPL3;RPS11;AGO2;MRPS18A
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.46856479367707293,1.0480633353796835,0.40512048192771083,0.8215732883877058,1.0,4/13,13.30%,SQSTM1;AKAP5;APP;ADCY8
prerank,positive regulation of lyase activity (GO:0051349),-0.3956875344520551,-1.0479739580098166,0.3768996960486322,1.0,1.0,4/14,7.52%,CACNA1D;CACNA1C;STIM1;ORAI1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.4389573984658143,-1.047501596655113,0.41899441340782123,1.0,1.0,5/10,33.44%,TLR4;CD36;MYD88;TICAM1;TLR6
prerank,microtubule polymerization (GO:0046785),0.41409662054354857,1.0472014057804326,0.43973509933774835,0.8233559952409575,1.0,6/29,9.42%,NDEL1;PIN1;FGF13;TUBGCP5;TUBGCP6;AKAP9
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.361141894650663,1.0470229243094,0.40736478711162255,0.8232527202595691,1.0,23/67,19.19%,MAPKAPK2;PRKD2;NCK1;NCF4;CYBB;ITGB3;PIK3R1;NCKAP1;VEGFC;PTK2B;CYFIP1;NCF2;BAIAP2;NRP2;ELMO2;CRK;ABI1;PGF;RAC1;PDCD6;MAPKAPK3;VEGFB;ELMO1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.45932392100584735,1.0469690309737065,0.4241486068111455,0.8228469789405427,1.0,1/15,0.47%,MAD2L1
prerank,intraciliary retrograde transport (GO:0035721),0.48670823178924777,1.0468837880587836,0.4305993690851735,0.8225294847698201,1.0,4/12,13.63%,WDR19;DYNLT2B;IFT43;DYNC2H1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.40202390866261334,1.0468293885446323,0.42297650130548303,0.8221317822987925,1.0,10/30,21.12%,DDOST;RPN2;TUSC3;MGAT5;DPM1;DPM2;UBE2J1;ALG8;MGAT1;STT3B
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.36236164291897455,1.046825866266365,0.40840140023337224,0.8215874668970047,1.0,21/60,19.63%,SOX9;RELA;TRIM28;TCF7L2;MED8;CTNNB1;RUNX2;CDK8;MED25;IL6;MED1;MED13;AGO3;NFKB1;MED20;TNRC6C;CEBPB;MED4;MED23;CSF1R;CCND1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.45500750393933503,1.0467899465371915,0.43202416918429004,0.8211398096005119,1.0,1/17,0.87%,KCNH2
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.3657163461360093,1.046507285471263,0.428078250863061,0.8213484200875173,1.0,17/65,15.65%,VPS4A;PSMD2;PSMC4;PSMD4;PSMD1;PSME3;PSMB6;PSMD10;PSMB1;CHFR;PSMD11;PSMA2;PSMD13;NABP1;PSMB10;PSMB3;SKP1
prerank,organelle fission (GO:0048285),0.4169105207180681,1.0462476067111182,0.4355495251017639,0.8215126969684464,1.0,4/24,10.09%,CORO1C;DNM2;MTFP1;GDAP1
prerank,regulation of mitotic spindle organization (GO:0060236),-0.30660593016627574,-1.0461754554559555,0.37272727272727274,1.0,1.0,20/35,32.05%,DRG1;NUMA1;TPR;VPS4B;CHMP3;RAE1;CHMP2B;EML3;GNAI1;CHMP1A;GPSM2;CHMP4B;BORA;CHMP1B;MAP9;CHMP2A;TACC3;CEP97;PARP3;TPX2
prerank,synaptic vesicle localization (GO:0097479),-0.39489315272211867,-1.0461374295730854,0.38315217391304346,1.0,1.0,6/13,17.31%,SPG11;NLGN1;RAB27A;KIF5C;TMEM230;CDK5
prerank,calcium ion transmembrane transport (GO:0070588),-0.2500816265145148,-1.0460225284832898,0.34408602150537637,1.0,1.0,32/86,26.41%,GRIN2B;CACNA1D;NALCN;PKD1;GAS6;SLC8B1;ITGAV;ATP2A2;CACNA1C;ORAI1;SLC8A3;TMCO1;LETM1;SLC8A1;MCUB;GRIN1;MICU3;PKD2;ATP2B1;ATP2B3;TRPC7;SPG7;TRPV4;PHB2;STOML2;MAIP1;TMEM165;RYR3;ATP2C1;PMPCA;P2RX7;GRIN2D
prerank,peroxisome organization (GO:0007031),-0.3327016153586812,-1.0457808260084953,0.35661764705882354,1.0,1.0,9/25,20.29%,LONP2;PLAAT3;ABCD3;ABCD2;PEX6;PEX19;FIS1;DNM1L;ACOT8
prerank,regulation of keratinocyte differentiation (GO:0045616),0.4187631118187006,1.0450822433021019,0.43646408839779005,0.8241191326616913,1.0,6/24,15.68%,CTSL;ZFP36;PRKCH;NCOA3;MED1;RUNX1
prerank,regulation of cellular amine metabolic process (GO:0033238),0.3751770004037548,1.0449115012760066,0.42568370986920334,0.8240180636360672,1.0,14/50,15.38%,PSMD2;PSMC4;PSMD4;PSMD1;PSME3;PSMB6;PSMD10;PSMB1;PSMD11;PSMA2;PSMD13;PSMB10;PSMB3;AZIN1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.402825926353127,1.0447962235838937,0.4119170984455959,0.8238096543026504,1.0,5/31,12.83%,MOCS1;LIAS;HSD17B1;GCH1;PYCR2
prerank,focal adhesion assembly (GO:0048041),-0.3540228823862775,-1.0445451014387963,0.38636363636363635,1.0,1.0,10/21,27.51%,TESK2;FERMT2;BCR;ACTN1;SRC;SORBS1;CTTN;ACTN2;PIP5K1A;THSD1
prerank,negative regulation of coagulation (GO:0050819),0.4794571883330318,1.0433511871274326,0.4276923076923077,0.8271088718934011,1.0,5/14,19.23%,SERPINE1;APOE;HS3ST5;PROC;SERPINE2
prerank,regulation of vacuole organization (GO:0044088),0.4371161990863088,1.0433194586535386,0.4228571428571429,0.8266373231595001,1.0,6/20,14.28%,NPRL2;MTM1;MTMR3;SCARB2;ANXA2;NPRL3
prerank,post-translational protein modification (GO:0043687),0.32722439579940993,1.043161194359133,0.35714285714285715,0.8265383310926497,1.0,73/332,18.57%,CSF1;FBXL15;DDB2;RNF7;FAM20C;PENK;CUL3;BTBD6;DCAF10;LGALS1;PSMD2;CHML;PSMC4;MBTPS1;FBXW11;PSMD4;SOCS6;PSMD1;FBXL3;PRKCSH;APOE;SPP1;GOLM1;DCUN1D1;KBTBD7;DCAF5;PSME3;CHGB;WDTC1;PSMB6;PSMD10;FBXL8;CAND1;TULP4;PDIA6;COPS3;COP1;SUMF1;FBXW4;ASB6;FBXW5;PSMB1;MGAT4A;NEDD8;PSMD11;CHM;FBXL5;PSMA2;PSMD13;APP;RABGGTB;DDB1;P4HB;PSMB10;NAE1;CUL2;WFS1;IL6;FBXO4;PSMB3;SKP1;UBE2F;CUL4A;EVA1A;PROC;FBXW9;PSMC1;KLHL25;ASB7;DCAF17;HSP90B1;ASB2;EPAS1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.3865676967421591,1.043141635313787,0.43018867924528303,0.8260448189565472,1.0,10/41,17.55%,SLAMF1;SIRPA;NLRC3;PTPN6;CD33;IGF1;C5AR2;ILRUN;TNFAIP3;ZC3H12A
prerank,receptor clustering (GO:0043113),-0.32932292914074474,-1.0430808665506284,0.35655737704918034,1.0,1.0,9/27,11.77%,DLG2;NLGN1;NRXN1;LRRC7;MAGI2;NRXN2;DLG1;DVL1;DLG3
prerank,regulation of dendrite morphogenesis (GO:0048814),0.39664362249866253,1.0430486531371252,0.4269230769230769,0.8257404623433356,1.0,8/32,12.74%,CDKL3;LZTS1;SS18L2;CAPRIN2;PTPRD;CDKL5;TNIK;SS18L1
prerank,nuclear membrane organization (GO:0071763),0.4368282809162227,1.0429664048032232,0.41125541125541126,0.8253989736670861,1.0,3/19,3.85%,VPS4A;NEMP1;TARDBP
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.44939601573254584,1.0428952830116816,0.42143906020558003,0.8250273732971429,1.0,8/16,21.33%,AGT;AKAP6;TRPC3;IGF1;MEF2A;SLC9A1;IL6ST;CAMK2D
prerank,negative regulation of angiogenesis (GO:0016525),0.3554877278434217,1.0427573794922589,0.40904079382579933,0.8248548036595488,1.0,8/84,7.23%,ADAMTS1;PGK1;CREB3L1;SERPINE1;SARS1;KRIT1;SPARC;SEMA6A
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.40196812167122004,1.042713079455865,0.4104193138500635,0.8244382696827076,1.0,5/33,8.25%,CCL2;PRMT2;FAM107A;JADE1;CDK6
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.4165881946114144,1.042542980573546,0.426027397260274,0.8243280194348238,1.0,2/25,0.93%,PGK1;PFKM
prerank,cellular protein-containing complex assembly (GO:0034622),0.334143603757439,1.042399763730059,0.43402061855670104,0.8241493266107168,1.0,41/160,18.24%,HSPA4;HIGD1A;NUP153;NCK1;HSP90AB1;MID1IP1;NDC1;PICALM;MIS12;PSMD4;ARL6;RTN4;BBS12;LONP1;VAMP1;PTGES3;GPX4;DHX9;PDE4DIP;COG4;COX7A2;TBCE;CLTC;DLGAP5;COX7A2L;PSMD11;CENPC;PSMD13;CLU;RAB5IF;NUP98;ADRB2;POMP;HSPD1;AP2M1;POGZ;SMAD3;TIAM1;RPL38;SGIP1;DMD
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.31944248263605335,-1.0420595286281,0.37662337662337664,1.0,1.0,4/28,4.00%,DRG1;NUMA1;CKAP5;NAV3
prerank,vesicle organization (GO:0016050),0.37801882843288015,1.0413488179150712,0.4211150652431791,0.8264003412870506,1.0,15/46,17.80%,SQSTM1;SRGN;ARFGEF2;ALS2;PHETA1;SNX33;ZFYVE16;HOOK2;SAR1B;USP8;PLEKHJ1;VPS18;AKTIP;CORO1A;SORT1
prerank,positive regulation of dendrite extension (GO:1903861),0.44935643995771,1.0412891857926552,0.42296918767507,0.8260316278595344,1.0,7/17,21.83%,CPNE9;RIMS1;SMURF1;SYT1;SYT4;PLAA;ITSN2
prerank,positive regulation of B cell proliferation (GO:0030890),-0.323815051231241,-1.040973612513283,0.3659574468085106,1.0,1.0,7/29,11.10%,NCKAP1L;VAV3;IRS2;CD38;EPHB2;SASH3;CD74
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.4736675094223294,1.0408242456622563,0.4259818731117825,0.8266763612448672,1.0,4/13,8.90%,ZBTB7B;SORL1;SIRT1;PRKCZ
prerank,bile acid and bile salt transport (GO:0015721),-0.34271157208529174,-1.0407978115693823,0.3619402985074627,1.0,1.0,3/24,4.14%,SLCO2B1;NCOA2;ABCC4
prerank,negative regulation of gene expression (GO:0010629),0.3234837164308,1.0406813373288835,0.3885542168674699,0.8265055736625171,1.0,70/302,18.47%,CCL3;SLC7A5;LSM5;CREB3L1;ZFP36;SRGN;ILF3;MALSU1;PICALM;RPL13A;RIDA;TOB1;EIF2AK2;TARDBP;FXR2;MAP2K1;FLOT2;APOE;TAF1;PDGFB;CNOT8;PTBP2;FOXP1;EIF2AK3;SIRT1;SAMD4B;ENG;SPI1;PARP10;HDAC1;YBX1;ZNF148;BTG2;GIGYF2;SETDB1;CNOT7;TMBIM6;PTRH2;IGF1;APP;DGKQ;DNMT3A;AEBP2;FMR1;NPTN;ANXA7;PTBP1;NCOR1;SLC11A1;LGR4;EIF4E2;RUNX1;DAPK1;FLCN;PUS7;CNOT10;AGO3;NFKB1;SMYD5;YTHDF2;SMO;GPNMB;ZC3H12A;EZH2;CALR;TNRC6C;MEF2C;ENC1;RBBP4;PRKAA1
prerank,cellular response to mechanical stimulus (GO:0071260),0.3734868917000199,1.0406380110008122,0.4294478527607362,0.8260781345587841,1.0,7/46,11.28%,KCNK4;LTBR;HABP4;SOX9;TLR7;MAPK8;BAD
prerank,neutrophil activation (GO:0042119),0.4774037467785004,1.0405646419476,0.44153846153846155,0.8257368277711962,1.0,1/12,2.30%,TYROBP
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.4382202669904352,-1.0403565113591977,0.4250681198910082,1.0,1.0,5/10,21.39%,SMARCAL1;BLM;DNA2;WRN;SLX4
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.4382202669904352,-1.0403565113591977,0.4250681198910082,1.0,1.0,5/10,21.39%,SMARCAL1;BLM;DNA2;WRN;SLX4
prerank,t-circle formation (GO:0090656),-0.4382202669904352,-1.0403565113591977,0.4250681198910082,1.0,1.0,5/10,21.39%,SMARCAL1;BLM;DNA2;WRN;SLX4
prerank,pyruvate metabolic process (GO:0006090),0.3751655153433323,1.0401232711366277,0.4186320754716981,0.8263179916894493,1.0,6/52,6.81%,PGK1;PFKM;PGM1;SLC16A3;SLC16A1;PDHA1
prerank,potassium ion transport (GO:0006813),0.34385139954117544,1.0400917951047974,0.40670859538784065,0.8258391430208076,1.0,10/120,9.60%,KCNK4;ABCB8;KCNH2;KCNJ6;KCNK9;SLC1A3;KCNMB2;KCNMB3;KCNJ2;KCNQ3
prerank,organelle organization (GO:0006996),0.3246852325715027,1.0400481209826276,0.3711133400200602,0.8254160210211965,1.0,69/388,14.25%,CCL3;MYC;CCL2;MICAL1;MTX1;IQCG;ATP8B1;VPS4A;CXADR;CATIP;TANGO2;FMNL3;RAB18;ABI2;NDP;SSBP1;TMED5;TJAP1;PDCD6IP;PLEKHM2;TMED4;USP6NL;PRPF40A;APOE;LONP1;TMEM135;RHOU;TRIP11;SEMA6A;RAB31;DNAJA3;EIF2AK3;TMED10;ATL3;PEX3;COG4;PACSIN2;CNTNAP1;POLG2;ANK1;ZRANB1;ADCK1;SLC25A33;RANBP10;MICAL2;SLC25A36;GABPB1;FGD1;PPRC1;SIRT5;TTC17;ZMYM4;BNIP1;ZFYVE16;TNIK;RAB32;DIAPH1;OPTN;RNF112;GORASP2;GBF1;CCL13;DYNC2H1;TMEM11;ARMC2;SAR1B;GOLGA8B;GOLGA5;TFB2M
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.500771060873434,1.0399657372450548,0.43993759750390016,0.8250849936407736,1.0,2/10,7.72%,PFKM;GFPT1
prerank,positive regulation of protein kinase activity (GO:0045860),0.3365332155253982,1.039964390712515,0.4061855670103093,0.8245459950423967,1.0,26/148,11.97%,EGR1;AGAP2;CSF1;CALCA;IL34;HSP90AB1;DUSP19;MAP2K3;ALS2;MAP2K1;CAMKK1;TGFBR2;ITGB3;PDGFB;AGT;XRCC5;RALB;PTK2B;PTPRC;PRNP;TOM1L1;DDR2;PRKAG1;TAOK2;CLU;TNIK
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.3974263402356522,1.0398248764456777,0.43391188251001334,0.8243946857860422,1.0,8/34,16.23%,RAB7B;ACOD1;GPS2;LGR4;GPR108;PTPRS;OTUD4;TNFAIP3
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.3701900874311368,1.0395527691333348,0.4199288256227758,0.8245437530127697,1.0,8/53,8.23%,UCHL5;HSP90AB1;NUPR1;PSME3IP1;APOE;GLMN;PSME3;USP19
prerank,regulation of osteoblast proliferation (GO:0033688),-0.3652069520946003,-1.0392765127455394,0.38414634146341464,1.0,1.0,5/17,16.66%,RHOA;TMEM119;ATRAID;FGFR2;NELL1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.4701399397827136,1.039220395289432,0.417298937784522,0.824842272309354,1.0,4/13,11.60%,LTO1;GLRX5;GLRX3;ISCA1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.34251777117725335,1.0391138959444715,0.4300847457627119,0.8245813052389751,1.0,28/109,17.13%,JUN;MAPK10;PSMD2;NFATC3;PSMC4;FBXW11;IKBKB;RELA;PSMD4;MAP2K7;PSMD1;PIK3R1;PSME3;PSMB6;PSMD10;MAPK8;PSMB1;PSMD11;PSMA2;PSMD13;PSMB10;SOS1;PSMB3;SKP1;RAC1;NFKB1;TEC;PSMC1
prerank,DNA metabolic process (GO:0006259),0.32667795967449204,1.0390541816490217,0.4056508577194753,0.8242123616409653,1.0,52/270,14.07%,DDB2;ACD;HMGB1;PARG;UBE2T;KMT5B;KAT5;GLRX2;MCM2;LIG1;DOT1L;RPS27A;UBC;GTF2H4;LTO1;RPAIN;PCNA;LONP1;USP3;PDS5A;TRRAP;PARP4;XRCC5;RAD52;PTGES3;TRIM28;CSNK1E;XRCC1;ORC5;POLB;TCF7L2;TDP1;DDX21;CNBP;STN1;NBN;SUMO1;CHD1L;MSH3;ENDOV;MPG;PARP2;BTG2;KPNA2;SMARCB1;DDB1;POLD4;NABP1;SRPK2;ADPRS;TSN;TDG
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.4824731087635314,1.0388406001446189,0.4616564417177914,0.8242460597807701,1.0,2/12,5.82%,ELOVL1;FADS1
prerank,phospholipid homeostasis (GO:0055091),0.49480888077355334,1.038784232265572,0.4421553090332805,0.8238559084090026,1.0,1/11,1.53%,TLCD2
prerank,positive regulation of histone modification (GO:0031058),0.3948204208494907,1.0386914284527713,0.41580310880829013,0.8235545303493421,1.0,10/33,14.96%,CHTOP;SAP30BP;ZBTB7B;TADA2A;TET1;ARRB1;KDM1A;FMR1;AKAP8L;SART3
prerank,cristae formation (GO:0042407),0.4182483845411309,1.0384511577631346,0.4327956989247312,0.8236391907023723,1.0,11/27,18.30%,ATP5MF;ATP5PF;ATP5F1E;ATP5PD;CHCHD6;ATP5MC2;AFG3L2;ATP5F1C;ATP5F1D;ATP5MC3;ATP5MG
prerank,regulation of interleukin-2 production (GO:0032663),0.38065145952396723,1.0383507410805723,0.42317073170731706,0.8233615801342224,1.0,8/43,9.29%,ZFP36;PRKD2;KAT5;PNP;GLMN;IL1A;PTPRC;PRNP
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.3991591280536874,-1.0382031255535071,0.41543026706231456,1.0,1.0,4/14,10.29%,AUTS2;SNW1;PAXIP1;WDR5
prerank,lipid droplet organization (GO:0034389),-0.3471746243633018,-1.0381400063483261,0.4015444015444015,1.0,1.0,3/22,8.12%,CDS1;FAF2;PPID
prerank,protein stabilization (GO:0050821),0.3302498940845875,1.0380258130648594,0.41468459152016546,0.8236763851677439,1.0,36/168,16.07%,BAG6;TBRG1;CRTAP;TYROBP;USP2;OTUD3;HSP90AB1;PIN1;PFN1;GET1;SEL1L;FLOT2;MDM4;RTN4;CTNND1;TAF1;PIK3R1;PTGES3;CCT8;USP19;TBL1X;MFSD1;ATP1B1;SUMO1;BAG1;GTPBP4;GLMP;CLU;IGF1;CCT7;WFS1;FLNA;CREB1;CDC37;FLOT1;HSPD1
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3236823495280546,1.0379683298466256,0.376,0.8232871933395554,1.0,80/509,15.04%,CCL3;SELP;OSM;CCL4;LITAF;PDGFRB;RTKN2;DLG5;BCL2L1;LTBR;ADAM8;RRAGC;C1QBP;PRKD2;RICTOR;LGALS1;BID;RPS15;PDGFA;HSP90AB1;HMGB1;SOX9;DUSP19;NUPR1;IKBKB;EIF2AK2;CHD5;RELA;NEK6;TBK1;TMED4;TGFBR1;SCHIP1;RHOG;RTN4;JCAD;RBCK1;PIK3R1;PDGFB;AGT;GSDME;CARD9;RYK;TCF7L2;TCIM;DDX21;SIRT1;ENG;TLR7;PTPRC;LARS1;F3;RIPK2;CARD16;PUM2;OSBPL8;RHEB;IL18;PTPN6;RNF31;SOX2;BAD;PTP4A3;IGF1;CFLAR;APP;MIER1;LPAR1;ROR1;GCNT2;SLC20A1;LIMS1;IKBKE;GOLT1B;MTDH;BRD4;ADRB2;FLNA;IL6;HGF
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.49320447706877213,1.03786922884784,0.4432,0.823010354144496,1.0,7/11,25.60%,ATF4;NONO;FBXO7;REST;PINK1;PRKN;RACK1
prerank,microtubule depolymerization (GO:0007019),0.44738942210909516,1.0374183094739116,0.43768545994065283,0.8236730418734411,1.0,1/17,0.24%,KIF19
prerank,regulation of innate immune response (GO:0045088),0.36457357438911303,1.0370948924219734,0.42621015348288077,0.8239854634570082,1.0,16/57,17.64%,ADAM8;TKFC;ACOD1;HSP90AB1;NLRC3;POLR3B;DHX9;AKIRIN2;PTPN6;POLR3F;CDC37;TNFAIP3;RIOK3;IFNAR2;TRAFD1;SLC15A4
prerank,regulation of microtubule polymerization (GO:0031113),-0.2943292819398843,-1.0370013239276967,0.36416184971098264,1.0,1.0,9/40,12.28%,TBCD;DRG1;NUMA1;NAV3;STMN2;STMN1;CAMSAP1;RPS3;PRUNE1
prerank,outflow tract septum morphogenesis (GO:0003148),-0.3331234502839443,-1.0361014339671164,0.37777777777777777,1.0,1.0,10/24,21.84%,ROBO1;BMPR2;SEMA3C;FGFR2;ROBO2;ZFPM2;NRP1;BMPR1A;TGFB2;PARVA
prerank,positive regulation of locomotion (GO:0040017),0.4136463796180145,1.0359546369992587,0.4322916666666667,0.8264483571159805,1.0,4/27,9.97%,PDGFRB;PDGFB;STX3;PPM1F
prerank,regulation of protein secretion (GO:0050708),0.3381831776005459,1.0351989020435375,0.43756558237145854,0.8279217395406958,1.0,25/119,17.30%,TFAP2B;ADAM8;LLGL1;RHBDF2;ATP13A2;ADAM9;CACNA1A;APOE;DNAJC1;TMED10;CD2AP;IL1A;BMP6;SERGEF;CD33;STXBP5L;APBB3;IGF1;SLC2A1;IL6;MYH10;STXBP5;MTNR1B;PICK1;UNC13B
prerank,protein modification process (GO:0036211),0.35414041117645967,1.0345999642449015,0.44518272425249167,0.8289846654152054,1.0,18/76,16.42%,UBE2S;CDKL3;GGCX;ABL2;RPN2;PARP4;UBE2D3;USP25;NEDD8;UBE2L3;UBE2I;RABGGTB;CSNK1G3;NAGPA;PHKA2;LCMT1;ST3GAL6;B4GALT7
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.34202070769463133,1.0345443076147105,0.43042071197411,0.8286039878825572,1.0,23/108,18.02%,MYC;CTSD;ARL6IP5;BID;HMGB1;NLRP3;CASP4;CARD9;EIF2AK3;SIRT1;F3;PYCARD;PPM1F;CASP9;BAD;CFLAR;MTCH1;NDUFA13;DAPK1;HSPD1;HTRA2;SMAD3;PDCD6
prerank,sphingolipid biosynthetic process (GO:0030148),0.35901498993330566,1.0340247516479812,0.42299107142857145,0.8294064355834456,1.0,22/71,21.18%,ALOXE3;SGPP2;PRKD2;ELOVL1;SPTSSA;DEGS1;SGMS1;CLN8;SMPD1;CSNK1G2;SMPD4;PLPP1;SPNS2;CERS2;SGPL1;ELOVL7;ELOVL6;ASAH2;ST6GALNAC5;PPM1L;PRKD3;CERS6
prerank,lipid translocation (GO:0034204),-0.3625026981012272,-1.0338079717375912,0.3701067615658363,1.0,1.0,7/21,12.76%,ABCA1;ATP11B;ATP10A;ABCB4;ATP8B4;ABCA7;ATP9B
prerank,histone H2A monoubiquitination (GO:0035518),0.44886131553734077,1.0334557890079508,0.43892045454545453,0.8303476052485271,1.0,6/17,18.52%,DDB2;RYBP;PCGF2;DDB1;SKP1;KDM2B
prerank,mRNA destabilization (GO:0061157),0.3864118066510385,1.03261638587371,0.44302176696542894,0.8320632049188952,1.0,14/38,21.54%,ZFP36;RIDA;TARDBP;TUT7;RC3H1;GIGYF2;RC3H2;YTHDF2;ZC3H12A;FTO;UPF1;CNOT1;METTL3;CPEB3
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.4082231387710654,-1.0324475896172884,0.4297752808988764,1.0,1.0,3/12,6.13%,KIF3A;BICD2;BICD1
prerank,icosanoid biosynthetic process (GO:0046456),0.496922042302694,1.032245822538636,0.463743676222597,0.832515616751662,1.0,2/10,5.82%,PLA2G4A;FADS1
prerank,negative regulation of protein binding (GO:0032091),0.34782380776361216,1.031858270256153,0.4241379310344828,0.8330080719593663,1.0,16/71,15.46%,TMC8;PIN1;PSME3IP1;GNL3L;PDGFB;CSNK1E;RALB;SORL1;MAPK8;CARD16;KDM1A;TMBIM6;DNAJB2;ADRB2;SYMPK;ACTB
prerank,regulation of cholesterol storage (GO:0010885),-0.37915844867174187,-1.0313772872149798,0.40061162079510704,1.0,1.0,8/15,22.45%,ABCA1;MSR1;SCARB1;SREBF2;PPARG;ABCG1;NR1H2;EHD1
prerank,positive regulation of vasculogenesis (GO:2001214),-0.43059822528198244,-1.0311818839559426,0.4301994301994302,1.0,1.0,9/10,51.55%,CD34;HIF1AN;TMEM100;CEACAM1;KDR;ASB4;RAPGEF2;RRAS;RIN2
prerank,Fc receptor signaling pathway (GO:0038093),0.3398753703892927,1.0309930828431586,0.4406779661016949,0.8346874999622148,1.0,28/110,17.13%,JUN;MAPK10;PSMD2;NFATC3;PSMC4;FBXW11;IKBKB;RELA;PSMD4;MAP2K7;PSMD1;PIK3R1;PSME3;PSMB6;PSMD10;MAPK8;PSMB1;PSMD11;PSMA2;PSMD13;PSMB10;SOS1;PSMB3;SKP1;RAC1;NFKB1;TEC;PSMC1
prerank,regulation of epithelial cell migration (GO:0010632),0.3665704871256009,1.0309697344465678,0.44,0.8342162705935,1.0,9/51,9.97%,CORO1C;SOX9;PFN1;HDAC6;ADIPOR1;RTN4;GLIPR2;PTPRR;PPM1F
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.3150119848034141,-1.030898210875714,0.3970037453183521,1.0,1.0,7/27,14.66%,FGF12;YWHAH;SNTA1;UTRN;DLG1;GPD1L;FXYD5
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.4098246858191199,-1.0307705857183969,0.428169014084507,1.0,1.0,9/12,51.38%,FUT9;MDK;SKAP1;ASS1;LCK;AKT1;PPARA;FUT4;ADTRP
prerank,action potential (GO:0001508),0.3808982404178598,1.0305911912194876,0.43742255266418834,0.8347093787746548,1.0,7/44,8.68%,KCNH2;SCN8A;CACNA1G;AKAP6;KCNMB2;KCNMB3;KCNJ2
prerank,response to purine-containing compound (GO:0014074),0.44664046383613343,1.030521013676434,0.4479768786127168,0.8343589626166753,1.0,4/17,12.62%,P2RY1;TRPC3;TRPM2;DGKQ
prerank,metal ion transport (GO:0030001),0.34776304113335466,1.0303997810068444,0.4280898876404494,0.834143314316869,1.0,14/86,12.38%,CCL3;CACNA1A;CACNG8;TUSC3;CACNA2D1;SLC3A2;SLC39A8;TRPC4;TRPC1;TRPC3;SLC30A5;CCR5;TRPM2;NIPA1
prerank,bicellular tight junction assembly (GO:0070830),-0.2744361621039503,-1.030040912043596,0.37988826815642457,1.0,1.0,8/46,8.71%,TBCD;MPP7;STRN;PATJ;PAK2;PRKCI;DLG1;CLDN14
prerank,protein localization to organelle (GO:0033365),0.3342610866141598,1.029801376879065,0.4375,0.8351919972541569,1.0,35/133,17.09%,WDR83OS;DCP1A;ATP6V1D;GET1;ARL6;COL1A1;ZBTB7A;TULP2;CROCC;BBS4;DHX9;ARL3;PACSIN2;SORL1;DNAJA1;PRNP;CTDNEP1;CNEP1R1;YBX1;VPS35;APP;OPTN;GBF1;UBAC2;CEP250;TMEM30A;CCDC47;TRAM1;STX5;ARL1;MICALL1;LMBRD1;LAMP5;CSNK1D;TOR1B
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.5093552147426815,1.0296060646395309,0.4402618657937807,0.8351540495532022,1.0,1/10,0.31%,CCL2
prerank,mitotic metaphase plate congression (GO:0007080),0.3663130442418758,1.0295955138063921,0.4297520661157025,0.8346445928108578,1.0,9/51,13.75%,CUL3;VPS4A;NUDC;MIS12;PDCD6IP;NDC80;EML4;CENPC;MAD1L1
prerank,negative regulation of cation channel activity (GO:2001258),-0.320072455721068,-1.0292087182510548,0.3983402489626556,1.0,1.0,8/26,16.55%,CALM2;CALM1;EPHB2;KCNAB1;SRI;PKD2;GNB5;CALM3
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.4262821936993206,1.0289724255007253,0.4388888888888889,0.835233589288401,1.0,6/22,11.08%,CLIP3;ZDHHC9;ZDHHC7;ZDHHC8;ZDHHC3;ZDHHC21
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.4262821936993206,1.0289724255007253,0.4388888888888889,0.835233589288401,1.0,6/22,11.08%,CLIP3;ZDHHC9;ZDHHC7;ZDHHC8;ZDHHC3;ZDHHC21
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.38637162421044247,-1.0287374818385788,0.434375,1.0,1.0,6/15,18.14%,DDX1;RTCB;CPSF4;RTRAF;TSEN15;CPSF1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.3848500429968028,1.0285480676142147,0.4496894409937888,0.8359070659376001,1.0,6/36,6.17%,HMGB1;ANGPT2;KRIT1;APOE;JUP;DNAJA4
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.41574017481798636,-1.0281838140715358,0.44173441734417346,1.0,1.0,5/12,29.62%,B3GNT2;B3GALT5;B3GALT1;B3GALNT1;B3GALT2
prerank,nucleotide-excision repair (GO:0006289),0.33958314388364874,1.0277720116409963,0.4234527687296417,0.8374357118711934,1.0,22/101,16.45%,UVSSA;DDB2;POLR2J;HMGN1;LIG1;RPS27A;UBC;GTF2H4;PCNA;XRCC1;POLB;SIRT1;COPS3;CHD1L;ERCC2;DDB1;POLD4;POLR2E;POLR2B;FANCC;CUL4A;POLR2G
prerank,macrophage differentiation (GO:0030225),0.46653590187745275,1.0268271061014023,0.4409448818897638,0.8393229907753913,1.0,2/13,8.55%,CSF1;SIRT1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.47936942725296194,1.0264847251240028,0.45652173913043476,0.8396402443800635,1.0,3/11,13.92%,TIMM8B;TIMM9;NDUFA13
prerank,membrane raft organization (GO:0031579),0.4611436032392655,1.0264618007173145,0.45317220543806647,0.8391556827858254,1.0,6/15,19.71%,FLOT2;PPT1;ANXA2;FLOT1;NPC1;RFTN1
prerank,excitatory postsynaptic potential (GO:0060079),-0.34628990220893735,-1.0254792555472794,0.4012738853503185,1.0,1.0,6/19,20.38%,GRIN2B;LRRK2;GSK3B;GRIN1;GSK3A;ARRB2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.3921333102151274,-1.0252498452108503,0.4107142857142857,1.0,1.0,6/13,17.55%,CD46;LTBP1;FSTL1;FBN1;DAND5;GREM2
prerank,negative regulation of signaling (GO:0023057),0.4078056157832829,1.0252290646630076,0.44235924932975873,0.8418036141696874,1.0,3/25,12.70%,OSM;HHIP;OPTN
prerank,negative regulation of JUN kinase activity (GO:0043508),0.49684176179080586,1.024889286120893,0.4403225806451613,0.8421541713651126,1.0,2/10,8.75%,DUSP19;DNAJA1
prerank,sprouting angiogenesis (GO:0002040),0.3659175117414655,1.0242197090830099,0.4447058823529412,0.8433436449258498,1.0,6/51,8.66%,EGR3;NR4A1;PIK3R3;VEGFC;PTK2B;ENG
prerank,negative regulation of potassium ion transport (GO:0043267),0.4672710997901325,1.02418464781103,0.4495548961424332,0.8428873887321697,1.0,2/13,7.92%,KCNH2;PTK2B
prerank,copper ion homeostasis (GO:0055070),0.4486838836994203,1.0241449104290985,0.48333333333333334,0.8424624656514352,1.0,6/17,15.95%,PRNP;SLC31A1;APP;CUTC;COX19;MT2A
prerank,regulation of primary metabolic process (GO:0080090),0.33400150152455677,1.0239319098594948,0.45654450261780105,0.8424696570915553,1.0,38/126,17.42%,TGS1;PSMD2;NFYA;NR1D2;PSMC4;PSMD4;PSMD1;ADIPOR1;APOE;PSME3;BBS4;PSMB6;PSMD10;TBL1X;CREBBP;PSMB1;ACACA;PSMD11;PSMA2;PSMD13;PSAP;GPS2;PSMB10;HMGCS1;PRKAB1;ZFP69;NCOR1;PLPP1;PSMB3;MED1;AZIN1;SC5D;SIN3A;OPA3;RXRA;PSMC1;NFYC;CERS2
prerank,RNA metabolic process (GO:0016070),0.332457973170295,1.023797793346719,0.4573560767590618,0.842270537636166,1.0,49/127,22.13%,DDX20;POLR2J;HNRNPK;HNRNPD;HNRNPU;HNRNPM;DDX54;RBPMS;HNRNPH2;RBM39;DHX9;TP53RK;PCBP2;NCBP1;DEDD2;GTF2F2;HNRNPL;POLR2E;DROSHA;HNRNPH1;SND1;SETX;PTBP1;POLR2B;ADARB1;RNASE3;RNASE1;SNRNP40;AGO3;POLR2G;HNRNPA1;ATXN2;ZC3H12A;HNRNPR;PRPF4;FTO;TBRG4;POLR2K;RNASEH1;RNASEH2A;AGO2;NOL9;METTL3;HNRNPA2B1;RNGTT;DHX8;DDX17;PCBP3;FASTKD2
prerank,global genome nucleotide-excision repair (GO:0070911),0.4051343926551984,1.0234982911585055,0.4396200814111262,0.8425207094722171,1.0,7/26,12.63%,DDB2;RPS27A;UBC;GTF2H4;CHD1L;ERCC2;DDB1
prerank,homeostasis of number of cells (GO:0048872),-0.4057491230226684,-1.0233187271800284,0.41818181818181815,1.0,1.0,5/12,20.93%,OCIAD1;LPCAT3;NOTCH1;NAPEPLD;CX3CR1
prerank,Rac protein signal transduction (GO:0016601),0.43617200952117785,1.0231381997134599,0.4295977011494253,0.8429425954600899,1.0,9/18,19.19%,ABI2;RHOG;NCKAP1;CYFIP1;DBNL;RAC1;TIAM1;CDH13;ELMO1
prerank,regulation of autophagy (GO:0010506),0.32553520084428184,1.0227787532090196,0.4450050454086781,0.8433352908300622,1.0,56/216,18.96%,GFAP;STAT3;RRAGC;RAB39B;FZD5;ATP6V1D;ATP6V1A;ATP6V0D1;HMGB1;NPRL2;ATP13A2;NUPR1;SNX6;HDAC6;UCHL1;KAT5;ABL2;RUBCN;ATP6V0E1;CTSA;MTMR3;ATP6V0A1;VPS29;MAPK8;EXOC7;ATP6V0C;RHEB;PRKAG1;UFL1;SIRT2;BAD;VPS35;EIF4G2;OPTN;PSAP;FOXO3;PRKAB1;MTDH;ATF6;MTOR;HGF;EIF4E;FOXK2;DAPK1;FLCN;GPR137B;HTRA2;ATP6V0B;ZC3H12A;TRIM5;ATP6V1G2;DDIT3;RPTOR;PRKAA1;EEF1A1;BMF
prerank,negative regulation of lipid catabolic process (GO:0050995),0.44884151799418115,1.0227584405940298,0.4526627218934911,0.8428444433351414,1.0,4/17,18.47%,APOC1;SORL1;PDE3B;PRKAA1
prerank,endothelial cell development (GO:0001885),0.4123567233205618,1.022757741413651,0.45165562913907287,0.8423102950637447,1.0,5/25,17.90%,MARVELD2;MSN;PPP1R16B;ICAM1;RAP1B
prerank,regulation of organelle organization (GO:0033043),0.34101590491333095,1.0226101571516026,0.42905027932960893,0.8421619178208172,1.0,14/80,13.84%,PISD;SQSTM1;TMEM33;ATP13A2;USP6NL;CLIC4;MTM1;PDE4DIP;AKAP9;MSN;SCARB2;VPS35;DIAPH1;SAR1B
prerank,mRNA export from nucleus (GO:0006406),0.3385381356110461,1.0225756041307268,0.45161290322580644,0.8417166179354507,1.0,18/102,11.17%,MAGOH;MAGOHB;CHTOP;SLBP;NUP153;NDC1;PCID2;SMG7;U2AF2;NUP88;NXF1;IWS1;SRSF2;U2AF1;NCBP1;NUP210;FIP1L1;NUP37
prerank,macroautophagy (GO:0016236),0.33456910047710153,1.0224740496638312,0.4458464773922187,0.8414439251572706,1.0,29/118,16.23%,LIX1;SQSTM1;VPS4A;VPS28;ATG16L1;GABARAP;ATP13A2;GABARAPL1;MTMR14;PIK3R4;VPS37B;ULK3;PIK3C3;VPS39;MAP1LC3A;TOMM20;MTMR3;MAP1LC3B;STAM;TECPR1;PRKAG1;ILRUN;PRKAB1;WIPI1;ATG4B;ARL8B;PLEKHM1;SNX14;VTA1
prerank,response to amino acid (GO:0043200),0.389702769047532,1.0221472954240474,0.43963254593175854,0.8417776596116525,1.0,6/31,11.84%,SESN2;IPO5;RRAGC;LARS1;CPEB1;TMBIM6
prerank,cellular response to nutrient levels (GO:0031669),0.35616085417756954,1.022039601466836,0.4519119351100811,0.8415271662650508,1.0,10/62,8.83%,LPL;RRAGC;FAM107A;HSPA8;FADS1;MAP1LC3A;RALB;SIRT1;MAP1LC3B;KLF10
prerank,ventricular septum morphogenesis (GO:0060412),-0.3156561085076101,-1.0218296314608284,0.39453125,1.0,1.0,13/27,27.78%,ROBO1;BMPR2;TGFBR3;NOTCH1;ROBO2;ZFPM2;BMPR1A;SLIT2;SOX4;TGFB2;SOX11;PROX1;CITED2
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.40014927672168177,-1.0217543569999366,0.45714285714285713,1.0,1.0,5/12,21.51%,RAB27A;GRIN1;PLCG2;TLR4;CD36
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.23348487534560447,-1.021553713001837,0.390625,1.0,1.0,17/108,13.12%,WWOX;NLK;SALL1;PSEN1;DISC1;AXIN1;CSNK2A1;SENP2;HMGXB4;LRRK2;KREMEN1;TLE1;FGFR2;BTRC;KANK1;CTNND2;NXN
prerank,mRNA splice site selection (GO:0006376),-0.3126581252016298,-1.0211030838519626,0.4009009009009009,1.0,1.0,12/30,19.75%,CELF2;SRSF5;PRPF39;SRSF1;CELF4;LUC7L;SRSF9;ISY1;LUC7L3;SRSF6;SF3A3;PUF60
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.3893864691052638,1.0205724633758977,0.4569620253164557,0.8448266651548736,1.0,2/33,1.61%,ADAMTS1;ADAM17
prerank,cell-cell junction assembly (GO:0007043),0.35193726611092807,1.0204566943112383,0.4532871972318339,0.8445931122759127,1.0,15/63,16.72%,WDR1;CD9;CTNND1;JUP;CNTNAP1;CTNNB1;ACTG1;CLDN11;ARVCF;CDH12;ACTB;DCHS1;CDH19;FLCN;PKP4
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.4212769170800285,1.019997213686058,0.4444444444444444,0.8446681938567578,1.0,4/23,10.23%,ADAM17;HSP90AB1;SDCBP;CREBBP
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.4212769170800285,1.019997213686058,0.4444444444444444,0.8446681938567578,1.0,4/23,10.23%,ADAM17;HSP90AB1;SDCBP;CREBBP
prerank,regulation of intracellular pH (GO:0051453),-0.29780605024487805,-1.0199503317911416,0.43103448275862066,1.0,1.0,7/34,8.24%,SLC4A7;SLC9A9;ATP5F1B;SLC9A6;GPR89B;GPR89A;LRRK2
prerank,response to chemokine (GO:1990868),-0.38559585458984935,-1.0198107312551719,0.4369747899159664,1.0,1.0,4/13,22.34%,RHOA;LRCH1;RIPOR2;DOCK8
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.39264667224551814,1.0197132991687852,0.45466666666666666,0.8448815748684169,1.0,6/30,12.61%,SAMSN1;PRKCZ;PTPRC;PTPN6;SH3BP5L;INPP5F
prerank,positive regulation of cation channel activity (GO:2001259),0.38179012934369355,1.0196075179641295,0.46545454545454545,0.844639985008248,1.0,5/40,10.87%,CCL2;STAC;AKAP6;STAC2;TMSB4X
prerank,branched-chain amino acid catabolic process (GO:0009083),0.4211966868197138,1.0194360039365218,0.4222222222222222,0.8439960013685617,1.0,6/20,18.32%,BCAT2;BCKDK;ACAD8;ACAT1;HIBADH;ALDH6A1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.4211966868197138,1.0194360039365218,0.4222222222222222,0.8439960013685617,1.0,6/20,18.32%,BCAT2;BCKDK;ACAD8;ACAT1;HIBADH;ALDH6A1
prerank,protein K63-linked deubiquitination (GO:0070536),-0.3030659530457187,-1.0193068845356112,0.3786008230452675,1.0,1.0,12/31,14.50%,USP33;CYLD;BABAM2;UIMC1;USP50;USP13;STAMBP;BABAM1;USP7;OTUD7A;OTUD5;ABRAXAS1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.46359639578550815,1.019220899399385,0.46444780635400906,0.8440100523933285,1.0,1/13,2.08%,AKAP5
prerank,mitochondrion transport along microtubule (GO:0047497),0.4596309218700898,1.0189934081602672,0.4503012048192771,0.8440583662035068,1.0,2/13,5.51%,MAP1S;UXT
prerank,UV-damage excision repair (GO:0070914),0.4699859601238029,1.0189730251222344,0.4470404984423676,0.8435894414545448,1.0,5/12,21.46%,DDB2;SIRT1;DDB1;POLD3;INO80
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.40511065220602505,1.0186622742600928,0.44370860927152317,0.8438677443776216,1.0,4/25,10.92%,FBXL15;ENG;ACVR2B;RBPJ
prerank,regulation of cellular component movement (GO:0051270),0.3602954040186017,1.0186467429117227,0.4435294117647059,0.8433718925708946,1.0,10/49,12.61%,CD9;ADAM17;HDAC6;ABL2;TGFBR1;MEMO1;CDK6;ZSWIM6;DIAPH1;INPP5F
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.42930925629293204,-1.0185566017792695,0.45925925925925926,1.0,1.0,4/10,35.57%,MYADM;MAPK7;KLF4;MAP2K5
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.42930925629293204,-1.0185566017792695,0.45925925925925926,1.0,1.0,4/10,35.57%,MYADM;MAPK7;KLF4;MAP2K5
prerank,peroxisomal membrane transport (GO:0015919),-0.31536012808721675,-1.0184054464047636,0.4163568773234201,1.0,1.0,10/27,17.42%,SLC25A17;ABCD3;ABCD2;PEX6;ALDH3A2;PEX13;ATAD1;PEX19;FIS1;PXMP4
prerank,positive regulation of biosynthetic process (GO:0009891),0.3785314558433467,1.0182972648551125,0.4451219512195122,0.843755853753628,1.0,8/40,15.68%,SERPINF2;CREB3L1;LARP6;APOE;SLC5A3;CREB1;MTOR;RUNX1
prerank,protein-containing complex subunit organization (GO:0043933),0.3319110544288039,1.0182576527545626,0.46304347826086956,0.8433382405789391,1.0,26/109,16.69%,SHANK1;LLGL1;WDR19;NDC1;SOX9;PICALM;RIMS1;NIFK;MDM4;SKAP2;PTK2B;CD2AP;ST13;CREBBP;TSPAN4;MITF;SLC2A1;NUP98;AFG3L2;TUBGCP4;WIPF1;NUP54;KMT2A;MAGI1;FANCC;APC
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.353127233057467,1.018055820774992,0.4548532731376975,0.8433467314876636,1.0,21/70,17.96%,PSMD2;PSMC4;IKBKB;PSMD4;NCF4;PSMD1;CYBB;PSME3;PSMB6;PSMD10;NCF2;PSMB1;PSMD11;PSMA2;PSMD13;PSMB10;FCGR1A;PSMB3;PSMC1;TAP2;CALR
prerank,tRNA 5'-leader removal (GO:0001682),0.4624841028878781,1.017963870619839,0.4458204334365325,0.8430368827724781,1.0,3/13,11.52%,RPP38;RPP30;POP1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.4485010674491307,1.0178651076872625,0.4642289348171701,0.8427471002187058,1.0,2/14,4.14%,PRKD2;RELA
prerank,maturation of SSU-rRNA (GO:0030490),0.38302523189192034,1.0177898028772012,0.4619289340101523,0.8424235929446832,1.0,7/34,12.43%,RIOK1;NOP14;NOB1;RPS8;UTP4;RRP36;RPS14
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.40673514018546253,1.017414629788312,0.45652173913043476,0.8428617362581866,1.0,11/24,24.45%,CTNNB1;SPAG9;TCF3;OLFM2;MEF2A;CTNNA2;MEF2C;CDC42;CDH2;CAMK1;BNIP2
prerank,protein ADP-ribosylation (GO:0006471),0.39772929703294085,1.017366729559289,0.44563758389261743,0.8424488667865332,1.0,9/28,14.82%,HPF1;PARP4;SIRT1;PARP10;SIRT5;PARP2;SIRT2;ARF4;ART4
prerank,calcium ion transport (GO:0006816),0.3354703680951996,1.017044257658645,0.4593147751605996,0.8427634388375902,1.0,15/113,12.09%,CCL3;CRACR2A;MCOLN3;CACNA1A;CACNG8;CACNA2D1;SLC3A2;TRPM4;CACNA1G;TRPC4;TRPC1;TRPC3;CCR5;TRPM2;TRPV2
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.4038558852744289,1.0170127170421008,0.44675324675324674,0.8423217211092847,1.0,8/25,19.17%,PLAUR;RTN4;AGT;DGKD;RBPJ;DOK1;CCDC88A;BCAR3
prerank,ceramide catabolic process (GO:0046514),-0.38289681922379515,-1.0168943813049898,0.4046242774566474,1.0,1.0,8/14,31.05%,HEXA;ASAH1;NEU1;GM2A;ACER3;GLA;HEXB;ACER2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.4890553064636734,1.016888329200086,0.4822934232715008,0.8420896688210859,1.0,1/11,1.93%,PLAUR
prerank,base conversion or substitution editing (GO:0016553),-0.41145463771329904,-1.0167373986378108,0.4420485175202156,1.0,1.0,2/11,10.95%,ADARB2;APOBEC1
prerank,positive regulation of axonogenesis (GO:0050772),0.37198540692227694,1.0167207971745833,0.45714285714285713,0.8420139907668484,1.0,13/43,19.36%,ARHGDIA;METRN;PLXNA1;RUFY3;BDNF;GOLGA4;CDKL5;LIMK1;DBNL;ZFYVE27;TIAM1;NTRK2;PLXND1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.47769357575089244,1.0167064461461324,0.46747352496217853,0.8415200468521506,1.0,3/12,8.55%,APOC1;WDTC1;SIRT1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.43561518430067503,1.0166841873804178,0.47493036211699163,0.8410541130464909,1.0,3/18,5.81%,GINS3;LIG1;PCNA
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.49574903973717666,1.0165782551116906,0.449438202247191,0.8407895306706428,1.0,3/10,8.55%,KLF15;SET;SIRT1
prerank,negative regulation of interleukin-10 production (GO:0032693),0.44029814196691597,1.016471446215335,0.4512372634643377,0.8405402607341919,1.0,2/16,6.32%,TYROBP;TRIB2
prerank,phospholipid translocation (GO:0045332),-0.3201439811058188,-1.0161451819135534,0.4148471615720524,1.0,1.0,13/28,26.29%,ABCA1;ATP11B;ATP10A;ABCB4;ATP8B4;ABCA7;ATP9B;PLSCR4;PLSCR1;ATP8A2;ATP9A;ATP10B;P2RX7
prerank,receptor catabolic process (GO:0032801),0.4141834092531845,1.0157260555750827,0.45714285714285713,0.8418837577357338,1.0,10/24,16.52%,PIK3R4;SMURF1;AP2A1;CLTC;MYLIP;RNF43;ZNRF3;VLDLR;GPRASP1;AP2M1
prerank,peptidyl-serine modification (GO:0018209),0.3267825573737211,1.0150761088988038,0.46321243523316064,0.8430310441252292,1.0,30/166,13.27%,STK38L;MAPKAPK2;HPF1;BRSK1;PRKD2;RICTOR;IKBKB;TLK1;NEK6;TBK1;TGFBR1;TGFBR2;ULK3;TAF1;PDGFB;PRKCH;CSNK1E;EIF2AK3;LATS1;PRKCZ;MAPK8;MGAT5B;GALNT1;PARP2;CSNK1G2;MKNK1;PDK3;DGKQ;CSNK1G3;SRPK2
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.47105241324469166,1.015037065201728,0.4590909090909091,0.8426182877063431,1.0,1/13,0.31%,CCL2
prerank,phosphatidylinositol metabolic process (GO:0046488),0.3348267538240758,1.0149909579603766,0.4522019334049409,0.8422209895694898,1.0,18/109,12.61%,PDGFRB;PI4KA;PLEK;MTMR10;INPP5K;PIK3R3;MTMR14;PLA2G4A;PIK3R4;PIK3C3;MTM1;PIK3R1;MTMR3;MTMR12;PI4KB;INPP4A;OCRL;INPP5F
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.2807122613923357,-1.0149390459390364,0.41317365269461076,1.0,1.0,9/42,9.18%,RHOA;JAK2;TBCD;MINK1;NPNT;PTK2;RSU1;NOTCH1;SPOCK1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.43429361301356945,-1.0149063614076668,0.45257452574525747,0.9998132774478442,1.0,7/10,42.16%,PRKCE;ATP1A2;NEDD4;HECW1;STK39;OSR1;NEDD4L
prerank,carbohydrate catabolic process (GO:0016052),0.37851649578078495,1.0147707976160896,0.4666666666666667,0.8422372221195739,1.0,8/38,17.21%,PGK1;PFKM;PGM1;NAGA;DERA;PGAM4;PGAM1;PFKFB2
prerank,positive regulation of peptidase activity (GO:0010952),0.4231362548738059,1.0145571227935606,0.4512893982808023,0.8422787466683883,1.0,3/20,7.30%,PRELID1;TANK;PSME3
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.47660392447704264,1.0142882277620775,0.4556765163297045,0.8424408643549447,1.0,1/11,0.87%,KCNH2
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.3923604564956571,1.014245906214269,0.4562091503267974,0.8420342878162643,1.0,6/29,14.20%,NAPA;COPE;TRAPPC10;TRAPPC3;NSF;GOLGA5
prerank,superoxide metabolic process (GO:0006801),0.39413787441723463,1.0141843033835505,0.46367239101717306,0.8416865183524869,1.0,5/29,9.74%,NCF4;CYBB;NRROS;NOXO1;NCF2
prerank,defense response to bacterium (GO:0042742),0.33466866597148515,1.0141376984160124,0.4587352625937835,0.8412835002979799,1.0,19/105,21.55%,SELP;ADAM17;SERPINE1;ANXA3;COLEC12;PYCARD;OPTN;DROSHA;SLC11A1;IL6;LYZL4;RNASE3;CEBPB;PLA2G6;TLR2;ANKRD17;ADGRB1;MBL2;MAVS
prerank,protein K63-linked ubiquitination (GO:0070534),0.3759736010425395,1.0141298890846657,0.4449760765550239,0.8407903967247305,1.0,12/41,19.69%,ARIH2;UBE2S;UBE2T;RNF115;TRIM56;PELI3;STUB1;TRAF3;ZFP91;TRIM5;HECTD1;ITCH
prerank,negative regulation of cell motility (GO:2000146),0.33219341835861504,1.0140244065837105,0.47249190938511326,0.8405630180645814,1.0,19/108,13.54%,EPHA1;DLG5;SERPINE1;TCAF1;RNF20;PIN1;RHOB;CLIC4;JAG1;ENG;MITF;GTPBP4;PTPRU;LIMCH1;SRGAP2;SRGAP3;DPEP1;FOXO3;CRK
prerank,regulation of angiogenesis (GO:0045765),0.3262401272186143,1.013860753976749,0.4764344262295082,0.8404535330475897,1.0,40/192,18.78%,ADAMTS1;PGK1;EPHA1;EPHA2;PRKD2;WARS1;SERPINE1;NINJ1;SARS1;RHOB;KRIT1;EMC10;ANXA3;JUP;SPARC;SEMA6A;VEGFC;IL1A;SIRT1;CEMIP2;SMOC2;F3;CTNNB1;SYNJ2BP;ADAM12;PPP1R16B;MTDH;IL6;RUNX1;PGF;TNFAIP3;FOXJ2;PRKCB;GPNMB;ZC3H12A;ETS1;PDCD6;PDE3B;PDCL3;VEGFB
prerank,T cell activation (GO:0042110),0.3503705133225256,1.013515222817769,0.4592760180995475,0.8407801165403648,1.0,8/69,9.52%,LCP1;TREML2;CXADR;NCK1;DDOST;NLRC3;PTPRC;MSN
prerank,lipid homeostasis (GO:0055088),0.3560396965279518,1.0131222991966409,0.4766899766899767,0.8412224748988797,1.0,8/57,8.80%,TLCD2;ATP13A2;NR1D2;ABHD8;APOE;CLN8;SIRT1;ADCK1
prerank,gene silencing by miRNA (GO:0035195),0.38544957243519934,1.0124798164168665,0.4479166666666667,0.8424376819304762,1.0,13/32,21.37%,ZFP36;TARBP2;EIF6;CNOT8;CNOT6;PUM2;CNOT7;AGO3;TNRC6C;RAN;CNOT1;AGO2;TNRC6A
prerank,positive regulation of cell projection organization (GO:0031346),0.33506260452111747,1.0123722429837654,0.48562300319488816,0.842181625237498,1.0,23/115,13.84%,ARHGDIA;METRN;PLXNA1;DVL2;KIDINS220;CDKL3;SS18L2;ABL2;APOE;RETREG3;PTK2B;SCN1B;CAPRIN2;PTPRD;BDNF;CDKL5;EPHA3;SCARB2;TOX;SS18L1;ROR1;NPTN;SETX
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.35361520292574017,1.0118553863028796,0.4549600912200684,0.8429592423248832,1.0,16/67,19.33%,PDGFRB;EPHA1;ABI2;ABL2;PDGFB;PTK2B;DDR2;EFEMP1;PTPN6;EPHA3;ABI1;DYRK1A;TEC;HCK;AATK;CSF1R
prerank,peptidyl-lysine modification (GO:0018205),0.3368364370892226,1.0118547069321262,0.4639397201291712,0.8424424235306801,1.0,18/99,12.23%,EGR2;NUP153;NDC1;HDAC6;KAT5;TRPM4;TRIM28;BCL11A;SENP3;NUP88;SIRT1;SUMO1;RANGAP1;SIRT5;NUP210;NUP37;SIRT2;UBE2I
prerank,response to UV-B (GO:0010224),0.4636422392919754,1.011805794089329,0.4576,0.8420529987518334,1.0,2/12,7.54%,RELA;CRIP1
prerank,negative regulation of cyclase activity (GO:0031280),0.4561076692395047,1.0116017794715488,0.464339908952959,0.8420158016564436,1.0,1/14,2.08%,AKAP5
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.456952085895092,1.011507828958497,0.4748858447488584,0.8417350829270294,1.0,6/13,19.32%,PIK3R4;PIK3C3;TLR7;IRAK2;IRAK4;PIK3AP1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.4504049753410537,1.0114663298681892,0.4526627218934911,0.8413333205891989,1.0,4/16,14.44%,SOX9;APOC1;WDTC1;NCOR1
prerank,wound healing (GO:0042060),0.35385757437304544,1.0112116710085506,0.4603174603174603,0.8414821333222758,1.0,13/62,15.78%,MYH9;PDGFA;TGFBR1;ITGB3;ANXA6;SMPD1;IGF1;CFLAR;COL3A1;SLC11A1;EPB41L4B;ARL8B;RAF1
prerank,keratan sulfate metabolic process (GO:0042339),-0.2987024418933074,-1.0112116527764081,0.41338582677165353,1.0,1.0,9/31,14.52%,ST3GAL2;B4GALT6;HEXA;GNS;B3GNT2;B4GALT1;ST3GAL4;B4GALT4;B4GALT3
prerank,response to hexose (GO:0009746),0.39618920853110273,1.011043858418493,0.4460431654676259,0.8413716070565334,1.0,3/25,8.35%,LPL;EIF2B2;TCF7L2
prerank,regulation of chromosome segregation (GO:0051983),-0.37123017438294503,-1.0108979140291618,0.47770700636942676,1.0,1.0,5/16,19.34%,NUMA1;CSNK2A1;CSNK2A2;PUM1;SMC5
prerank,regulation of necroptotic process (GO:0060544),0.41625677590329774,1.0107440892366466,0.4793388429752066,0.841628557494193,1.0,10/23,17.01%,PDCD6IP;FLOT2;SDCBP;CFLAR;MLKL;YBX3;STUB1;CDC37;FLOT1;ARHGEF2
prerank,peptidyl-asparagine modification (GO:0018196),0.38463119414972224,1.0102575960286997,0.4601542416452442,0.8423855743858124,1.0,10/31,21.12%,DDOST;RPN2;TUSC3;MGAT5;DPM1;DPM2;UBE2J1;ALG8;MGAT1;STT3B
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.37581131002811263,1.0100558473998236,0.46608040201005024,0.8424001975241453,1.0,9/39,12.96%,DDB2;RPS27A;UBC;GTF2H4;PCNA;CHD1L;ERCC2;DDB1;POLD4
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.4622805384013284,1.010039317621739,0.463768115942029,0.8419233521943297,1.0,1/12,3.29%,SOX9
prerank,response to UV-A (GO:0070141),-0.3773517124649496,-1.009750949648729,0.4323529411764706,1.0,1.0,3/14,14.22%,PPID;MMP1;MME
prerank,regulation of DNA repair (GO:0006282),0.3665063516046039,1.0091090561814267,0.44746600741656367,0.8437608687385711,1.0,8/44,8.55%,WRNIP1;PARG;RADX;PCNA;RAD52;TRIM28;DHX9;SIRT1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.38793242053292043,-1.0090884932759179,0.4431137724550898,1.0,1.0,6/14,18.14%,DDX1;RTCB;CPSF4;RTRAF;TSEN15;CPSF1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.3840134195508524,1.0089733867768778,0.47959183673469385,0.8435848047560968,1.0,7/35,12.91%,SCD5;HMGCL;ACLY;PPT1;FAR1;ACACA;ACAT1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.41645261487308416,1.0085634886777903,0.47406340057636887,0.8440955999882965,1.0,6/19,16.56%,PDGFB;MAPK8;HPN;APP;WFS1;NFKB1
prerank,nucleosome assembly (GO:0006334),0.387321942478879,1.0084657394746306,0.4792746113989637,0.843837199478475,1.0,10/31,18.97%,SOX9;NASP;NAA60;UBN1;CABIN1;IPO4;SART3;BRD2;RBBP4;KAT6B
prerank,protein-DNA complex assembly (GO:0065004),0.3281174606642686,1.0084023827138209,0.4835978835978836,0.8434770399360729,1.0,28/116,17.18%,DDB2;PSMD2;SOX9;PSMC4;PSMD4;PSMD1;MCM2;RPS27A;UBC;NAA60;GTF2H4;PSME3;PSMB6;ORC5;PSMD10;CHD1L;ERCC2;PSMB1;PSMD11;PSMA2;PSMD13;DDB1;PSMB10;SART3;PSMB3;CUL4A;PSMC1;BRD2
prerank,negative regulation of neurogenesis (GO:0050768),0.3766936277361865,1.0081041018174481,0.4594594594594595,0.8437293886798473,1.0,5/34,8.32%,ARHGDIA;RUFY3;RTN4;LRP4;SORL1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.41177265607804847,1.0077431393856346,0.4406548431105048,0.8441375407458113,1.0,3/22,8.39%,IPO5;INCA1;LATS1
prerank,purine-containing compound biosynthetic process (GO:0072522),0.40065951374444386,1.0075421558328739,0.4478203434610304,0.8440930702709379,1.0,5/25,12.75%,SHMT2;GMPR2;PNP;GART;AMPD2
prerank,regulation of DNA recombination (GO:0000018),-0.29680581039280834,-1.007054115145914,0.42342342342342343,1.0,1.0,19/32,39.94%,THOC1;MRE11;SPIDR;BLM;ZRANB3;ZCWPW1;SMARCAD1;MSH6;IL7R;PPP4C;RTEL1;RAD50;SETD2;PPP4R2;RAD51AP1;SIRT6;ALYREF;RAD51;H1-0
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.41319563439174084,-1.006848825240783,0.44155844155844154,1.0,1.0,3/10,19.59%,NCKAP1L;VSIR;TLR4
prerank,response to reactive oxygen species (GO:0000302),0.35688568369510854,1.00659839013892,0.46335697399527187,0.8459445214254725,1.0,10/54,9.32%,JUN;APOD;ADAM9;GLRX2;APTX;APOE;PRDX5;SIRT1;ERCC6L2;MAPK8
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.4342386671839053,1.0065399656231313,0.47953216374269003,0.8455625509450647,1.0,2/18,2.64%,ELOVL1;ACSF3
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.30879126044721733,-1.006529260951103,0.472,1.0,1.0,8/26,14.27%,MAP2K6;CYLD;CASP8;TIFA;TRAF6;IKBKG;NOD1;MAP3K7
prerank,pulmonary valve morphogenesis (GO:0003184),-0.35589585176189,-1.0064693667891214,0.45151515151515154,1.0,1.0,5/17,21.68%,ROBO1;NOTCH1;ROBO2;SLIT2;TGFB2
prerank,negative regulation of interleukin-8 production (GO:0032717),0.42183993174835377,1.0062044336275535,0.47297297297297297,0.8459488952046246,1.0,4/17,11.24%,OTUD7B;ARRB1;TMSB4X;CD33
prerank,regulation of kinase activity (GO:0043549),0.3381078821509671,1.006036842381944,0.46637744034707157,0.8458665894762056,1.0,21/89,19.33%,PDGFRB;EPHA1;EPHA2;NPRL2;HNRNPU;TSPYL2;RYK;NBN;DDR2;EPHA3;ANKRD54;ROR1;CAMKK2;EPHA6;LDB2;LDB1;VAC14;NLRC5;EEF1A1;NTRK2;CSF1R
prerank,sterol transport (GO:0015918),-0.34866091605651434,-1.0053258211788585,0.42574257425742573,1.0,1.0,5/19,13.06%,MSR1;NPC2;LDLRAP1;LDLR;ARV1
prerank,positive regulation of protein modification process (GO:0031401),0.317498474610592,1.0051727898512604,0.5010121457489879,0.8474953525734193,1.0,51/203,19.63%,DVL2;ADAM17;PLAUR;CLIP3;PIK3R3;IL34;PIN1;SOX9;KAT5;FXR2;ITGB3;SPPL3;PPP2R5A;RALB;VEGFC;P2RY1;SMPD1;SIRT1;ENG;ARRB1;ALG10B;CNEP1R1;TNIK;LIMCH1;APP;FMR1;NPTN;PTBP1;PPP1R16B;CAMKK2;SYMPK;HGF;RALBP1;TRABD2B;FLOT1;PGF;RAC1;FLCN;DYRK1A;FGF9;ILK;KRAS;AKTIP;CSNK1D;GPNMB;VEGFB;NTRK2;RAB3GAP1;CSF1R;TERF2IP;CCND1
prerank,organophosphate biosynthetic process (GO:0090407),0.37568928691825043,1.0051476452328094,0.46691635455680397,0.8470537267540778,1.0,8/37,10.89%,MOCS1;AGPAT4;FADS1;ITPKC;ITPKB;IP6K2;LPCAT1;IPPK
prerank,transition metal ion transport (GO:0000041),0.3810424810598074,1.004540518879522,0.4772151898734177,0.8480501387513173,1.0,10/35,18.56%,SLC39A8;TRPC4;TRPC1;TRPC3;SLC31A1;SLC30A5;CUTC;SLC11A1;IREB2;TRPC5
prerank,respiratory tube development (GO:0030323),0.3930542257508312,1.0045068683288039,0.446524064171123,0.8476106127878109,1.0,1/28,0.41%,BAG6
prerank,peptidyl-arginine modification (GO:0018195),-0.36429029981462546,-1.004386486430554,0.4447852760736196,1.0,1.0,9/15,37.49%,PRMT5;PARK7;ART3;PRMT7;NDUFAF5;PADI2;PRMT8;PADI4;KRTCAP2
prerank,sodium-independent organic anion transport (GO:0043252),-0.4176179084680754,-1.0035459607391342,0.46380697050938335,1.0,1.0,1/10,0.04%,SLCO2B1
prerank,positive regulation of protein transport (GO:0051222),0.3428567010985655,1.0035418173316755,0.47278911564625853,0.8495624487633947,1.0,13/67,12.34%,ADAM8;VPS28;ATP13A2;RUFY3;ADAM9;TMED10;CD2AP;IL1A;CNST;BMP6;CD33;APBB3;IGF1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.3385921236471951,1.0029647613571804,0.4720357941834452,0.850538449084433,1.0,19/76,19.55%,RTKN2;NLRP3;EIF2AK2;RELA;ADIPOR1;NLRC3;TCIM;TLR7;SPI1;TMSB4X;PTP4A3;APP;LIMS1;CD86;ILK;ZC3H12A;PPM1B;TERF2IP;TLR2
prerank,protein destabilization (GO:0031648),0.3837196154232003,1.0029080080329738,0.46589446589446587,0.850176022585407,1.0,7/32,12.49%,CUL3;FBXW11;FBXL3;SIRT1;PRNP;CREBBP;DERL1
prerank,pyroptosis (GO:0070269),0.4377432873609238,1.0027648948378127,0.4667630057803468,0.8500093789863039,1.0,3/15,7.77%,CASP4;GSDME;DHX9
prerank,nuclear pore organization (GO:0006999),0.4504508781626267,1.002700385345858,0.49228395061728397,0.8496363362904674,1.0,5/14,15.64%,NUP153;NDC1;RTN4;NUP98;NUP54
prerank,endocytic recycling (GO:0032456),0.3617346139358569,1.002660909034864,0.4611764705882353,0.849220175072626,1.0,18/50,21.17%,VPS26C;VPS50;ANKRD50;VPS39;VPS52;EHD4;VPS29;CMTM6;VPS35;DENND1B;MICALL1;RAB7A;DENND1A;CCDC93;SNX4;EPS15;VPS26A;DENND1C
prerank,apoptotic process (GO:0006915),0.3208798983333263,1.002611868894048,0.5127161749745677,0.8488284949038258,1.0,38/203,16.07%,MYC;BAG6;BCL2L1;RRAGC;CXCR4;AIFM2;BID;NLRP3;GLRX2;RHOB;MCM2;DPF2;TGFBR2;RTN4;DDX41;CASP4;NCKAP1;SEMA6A;JADE1;IER3;ARHGEF6;PTK2B;IL1A;PYCARD;ERCC2;CASP9;TAOK2;BAD;BNIP1;CFLAR;APP;NAE1;CIT;MTOR;ING4;RAF1;DAPK1;HSPD1
prerank,regulation of response to oxidative stress (GO:1902882),0.46677787535121706,1.0024384426822828,0.46755407653910147,0.8487917192433364,1.0,1/11,2.05%,AIFM2
prerank,protein localization to phagophore assembly site (GO:0034497),-0.3986219167922127,-1.002412321632433,0.43169398907103823,1.0,1.0,3/11,11.04%,WDR45B;STX17;MFN2
prerank,negative regulation of hemostasis (GO:1900047),0.47124448234921845,1.0022470199861384,0.4728682170542636,0.8487663329503135,1.0,4/12,19.23%,SERPINE1;APOE;PROC;SERPINE2
prerank,calcium ion homeostasis (GO:0055074),0.33473022235149325,1.0022430572553567,0.47807486631016044,0.84826287926415,1.0,10/95,14.27%,CCL3;TFAP2B;ATP13A2;ATP13A1;HTR2C;ATP1B1;ATP13A3;CCL13;NPTN;WFS1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.3217842934436307,-1.002147445150227,0.45528455284552843,1.0,1.0,9/25,24.46%,FUT9;NDST4;B3GNT2;CSGALNACT2;B3GALT5;EXT1;NDST1;B3GALT1;B3GALNT1
prerank,generation of neurons (GO:0048699),0.32167162966666113,1.0020320245437722,0.5015353121801432,0.8483045711038543,1.0,34/190,16.59%,BRSK1;WNT5B;FZD5;LRP12;PIN1;FGF13;IER2;MAP2K1;ELP3;BRSK2;RYK;CDK6;ITM2C;SMARCA1;DTNB;ARTN;CTNNB1;RUNX2;POU3F2;PTPRD;MYEF2;CDKL5;PAFAH1B1;RNF112;SNPH;LMX1B;TUBB2A;CIT;GPM6A;LDB1;RUNX1;RAC1;SEMA3A;YTHDF2
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.44663932862859734,1.002026746038053,0.4742857142857143,0.847813953320817,1.0,5/16,17.07%,PLEKHM2;TUBB;RAET1E;ARL8B;CORO1A
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.39028739999891776,1.0016540871406,0.48226018396846254,0.8482827999164541,1.0,9/30,14.44%,PRMT2;HDAC6;ZBTB7A;FOXP1;SIRT1;HDAC1;KDM1A;DDX5;NCOR1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.38983443123556155,1.0014361061009815,0.4805194805194805,0.8483200060208737,1.0,7/30,11.29%,ARIH2;FZD5;RHOU;UBE2D3;NPEPPS;RNF31;UBE2L3
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.44374531874342005,1.0012897457720003,0.47801418439716314,0.8481762986656174,1.0,2/15,5.51%,APOC1;APOE
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.31459214645209754,-1.0012346279623794,0.4274193548387097,1.0,1.0,12/26,28.83%,ITPR2;SLC8B1;LETM1;ITPR1;HTR2B;PKD2;PLCG2;FGF2;ITPR3;RYR3;HTR2A;CHERP
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.4647697898856873,1.0010463127983678,0.4643423137876387,0.8482850750192645,1.0,3/10,18.37%,SERPINE1;NEXMIF;PDE3B
prerank,skeletal system development (GO:0001501),0.32205821177628163,1.0007950820988727,0.4891416752843847,0.8484056391314622,1.0,16/148,10.19%,BMP5;BCAN;NCAN;SOX9;COL1A2;GNAS;TGFBR1;COL1A1;CMKLR1;TRIP11;EIF2AK3;XYLT1;ANKH;BMP6;KIAA1217;HHIP
prerank,lysosome localization (GO:0032418),0.3719275957034342,1.0007052926735704,0.46002460024600245,0.8481217153210476,1.0,9/37,17.87%,MYH9;NDEL1;HDAC6;PLEKHM2;SPAG9;ARL8B;PLEKHM1;FLCN;PIK3CG
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.44523222425587755,1.000690931097642,0.4651851851851852,0.8476576949849695,1.0,1/14,1.46%,CREB3L1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.4120257358713285,1.000595185424359,0.4901129943502825,0.8473864543193571,1.0,9/20,21.37%,EIF6;CNOT8;CNOT6;CNOT7;AGO3;TNRC6C;CNOT1;AGO2;TNRC6A
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.42574244869632005,1.000389761706903,0.5064194008559201,0.8474021384883694,1.0,5/18,17.28%,NFE2L2;SIRT1;NONO;SOD2;HTRA2
prerank,protein alkylation (GO:0008213),0.4123536363913995,1.0003267219435599,0.46831955922865015,0.8470494478738493,1.0,8/22,21.05%,PRMT2;ETF1;FAM98B;PRMT3;LCMT1;EEF1AKMT1;PRMT1;CAMKMT
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.31751703244559304,0.9999758495280954,0.5056065239551478,0.8474328256586781,1.0,32/185,11.81%,MAD2L1;SFI1;CUL3;SSNA1;UBE2S;PSMD2;PSMC4;PSMD4;NEK6;PSMD1;RPS27A;UBC;UBE2D1;PSME3;CSNK1E;PSMB6;PSMD10;TUBB;HAUS8;ANAPC5;UBE2E1;AKAP9;ERCC2;DCTN3;PSMB1;PTPN6;SIRT2;PSMD11;ANAPC10;PAFAH1B1;PSMA2;PSMD13
prerank,regulation of muscle contraction (GO:0006937),-0.31324398186156677,-0.9998968357723247,0.4444444444444444,1.0,1.0,5/26,13.75%,KCNB2;TPM1;CHRM2;SRI;ATP1A2
prerank,Golgi inheritance (GO:0048313),-0.41147334202303354,-0.9998021421371289,0.47592067988668557,1.0,1.0,4/11,14.70%,VCPIP1;PDCD10;GOLGA2;VRK1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.3346886428552361,0.9996862730121996,0.49075081610446136,0.8476171086573128,1.0,21/96,15.69%,MAGOH;MAGOHB;CHTOP;SLBP;NUP153;NDC1;SMG7;U2AF2;NUP88;NXF1;SRSF2;U2AF1;NCBP1;NUP210;FIP1L1;NUP37;NUP98;SYMPK;EIF4E;NUP54;RBM8A
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3365818035090463,0.9994781951502236,0.47150837988826816,0.8476582132221496,1.0,19/80,16.69%,NDEL1;ABI2;PFN1;ARPC2;PIK3R1;NCKAP1;CROCC;CDC42EP3;BBS4;CYFIP1;TAPT1;TENM2;RHOQ;FMR1;GPM6A;PLEKHM1;RAC1;CCDC88A;APC
prerank,T cell mediated immunity (GO:0002456),0.4513269229961652,0.9992381262314158,0.4817073170731707,0.8477398224778475,1.0,3/13,7.26%,CADM1;CD55;JAG1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.3589300886963011,0.9990509037830916,0.4744958481613286,0.8476997460348745,1.0,15/54,17.38%,ADAM17;CLIP3;IKBKB;RBCK1;CASP4;PELI3;PYCARD;CARD16;RNF31;PYDC1;CFLAR;GPS2;SPPL2A;TNFAIP3;OTULIN
prerank,cellular sodium ion homeostasis (GO:0006883),-0.35996441179385597,-0.9988996898816752,0.4551282051282051,1.0,1.0,4/15,13.93%,ATP1B3;SLC8A1;ATP1A2;ATP1B2
prerank,cellular response to calcium ion (GO:0071277),0.3475022816334319,0.9988498782180298,0.49325842696629213,0.8476946142375097,1.0,23/67,22.96%,CPNE9;ADD1;CPNE8;CLIC4;SMPD1;ITPKB;TRPM2;DPEP1;ADCY8;SYT1;RASGRP2;MEF2A;CPNE3;SYT4;MEF2C;PRKAA1;CARF;SYT10;CAMK2D;CPNE4;MCOLN1;SYT9;ALOX5AP
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.31553718938210573,0.9987693639472249,0.4979296066252588,0.8473930407007605,1.0,27/182,12.70%,CCL3;SLC7A5;CREB3L1;HSP90AB1;PICALM;TARDBP;MAP2K1;FLOT2;APOE;TAF1;SDCBP;PDGFB;FOXP1;SIRT1;ENG;SPI1;PARP10;TET1;HDAC1;ZNF148;SETDB1;CNOT7;PTRH2;IGF1;APP;DGKQ;OPTN
prerank,positive chemotaxis (GO:0050918),-0.35681047388407916,-0.9985088520384446,0.42950819672131146,1.0,1.0,7/17,24.51%,SEMA5A;ANGPT1;NRP1;FGF10;VEGFA;CX3CL1;PLXNB3
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.4027854606355268,0.9984251871778569,0.4717514124293785,0.8477360297594033,1.0,6/23,16.26%,DDB2;RPS27A;UBC;COPS3;DDB1;CUL4A
prerank,regulation of dendrite development (GO:0050773),0.3707915859191901,0.9982894432915981,0.47793190416141235,0.8475579556781424,1.0,6/37,13.89%,BMP5;LZTS1;BCL11A;CDKL5;TNIK;VLDLR
prerank,positive regulation of macroautophagy (GO:0016239),-0.26639578805946895,-0.9982206898525499,0.38596491228070173,1.0,1.0,18/48,18.66%,PIP4K2A;SPTLC2;SESN1;PIP4K2B;RAB3GAP2;IKBKG;IRGM;LARP1;BNIP3;SLC25A4;PAFAH1B2;GPSM1;SMCR8;MAP3K7;VPS13D;BNIP3L;DCN;EPM2A
prerank,stress granule assembly (GO:0034063),-0.34067129758420844,-0.9980144087578451,0.4574468085106383,1.0,1.0,5/20,12.08%,PRRC2C;BICD1;LSM14A;DDX6;RPS23
prerank,fluid transport (GO:0042044),-0.3919266746186202,-0.9978873837788146,0.45244956772334294,0.9977604507857153,1.0,6/12,60.81%,SLC26A6;PDPN;AQP11;AQP4;AQP1;SLC4A11
prerank,regulation of mitochondrion organization (GO:0010821),0.3606159189066311,0.9975588531934326,0.47648514851485146,0.8488062286209931,1.0,5/47,3.98%,PISD;SQSTM1;FZD5;ATP13A2;HDAC6
prerank,interstrand cross-link repair (GO:0036297),0.3548203874056978,0.9974566398154968,0.4729241877256318,0.848543853898415,1.0,7/53,11.21%,RAD51AP2;UBE2T;FANCE;RPS27A;UBC;ERCC6L2;RFWD3
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.42896050041428246,-0.9973538097371811,0.4654255319148936,0.9968334012147223,1.0,7/10,42.16%,PRKCE;COMMD1;NEDD4;HECW1;STK39;OSR1;NEDD4L
prerank,glucose import (GO:0046323),0.4599504279869161,0.9972822365864717,0.47641509433962265,0.8484891854375884,1.0,3/13,17.80%,ZDHHC7;SLC2A1;SORT1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.35674686062870703,0.9967240092340834,0.4882280049566295,0.8493455871353918,1.0,3/47,1.92%,CORO1C;TRIOBP;C1QBP
prerank,negative regulation of autophagy (GO:0010507),0.3506443111588537,0.9963231494408954,0.4947613504074505,0.8498046615381174,1.0,18/54,22.39%,STAT3;NUPR1;LZTS1;RUBCN;CTSA;SIRT2;EIF4G2;MTOR;HGF;EIF4E;FOXK2;SNRNP70;BMF;NRBP2;SNCA;ZKSCAN3;USP36;EIF4G1
prerank,regulation of cellular component organization (GO:0051128),0.3256533156829314,0.9960656573351437,0.5047318611987381,0.8499191806436687,1.0,19/135,11.69%,LTBP4;STK38L;GFAP;TMC8;HNRNPU;PICALM;FAM107A;ABL2;HSPA8;APOE;EGLN2;AGT;PACSIN2;LATS1;STON1;TAOK2;HJURP;SNCAIP;ZFYVE16
prerank,negative regulation of T cell activation (GO:0050868),0.37637239695466457,0.9958155545195989,0.4833759590792839,0.8500094047821815,1.0,9/35,18.69%,DLG5;SDC4;GLMN;TNFAIP8L2;CD86;PAG1;GPNMB;CEBPB;DUSP3
prerank,regulation of T cell migration (GO:2000404),0.43370787056373544,0.9958019040990068,0.49711815561959655,0.8495386097060631,1.0,5/18,12.57%,APOD;CD200R1;PYCARD;CD200;APP
prerank,regulation of focal adhesion assembly (GO:0051893),0.3475486385636477,0.9956245277806669,0.4744958481613286,0.8494841661637453,1.0,19/54,20.82%,CORO1C;APOD;FAM107A;COL16A1;ACTG1;PPM1F;PTPRA;EPHA3;LIMCH1;LIMS1;LDB1;PEAK1;RAC1;GPM6B;DUSP3;SLC9A1;MAP4K4;THY1;VCL
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.4187391605276232,0.9956095468201283,0.45203488372093026,0.8490222758962385,1.0,7/18,18.15%,APOD;OTUD7B;LATS1;ILRUN;FLCN;SIN3A;MDFIC
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.31255904265787626,0.9955642627321846,0.5205616850551655,0.8486357102080831,1.0,95/390,19.33%,MAPKAPK2;CSF1;STAT3;PDGFRB;EPHA1;EPHA2;PRKD2;POLR2J;SLC39A14;ATP6V1D;PIK3R3;ATP6V1A;ATP6V0D1;SH2B2;NCK1;PDGFA;HNRNPM;ANGPT2;KALRN;NCF4;FIBP;ARPC2;CYBB;ATP6V0E1;ITGB3;COL1A1;PIK3R1;SDCBP;PDGFB;NCKAP1;EIF2AK3;VEGFC;PTK2B;RYK;AP2A1;CYFIP1;ATP6V0A1;ARPC3;NCF2;DDR2;RHOQ;ACTG1;NCBP1;ATP6V0C;BDNF;BAIAP2;BLNK;ATP6AP1;NRP2;GTF2F2;SIRT2;GIGYF2;HPN;ELMO2;GIGYF1;EPHA3;IGF1;POLR2E;IDE;CRK;ROR1;HNRNPH1;SETX;PTBP1;SULF2;POLR2B;ADRB2;ABI1;SOS1;HGF;ARPC5;EPHA6;ACTB;PGF;RAC1;ZFYVE27;POLR2G;AP2M1;FGF9;APC;HNRNPA1;ATP6V0B;ATP6V1G2;SORT1;TIAM1;MAPKAPK3;ITSN1;HCK;VEGFB;POLR2K;NTRK2;BCAR3;ELMO1;TSC2;CSF1R
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.3651017220910848,0.9954831275257283,0.46153846153846156,0.8483360711840369,1.0,10/45,14.67%,MAD2L1;TOM1L1;CTNNB1;CHFR;BTG2;ANGEL2;NABP1;SCRIB;BCL6;NME6
prerank,regulation of defense response to virus by host (GO:0050691),-0.30244863936727523,-0.9954029703503648,0.45081967213114754,1.0,1.0,7/30,11.08%,HSP90AA1;STAT1;TOMM70;PARP9;ZDHHC1;DTX3L;EIF2AK4
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.3337231768352015,0.9951062505501139,0.5076586433260394,0.8487954281542135,1.0,19/88,13.98%,NAPA;LLGL1;BLOC1S6;ARFGEF2;HSPA8;DNM2;TXNDC5;ACBD3;EXOC5;ARL3;SORL1;AP2A1;CLTC;ARRB1;AP1M1;APP;RP2;GBF1;AP1G1
prerank,NAD biosynthetic process (GO:0009435),0.4162374232596894,0.995098144691706,0.48988439306358383,0.8483122055028343,1.0,4/20,13.15%,NAXD;NMNAT1;PARP10;NMNAT2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.4581218655268985,0.9949097430648911,0.4857142857142857,0.8482845715030375,1.0,3/12,12.34%,PPP1R3E;EPM2AIP1;IGF1
prerank,regulation of anoikis (GO:2000209),-0.33678346981379326,-0.9948751173762068,0.4612676056338028,0.9995748240721505,1.0,6/19,14.91%,PTK2;NOTCH1;TLE1;SRC;TLE5;ITGB1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.37852720465315204,0.994746369272993,0.4830188679245283,0.8481824103776721,1.0,8/32,18.17%,RIMS1;RIMS3;PNKD;SNCAIP;FMR1;PREPL;VPS18;MEF2C
prerank,endocardial cushion development (GO:0003197),0.40646010785735737,0.9942230317337558,0.4696755994358251,0.8489382248591433,1.0,5/21,17.44%,SOX9;MDM4;ENG;CRELD1;ACVR1
prerank,intracellular lipid transport (GO:0032365),0.4106773429194147,0.9940598318433536,0.485273492286115,0.8488296450193902,1.0,2/21,3.01%,THRSP;MID1IP1
prerank,endoderm formation (GO:0001706),0.3753349697898958,0.9939980835302754,0.490613266583229,0.8484948322700013,1.0,2/35,1.66%,DUSP5;LAMA3
prerank,regulation of RNA export from nucleus (GO:0046831),0.46791000439941544,0.9939014157192949,0.47151898734177217,0.8482323381113704,1.0,5/11,13.80%,NUP153;DHX9;CPSF6;IWS1;AKAP8L
prerank,response to muscle stretch (GO:0035994),-0.3681654786498425,-0.9936951520189674,0.4688427299703264,1.0,1.0,3/15,9.74%,PTK2;GSN;SLC8A1
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.30044729616503707,-0.9934038279389117,0.4305555555555556,0.9991861739324732,1.0,8/32,12.27%,PID1;ZBTB20;PSEN1;INSR;PRXL2C;PPARGC1A;PFKFB4;HIF1A
prerank,endomembrane system organization (GO:0010256),0.3155772136564134,0.9931576756415719,0.49031600407747195,0.8495429859519145,1.0,42/178,17.09%,SQSTM1;ATP8B1;TLCD2;VPS4A;SRGN;LEMD2;TANGO2;ARFGEF2;ALS2;TMED5;TJAP1;PLEKHM2;TMED4;USP6NL;PHETA1;SNX33;TRIP11;EIF2AK3;TMED10;ATL3;COG4;SUN2;SYP;CTDNEP1;BNIP1;HOOK2;OPTN;RNF112;GORASP2;GBF1;LEMD3;DYNC2H1;USP8;GOLGA8B;GOLGA5;PLEKHJ1;SMPD4;ARL1;VPS18;AKTIP;CSNK1D;TOR1B
prerank,endoplasmic reticulum organization (GO:0007029),0.34206964333029394,0.9931391958786723,0.5153933865450399,0.8490886083385514,1.0,19/72,18.29%,WDR83OS;REEP2;TMEM33;RAB18;GET1;RTN4;EIF2AK3;ATL3;PRNP;BNIP1;APP;RNF112;CCDC47;SMPD4;TRAM1;STX5;TOR1B;ZBED3;LNPK
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.41529885848452464,-0.9928823077625931,0.45707070707070707,0.9983163057597273,1.0,3/10,16.30%,MGRN1;RNF157;PDE4D
prerank,positive regulation of protein ubiquitination (GO:0031398),0.3361243318875212,0.9928423309847009,0.5005649717514125,0.8492920020263096,1.0,19/80,15.10%,CUL3;PIN1;FAM107A;PTTG1IP;PRICKLE1;UBE3A;DCUN1D1;UBE2D1;PSMD10;RIPK2;PEF1;KDM1A;UBE2L3;MAGEC2;DERL1;STUB1;WFS1;TBC1D7;FBXO4
prerank,positive regulation of signaling (GO:0023056),0.37343824423138117,0.9926850826236715,0.500651890482399,0.8491584508087252,1.0,9/37,16.75%,RIMS1;RIMS3;CLSTN1;ANXA2;NSF;INPP5F;SCRIB;SYT1;ILK
prerank,positive regulation of vasculature development (GO:1904018),0.3344175671900484,0.9925721629877032,0.5054347826086957,0.8489288226842668,1.0,23/94,18.78%,EPHA1;PRKD2;SERPINE1;NINJ1;RHOB;EMC10;ANXA3;JUP;VEGFC;IL1A;SIRT1;SMOC2;F3;ADAM12;MTDH;RUNX1;PGF;PRKCB;ZC3H12A;ETS1;PDCD6;PDCL3;VEGFB
prerank,receptor internalization (GO:0031623),0.3586427763973234,0.9925331576147666,0.4831325301204819,0.8485346759207467,1.0,7/44,10.01%,CD9;PICALM;DNM2;RAB31;LRP1;CLTC;ARRB1
prerank,ncRNA transcription (GO:0098781),0.4543053509575161,0.9924025500405425,0.4946889226100152,0.8483442515087756,1.0,3/13,10.03%,GTF3A;NIFK;RPAP2
prerank,positive regulation of phospholipase activity (GO:0010518),0.41310344700157964,0.9918670219205143,0.4837340876944837,0.8491605859271297,1.0,2/22,4.45%,PDGFRB;ABL2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.34285662205791945,-0.991673376169324,0.4641638225255973,0.999527701779841,1.0,15/19,52.37%,OFD1;NPHP3;CCDC39;NEK10;CCDC40;CABYR;ODAD4;CFAP53;RFX3;ADCY10;SPAG17;AQP4;DNAAF2;SPA17;DNAAF1
prerank,cotranslational protein targeting to membrane (GO:0006613),0.3335512413120081,0.9911810547558468,0.5115766262403528,0.8503612242219869,1.0,29/91,20.80%,RPL31;RPS15;RPL3;SRP72;RPL13A;RPL15;RPL10;RPS8;RPS27A;RPL9;RPL22;RPS21;RPL23A;RPL34;RPSA;RPS14;SSR1;RPL27;TRAM1;RPL8;RPS24;RPL38;RPL27A;RPLP1;RPL17;RPL23;RPS11;RPS26;RPL36
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.4139081083142315,-0.9910833778207668,0.49166666666666664,0.9988431699440972,1.0,8/10,42.66%,NUFIP1;NAF1;SHQ1;RUVBL1;ZNHIT6;RUVBL2;TAF9;ZNHIT3
prerank,sensory perception of chemical stimulus (GO:0007606),0.4445963209807803,0.9908915897505597,0.503003003003003,0.8505575443039098,1.0,3/15,13.31%,GNAS;BBS4;ADCY3
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.4048685450901207,0.9908365568646171,0.49162011173184356,0.8501941372582378,1.0,2/23,3.49%,PLEK;NUPR1
prerank,negative regulation of phagocytosis (GO:0050765),0.42820766820730993,0.9906021852158147,0.49028400597907323,0.8502664045633067,1.0,2/17,4.33%,HMGB1;SIRPA
prerank,error-prone translesion synthesis (GO:0042276),0.3983601701356106,0.9900483447588796,0.49359886201991465,0.8510890037970978,1.0,3/21,5.81%,RPS27A;UBC;PCNA
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.39600465415065095,0.9900382725221871,0.4793608521970706,0.850616168921136,1.0,7/25,16.81%,PICALM;APOC1;ITGB3;SDCBP;APP;RAC1;ATXN2
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.2617376190069858,-0.9899252091532014,0.4748603351955307,0.9999801986064415,1.0,8/46,5.61%,RHOA;ATRNL1;FER;ITGAV;LPXN;PXN;FERMT2;PARVG
prerank,cellular response to chemical stress (GO:0062197),0.32928651667303743,0.9899232574213114,0.5,0.8504083570769979,1.0,17/96,13.84%,SESN2;NFE2L2;ATP13A2;ATF4;EIF2S1;LRRC8D;NCF4;CYBB;PRDX5;LONP1;RAD52;NCF2;SIRT2;TXNRD1;PYCR2;FOXO3;SETX
prerank,development of primary male sexual characteristics (GO:0046546),0.37647435017591047,0.9895079021697547,0.49238578680203043,0.8509547663587552,1.0,2/34,3.29%,NCOA4;SOX9
prerank,eye photoreceptor cell development (GO:0042462),-0.36049577963212226,-0.9889321401353279,0.468944099378882,1.0,1.0,5/15,21.78%,RORB;TOPORS;RPGRIP1L;VEGFA;CEP290
prerank,vesicle transport along actin filament (GO:0030050),0.4154505776558124,0.9888435438536247,0.4882005899705015,0.8520404366136847,1.0,7/19,23.00%,MYO1E;MYO1C;MYO15A;MYO1B;WASL;MYO1D;MYO7A
prerank,lipid transport (GO:0006869),-0.23609560905752866,-0.9887607536905956,0.44871794871794873,0.998626492136918,1.0,19/97,13.84%,SLCO2B1;NCOA2;ABCA9;ABCA1;ACSL1;ABCC4;SLC25A17;ABCD3;NPC2;SCARB1;GLTP;ABCD2;PRELID2;ABCA5;PITPNC1;LDLR;ABCA7;PEX19;PITPNM1
prerank,metal ion homeostasis (GO:0055065),0.3641183020934249,0.9879047609467677,0.4861111111111111,0.8538171174171151,1.0,6/40,15.82%,KCNH2;TFAP2B;SLC12A6;CNNM2;WFS1;SELENON
prerank,regulation of myoblast differentiation (GO:0045661),0.37410520774483214,0.9878721963350174,0.5026178010471204,0.8533975726651488,1.0,4/32,6.15%,SOX9;EID2B;FLOT2;XKR8
prerank,positive regulation of insulin secretion (GO:0032024),0.371984904377355,0.9877136558493194,0.4864864864864865,0.8532756394420454,1.0,6/36,13.30%,MYRIP;TRPM4;TCF7L2;GLUD1;BAD;ADCY8
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.4468092236515616,0.9876767109123402,0.5102685624012638,0.8528787565580764,1.0,3/13,12.34%,PPP1R3E;EPM2AIP1;IGF1
prerank,DNA repair (GO:0006281),0.3101365634842875,0.987673907396614,0.5438950554994955,0.8523919035038358,1.0,54/284,14.35%,RAD51AP2;HPF1;DDB2;NEIL2;WRNIP1;UBE2T;KMT5B;KAT5;APTX;FANCE;LIG1;DOT1L;RPS27A;UBC;GTF2H4;RPAIN;PCNA;USP3;PDS5A;TRRAP;MLH3;PARP4;XRCC5;RAD52;TRIM28;CSNK1E;XRCC1;BAZ1B;POLB;TDP1;SIRT1;ERCC6L2;MAPK8;NBN;SUMO1;CHD1L;MSH3;ERCC2;ENDOV;MPG;PARP2;BTG2;RFWD3;UBXN1;KPNA2;DDB1;POLD4;NABP1;ADPRS;HERC2;SETX;TDG;FAM111A;MDC1
prerank,embryonic skeletal system development (GO:0048706),0.37417945124933233,0.9876319499204813,0.4921052631578947,0.8520178281800999,1.0,6/35,16.71%,HOXD9;COL1A1;XYLT1;KIAA1217;SULF2;HOXB3
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.31931339326606534,0.9875772856643525,0.5026455026455027,0.8516599472919435,1.0,32/138,16.45%,NR4A1;NR2F6;POLR2J;TAF8;MAML3;NR1D2;NRBF2;GTF2A1;TAF15;GTF2H4;TAF1;TAF12;TBP;TBL1X;HDAC1;CREBBP;ERCC2;HDAC5;RBPJ;GTF2F2;DR1;MAML1;TAF6;POLR2E;NR2C2AP;RORA;POLR2B;NCOR1;MED1;WWTR1;RXRA;POLR2G
prerank,positive regulation of vacuole organization (GO:0044090),-0.41758304174203376,-0.9873626008348336,0.5040431266846361,1.0,1.0,3/10,8.38%,PIP4K2A;PIP4K2B;RAB3GAP2
prerank,ERAD pathway (GO:0036503),0.33651641749276273,0.9872346433572672,0.5022123893805309,0.8519798319475931,1.0,17/83,15.34%,BAG6;DERL2;JKAMP;ERLEC1;SEL1L;UBXN4;BRSK2;USP19;HSPA5;DNAJB2;DERL1;UBE4A;STUB1;WFS1;CCDC47;UBE2J1;EDEM1
prerank,regulation of autophagosome assembly (GO:2000785),-0.2925416789696399,-0.987183358950795,0.4897959183673469,0.9985504841411335,1.0,8/33,8.38%,PIP4K2A;SCFD1;RAB5A;PIP4K2B;IFT88;TMEM39A;LRRK2;RAB3GAP2
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.3672274820744714,0.9870727042016051,0.49051833122629585,0.8518712513150218,1.0,10/33,20.39%,STAT3;RAB7B;ACVR1B;ANKRD54;FOXO3;ABCB10;MED1;ETS1;PRMT1;TAL1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.35364612985596167,0.9870141056510205,0.5048192771084338,0.8515322301506533,1.0,7/47,8.12%,LPL;ZFP36;HNRNPU;CMKLR1;TRPM4;METRNL;ZBTB7B
prerank,bone development (GO:0060348),-0.27309154568674116,-0.9866622271506099,0.47692307692307695,0.9975762341071436,1.0,6/39,11.63%,LRP6;AKAP13;PLS3;FGFR2;PPIB;PTGER4
prerank,myotube cell development (GO:0014904),0.46952600427867786,0.9864940126830596,0.5016233766233766,0.8522725826986958,1.0,2/10,15.82%,IGF1;SELENON
prerank,regulation of cell adhesion (GO:0030155),0.32311300646260743,0.9863131489883352,0.5301587301587302,0.8522039155735163,1.0,15/129,10.68%,ARHGDIA;EPHA2;PLXNA1;ADAM8;CXCR4;C1QBP;PRKD2;CELSR2;ABL2;ADGRG1;PPP1CB;PTK2B;STX3;DSCAM;IL18
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.46129523600076716,0.9861592192116542,0.48575949367088606,0.8520761245674741,1.0,7/11,25.40%,ACOD1;TNFAIP3;CYBA;LYN;TIRAP;MFHAS1;TREM2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.33267336131349734,0.9860647685947461,0.5071350164654226,0.8518144450661259,1.0,16/86,12.57%,WDR1;PLEK;NCK1;PFN1;BAIAP2L1;APOE;NCKAP1;CDC42EP3;PTK2B;COLGALT1;PYCARD;AKAP9;BAIAP2;CLU;LIMK1;APP
prerank,protein modification by small protein removal (GO:0070646),0.31292298981478256,0.9859730505355905,0.5444444444444444,0.8515361713601765,1.0,62/252,17.55%,MYC;UCHL5;DDB2;USP2;SIAH2;USP32;OTUD3;PSMD2;NLRP3;PSMC4;UCHL1;PSMD4;PSMD1;ACTL6A;MDM4;TGFBR1;RPS27A;UBC;USP5;USP3;TRRAP;UBE2D1;OTUD7B;PSME3;TOMM20;PSMB6;SENP3;USP19;POLB;PSMD10;ZRANB1;WDR20;STAM;USP25;USP21;COPS3;JOSD1;PSMB1;NEDD8;PSMD11;PSMA2;PSMD13;TNIP1;PSMB10;TRAF3;USP8;ADRB2;MYSM1;ABRAXAS2;PSMB3;OTUD4;ACTB;FOXK2;OTUB1;TNFAIP3;USP40;APC;SENP5;KAT2A;PSMC1;SMAD3;ZC3H12A
prerank,cholesterol transport (GO:0030301),0.36585573400353716,0.9859255224498779,0.5239263803680981,0.8511659483965658,1.0,10/45,17.03%,VPS4A;LIMA1;APOC1;APOE;STARD3;STARD5;CLU;OSBP;CEL;NPC1
prerank,autophagosome organization (GO:1905037),0.35229270147405967,0.9855837940163732,0.5082159624413145,0.8514935016472488,1.0,9/50,8.73%,ATG16L1;GABARAP;ATP13A2;GABARAPL1;ATG16L2;ULK3;PIK3C3;MAP1LC3A;MAP1LC3B
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.3333851301607853,0.9854611974248814,0.5149171270718232,0.851312875111588,1.0,27/87,20.80%,RPL31;RPS15;RPL3;SRP72;RPL13A;RPL15;RPL10;RPS8;RPS27A;RPL9;RPL22;RPS21;RPL23A;RPL34;RPSA;RPS14;RPL27;RPL8;RPS24;RPL38;RPL27A;RPLP1;RPL17;RPL23;RPS11;RPS26;RPL36
prerank,membrane lipid biosynthetic process (GO:0046467),0.347526473286508,0.9854412484692141,0.5005727376861397,0.8508765934723772,1.0,19/58,21.87%,SGPP2;PRKD2;ELOVL1;SPTSSA;GBGT1;ST8SIA6;DEGS1;SGMS1;CSNK1G2;PLPP1;SPNS2;CERS2;SGPL1;ELOVL7;ELOVL6;PPM1L;PRKD3;CERS6;HACD1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.4168420546931891,0.9851794318262386,0.506006006006006,0.8509901506331115,1.0,2/16,9.03%,CYRIB;PTPRC
prerank,response to peptide hormone (GO:0043434),0.3598448688736821,0.9851235947845287,0.5056179775280899,0.8506333305266246,1.0,11/43,17.93%,STAT3;EIF2B2;EIF6;STAT6;ZBTB7B;SIRT1;EPM2AIP1;CREB1;EIF2B3;SORT1;ZBED3
prerank,female gamete generation (GO:0007292),-0.2982427707851518,-0.9849945404368193,0.48945147679324896,1.0,1.0,2/29,0.93%,FMN2;MARF1
prerank,regulation of histone deacetylation (GO:0031063),-0.3788749821485651,-0.984958291272974,0.4914772727272727,0.9979203958107233,1.0,4/13,9.79%,AKAP8;NIPBL;CTBP1;ING2
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.45047957537443273,0.9849060699608176,0.5031446540880503,0.8506777826728024,1.0,6/13,24.49%,AP1G1;ITGB2;LAMP1;GAB2;ITGAM;FGR
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.46312451800650706,0.9847020562992258,0.5172955974842768,0.8506987585257784,1.0,4/12,19.02%,CTBP2;EZH2;CALR;CNOT1
prerank,rRNA modification (GO:0000154),-0.3342782044619429,-0.9843365828621614,0.46075085324232085,0.997152955764608,1.0,14/21,37.65%,ZCCHC4;NSUN3;DIMT1;DKC1;BUD23;THUMPD1;FTSJ3;FBL;GAR1;TSR3;MTERF4;TRMT112;MRM2;NAT10
prerank,regulation of smoothened signaling pathway (GO:0008589),0.351579861985011,0.983727171959944,0.5154761904761904,0.8526130720423878,1.0,15/50,21.91%,ZIC1;UCHL5;DLG5;ULK3;HHIP;CREBBP;FBXL17;RORA;TUBD1;SMO;IFT81;VCP;WDR11;TULP3;GPC3
prerank,peptidyl-amino acid modification (GO:0018193),-0.40656577502109703,-0.9834127485014917,0.4668304668304668,0.997461795619997,1.0,2/10,11.06%,METAP1D;TTLL4
prerank,protein homotrimerization (GO:0070207),-0.3716207318014352,-0.98332652170558,0.48703170028818443,0.9925652236547858,1.0,5/14,22.36%,CLYBL;DISP1;PNPT1;SLC1A5;SLC1A2
prerank,protein trimerization (GO:0070206),-0.3716207318014352,-0.98332652170558,0.48703170028818443,0.9925652236547858,1.0,5/14,22.36%,CLYBL;DISP1;PNPT1;SLC1A5;SLC1A2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.40267711631444364,-0.9831975282867902,0.47107438016528924,0.987876557559148,1.0,5/11,16.55%,CALM2;CALM1;SRI;PKD2;CALM3
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.40267711631444364,-0.9831975282867902,0.47107438016528924,0.987876557559148,1.0,5/11,16.55%,CALM2;CALM1;SRI;PKD2;CALM3
prerank,sterol homeostasis (GO:0055092),0.3405197758523344,0.9828204044206673,0.5033783783783784,0.8542888080871432,1.0,7/65,10.68%,DISP3;LPL;LIMA1;APOE;SIRT1;CNBP;IL18
prerank,neuron cell-cell adhesion (GO:0007158),-0.37084393072748023,-0.9826623736231698,0.4899135446685879,0.987109306134828,1.0,4/14,8.31%,NLGN1;ASTN1;NRXN1;NRXN2
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.41284591136044085,0.9825198854134783,0.48546511627906974,0.8545079532367174,1.0,4/19,9.17%,JCAD;SEMA6A;MYO1C;SMOC2
prerank,cholesterol homeostasis (GO:0042632),0.34215712831897277,0.9824668083272577,0.5090497737556561,0.8541563381867623,1.0,7/64,10.68%,DISP3;LPL;LIMA1;APOE;SIRT1;CNBP;IL18
prerank,AMP metabolic process (GO:0046033),0.44757902711635333,0.9824601600269942,0.49686520376175547,0.8536847398791599,1.0,3/13,18.28%,ADSS2;AMPD2;ADSL
prerank,protein K48-linked ubiquitination (GO:0070936),0.3472954782880355,0.9824210148710605,0.5296208530805687,0.8532956873380338,1.0,9/54,9.49%,ARIH2;CUL3;UBE2T;RNF115;UBE3A;KBTBD7;UBE2D1;UBE2E1;UBE2D3
prerank,transport along microtubule (GO:0010970),-0.38406211024887554,-0.9823481491590883,0.4948186528497409,0.985645115845853,1.0,5/13,11.05%,SPG11;APBA1;ARHGAP21;COPG1;COPG2
prerank,actomyosin structure organization (GO:0031032),0.3327081862552251,0.98229950866854,0.5175141242937853,0.853112278205198,1.0,5/75,3.02%,WDR1;MYH9;ZYX;CUL3;FLII
prerank,positive regulation of protein polymerization (GO:0032273),-0.24792302437454494,-0.9821644300958565,0.5238095238095238,0.9836828056499916,1.0,12/65,10.81%,NCKAP1L;FCHSD2;HSP90AA1;FER;SNX9;DRG1;NUMA1;NAV3;BIN1;TPPP;PRKCE;RPS3
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.3524587876542216,0.9821020152612493,0.4853658536585366,0.8530911110880391,1.0,13/46,17.55%,ZIC1;IPO5;JUP;PIK3R1;TRIM28;DHX9;TCF7L2;CPSF6;ZPR1;FLNA;UBR5;SMAD3;ZC3H12A
prerank,positive regulation of DNA repair (GO:0045739),-0.2676470589219749,-0.9818196943835771,0.4682080924855491,0.9822546031175251,1.0,22/46,25.63%,FMN2;PARP1;BABAM2;SPIDR;UIMC1;RNF168;RPS3;ERCC6;ERCC8;BABAM1;ABRAXAS1;TMEM161A;ZCWPW1;PRKCG;FGF10;EYA1;TIGAR;SMCHD1;NPAS2;WRAP53;DDX11;BRCA1
prerank,neuron projection organization (GO:0106027),-0.3678125004581309,-0.9816615964459194,0.4723926380368098,0.9802890822869585,1.0,6/15,16.26%,PSEN1;INSR;ABCD2;LGMN;GSK3B;CHRNA7
prerank,long-chain fatty acid import into cell (GO:0044539),-0.4280671181865191,-0.9815590060505139,0.4914772727272727,0.978087042906555,1.0,5/10,23.69%,ACSL1;ACSL3;RPS6KB1;CD36;SLC27A4
prerank,positive regulation of stress fiber assembly (GO:0051496),0.35869669308064406,0.9809837675846156,0.49287410926365793,0.8551728006266338,1.0,11/44,17.24%,SERPINF2;EPHA1;TGFBR1;PPM1F;LIMK1;LIMCH1;LPAR1;ARHGEF10;RAC1;CCDC88A;GPR65
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.36661628250994244,-0.9808706292287722,0.4527687296416938,0.9776609713049296,1.0,11/15,36.73%,PRKCD;NSMAF;TNFRSF1A;SIRT3;SAMD8;SPHK2;ORMDL3;ORMDL2;TNF;ORMDL1;SMPD2
prerank,DNA duplex unwinding (GO:0032508),0.35466324389678067,0.9807099273438663,0.49391727493917276,0.8553427892341067,1.0,10/50,10.23%,DDB2;SSBP1;MCM2;RPS27A;UBC;GTF2H4;DHX9;NBN;CHD1L;ERCC2
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.3210288038444975,-0.9807056893915524,0.49809885931558934,0.9757306901580947,1.0,7/24,17.72%,PARP1;CFAP20;TTLL11;VKORC1L1;TTLL4;TTLL7;TTLL3
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.3906117370771218,0.9805251156282703,0.4966532797858099,0.855279799216095,1.0,2/27,4.12%,PISD;SELENOI
prerank,carbohydrate biosynthetic process (GO:0016051),-0.33379773518471056,-0.9802723544881871,0.496551724137931,0.9747346454619422,1.0,5/21,17.98%,FUT9;ST3GAL2;B4GALT1;ST3GAL4;B3GALT5
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.4731850515957681,0.9797679390039398,0.5079113924050633,0.8566259189639273,1.0,2/10,7.63%,STAT3;STAT6
prerank,neuronal action potential (GO:0019228),0.41177970010833465,0.9792483608241662,0.502865329512894,0.8573748976840699,1.0,4/22,8.08%,SCN8A;CACNA1G;KCNMB2;KCNMB3
prerank,regulation of cholesterol metabolic process (GO:0090181),0.4037979080124942,0.9792239399509013,0.49266862170087977,0.8569491686957037,1.0,3/20,5.51%,SEC14L2;MBTPS1;APOE
prerank,glycosphingolipid metabolic process (GO:0006687),0.3570072939210274,0.9787351830079205,0.4962962962962963,0.8575791976951744,1.0,9/42,14.99%,B4GALNT1;ARSA;GLB1;SMPD3;CTSA;SMPD1;SUMF1;PSAP;SMPD4
prerank,glycerophospholipid catabolic process (GO:0046475),0.37930600781971846,0.9783199678680933,0.5168393782383419,0.8580739981107361,1.0,7/27,19.21%,PLA2G4A;ENPP6;INPP5F;SMPD4;PNPLA8;GPCPD1;PLA2G6
prerank,actin filament-based transport (GO:0099515),0.4009926361659502,0.9779160210021878,0.5,0.858552175603559,1.0,8/21,23.00%,MYO1E;MYO1C;SUN2;MYO15A;MYO1B;WASL;MYO1D;MYO7A
prerank,mRNA 3'-end processing (GO:0031124),0.3302875400269083,0.9777691334626784,0.5239687848383501,0.8584162728127713,1.0,15/78,15.69%,MAGOH;MAGOHB;CHTOP;SLBP;U2AF2;CPSF6;SRSF2;U2AF1;NCBP1;FIP1L1;TUT1;APP;RPRD1A;SYMPK;RBM8A
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.4048141583173188,0.9777008580643115,0.5172890733056709,0.8580998947263503,1.0,5/21,15.75%,HDAC6;SIRT5;SIRT2;ABCB7;PAX2
prerank,positive regulation of protein maturation (GO:1903319),0.4659603602149556,0.9776298713254468,0.5077399380804953,0.8578005028385481,1.0,1/11,1.52%,ADAM8
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3930771309649974,0.9771033919743414,0.5178571428571429,0.8585424537547096,1.0,5/24,11.07%,ACD;HNRNPU;GNL3L;STN1;EXOSC10
prerank,positive regulation of interleukin-13 production (GO:0032736),0.47092548107376575,0.9770060951072382,0.4953125,0.8582941626503023,1.0,2/10,10.68%,PRKCZ;IL18
prerank,regulation of lipid kinase activity (GO:0043550),0.46676468567975404,0.9768402190172727,0.5038284839203675,0.8582079953939802,1.0,3/11,6.81%,PIK3R3;PIK3R1;PPP2R5A
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.38928206918664326,0.9766711703120744,0.5068870523415978,0.8581118531881006,1.0,7/25,20.29%,BCAS2;SRSF10;SCAF11;SNRNP40;PRPF4;SF3B3;PRPF6
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.37276766566863384,0.9763418312344664,0.5038071065989848,0.8583776297974907,1.0,2/33,2.92%,CSF1;IL34
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.453532213046438,0.9761007942257044,0.4976,0.8584549054158656,1.0,2/11,5.39%,TGFBR1;TGFBR2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.2477957827156257,-0.9759506119563779,0.45806451612903226,0.9861398526399973,1.0,14/54,12.81%,RBL2;CNOT3;CARM1;CHEK2;ARID3A;PML;TFDP2;CDKN1B;EP300;CNOT6L;CNOT9;BAX;RPL26;CASP2
prerank,response to axon injury (GO:0048678),0.4163746186731918,0.9759328983729907,0.49857954545454547,0.8583871782615676,1.0,2/18,3.82%,TYROBP;APOD
prerank,embryonic hemopoiesis (GO:0035162),0.45693421248846355,0.9756646934458046,0.5289514866979655,0.8585246593947725,1.0,2/12,5.39%,ATF4;TGFBR2
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.3610966444887897,0.9748706312256544,0.5294117647058824,0.8599423024294236,1.0,10/43,17.55%,SLAMF1;SIRPA;NLRC3;PTPN6;CD33;IGF1;C5AR2;ILRUN;TNFAIP3;ZC3H12A
prerank,B cell differentiation (GO:0030183),0.3518451185003536,0.974865781473845,0.5096852300242131,0.8594640502030602,1.0,9/46,13.07%,ADAM17;ZBTB7A;PTPRC;HDAC5;BLNK;TPD52;TCF3;SLC25A5;GPS2
prerank,neurotransmitter uptake (GO:0001504),0.4534708190054396,0.9748324738393814,0.5112179487179487,0.8590577460814396,1.0,3/12,13.66%,SLC29A1;SLC1A3;SLC38A1
prerank,regulation of lipase activity (GO:0060191),0.439315120056332,0.9746667261350542,0.5113464447806354,0.8589503517795426,1.0,2/13,8.78%,LPL;FURIN
prerank,vascular transport (GO:0010232),0.3257898234527682,0.9745648378481432,0.5210643015521065,0.8587063155791954,1.0,12/81,14.53%,SLC7A5;SLC7A1;SLC16A1;ABCC5;SLC29A1;SLC1A3;LRP1;SLC6A6;SLC1A1;SLC2A1;SLC38A1;SLC5A3
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.31911085148168533,-0.9743488834461606,0.4610169491525424,0.9887977186856327,1.0,4/22,2.17%,CCNT2;TCERG1;THOC1;DDX39B
prerank,response to progesterone (GO:0032570),0.4095799477171779,0.9743119459668683,0.5071022727272727,0.8588290133636972,1.0,2/18,5.57%,ACOD1;UBE3A
prerank,cellular amide metabolic process (GO:0043603),0.32371459769061073,0.9741462425011885,0.5141921397379913,0.8587242840668236,1.0,12/102,12.78%,CPXM1;SHMT2;PDZD11;MTHFD1L;ATF4;SMPD3;CLN8;MTHFD2;SMPD1;GPAT4;FPGS;PCCA
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.3503122599217452,-0.9737678960200936,0.4884393063583815,0.9881051796160614,1.0,8/15,23.45%,SCARB1;LDLR;SREBF1;FBXW7;NR1H2;C3;SIK1;GPLD1
prerank,RNA export from nucleus (GO:0006405),0.3248191529440406,0.9733167188129729,0.5412147505422994,0.8602033290851847,1.0,21/100,15.69%,MAGOH;MAGOHB;CHTOP;SLBP;NUP153;NDC1;SMG7;U2AF2;NUP88;NXF1;SRSF2;U2AF1;NCBP1;NUP210;FIP1L1;NUP37;NUP98;SYMPK;EIF4E;NUP54;RBM8A
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.23761939432596518,-0.9732279667407537,0.512,0.9874010992634701,1.0,17/73,15.76%,JAK2;HIP1;ROBO1;CASP8;ANP32B;AIFM1;BCL2L13;TRAF2;IFT57;PPARG;RIPK1;NOD1;BAX;CASP2;CASP1;DAP;DIABLO
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.30250156610435214,0.9729880173482777,0.6046046046046046,0.8604837857435007,1.0,103/497,17.01%,BASP1;CALCA;TFAP2B;CREB3L1;ATP8B1;CTBP2;JUN;PRMT2;ILF3;INPP5K;FOXE1;MALSU1;SOX9;NR1D2;RPL13A;SNX6;RIDA;FBXW11;TOB1;KMT5A;EIF2AK2;EIF2AK1;HDAC6;KAT5;RELA;SBNO2;FXR2;PRICKLE1;ARID5A;EID2B;DPF2;HSPA8;CCDC85B;PDGFB;ZBTB7A;PDS5A;TSPYL2;XRCC5;CNOT8;TRIM28;FOXP1;EIF2AK3;CRY2;SET;TCF7L2;SIRT1;SAMD4B;SPI1;KLF10;GCFC2;CTNNB1;SUMO1;RUNX2;PPM1F;HDAC1;PA2G4;HDAC5;YBX1;SFPQ;BTAF1;RBPJ;KDM1A;ZNF148;GTPBP4;BTG2;DEDD2;SIRT2;GIGYF2;CBX4;CNOT7;UBE2I;PHF10;MBD1;SAMD1;HMBOX1;FMR1;BCL6;NDUFA13;CBX5;LIMS1;NCOR1;VGLL4;EIF4E2;ARID5B;ING4;CTCF;LDB1;FOXK2;PAX2;DAPK1;WAPL;TMPRSS6;SIN3A;GATAD2A;PUS7;CNOT10;PRDM11;RBAK;ZBTB4;PSPC1;NONO;PER1;EID1
prerank,myotube differentiation (GO:0014902),0.42240948873684114,0.972767781287021,0.5022288261515602,0.8605264400039928,1.0,6/17,18.17%,PLD3;MYEF2;IGF1;ADAM12;SORT1;MEF2C
prerank,dicarboxylic acid transport (GO:0006835),0.3738093839909776,0.971858496385487,0.49666221628838453,0.8621894017032087,1.0,4/28,12.37%,ARL6IP5;SLC25A13;SLC1A3;SLC1A1
prerank,pteridine-containing compound metabolic process (GO:0042558),0.42809980629249483,0.9717041006665221,0.5109034267912772,0.8620860182126892,1.0,3/13,11.67%,MTHFD1L;GCH1;FPGS
prerank,negative regulation of reproductive process (GO:2000242),0.43107560233394104,0.971664242849027,0.5066469719350074,0.8616916716163868,1.0,4/17,18.76%,NPPC;IGF1;CALR;GJA1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3302424475324395,0.9713700525503138,0.5334075723830735,0.861908338226486,1.0,11/75,9.33%,IPO5;INPP5K;INCA1;UCHL1;APOE;AGT;SORL1;LATS1;SMPD1;SIRT1;PYCARD
prerank,myelin maintenance (GO:0043217),0.46063198313024545,0.9712631575978978,0.49429037520391517,0.8616909773765334,1.0,3/10,11.94%,CXCR4;DEGS1;CLU
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.4391717474231526,0.9712316314148316,0.5154798761609907,0.8612793514660253,1.0,2/12,6.44%,ADAMTS1;PDGFB
prerank,fatty acid oxidation (GO:0019395),-0.25695115055332,-0.9708611962382642,0.4935897435897436,0.9923621671161534,1.0,19/57,22.20%,SLC25A17;ABCD3;ECHS1;AUH;CROT;HADHB;ABCD2;PPARGC1A;PECR;ALDH3A2;ECHDC1;PEX13;PHYH;DECR1;ACAD11;ACADM;HADH;ACOX1;ACAA2
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.3917718083816548,0.9704346314451868,0.5166666666666667,0.8626950723056049,1.0,2/23,1.00%,TIMM8B;HSPA4
prerank,response to interleukin-4 (GO:0070670),-0.40189415789104305,-0.9703979891519839,0.521978021978022,0.9912692357903192,1.0,6/10,47.57%,XBP1;JAK3;SHPK;LEF1;TCF7;GATA3
prerank,inner dynein arm assembly (GO:0036159),-0.3908349026993094,-0.9702127208217172,0.5084745762711864,0.9893626526991205,1.0,9/11,60.94%,DNAAF5;CCDC39;CCDC40;DNAI3;DNAAF1;DNAH1;CFAP100;DNAAF4;CFAP73
prerank,negative regulation of interferon-gamma production (GO:0032689),0.3954666421098769,0.9696993793883976,0.5074224021592443,0.8638862450091591,1.0,3/23,9.29%,C1QBP;HMGB1;PRNP
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.40711445174901323,0.9696085946610123,0.5007112375533428,0.8636127010152562,1.0,1/20,0.31%,CCL2
prerank,regulation of protein autophosphorylation (GO:0031952),0.36034329919617386,0.9695983671436953,0.529113924050633,0.8631524030163048,1.0,9/36,11.13%,PDGFA;PPP2R5B;PDGFB;MOB1B;PPP2R5A;ENG;TOM1L1;NBN;TAOK2
prerank,negative regulation of peptidase activity (GO:0010466),0.3554325373519187,0.9695583329651745,0.5461254612546126,0.8627726585537261,1.0,6/47,14.16%,SERPINF2;SERPINE1;AGT;LRP1;UBXN1;CST7
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.3434016334281455,0.9694278216884403,0.5299043062200957,0.8625854433791426,1.0,16/56,17.72%,VPS4A;EFHC1;EFHC2;RHOB;PDCD6IP;SNX33;BBS4;ARL3;DCTN3;USP8;CIT;IST1;MYH10;TRIM36;APC;TTC19
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.31510350688194505,0.9689013354364535,0.5481481481481482,0.863392862796012,1.0,15/118,10.70%,GDNF;BRSK1;EPHA2;WARS1;ABI2;RUFY3;LZTS1;SPARC;PHLDB1;BRSK2;CYRIB;ZRANB1;CTNNB1;RC3H1;ZMYM4
prerank,cytosolic transport (GO:0016482),0.3169080177000036,0.9688042247139838,0.5466237942122186,0.8631460184199403,1.0,30/108,18.30%,TBC1D10B;CLN5;TBC1D17;SNX6;VPS50;PHETA1;PIK3C3;GGA1;VPS52;AP2A1;VPS29;CLTC;SPAG9;RIC1;VPS35;HOOK2;ERC1;GBF1;DENND5A;AP1G1;PREPL;PLEKHJ1;STX5;ARL1;AKTIP;TBC1D10A;RAB7A;SORT1;DCTN1;STX8
prerank,ncRNA 3'-end processing (GO:0043628),0.4280658583879272,0.9686746520668327,0.5160796324655437,0.8629758131039693,1.0,4/14,12.05%,INTS6;PTCD1;INTS14;INTS8
prerank,regulation of actomyosin structure organization (GO:0110020),-0.37963875979580564,-0.9682620306735337,0.4971751412429379,0.9929429152339073,1.0,4/13,11.63%,ROCK2;AKAP13;FHOD1;PTGER4
prerank,regulation of metal ion transport (GO:0010959),-0.35954052527913705,-0.9680997458665748,0.4812680115273775,0.9909865737766222,1.0,5/16,11.50%,ANK2;STIM1;ORAI1;DLG1;SRI
prerank,regulation of signal transduction (GO:0009966),0.3084191709796173,0.9680677650929778,0.5762538382804504,0.863888285770194,1.0,30/190,14.32%,GDNF;CASTOR1;ZIC1;TMEM204;LLGL1;NCK1;GLRX2;RGS11;CD55;ZDHHC7;TSPYL2;POFUT1;ZDHHC3;SIRT1;PRNP;HHIP;CREBBP;CDC42SE2;CLU;IRAK2;TCF7L1;FBXL17;ANKRD54;APP;DGKQ;MTCH1;SYNJ2BP;CRK;RORA;LFNG
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.33885844759105244,0.9680533320932115,0.5360094451003542,0.8634441827702388,1.0,10/53,14.84%,MYC;FXR2;PCNA;TRIM28;DHX9;SIRT1;EYA2;DDX5;FMR1;NSMCE1
prerank,regulation of protein localization to centrosome (GO:1904779),-0.41280385686441096,-0.9679951264631125,0.508641975308642,0.9888709295299741,1.0,4/10,13.82%,BICD1;NSFL1C;UBXN2B;GSK3B
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.27142764000274444,-0.9669307290079416,0.5327102803738317,0.9897970223728346,1.0,25/40,39.22%,THOC1;NUCKS1;FBH1;SMARCAL1;BLM;BOD1L1;MMS22L;ZRANB3;TIPIN;WRN;ATR;DDX11;DONSON;RTEL1;TIMELESS;GEN1;EME2;TRAIP;POLD1;CENPX;SETMAR;POLE;ATRX;ALYREF;RAD51
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.35776142087958457,0.9668855294536706,0.5168961201501877,0.8657195009233407,1.0,12/41,15.64%,NUP153;NDC1;ZBTB7A;EIF6;NUP88;NUP210;PRKAG1;NUP37;SCARB2;NUP98;PGAM1;NUP54
prerank,cellular response to purine-containing compound (GO:0071415),0.45938969657099793,0.9668639259714203,0.5241157556270096,0.8652859254638258,1.0,2/10,11.95%,P2RY1;TRPM2
prerank,regulation of immunoglobulin production (GO:0002637),-0.3174332700798458,-0.9662835706879443,0.48056537102473496,0.9895354887352161,1.0,8/23,26.84%,GPI;FCGR2B;EPHB2;SASH3;XBP1;PHB2;VAMP3;DNAJB9
prerank,dendrite self-avoidance (GO:0070593),-0.3529156586366027,-0.9660922200477619,0.47416413373860183,0.9877428681944035,1.0,4/16,9.62%,DSCAML1;CNTN6;CNTN2;BSG
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.41300777254774196,0.9657930860224958,0.5175438596491229,0.8672821522828089,1.0,6/17,17.43%,ABI2;NCKAP1;CYFIP1;GMFB;PICK1;CTNNA2
prerank,peptidyl-serine phosphorylation (GO:0018105),0.31136539494838145,0.9656235008079788,0.5639412997903563,0.8671845865697478,1.0,37/153,18.81%,STK38L;MAPKAPK2;BRSK1;PRKD2;RICTOR;IKBKB;TLK1;NEK6;TBK1;TGFBR1;TGFBR2;ULK3;TAF1;PDGFB;PRKCH;CSNK1E;EIF2AK3;LATS1;PRKCZ;MAPK8;CSNK1G2;MKNK1;PDK3;DGKQ;CSNK1G3;SRPK2;IKBKE;MTOR;DYRK1A;MAST2;CSNK1D;PRKCB;GRK2;MAPKAPK3;TTBK2;SGK1;STK38
prerank,positive regulation of cell adhesion (GO:0045785),0.33175286106521457,0.9654774836902279,0.5300113250283126,0.8670383525844332,1.0,14/74,15.91%,ADAM8;C1QBP;PRKD2;ADAM9;ADGRG1;PDGFB;STX3;PPM1F;P4HB;LIMS1;EPB41L4B;MAGI1;RAC1;FLCN
prerank,potassium ion transmembrane transport (GO:0071805),0.31602454043347833,0.96501353558237,0.5578727841501564,0.8676542804199995,1.0,10/135,9.67%,KCNK4;ABCB8;KCNH2;KCNJ6;KCNK9;SLC1A3;KCNJ2;SLC12A6;KCNQ3;ATP1B1
prerank,growth hormone receptor signaling pathway (GO:0060396),0.42668576969792466,0.9647968643884822,0.5255681818181818,0.8676639760599145,1.0,3/14,7.63%,STAT3;PIK3R1;STAT6
prerank,positive regulation of B cell activation (GO:0050871),-0.2568884968357387,-0.9644041329376362,0.5144508670520231,0.9905511505406729,1.0,10/50,11.10%,NCKAP1L;VAV3;KMT5C;IRS2;PAXIP1;CD38;PPP2R3C;EPHB2;SASH3;CD74
prerank,positive regulation of neuron projection development (GO:0010976),0.32569003965911786,0.9642707577856959,0.5454545454545454,0.8684209043824871,1.0,16/85,13.89%,BMP5;KIDINS220;ABL2;APOE;RETREG3;PTK2B;SCN1B;CAPRIN2;BDNF;EPHA3;SCARB2;TOX;ROR1;NPTN;SETX;VLDLR
prerank,regulation of establishment of cell polarity (GO:2000114),0.4223137969905164,0.9639427491083069,0.5230998509687034,0.8687152237874732,1.0,4/16,8.46%,RUFY3;KRIT1;PTK2B;CYRIB
prerank,negative regulation of cellular component movement (GO:0051271),0.41668361753459227,0.9636986155625094,0.5030864197530864,0.8687810654270453,1.0,2/15,3.17%,CD9;PIN1
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.3110946075229682,0.9636982411657007,0.5592515592515592,0.8683039696231581,1.0,21/151,11.18%,SGPP2;PRKD2;ELOVL1;MOCS1;SPTSSA;CDO1;PLA2G4A;HPGDS;APOE;DEGS1;STARD7;SGMS1;FURIN;PCSK1;ESD;GCH1;GSTO2;GPAT4;LPCAT1;B4GALT5;CSNK1G2
prerank,signal transduction by p53 class mediator (GO:0072331),0.3677173935347496,0.9634151796601491,0.5197368421052632,0.8685116803571821,1.0,5/30,13.08%,SESN2;MDM4;PYCARD;NBN;DDX5
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.29728218795881844,-0.9632470180447376,0.5298507462686567,0.9918208582509958,1.0,7/27,16.30%,CALM2;AHNAK;ANK2;CALM1;PRKACA;CACNB2;PDE4D
prerank,visual perception (GO:0007601),0.325680316657013,0.9631925527845041,0.5499451152579583,0.8685393701763062,1.0,14/84,16.12%,COL1A1;DNAJC19;TULP2;EFEMP1;MYO9A;RABGGTB;RP2;POU6F2;CEP250;WFS1;ATF6;PITPNA;PAX2;OPA3
prerank,establishment of vesicle localization (GO:0051650),-0.3347417092299491,-0.9624713780645651,0.5047923322683706,0.9917816990780786,1.0,8/18,22.61%,SPG11;RAB27A;IKBKG;KIF5C;TMEM230;CDK5;LIMK2;TESK1
prerank,GPI anchor biosynthetic process (GO:0006506),0.3778809795788129,0.9624536526784233,0.5254901960784314,0.8697526531807007,1.0,10/30,17.27%,PIGX;PIGQ;DPM1;PIGN;PIGM;PGAP4;PIGP;DPM2;PIGF;PIGC
prerank,actin filament network formation (GO:0051639),-0.3766590396775792,-0.9624122618574076,0.5401662049861495,0.9895650507682724,1.0,4/11,7.42%,FHOD3;PLS3;FHOD1;ACTN1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.3381301916044836,0.9623634061700772,0.5506555423122765,0.8694972451284261,1.0,6/57,12.61%,OSM;STAT3;IL18;CNOT7;IGF1;INPP5F
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.39221594475831767,-0.9621553581580843,0.49473684210526314,0.9880155996749557,1.0,6/11,60.78%,PKD2L1;PKD1L3;RTP4;LPO;RTP2;TAS1R3
prerank,positive regulation of response to wounding (GO:1903036),-0.308055387903588,-0.9618564265473953,0.5019011406844106,0.9865541879543909,1.0,13/24,38.67%,PTK2;ARFGEF1;PRKCE;KANK1;ITGB1;DMTN;MDK;VTN;HRAS;GRN;ANXA1;HBEGF;ADRA2A
prerank,canonical Wnt signaling pathway (GO:0060070),0.33542102090498493,0.9618312208574953,0.5588235294117647,0.8702053863073772,1.0,8/68,9.75%,DVL2;WNT5B;FZD5;FZD6;CSNK1E;RYK;TCF7L2;CTNNB1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.3420192502575651,0.9617882739184622,0.5361803084223014,0.8698231065732559,1.0,15/55,17.13%,PSMD2;PSMC4;PSMD4;PSMD1;PSME3;PSMB6;PSMD10;PSMB1;PSMD11;PSMA2;PSMD13;PSMB10;PSMB3;SKP1;PSMC1
prerank,anterograde trans-synaptic signaling (GO:0098916),0.3057103015500089,0.9617278164696879,0.5841784989858012,0.8694781447326267,1.0,40/224,17.46%,NPY;LPAR3;PCDHB14;CNP;PENK;AKAP5;GABARAP;HRH2;GABRB2;CAMKK1;CACNA1A;SDCBP;KIF5A;SLC1A3;HTR2C;SYPL1;SLC12A6;DTNA;AKAP9;KCNQ3;MPZ;PAFAH1B1;PRKAR2A;SLC1A1;GPR176;SYNJ2BP;GAD2;PLP1;GRIN2A;SLC6A2;SLC6A5;CAMKK2;SYT1;GABRA4;MTNR1B;PMP22;CEL;GRIA4;UNC13B;PTCHD1
prerank,regulation of protein neddylation (GO:2000434),0.4586382495041451,0.9614533002390877,0.5243697478991597,0.8696210278105156,1.0,2/10,6.05%,COPS9;DCUN1D1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.3821050772990285,0.9606765142128989,0.5548216644649934,0.8709293419825155,1.0,6/26,17.19%,CUL3;NEK6;ANAPC5;DLGAP5;LCMT1;ANAPC7
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.29210929290262394,-0.9606443639849632,0.4892703862660944,0.9880160974976704,1.0,14/28,35.32%,PARP9;KMT5C;DTX3L;HSF1;ERCC6;RIF1;SMCHD1;WRAP53;MRNIP;KDM4D;HMGA2;PARP3;NUDT16L1;SETMAR
prerank,establishment of melanosome localization (GO:0032401),0.40231806606479065,0.9606368171961528,0.5034674063800277,0.8705498069140942,1.0,3/19,7.38%,BLOC1S6;ARL6;BBS4
prerank,positive regulation of dephosphorylation (GO:0035306),0.3832184425997218,0.9606150312512505,0.5265306122448979,0.8701143140897533,1.0,8/27,15.02%,PIN1;SPPL3;PPP2R5A;SMPD1;CNEP1R1;PTBP1;PPP1R16B;SYMPK
prerank,inorganic anion transport (GO:0015698),0.34410017720723834,0.9603578247958464,0.528235294117647,0.870234111847818,1.0,7/53,14.69%,CLCN2;TTYH3;CLIC4;CLCN6;ANO10;ANO4;SLC11A1
prerank,positive regulation of TOR signaling (GO:0032008),-0.2752284124071818,-0.959956007713244,0.5027624309392266,0.9876596210490174,1.0,12/40,14.02%,NCKAP1L;SLC38A9;GAS6;MIOS;LAMTOR1;KLHL22;RRAGD;SEH1L;RRAGB;GOLPH3;SMCR8;HDAC3
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.3982275605692499,-0.9597983247168898,0.5178082191780822,0.985840347077607,1.0,2/10,2.17%,THOC1;DDX39B
prerank,cellular response to oxygen levels (GO:0071453),0.4698757191849592,0.9597491801195689,0.5521669341894061,0.8712088125882713,1.0,3/10,10.94%,ATP6V1A;ATP6V0D1;ATP6AP1
prerank,actin nucleation (GO:0045010),0.403602549733795,0.9596648432991945,0.5300400534045394,0.8709333314912042,1.0,5/21,15.06%,ARPC2;ARPC5L;ARPC3;WHAMM;ARPC5
prerank,sensory perception of taste (GO:0050909),-0.4024101350190303,-0.9588484250723104,0.4962025316455696,0.9865179721562282,1.0,4/10,40.81%,CD36;PKD2L1;ASIC1;PKD1L3
prerank,regulation of lymphocyte differentiation (GO:0045619),0.406185405133728,0.9587037567104439,0.5232876712328767,0.872644732303703,1.0,1/18,0.55%,PRELID1
prerank,regulation of protein export from nucleus (GO:0046825),-0.29948044101947874,-0.9586934294003632,0.5266666666666666,0.9846284253018118,1.0,7/23,15.14%,SP100;GAS6;TPR;ANP32B;GSK3B;RBM22;IFI27
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.2794086230839733,-0.9585520515963947,0.5341880341880342,0.9827234168117651,1.0,13/33,21.87%,PKD1;CDKN1B;PTEN;DDRGK1;STXBP4;TRIM39;PLCG2;PSME1;PAF1;FBXW7;ID2;PSME2;PHB2
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.25735925064993487,-0.9584507445063394,0.5515151515151515,0.9807156942373468,1.0,8/50,8.86%,CCNT2;GTF2H1;CCND3;CDK7;MNAT1;BLM;CDKN1B;CCNG2
prerank,mitotic spindle organization (GO:0007052),0.3068028959619634,0.9582152328775323,0.5831600831600832,0.8733038581781575,1.0,29/153,16.22%,MAD2L1;NDEL1;CEP126;NUDC;CENPP;EFHC1;EFHC2;MIS12;NEK6;MAP4;CCDC61;SUN2;TBCE;RANGAP1;DLGAP5;NDC80;RCC1;NUP37;EML4;CENPC;PAFAH1B1;MAD1L1;WRAP73;NUP98;FLNA;ABRAXAS2;ARHGEF10;KIF3B;DYNC1LI1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.34948624583679344,-0.9581901830765,0.5101351351351351,0.9792485069716068,1.0,5/16,15.00%,PRPF39;SRSF1;DCPS;SART1;RBM22
prerank,regulation of protein dephosphorylation (GO:0035304),0.36136382819924523,0.9579160504089852,0.550251256281407,0.8734989861484186,1.0,10/37,15.02%,PIN1;PPP6R1;SPPL3;PPP2R5A;SMPD1;PPP6R3;CNEP1R1;PTBP1;PPP1R16B;SYMPK
prerank,response to glucose (GO:0009749),0.34373497790303975,0.957535204165544,0.5263803680981595,0.8738767030010733,1.0,11/46,18.47%,LPL;SLC39A14;EIF2B2;TCF7L2;PDK3;ADCY8;PAX2;EIF2B3;UNC13B;ZBED3;PRKAA1
prerank,chloride transmembrane transport (GO:1902476),-0.2570238144437924,-0.9571817614198297,0.532608695652174,0.9801783620219244,1.0,18/48,25.40%,GLRB;GABRG3;GABRG2;GLRA1;SLC12A9;GABRA5;SLC6A1;GLRA2;GLRA3;GABRG1;ANO5;GABRA1;SLC12A7;SLC4A8;SLC12A5;LRRC8A;CLCN3;ANO3
prerank,lymphocyte differentiation (GO:0030098),0.3320554705238198,0.9570840730357844,0.5470383275261324,0.8744412911253941,1.0,12/68,14.32%,RELB;ADAM17;ZBTB7A;PTPRC;HDAC5;BLNK;TPD52;TOX;TCF3;SLC25A5;GPS2;LFNG
prerank,spliceosomal complex assembly (GO:0000245),-0.2648603419791944,-0.9569995092151196,0.5168539325842697,0.9784308636249525,1.0,9/46,6.51%,CELF2;SRSF5;DDX39B;RBM5;SRPK1;SRSF1;CELF4;DDX1;LUC7L
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.4112346815323698,0.9569067020714755,0.518796992481203,0.8744019295302033,1.0,4/18,8.90%,SHANK1;RIMS1;PTK2B;PRKCZ
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.39086691112975513,0.9568664716359978,0.5258019525801952,0.8740182011475162,1.0,1/22,1.10%,CBR1
prerank,regulation of dendritic spine development (GO:0060998),0.4067945990922408,0.95673659937346,0.5275707898658718,0.873841882191186,1.0,3/19,5.51%,DLG5;SHANK1;APOE
prerank,sodium ion import across plasma membrane (GO:0098719),-0.3416241610007559,-0.9566004202168746,0.5031446540880503,0.9773718303027281,1.0,5/17,16.82%,SLC9A9;SLC9A6;SLC8A1;SLC6A1;HCN2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.2821559467012236,-0.9564719622541124,0.4834123222748815,0.9754844818441508,1.0,9/32,24.94%,CALM2;CALM1;PLCG1;CAPN3;PKD2;CALM3;CX3CL1;CEMIP;PDPK1
prerank,acute inflammatory response (GO:0002526),-0.3089219076061724,-0.9559148669747373,0.49411764705882355,0.9749320720872547,1.0,2/23,5.39%,IL6R;IL22
prerank,intestinal lipid absorption (GO:0098856),0.4511136875394913,0.9558735988111902,0.5374800637958532,0.875413928355001,1.0,1/11,2.77%,LIMA1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.396610929716584,0.9558261085425783,0.5284900284900285,0.875035416425437,1.0,5/19,16.13%,AMDHD2;GFPT1;PMM1;SLC35D1;PMM2
prerank,regulation of establishment of protein localization (GO:0070201),-0.3463041165706828,-0.9557405907162453,0.5031446540880503,0.9731931111765255,1.0,4/14,4.18%,SCFD1;GAPVD1;CEP135;SPIDR
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.3838458413584935,0.9557379030971956,0.5263157894736842,0.8747914696524087,1.0,9/26,20.09%,SPPL3;AKAP6;PRNP;IGF1;PTBP1;HOMER2;SLC9A1;DYRK2;ATP2B4
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.3324054475448024,0.9554398696192994,0.5480225988700564,0.8750070823655046,1.0,19/69,19.94%,BAG6;DERL2;JKAMP;SEL1L;UBXN4;USP19;HSPA5;DNAJB2;DERL1;UBE4A;STUB1;WFS1;UBE2J1;EDEM1;HSP90B1;TMEM67;UBE4B;VCP;DNAJC18
prerank,positive regulation of cytokinesis (GO:0032467),-0.27887678532101867,-0.9554216547838329,0.5407725321888412,0.9719646972665381,1.0,5/32,10.61%,RHOA;CSPP1;SVIL;CENPV;PRKCE
prerank,calcium ion transport into cytosol (GO:0060402),-0.3228710574077941,-0.9554006242173977,0.5190311418685121,0.9697831613033228,1.0,8/21,22.11%,GRIN2B;CACNA1C;SLC8A1;GRIN1;ADRA1A;JPH4;TRPV4;ITPR3
prerank,positive regulation of catalytic activity (GO:0043085),0.36036606247786707,0.9552421074214344,0.5364321608040201,0.8749818187789595,1.0,7/37,10.15%,CHTOP;MID1IP1;SSBP1;ABL2;XRCC5;MAPK8;MSH3
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3352789204185277,0.9551421520697352,0.5424912689173458,0.8747337398956702,1.0,12/57,18.51%,RGS1;AKAP5;MTNR1A;ADCY5;PSAP;ADCY8;ADCY3;LPAR1;FLNA;ADCY7;INSL3;ADCY9
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.3025088800855371,-0.9550564756579557,0.49372384937238495,0.9685901590827108,1.0,9/26,15.12%,C2CD5;INSR;PRKCI;BRAF;IRS2;IRS1;AKT2;PTPN11;SORBS1
prerank,positive regulation of protein catabolic process (GO:0045732),0.3215667011354507,0.9548192803804975,0.5804274465691789,0.8750071335568884,1.0,29/84,21.91%,ADAM8;VPS28;ADAM9;PTTG1IP;APOE;EGLN2;SNX33;SMURF1;SORL1;FURIN;MSN;VPS35;NSF;DDB1;IDE;NDUFA13;VGLL4;STX5;TNFRSF1B;TNFAIP3;APC;RAB7A;PLK3;ITCH;VCP;FOXO1;DAB2IP;AREL1;GPC3
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.2762716693816142,-0.9547995270410757,0.5297297297297298,0.9671492183397142,1.0,10/36,18.59%,NLK;JAK2;OCIAD1;ERBB4;NOTCH1;VHL;CENPJ;NF2;IL10RA;BCL3
prerank,lytic vacuole organization (GO:0080171),0.36714549931776963,0.9545988075390998,0.548051948051948,0.8750394115352725,1.0,9/32,17.04%,GNPTAB;CLN5;TPP1;MBTPS1;HOOK2;NAGPA;MTOR;VPS18;AKTIP
prerank,isotype switching (GO:0045190),-0.39946324267661026,-0.9544956290876795,0.5216216216216216,0.9658413503474157,1.0,7/10,42.21%,RNF168;BATF;MSH6;EXOSC3;CCR6;MSH2;LIG4
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.30996805508754094,-0.9540955122286978,0.5433962264150943,0.964858792026753,1.0,9/23,21.58%,NCKAP1L;CAMK1D;JAM3;CD74;SLIT2;RAC2;DNM1L;RIPOR2;MDK
prerank,pigment granule transport (GO:0051904),0.40487493547408715,0.9540609381824409,0.5185185185185185,0.8752926683509457,1.0,3/18,7.38%,BLOC1S6;ARL6;BBS4
prerank,melanosome transport (GO:0032402),0.40487493547408715,0.9540609381824409,0.5185185185185185,0.8752926683509457,1.0,3/18,7.38%,BLOC1S6;ARL6;BBS4
prerank,protein homooligomerization (GO:0051260),0.3119756297675466,0.9540424852117599,0.56941431670282,0.8748734418047253,1.0,18/114,13.30%,SHMT2;FUS;NINJ1;SSBP1;ALS2;PDCD6IP;TRPM4;GLS;CARD9;ATL3;KCNJ2;EHD4;PYCARD;ACACA;TRPM2;MLKL;RNF112;ADCY8
prerank,cellular response to insulin stimulus (GO:0032869),0.31143550519253466,0.9537322211284678,0.5694736842105264,0.8751352249563439,1.0,25/124,15.41%,SLC39A14;INPP5K;ATP6V1D;PIK3R3;ATP6V1A;ATP6V0D1;SH2B2;RAB8B;ATP6V0E1;PIK3R1;ZDHHC7;RAB31;SLC25A33;ATP6V0A1;CPEB1;RHOQ;ATP6V0C;HDAC5;BAIAP2;ATP6AP1;IDE;GOT1;TBC1D4;SOS1;SYAP1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.37269804678690815,0.9536685167653973,0.5283286118980169,0.8748119232261834,1.0,7/25,15.60%,HNRNPU;LARP7;ELL;WDR43;CDK12;BRD4;LDB1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.38523405013215106,0.9535015978986159,0.5162162162162162,0.8747386543876168,1.0,4/23,12.36%,CACNA2D1;PTK2B;PRNP;DIAPH1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.4402341209036225,0.9532225448272588,0.5347003154574133,0.8748923261927808,1.0,3/12,18.93%,CARD9;SLC11A1;ZBTB1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.40273018160851315,0.9532208154037076,0.5152838427947598,0.8744228675338817,1.0,3/17,5.51%,SEC14L2;MBTPS1;APOE
prerank,cellular response to increased oxygen levels (GO:0036295),0.4542852636904713,0.952970882485601,0.5511811023622047,0.8745385857392631,1.0,3/11,10.94%,ATP6V1A;ATP6V0D1;ATP6AP1
prerank,negative regulation of DNA binding (GO:0043392),0.36916432924692144,0.9528106636004341,0.5194109772423026,0.8743920127075457,1.0,7/28,17.14%,JUN;HABP4;SUMO1;KDM1A;ILRUN;SIN3A;SMO
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.3847374610255184,0.9522429900870303,0.5305851063829787,0.8751776808853976,1.0,4/24,11.94%,BCL2L1;SIRT1;KDM1A;CLU
prerank,regulation of inclusion body assembly (GO:0090083),0.44700880918721586,0.9520444980793357,0.5480916030534351,0.8751395204940355,1.0,3/11,12.18%,DNAJA4;SNCAIP;DNAJB2
prerank,acyl-CoA metabolic process (GO:0006637),-0.2740620501606759,-0.9519070736663054,0.5260663507109005,0.9695362378118932,1.0,14/35,30.13%,SUCLG2;ACBD6;ACSF2;ACSL6;SUCLA2;ACOT11;MCEE;ACOT8;THEM4;ACOT9;DLST;MLYCD;OXSM;ACOT6
prerank,positive regulation of glucose import (GO:0046326),-0.3212270190543858,-0.9519058181096639,0.5018181818181818,0.9673176194187311,1.0,7/21,15.12%,INSR;PRKCI;IRS2;IRS1;AKT2;PTPN11;SORBS1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.4269702913438263,0.9518555346376055,0.5429799426934098,0.8751166648446566,1.0,5/15,15.06%,ARPC2;ARPC5L;ARPC3;WHAMM;ARPC5
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.3796054712566038,0.9517213564665158,0.5231788079470199,0.8749412806355021,1.0,8/25,19.94%,HSPA8;PTGES3;ST13;BAG1;HSPA5;SDF2;GAK;DNAJC18
prerank,positive regulation of cell junction assembly (GO:1901890),0.33171134187207585,0.9513981421485627,0.530952380952381,0.8751873571804067,1.0,11/56,15.90%,DLG5;EPHA2;AGT;CLSTN1;COL16A1;PTPRD;PPM1F;BDNF;LIMS1;FLOT1;RAC1
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.3683228269905492,-0.9512657272260817,0.48360655737704916,0.9670294060383101,1.0,2/12,6.76%,RHOA;JAM2
prerank,protein import into peroxisome membrane (GO:0045046),-0.31597378059431125,-0.9512340454190915,0.5205047318611987,0.9649027728525865,1.0,9/22,17.42%,SLC25A17;ABCD3;ABCD2;ALDH3A2;PEX13;ATAD1;PEX19;FIS1;PXMP4
prerank,regulation of sodium ion transport (GO:0002028),-0.2841596148898717,-0.9510655241096443,0.5211267605633803,0.9631969541599956,1.0,9/34,13.83%,FGF12;YWHAH;SNTA1;DLG1;WNK2;NKAIN3;NKAIN1;WNK3;GPD1L
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.4562774898458841,0.9508131518630681,0.5502471169686985,0.8755162546440447,1.0,1/10,13.91%,CEP250
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.4562774898458841,0.9508131518630681,0.5502471169686985,0.8755162546440447,1.0,1/10,13.91%,CEP250
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.443872569066785,0.9508074998277029,0.5181102362204725,0.8741182113849179,1.0,6/11,22.34%,PPCS;PANK3;ACAT1;DCAKD;PANK1;PANK2
prerank,coenzyme A biosynthetic process (GO:0015937),0.443872569066785,0.9508074998277029,0.5181102362204725,0.8741182113849179,1.0,6/11,22.34%,PPCS;PANK3;ACAT1;DCAKD;PANK1;PANK2
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.443872569066785,0.9508074998277029,0.5181102362204725,0.8741182113849179,1.0,6/11,22.34%,PPCS;PANK3;ACAT1;DCAKD;PANK1;PANK2
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.3154226678902368,-0.9507725256855776,0.5126050420168067,0.9618468744738312,1.0,8/22,23.93%,CACNA1D;CACNA1C;STIM1;ORAI1;CCR2;EDNRB;PALM;ADGRV1
prerank,protein targeting to membrane (GO:0006612),0.3200041826823271,0.9506957773946222,0.5666666666666667,0.873893926470745,1.0,19/83,16.39%,NACAD;ARL6;RABGEF1;RAB8B;ZDHHC9;VPS37B;SDCBP;ZDHHC7;MYO1C;ZDHHC3;PEX3;GDAP1;ZDHHC21;TAOK2;CHM;SSR1;TRAM1;MICALL1;PXMP2
prerank,transport across blood-brain barrier (GO:0150104),0.3182865021842783,0.9505661411141656,0.5522222222222222,0.873710951122383,1.0,12/83,14.53%,SLC7A5;SLC7A1;SLC16A1;ABCC5;SLC29A1;SLC1A3;LRP1;SLC6A6;SLC1A1;SLC2A1;SLC38A1;SLC5A3
prerank,endocrine system development (GO:0035270),0.39291007207858275,0.9502384787827111,0.5396383866481224,0.8739493217092291,1.0,3/21,11.10%,FOXE1;TGFBR1;SOX2
prerank,L-serine metabolic process (GO:0006563),0.46081782107544655,0.9500685302469557,0.5408163265306123,0.8738609257302882,1.0,1/10,0.79%,SHMT2
prerank,positive regulation of cellular component organization (GO:0051130),0.3161138691363156,0.9500053559927036,0.5925925925925926,0.8735316640839996,1.0,21/107,15.68%,WARS1;CLIP3;ADD1;BID;FNIP2;PLEKHM2;TGFBR1;APOE;ASAP1;GNL3L;LRP1;LRP4;SMPD1;SUMO1;FRMPD4;CLU;TMEM30A;ABCB7;TRABD2B;FLOT1;RUNX1
prerank,organic anion transport (GO:0015711),0.31996357774034506,0.9499600952308264,0.5639013452914798,0.8731561609376032,1.0,6/76,6.62%,SLC52A2;SLC23A1;LRRC8D;ABCC5;SLC4A2;SLC39A8
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.4084141824389592,0.9498591615336398,0.5365497076023392,0.872910107916695,1.0,4/17,16.47%,ACOD1;UBE2L3;MED1;ATP1A3
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.32744521633590384,0.9497913195361118,0.5579545454545455,0.8725925388358444,1.0,21/70,15.90%,NCK1;HSP90AB1;ARPC2;MYH2;PIK3R1;NCKAP1;MYO1C;CYFIP1;ARPC3;ACTG1;BAIAP2;ELMO2;LIMK1;CRK;MYO10;FCGR1A;ABI1;ARPC5;WIPF1;ACTB;RAC1
prerank,positive regulation of ruffle assembly (GO:1900029),0.4299687755844429,0.949776584205916,0.5458715596330275,0.8721682584180329,1.0,2/13,3.73%,NDEL1;PFN1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.2746010869773768,-0.9496197461977941,0.5320197044334976,0.9631099298510747,1.0,7/33,9.45%,PIK3C2A;PIK3R5;NYAP2;MYO16;PIK3C2B;IRS1;PTEN
prerank,triglyceride biosynthetic process (GO:0019432),-0.3295858429687143,-0.9495761954309049,0.5185185185185185,0.9610616660421767,1.0,5/18,19.15%,LPIN2;PCK2;MOGAT3;GPAM;DGAT1
prerank,P-body assembly (GO:0033962),0.43676155241438797,0.9492819864217805,0.55,0.8728115700696697,1.0,4/12,16.81%,EDC3;RC3H1;PATL1;ATXN2
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.4355531188995002,0.9481178355959147,0.54,0.8749686645370823,1.0,3/12,11.74%,TRIM28;TET1;SETDB1
prerank,protein deacetylation (GO:0006476),0.34964695150157593,0.9478387661653416,0.5648949320148331,0.8751638084025154,1.0,15/41,17.68%,HDAC6;BAZ2A;SIRT1;TBL1X;HDAC1;SIRT5;HDAC5;SIRT2;MIER1;MORF4L2;MORF4L1;FLNA;SIN3A;HDAC11;RBM14
prerank,vasculature development (GO:0001944),0.4152144502050608,0.9477586083176838,0.5476529160739687,0.8748626622299753,1.0,1/16,0.63%,PDGFRB
prerank,regulation of stress fiber assembly (GO:0051492),0.32341671654114607,0.9476682461394077,0.5660377358490566,0.8746054380395311,1.0,15/74,17.24%,SERPINF2;EPHA1;INPP5K;PFN1;TGFBR1;PIK3R1;ACTG1;PPM1F;LIMK1;LIMCH1;LPAR1;ARHGEF10;RAC1;CCDC88A;GPR65
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.39481452656938254,-0.9475836859166611,0.5216284987277354,0.9647867052785124,1.0,1/10,2.06%,GAS6
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.34496004046320966,0.9475570838420694,0.5667915106117354,0.8743898308209106,1.0,12/42,21.22%,WRNIP1;RPS27A;UBC;PCNA;SIRT1;PARP10;POLD4;POLD3;ZBTB1;VCP;POLI;RPA1
prerank,tRNA 5'-end processing (GO:0099116),0.4219756822277988,0.947392156743543,0.547112462006079,0.8742615616719288,1.0,3/15,11.52%,RPP38;RPP30;POP1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.3578715263720864,0.9470851995242814,0.5480153649167734,0.8744883734712974,1.0,7/37,11.28%,BCL2L1;BID;NCK1;NUPR1;GSDME;SFPQ;BAD
prerank,hemidesmosome assembly (GO:0031581),0.44484949065948354,0.9468523242009859,0.5466034755134281,0.8745648978624427,1.0,1/11,1.66%,LAMA3
prerank,myoblast fusion (GO:0007520),0.4446202441668394,0.9468292330989136,0.5344262295081967,0.8741635680546376,1.0,1/12,0.55%,CD9
prerank,dendrite morphogenesis (GO:0048813),0.35458598533887953,0.9465997396450595,0.5477707006369427,0.8742195674828785,1.0,13/35,21.09%,SHANK1;CELSR2;LRP4;KLF7;TAOK2;DOCK10;BTBD3;MEF2A;CTNNA2;PTN;WASL;CDC42;DIP2A
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.35984098374762546,0.9465904450507394,0.538562091503268,0.8737759665533145,1.0,6/32,14.51%,KLF11;CDK18;PCNA;NPAT;ZPR1;BRD4
prerank,regulation of vasculature development (GO:1901342),0.3804277447217951,0.9465798495120672,0.555858310626703,0.8733361766728092,1.0,7/26,19.36%,EPHA2;WARS1;CTNNB1;IL6;GPNMB;ETS1;PLXND1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.37454145626925633,0.9465441966451429,0.5611038107752957,0.8729552664778988,1.0,10/26,25.00%,NFE2L2;ATF4;SIRT1;SOD2;HTRA2;FBXO7;REST;PINK1;FYN;PRKN
prerank,membrane lipid metabolic process (GO:0006643),0.3840575389330351,0.9465074995004257,0.5463347164591977,0.8725853249294196,1.0,2/22,5.38%,ALOXE3;SERINC1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.44212603901020786,0.9464826385361184,0.5388127853881278,0.8721685396973582,1.0,2/11,7.72%,AMDHD2;GFPT1
prerank,epithelial cell development (GO:0002064),0.38614251751127354,0.9463832663889751,0.5413223140495868,0.8719360422109801,1.0,1/20,1.70%,WNT5B
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.2831628920338012,-0.946296106576241,0.5531914893617021,0.9664546543748971,1.0,9/28,14.27%,MAP2K6;CYLD;CASP8;LACC1;TRAF6;IKBKG;IRGM;NOD1;MAP3K7
prerank,response to amyloid-beta (GO:1904645),0.34377880439355224,0.9462807669251025,0.5460199004975125,0.8717143386326355,1.0,13/44,18.76%,SNX6;CACNA1A;CASP4;CACNA2D1;LRP1;PRNP;IGF1;APP;GRIN2A;ADRB2;ATP1A3;ICAM1;GJA1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.3929154244012746,-0.9461670611485915,0.5417789757412399,0.9625102471922473,1.0,3/10,7.21%,ALKBH1;ASCC1;ALKBH3
prerank,DNA dealkylation (GO:0035510),-0.3929154244012746,-0.9461670611485915,0.5417789757412399,0.9625102471922473,1.0,3/10,7.21%,ALKBH1;ASCC1;ALKBH3
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.43416118263846537,0.946117696836492,0.5558912386706949,0.871607721149286,1.0,3/13,15.16%,NEIL2;TDG;MBD4
prerank,ERBB2 signaling pathway (GO:0038128),-0.28144484265140984,-0.9458261018712014,0.5308056872037915,0.9613512073313206,1.0,8/31,12.03%,HSP90AA1;GRB2;NRG2;GAB1;ERBB4;CUL5;PTPN18;SRC
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3285148788912241,0.9457390348143792,0.5595794392523364,0.8720003054157387,1.0,18/67,17.52%,EPHA2;TBC1D10B;ATP8B1;TBC1D17;FXR2;USP6NL;DYNLT2B;RABGAP1;RABEP2;CDKL5;TRPM2;FMR1;MYO10;PPP1R16B;RAC1;TBC1D22A;TBC1D10A;TBC1D15
prerank,male gonad development (GO:0008584),0.36041215240101454,0.945577286537604,0.5379746835443038,0.8718869984526246,1.0,2/34,3.29%,NCOA4;SOX9
prerank,cell junction assembly (GO:0034329),0.3089027363308502,0.9453150374753997,0.5720430107526882,0.8720064731324423,1.0,24/100,17.48%,PCDHB14;FZD5;FBLIM1;CTNND1;SDK2;SH3BP1;RYK;DSCAM;ACTG1;BDNF;MYO9A;ARVCF;CDH12;LIMS1;FLNA;GPM6A;DBNL;ACTB;DCHS1;CDH19;FLCN;PKP4;ILK;NRCAM
prerank,phosphatidylcholine catabolic process (GO:0034638),0.4583207484341093,0.9448078471492212,0.556836902800659,0.8726396216067847,1.0,3/10,19.21%,PLA2G4A;PNPLA8;PLA2G6
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.3248217216720328,0.9444878028618048,0.5811577752553916,0.8728930417290202,1.0,21/71,15.90%,NCK1;HSP90AB1;ARPC2;MYH2;PIK3R1;NCKAP1;MYO1C;CYFIP1;ARPC3;ACTG1;BAIAP2;ELMO2;LIMK1;CRK;MYO10;FCGR1A;ABI1;ARPC5;WIPF1;ACTB;RAC1
prerank,rRNA 3'-end processing (GO:0031125),0.45498228931803025,0.9439418371047842,0.5485436893203883,0.8735892107184253,1.0,3/10,11.07%,RPS21;EXOSC8;EXOSC10
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3044450210952294,0.943926000461658,0.6075156576200418,0.873167461677178,1.0,23/144,11.29%,ARIH2;ZIC1;IPO5;AKAP5;FZD5;TM9SF4;BID;TCAF1;RUFY3;JUP;PIK3R1;RHOU;TRIM28;MYO1C;SORL1;TCF7L2;PRNP;MAPK8;UBE2D3;NPEPPS;RNF31;BAD;UBE2L3
prerank,nucleosome disassembly (GO:0006337),0.423212733664113,0.9437759788904863,0.5442670537010159,0.8725583278705195,1.0,4/14,12.03%,SMARCC1;SMARCD2;SET;SMARCB1
prerank,chromatin disassembly (GO:0031498),0.423212733664113,0.9437759788904863,0.5442670537010159,0.8725583278705195,1.0,4/14,12.03%,SMARCC1;SMARCD2;SET;SMARCB1
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.40456616725087663,-0.9436527947335298,0.555256064690027,0.9658074719361902,1.0,4/10,12.74%,ABCA1;PRKACB;PRKACA;ABCA7
prerank,base-excision repair (GO:0006284),0.3424944320736653,0.9436092974763187,0.5598548972188634,0.8724601061546987,1.0,13/48,17.97%,NEIL2;PARG;LIG1;PCNA;XRCC1;POLB;MPG;POLD4;ADPRS;TDG;MBD4;NEIL3;POLD3
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.34220459115130525,-0.9431621537465237,0.5408163265306123,0.9651035203000772,1.0,6/16,14.62%,BCAP31;ANK2;LRRK2;DDRGK1;GABARAPL2;VAPA
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3482040981954412,0.9430119470663335,0.547945205479452,0.8733223635287328,1.0,11/42,15.49%,ACTL6B;SMARCC1;NASP;ACTL6A;SMARCD2;CHD4;SMARCA1;HDAC1;SMARCB1;ACTB;PBRM1
prerank,regulation of protein acetylation (GO:1901983),0.4406413893835867,0.9429981665124807,0.5292259083728278,0.8728941461418542,1.0,6/12,24.32%,KAT5;SIRT1;TERF2IP;TAOK1;CAMK1;DDX3X
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.39219127133249054,0.9427501186144313,0.5502121640735502,0.8729749916392378,1.0,3/22,8.46%,FZD5;CD55;CYRIB
prerank,negative regulation of stress fiber assembly (GO:0051497),0.37641992847249295,0.9426049971245467,0.5666666666666667,0.8728244358937968,1.0,3/24,6.09%,INPP5K;PFN1;PIK3R1
prerank,lamellipodium assembly (GO:0030032),0.36939141153163424,0.9420985138353893,0.5299600532623169,0.8734474396236094,1.0,10/26,18.25%,ARHGEF4;ARHGEF6;CYFIP1;PTPRO;SRGAP2;WHAMM;S1PR1;RAC1;CCDC88A;CDH13
prerank,synapse organization (GO:0050808),0.3084159665300802,0.9419764585292844,0.5889830508474576,0.8732626830770424,1.0,41/125,22.30%,PCDHB14;RAB39B;FZD5;PIN1;SLITRK3;PPFIBP2;SDK2;RYK;LRP4;CYFIP1;ELFN1;C1QC;PPFIA4;DSCAM;PTPRD;BDNF;ZC4H2;APP;PDZRN3;PTPRS;GPM6A;DBNL;LRRC4;UNC13B;NRCAM;DCTN1;PPFIBP1;LRFN5;PLXND1;GPC6;SNCA;CACNB4;KIRREL3;CDC42;C1QA;AGRN;PTPRF;REST;NTNG1;CDH2;CAST
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.3523561049064624,0.941883173742747,0.5461346633416458,0.8730159834271959,1.0,10/35,17.59%,NCOA4;DDX54;ZMIZ1;UBE3A;EGLN2;DDX5;PLPP1;MED1;UBR5;SAFB
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.3950057310694926,0.9418724504887465,0.5287356321839081,0.8725788324489933,1.0,7/20,19.48%,ZFP36;PTK2B;CDK6;HOXB8;LDB1;CTR9;PRMT1
prerank,negative regulation of metabolic process (GO:0009892),0.33403789997518335,0.9415826052433751,0.5635294117647058,0.8727491262785533,1.0,12/54,15.91%,ADAM17;LAMA4;ATF4;APOC1;ZDHHC7;ALDH1A1;RHEB;ACVR2B;RBPJ;TLE3;LGR4;FLCN
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.36533283320155385,0.9411559156913248,0.564276048714479,0.873149281404298,1.0,5/30,9.70%,KCNH2;CACNA2D1;CACNA1G;KCNJ2;SCN1B
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.41282735010818417,0.9410875411572266,0.5348837209302325,0.8728416999354418,1.0,4/15,17.44%,ACVR1B;ACVR2B;LEMD3;ACVR1
prerank,positive regulation of cell cycle process (GO:0090068),0.3118992547341381,0.9406683307703426,0.5858695652173913,0.8732753912417844,1.0,15/91,17.19%,MAD2L1;PDGFRB;CUL3;PCID2;PDGFB;IL1A;USP19;NDC80;SIRT2;IGF1;CIT;LRP5;DYNC1LI1;PKP4;RAD21
prerank,primary neural tube formation (GO:0014020),0.3686064857639231,0.9405489017979933,0.5673202614379085,0.873087016216715,1.0,9/30,19.27%,DVL2;MTHFD1L;PRICKLE1;BBS4;SEMA4C;SCRIB;PAX2;COBL;TSC2
prerank,protein acylation (GO:0043543),-0.266781479016123,-0.9404956002897654,0.5663265306122449,0.9706533183226133,1.0,13/38,14.80%,ZDHHC14;ZDHHC17;ZDHHC13;ZDHHC18;CLOCK;ZDHHC1;ZDHHC6;EP300;HHAT;ZDHHC2;GTF2B;KAT2B;ZDHHC20
prerank,activation of protein kinase B activity (GO:0032148),0.3624860496572099,0.9404507403106795,0.5535483870967742,0.872867609508377,1.0,7/29,16.67%,RICTOR;PDGFB;OSBPL8;IL18;IGF1;MTOR;CCDC88A
prerank,organic acid transport (GO:0015849),0.3141295398607888,0.940204083898057,0.5943293347873501,0.8729183920985157,1.0,13/94,13.66%,SLC7A1;ATP8B1;SLC23A2;SLC23A1;SLC16A1;LRRC8D;SLC3A2;STARD5;SLC6A6;SLC36A1;GOT2;SFXN5;SLC38A1
prerank,cell projection assembly (GO:0030031),0.3829692186120929,0.9401601775180894,0.5363372093023255,0.8725526263727109,1.0,6/22,9.86%,PDGFA;RHOG;NCKAP1;RHOU;CYFIP1;RHOQ
prerank,exit from mitosis (GO:0010458),0.43814685819010624,0.9397546525254117,0.56120826709062,0.8729443102175203,1.0,3/12,10.31%,UBE2S;PPP2R2D;CTDP1
prerank,regulation of response to external stimulus (GO:0032101),0.30586746239141316,0.9395778705672174,0.5991561181434599,0.8728790667904016,1.0,19/121,15.31%,ADAMTS12;IL1R1;TKFC;CXCR4;NR1D2;RELA;SBNO2;FNTA;CASP4;CD55;FOXP1;NMT2;CYRIB;TMSB4X;UFL1;BCL6;TRAF3;BRD4;AKNA
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.2554384091959818,-0.9395284529696382,0.5638297872340425,0.971377666006348,1.0,8/43,8.28%,IL6R;SUCO;NPNT;BMPR2;FERMT2;PRKD1;TMEM119;ATRAID
prerank,histone H3 acetylation (GO:0043966),0.34602435553873684,0.9394979799786544,0.5427872860635696,0.872594221167876,1.0,14/40,17.46%,TADA1;NAA60;TAF12;TAF5L;JADE1;TADA2A;SPI1;DR1;MBIP;ING4;LDB1;PER1;KAT2A;BRPF3
prerank,protein modification by small protein conjugation (GO:0032446),0.2949771812559597,0.9393325096233575,0.6746987951807228,0.8724970049478938,1.0,75/361,16.26%,EGR2;UVSSA;FBXL15;TRIM69;ARIH2;RNF7;NFE2L2;CUL3;NUP153;UBE2S;RNF20;NDC1;UBE2T;FBXW11;FBXL3;RPS27A;UBC;USP5;PCNA;DCUN1D1;TRPM4;SMURF1;UBE2D1;TRIM28;BCL11A;NUP88;CAND1;SIRT1;UBR1;UBA6;UBE2E1;UBA1;UBE2D3;SUMO1;RNF25;ARRB1;RANGAP1;FBXW5;BIRC6;RNF38;DTX3;CHFR;TRIM17;NUP210;NEDD8;CNOT4;NUP37;UFL1;RFWD3;UBE2L3;FBXL5;MYLIP;RNF43;UBE2I;DERL1;FBXL17;DDB1;RNF144A;PDZRN3;UBE2Z;STUB1;ZNRF3;HERC2;NAE1;NUP98;CUL2;FBXO4;NUP54;SKP1;UBE2F;ARIH1;VPS18;KLHL7;RNF34;CUL4A
prerank,maintenance of protein localization in organelle (GO:0072595),0.3979748086068938,0.9392819253073121,0.5563583815028902,0.8721586137690069,1.0,6/19,15.65%,TAF8;HNRNPU;BBS4;TAPT1;HSPA5;SKP1
prerank,histone H4-K8 acetylation (GO:0043982),-0.35165488321483296,-0.9390457691421764,0.5468277945619335,0.9684846140002823,1.0,7/15,16.70%,PHF20;JADE2;HCFC1;JADE3;WDR5;KAT7;KAT8
prerank,histone H4-K5 acetylation (GO:0043981),-0.35165488321483296,-0.9390457691421764,0.5468277945619335,0.9684846140002823,1.0,7/15,16.70%,PHF20;JADE2;HCFC1;JADE3;WDR5;KAT7;KAT8
prerank,DNA replication initiation (GO:0006270),-0.2711817411690257,-0.9389755129573982,0.5763546798029556,0.9665897333186638,1.0,26/37,44.58%,PURA;PRIM2;NOC3L;POLA2;DBF4;POLE4;CDK2;MCM3;POLA1;LRWD1;PRIM1;CDC7;ORC6;MCM6;POLE2;RPA3;ORC1;POLE;CDC34;POLE3;MCM4;MCM8;MCM7;ORC4;MCM10;CDT1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.32271346894391556,0.9388961110804459,0.5767918088737202,0.8725456636913329,1.0,21/73,15.90%,NCK1;HSP90AB1;ARPC2;MYH2;PIK3R1;NCKAP1;MYO1C;CYFIP1;ARPC3;ACTG1;BAIAP2;ELMO2;LIMK1;CRK;MYO10;FCGR1A;ABI1;ARPC5;WIPF1;ACTB;RAC1
prerank,atrial septum development (GO:0003283),-0.3557483036316894,-0.93875177487991,0.521978021978022,0.965081083273111,1.0,5/13,21.68%,ANK2;BMPR2;NPHP3;DAND5;TGFB2
prerank,amino sugar biosynthetic process (GO:0046349),0.43086588024176786,0.9386984541708524,0.5558912386706949,0.8725304204114194,1.0,2/12,7.72%,AMDHD2;GFPT1
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.3206405248888636,-0.9386041375712818,0.5346534653465347,0.9634176924475588,1.0,11/19,32.97%,SOD1;NOX1;PRDX2;PRDX3;ACOX1;PARK7;GPX1;PRDX1;PXDN;PRDX4;MAOB
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.3176086317641848,0.9384183867891703,0.5863586358635864,0.8727086757653936,1.0,11/83,10.81%,MYC;CUL3;KLF11;NASP;CDK18;PCNA;CDK6;LATS1;ACVR1B;RCC1;NPAT
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.3813569311622344,-0.9383231975283731,0.5352480417754569,0.9621640426111507,1.0,5/10,27.97%,CALM1;GNB5;CALM3;CBARP;GPR35
prerank,regulation of cholesterol transport (GO:0032374),-0.30510119243184813,-0.9381146824611368,0.5487364620938628,0.9606113861479526,1.0,6/20,14.60%,OSBPL6;LAMTOR1;ABCB4;ABCA5;ARV1;NUS1
prerank,B cell homeostasis (GO:0001782),-0.40044864612615827,-0.9380475279262225,0.5555555555555556,0.9587281238327824,1.0,2/10,8.32%,NCKAP1L;PPP2R3C
prerank,steroid metabolic process (GO:0008202),0.3214811134201605,0.9377133285426944,0.5825892857142857,0.873739261432278,1.0,8/72,17.03%,FDX1;HSD17B1;DHRS4;STARD3;MSMO1;CYP2A6;LIPA;NPC1
prerank,negative regulation of myotube differentiation (GO:0010832),-0.3716461904690846,-0.9376354431379333,0.546916890080429,0.9578182707464891,1.0,5/12,14.67%,TMEM119;BHLHE41;NOTCH1;HDAC3;XBP1
prerank,tube closure (GO:0060606),0.3655885783820324,0.9376193083793202,0.5749354005167958,0.8734909391163425,1.0,9/31,19.27%,DVL2;MTHFD1L;PRICKLE1;BBS4;SEMA4C;SCRIB;PAX2;COBL;TSC2
prerank,positive regulation of cell division (GO:0051781),-0.2672805352348457,-0.9374807903232575,0.5948717948717949,0.9561793234613961,1.0,7/38,13.16%,RHOA;CSPP1;SVIL;CENPV;PRKCE;FGFR2;HTR2B
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.4314569863349495,0.9373006634508271,0.5537555228276878,0.8732947514465697,1.0,5/12,19.39%,SPPL3;AKAP6;IGF1;PTBP1;SLC9A1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.4314569863349495,0.9373006634508271,0.5537555228276878,0.8732947514465697,1.0,5/12,19.39%,SPPL3;AKAP6;IGF1;PTBP1;SLC9A1
prerank,regulation of keratinocyte migration (GO:0051547),0.43764141451747546,0.9372823116892872,0.5736196319018405,0.8728790716136434,1.0,4/12,20.05%,ADAM9;EPB41L4B;MTOR;MAP4K4
prerank,negative regulation of cholesterol transport (GO:0032375),0.46232610365724003,0.9372666026406236,0.5510534846029174,0.8724616496807968,1.0,2/10,16.56%,APOC1;NFKB1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.36320989134975984,-0.9371916431257573,0.5308310991957105,0.9549585491294224,1.0,3/13,5.87%,RHOA;FUT9;TRAF6
prerank,neuromuscular junction development (GO:0007528),0.3803254161968549,0.9371679990865567,0.5594125500667557,0.8722238650883763,1.0,10/24,21.35%,PPFIBP2;DNAJA3;LRP4;ZC4H2;PDZRN3;UNC13B;DCTN1;PPFIBP1;CACNB4;AGRN
prerank,regulation of transmembrane transport (GO:0034762),0.3630999010506329,0.9368865847796772,0.5549872122762148,0.872402625922479,1.0,7/31,19.99%,KCNJ6;KCNJ2;CTTNBP2NL;SLC2A1;ACTB;PRKCB;SNCA
prerank,7-methylguanosine RNA capping (GO:0009452),0.355044889290623,0.9368429094027685,0.5546772068511199,0.8715851853513173,1.0,10/31,16.45%,POLR2J;RAMAC;GTF2H4;NCBP1;ERCC2;GTF2F2;POLR2E;POLR2B;CMTR2;POLR2G
prerank,7-methylguanosine mRNA capping (GO:0006370),0.355044889290623,0.9368429094027685,0.5546772068511199,0.8715851853513173,1.0,10/31,16.45%,POLR2J;RAMAC;GTF2H4;NCBP1;ERCC2;GTF2F2;POLR2E;POLR2B;CMTR2;POLR2G
prerank,cholesterol efflux (GO:0033344),-0.31716795934076764,-0.9362667769939816,0.5245283018867924,0.9555741873176704,1.0,6/20,17.44%,ABCA1;NPC2;SCARB1;ABCA5;ABCA7;ABCG1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.29486247536541194,-0.9360696366606798,0.5555555555555556,0.9541442395927742,1.0,11/26,28.49%,CALM2;CALM1;SRI;ATP1A2;PKD2;GNB5;CALM3;YWHAE;CBARP;GPR35;GSTO1
prerank,positive regulation of angiogenesis (GO:0045766),0.3109761665239093,0.9358942212538499,0.6027837259100642,0.8732071331081146,1.0,27/108,20.13%,EPHA1;PRKD2;SERPINE1;NINJ1;RHOB;EMC10;ANXA3;JUP;VEGFC;IL1A;SIRT1;SMOC2;F3;ADAM12;MTDH;RUNX1;PGF;ITGA5;PRKCB;ZC3H12A;ETS1;PDCD6;PDCL3;VEGFB;JAK1;TJP1;AGO2
prerank,positive regulation of actin nucleation (GO:0051127),0.43997414461721507,0.9358681625099198,0.5454545454545454,0.8728087106730363,1.0,4/11,14.36%,ABI2;NCKAP1;CYFIP1;WHAMM
prerank,ear morphogenesis (GO:0042471),0.3890446192363824,0.9358316799748301,0.5418439716312057,0.8724345198949672,1.0,1/20,0.99%,ZIC1
prerank,centromere complex assembly (GO:0034508),0.34879121195798535,0.935631690851271,0.5643939393939394,0.8724102537574424,1.0,6/36,11.50%,CENPP;MIS12;NASP;DLGAP5;HJURP;CENPC
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.4439884883134066,0.935569811036958,0.5857142857142857,0.8720945207856937,1.0,5/11,18.34%,NASP;UBN1;CABIN1;IPO4;RBBP4
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.4221729119506832,0.9353329179108563,0.5691823899371069,0.872151533462988,1.0,2/13,9.48%,NAXD;PARP10
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.424312964265118,0.9352931538341178,0.5376506024096386,0.8717822352402929,1.0,2/13,7.72%,AMDHD2;GFPT1
prerank,regulation of smooth muscle contraction (GO:0006940),-0.3235584963712793,-0.9351178618675492,0.5674846625766872,0.9548307371601329,1.0,11/20,36.31%,KCNB2;CHRM2;ATP2B1;DAPK3;CTTN;NMU;PLCE1;CHRM3;F2R;SRF;CAV1
prerank,glycogen catabolic process (GO:0005980),-0.3455547281117065,-0.935055708506218,0.5259938837920489,0.9529789023272575,1.0,5/15,17.06%,CALM1;RB1CC1;PYGL;PYGB;PHKA1
prerank,regulation of sprouting angiogenesis (GO:1903670),0.35177039529146176,0.9349070021687607,0.5760309278350515,0.8721638690718184,1.0,10/33,20.81%,CREB3L1;SEMA6A;CEMIP2;SYNJ2BP;PPP1R16B;ITGA5;EPN1;JAK1;TJP1;E2F2
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.24949153026520213,-0.9347415866616989,0.5769230769230769,0.9518201446773787,1.0,31/57,34.92%,FOXN3;BABAM2;RINT1;MRE11;UIMC1;CHEK2;BLM;TIPIN;BABAM1;ABRAXAS1;TRIM39;CDK2;RAD9B;SDE2;CDK5RAP3;RAD9A;DONSON;MRNIP;ATF2;BRCA1;CDC14B;HUS1;HMGA2;FANCD2;CLSPN;NOP53;CDKN1A;STK33;EME2;NEK11;WAC
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.32043730698193157,-0.9344775373662688,0.5257731958762887,0.9505365346429279,1.0,8/19,17.66%,CEP135;CCT4;TCP1;CCT2;CENPJ;CCT5;CEP120;DKC1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.3583329458216742,0.9340430341008477,0.5581395348837209,0.8736023561097301,1.0,5/30,11.07%,ACD;HNRNPU;GNL3L;STN1;EXOSC10
prerank,synapse assembly (GO:0007416),0.3225492701262805,0.9339596001061801,0.5905420991926182,0.8733342901747426,1.0,9/67,10.45%,PCDHB14;FZD5;FGF13;GABRB2;LGI2;SDK2;RYK;DSCAM;BDNF
prerank,regulation of protein kinase A signaling (GO:0010738),0.3885933043131146,0.9328514127482878,0.5620736698499318,0.8752537557751441,1.0,5/20,14.53%,AKAP5;AKAP6;TCIM;PRKAR2A;ADRB2
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.3704722165588971,0.932529772723111,0.5585106382978723,0.8755018770805014,1.0,7/26,15.26%,ADCY5;TRPM4;BRSK2;PIM3;KLF7;ADCY8;LRP5
prerank,positive regulation of neutrophil migration (GO:1902624),0.39684416938629746,0.9321744487101989,0.5664739884393064,0.8757739792089484,1.0,2/18,1.92%,ADAM8;C1QBP
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.34857870523648876,-0.932001636863705,0.5287009063444109,0.9557379164034867,1.0,4/14,11.26%,PKIG;PKIA;PRKAR2B;PKIB
prerank,snRNA 3'-end processing (GO:0034472),0.3843647080232759,0.9316531650377282,0.5633187772925764,0.8764226117847267,1.0,5/19,12.05%,INTS6;INTS14;EXOSC8;TUT1;INTS8
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.4084122002912913,0.930592617175089,0.5675675675675675,0.8782305570957477,1.0,5/15,19.00%,RPP30;LACTB2;POP1;ZC3H12A;RNASEH1
prerank,sodium ion transport (GO:0006814),0.31238728776489977,0.930153405285207,0.6026637069922308,0.8786616259105352,1.0,8/85,9.70%,SLC6A8;SLC23A1;FGF13;SLC6A11;SCN8A;SLC6A6;ATP1B1;SCN1B
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.3377739433706087,-0.9296925516967107,0.5471698113207547,0.9600671227003601,1.0,7/16,19.48%,TGFBR3;ERBB4;NOTCH1;FGFR2;ZFPM2;BMPR1A;FGF2
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.316764395764738,-0.929616100218495,0.5704697986577181,0.9582492411965494,1.0,7/19,21.58%,NCKAP1L;CAMK1D;CD74;RAC2;DNM1L;RIPOR2;MDK
prerank,granulocyte differentiation (GO:0030851),-0.3239335446681972,-0.9296142445456262,0.5916398713826366,0.9562342200125286,1.0,10/18,32.26%,PML;CBFA2T3;EP300;LBR;CDK2;JAGN1;RARA;CDK4;E2F1;CDKN1A
prerank,cartilage development (GO:0051216),0.3347314143400694,0.9295026116511743,0.5769230769230769,0.8795947882889541,1.0,6/49,9.98%,WNT5B;SLC39A14;SOX9;TRIP11;RUNX2;SNX19
prerank,regulation of ERBB signaling pathway (GO:1901184),0.41216926785662616,0.9292743942713597,0.5400291120815138,0.8796379343011005,1.0,3/15,10.92%,RHBDF2;PTPN12;RBPJ
prerank,protein autoubiquitination (GO:0051865),0.3243115082843946,0.9289213317677979,0.5981630309988519,0.8799666778394362,1.0,12/61,13.29%,DDB2;CUL3;UBE2T;RNF115;UBE3D;UBE3A;UBE2D3;TRIM17;CNOT4;RNF19B;RNF112;STUB1
prerank,glycogen metabolic process (GO:0005977),0.36529173933963455,0.9287664788741987,0.5597315436241611,0.8798335693929578,1.0,5/27,15.34%,PGM1;GYS1;PHKG1;PGM2L1;PHKA2
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.35918392227445967,0.9283000383479261,0.5987577639751552,0.880360333282946,1.0,5/34,11.76%,DUSP5;DUSP16;PTPN12;PTPN6;PTPRO
prerank,transcription by RNA polymerase III (GO:0006383),0.36908307343840807,0.9282424898913046,0.565880721220527,0.8800513200461858,1.0,12/27,22.00%,GTF3A;ICE2;GTF3C2;TBP;ELL;CRCP;GTF3C5;SNAPC1;POLR2K;GTF3C4;POLR3G;IVNS1ABP
prerank,mitochondrion morphogenesis (GO:0070584),-0.37914502088542523,-0.92812925458601,0.5645161290322581,0.9585308311707202,1.0,5/11,19.86%,PID1;FIS1;PNPT1;DNM1L;SUPV3L1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.32467672692015986,0.928126434399531,0.597877358490566,0.8798513948085841,1.0,10/55,11.28%,BCL2L1;LTBR;BID;NUPR1;TGFBR1;AGT;GSDME;PYCARD;DEDD2;BAD
prerank,heme biosynthetic process (GO:0006783),-0.29980394329623605,-0.9278663455996902,0.5932835820895522,0.9573142870323571,1.0,10/22,28.93%,ABCG2;FLVCR1;CPOX;ALAS1;SLC25A38;PPOX;COX15;FECH;UROS;FXN
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.36191915759155946,0.9278174161180075,0.5536193029490617,0.8800356619792482,1.0,6/30,11.94%,BCL2L1;PTTG1IP;PSMD10;SIRT1;KDM1A;CLU
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.3887136024047674,-0.9277456644787083,0.5699208443271768,0.955623735787029,1.0,7/10,27.17%,GALNT13;GALNT3;GALNT16;POGLUT1;POGLUT3;POGLUT2;GALNT2
prerank,clathrin coat assembly (GO:0048268),-0.34048967346702996,-0.9277243285622443,0.5443037974683544,0.9536724569606015,1.0,3/15,2.71%,HIP1;PIK3C2A;FCHO2
prerank,cellular macromolecule catabolic process (GO:0044265),0.3334198432392693,0.9276361779374186,0.6019184652278178,0.8799558505352418,1.0,14/49,21.20%,DENND3;SIAH2;HNRNPD;NCBP1;MAGEC2;IDE;SND1;RNASE3;DNASE1L1;HTRA2;RNASEH1;RNASEH2A;STT3B;DAB2IP
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.39071262860229267,0.9272168802598427,0.5555555555555556,0.880402561659095,1.0,7/18,22.98%,MAP2K1;DDX5;NCOR1;IL6;ZC3H12A;ESR1;TGFB1
prerank,membrane fusion (GO:0061025),0.3433537010659621,0.9268521832475892,0.5644955300127714,0.880738662762344,1.0,4/33,6.36%,NAPA;RIMS1;DNM2;GCA
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.4400597320134912,0.9268348427730446,0.5761904761904761,0.8803325971682493,1.0,2/11,7.34%,WNT5B;CSNK1E
prerank,response to interferon-alpha (GO:0035455),0.40393397842859324,0.9260975351770185,0.5393586005830904,0.8814568446813689,1.0,3/16,7.90%,EIF2AK2;IFITM3;IFNAR1
prerank,cellular response to ketone (GO:1901655),0.35279592456480824,0.9260481747985165,0.5636132315521628,0.8811154301223074,1.0,8/35,13.31%,NCOA4;ACOD1;SPP1;ADCY5;MSN;GNB1;ADCY8;ADCY3
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.3195128842268511,-0.9258742845132641,0.5475285171102662,0.9548436967730126,1.0,6/20,12.27%,ZBTB20;PSEN1;INSR;PRXL2C;PFKFB4;HIF1A
prerank,positive regulation of glycolytic process (GO:0045821),-0.3195128842268511,-0.9258742845132641,0.5475285171102662,0.9548436967730126,1.0,6/20,12.27%,ZBTB20;PSEN1;INSR;PRXL2C;PFKFB4;HIF1A
prerank,protein localization to cell periphery (GO:1990778),0.29822101966959824,0.9257208669744944,0.6175548589341693,0.8813715047250702,1.0,21/133,9.67%,EPHA2;PDZD11;INPP5K;WDR19;FGF13;IKBKB;FLOT2;RAB8B;LIN7C;JUP;TSPAN14;MRAP2;SMURF1;EFR3B;ARL3;ZDHHC3;SLMAP;P2RY1;ANK1;EHD4;ATP1B1
prerank,Rho protein signal transduction (GO:0007266),0.33200032033987414,0.9256267337055922,0.5959232613908872,0.8811222203526331,1.0,13/53,18.25%,ARHGDIA;COL1A2;RHOB;RHOG;ADGRG1;RHOU;CDC42EP3;LIMK1;ARHGAP5;MYO9B;ARHGAP1;ARHGEF3;CDH13
prerank,cellular response to peptide (GO:1901653),0.32459989762112174,0.9252557354704749,0.5935251798561151,0.8814132151476237,1.0,16/56,19.44%,SNX6;CACNA1A;CASP4;CACNA2D1;LRP1;PRNP;RIPK2;IGF1;APP;GRIN2A;ADRB2;ATP1A3;ARHGEF2;ICAM1;GJA1;RPL23
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.43020058394592364,0.9249612504786644,0.5736196319018405,0.8811635341677962,1.0,4/12,20.09%,PRNP;HOMER2;DYRK2;ATP2B4
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.43020058394592364,0.9249612504786644,0.5736196319018405,0.8811635341677962,1.0,4/12,20.09%,PRNP;HOMER2;DYRK2;ATP2B4
prerank,innate immune response (GO:0045087),0.2938505553771009,0.9249063325784652,0.6703967446592065,0.8808344874804375,1.0,43/217,20.22%,RELB;CLEC4E;SHMT2;TKFC;TYROBP;HMGB1;IKBKB;RELA;TBK1;CYBB;IFITM3;NRROS;TRIM56;TRIM28;COLEC12;CARD9;PTK2B;SMPD1;GCH1;NCF2;RIPK2;TRIM17;PYDC1;APP;SRPK2;MASP1;CXCL16;SLC11A1;RNASE3;CORO1A;NLRC5;OTULIN;TTC4;TRIM5;PIK3CG;HCK;ALPK1;IRAK4;TLR2;TRIM8;TRIM26;SNCA;ANKRD17
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.2907182487928472,-0.9247479905027481,0.58203125,0.9559106065699093,1.0,5/24,16.30%,MGRN1;RNF157;PRKAR2B;GNAI1;PDE4D
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.35757380538879135,0.92452111648748,0.5719794344473008,0.8811601500615406,1.0,4/33,8.21%,ADAM17;PLAUR;AGT;DGKD
prerank,small GTPase mediated signal transduction (GO:0007264),0.3045668102198215,0.9244982740560485,0.6284796573875803,0.8807686935732932,1.0,25/103,16.97%,RRAGC;JUN;ARHGAP30;SIAH2;RAB18;KRIT1;TRIM28;RALB;NRAS;ARL3;KSR2;RASGRP3;RHEB;GNB1;SETDB1;IGF1;USP8;SOS1;RALBP1;RAC1;ARHGAP1;CCDC88A;RASGRP2;ARHGAP32;KRAS
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.300969421832134,0.9243931973363128,0.6198083067092651,0.8805386704349603,1.0,28/119,16.38%,PI4KA;INPP5K;PIK3R3;MTMR14;SOCS6;PIK3R4;PIGQ;ITPKC;PIK3C3;MTM1;PIK3R1;EFR3B;DPM1;MTMR3;MTMR12;ITPKB;PI4KB;IP6K2;PIGN;INPP4A;OCRL;INPP5F;PIGM;PGAP4;PIGP;DPM2;PIGF;VAC14
prerank,aortic valve development (GO:0003176),-0.27228023978333915,-0.92434419042545,0.5575221238938053,0.9551032644926382,1.0,8/34,18.64%,ROBO1;ROCK2;BMPR2;NOTCH1;ROBO2;TNFRSF1A;RB1;SLIT2
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.26366947824846554,-0.9243012329880415,0.5571428571428572,0.9532159975957654,1.0,8/37,10.23%,CYLD;BICD2;STMN2;MAP6;BICD1;TPPP;CLASP2;STMN1
prerank,negative regulation of calcium ion transport (GO:0051926),0.4089432221313012,0.9240804427599624,0.5762962962962963,0.8807550910045341,1.0,3/15,11.84%,INPP5K;CD33;TMBIM6
prerank,phosphatidylcholine metabolic process (GO:0046470),0.32093238966032867,0.9237570497119821,0.6006864988558352,0.8810004935422597,1.0,5/70,10.71%,PLB1;PLA2G4A;STARD7;GPAT4;LPCAT1
prerank,histone modification (GO:0016570),0.3034107820088733,0.9235865893867227,0.6150537634408603,0.880912920690863,1.0,34/109,20.20%,PRMT2;HDAC6;KAT5;USP3;TRRAP;BAZ2A;BAZ1B;SIRT1;TBL1X;BRD8;USP21;HDAC1;CREBBP;HDAC5;PARP2;UFL1;SIRT2;TAF6;EYA2;NAA50;MIER1;MORF4L2;MORF4L1;PHF20L1;SIN3A;HDAC11;KAT2A;ENY2;RBM14;EZH2;KAT6B;PRMT1;EYA4;USP16
prerank,renal filtration (GO:0097205),0.4476675588278812,0.9232240811285922,0.5553772070626003,0.881194592129164,1.0,1/10,0.80%,MYO1E
prerank,apical protein localization (GO:0045176),0.44874399970677725,0.9231729671218458,0.5668276972624798,0.8808594401110575,1.0,4/10,19.20%,ATP8B1;ACTB;SHROOM3;INSC
prerank,positive regulation of superoxide anion generation (GO:0032930),0.42069552651690284,0.9229562654998718,0.5581039755351682,0.8808700954875104,1.0,1/13,2.30%,TYROBP
prerank,lysosome organization (GO:0007040),0.34960848740608896,0.9225287169426131,0.5888324873096447,0.8813007061861502,1.0,10/36,17.07%,GNPTAB;CLN5;TPP1;MBTPS1;HOOK2;NAGPA;MTOR;VPS18;AKTIP;CORO1A
prerank,basement membrane organization (GO:0071711),0.41751207381045746,0.9221612192337644,0.5794117647058824,0.8815948454519941,1.0,6/14,24.50%,NID1;HPN;NTNG2;NTNG1;CTSS;FLRT2
prerank,purine-containing compound salvage (GO:0043101),0.42685107025226937,0.9218678989663158,0.5582089552238806,0.8817701789279107,1.0,3/12,12.75%,GMPR2;PNP;AMPD2
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.2874589177957157,0.921667265392113,0.7254509018036072,0.881722186202936,1.0,89/417,18.36%,BASP1;CALCA;TFAP2B;CREB3L1;ATP8B1;CTBP2;JUN;PRMT2;ILF3;INPP5K;FOXE1;SOX9;NR1D2;SNX6;FBXW11;KMT5A;HDAC6;KAT5;RELA;SBNO2;PRICKLE1;ARID5A;EID2B;DPF2;HSPA8;CCDC85B;PDGFB;ZBTB7A;XRCC5;TRIM28;EIF4A2;FOXP1;CRY2;SET;TCF7L2;SIRT1;SPI1;KLF10;GCFC2;CTNNB1;SUMO1;RUNX2;PPM1F;HDAC1;PA2G4;HDAC5;SFPQ;BTAF1;RBPJ;KDM1A;ZNF148;DEDD2;SIRT2;CBX4;CNOT7;UBE2I;PHF10;MBD1;SAMD1;HMBOX1;BCL6;NDUFA13;CBX5;LIMS1;NCOR1;VGLL4;ARID5B;ING4;CTCF;LDB1;FOXK2;PAX2;TMPRSS6;SIN3A;GATAD2A;PRDM11;RBAK;ZBTB4;PSPC1;NONO;PER1;EID1;RUNX1T1;EZH2;CALR;DDIT3;MDFIC;PATZ1;CEBPA
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.3776902362919611,0.9216647077554219,0.5489913544668588,0.881284192121611,1.0,3/22,12.11%,DISP3;KDM1A;TOX
prerank,negative regulation of catalytic activity (GO:0043086),0.37264681479143846,0.9216265544011705,0.5641379310344827,0.8809264064779946,1.0,4/24,8.55%,HDAC6;NOSIP;CAND1;SIRT1
prerank,mesonephros development (GO:0001823),-0.3709523775417556,-0.9214012606582529,0.5408450704225352,0.9594788996565858,1.0,3/11,20.31%,ZBTB16;FGF10;PAX8
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.38643734791071677,-0.9213293469404626,0.5613079019073569,0.9576683335595014,1.0,1/10,0.09%,LRP6
prerank,synaptic vesicle membrane organization (GO:0048499),-0.3293817784378953,-0.9210734372643634,0.595679012345679,0.9563920302449832,1.0,9/17,25.84%,STX2;AP3D1;SNAP23;SNAP25;SNAP29;SYNGR1;STX1A;SYNGR2;STX1B
prerank,plasma membrane organization (GO:0007009),0.3222149401885345,0.9206953734779257,0.590702947845805,0.8824232822406485,1.0,12/61,15.91%,MYH9;TLCD2;CXCR4;DEGS1;SNX33;PACSIN2;ANXA6;SMPD1;NSF;WHAMM;ARL8B;MICALL1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.439322151256926,0.9204652420404293,0.5634028892455859,0.8824515771826414,1.0,1/10,1.41%,AMDHD2
prerank,cellular response to interleukin-7 (GO:0098761),0.3950248049125723,0.9204367717594111,0.5671852899575672,0.8816266152777711,1.0,1/17,0.61%,STAT3
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.3950248049125723,0.9204367717594111,0.5671852899575672,0.8816266152777711,1.0,1/17,0.61%,STAT3
prerank,protein ubiquitination (GO:0016567),0.28784604906377004,0.9203948413150083,0.742,0.8812732457456282,1.0,105/471,17.71%,UVSSA;FBXL15;TRIM69;ARIH2;DDB2;RNF7;NFE2L2;CUL3;HECTD2;SIAH2;UBE2S;PSMD2;RNF20;UBE2T;PSMC4;FBXW11;RNF115;UBE3D;PSMD4;PSMD1;FBXL3;RPS27A;UBC;UBE3A;USP5;PCNA;TAF1;RBCK1;KLHL12;SMURF1;UBE2D1;PSME3;PSMB6;PSMD10;FBXL8;CAND1;SIRT1;UBR1;UBA6;PELI3;UBE2E1;UBA1;UBE2D3;CTNNB1;RNF25;ARRB1;FBXW4;FBXW5;BIRC6;PSMB1;RNF38;DTX3;RC3H1;CHFR;TRIM17;NPEPPS;RNF167;NEDD8;RNF31;CNOT4;RFWD3;UBE2L3;PSMD11;RC3H2;FBXL5;PSMA2;PSMD13;MYLIP;RNF43;DERL1;FBXL17;DDB1;RNF144A;RNF19B;UBE4A;RNF112;PDZRN3;UBE2Z;STUB1;PSMB10;ZNRF3;HERC2;CUL2;FBXO4;PSMB3;UBE2J1;SKP1;TPP2;TRIM36;ARIH1;VPS18;KLHL7;RNF34;CUL4A;UNKL;FBXW9;UBR2;AKTIP;PSMC1;ANAPC7;UBR5;OTULIN;TRIM5;CTR9;KLHL25
prerank,connective tissue development (GO:0061448),-0.2691298345994364,-0.9201457691615776,0.5841584158415841,0.9569909635778454,1.0,7/35,10.68%,SPTLC2;PKD1;SOX6;ZBTB16;ITGB8;SLC39A13;DDRGK1
prerank,cellular response to glucose stimulus (GO:0071333),-0.2776794213281521,-0.9201248053057777,0.5796460176991151,0.9550716630879602,1.0,10/30,21.12%,ZBTB20;RAB11FIP2;GAS6;PRKACA;PCK2;RAB11B;XBP1;PTPRN;SOX4;KCNB1
prerank,renal water homeostasis (GO:0003091),0.37438752539824594,0.9199839062260344,0.5699208443271768,0.8817007456348053,1.0,8/23,18.51%,TFAP2B;ADCY5;PRKAR2A;ADCY8;ADCY3;WFS1;ADCY7;ADCY9
prerank,cAMP biosynthetic process (GO:0006171),0.4520967498819711,0.9195997868257239,0.5930599369085173,0.8820983375862139,1.0,5/10,18.51%,ADCY5;ADCY8;ADCY3;ADCY7;ADCY9
prerank,cellular protein localization (GO:0034613),0.28716724390341647,0.9194662137216839,0.6935483870967742,0.8819409852913338,1.0,72/285,19.43%,NAPA;ARFGAP3;TBC1D10B;RRAGC;UNC50;TM9SF4;VPS26C;TBC1D17;ACD;RAB18;SNX6;TLK1;HDAC6;TMED5;ARL6;TMED4;USP6NL;SNX13;RABGAP1;GGA1;SGSM2;CROCC;SMURF1;RAB31;BBS4;CTSA;TMED10;SCFD2;CNTNAP1;AP2A1;STX3;VPS29;TBC1D30;CTNNB1;CLTC;STXBP3;RIC1;PTPRU;VPS35;NSF;RAB32;EVI5L;HERC2;SAR1B;CEP250;ARF4;WIPI1;FLNA;TBC1D4;RUNDC1;STX5;USO1;ARL1;VPS45;ARHGEF2;PICK1;DNAJC27;TBC1D22A;TBC1D10A;TBC1D15;ARL5B;PDCD6;SYNDIG1;ITSN1;DMD;STX8;VIPAS39;GJA1;ARMCX3;WIPI2;TMED2;ARL5C
prerank,cardiac muscle cell action potential (GO:0086001),0.35727105792443153,0.9192133652060751,0.5773333333333334,0.8820440963916925,1.0,6/30,9.70%,KCNH2;CACNA2D1;CACNA1G;KCNJ2;ATP1B1;SCN1B
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.29344708244202605,0.9186376319601052,0.6666666666666666,0.882806739120742,1.0,37/173,16.70%,NAPA;ARFGAP3;COPE;CUL3;TRAPPC5;TRAPPC2L;TMED5;TMED4;KLHL12;CD55;TRIP11;TMED10;ATL3;COG4;ANK1;TRAPPC4;TRAPPC3;ERGIC2;PEF1;DCTN3;NSF;SEC24C;USE1;PROS1;GBF1;SEC24A;SPTAN1;SAR1B;ARF4;WHAMM;GOLT1A;HYOU1;STX5;USO1;ERGIC1;DYNC1LI1;PROC
prerank,regulation of MAPK cascade (GO:0043408),0.2947840533464435,0.9182904225329275,0.668041237113402,0.8830726940025952,1.0,31/157,19.17%,OSM;EPHA2;PEBP1;PDGFA;HMGB1;DUSP19;MAP2K1;JCAD;PDGFB;GSDME;RYK;PSMD10;PTPRC;PHLPP1;PTPN6;SOX2;TAOK2;TNIK;IGF1;LPAR1;ROR1;ATP6AP2;ADRB2;IL6;PRDM11;YWHAZ;DAG1;TRIM5;DUSP3;NTRK2;BCAR3
prerank,non-motile cilium assembly (GO:1905515),0.3559695883481243,0.9181707898877,0.5894736842105263,0.8828726374242198,1.0,6/30,18.12%,CCDC13;BBS4;TTC8;CEP250;CSNK1D;DCTN1
prerank,protein targeting to mitochondrion (GO:0006626),0.3282169435474508,0.9175732893062832,0.6101295641931684,0.883726611169616,1.0,9/52,13.92%,TIMM8B;HSPA4;DNAJC19;TOMM20;GDAP1;TIMM44;DNAJC15;TIMM9;NDUFA13
prerank,long-chain fatty acid transport (GO:0015909),0.35565253612678976,0.917435832725,0.5731225296442688,0.8835893738428066,1.0,3/30,5.51%,THRSP;MID1IP1;APOE
prerank,histone H2B ubiquitination (GO:0033523),0.44525876693994876,0.9170526670516324,0.5899159663865546,0.8839540197359786,1.0,4/10,20.46%,RNF20;UBE2E1;CTR9;RNF40
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.34871713055805403,0.9170254326434192,0.6095717884130982,0.8835626523482109,1.0,11/35,20.99%,ARHGDIA;ABL2;BAIAP2L1;PTK2B;BAIAP2;TRPM2;HCK;CSF1R;IQGAP2;TJP1;CDC42
prerank,reverse cholesterol transport (GO:0043691),-0.34599907756015563,-0.9166929599014279,0.5647058823529412,0.9624560189284793,1.0,4/13,17.44%,ABCA1;SCARB1;ABCA5;ABCG1
prerank,positive regulation of integrin activation (GO:0033625),-0.3657857973000517,-0.9165840240810228,0.5571030640668524,0.9608174291069095,1.0,4/11,12.03%,P2RY12;FERMT2;PIEZO1;SRC
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.35679379130630506,0.9162941541720727,0.5891677675033025,0.8846759323921732,1.0,7/29,12.63%,DDB2;RPS27A;UBC;GTF2H4;CHD1L;ERCC2;DDB1
prerank,regulation of postsynapse organization (GO:0099175),-0.2825557223271029,-0.9162261184736821,0.6120689655172413,0.9599274150837932,1.0,13/28,26.10%,ARHGAP44;ABI3;SIPA1L1;PDLIM5;LRRK2;FCGR2B;PPFIA2;CDK5;EPHA4;SHANK3;TANC2;ABHD17A;ZDHHC15
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.2938664862164978,0.9157822468841222,0.6443298969072165,0.8852813475626637,1.0,27/172,12.62%,PISD;PI4KA;INPP5K;PIK3R3;AGPAT4;MTMR14;SELENOI;PLA2G4A;ABHD8;DGKZ;PIK3R4;PIK3C3;MTM1;PIK3R1;PTDSS2;STARD7;MTMR3;DGKD;MTMR12;PI4KB;GPAT4;LPCAT1;FAR1;INPP4A;OCRL;INPP5F;DGKQ
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.38801776563991114,0.9157651924828256,0.5852272727272727,0.884870543655137,1.0,3/19,9.33%,BAG6;SIRT1;PYCARD
prerank,response to organonitrogen compound (GO:0010243),0.3357521048339504,0.9156459565185797,0.5864661654135338,0.8846557450422055,1.0,9/38,15.03%,RRAGC;ERLEC1;SEL1L;BRSK2;TRPM2;DERL1;CCDC47;MTOR;IL6
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.40766142398636535,0.9151345249763067,0.5797317436661699,0.8852754228734281,1.0,4/14,13.07%,PELI3;CARD16;PYDC1;GPS2
prerank,negative regulation of lyase activity (GO:0051350),0.39985865676940757,0.9149698117347612,0.582723279648609,0.8851578141281068,1.0,1/16,2.08%,AKAP5
prerank,sulfate transport (GO:0008272),-0.3500207120574407,-0.9149614225785437,0.5732899022801303,0.9615293207191061,1.0,7/14,35.57%,SLC26A11;SLC25A30;SLC25A11;RACGAP1;SLC26A8;SLC26A6;SLC25A10
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.3749107624928515,0.9147316405323656,0.589572192513369,0.8852236146434785,1.0,7/22,18.18%,NFE2L2;PSMB6;PSMB1;PSMA2;PSMB10;PSMB3;ENC1
prerank,positive regulation of stem cell differentiation (GO:2000738),0.3982352347759831,0.9143707641682818,0.591044776119403,0.8855226564333594,1.0,2/16,7.80%,SOX9;LTBP3
prerank,chemical homeostasis (GO:0048878),0.3186644588474155,0.9137438796336957,0.6069767441860465,0.8863644685468758,1.0,7/61,8.80%,TLCD2;ATP13A2;NR1D2;ABHD8;SLC4A2;CLN8;ADCK1
prerank,phospholipid catabolic process (GO:0009395),0.3664305367543325,0.9137120322023426,0.5733157199471598,0.8859847992172016,1.0,5/24,15.53%,PLA2G4A;ENPP6;SMPD1;SMPD4;GPCPD1
prerank,regulation of dephosphorylation (GO:0035303),0.4044608936527646,0.9134537249232172,0.5867269984917044,0.8860740307218511,1.0,4/15,14.22%,INPP5K;SMG7;MTMR3;PPP1R16B
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.2789525110759512,-0.9128455088819576,0.6007905138339921,0.9655016514178996,1.0,11/28,27.41%,STMN2;MAP1B;CLASP2;STMN1;CAMSAP1;PRUNE1;SKA2;ARL2;ABL1;GBA2;CLASP1
prerank,positive regulation of RNA splicing (GO:0033120),0.35765486138289715,0.9127972886809906,0.5855614973262032,0.8869789045793117,1.0,9/29,16.13%,HABP4;PIK3R1;U2AF2;NCBP1;SETX;NUP98;ZPR1;DYRK1A;HNRNPLL
prerank,protein insertion into membrane (GO:0051205),0.3511165843489071,0.9125255112958891,0.5856573705179283,0.8870795280667783,1.0,7/32,15.35%,WDR83OS;GET1;PRNP;APP;CCDC47;TRAM1;STX5
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.3739275307851728,-0.9124054175194156,0.5822454308093995,0.9647884169480758,1.0,2/11,5.92%,HSP90AA1;CALM1
prerank,coenzyme A metabolic process (GO:0015936),0.40277776921705566,0.9122953433803619,0.6036036036036037,0.8871040755828604,1.0,6/14,18.52%,ACLY;PPCS;PANK3;ACAT1;DCAKD;PANK1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.36426866036522854,0.9122925284029423,0.5983263598326359,0.8866688080779943,1.0,4/25,11.28%,PLAUR;BID;PYCARD;BAD
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.31182949410304844,0.9121580285081068,0.6364678899082569,0.8865084623956176,1.0,19/72,19.99%,SHANK1;CLIP3;LIMA1;MID1IP1;FGF13;PFN1;HSPA8;APOE;CYRIB;PFDN1;CLU;DYRK1A;APC;ARHGEF2;CORO1A;TTBK2;SSH3;TUBB4A;SNCA
prerank,cytoplasmic microtubule organization (GO:0031122),0.3256601525838629,0.9121207895476389,0.5997624703087886,0.8861482262575094,1.0,12/54,18.37%,CCDC13;CLIP3;CEP126;CLIP2;TUBGCP5;TUBGCP6;HOOK2;TUBGCP4;KATNAL1;CCDC88A;DCTN1;PLK3
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.416764147036963,0.9120959858294981,0.5723370429252782,0.8857592636324877,1.0,2/12,6.09%,TMEM33;PIK3R1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.364517855542267,0.9119901916268507,0.5814266487213997,0.8855425066780036,1.0,8/24,20.62%,PIK3R1;COL16A1;PPM1F;LIMS1;RAC1;DUSP3;MAP4K4;THY1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.36956512744902387,-0.9118769925225224,0.5792207792207792,0.9643418762802607,1.0,4/11,14.49%,CASP8;UNC93B1;RIPK1;TLR3
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.2971448732860258,0.9116512085838229,0.664576802507837,0.8857960308412944,1.0,22/121,17.44%,OSM;STAT3;IL34;CSPG4;ITGB3;PDGFB;AGT;PTK2B;BMP6;PTPRC;PRNP;RIPK2;IL18;IGF1;DGKQ;FCGR1A;IL6;HGF;ITGA5;TEC;ARHGEF2;ACVR1
prerank,polyol biosynthetic process (GO:0046173),0.3980644855600971,0.9113796440715349,0.5762962962962963,0.8859212146720855,1.0,5/16,16.55%,ITPKC;ITPKB;IP6K2;IPPK;PPIP5K1
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.36893276440561695,0.9113508225182447,0.5930388219544847,0.8855336525389805,1.0,4/24,12.34%,PPP1R3E;INPP5K;EPM2AIP1;IGF1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.2355933938733041,-0.9112755351950175,0.7071428571428572,0.9641223077464945,1.0,24/58,23.10%,BABAM2;MRE11;UIMC1;RNF168;PAXIP1;SMARCAL1;DCLRE1C;PIAS4;NHEJ1;LIG3;XRCC4;ERCC6;ERCC8;BABAM1;ABRAXAS1;RIF1;NSMCE2;POLM;SMC5;POLA1;HMGB2;DCLRE1A;DCLRE1B;ATP23
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.40170533519227997,0.9112319486872843,0.5784023668639053,0.8853226166328119,1.0,3/15,10.92%,PTTG1IP;SIRT1;KDM1A
prerank,negative regulation of heart contraction (GO:0045822),0.4268773620314574,0.9111712511074884,0.5795275590551181,0.8850170299117621,1.0,4/11,17.90%,FKBP1B;ZC3H12A;PIK3CG;GRK2
prerank,regulation of mRNA processing (GO:0050684),0.35112826079866655,0.9109035379504843,0.5740740740740741,0.8851402810040617,1.0,16/32,20.27%,HNRNPK;LARP7;RBM39;DHX9;IWS1;SRSF10;NCBP1;SLTM;SRPK2;SAFB;PTCD2;QKI;AHCYL1;KHDRBS3;SF1;YTHDC1
prerank,protein kinase A signaling (GO:0010737),0.42020896298535787,0.9107456047623623,0.5921875,0.8850456271545734,1.0,1/12,1.49%,LCP1
prerank,histone H4 deacetylation (GO:0070933),-0.37391385163763935,-0.9106165623170203,0.6077922077922078,0.963972767327175,1.0,5/10,18.91%,HDAC8;HDAC2;HDAC3;SMARCAD1;HDAC9
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.3698017626402425,-0.9105388274396073,0.6021798365122616,0.9622315697513293,1.0,1/11,0.09%,LRP6
prerank,protein K48-linked deubiquitination (GO:0071108),0.36994268512039485,0.9104240467227085,0.5956873315363881,0.885233373019998,1.0,8/23,16.23%,OTUD3;USP5;OTUD7B;USP25;USP8;OTUD4;OTUB1;TNFAIP3
prerank,negative regulation of protein depolymerization (GO:1901880),0.37053781414210174,0.9096810873901724,0.5794655414908579,0.8862984420117714,1.0,3/24,3.30%,LIMA1;MID1IP1;FGF13
prerank,negative regulation of translational initiation (GO:0045947),-0.3544900144995137,-0.9095689979438218,0.5552238805970149,0.9628783749291208,1.0,7/13,20.69%,PAIP2;TPR;LARP1;EIF2AK4;RBM4;PAIP2B;EIF3E
prerank,regulation of transposition (GO:0010528),0.4121983187693729,0.909514498319815,0.6003134796238244,0.8862002578901288,1.0,3/13,16.93%,TEX15;SMYD5;UBR2
prerank,dopamine metabolic process (GO:0042417),0.38730812479650656,0.909405740811517,0.5693848354792561,0.8859756819543297,1.0,3/18,12.36%,GCH1;SNCAIP;COMT
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.35629985292893307,0.9093644204739371,0.5904887714663144,0.8856279971442319,1.0,4/27,9.42%,FGF13;JUP;TRPM4;AKAP9
prerank,regulation of cytoskeleton organization (GO:0051493),0.3000734236395115,0.9092774080241169,0.654876741693462,0.8853879352006496,1.0,25/108,17.07%,PDGFRB;IQGAP3;RICTOR;PDGFA;FAM107A;RHOB;CLIC4;RHOG;PHLDB1;SH3BP1;LRP1;TRAF3IP1;RHOQ;BAIAP2;TAOK2;EPHA3;DIAPH1;CRK;MTOR;ARHGAP17;RAC1;TRIM36;CCDC88A;GPM6B;CORO1A
prerank,multivesicular body assembly (GO:0036258),0.3509267602430336,0.9092518097781371,0.5945945945945946,0.8850011869783224,1.0,5/30,9.05%,VPS4A;VPS28;PDCD6IP;VPS37B;STAM
prerank,positive regulation of protein metabolic process (GO:0051247),0.29514472631397104,0.9091309185707404,0.6420150053590568,0.8848023753880278,1.0,31/110,21.40%,CSF1;VPS28;APOE;EGLN2;AGT;SMURF1;CARD9;SORL1;MAPK8;IL18;CLU;NSF;APP;DDB1;IDE;NDUFA13;ABCB10;WFS1;STX5;CD86;LDB1;TNFAIP3;APC;RAB7A;SLC6A9;PRMT1;ITCH;VCP;FOXO1;DAB2IP;AREL1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.4130177918193325,0.9089858602445658,0.5772727272727273,0.8846609254908815,1.0,3/13,8.92%,RBPMS;TGFBR1;BMP6
prerank,protein autophosphorylation (GO:0046777),0.29195457827099547,0.9086896049983567,0.6694473409801877,0.8848197183954081,1.0,33/157,19.50%,MAPKAPK2;PDGFRB;EPHA1;PRKD2;ATP13A2;EIF2AK2;EIF2AK1;NEK6;ULK3;TAF1;EIF2AK3;PTK2B;ACVR1B;PIM3;DDR2;TAOK2;CDKL5;TNIK;MKNK1;STK17B;CDK12;CAMKK2;MTOR;PEAK1;DAPK1;DYRK1A;TEC;MAPKAPK3;HCK;AATK;NTRK2;CSF1R;STK16
prerank,extracellular matrix disassembly (GO:0022617),0.3255205848822767,0.9081870596191706,0.6033254156769596,0.8853858432351758,1.0,10/53,17.05%,LCP1;ADAM8;CTSL;NOXO1;FURIN;HPN;SCUBE1;FLOT1;TMPRSS6;ADAMTS4
prerank,positive regulation of type I interferon production (GO:0032481),0.3085044199075128,0.9081805664333352,0.6230248306997742,0.8849614764204137,1.0,26/73,21.55%,RELA;TBK1;DDX41;TRIM56;XRCC5;POLR3B;STAT6;DHX9;CRCP;TLR7;CTNNB1;RIPK2;CREBBP;POLR3F;POLR2E;FLOT1;HSPD1;NFKB1;RIOK3;CGAS;POLR2K;POLR3E;TLR2;LRRFIP1;POLR3G;MAVS
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.2984260343003741,0.9081114897066405,0.6577825159914712,0.8846655120693951,1.0,20/101,15.05%,CSF1;HNRNPD;FBXW11;FXR2;PTTG1IP;LARP6;LARP4B;AGT;EIF6;MSN;ASPH;BAD;NSUN5;VPS35;STUB1;FMR1;VGLL4;MTOR;IL6;IST1
prerank,positive regulation of JUN kinase activity (GO:0043507),0.36757732632844353,0.9078152305568677,0.5981308411214953,0.8848075512786299,1.0,2/23,3.36%,DVL2;DUSP19
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.4478392919375097,0.9074156830828107,0.6089108910891089,0.8852072262843618,1.0,4/10,18.44%,HDAC5;SMARCB1;KMT2A;PIH1D1
prerank,keratan sulfate catabolic process (GO:0042340),0.4268685341604984,0.9073731526544786,0.5911949685534591,0.8848612785916098,1.0,2/11,6.31%,GLB1;GALNS
prerank,histone H4-K16 acetylation (GO:0043984),-0.3123522573931684,-0.9073417448671599,0.5993377483443708,0.967022513717467,1.0,7/19,16.70%,PHF20;JADE2;HCFC1;JADE3;WDR5;KAT7;KAT8
prerank,GPI anchor metabolic process (GO:0006505),0.3663890042459289,0.9071941344842852,0.601889338731444,0.8848214136677179,1.0,9/26,17.27%,PIGQ;DPM1;PIGN;PIGM;PGAP4;PIGP;DPM2;PIGF;PIGC
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.3732530475646344,0.9071553403976141,0.5897079276773296,0.8844549710619922,1.0,3/21,9.75%,DVL2;FZD5;CTNNB1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.3751726642025437,-0.9070285602334334,0.5726495726495726,0.9658806787478567,1.0,4/11,22.00%,MPV17L;ABCD2;TRAP1;PARK7
prerank,telomere organization (GO:0032200),0.32871748412831886,0.9067534277800109,0.6057213930348259,0.8848120121390445,1.0,8/43,9.60%,ACD;DOT1L;LTO1;PCNA;XRCC5;PTGES3;STN1;NBN
prerank,DNA replication checkpoint signaling (GO:0000076),-0.3221944938336676,-0.9066224231908668,0.5838323353293413,0.9651147579532983,1.0,8/16,32.93%,DNA2;TIPIN;RAD9B;RAD9A;HUS1;CLSPN;TIMELESS;ORC1
prerank,cellular response to oxidative stress (GO:0034599),0.29640113977654553,0.9065126478457567,0.667375132837407,0.884864433100388,1.0,25/118,17.55%,SESN2;NFE2L2;JUN;ATP13A2;ATF4;EIF2S1;NCF4;CYBB;PRDX5;LONP1;RAD52;ERCC6L2;MAPK8;NCF2;SIRT2;TXNRD1;PYCR2;FOXO3;SETX;CAMKK2;DAPK1;FANCC;SOD2;HTRA2;ZC3H12A
prerank,motor neuron axon guidance (GO:0008045),-0.3464891828542036,-0.9063218080468801,0.5914634146341463,0.9640325096997774,1.0,6/15,21.55%,RHOH;CHN1;TMEFF1;SLIT2;RAC2;EPHA4
prerank,regulation of endocytosis (GO:0030100),0.3196000586438634,0.9060927128849637,0.6317016317016317,0.8852465245487594,1.0,12/61,11.88%,CLIP3;PICALM;ABL2;RUBCN;APOE;SNX33;LRP1;PACSIN2;SMPD1;STON1;ZFYVE16;EPHA3
prerank,negative regulation of protein transport (GO:0051224),0.3591927897753342,0.9049051261599292,0.6062246278755075,0.887173697918658,1.0,4/25,9.97%,RHBDF2;APOE;SERGEF;PPM1F
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.3400468208854256,0.9048939021095792,0.5886157826649417,0.8867650591695547,1.0,6/33,9.22%,ACD;HSP90AB1;ZBTB48;PTGES3;PPP6R3;STN1
prerank,response to ATP (GO:0033198),0.3859376510359835,0.9047139447162003,0.5827338129496403,0.8866973055554449,1.0,4/18,12.62%,TAF1;P2RY1;TRPC3;DGKQ
prerank,telomere maintenance (GO:0000723),0.3226658614890596,0.9046671330531671,0.6161251504211793,0.8863608366408849,1.0,9/50,9.60%,ACD;ZBTB48;LTO1;PCNA;XRCC5;PTGES3;TPRKB;STN1;NBN
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.38832907035945696,0.9045669830151037,0.6005961251862891,0.8861263335095516,1.0,5/17,9.70%,CACNA2D1;TRPM4;CACNA1G;KCNJ2;SCN1B
prerank,organophosphate catabolic process (GO:0046434),-0.36762150950815253,-0.9045420877177149,0.5714285714285714,0.9668613091154505,1.0,5/11,41.90%,PLBD2;ABHD12;PLBD1;ANGPTL3;PDXP
prerank,regulation of amyloid fibril formation (GO:1905906),-0.3375905122789382,-0.9040466684211731,0.5919540229885057,0.966285126124832,1.0,8/15,19.44%,PSEN1;PFDN2;VBP1;LDLR;PFDN5;IAPP;CHRNA7;CRYAB
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.31679146821012855,-0.9039692628169169,0.5833333333333334,0.9645839105761815,1.0,7/17,21.58%,NCKAP1L;CAMK1D;CD74;RAC2;DNM1L;RIPOR2;MDK
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.33391850094619524,-0.9037454796083908,0.5946745562130178,0.9632689664785317,1.0,14/16,58.58%,SLX4;RMI1;HFM1;TOP2A;EME2;CENPX;MUS81;MSH4;EME1;CENPS;TOP2B;MEIOB;SHOC1;CORT
prerank,protein K11-linked ubiquitination (GO:0070979),0.35184114182187476,0.9036000641860797,0.5989445910290238,0.8876369247493985,1.0,6/27,11.44%,UBE2S;UBE2T;ANAPC5;UBE2D3;UBE2L3;ANAPC10
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.30584277651936453,0.9035719079573977,0.6469945355191257,0.8872515063502013,1.0,16/87,16.49%,SURF1;NDUFS6;SMIM20;NDUFB10;TMEM126A;TIMMDC1;SLC25A33;NDUFB4;NDUFA10;NDUFA3;UQCRFS1;NDUFA13;NDUFA5;COX19;NDUFAF2;NDUFV2
prerank,regulation of protein targeting to membrane (GO:0090313),0.35569786473469683,0.9030787713067233,0.625,0.8878028161556941,1.0,4/28,9.29%,INPP5K;TCAF1;MYO1C;PRNP
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.2920503472106288,0.9030195630908273,0.678125,0.8874824301259996,1.0,35/140,17.01%,ARHGDIA;SQSTM1;ARHGAP30;KALRN;RHOB;RHOG;ARHGEF26;RASGRF1;RHOU;ARHGEF4;SH3BP1;ARHGEF6;CD2AP;CYRIB;GMIP;ARHGAP22;FGD1;RHOQ;TAGAP;MYO9A;TRIO;SRGAP2;SRGAP3;OCRL;ARHGAP5;SOS1;RALBP1;ARHGAP17;RAC1;FLCN;MYO9B;ARHGAP1;ARHGAP32;ARHGEF3;ARHGEF2
prerank,mitochondrial transcription (GO:0006390),0.4424699884407422,0.9030193013278569,0.593996840442338,0.8870507752475335,1.0,4/10,19.70%,SLC25A33;FOXO3;TFB2M;TFAM
prerank,cognition (GO:0050890),0.3353256997352501,0.9028874592906502,0.629156010230179,0.8868935178254828,1.0,9/42,12.57%,DGCR2;CBR3;FAM107A;TUSC3;BBS4;CYFIP1;NSUN5;TTC8;APP
prerank,response to ionizing radiation (GO:0010212),0.31009350032766037,0.9027737064768969,0.6334841628959276,0.8866967108469412,1.0,9/70,11.21%,MYC;BRSK1;KAT5;TANK;RHOB;SMPD1;SIRT1;COP1;RFWD3
prerank,regulation of interferon-alpha production (GO:0032647),0.3718068947743364,0.9027250129658627,0.5985915492957746,0.886362221702667,1.0,7/23,16.07%,TBK1;NLRC3;DHX9;TLR7;RIPK2;PTPRS;HSPD1
prerank,defense response to symbiont (GO:0140546),0.30252732719294123,0.9026532926594649,0.6430939226519337,0.8860799253983285,1.0,24/92,20.16%,BCL2L1;ACOD1;EIF2AK2;RELA;IFITM3;NCBP3;TRIM56;TLR7;PTPRC;PYCARD;CNOT7;MLKL;NT5C3A;FLNA;IL6;RNASE1;IFNAR2;NLRC5;TTC4;TRIM5;CGAS;TLR2;MAP3K14;AGBL5
prerank,negative regulation of neuron projection development (GO:0010977),0.31928394998847526,0.9026394869497697,0.6436233611442194,0.8856708370382166,1.0,14/56,16.48%,ARHGDIA;RUFY3;RTN4;APOE;BCL11A;ITM2C;LRP4;PTPRO;MYLIP;LPAR1;DENND5A;PTPRS;MAG;SEMA3A
prerank,eye morphogenesis (GO:0048592),0.38856931222409796,0.9025644390841516,0.6051136363636364,0.8854008342426429,1.0,2/19,10.24%,STAT3;EFEMP1
prerank,cellular potassium ion homeostasis (GO:0030007),0.4092560613273213,0.90228138811751,0.5867269984917044,0.8855769163575293,1.0,4/13,16.47%,KCNJ2;ATP1B1;KCNMA1;ATP1A3
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.3238812598189743,0.9020780345014434,0.6256038647342995,0.8855239339707138,1.0,12/50,19.55%,RTKN2;EIF2AK2;RELA;TCIM;TLR7;PTP4A3;APP;LIMS1;CD86;ILK;TERF2IP;TLR2
prerank,regulation of myotube differentiation (GO:0010830),-0.292876533651392,-0.9016625276410298,0.6062992125984252,0.9668649904607542,1.0,9/24,22.67%,TMEM119;BHLHE41;NOTCH1;PIEZO1;HDAC3;MAPK14;XBP1;HDAC9;SIK1
prerank,regulation of glycolytic process (GO:0006110),0.3125550067708624,0.9016245067792616,0.6408209806157354,0.8859899497828357,1.0,17/68,15.64%,NUP153;NDC1;PFKFB3;NUPR1;ZBTB7A;EIF6;NUP88;NUP210;PRKAG1;NUP37;IGF1;APP;ENTPD5;NUP98;NCOR1;PGAM1;NUP54
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.41303688938931693,0.9016074753312767,0.6064814814814815,0.8855940638367091,1.0,4/13,15.03%,DOT1L;MGAT5;PTPRC;IL6
prerank,sodium ion homeostasis (GO:0055078),0.3732572121092238,0.9014928459304937,0.6083333333333333,0.885411412164772,1.0,4/21,19.39%,TFAP2B;ATP1B1;ATP1A3;SLC9A1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.281712768868116,-0.9013988576927401,0.5991561181434599,0.9656638113457914,1.0,9/26,22.00%,RAB27A;ABCD2;ALOX5;GRIN1;PLCG2;TLR4;CD36;TRAP1;PARK7
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.26686934388614625,-0.901128750285505,0.6428571428571429,0.964453876625112,1.0,9/33,18.05%,CDKN1B;PPARG;PTEN;TPM1;MFN2;IGFBP5;TAFA5;NDRG4;HMOX1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.3812499537532766,-0.9008328576704702,0.6165413533834586,0.9633361048837439,1.0,1/10,0.65%,DPYD
prerank,receptor-mediated endocytosis (GO:0006898),0.2922095688916091,0.9007726724003915,0.6761006289308176,0.8864162752388319,1.0,35/132,20.17%,CD9;CTSL;PICALM;DNM2;APOE;SPARC;COLEC12;RAB31;LRP1;PPT1;SORL1;AP2A1;CLTC;PI4KB;SCARB2;INPP5F;VLDLR;FCGR1A;AP1G1;MASP1;CXCL16;ADRB2;HYOU1;MICALL1;AP2M1;LMBRD1;GRK2;CALR;SGIP1;HSP90B1;ITGB2;GAK;SNCA;M6PR;EPS15
prerank,negative regulation of transport (GO:0051051),0.32158393302766125,0.9006968867908176,0.6318347509113001,0.8861473319470988,1.0,9/51,13.22%,ARL6IP5;SIRPA;RUBCN;ITGB3;SNX33;YRDC;PPM1F;EPHA3;CTTNBP2NL
prerank,nucleoside phosphate catabolic process (GO:1901292),0.40826651917041795,0.9003669212307831,0.602803738317757,0.8863968479474886,1.0,3/13,12.68%,ENTPD1;ENTPD7;ENTPD5
prerank,spinal cord development (GO:0021510),-0.3542986550293502,-0.9001941051634887,0.5785123966942148,0.9632092709440271,1.0,4/12,24.70%,PKD1;PKD2;SOX4;SOX11
prerank,pre-miRNA processing (GO:0031054),0.4057375823723472,0.8999452857566406,0.6056129985228951,0.8867923020157721,1.0,5/14,20.13%,TARBP2;TUT7;DROSHA;AGO3;AGO2
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.31097936701951,0.8999187636610264,0.6475225225225225,0.8864067809697084,1.0,7/75,9.75%,ADAMTS1;PGK1;SARS1;KRIT1;SPARC;SEMA6A;CTNNB1
prerank,histone deacetylation (GO:0016575),0.33099015031684037,0.8997429822288624,0.631578947368421,0.8863278568756472,1.0,15/43,17.68%,HDAC6;BAZ2A;SIRT1;TBL1X;HDAC1;HDAC5;SFPQ;SIRT2;MIER1;MORF4L2;MORF4L1;SIN3A;PER1;HDAC11;RBM14
prerank,positive regulation of mitochondrial translation (GO:0070131),0.40390384631688453,0.8996918260430371,0.608433734939759,0.8860040459880685,1.0,3/14,14.75%,C1QBP;MRPS27;RMND1
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.2954501480102991,-0.8994372375416037,0.5789473684210527,0.9633240678160143,1.0,9/22,21.58%,KLF9;PRKD1;CASK;FGFR2;STXBP4;SRSF6;FGF10;ZFP36L1;MDK
prerank,ion transport (GO:0006811),-0.20690070842085878,-0.899398732715067,0.6923076923076923,0.961559890633306,1.0,15/111,9.74%,GLRB;ATP11B;SLC8B1;KCNN2;SLC9A9;PIEZO2;GLRA1;SLC26A11;CTNS;SLC25A26;SLC9A6;PIEZO1;SLC8A3;SLC15A2;SLC8A1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.3791803576983618,0.8991478957853578,0.6081081081081081,0.8866346848593503,1.0,3/17,8.37%,ADAM17;PDGFB;PSMD10
prerank,chloride transport (GO:0006821),0.30556736018886893,0.8990659773442977,0.6515323496027242,0.8863680569768929,1.0,11/74,15.07%,CLCN2;TTYH3;GABRB2;CLIC4;SLC1A3;CLCN6;SLC12A6;ANO10;SLC1A1;ANO4;GABRA4
prerank,neuron maturation (GO:0042551),0.3808908470047091,0.898634130512332,0.5918079096045198,0.8867830608197402,1.0,5/18,12.87%,ACTL6B;CLN5;B4GALT5;APP;MTCH1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3067156630283556,0.8986291789053933,0.6617812852311161,0.8863668986988658,1.0,11/76,12.04%,WDR1;PLEK;NCK1;PFN1;BAIAP2L1;NCKAP1;CDC42EP3;PTK2B;PYCARD;BAIAP2;LIMK1
prerank,"wound healing, spreading of cells (GO:0044319)",0.3705941604158231,0.8982438759164042,0.6005509641873278,0.8866867775392525,1.0,2/24,1.61%,LCP1;ADAM17
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.3736162480069171,0.8982014753067661,0.606508875739645,0.8863330072708515,1.0,6/21,18.42%,JUN;MITF;SETX;MED1;MED13;MED4
prerank,nitric oxide mediated signal transduction (GO:0007263),0.3990086052942014,0.8982000256545212,0.6182634730538922,0.8859116208131068,1.0,3/16,12.02%,APOE;AGT;DDAH2
prerank,negative regulation of JNK cascade (GO:0046329),0.3429551350712324,0.8981400801489908,0.6138107416879796,0.885613404672367,1.0,8/31,19.69%,DUSP19;SIRPA;DNAJA1;GPS2;NCOR1;PER1;DUSP3;ITCH
prerank,mitotic nuclear membrane organization (GO:0101024),0.31916579461894196,0.8981353884658383,0.638525564803805,0.8847710275955095,1.0,14/51,19.30%,VPS4A;LEMD2;NDC1;SUMO1;RANGAP1;RCC1;NUP37;SIRT2;UBE2I;NUP98;IST1;CC2D1B;RAN;PPP2R2A
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.31916579461894196,0.8981353884658383,0.638525564803805,0.8847710275955095,1.0,14/51,19.30%,VPS4A;LEMD2;NDC1;SUMO1;RANGAP1;RCC1;NUP37;SIRT2;UBE2I;NUP98;IST1;CC2D1B;RAN;PPP2R2A
prerank,tyrosine metabolic process (GO:0006570),-0.360437298800413,-0.8980721663557972,0.6031331592689295,0.9631319765994253,1.0,3/11,34.01%,THAP4;FAH;IL4I1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.29466660622709606,0.8974589149521518,0.6898340248962656,0.8856202951210368,1.0,16/138,12.13%,CSF1;PDGFRB;EPHA1;NPPC;EPHA2;PTK2B;RYK;ACVR1B;DDR2;PTPRD;BDNF;ACVR2B;BLNK;PTPRU;EPHA3;TRIO
prerank,microtubule bundle formation (GO:0001578),-0.25544844574511033,-0.897395806003392,0.6284153005464481,0.9631646798098563,1.0,11/42,21.61%,NAV1;NCKAP5;NUMA1;CCDC66;DCX;TPPP;MTCL1;CFAP74;TTLL3;NCKAP5L;AAAS
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.35460079181682747,-0.8972813607310718,0.6275071633237822,0.9615871947976016,1.0,6/13,22.15%,MFN1;GTPBP1;LRRK2;AK3;RAB23;OPA1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.40920143480341054,0.8969862579597643,0.6028938906752411,0.8861192362508303,1.0,2/12,5.34%,HNRNPU;LARP7
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3748746264557131,0.8968453972951405,0.5942622950819673,0.8859767320781977,1.0,4/20,12.75%,ADSS2;GMPR2;GART;AMPD2
prerank,regulation of ruffle assembly (GO:1900027),-0.29639913347389146,-0.8968131045340663,0.6338582677165354,0.9609527835353648,1.0,5/23,5.09%,P2RY12;NLGN1;EPS8;ABI3;RDX
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.304273947527947,0.896761433077093,0.6474576271186441,0.8852839515516758,1.0,23/78,20.16%,CTSD;CTSL;DNM2;KLC1;KIF5A;AP2A1;OSBPL1A;CLTC;DCTN3;ACTR1B;AP1M1;SEC24C;SEC24A;SAR1B;AP1G1;KIF3B;DYNC1LI1;AP2M1;RAB7A;DCTN1;DCTN4;KIFAP3;ACTR1A
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.304273947527947,0.896761433077093,0.6474576271186441,0.8852839515516758,1.0,23/78,20.16%,CTSD;CTSL;DNM2;KLC1;KIF5A;AP2A1;OSBPL1A;CLTC;DCTN3;ACTR1B;AP1M1;SEC24C;SEC24A;SAR1B;AP1G1;KIF3B;DYNC1LI1;AP2M1;RAB7A;DCTN1;DCTN4;KIFAP3;ACTR1A
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3225867617957249,0.8963935632010747,0.6287787182587666,0.8855911371107723,1.0,20/51,22.99%,MAP1S;ALS2;DNM2;NCKAP1;CNTNAP1;BDNF;TAOK2;TNIK;TRIO;SRGAP2;GPM6A;DBNL;SGK1;MAP4K4;DAB2IP;PACSIN1;CNTNAP2;PAK1;SHTN1;TAOK1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.2662204592098495,-0.8961155126379785,0.6188524590163934,0.9609547460303351,1.0,18/32,32.26%,FOXN3;BABAM2;RINT1;MRE11;UIMC1;BLM;BABAM1;ABRAXAS1;TRIM39;CDK5RAP3;DONSON;MRNIP;BRCA1;CDC14B;HMGA2;CLSPN;NOP53;CDKN1A
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.3464148173205036,0.8960661573385026,0.617300131061599,0.8858359083471432,1.0,6/29,12.43%,NOP14;RPS8;RPS21;UTP4;RRP36;RPS14
prerank,defense response to protozoan (GO:0042832),-0.34932180932998513,-0.8960054377500078,0.5888888888888889,0.9593509903132584,1.0,10/12,44.79%,BATF;GBP7;MYD88;CD40;LYST;IRF4;PF4;GBP2;GBP4;BATF2
prerank,adherens junction organization (GO:0034332),0.3204627235019078,0.8956668656969701,0.6392479435957696,0.8861861001026512,1.0,18/48,21.95%,NECTIN3;CADM3;CADM1;CTNND1;JUP;CTNNB1;CDH12;ACTB;DCHS1;CDH19;CDH13;NECTIN4;CDH20;TJP1;NECTIN2;VCL;PIP5K1C;CDH2
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.4112250017681963,0.8956549970059967,0.6162246489859594,0.8857842165762589,1.0,3/13,8.12%,PNP;TGFBR2;ZBTB7B
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.4099281372426414,0.8952880569055505,0.5906344410876133,0.886081571865695,1.0,5/13,17.50%,RIPK2;ASPH;BAD;GRIN2A;TBC1D10A
prerank,regulation of neuron migration (GO:2001222),0.3573086498514167,0.8952752344818794,0.6172185430463576,0.8856901221993766,1.0,14/26,23.72%,ADGRG1;SEMA6A;SRGAP2;COL3A1;NEXMIF;SEMA3A;ARHGEF2;CTNNA2;DAB2IP;PLAA;NTNG2;NTNG1;SHTN1;ULK4
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.2687332719098742,-0.8952743496639293,0.6457564575645757,0.9594582505393136,1.0,4/29,10.71%,TGFBR3;NOTCH1;TPM1;FGFR2
prerank,autophagosome maturation (GO:0097352),0.34371542662467575,0.8951532405568101,0.6221374045801527,0.8855134502815766,1.0,14/32,22.35%,LIX1;GABARAP;GABARAPL1;MAP1LC3A;MAP1LC3B;TECPR1;SNX14;VIPAS39;WIPI2;VPS16;VCP;LAMP2;VAMP8;VMP1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.31018823868883866,0.8951482420007172,0.629418472063854,0.885101164726633,1.0,5/64,7.25%,ALOXE3;ELOVL1;PLA2G4A;FADS1;GPX4
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.39427484129842916,0.8951453482845797,0.6198830409356725,0.8846842791956775,1.0,2/16,5.65%,B4GALNT1;ST8SIA6
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.33372549462542267,0.8951376817126965,0.6408010012515645,0.8842812655738096,1.0,8/38,16.49%,NDUFS6;NDUFB10;NDUFB4;NDUFA10;NDUFA3;NDUFA13;NDUFA5;NDUFV2
prerank,natural killer cell activation (GO:0030101),0.36308171897416697,0.8951119743554923,0.6182336182336182,0.8839080664375887,1.0,3/23,12.11%,BAG6;PTPRC;TOX
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.4265690912027814,0.8944064939932156,0.5913621262458472,0.884812104831414,1.0,3/10,15.17%,PRKCH;NCOA3;MED1
prerank,cellular response to interleukin-12 (GO:0071349),0.3170074231083315,0.8939434381730313,0.6278787878787879,0.8853166029115505,1.0,13/48,21.19%,LMNB1;LCP1;SIRPA;SNRPA1;MSN;ANXA2;P4HB;PITPNA;SOD2;RAP1B;JAK1;CDC42;HNRNPA2B1
prerank,negative regulation of histone modification (GO:0031057),-0.3365861901854996,-0.8939361535828587,0.6186186186186187,0.9610724907573702,1.0,7/14,28.98%,NOC2L;CTBP1;JARID2;TAF7;BRCA1;SPHK2;THAP7
prerank,mitotic cytokinesis (GO:0000281),0.3222648634335716,0.8936824447516786,0.6254635352286774,0.8854181457299788,1.0,13/47,17.72%,EFHC1;EFHC2;RHOB;PDCD6IP;SNX33;BBS4;ARL3;USP8;CIT;MYH10;TRIM36;APC;TTC19
prerank,organic hydroxy compound transport (GO:0015850),0.3372111298770823,0.8936754660988023,0.6357868020304569,0.8850062813914227,1.0,7/36,16.45%,ATP8B1;SLC16A1;STARD5;SLC5A3;RALBP1;OSBP;RXRA
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.33300443731142854,0.8936140071610359,0.6245210727969349,0.8847052844400615,1.0,15/38,21.20%,TANK;NLRC3;OTUD7B;SIRT1;PYCARD;TNIP1;RORA;TNFAIP3;RIOK3;PER1;ZC3H12A;NLRX1;PPM1B;ESR1;DAB2IP
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.3375017436431514,-0.8934244696333545,0.5568513119533528,0.960642238850393,1.0,4/14,11.00%,IRS2;IRS1;PPARGC1A;AKT2
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.3494351072978813,0.8932454911796244,0.5978695073235686,0.8850218512603,1.0,9/25,20.39%,STAT3;ACVR1B;ANKRD54;FOXO3;ABCB10;MED1;ETS1;PRMT1;TAL1
prerank,synaptic vesicle transport (GO:0048489),-0.36054407631107155,-0.8929526831959272,0.599476439790576,0.9600283878460298,1.0,5/11,17.31%,SPG11;RAB27A;KIF5C;TMEM230;CDK5
prerank,membrane depolarization during action potential (GO:0086010),0.35731092300995576,0.8927245590001233,0.6170500676589986,0.8855961475608246,1.0,5/26,9.70%,KCNH2;SCN8A;CACNA1G;KCNJ2;SCN1B
prerank,response to laminar fluid shear stress (GO:0034616),0.4187077671784314,0.8926642795710156,0.5916666666666667,0.8852918206285038,1.0,1/10,1.39%,NFE2L2
prerank,cellular response to estradiol stimulus (GO:0071392),0.37867809073742364,0.8925211620286646,0.6086956521739131,0.8851323208600662,1.0,4/18,21.78%,KAT5;NCOA3;ESR1;NRIP1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.3566614615725637,-0.8922211414325587,0.6114130434782609,0.9600288195782797,1.0,4/12,10.06%,STX2;SNAP23;SNAP25;SNAP29
prerank,stem cell differentiation (GO:0048863),-0.24963194659059973,-0.8921849861450205,0.693069306930693,0.9583112431087719,1.0,16/39,32.27%,LRP6;MLLT3;FGFR2;NELFB;HTR2B;PUM1;JARID2;BATF;TGFB2;KIT;MTF2;HOXB4;HMGA2;SETD2;EEF1AKMT4-ECE2;FOXO4
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.4028807263137378,0.8919349704975045,0.6018808777429467,0.8859157511466529,1.0,2/12,9.27%,APOD;F3
prerank,regulation of microtubule depolymerization (GO:0031114),0.35885130944210897,0.8918013085174155,0.603021978021978,0.8857486635467825,1.0,3/25,3.30%,MAP1S;MID1IP1;FGF13
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.41733847620474307,0.8916143020272679,0.6086956521739131,0.8856774603533037,1.0,3/11,15.03%,MAP2K1;DDX5;IL6
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.3576438492756801,0.8915177850750755,0.6073369565217391,0.8854347930364544,1.0,4/24,17.67%,PLA2G4A;LPCAT1;PNPLA8;CRLS1
prerank,neural tube closure (GO:0001843),0.3424262291263711,0.8915071378738614,0.6361355081555834,0.8850377526478101,1.0,10/34,19.27%,DVL2;MTHFD1L;PRICKLE1;BBS4;SEMA4C;SCRIB;PAX2;KDM2B;COBL;TSC2
prerank,microtubule nucleation (GO:0007020),0.37187107766339894,0.8913431804566969,0.5985915492957746,0.884934297635568,1.0,6/20,17.08%,NDEL1;TUBGCP5;TUBGCP6;AKAP9;TUBGCP4;CSNK1D
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3177326162009667,0.8908629150838365,0.6462427745664739,0.8854284693380952,1.0,10/52,11.29%,ARIH2;FZD5;BID;RHOU;MAPK8;UBE2D3;NPEPPS;RNF31;BAD;UBE2L3
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.3710305635679706,0.890610612753738,0.6051502145922747,0.8854743628761416,1.0,3/20,10.90%,BCL2L1;BCL2L2;CASP9
prerank,secretory granule organization (GO:0033363),0.43290476631296504,0.8905609162357226,0.6161290322580645,0.8851468010288519,1.0,1/10,1.96%,SRGN
prerank,membrane assembly (GO:0071709),0.339802807595787,0.8903048534916359,0.6078431372549019,0.8852086034426587,1.0,7/34,12.12%,TLCD2;VPS4A;PICALM;FLOT2;LRP4;PTPRD;ANXA2
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.40685666084191513,0.8902686501077951,0.6178736517719569,0.884862205336915,1.0,1/13,1.39%,NFE2L2
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.39273911769978037,0.8902223397378767,0.6178247734138973,0.8845289749021967,1.0,1/15,1.41%,AMDHD2
prerank,mitotic cell cycle phase transition (GO:0044772),0.2814728935949422,0.8901503928649481,0.7373225152129818,0.884250360390888,1.0,49/204,20.84%,MYC;FBXL15;BRSK1;SFI1;CUL3;SSNA1;UBE2S;FBXW11;NASP;FBXL3;DNM2;PPP1CB;CSNK1E;BRSK2;CDK6;LATS1;FBXL8;ACVR1B;PPP2R2D;TUBB;HAUS8;AKAP9;CTDP1;DCTN3;RCC1;PAFAH1B1;FBXL17;OPTN;CEP250;CUL2;EIF4E;SKP1;LCMT1;CUL4A;CSNK1D;ANAPC7;PPP1R12B;ACVR1;DCTN1;PLK3;PPP2R2A;ODF2;TUBB4A;CCND1;HAUS3;ACTR1A;SDCCAG8;CRLF3;EIF4EBP1
prerank,regulation of viral genome replication (GO:0045069),0.31214189618638655,0.890032847671527,0.6474056603773585,0.8840593438102764,1.0,11/56,15.28%,ILF3;TARBP2;EIF2AK2;IFITM3;PARP10;CNOT7;DDB1;TNIP1;SRPK2;FAM111A;ADARB1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.28728539228563627,0.8898892619712783,0.680672268907563,0.8839395262185662,1.0,32/129,20.59%,FBXL15;BRSK1;SFI1;SSNA1;FBXW11;FBXL3;DNM2;PPP1CB;CSNK1E;BRSK2;LATS1;FBXL8;TUBB;HAUS8;AKAP9;DCTN3;PAFAH1B1;FBXL17;OPTN;CEP250;SKP1;LCMT1;CSNK1D;PPP1R12B;DCTN1;PLK3;PPP2R2A;ODF2;TUBB4A;HAUS3;ACTR1A;SDCCAG8
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.32677682344780395,0.8898654037718462,0.6402048655569782,0.883576300997932,1.0,4/39,11.28%,MYRIP;TCF7L2;GLUD1;BAD
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.3478773605700951,0.8892107510312539,0.6263440860215054,0.8844141868427232,1.0,4/29,8.46%,SHANK1;LIMA1;PFN1;CYRIB
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.38666439930296065,0.8891592509496126,0.6235294117647059,0.8840949118547077,1.0,3/16,5.65%,NCOA4;DDX54;EGLN2
prerank,regulation of superoxide anion generation (GO:0032928),0.3989739913713788,0.8890996471216623,0.5960960960960962,0.8837808595503192,1.0,1/14,2.30%,TYROBP
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.31217487696394486,-0.8890917025531369,0.6111111111111112,0.9643100091549135,1.0,9/17,31.70%,NLGN1;RAB27A;STX1A;KCNB1;SLC4A8;UNC13D;RAB3A;SCAMP5;CACNA1I
prerank,positive regulation of coagulation (GO:0050820),0.4315110659254768,0.8889877460679456,0.6152512998266898,0.8831664263724623,1.0,1/10,2.70%,SERPINE1
prerank,positive regulation of hemostasis (GO:1900048),0.4315110659254768,0.8889877460679456,0.6152512998266898,0.8831664263724623,1.0,1/10,2.70%,SERPINE1
prerank,regulation of osteoblast differentiation (GO:0045667),0.2979836386660407,0.8884630842596877,0.6644444444444444,0.8837488893608639,1.0,17/82,15.26%,BAMBI;SOX9;ATF4;CRIM1;TRPM4;CDK6;BMP6;RUNX2;DDR2;ACVR2B;ATP6AP1;IGF1;DDX5;IL6;HGF;WWTR1;LRP5
prerank,rRNA transcription (GO:0009303),0.40000196281662104,0.8882957452505194,0.6380090497737556,0.8836316323336455,1.0,4/17,12.20%,GTF3A;NIFK;GTF3C2;GTF3C5
prerank,atrial septum morphogenesis (GO:0060413),-0.36860107552200627,-0.888277279696442,0.5873417721518988,0.9646130495973202,1.0,3/10,21.68%,BMPR2;SOX4;TGFB2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.40988829528927406,0.8878519774817173,0.6092814371257484,0.8840969386251508,1.0,3/12,11.58%,TAPT1;ANKRD13C;HSPA5
prerank,metal ion export (GO:0070839),0.34364096588692494,0.8873537224736989,0.6315104166666666,0.8846074604137008,1.0,6/31,20.09%,KCNH2;ATP1B1;SLC11A1;ATP1A3;SLC9A1;ATP2B4
prerank,cAMP-mediated signaling (GO:0019933),-0.28073590148961486,-0.8870214268299615,0.6141732283464567,0.966014259621932,1.0,7/24,16.30%,EPHA5;PDE7B;ADCY2;RIMS2;KSR1;ADCY1;PDE4D
prerank,steroid catabolic process (GO:0006706),0.43181021799116676,0.8869285489063987,0.6025641025641025,0.8850041644253658,1.0,1/10,5.63%,SPP1
prerank,membrane organization (GO:0061024),0.27953998866133123,0.8862930808713434,0.7505070993914807,0.8857717431445211,1.0,46/227,17.26%,CORO1C;NAPA;DVL2;TLCD2;VPS4A;TMEM33;LEMD2;NEMP1;PICALM;RIMS1;PDCD6IP;ARPC2;HSPA8;DNM2;RPS27A;UBC;GCA;PACSIN2;PPT1;AP2A1;STAM;ARPC3;SUN2;SYP;CLTC;CTDNEP1;ACTG1;ARRB1;EPS15L1;SCARB2;OCRL;MTCH1;LEMD3;SAR1B;ADRB2;SYT1;ARPC5;REPS1;USO1;ACTB;AP2M1;CCDC88A;EPN1;NPC1;TOR1B;PICK1
prerank,sphingolipid catabolic process (GO:0030149),0.39639335317814417,0.8861918205904691,0.6286127167630058,0.8855440117353783,1.0,7/15,23.93%,PPT1;SMPD1;SMPD4;SGPL1;ASAH2;SMPDL3A;ENPP2
prerank,regulation of cell-cell adhesion (GO:0022407),0.3232094312084731,0.886029287859504,0.6208651399491094,0.8854580914737696,1.0,6/39,11.02%,ADAM8;CELSR2;FLOT2;JAG1;PTPRR;GTPBP4
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.4219192961576721,0.8852969937192692,0.6238390092879257,0.8864055814625555,1.0,3/10,14.64%,BMP6;PPM1F;NEXMIF
prerank,negative regulation of histone methylation (GO:0031061),-0.3760556590675422,-0.8852577074106427,0.6005089058524173,0.9687100036244197,1.0,6/10,25.91%,WDR5;JARID2;MTF2;DNMT3B;BRCA1;DNMT1
prerank,regulation of vasoconstriction (GO:0019229),0.3515729675586621,0.8851791474822998,0.625503355704698,0.886209690680046,1.0,4/27,11.08%,AGT;TRPM4;KCNMB2;ZDHHC21
prerank,regulation of cellular response to heat (GO:1900034),0.30257384832754447,0.885095694491428,0.6792452830188679,0.8859518453004458,1.0,14/77,11.17%,MAPKAPK2;NUP153;HSP90AB1;NDC1;HSPA8;PTGES3;CAMK2G;NUP88;SIRT1;IER5;CREBBP;BAG1;NUP210;NUP37
prerank,apical junction assembly (GO:0043297),0.31589379190674927,0.8845422938939569,0.6526442307692307,0.8865926143552402,1.0,3/53,4.74%,WDR1;MARVELD2;PDCD6IP
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.34456144950350126,-0.8844475426252247,0.6323119777158774,0.9690612633331122,1.0,4/12,13.93%,ATP1B3;WNK2;WNK3;ATP1B2
prerank,cellular defense response (GO:0006968),0.3278422025717054,0.8843416026386529,0.6473429951690821,0.8865367118199677,1.0,6/40,11.82%,TYROBP;RELA;PTK2B;NCF2;ZNF148;CCR5
prerank,digestive tract development (GO:0048565),0.341090649183883,0.8842765206352075,0.6269430051813472,0.8862473165009617,1.0,1/33,0.11%,NPY
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.30099099621194586,0.8841755641616597,0.6495535714285714,0.88602753812636,1.0,17/76,15.10%,CUL3;FAM107A;PTTG1IP;PRICKLE1;TANK;UBE3A;DCUN1D1;UBE2D1;PSMD10;RIPK2;UBE2L3;DERL1;TNIP1;STUB1;WFS1;TBC1D7;FBXO4
prerank,protein mannosylation (GO:0035268),0.36213708383878507,0.8839993374535094,0.6323529411764706,0.8859500110991556,1.0,6/22,16.03%,FKRP;DPM1;DPY19L3;DPY19L4;DPM2;RXYLT1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.3854140770080905,0.8839179428407542,0.6158273381294964,0.8856939830535169,1.0,4/17,12.49%,DERL2;SEL1L;HM13;DERL1
prerank,regulation of TOR signaling (GO:0032006),0.30845117577262327,0.8838641830045576,0.6591422121896162,0.8853733322377134,1.0,20/67,19.27%,RRAGC;RICTOR;NPRL2;ITFG2;TMEM127;SIRT1;UBR1;LARS1;RHEB;DGKQ;NPRL3;TBC1D7;FLCN;UBR2;PDCD6;PIH1D1;RPTOR;ARAF;PRKAA1;TSC2
prerank,myeloid cell development (GO:0061515),0.37116747791741533,0.88376074210875,0.6217765042979942,0.88515193238213,1.0,6/18,15.17%,NRROS;FOXP1;ANXA2;APP;ABCB10;MED1
prerank,regulation of phosphate metabolic process (GO:0019220),0.3865966274139764,0.8835496860748783,0.606508875739645,0.8851363471017677,1.0,4/16,15.44%,IKBKB;SMG7;SIRT2;PGAM1
prerank,negative regulation of receptor binding (GO:1900121),-0.374050272560862,-0.8835058239452507,0.6181818181818182,0.9694967755856508,1.0,4/10,40.02%,ATP2A2;HFE;ADAM15;ATP2A3
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.31682116055061516,-0.8831784882744482,0.6452599388379205,0.9684866586710071,1.0,4/16,10.29%,AUTS2;SNW1;PAXIP1;WDR5
prerank,cell cycle G2/M phase transition (GO:0044839),0.2841627202086869,0.8831746166811107,0.6910229645093946,0.8854699536720114,1.0,33/130,20.59%,FBXL15;BRSK1;SFI1;SSNA1;FBXW11;FBXL3;DNM2;PPP1CB;CSNK1E;BRSK2;LATS1;FBXL8;TUBB;HAUS8;AKAP9;DCTN3;PAFAH1B1;FBXL17;OPTN;AKAP8L;CEP250;SKP1;LCMT1;CSNK1D;PPP1R12B;DCTN1;PLK3;PPP2R2A;ODF2;TUBB4A;HAUS3;ACTR1A;SDCCAG8
prerank,protein targeting to ER (GO:0045047),0.29628572855912527,0.8829451480440684,0.6995614035087719,0.8854766265816443,1.0,28/99,20.80%,RPL31;RPS15;RPL3;SRP72;RPL13A;RPL15;RPL10;RPS8;RPS27A;RPL9;RPL22;RPS21;RPL23A;RPL34;RPSA;RPS14;RPL27;EDEM1;RPL8;RPS24;RPL38;RPL27A;RPLP1;RPL17;RPL23;RPS11;RPS26;RPL36
prerank,regulation of catabolic process (GO:0009894),0.3753148334186487,0.8828371563543115,0.6246376811594203,0.8852599689897779,1.0,4/18,8.78%,TMEM9;ZDHHC7;CENATAC;FURIN
prerank,determination of left/right symmetry (GO:0007368),-0.25221437738915814,-0.8823909867056353,0.6822916666666666,0.9686594171501643,1.0,21/37,43.86%,OFD1;NOTCH1;MEGF8;BBS7;PKD2;NPHP3;DAND5;GALNT11;CCDC39;CITED2;DNAH11;ENKUR;DNAH5;MKKS;ODAD2;CCDC40;ODAD4;STIL;CFAP53;FOXJ1;RFX3
prerank,ceramide metabolic process (GO:0006672),0.32085825401699125,0.8821141886424593,0.6495925494761351,0.8862038707543862,1.0,6/49,8.49%,ALOXE3;SPTSSA;DEGS1;SGMS1;CLN8;SMPD1
prerank,negative regulation of insulin secretion (GO:0046676),0.3831288101312008,0.8820466089252181,0.6179775280898876,0.8859282594221695,1.0,3/17,10.29%,MIDN;PIM3;KLF7
prerank,ganglioside biosynthetic process (GO:0001574),0.3933382944388435,0.8819112930660415,0.624251497005988,0.8857607665241047,1.0,3/15,11.12%,B4GALNT1;ST8SIA6;B4GALT5
prerank,C4-dicarboxylate transport (GO:0015740),0.3990522147103479,0.8818748287681495,0.6326530612244898,0.8854122840667517,1.0,4/14,17.61%,LRRC8D;SLC25A13;SLC1A1;SLC25A14
prerank,regulation of multicellular organismal development (GO:2000026),0.35503112795891556,0.8818494707540799,0.6395663956639567,0.8850422807666714,1.0,1/25,0.41%,BAG6
prerank,tight junction assembly (GO:0120192),0.3185917782408193,0.8818168719778751,0.644927536231884,0.8846905723686265,1.0,5/49,10.21%,MARVELD2;LSR;PDCD6IP;ACTG1;CLDN11
prerank,negative regulation of histone acetylation (GO:0035067),0.42019560187201416,0.8816457910845399,0.6212361331220285,0.8846039824573925,1.0,5/11,19.99%,SET;SIRT1;SPI1;SIN3A;SNCA
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.29520893242939816,-0.8813130265428725,0.6304347826086957,0.969635915235051,1.0,3/22,2.15%,RELL1;MINK1;PJA2
prerank,microvillus organization (GO:0032528),-0.3420209565621509,-0.8810801480113754,0.6311239193083573,0.9683956259705088,1.0,5/13,20.48%,MINK1;RAP2C;FXYD5;RAPGEF6;RAP2A
prerank,regulation of cytokinesis (GO:0032465),0.2994002812059633,0.8806015365682887,0.6860335195530727,0.8861394265644782,1.0,8/78,7.38%,BCL2L1;CUL3;VPS4A;PIN1;PIK3R4;PRPF40A;PIK3C3;BBS4
prerank,regulation of oxidoreductase activity (GO:0051341),0.40798351188258974,0.8804684629781325,0.6400625978090767,0.8859742389016396,1.0,2/13,4.45%,HDAC6;ABL2
prerank,regulation of p38MAPK cascade (GO:1900744),-0.2589123686195992,-0.880189374315426,0.6798029556650246,0.9687211461954465,1.0,4/35,2.15%,CYLD;RELL1;MINK1;PJA2
prerank,entry into host (GO:0044409),0.4027111576017609,0.8800741219657209,0.6194029850746269,0.8862809082057564,1.0,4/13,11.82%,CXCR4;CTNND1;CTNNB1;CCR5
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.3246851130476396,0.8796483295643528,0.6372795969773299,0.8866550641791637,1.0,11/41,15.64%,NUP153;NDC1;ZBTB7A;EIF6;NUP88;NUP210;PRKAG1;NUP37;NUP98;PGAM1;NUP54
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.3218698936916772,-0.8795947603744237,0.595679012345679,0.9665892744947937,1.0,3/15,3.49%,AP3D1;AP3S2;AP3M1
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.3218698936916772,-0.8795947603744237,0.595679012345679,0.9665892744947937,1.0,3/15,3.49%,AP3D1;AP3S2;AP3M1
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.3621720023445464,-0.879415648662035,0.6102150537634409,0.965230225864078,1.0,1/10,0.31%,MLLT3
prerank,positive regulation of neurogenesis (GO:0050769),0.30142437795102206,0.8792271271238096,0.6803097345132744,0.8870066174793395,1.0,12/68,13.81%,ARHGDIA;METRN;PLXNA1;CDKL3;SS18L2;CAPRIN2;CTNNB1;PTPRD;KDM1A;CDKL5;SS18L1;NPTN
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.3176275603602723,-0.8780837846183995,0.6193353474320241,0.9667150587173692,1.0,7/16,36.58%,TNFSF8;FGF10;SOX11;IL27;IKZF3;AHR;CD22
prerank,protein complex oligomerization (GO:0051259),0.29555314239717834,0.8779630296043542,0.6951219512195121,0.8889451039162466,1.0,15/85,13.30%,SHMT2;FUS;NINJ1;LRRC8D;ALS2;PDCD6IP;CARD9;ATL3;EHD4;CPSF6;PYCARD;CUTC;RNF112;KCNC1;ADCY8
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.2982364024164199,0.877906421307394,0.6799091940976163,0.888636882487816,1.0,23/79,20.16%,CTSD;CTSL;DNM2;KLC1;KIF5A;AP2A1;OSBPL1A;CLTC;DCTN3;ACTR1B;AP1M1;SEC24C;SEC24A;SAR1B;AP1G1;KIF3B;DYNC1LI1;AP2M1;RAB7A;DCTN1;DCTN4;KIFAP3;ACTR1A
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.29615819722004916,0.8771737884559879,0.664488017429194,0.8895639509278447,1.0,18/84,14.15%,MAGOH;C1QBP;HNRNPK;HNRNPU;FXR2;LARP7;ZBTB7A;U2AF2;RBM39;SRSF10;NCBP1;SRSF12;HNRNPL;DDX5;SRPK2;FMR1;NUP98;PTBP1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.36184030618886903,-0.8770929891012098,0.6527415143603134,0.9673338625869129,1.0,4/10,16.42%,PID1;ENPP1;GSK3A;SELENOS
prerank,regulation of cellular localization (GO:0060341),0.31943216086372156,0.8768703778531435,0.6439024390243903,0.8897053606477221,1.0,10/46,15.26%,BRSK1;HSP90AB1;TTL;ADCY5;CSNK1E;BRSK2;PPM1F;KDM1A;MAD1L1;LRP5
prerank,positive regulation of phagocytosis (GO:0050766),0.3176382467768913,0.8765526864936105,0.6572481572481572,0.8898780177250397,1.0,6/47,9.33%,CCL2;C4B;SIRPA;RAB31;PTPRC;PYCARD
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.32955194478234684,0.8759543952538059,0.6329923273657289,0.8905856207998724,1.0,9/34,17.96%,TRIOBP;C1QBP;P4HB;CRK;LIMS1;FLNA;RAC1;ILK;CALR
prerank,dorsal/ventral pattern formation (GO:0009953),0.36916085779464014,0.875293112920094,0.6282420749279539,0.8914203789366675,1.0,1/20,0.62%,FBXL15
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.3899356679518224,0.8749756083328871,0.6334841628959276,0.8916141834995248,1.0,2/13,10.92%,TGFBR2;RBPJ
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.4212532999335731,0.8745962373040074,0.6318327974276527,0.8919277892943757,1.0,1/10,1.39%,NFE2L2
prerank,melanosome localization (GO:0032400),0.3621165986062072,0.8745109847049287,0.6356164383561644,0.8916742353339764,1.0,3/21,7.38%,BLOC1S6;ARL6;BBS4
prerank,protein import into peroxisome matrix (GO:0016558),-0.34283829172687236,-0.8741564560401694,0.6295264623955432,0.9727782314373068,1.0,6/12,37.68%,PEX6;PEX13;PEX26;PEX10;PEX16;PEX12
prerank,negative regulation of macroautophagy (GO:0016242),0.3424972053006683,0.87410318264819,0.6180081855388813,0.8919913765117324,1.0,4/26,6.07%,NUPR1;LZTS1;RUBCN;MTM1
prerank,regulation of astrocyte differentiation (GO:0048710),-0.3567038339349613,-0.8738921203420499,0.6524064171122995,0.9716246390364098,1.0,4/12,21.55%,BIN1;NOTCH1;ID2;EPHA4
prerank,neurotrophin signaling pathway (GO:0038179),0.3674805222947637,0.8738447488918636,0.6441379310344828,0.8920464636091424,1.0,8/21,21.66%,KIDINS220;BDNF;SOS1;ZFYVE27;SORT1;NTRK2;BCAR1;RAPGEF1
prerank,amino acid transport (GO:0006865),0.31541699860261696,0.873490212276309,0.6634382566585957,0.8922621409452735,1.0,6/49,13.66%,SLC7A5;SLC7A1;SLC3A2;SLC6A6;SLC36A1;SLC38A1
prerank,B cell activation (GO:0042113),0.30005241262596366,0.8734612000558029,0.6765039727582293,0.8919113088078705,1.0,15/68,18.17%,ADAM17;ZBTB7A;GPR183;PTPRC;HDAC5;BLNK;TPD52;TCF3;SLC25A5;GPS2;CD86;FCRL1;HSPD1;PRKCB;MEF2C
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.3282771935860623,0.8731136913098296,0.6492346938775511,0.8921518372762021,1.0,7/36,12.02%,NOSIP;DNM2;APOE;IL1A;GCH1;ZDHHC21;DDAH2
prerank,regulation of programmed cell death (GO:0043067),0.2810788283460974,0.8730431023195637,0.7347150259067358,0.8918830282572051,1.0,28/161,15.86%,PRELID1;CTSB;BEX2;DDX42;AIFM2;LGALS1;BID;SOX9;TARDBP;RTN4;ZBTB7A;AGT;GLS2;DNAJA3;SIRT1;PHLPP1;CREBBP;PTPN6;CHM;CLU;RABGGTB;BCL6;NAE1;WFS1;PAX2;RAF1;DAPK1;LCMT1
prerank,regulation of cell communication (GO:0010646),0.3291374480650681,0.8726362055340657,0.6526181353767561,0.8922462494091489,1.0,6/35,13.54%,CXADR;GLRX2;TSPYL2;CDC42SE2;MTCH1;CRK
prerank,peptidyl-lysine trimethylation (GO:0018023),0.3499805070050199,0.8725358794583837,0.6596306068601583,0.8920165119908124,1.0,8/26,17.70%,KMT5B;TET2;WDR82;KMT2D;KMT2A;SMYD5;TET3;CTR9
prerank,cellular response to topologically incorrect protein (GO:0035967),0.3346295878682562,0.8721116258122898,0.640479360852197,0.8923716651760486,1.0,6/31,13.29%,HDAC6;HSPA8;HSPA5;TMBIM6;OPTN;STUB1
prerank,positive regulation of protein deacetylation (GO:0090312),0.38849984436462764,0.8718324246117082,0.6047548291233283,0.8924551417193395,1.0,5/14,16.00%,FNTA;SAP30BP;ZBTB7B;AKAP8L;DYRK1A
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.4030638116609593,0.8717803682250207,0.6244131455399061,0.892157577569455,1.0,2/11,10.02%,STAT3;IL27RA
prerank,positive regulation of secretion by cell (GO:1903532),0.29785055020610846,0.8716685660660486,0.6640181611804767,0.891969972255517,1.0,15/70,17.90%,ADAM8;ATP13A2;ADAM9;TMED10;CD2AP;IL1A;BMP6;ATP6AP1;CD33;APBB3;IGF1;MYH10;STXBP5;UNC13B;GRK2
prerank,regulation of synapse maturation (GO:0090128),-0.3651152650982723,-0.8716084407628913,0.6534653465346535,0.9751813675536378,1.0,3/10,21.15%,NRXN1;ADGRL1;CAMK2B
prerank,negative regulation of RNA metabolic process (GO:0051253),0.3658921738033998,0.8711150071560837,0.6276747503566333,0.8925815928324375,1.0,8/18,22.98%,PTBP2;TMBIM6;PTBP1;NCOR1;ZC3H12A;RPS26;ESR1;TGFB1
prerank,regulation of double-strand break repair (GO:2000779),-0.2409044408041874,-0.8707154371565557,0.7868852459016393,0.9755425486279988,1.0,18/39,39.22%,FMN2;SPIDR;PML;ZCWPW1;PPP4C;WRAP53;DDX11;TRIP12;MRNIP;RTEL1;SETD2;TIMELESS;MGMT;PPP4R2;RAD51AP1;SIRT6;SLF1;RAD51
prerank,histone lysine demethylation (GO:0070076),0.34070365731007324,0.8705373882821751,0.6316507503410641,0.8932223243036915,1.0,9/25,22.49%,KDM6B;HR;KDM1A;JMJD1C;KDM2B;KDM2A;KDM3B;KDM5C;PHF2
prerank,regulation of actin nucleation (GO:0051125),-0.3461361967135176,-0.8703392909735311,0.6102150537634409,0.9746540380079511,1.0,2/12,4.22%,WASHC5;GSN
prerank,cellular metal ion homeostasis (GO:0006875),0.2892882284336975,0.8703371799312914,0.7035069075451648,0.8932047735509676,1.0,10/102,13.81%,CCL3;ATP13A2;ATP13A1;HTR2C;KCNJ2;ATP1B1;ATP13A3;CCL13;KCNMA1;NPTN
prerank,substrate-dependent cell migration (GO:0006929),0.39106294143037734,0.8703168466135216,0.6456456456456456,0.892832005439676,1.0,4/14,9.03%,SDCBP;VEGFC;CD2AP;PTPRC
prerank,maintenance of protein location in nucleus (GO:0051457),0.36191893424200616,0.8702993768892475,0.6220028208744711,0.8924571880016651,1.0,5/20,10.13%,TAF8;HNRNPU;BBS4;SUN2;RANGAP1
prerank,protein import into mitochondrial matrix (GO:0030150),0.36433056984034873,0.8702074673514958,0.6336633663366337,0.8922193262450271,1.0,4/18,13.53%,DNAJC19;TOMM20;TIMM44;DNAJC15
prerank,negative regulation of synaptic transmission (GO:0050805),-0.2776980143667353,-0.8700571132571615,0.6788321167883211,0.973547772038917,1.0,13/23,39.55%,MTMR2;LRRK2;PTEN;ATAD1;SHANK2;GRIK3;PRRT1;SLC30A1;PLK2;SYT11;CBLN1;IL1B;DRD2
prerank,regulation of adaptive immune response (GO:0002819),0.3720313397104017,0.8696616909227357,0.6534090909090909,0.8928105398809711,1.0,3/18,9.33%,SAMSN1;SIRT1;PYCARD
prerank,catecholamine metabolic process (GO:0006584),0.38384045428765046,0.8691868341727329,0.6409861325115562,0.8932804742262253,1.0,2/14,12.36%,SNCAIP;COMT
prerank,histone lysine methylation (GO:0034968),0.33280436584831513,0.8688226905633383,0.6490322580645161,0.8935214888382533,1.0,9/33,17.83%,DOT1L;CXXC1;SMYD3;WDR82;SETDB1;KMT2B;KMT2D;KMT2A;EZH2
prerank,nucleotide biosynthetic process (GO:0009165),0.3727625703735511,0.8686020937054286,0.6552706552706553,0.8935286514941786,1.0,6/18,18.28%,NMNAT1;PNP;GART;NMNAT2;RRM2B;ADSL
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.4068772104109299,0.8685891394966913,0.644122383252818,0.8931492978440262,1.0,5/11,18.44%,PWP1;IPPK;SMARCB1;MTOR;PIH1D1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.36671738004823373,-0.8685432382371755,0.6613333333333333,0.9754838882700247,1.0,5/10,22.44%,CALM1;SRI;CACNB2;CALM3;NOS1AP
prerank,protein localization to synapse (GO:0035418),-0.3422500216175194,-0.8683684549081632,0.6420765027322405,0.9741271463638302,1.0,4/12,8.31%,NLGN1;NRXN1;PCLO;NRXN2
prerank,protein tetramerization (GO:0051262),0.2969053529853992,0.8683460332636508,0.6720554272517321,0.8931628160173227,1.0,10/67,13.26%,SHMT2;SSBP1;TRPM4;GLS;KCNJ2;CPSF6;ACACA;TRPM2;CUTC;KCNC1
prerank,cardiac ventricle development (GO:0003231),0.3629209825827485,0.8682321716456883,0.6416430594900849,0.89295205480644,1.0,3/20,8.66%,MATR3;MDM4;ENG
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.2746685762742235,-0.8682039310490508,0.6771653543307087,0.9727675437900907,1.0,12/24,30.31%,TAPBP;BCAP31;SEC23A;SEC24D;SEC31A;MFSD6;SEC13;PDIA3;ABCB9;CANX;ERAP1;HFE
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.3143381914040587,-0.867818699922819,0.6295180722891566,0.9719170285983866,1.0,9/15,29.50%,CCT4;TCP1;CCT2;NAF1;CCT5;DKC1;SHQ1;RUVBL1;CCT3
prerank,circulatory system development (GO:0072359),0.28314294347119473,0.8677666070423733,0.7061965811965812,0.8934273068836788,1.0,13/118,11.22%,KDM6B;DVL2;LDB3;CXADR;SOX9;POPDC3;TGFBR1;TGFBR2;PDGFB;CRIP1;MICAL2;SMYD4;TCF25
prerank,regulation of transforming growth factor beta production (GO:0071634),0.37495566194785457,0.8676567448108097,0.6493506493506493,0.893224704199992,1.0,1/18,0.31%,SERPINF2
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.30466865906684104,0.8674083448198443,0.652073732718894,0.893284762847468,1.0,3/56,1.71%,ADAMTS1;ADAM17;CUL3
prerank,hyaluronan metabolic process (GO:0030212),0.35112811522461723,0.86720541176851,0.6504178272980501,0.893225470011763,1.0,3/23,8.58%,GUSB;ABCC5;CEMIP2
prerank,positive regulation of translation (GO:0045727),0.28704081053625835,0.8671806333155402,0.7183098591549296,0.8928664610056753,1.0,19/94,16.59%,C1QBP;HNRNPD;HABP4;CDC123;FXR2;LARP6;LARP4B;EIF6;DHX9;CNBP;NSUN5;YBX3;MRPS27;FMR1;RMND1;MTOR;IL6;POLR2G;YTHDF2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.27458473845246545,-0.8670499999832315,0.6761133603238867,0.9720279236224897,1.0,8/24,17.70%,MAP2K6;CYLD;CASP8;TRAF6;IKBKG;NOD1;MAP3K7;TAB2
prerank,regulation of peptide hormone secretion (GO:0090276),-0.21592118418696285,-0.8668711462009956,0.7540983606557377,0.9707446096175485,1.0,25/67,32.01%,CACNA1D;ITPR2;SLC8B1;CACNA1C;CLOCK;KCNC2;SNAP25;ITPR1;CACNA1E;PPP3CB;ALOX5;SYT7;STX1A;PAX8;KCNB1;HADH;ITPR3;PER2;DPP4;UQCC2;RAPGEF3;HFE;KCNG2;KCNS3;TNF
prerank,regulation of gluconeogenesis (GO:0006111),-0.2739863872705813,-0.8668128783412644,0.6850393700787402,0.9691331945956991,1.0,8/27,22.67%,SDHAF3;PPARGC1A;EP300;ZNF692;USP7;SELENOS;CLK2;SIK1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.38716761325773663,0.8667706432792168,0.6382660687593423,0.8931963185142975,1.0,2/15,4.09%,DERL2;SEL1L
prerank,negative regulation of dephosphorylation (GO:0035305),0.3641681407482537,0.8666335266931274,0.6316568047337278,0.8930365225169499,1.0,3/18,14.22%,INPP5K;GPATCH2;PPP1R16B
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.4123498827325777,0.8664853909752694,0.647244094488189,0.8928877830548351,1.0,2/11,6.19%,PICALM;SNX33
prerank,negative regulation of organelle assembly (GO:1902116),-0.2473203313091038,-0.8662975959065312,0.7655502392344498,0.9685749684396613,1.0,15/35,23.25%,SCFD1;ODF2L;CCP110;TMEM39A;LRRK2;NBDY;CDK10;SMCR8;KAT2B;PHF23;LIMK2;TCHP;TESK1;CHMP4B;CHMP4A
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.2919421299514485,-0.8661053565320844,0.6578073089700996,0.9672832006838269,1.0,11/19,29.87%,DRG1;TPR;VPS4B;CHMP3;CHMP2B;EML3;CHMP1A;CHMP4B;CHMP1B;CHMP2A;CEP97
prerank,positive regulation of DNA binding (GO:0043388),0.33191756231632097,0.8658205048825615,0.6683544303797468,0.8936382822976787,1.0,4/31,12.34%,PLAUR;HMGB1;SIRT2;IGF1
prerank,regulation of mast cell activation (GO:0033003),0.4131055572054562,0.8657924096151982,0.6283891547049442,0.8932780027506101,1.0,1/10,2.60%,CD84
prerank,regulation of Rho protein signal transduction (GO:0035023),0.29770090100402935,0.8657255617593704,0.6918735891647856,0.8929976444827077,1.0,16/72,17.24%,ARHGDIA;CUL3;ABL2;ADGRG1;APOE;ARRB1;COL3A1;LPAR1;RALBP1;RAF1;RAC1;FLCN;MYO9B;ARHGEF3;ARHGEF2;GPR65
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.3060309042669892,0.8651112719761739,0.6839622641509434,0.8936826709760958,1.0,6/59,11.00%,LPL;ACSF3;GATM;ACLY;OSBPL1A;ACACA
prerank,regulation of cellular pH (GO:0030641),-0.2653387602176671,-0.8647875226815533,0.7049180327868853,0.9687790610132039,1.0,5/29,7.73%,SLC4A7;SLC9A9;LACC1;ATP5F1B;SLC9A6
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.28098448472243814,-0.8646123125088864,0.6823104693140795,0.9674731194233708,1.0,11/22,26.99%,GSN;PRKCD;TWF2;ARFGEF1;KANK1;MYADM;SLIT2;PFN2;TMSB10;SSH2;HIP1R
prerank,peptidyl-methionine modification (GO:0018206),-0.3433208770028156,-0.8640306164526884,0.6295264623955432,0.9671289146551276,1.0,3/12,14.21%,METAP1D;NAA15;NAA16
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.20290736275094845,-0.8633509789911195,0.8651685393258427,0.9670370261745608,1.0,45/95,33.02%,HSP90AA1;CNTRL;CKAP5;CEP135;CEP152;OFD1;CCP110;PRKACA;PRKAR2B;CEP70;PCNT;CC2D2A;CEP89;RPGRIP1L;NDE1;DCTN2;CENPJ;MKS1;AHI1;KIF24;HAUS2;CEP78;TUBA1A;CEP63;CEP290;TCTN3;TCTN1;HAUS4;CEP76;YWHAE;HAUS5;DYNC1I2;CLASP1;HAUS1;PPP2R1A;CEP41;CEP97;CEP83;HAUS7;MARK4;IQCB1;TCTN2;TUBA4A;MAPRE1;TMEM216
prerank,calcium ion import across plasma membrane (GO:0098703),0.38831209769293146,0.8630708644086986,0.6398176291793313,0.896973838048716,1.0,3/14,12.09%,CACNA2D1;TRPM2;TRPV2
prerank,response to interleukin-6 (GO:0070741),0.40801683699582636,0.8629236881250109,0.6382978723404256,0.8968303472633566,1.0,4/10,16.56%,RELA;SBNO2;ST3GAL6;NFKB1
prerank,spermatid development (GO:0007286),0.3299496625640181,0.8628131151330494,0.6470588235294118,0.8966127365887367,1.0,2/32,7.38%,IQCG;BBS4
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.2815018234447181,-0.8625252604443873,0.6421052631578947,0.9672985000672865,1.0,8/24,20.92%,NIBAN2;BMPR2;BLM;ZRANB3;RPS3;MSH6;DFFA;ACVRL1
prerank,regulation of cilium assembly (GO:1902017),0.3007221828683867,0.8625203645227066,0.7032332563510393,0.8967394574007154,1.0,17/62,17.52%,TBC1D10B;TBC1D17;USP6NL;DYNLT2B;RABGAP1;CROCC;BBS4;TAPT1;TBC1D30;RABEP2;CDKL5;EVI5L;TBC1D7;CCDC88A;TBC1D22A;TBC1D10A;TBC1D15
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.4153655921722085,0.8623886026905931,0.6221498371335505,0.8961618037809924,1.0,2/10,14.44%,NUPR1;NCOR1
prerank,negative regulation of glycolytic process (GO:0045820),0.4153655921722085,0.8623886026905931,0.6221498371335505,0.8961618037809924,1.0,2/10,14.44%,NUPR1;NCOR1
prerank,ribosomal large subunit assembly (GO:0000027),0.34386383088971934,0.8623390013360038,0.6386666666666667,0.8958306447617346,1.0,4/24,8.93%,RPL3;RPL10;NOP2;RPL23A
prerank,response to histamine (GO:0034776),0.4165513840433914,0.8618968061999983,0.6329113924050633,0.8962264504805474,1.0,2/10,12.36%,GABRB2;DIAPH1
prerank,positive regulation of interleukin-2 production (GO:0032743),0.34796518752519556,0.8616638576510676,0.6495263870094723,0.8962224132089501,1.0,7/25,15.68%,PRKD2;PNP;GLMN;IL1A;PTPRC;CD86;RUNX1
prerank,aspartate family amino acid catabolic process (GO:0009068),0.36134753586251056,0.8616525781069243,0.6509572901325479,0.8958336873229088,1.0,4/19,14.48%,SLC25A21;GOT2;OGDH;GOT1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3225277542241014,0.8615967183570223,0.6687268232385661,0.8955371999465516,1.0,7/38,11.29%,ARIH2;FZD5;RHOU;UBE2D3;NPEPPS;RNF31;UBE2L3
prerank,RNA 3'-end processing (GO:0031123),0.2988377035944654,0.8615641124616836,0.6937354988399071,0.8951910518572715,1.0,10/69,11.36%,MAGOH;MAGOHB;CHTOP;TUT7;U2AF2;SRSF2;U2AF1;NCBP1;FIP1L1;TUT1
prerank,protein hydroxylation (GO:0018126),-0.3227402338648304,-0.8614902383174815,0.6676646706586826,0.9680060353810134,1.0,10/15,37.24%,P3H3;PLOD3;VPS33B;PLOD2;HIF1AN;P3H2;JMJD4;PLOD1;P3H1;P3H4
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.3400639691602144,-0.8614604427728781,0.6265060240963856,0.9663643299537202,1.0,5/13,8.97%,MOV10;GTPBP1;NUDT21;PRR5L;ZC3HAV1
prerank,signal transduction in response to DNA damage (GO:0042770),0.30560583307954414,0.8614309361116272,0.681087762669963,0.895015644850463,1.0,6/49,10.90%,SESN2;BID;DOT1L;MDM4;NBN;CASP9
prerank,mitochondrion distribution (GO:0048311),0.399865607116627,0.8608827140505324,0.6468797564687976,0.8956135738807389,1.0,4/12,16.96%,MTM1;TRAK1;ARMC1;MEF2A
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.3324140630775161,0.8605574429484156,0.6627140974967062,0.8958054999880255,1.0,7/30,17.24%,ADGRG1;ARRB1;COL3A1;LPAR1;RAC1;ARHGEF3;GPR65
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.4088411349183842,0.8602987230852883,0.646964856230032,0.8958665473834794,1.0,1/10,3.98%,HDAC6
prerank,smoothened signaling pathway (GO:0007224),0.32998706084084184,0.8602491162026551,0.6584415584415585,0.8955595644011642,1.0,2/32,5.58%,DISP3;ULK3
prerank,ganglioside metabolic process (GO:0001573),0.3600309160178019,0.8602138554135782,0.6534653465346535,0.89522138380303,1.0,2/20,5.65%,B4GALNT1;ST8SIA6
prerank,retinol metabolic process (GO:0042572),-0.32097931057468254,-0.8599834460492831,0.6436781609195402,0.9681624874264291,1.0,8/14,52.15%,RDH10;DHRS3;RBP4;RETSAT;CYP1A1;DHRS9;CYP1B1;RDH12
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3936806540192467,0.8598368411634092,0.6682389937106918,0.8954863890182737,1.0,2/13,8.53%,NOP14;RPS21
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.3630561019350327,-0.8597540797064747,0.634020618556701,0.9669390681073764,1.0,1/10,0.06%,NCKAP1L
prerank,tRNA transport (GO:0051031),0.32173611485444736,0.8596422986922148,0.6784363177805801,0.8954371787448223,1.0,9/35,15.64%,NUP153;NDC1;TOMM20;NUP88;YBX1;NUP210;NUP37;NUP98;NUP54
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.3075044252416045,0.8596359763458195,0.6818181818181818,0.8950464973865492,1.0,13/46,20.00%,ADAM17;LAMA4;ATF4;ALDH1A1;RHEB;ACVR2B;RBPJ;TLE3;LGR4;FLCN;DDIT3;ACOT13;TFE3
prerank,endochondral bone morphogenesis (GO:0060350),-0.34919658169537204,-0.8592586053192729,0.6504065040650406,0.9663940526298056,1.0,8/11,45.01%,BMPR2;TMEM119;TRPV4;FGFR3;FOXC1;COL13A1;SCX;BMP4
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.3384920301667553,-0.858805062387895,0.628099173553719,0.9657466235502524,1.0,3/12,6.98%,PRPSAP2;HPRT1;MTHFD1
prerank,multivesicular body organization (GO:0036257),0.3301720516923323,0.858692868819762,0.6688144329896907,0.8962959239245593,1.0,5/31,9.05%,VPS4A;VPS28;PDCD6IP;VPS37B;STAM
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.22931845653341829,-0.8585163273793832,0.75,0.964702978145615,1.0,9/50,8.22%,CAAP1;XIAP;GAS6;RFFL;PAK2;SH3RF1;CSNK2A1;ARL6IP1;DNAJB6
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.3816629100987168,0.8584083079600086,0.6226415094339622,0.8963879632186873,1.0,4/13,19.84%,IPO5;KPNA2;NUP54;RANBP2
prerank,anterograde axonal transport (GO:0008089),-0.24239345858939984,-0.8582215258739136,0.7230769230769231,0.9636690282973553,1.0,9/37,16.10%,DLG2;KIF3A;AP3D1;AP3S2;AP3M1;KIF5C;RAB27B;BLOC1S2;SOD1
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.25706508284038543,-0.8580190185769323,0.7125984251968503,0.962450686564254,1.0,9/30,23.69%,ACSL1;HACD4;ABCD3;ABCD2;ACSL6;ELOVL5;ELOVL4;ACOX1;SLC27A4
prerank,"phagocytosis, engulfment (GO:0006911)",0.3224464975881292,0.8575086901219241,0.6737766624843162,0.897612716505024,1.0,13/36,21.37%,MYH9;RHOG;XKR8;GULP1;SH3BP1;FCGR1A;RAC1;ARHGAP25;ELMO1;ITGB2;ADGRB1;CDC42;RHOBTB1
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.37313233500357895,0.8573546731916581,0.6681481481481482,0.8974896147338867,1.0,3/17,11.08%,ADD1;IKBKB;ZDHHC21
prerank,cellular component disassembly (GO:0022411),0.30591204780017545,0.8570730620438676,0.6945754716981132,0.8976338887537288,1.0,9/53,17.05%,LCP1;ADAM8;CTSL;NOXO1;FURIN;SCUBE1;FLOT1;TMPRSS6;ADAMTS4
prerank,phosphatidylserine metabolic process (GO:0006658),0.3290880441093319,0.8569879852502255,0.6520051746442432,0.8973822267815104,1.0,4/32,10.29%,PLA2G4A;SERINC1;PTDSS2;OSBPL8
prerank,T cell proliferation (GO:0042098),0.392407428030518,0.8565612244407236,0.6524486571879937,0.8977256380804776,1.0,4/13,17.87%,CADM1;MSN;SLC11A1;PIK3CG
prerank,muscle cell development (GO:0055001),-0.2576125569844159,-0.8563178239808676,0.7058823529411765,0.9647471752924773,1.0,9/30,21.64%,SGCZ;ANK2;BIN1;SLC8A1;MEGF10;NEBL;NRAP;VEGFA;MYOF
prerank,positive regulation of axon extension (GO:0045773),0.35170010350734193,0.8560528599402997,0.6588720770288858,0.8981748516816139,1.0,7/22,16.37%,RUFY3;DSCAM;GOLGA4;CDKL5;LIMK1;DBNL;ZFYVE27
prerank,sphingoid metabolic process (GO:0046519),0.3976271390735041,0.855888938580041,0.6696969696969697,0.8980391584776337,1.0,1/12,1.79%,SGPP2
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.32057877578170296,-0.855075001905437,0.6808510638297872,0.9658994689449414,1.0,5/16,15.83%,NIPBL;MAU2;PDS5B;SMC1A;RB1
prerank,midbody abscission (GO:0061952),0.36867583280269617,0.8549140856146858,0.6598540145985401,0.8993985261603371,1.0,2/17,4.74%,VPS4A;PDCD6IP
prerank,calcium ion import into cytosol (GO:1902656),0.3780583841084396,0.8546788662703994,0.644542772861357,0.8993945171319668,1.0,3/15,12.09%,CACNA2D1;TRPM2;TRPV2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.34951964918440837,0.8544728903734339,0.6361111111111111,0.899359249025118,1.0,4/22,7.92%,FKBP1B;IKBKB;MGAT5;CRY2
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.2928280278932398,0.8542106672215882,0.6947743467933492,0.899397703360199,1.0,21/62,18.93%,POLR2J;PCID2;GTF2H4;ELOA;ELL;CCNK;IWS1;NCBP1;ERCC2;CTDP1;GTF2F2;CDK12;POLR2E;POLR2B;CCNT1;POLR2G;ELP2;CTR9;TCEA1;CDK9;POLR2K
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.3414347397205084,0.8539654337865624,0.6875834445927904,0.8994025576871346,1.0,8/26,18.68%,ALG11;GBGT1;ST8SIA6;B4GALT5;TNIP1;TKT;RRM2B;ALG8
prerank,glycerol metabolic process (GO:0006071),0.4122146002988959,0.85393375122813,0.627287853577371,0.8990569877118081,1.0,1/10,1.58%,TKFC
prerank,response to retinoic acid (GO:0032526),0.3041227395594526,0.8538171101320072,0.6989737742303307,0.8988547185314874,1.0,11/59,17.28%,WNT5B;SOX9;ABL2;PTK2B;EPHA3;SETX;NDUFA13;CREB1;PAX2;RXRA;HTRA2
prerank,negative regulation of multicellular organismal process (GO:0051241),0.26792168305313024,0.8526368541386435,0.7814096016343207,0.9004995445923711,1.0,34/199,19.03%,BMP5;CORO1C;ADAM17;LAMA4;SRGN;SOX9;ATF4;ADIPOR1;USF3;LRP4;SPI1;PTPRR;KLF7;ALDH1A1;RHEB;ACVR2B;RBPJ;HPN;PTPRO;WWC2;NPTN;TLE3;SLC11A1;LGR4;FLCN;HS3ST5;PROC;GPNMB;CALR;DDIT3;MEF2C;LDLRAD4;GJA1;ACOT13
prerank,positive regulation of actin filament polymerization (GO:0030838),0.3161352418042543,0.8526087083811237,0.6921182266009852,0.9001520863872392,1.0,8/44,10.78%,NCK1;PFN1;BAIAP2L1;NCKAP1;CDC42EP3;PTK2B;PYCARD;BAIAP2
prerank,diol biosynthetic process (GO:0034312),-0.3179368815359017,-0.8525399197958986,0.6591639871382636,0.9700328253314974,1.0,7/15,32.59%,SPTLC2;ASAH1;ACER3;SPHK2;SPTLC1;ACER2;DHFR
prerank,regulation of supramolecular fiber organization (GO:1902903),0.3438303076092324,0.8525255290390389,0.6742532005689901,0.89989192099518,1.0,3/22,5.51%,MAP1S;HSPA8;APOE
prerank,androgen receptor signaling pathway (GO:0030521),0.3985719176600034,0.8523017434437213,0.6288492706645057,0.8998858491874523,1.0,5/11,22.88%,ZMIZ1;DDX5;PLPP1;DDX17;RNF14
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.36510800301245466,0.852279003201087,0.6578947368421053,0.8995307603224323,1.0,1/18,0.87%,KCNH2
prerank,negative regulation of cellular catabolic process (GO:0031330),0.29641928026305203,0.8520473180118934,0.7031431897555297,0.8995415774100947,1.0,12/63,15.71%,STAT3;NUPR1;RUBCN;APOC1;SORL1;SIRT2;RIC1;EIF4G2;MTOR;HGF;EIF4E;FOXK2
prerank,'de novo' posttranslational protein folding (GO:0051084),0.3288510201520217,0.8519507340417153,0.6610824742268041,0.8993118611419505,1.0,9/30,19.94%,HSPA8;PTGES3;ST13;BAG1;HSPA5;ENTPD5;SDF2;GAK;DNAJC18
prerank,male meiosis I (GO:0007141),-0.3033045048790274,-0.8518413289932273,0.6567164179104478,0.969954549394778,1.0,8/16,47.07%,ZSCAN21;ING2;MYBL1;FOXJ3;DDX4;SYCP3;BRDT;HSF2BP
prerank,SNARE complex assembly (GO:0035493),0.4035257021296322,0.8516754485493604,0.6502463054187192,0.8993673217141125,1.0,5/10,23.83%,VAMP1;SNCA;STXBP6;VAMP8;UVRAG
prerank,GTP metabolic process (GO:0046039),-0.31678470828799443,-0.8507092673051008,0.6795252225519288,0.9708457468093046,1.0,6/15,22.15%,MFN1;GTPBP1;LRRK2;AK3;RAB23;OPA1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.3252968392810071,0.8502630481734795,0.6918075422626788,0.9014250132554987,1.0,10/32,19.99%,CLIP3;MID1IP1;FGF13;DYRK1A;APC;ARHGEF2;TTBK2;TUBB4A;FKBP4;SNCA
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.35536743184406094,0.8499819933693736,0.667144906743185,0.901113977262416,1.0,6/21,16.26%,DDB2;GTF2H4;CHD1L;ERCC2;DDB1;CUL4A
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.35536743184406094,0.8499819933693736,0.667144906743185,0.901113977262416,1.0,6/21,16.26%,DDB2;GTF2H4;CHD1L;ERCC2;DDB1;CUL4A
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.27034032634443084,0.8499518255242965,0.8040816326530612,0.9007714904885126,1.0,53/208,20.41%,LITAF;LTBR;SQSTM1;LGALS1;IKBKB;RELA;NEK6;TANK;TBK1;TMED4;RBCK1;NLRC3;OTUD7B;CARD9;DDX21;SIRT1;PYCARD;RIPK2;CARD16;RNF31;UFL1;CFLAR;MIER1;OPTN;TNIP1;LPAR1;RORA;ROR1;TRAF3;SLC20A1;IKBKE;GOLT1B;MTDH;BRD4;FLNA;TNFAIP3;RIOK3;PER1;PRKCB;ZC3H12A;TRIM5;PPP5C;GJA1;ALPK1;IRAK4;NLRX1;PPM1B;TERF2IP;TRIM8;MAP3K14;NDFIP2;ANKRD17;TMEM106A
prerank,oxoacid metabolic process (GO:0043436),-0.2621422012458254,-0.849925591418045,0.7125,0.9709732314405475,1.0,4/27,4.33%,TPST2;ENPP1;TPST1;BPNT2
prerank,antibacterial humoral response (GO:0019731),-0.30368159127431715,-0.8498111111987661,0.7130177514792899,0.9695801880368861,1.0,4/16,23.71%,DEFA6;RNASE7;RPL39;ANG
prerank,regulation of T cell differentiation (GO:0045580),0.3219844103412214,0.8492807921777759,0.6955974842767295,0.9014888792091021,1.0,7/33,20.63%,PRELID1;ZMIZ1;CLPTM1;RUNX1;KAT2A;ZBTB1;METTL3
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.3783939212048525,0.848582489590832,0.656832298136646,0.902309785357956,1.0,2/13,5.34%,HNRNPU;LARP7
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.28439272856654046,-0.8483564022867908,0.6630434782608695,0.9712224273148587,1.0,7/21,14.10%,BOD1L1;YWHAB;PPP4R4;TIPRL;PPP1R8;GSK3B;PPP1R11
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.3829112289480283,0.8483560447988269,0.6452648475120385,0.9023221081053555,1.0,4/13,18.07%,TAF1;TMSB4X;SIN3A;DDIT3
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.3033271752790863,-0.8481296550183277,0.6697530864197531,0.9700425550477579,1.0,3/17,7.30%,PID1;PARP1;CBFA2T3
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.42137146822968785,0.8477572844367474,0.6709470304975923,0.9030179751203636,1.0,5/10,20.66%,DGKD;PLPP1;PICK1;DGKH;PRKD3
prerank,heart development (GO:0007507),0.2728225989039121,0.8476736322121076,0.7651991614255765,0.9027586146527677,1.0,15/150,11.68%,BMP5;KDM6B;DVL2;LDB3;CXADR;SOX9;POPDC3;TGFBR1;TGFBR2;PDGFB;CRIP1;MICAL2;SMYD4;TCF25;SCUBE1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.29964841135335113,0.8471825666605748,0.70267131242741,0.9027846683873131,1.0,11/56,16.49%,NDUFS6;NDUFB10;TMEM126A;TIMMDC1;NDUFB4;NDUFA10;NDUFA3;NDUFA13;NDUFA5;NDUFAF2;NDUFV2
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.29964841135335113,0.8471825666605748,0.70267131242741,0.9027846683873131,1.0,11/56,16.49%,NDUFS6;NDUFB10;TMEM126A;TIMMDC1;NDUFB4;NDUFA10;NDUFA3;NDUFA13;NDUFA5;NDUFAF2;NDUFV2
prerank,response to ketone (GO:1901654),-0.27284546973921586,-0.847136562643735,0.6985294117647058,0.970585926364027,1.0,11/24,36.31%,TGFBR3;ABCB4;SLIT2;CATSPER2;TGFB2;THBS1;ABHD2;YAP1;CATSPER3;NR1H3;CAV1
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.2897131965989477,0.8470723499586713,0.7053254437869823,0.9025659190607229,1.0,21/64,18.93%,POLR2J;PCID2;GTF2H4;ELOA;ELL;CCNK;IWS1;NCBP1;ERCC2;CTDP1;GTF2F2;CDK12;POLR2E;POLR2B;CCNT1;POLR2G;ELP2;CTR9;TCEA1;CDK9;POLR2K
prerank,microvillus assembly (GO:0030033),-0.3178630538175996,-0.8462797557692177,0.656891495601173,0.9708145830100171,1.0,5/14,20.48%,MINK1;RAP2C;FXYD5;RAPGEF6;RAP2A
prerank,regulation of Ras protein signal transduction (GO:0046578),0.28744279583812027,0.8461355348540739,0.7368421052631579,0.9038079082919565,1.0,9/86,7.30%,ARHGDIA;SQSTM1;DENND3;DENND4B;GABARAP;RASGRF1;ERBIN;KBTBD7;SH3BP1
prerank,regulation of intracellular transport (GO:0032386),0.31515880196549473,0.8460647095203693,0.7054455445544554,0.9035326267527746,1.0,4/38,5.28%,NDEL1;LCP1;ATP13A2;DYNLT2B
prerank,DNA geometric change (GO:0032392),-0.27796465455181973,-0.846038145069513,0.7127272727272728,0.9697225162784678,1.0,12/24,26.77%,MRE11;DDX1;BLM;DNA2;ZRANB3;WRN;RECQL;SUPV3L1;HMGB2;DDX11;RTEL1;RAD50
prerank,protein maturation (GO:0051604),0.2802635310390959,0.845920771165522,0.7351063829787234,0.9033719308291209,1.0,14/95,13.29%,CPXM1;ADAM17;SRGN;NAA60;TSPAN14;ADAM19;SORL1;FURIN;F3;PCSK1;GLRX3;ISCA1;NAA50;STUB1
prerank,negative regulation of leukocyte activation (GO:0002695),0.36953685964522515,0.8453073385546457,0.6551724137931034,0.9040856254660722,1.0,4/15,19.03%,CD84;CD200;ZC3H12A;LRFN5
prerank,atrioventricular valve development (GO:0003171),0.37597094047970286,0.8450883327820606,0.6591251885369532,0.9040726983156141,1.0,2/14,5.39%,MDM4;TGFBR2
prerank,positive regulation of cell development (GO:0010720),-0.25177938523266974,-0.8449861191909659,0.6696035242290749,0.9704959980839784,1.0,13/31,28.44%,NIBAN2;SNW1;OPRM1;MME;TGM2;FAIM;RGS14;CX3CR1;SOX11;NUMBL;TRIM32;SPEN;NAP1L1
prerank,regulation of cell cycle process (GO:0010564),0.27775317745482997,0.844945276927633,0.7616525423728814,0.9039331577729743,1.0,19/104,16.96%,BCL2L1;PIN1;SOX9;TTL;PIK3R4;PRPF40A;PIK3C3;BBS4;USP19;CTNNB1;BIRC6;RCC1;MAD1L1;SND1;CEP250;FLCN;YTHDF2;APC;RPRD1B
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.32361418084672033,0.8447560963876495,0.7003792667509482,0.9038673800658367,1.0,3/33,3.93%,EPHA2;SERPINE1;ADAM9
prerank,aerobic electron transport chain (GO:0019646),0.2926466530072224,0.8445842622563615,0.7105263157894737,0.9037464542278366,1.0,12/68,14.37%,NDUFS6;COX5A;NDUFB10;UQCRC1;NDUFB4;COX7A2L;UQCRB;NDUFA10;NDUFA3;UQCRFS1;NDUFA13;NDUFA5
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.34674516487366286,0.8445319793587173,0.689795918367347,0.9034347979417283,1.0,4/21,10.20%,SH3BP1;CD2AP;CYRIB;SYNGAP1
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.2995462492879169,-0.8444740298753641,0.6666666666666666,0.9699103069075787,1.0,5/18,8.28%,HSP90AA1;FAF1;WDR91;RDX;ATRAID
prerank,positive regulation of T cell migration (GO:2000406),0.3589037886574082,0.844012193337413,0.6822033898305084,0.9039636471192362,1.0,3/20,12.57%,ADAM17;PYCARD;APP
prerank,negative regulation of nuclear division (GO:0051784),0.3975975875921336,0.8437873475695796,0.649671052631579,0.9039540235941279,1.0,2/11,14.67%,TOM1L1;NME6
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.23424797743235534,-0.8431771548726342,0.7745098039215687,0.9711556745047368,1.0,16/41,28.83%,GRIN2B;ITPR2;SLC8A3;SLC8A1;ITPR1;HTR2B;GRIN1;PKD2;PLCG2;FGF2;TRPV4;ITPR3;RYR3;GRIN2D;HTR2A;CHERP
prerank,myeloid cell differentiation (GO:0030099),-0.22983611915454855,-0.8431467621814892,0.810126582278481,0.9695613250913763,1.0,6/47,5.70%,JAK2;IKZF1;NCOA6;ZBTB16;FLVCR1;UBA5
prerank,regulation of exocytosis (GO:0017157),-0.2291118506576233,-0.8431224390286044,0.7658227848101266,0.967951959521512,1.0,11/46,16.27%,RAB5A;RAB27A;RALA;CLASP2;RAB9A;CHMP3;RIMS2;RAB27B;RAB8A;VAMP2;LGI3
prerank,regulation of cell development (GO:0060284),-0.24186215801859626,-0.8416555225646347,0.7586206896551724,0.9696259050464937,1.0,14/36,33.34%,DOCK7;CLOCK;BHLHE41;PRUNE1;HDAC9;CX3CR1;HMGB2;BHLHE40;CX3CL1;PER2;SLAMF8;YAP1;HES6;GRN
prerank,quinone biosynthetic process (GO:1901663),0.37949373487043214,0.8410434104244716,0.6651376146788991,0.9082268445567749,1.0,2/14,4.84%,PDSS2;COQ10B
prerank,detection of mechanical stimulus (GO:0050982),0.3611441561499748,0.841011153819071,0.6865889212827988,0.907877047897554,1.0,4/19,10.55%,JUP;PKD2L2;CTNNB1;PKD1L2
prerank,sodium ion export across plasma membrane (GO:0036376),-0.3279270361481534,-0.8403385769345568,0.6871345029239766,0.9708574754462032,1.0,3/13,13.93%,ATP1B3;ATP1A2;ATP1B2
prerank,positive regulation of histone methylation (GO:0031062),0.33746849673838947,0.8402503228145232,0.6735253772290809,0.9087407310491808,1.0,4/24,9.75%,CHTOP;SIRT1;TET1;CTNNB1
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.251456558998757,-0.8400044936212498,0.7257383966244726,0.9699545240782306,1.0,10/30,19.15%,SPTBN1;GOLPH3L;GOLPH3;KIF13A;GGA3;VAMP5;BBS2;VAMP2;ARFRP1;GGA2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.3917323894997253,0.8399708144715021,0.687402799377916,0.9080256419119852,1.0,3/12,10.22%,CUL3;ANAPC5;DLGAP5
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.3917323894997253,0.8399708144715021,0.687402799377916,0.9080256419119852,1.0,3/12,10.22%,CUL3;ANAPC5;DLGAP5
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.3917323894997253,0.8399708144715021,0.687402799377916,0.9080256419119852,1.0,3/12,10.22%,CUL3;ANAPC5;DLGAP5
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.3464772208521414,0.8399046605218894,0.67578125,0.9077476938133533,1.0,4/22,10.68%,STAC;AKAP6;ATP1B1;STAC2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.34400487377025035,0.8399020065150892,0.6796116504854369,0.9073546136397572,1.0,7/21,19.57%,PRKCH;FOXP1;ELF2;GPS2;RUNX1;PRKCB;SLC39A10
prerank,Notch signaling involved in heart development (GO:0061314),0.3951300668071781,0.8396523990670951,0.6650485436893204,0.9073911408273364,1.0,2/11,10.92%,JAG1;RBPJ
prerank,positive regulation of DNA replication (GO:0045740),0.36195735948026114,0.8396075118452405,0.654490106544901,0.9070841004842919,1.0,6/16,19.17%,PCNA;DHX9;STN1;ATAD5;BRPF3;BCAR3
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.3143469146620689,-0.8395382363693793,0.6783783783783783,0.9693317141814833,1.0,4/14,20.42%,PHACTR4;PRKD1;ITGB1BP1;DMTN
prerank,response to insulin (GO:0032868),0.2835028605026644,0.8393461703014624,0.7294633077765608,0.9071257434779123,1.0,13/80,10.59%,SLC39A14;INPP5K;RAB8B;PIK3R1;EIF6;RAB31;ZBTB7B;SIRT1;SLC25A33;CPEB1;RHOQ;EPM2AIP1;HDAC5
prerank,adipose tissue development (GO:0060612),-0.3439429912377511,-0.8385490083397887,0.672972972972973,0.9699058232519071,1.0,6/11,31.34%,SPTLC2;XBP1;NAMPT;SH3PXD2B;SOX8;DYRK1B
prerank,regulation of microtubule-based process (GO:0032886),0.31236182658499523,0.8383032257568825,0.6987012987012987,0.9085156134980594,1.0,10/36,18.47%,HDAC6;FAM107A;PHLDB1;MEMO1;TRAF3IP1;EPHA3;DIAPH1;TRIM36;APC;PRKAA1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.29794678295833055,0.8381666793017731,0.7263922518159807,0.9079536801678211,1.0,13/50,16.45%,POLR2J;NUP153;NDC1;NUP88;PUM2;NUP210;NUP37;POLR2E;FMR1;NUP98;POLR2B;NUP54;POLR2G
prerank,regulation of gene silencing by RNA (GO:0060966),0.29794678295833055,0.8381666793017731,0.7263922518159807,0.9079536801678211,1.0,13/50,16.45%,POLR2J;NUP153;NDC1;NUP88;PUM2;NUP210;NUP37;POLR2E;FMR1;NUP98;POLR2B;NUP54;POLR2G
prerank,negative regulation of ion transport (GO:0043271),0.3361875769991076,0.8379715775154598,0.6941015089163237,0.9078853258409912,1.0,5/24,19.99%,INPP5K;PTK2B;CD33;GPM6B;SNCA
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.27688771653632993,0.8378008937381284,0.7676874340021119,0.9077855503448473,1.0,36/113,23.17%,DDB2;LCP1;PLEK;WARS1;BID;PSMC4;FNIP2;ASAP1;GTF2H4;GNL3L;SUMO1;CHD1L;ERCC2;CLU;DDB1;STUB1;MED25;TRABD2B;CUL4A;UNC13B;RAP1B;PIH1D1;BMF;VCP;SNCA;TAL1;ESR1;DAB2IP;RPA1;ATM;EIF4G1;ERCC4;SLF2;TGFB1;TTBK1;TIRAP
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.3751431073962054,0.8370981821906339,0.6782477341389728,0.908576058770211,1.0,3/15,11.53%,EIF2AK2;NLRC3;PYDC1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.2982638088511429,0.8369221240360348,0.712378640776699,0.9084628500224546,1.0,13/46,22.15%,LMNB1;LCP1;SNRPA1;MSN;ANXA2;P4HB;PITPNA;SOD2;RAP1B;JAK1;CDC42;HNRNPA2B1;CAPZA1
prerank,nucleocytoplasmic transport (GO:0006913),0.3085889907616779,0.8367644432788096,0.6943396226415094,0.9083506510535813,1.0,17/40,24.84%,DDX20;GEMIN7;NCBP1;NUP98;SNRPG;BACH2;HNRNPA1;SNUPN;SNRPD2;SNRPD1;NEMF;NCBP2;MALT1;XPO1;GEMIN8;NUP205;PHAX
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.352099094775841,-0.8365251799504408,0.6683544303797468,0.9726814229718326,1.0,5/10,20.05%,GABRG3;GABRG2;GABRA5;GABRG1;GABRA1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.3632173666753636,0.8362994103682512,0.6783114992721979,0.9087404541491211,1.0,2/18,4.45%,CUL3;ABL2
prerank,positive regulation of phospholipase C activity (GO:0010863),0.30997275092897086,0.8360231117427456,0.7047146401985112,0.9088103323749908,1.0,6/40,15.46%,PDGFRB;ABL2;BDNF;GNA15;LPAR1;CD86
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.2897955392218932,0.8360089323297176,0.7285223367697594,0.9084432989798549,1.0,12/69,14.37%,NDUFS6;COX5A;NDUFB10;UQCRC1;NDUFB4;COX7A2L;UQCRB;NDUFA10;NDUFA3;UQCRFS1;NDUFA13;NDUFA5
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.3137976547904494,-0.8359911944144682,0.6923076923076923,0.9722043930252985,1.0,6/14,35.02%,DPYD;UMPS;NT5C;DHODH;NT5E;UPP2
prerank,ubiquinone biosynthetic process (GO:0006744),0.3739800469003932,0.8357621418196969,0.6889226100151745,0.908465940585048,1.0,2/15,4.84%,PDSS2;COQ10B
prerank,regulation of viral release from host cell (GO:1902186),0.3488598854644112,0.8354973935217809,0.6685552407932012,0.9084972010384511,1.0,7/21,19.69%,VPS4A;VPS37B;TRIM28;DDB1;TRIM5;TRIM8;TRIM26
prerank,cell cycle G1/S phase transition (GO:0044843),0.2915926164193826,0.8349489424689315,0.7118451025056948,0.909031522441831,1.0,7/61,10.61%,MYC;CUL3;NASP;CDK6;LATS1;ACVR1B;RCC1
prerank,inositol phosphate catabolic process (GO:0071545),0.3848343140248782,0.8349316850123375,0.6845425867507886,0.9086663925765082,1.0,3/12,17.57%,INPP5K;OCRL;INPP5A
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.2549531422125982,-0.8348357522546932,0.7633928571428571,0.9731108455568372,1.0,7/31,16.03%,GPI;KMT5C;PAXIP1;EPHB2;SASH3;XBP1;RIF1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.34175811769740627,0.8343806585829339,0.6824512534818942,0.9091711171496533,1.0,6/23,20.61%,CADM1;RAET1E;AP1G1;SLAMF6;NECTIN2;LAMP1
prerank,purine-containing compound catabolic process (GO:0072523),-0.3196351239155881,-0.834281781587507,0.6563380281690141,0.9726361344148341,1.0,6/13,31.13%,DPYD;GDA;GPX1;ITPA;NT5C;NT5E
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.30770276691467974,0.8340903205542014,0.6998754669987547,0.9092628364765855,1.0,7/38,14.14%,CENPP;NASP;UBN1;HJURP;CENPC;CABIN1;IPO4
prerank,regulation of fibroblast migration (GO:0010762),0.34604727232280663,0.8339333076033533,0.6701183431952663,0.9091085853292622,1.0,1/20,0.26%,CORO1C
prerank,CENP-A containing chromatin organization (GO:0061641),0.3214549784833314,0.8338301861855693,0.6842800528401585,0.908474574571887,1.0,4/29,11.50%,CENPP;NASP;HJURP;CENPC
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.3214549784833314,0.8338301861855693,0.6842800528401585,0.908474574571887,1.0,4/29,11.50%,CENPP;NASP;HJURP;CENPC
prerank,presynapse assembly (GO:0099054),-0.30225341093109204,-0.8329448982015019,0.6928327645051194,0.9738605204081089,1.0,7/16,24.11%,NLGN1;PCLO;PTEN;DVL1;BSN;NLGN2;NLGN3
prerank,cellular response to unfolded protein (GO:0034620),0.32984828217125506,0.8324656097807345,0.6825613079019074,0.9102954081184584,1.0,6/26,16.07%,HSPA8;HSPA5;TMBIM6;OPTN;ABCB10;HSPD1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.35220089201441585,0.8324074345199818,0.6652601969057665,0.9099951470721972,1.0,3/18,7.65%,ADAM17;APOE;ADAM19
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.23852063871115078,-0.8323375009376608,0.7688888888888888,0.9734822031629736,1.0,14/36,22.87%,CYLD;CSNK2A1;CSNK2A2;MAZ;RPS3;TRAF7;TRIM39;RB1;CX3CR1;QARS1;TPD52L1;PPIA;MADD;CX3CL1
prerank,peptide catabolic process (GO:0043171),0.3399602670235706,0.8322484828129731,0.7006711409395974,0.9098712431998877,1.0,5/23,13.52%,TPP1;CHAC2;NPEPPS;DPEP1;IDE
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.2845632665351511,0.8320632811411233,0.7441601779755284,0.9097795737056774,1.0,9/75,9.70%,PLEK;SLC39A14;FNTA;RGS11;ZDHHC7;MRAP2;ZDHHC3;NMT2;SYP
prerank,embryonic eye morphogenesis (GO:0048048),-0.3443134939323925,-0.8315930857724567,0.7046070460704607,0.973435787669001,1.0,1/11,0.09%,LRP6
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.27461465849617317,0.8313175413601812,0.7551240560949298,0.9106102277203206,1.0,11/101,8.55%,PDGFRB;ADAM8;ADAM17;PDGFA;IL34;MAP2K1;PDGFB;RALB;PSMD10;TCIM;SIRT1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.34538015295851626,0.831037474256397,0.691304347826087,0.9106883106714637,1.0,6/21,20.70%,INPP5K;NCK1;PPM1F;CNKSR3;DMD;MLXIPL
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.2963539932285335,-0.8310073351454178,0.677710843373494,0.973080873624059,1.0,7/16,26.31%,PARP9;KMT5C;DTX3L;RIF1;SMCHD1;WRAP53;KDM4D
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.3037225709785053,0.8301650079639886,0.7128834355828221,0.9117270912207173,1.0,8/46,12.62%,AGPAT4;PLA2G4A;ABHD8;DGKZ;DGKD;GPAT4;LPCAT1;DGKQ
prerank,regulation of hydrolase activity (GO:0051336),0.28247794248085834,0.8296659740284646,0.735582154515778,0.9121370890404142,1.0,19/71,19.36%,EPHA1;PLXNA1;TBC1D10B;FBXW11;RABGAP1;FGD1;PAFAH1B1;EPHA3;SCARB2;OCRL;CRK;TDG;RALBP1;GPR137B;TBC1D15;PRKG1;NTRK2;RAB3GAP1;PLXND1
prerank,organelle assembly (GO:0070925),0.25895835694947833,0.8295309974795928,0.8868868868868869,0.9119696877257919,1.0,73/385,17.08%,VPS4A;NEK7;CFAP70;VPS28;CEP126;ATG16L1;GABARAP;ATP6V1D;ATP6V0D1;FLII;WDR19;GABARAPL1;MIS12;HDAC6;ATAT1;EIF2S1;NEK6;ARL6;PDCD6IP;ATG16L2;EDC3;RAB8B;DYNLT2B;VPS37B;ASAP1;PIK3C3;MAP1LC3A;TRAPPC14;BBS4;EXOC5;ARL3;CCDC61;MAP1LC3B;LZTFL1;TUBGCP5;EHD4;HAUS8;STAM;TUBGCP6;TRAF3IP1;EXOC7;DLGAP5;RC3H1;RCC1;SSX2IP;IFT43;CENPC;TTC8;IFT172;RAB32;OCRL;RP2;GORASP2;GBF1;DYNC2H1;CEP250;GOLGA8B;ARF4;WIPI1;NCOR1;FLNA;TUBGCP4;PATL1;IST1;DBNL;KIF3B;VTA1;CFAP43;YTHDF2;ATXN2;POGZ;CORO1A;CSNK1D
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.26645885944850056,-0.8294897258503622,0.7293233082706767,0.9746430277930134,1.0,7/24,16.55%,CALM2;CALM1;PRKACA;SRI;PKD2;PDE4D;CALM3
prerank,positive regulation of heart contraction (GO:0045823),-0.28686327182153104,-0.8293735687317263,0.6920289855072463,0.9733074358337187,1.0,5/19,21.68%,ATP2A2;ATP1A2;GSK3A;ADRA1A;TGFB2
prerank,sensory organ development (GO:0007423),-0.2203523945591605,-0.8292864484166433,0.8356164383561644,0.9718852758671302,1.0,14/51,24.76%,PBX3;PBX1;MAFB;HIPK1;MEIS2;ECE1;AHI1;PAX8;SMCHD1;TGFB2;SMOC1;SH3PXD2B;ZDHHC16;SMG9
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.36314229086769073,0.8286431881708937,0.676923076923077,0.9130322992141912,1.0,3/14,11.58%,TMEM33;UFL1;HSPA5
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.34661435138842345,0.8286067186222494,0.6934306569343066,0.9127013462114272,1.0,8/19,20.94%,ICE2;PRDX5;ELL;POLR3F;MTOR;CEBPA;RPTOR;POLR3G
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.2709269171876517,-0.8282292108802641,0.7220338983050848,0.9724040054078865,1.0,11/22,24.65%,SP100;SUFU;LRRK2;LMAN1;BAG4;RAB23;ITGB1BP1;DMTN;UFM1;PARK7;INSIG1
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.329943353113977,0.8279037369342878,0.6953020134228188,0.9134908114559017,1.0,8/25,16.75%,SDCBP;GLMN;PTGES3;DSCAM;KCTD20;APP;BTBD10;ILK
prerank,cell-substrate junction assembly (GO:0007044),-0.24011606812511743,-0.82782026584559,0.7549019607843137,0.9716129991689506,1.0,13/33,27.51%,TESK2;DST;FERMT2;BCR;ACTN1;PLEC;SRC;SORBS1;ITGA6;CTTN;ACTN2;PIP5K1A;THSD1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.29847522998238085,0.8278006602842122,0.7300613496932515,0.913274435278282,1.0,5/46,9.07%,CCL2;DGKZ;CACNG8;PTK2B;CACNG2
prerank,autophagosome assembly (GO:0000045),0.29422863129855226,0.8277794595300061,0.7321637426900585,0.9129167720812169,1.0,8/52,8.73%,ATG16L1;GABARAP;GABARAPL1;ATG16L2;PIK3C3;MAP1LC3A;SMURF1;MAP1LC3B
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.3524254201084891,0.82768400482191,0.6839762611275965,0.9126882187297103,1.0,4/18,18.69%,TNFAIP8L2;PAG1;GPNMB;DUSP3
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.2756566790541682,-0.8275403155725427,0.7068965517241379,0.9706392644106531,1.0,6/20,22.92%,AKAP13;PDE4D;ADRA1A;ADRA1B;ADRB1;LMBRD2
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.3483122726745408,0.8275036613347638,0.7110799438990182,0.9125841071316609,1.0,4/21,15.18%,RBPMS;TGFBR1;BMP6;WWTR1
prerank,negative regulation of cellular senescence (GO:2000773),0.37291649143969463,0.8273616475889101,0.6974921630094044,0.912433288010871,1.0,3/13,10.69%,CDK6;SIRT1;YBX1
prerank,regulation of interleukin-13 production (GO:0032656),0.37797661235928137,0.8273343926943478,0.700920245398773,0.9120851460287231,1.0,2/13,10.68%,PRKCZ;IL18
prerank,mitochondrial membrane organization (GO:0007006),0.31801662608122794,0.8262798731827427,0.6940874035989717,0.9134695522789337,1.0,6/32,13.64%,MTX1;BCL2L1;BAD;SLC25A5;CHCHD6;TMEM11
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.3899519699125661,0.8260462495430322,0.6852459016393443,0.9130719926522802,1.0,3/11,17.57%,INPP5K;OCRL;INPP5A
prerank,inositol phosphate dephosphorylation (GO:0046855),0.3899519699125661,0.8260462495430322,0.6852459016393443,0.9130719926522802,1.0,3/11,17.57%,INPP5K;OCRL;INPP5A
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.4031742007541994,0.8260349975093462,0.7046875,0.9126985804321677,1.0,1/10,3.01%,MID1IP1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.3560142377152792,0.8258807428995995,0.6915204678362573,0.9125687454232126,1.0,5/18,14.77%,PTTG1IP;APOE;MSN;VPS35;VGLL4
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.36962662332898916,0.8258273605100207,0.6824427480916031,0.9122698911750818,1.0,5/14,19.68%,SERPINE1;LRP1;MEF2C;PRKG1;TRIB1
prerank,positive regulation of cell cycle (GO:0045787),0.2877762574646339,0.8257507744447358,0.7350917431192661,0.912011203050007,1.0,18/62,20.84%,ADAM17;USP2;NUPR1;TTL;PDGFB;USP19;PSMD10;SMOC2;APP;SRPK2;EIF4E;CALR;DUSP3;MAPRE3;CCND1;ANKRD17;TAL1;EIF4EBP1
prerank,nitric oxide metabolic process (GO:0046209),0.3744524892960274,0.8256013574832266,0.7039877300613497,0.9118612098924901,1.0,2/14,12.02%,GCH1;DDAH2
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.3346341648750686,0.8253298484117726,0.7029702970297029,0.9119429849431686,1.0,6/22,21.52%,FLOT2;GCNT2;FLOT1;THY1;CD44;MBP
prerank,detection of calcium ion (GO:0005513),-0.30978113662164,-0.8245538378957348,0.7277936962750716,0.9752028012891583,1.0,3/13,6.24%,CALM2;CALM1;STIM1
prerank,dendritic spine organization (GO:0097061),-0.2593720147170937,-0.8245043149886264,0.7566539923954373,0.9736933292523243,1.0,8/26,16.26%,MTMR2;INSR;EPHB1;LGMN;PTEN;EPHB2;CTNND2;CHRNA7
prerank,regulation of Golgi organization (GO:1903358),0.3505631371580727,0.8244844556176034,0.6903323262839879,0.9129539885155367,1.0,4/17,9.42%,MAP2K1;USP6NL;PDE4DIP;AKAP9
prerank,lymphocyte mediated immunity (GO:0002449),0.3786688967465805,0.8244712645694778,0.6737160120845922,0.9125857727391767,1.0,2/12,7.26%,CD55;JAG1
prerank,cellular senescence (GO:0090398),0.3311402021143378,0.8244441155173089,0.6958333333333333,0.9122433774497934,1.0,4/27,8.74%,MAP2K1;ULK3;SIRT1;SPI1
prerank,glycolipid biosynthetic process (GO:0009247),0.3084617648432134,0.8244324133045016,0.7227848101265822,0.9118739904156647,1.0,11/38,17.27%,GBGT1;PIGQ;ST8SIA6;DPM1;PIGN;PIGM;PGAP4;PIGP;DPM2;PIGF;PIGC
prerank,tRNA wobble uridine modification (GO:0002098),0.368368792957569,0.8242276604946015,0.6897058823529412,0.911799551061273,1.0,2/14,5.74%,CTU2;ELP3
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.33907542650233247,0.8239669625612991,0.6962552011095701,0.9118404752541907,1.0,2/23,2.64%,ELOVL1;ACSF3
prerank,positive regulation of histone deacetylation (GO:0031065),0.37765037369109883,0.8238800659596295,0.7035330261136713,0.9115910038397574,1.0,4/12,13.80%,PRKD2;SAP30BP;ZBTB7B;AKAP8L
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.26437339819462713,0.8229064379642386,0.8425443169968717,0.9127652456428158,1.0,31/166,15.18%,NR4A1;NR2F6;POLR2J;TAF8;MAML3;NR1D2;NRBF2;GTF2A1;TAF15;GTF2H4;TAF1;TAF12;TBP;TBL1X;CRCP;HDAC1;CREBBP;ERCC2;HDAC5;RBPJ;GTF2F2;MAML1;TAF6;POLR2E;NR2C2AP;RORA;TFB2M;POLR2B;NCOR1;MED1;WWTR1
prerank,spindle assembly checkpoint signaling (GO:0071173),0.3444949662461173,0.8228735276310791,0.6931818181818182,0.9116548149236895,1.0,1/20,0.47%,MAD2L1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.3444949662461173,0.8228735276310791,0.6931818181818182,0.9116548149236895,1.0,1/20,0.47%,MAD2L1
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.3444949662461173,0.8228735276310791,0.6931818181818182,0.9116548149236895,1.0,1/20,0.47%,MAD2L1
prerank,nucleosome organization (GO:0034728),0.29165338914964867,0.8226036242677495,0.7399527186761229,0.9116845522608726,1.0,17/55,22.80%,SOX9;SMARCC1;NASP;NAA60;SMARCD2;SET;SMARCB1;SART3;CTCF;BRD2;KAT6B;ARID2;INO80;SMARCA5;SRCAP;ZNHIT1;SMARCA4
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.2364366702254948,-0.822469643598487,0.8097560975609757,0.9762433729762988,1.0,9/35,12.42%,ARHGAP44;KCTD13;EPHB2;LZTR1;STAMBP;STMN1;MFN2;TNFAIP1;KANK1
prerank,urogenital system development (GO:0001655),0.3859554422035725,0.8224224315924704,0.6843800322061192,0.9115801481134864,1.0,2/11,15.75%,SOX9;PAX2
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.3161544869908891,-0.8223175609086777,0.711484593837535,0.9749381342343945,1.0,5/14,19.11%,DDX60;USP15;PUM1;TLR3;DHX58
prerank,protein localization to cell surface (GO:0034394),0.33009618695552023,0.8220698893272862,0.7254098360655737,0.9117617662460834,1.0,6/26,14.70%,UNC50;GGA1;SMURF1;CTNNB1;PTPRU;FLNA
prerank,positive regulation of autophagy (GO:0010508),0.2781385029423848,0.8219345106385219,0.7802690582959642,0.9115995433244258,1.0,22/81,20.18%,SESN2;HMGB1;NPRL2;KAT5;TBK1;SIRT1;UFL1;BAD;OPTN;FOXO3;MTDH;CAMKK2;ATF6;DAPK1;FLCN;ZC3H12A;TRIM5;PLK3;PRKAA1;TSC2;TRIM8;FBXO7
prerank,negative regulation of transmembrane transport (GO:0034763),0.39464277281541954,0.8214786210648422,0.6791171477079796,0.9119492092455087,1.0,3/10,17.32%,INPP5K;CTTNBP2NL;PRKCB
prerank,tRNA wobble base modification (GO:0002097),0.3665675606310973,0.8212290645838541,0.687964338781575,0.9119605211490548,1.0,2/14,5.74%,CTU2;ELP3
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.36659625416802866,0.8204827415374834,0.6849529780564263,0.9128161627609017,1.0,4/14,11.36%,CPSF6;NCBP1;FIP1L1;TUT1
prerank,regulation of neuroblast proliferation (GO:1902692),-0.3011353617176854,-0.8204639095377481,0.7287581699346405,0.9772041647342153,1.0,6/15,22.87%,DISC1;LRRK2;VEGFA;TAFA1;CX3CR1;CX3CL1
prerank,melanocyte differentiation (GO:0030318),-0.3349699667467315,-0.8202988687233933,0.6549865229110512,0.9759744700049472,1.0,4/11,22.33%,ENPP1;USP13;MREG;KIT
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.2988077157119442,0.8201631419967924,0.7303102625298329,0.9129599831557796,1.0,13/45,16.90%,RBM4B;MATR3;RPL10;CYFIP1;PUM2;RC3H1;APP;FOXO3;GCNT2;EIF4E;METAP1;ATXN2;PER1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.275295662527219,0.8199661521900783,0.7847682119205298,0.9128753391193593,1.0,16/80,15.73%,NAPA;ARFGAP3;COPE;KLC1;KIF5A;TMED10;COG4;ERGIC2;BNIP1;NSF;USE1;GBF1;SCYL1;ARF4;ERGIC1;KIF3B
prerank,protein localization to cell-cell junction (GO:0150105),0.3627206979991359,0.8198310863469052,0.7022556390977444,0.9127041755970624,1.0,6/15,20.09%,LSR;ACTG1;SCRIB;ACTB;JAK1;TJP1
prerank,regulation of protein localization to cell periphery (GO:1904375),0.3427552699395251,0.8195737853878566,0.6880222841225627,0.9127102610689433,1.0,5/18,18.89%,VPS4A;ZDHHC7;ACTB;STX8;MMP14
prerank,regulation of glucose metabolic process (GO:0010906),0.3098254294817243,0.8195530327761731,0.7256176853055917,0.9123556283067933,1.0,7/34,15.71%,BCKDK;ADIPOR1;SIRT1;PDK3;DGKQ;RORA;FOXK2
prerank,nuclear membrane reassembly (GO:0031468),0.2866613586663046,0.8194409573680296,0.7464953271028038,0.912164944995275,1.0,11/54,15.05%,VPS4A;LEMD2;NDC1;SUMO1;RANGAP1;RCC1;NUP37;SIRT2;UBE2I;NUP98;IST1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.2811339287801359,0.8186050158760607,0.7645714285714286,0.9131110596588782,1.0,8/70,8.74%,EPHA1;EPHA2;ABI2;ATF4;ITGB3;PIK3R1;ANTXR1;SPI1
prerank,regulation of phospholipid metabolic process (GO:1903725),0.3944656423596947,0.8183638123972498,0.6947723440134908,0.9131191783094569,1.0,2/10,8.10%,DNAJC19;MTMR3
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.340564078019784,0.8183156616095426,0.7024320457796852,0.9128021786586725,1.0,1/21,0.47%,MAD2L1
prerank,ESCRT complex disassembly (GO:1904896),0.39342904234891013,0.8182186232275486,0.698019801980198,0.9122066002377772,1.0,3/10,16.23%,VPS4A;IST1;VTA1
prerank,ESCRT III complex disassembly (GO:1904903),0.39342904234891013,0.8182186232275486,0.698019801980198,0.9122066002377772,1.0,3/10,16.23%,VPS4A;IST1;VTA1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.30328820802607287,0.8182020611172174,0.7344701583434835,0.9118443810941246,1.0,6/41,10.45%,ADAM17;IL34;PDGFB;AGT;PRNP;BDNF
prerank,placenta development (GO:0001890),-0.31489678724230963,-0.8181633593845055,0.7493403693931399,0.9785740850078352,1.0,4/12,23.71%,PTK2;PPARG;SOD1;ANG
prerank,regulation of receptor recycling (GO:0001919),-0.2875494275385866,-0.8175284560060854,0.7275541795665634,0.9782188949031058,1.0,3/16,5.58%,KIF16B;TBC1D16;LAMTOR1
prerank,motile cilium assembly (GO:0044458),-0.3213230689025248,-0.8171930208388904,0.7065868263473054,0.9772974620534687,1.0,5/12,26.45%,SPATA6;BBOF1;E2F4;BBS5;CCDC39
prerank,positive regulation of cholesterol transport (GO:0032376),0.3199640396939404,0.8171597373672809,0.7272727272727273,0.913163648400336,1.0,6/27,16.45%,APOE;ZDHHC8;LRP1;SIRT1;GPS2;RXRA
prerank,activation of protein kinase activity (GO:0032147),0.27120481519163253,0.8169735118257435,0.798728813559322,0.9130744850433805,1.0,26/106,18.51%,CALCA;RICTOR;TGFBR2;ITGB3;ADCY5;PDGFB;PTK2B;TOM1L1;OSBPL8;IL18;TAOK2;TNIK;PRKAR2A;IGF1;ADCY8;ADCY3;ADRB2;PRRC1;SLC11A1;MTOR;CD86;ZFP91;CCDC88A;ADCY7;STRADA;ADCY9
prerank,mammary gland epithelium development (GO:0061180),0.37135629387611685,0.8168269092228317,0.6883308714918759,0.9129367977716669,1.0,3/14,13.41%,EPHA2;LATS1;SCRIB
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.36153633459653534,0.8165642190673555,0.7031963470319634,0.9129772010573189,1.0,2/14,8.34%,ECI2;CRAT
prerank,sterol metabolic process (GO:0016125),0.28262517370097406,0.8164531326883273,0.7465437788018433,0.9127438788077514,1.0,9/60,16.79%,FDX1;APOE;STARD3;CLN8;OSBPL1A;MSMO1;SC5D;RXRA;LIPA
prerank,activation of adenylate cyclase activity (GO:0007190),0.3091640047901887,0.8158535430579187,0.7223618090452262,0.9132807377380556,1.0,9/35,18.51%,ADCY5;ADCY8;ADCY3;CAP1;ADRB2;LGR4;RAF1;ADCY7;ADCY9
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.31203502553142365,-0.8155780368639377,0.7362637362637363,0.9789469559420968,1.0,7/13,23.25%,SCFD1;TMEM39A;LRRK2;SMCR8;PHF23;CHMP4B;CHMP4A
prerank,histone H3-K4 methylation (GO:0051568),0.32582812538653544,0.8155316369721252,0.7225201072386059,0.9134166565231405,1.0,8/26,17.70%,CXXC1;TET2;WDR82;KMT2B;KMT2D;KMT2A;TET3;CTR9
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.36766641721769777,0.8154901023895024,0.692063492063492,0.9130930634129861,1.0,4/13,11.36%,CPSF6;NCBP1;FIP1L1;TUT1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.37688733793783086,0.8153007450225729,0.7099125364431487,0.9130024295470585,1.0,5/14,19.70%,SLC25A33;EARS2;FOXO3;TFB2M;TFAM
prerank,error-free translesion synthesis (GO:0070987),0.33189543624262025,0.8152182725041521,0.7212885154061625,0.9127422756717164,1.0,4/22,10.75%,RPS27A;UBC;PCNA;POLDIP2
prerank,cilium organization (GO:0044782),0.2581548901152991,0.815043098703327,0.8520408163265306,0.9126258863046779,1.0,34/210,14.70%,IQCG;CFAP70;CATIP;CEP126;ATP6V1D;ATP6V0D1;WDR19;HDAC6;ATAT1;ARL6;RAB8B;DYNLT2B;ASAP1;TRAPPC14;BBS4;EXOC5;ARL3;LZTFL1;EHD4;TRAF3IP1;EXOC7;TTC17;SSX2IP;IFT43;TTC8;IFT172;OCRL;RP2;GBF1;DYNC2H1;ARMC2;CEP250;ARF4;FLNA
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.20831110509891063,-0.8140121252754506,0.8782608695652174,0.9805758176428898,1.0,14/63,12.81%,RBL2;CNOT3;CARM1;CHEK2;ARID3A;PML;TFDP2;CDKN1B;EP300;CNOT6L;CNOT9;BAX;RPL26;CASP2
prerank,embryonic heart tube development (GO:0035050),-0.3090296863555155,-0.813871440764254,0.7282913165266106,0.9792846267583414,1.0,3/14,27.78%,MEGF8;NDRG4;CITED2
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.30695156029531623,-0.8138080258241287,0.7229551451187335,0.9778230864998356,1.0,5/13,28.41%,RPL26;SPRED1;ATR;SPRED3;EEF1E1
prerank,histone mRNA metabolic process (GO:0008334),0.3227963538051006,0.8133886878840481,0.7331536388140162,0.914869182757026,1.0,6/27,14.41%,SLBP;TUT7;NCBP1;EXOSC10;TUT1;SNRPG
prerank,positive regulation of translational initiation (GO:0045948),0.3522036123017331,0.812944414320387,0.6878612716763006,0.9151492769423996,1.0,5/18,16.59%,HABP4;CDC123;MTOR;POLR2G;YTHDF2
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.29287893601391335,0.8127017158173115,0.7521160822249093,0.9151402070791711,1.0,11/48,15.64%,NUP153;NDC1;ZBTB7A;EIF6;NUP88;NUP210;PRKAG1;NUP37;NUP98;PGAM1;NUP54
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.27897653616552737,0.8126933814568804,0.7505720823798627,0.9147737618739887,1.0,10/66,13.02%,SOX9;NUPR1;KRIT1;APOE;SPARC;NLRC3;CDK6;SOX2;HPN;SYNJ2BP
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.38051637316624365,0.8124322805809095,0.6992125984251969,0.9148303278893054,1.0,4/11,22.40%,SIRT1;MEF2C;PIK3CD;LYN
prerank,nitric oxide biosynthetic process (GO:0006809),0.37446003407821216,0.812428778465998,0.7147286821705426,0.914455096351191,1.0,2/13,12.02%,GCH1;DDAH2
prerank,histone H3-K9 demethylation (GO:0033169),-0.33092484650506265,-0.8123631947090731,0.7052631578947368,0.9791416511715973,1.0,7/11,26.31%,KDM4C;KDM4B;PHF8;KDM7A;KDM4A;KDM3A;KDM4D
prerank,positive regulation of immune effector process (GO:0002699),-0.25519406600345873,-0.8123007051605424,0.7781954887218046,0.9776532937499312,1.0,5/27,19.11%,DDX60;CD46;XBP1;CCR2;DHX58
prerank,regulation of actin filament polymerization (GO:0030833),0.2797859887109279,0.8121020208484608,0.7596371882086168,0.9146153602306969,1.0,11/69,10.78%,NCK1;PFN1;BAIAP2L1;NCKAP1;CDC42EP3;COTL1;PTK2B;LATS1;CYRIB;PYCARD;BAIAP2
prerank,negative regulation of macrophage activation (GO:0043031),0.34738639414684136,0.8120362801270398,0.6953352769679301,0.9143397129742814,1.0,5/16,19.03%,PTPRC;CD200;CST7;ZC3H12A;LRFN5
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3092526814008172,0.811471048727238,0.71334214002642,0.9148284510506943,1.0,5/33,10.59%,HMGB1;ANGPT2;APOE;JUP;HDAC5
prerank,positive regulation of cell communication (GO:0010647),0.3170279090807905,0.8107419970245524,0.7081081081081081,0.9155956541441033,1.0,5/28,16.75%,RIMS1;RIMS3;CLSTN1;SYT1;ILK
prerank,phospholipid transport (GO:0015914),0.29675844175528804,0.8107086873460085,0.7598097502972652,0.9152664703748474,1.0,8/52,14.92%,PRELID1;ATP8B1;APOC1;APOE;OSBPL8;SCARB2;TMEM30A;PITPNA
prerank,contractile actin filament bundle assembly (GO:0030038),0.3586621848006956,0.8102467804575588,0.7076923076923077,0.915245242975252,1.0,2/15,1.71%,ZYX;CUL3
prerank,stress fiber assembly (GO:0043149),0.3586621848006956,0.8102467804575588,0.7076923076923077,0.915245242975252,1.0,2/15,1.71%,ZYX;CUL3
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.24608779223344382,-0.8100366498726245,0.78099173553719,0.9804965468571181,1.0,9/29,22.24%,RAB5A;SHISA6;EPHB2;ZDHHC2;NSMF;SYNGR1;CAMK2A;CAMK2B;NCDN
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.28472042060138114,-0.8098653265118911,0.7484848484848485,0.9792516270001977,1.0,8/18,19.55%,DDX60;UFD1;USP15;PUM1;BIRC2;BIRC3;DHX58;GPATCH3
prerank,regulation of myeloid cell differentiation (GO:0045637),0.2836893037258686,0.8092968977989045,0.7616279069767442,0.9163414895767125,1.0,18/62,18.17%,EIF6;PTK2B;CDK6;SPI1;HDAC1;CREBBP;HOXB8;CNOT4;KMT2B;KMT2D;KMT2A;RUNX1;SIN3A;AGO3;PRKCB;CTR9;TNRC6C;MEF2C
prerank,DNA biosynthetic process (GO:0071897),0.355435363785673,0.8079140352820844,0.6933534743202417,0.9181338623717493,1.0,4/16,17.97%,WRNIP1;SIRT1;POLD4;POLD3
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.2846511436914999,0.8079099810397447,0.771689497716895,0.9177592555989698,1.0,7/63,10.68%,SLC7A1;NCK1;TNFSF13B;PNP;GPR183;PTPRC;IL18
prerank,regulation of protein kinase C signaling (GO:0090036),-0.3009382957327957,-0.8078886869104689,0.7379518072289156,0.9814910156964697,1.0,7/14,30.70%,GPD1L;MYADM;ADRA1A;VEGFA;ADGRV1;SPHK2;CD40
prerank,phosphatidic acid metabolic process (GO:0046473),0.29293186697476137,0.8075682821998024,0.741190765492102,0.9179157227646376,1.0,8/48,12.62%,AGPAT4;PLA2G4A;ABHD8;DGKZ;DGKD;GPAT4;LPCAT1;DGKQ
prerank,tRNA processing (GO:0008033),0.2844970849316639,0.8075286030616068,0.7670126874279123,0.9175874064471634,1.0,14/61,17.88%,CTU2;KARS1;SARS1;PTCD1;QTRT1;TRMT10A;FAM98B;RPP30;POP1;TRMT10B;ZBTB8OS;CDKAL1;TYW5;NSUN6
prerank,RNA destabilization (GO:0050779),-0.28423914214111695,-0.806488335499572,0.7538461538461538,0.9826271762948842,1.0,3/18,3.04%,METTL16;ROCK2;LIN28B
prerank,purine ribonucleotide metabolic process (GO:0009150),0.2832700645661581,0.8064636448110734,0.7878787878787878,0.9188350304294477,1.0,10/68,12.91%,ADSS2;EPHA2;GMPR2;ACLY;RHOQ;GPAT4;ENTPD7;BAD;AMPD2;ACAT1
prerank,neuron fate commitment (GO:0048663),0.36625402559232684,0.8063330781979374,0.7423312883435583,0.9186576867772668,1.0,2/14,9.92%,TGFBR1;POU3F2
prerank,mitotic sister chromatid segregation (GO:0000070),0.2693819902748121,0.8062800182147913,0.8099352051835853,0.9183578423639698,1.0,15/98,13.94%,CUL3;VPS4A;NUDC;MIS12;KMT5A;PDCD6IP;PDS5A;SET;DLGAP5;NDC80;EML4;NAA50;WRAP73;AKAP8L;NCAPH2
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.2676180843602142,0.8062636186410445,0.8089647812166488,0.9179971671292956,1.0,22/102,18.51%,NR4A1;SLC39A14;INPP5K;RELA;RAB8B;ADCY5;PIK3R1;RAB31;SLC25A33;CPEB1;RHOQ;HDAC5;PRKAR2A;ADCY8;ADCY3;GOT1;TBC1D4;SYAP1;NFKB1;ADCY7;PDE3B;ADCY9
prerank,bicarbonate transport (GO:0015701),0.32033276520922865,0.806196180806729,0.7311522048364154,0.9177205249959913,1.0,3/25,13.27%,SLC4A2;SLC39A8;CYB5R1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.36434614804935556,0.8060910848110459,0.6973058637083994,0.917521708078747,1.0,5/12,22.98%,NCOR1;ZC3H12A;ELAVL1;ESR1;TGFB1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.3427069398109684,0.805701199652119,0.7191977077363897,0.9177513943506611,1.0,7/18,19.22%,RIMS1;RIMS3;FMR1;PREPL;VPS18;RAP1B;RAB3GAP1
prerank,nuclear migration (GO:0007097),0.36487195257768007,0.8056335281725616,0.713855421686747,0.9174812973933544,1.0,5/13,18.68%,FBXW11;SUN2;PAFAH1B1;DCTN1;CLMN
prerank,negative regulation of response to wounding (GO:1903035),0.3375885861055537,0.8048667617099298,0.7377521613832853,0.918326441436159,1.0,6/19,20.77%,SERPINE1;INPP5F;CRK;PTPRS;CERS2;RTN4RL1
prerank,nucleotide catabolic process (GO:0009166),0.3538454709082304,0.8045505771776607,0.7205240174672489,0.9184284280159184,1.0,2/16,10.67%,PNP;DERA
prerank,replicative senescence (GO:0090399),0.36784076898208573,0.8044368212878112,0.6987577639751553,0.9182279898583307,1.0,1/12,2.70%,SERPINE1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.37264554941592865,0.8044126562291395,0.7417840375586855,0.9178820463583218,1.0,2/12,8.49%,ADSS2;GART
prerank,lamellipodium organization (GO:0097581),0.3109987081618503,0.8038842535776856,0.7486702127659575,0.918320517694882,1.0,9/29,18.25%,ARHGEF4;ARHGEF6;CYFIP1;PTPRO;WHAMM;S1PR1;RAC1;CCDC88A;CDH13
prerank,positive regulation of chromosome organization (GO:2001252),0.3563228840289411,0.8035696359498365,0.7233082706766917,0.9184253788918,1.0,4/15,17.19%,PPP1R10;NBN;SHCBP1L;RAD21
prerank,mitochondrion disassembly (GO:0061726),0.3047176995100809,0.8035678358904568,0.7346938775510204,0.9180463427182599,1.0,7/34,14.40%,SQSTM1;GABARAP;GABARAPL1;MAP1LC3A;MAP1LC3B;FUNDC2;WIPI1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.34014888924505743,0.8033484488523617,0.7088989441930619,0.9180209945613084,1.0,5/17,18.76%,FKBP1B;GJC3;ATP1B1;ATP1A3;GJA1
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.3280365597759443,-0.8028994059228144,0.7049180327868853,0.9879616426908109,1.0,2/10,3.27%,WWP2;SNX12
prerank,regulation of organelle assembly (GO:1902115),0.27339503966552225,0.8028671913210988,0.7787810383747178,0.9183762331189071,1.0,12/73,11.18%,TBC1D10B;TBC1D17;NPRL2;PDCD6IP;USP6NL;DYNLT2B;RABGAP1;MTMR3;STAM;MSN;RABEP2;CDKL5
prerank,innate immune response in mucosa (GO:0002227),-0.34362414774262195,-0.8027771068957138,0.725130890052356,0.9866115700258405,1.0,2/10,20.33%,DEFA6;RPL39
prerank,positive regulation of bone mineralization (GO:0030501),-0.23259128516448635,-0.8024750055707054,0.817258883248731,0.9856098372236528,1.0,12/35,26.29%,BMPR2;TMEM119;ATRAID;SLC8A1;ALOX5;NELL1;BMPR1A;ATP2B1;PKDCC;ADGRV1;ACVR2A;P2RX7
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.3591247779568219,0.8024726020480065,0.7310030395136778,0.9185624445727593,1.0,3/15,10.87%,PRKD2;SMOC2;TMSB4X
prerank,negative regulation of signal transduction (GO:0009968),0.2544755149983986,0.8024391729883978,0.9048582995951417,0.9182325402997885,1.0,47/249,19.99%,BMP5;ADAMTS12;SLAMF1;CREB3L1;PLEK;SIAH2;INPP5K;NCK1;APOD;PTPN12;ULK3;ZBTB7A;AGT;SEMA6A;LRP1;TCIM;SMPD1;PRKCZ;PTPRC;ARRB1;CARD16;HHIP;BDNF;TMBIM6;RNF43;GPS2;PTPRE;SULF2;LGR4;VGLL4;GPR108;TRABD2B;OTUD4;TNFAIP3;YTHDF2;PRKCB;ACVR1;EZH2;CALR;PDCD6;MMP14;CNOT1;TSC2;TRIB1;ASAH2;VCP;SNCA
prerank,axonal transport (GO:0098930),-0.23163901324161185,-0.8024176244425969,0.8256410256410256,0.9841396678221274,1.0,5/36,4.37%,KIF3A;AP3D1;AP3S2;AP3M1;DST
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.3448412881128742,0.8019904570109588,0.7161572052401747,0.9185239737498847,1.0,2/18,4.73%,BID;SLC35F6
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.3910616944344273,0.801916765800773,0.7230273752012882,0.9182701722035721,1.0,1/10,11.35%,GNB1
prerank,positive regulation of cilium assembly (GO:0045724),0.3414746749179307,0.8007020636307155,0.7067448680351907,0.9197297003408398,1.0,5/18,16.67%,CROCC;BBS4;TAPT1;WRAP73;CCDC88A
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.3299052384966224,-0.8005840885549481,0.7211796246648794,0.986020631185744,1.0,6/11,22.98%,CCT4;TCP1;CCT2;CCT5;DKC1;WRAP53
prerank,regulation of secretion (GO:0051046),0.3622685850454633,0.8004846488579773,0.7068702290076336,0.9196881467808552,1.0,1/13,2.26%,POFUT2
prerank,sensory perception of light stimulus (GO:0050953),0.2706992244576699,0.8004545286930141,0.8063806380638063,0.9193506705300851,1.0,13/87,16.12%,COL1A1;DNAJC19;TULP2;EFEMP1;MYO9A;RABGGTB;RP2;POU6F2;WFS1;ATF6;PITPNA;PAX2;OPA3
prerank,chromosome condensation (GO:0030261),-0.23423453742211572,-0.7995393294840399,0.8235294117647058,0.986407803285556,1.0,10/36,18.52%,NCAPD3;AIFM1;CSNK2A1;CSNK2A2;PHF8;NCAPG2;SMC2;INCENP;RB1;CHMP1A
prerank,estrogen metabolic process (GO:0008210),0.3534350194559319,0.7993385011082398,0.7377777777777778,0.9207054405396572,1.0,1/15,4.32%,HSD17B1
prerank,Golgi to endosome transport (GO:0006895),-0.28979821783363413,-0.7993326474887932,0.739938080495356,0.9852363751873722,1.0,5/16,15.93%,KIF16B;CORO7;DOP1B;AP4M1;VPS13C
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.33850809018139416,-0.7985447893395581,0.7049608355091384,0.9836470281459646,1.0,4/10,15.93%,PRKCD;NSMAF;TNFRSF1A;SIRT3
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.33850809018139416,-0.7985447893395581,0.7049608355091384,0.9836470281459646,1.0,4/10,15.93%,PRKCD;NSMAF;TNFRSF1A;SIRT3
prerank,negative regulation of viral process (GO:0048525),0.2853861710914395,0.7984600891717901,0.7861409796893668,0.9216328163399197,1.0,10/57,14.26%,ZFP36;ILF3;EIF2AK2;LARP7;IFITM3;TRIM28;PARP10;TNIP1;SRPK2;FAM111A
prerank,cell-cell junction maintenance (GO:0045217),-0.32370266787539553,-0.7984592060634151,0.7377049180327869,0.9822762026928269,1.0,3/11,21.07%,FERMT2;MYADM;NLGN2
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.335619004807539,0.7982545733546046,0.7237960339943342,0.9215780138805836,1.0,7/20,20.13%,TARBP2;PUM2;DROSHA;TSN;AGO3;TSNAX;AGO2
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.28290398288446383,0.7979992092373679,0.7733175914994097,0.9215919401657248,1.0,15/59,20.74%,CELSR2;CD84;NECTIN3;CADM3;CADM1;SDK2;DSCAM;NPTN;IGSF11;CNTN4;PALLD;CDH13;NECTIN4;NECTIN2;KIRREL3
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.3697485674118697,0.7979686353648703,0.7245696400625978,0.9212586926489416,1.0,4/12,17.30%,RIMS1;RIMS3;SYT1;UNC13B
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.28500413579193656,-0.7978751830089643,0.7272727272727273,0.9818317653883412,1.0,3/17,10.86%,PLAAT3;LCLAT1;MBOAT7
prerank,negative regulation of protein secretion (GO:0050709),0.301322760776799,0.7975701773952765,0.7737948084054388,0.9214743037091946,1.0,5/38,11.37%,RHBDF2;MIDN;APOE;SERGEF;CD200
prerank,negative regulation of cell aging (GO:0090344),0.34062892629978997,0.7972400259129993,0.7229629629629629,0.9216181184156143,1.0,3/16,10.69%,CDK6;SIRT1;YBX1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.2916896464963357,-0.7969155061085551,0.742603550295858,0.982114190577325,1.0,6/16,21.27%,KLHL15;FBH1;UBQLN4;HELB;RIF1;SMCHD1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.2817345197549582,-0.7968598077414424,0.7024221453287197,0.9806769585147057,1.0,4/18,13.95%,OPRM1;RGS10;CHRM2;GNA11
prerank,regulation of protein localization to membrane (GO:1905475),0.31176419448016046,0.7967614514622123,0.73342175066313,0.9219990080555932,1.0,10/28,21.91%,VPS4A;ZDHHC7;GPC5;SLC5A3;ACTB;STX8;MMP14;GPC6;VAMP8;GPC3
prerank,positive regulation of transport (GO:0051050),0.271516574691911,0.7965922036042584,0.7957824639289678,0.9218605600817974,1.0,18/85,18.43%,CLIP3;INPP5K;BID;SIRPA;APOE;LRP1;SMPD1;PYCARD;ANXA2;DOCK2;FMR1;SLC11A1;ACTB;FLOT1;KMT2A;RXRA;CALR;SGK1
prerank,intracellular protein transmembrane transport (GO:0065002),-0.21751577756334944,-0.7965594190070951,0.8797814207650273,0.9796722390585294,1.0,25/42,38.77%,C2CD5;TOMM70;AIFM1;SEC61A1;SEC62;PEX6;AKT2;SEC61G;TIMM23;TIMM21;SEC61B;PEX26;GRPEL1;PEX10;PAM16;CHCHD4;ZFAND2B;PEX16;TIMM50;SEC61A2;TOMM40L;TIMM17B;ROMO1;PEX12;TOMM40
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.3276469501067429,0.7963434749738652,0.7277856135401974,0.9218717503338736,1.0,2/22,3.90%,RPS15;CHD5
prerank,primary miRNA processing (GO:0031053),0.377007988785327,0.796231009490706,0.7154340836012861,0.9216503379121216,1.0,5/10,21.19%,DGCR8;DROSHA;SMAD3;METTL3;HNRNPA2B1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.35220629393905367,0.795696937331576,0.7155688622754491,0.9220503934779296,1.0,1/15,2.57%,RICTOR
prerank,embryonic organ morphogenesis (GO:0048562),0.2933565056879237,0.7955693031246848,0.7625,0.9218630891974594,1.0,2/42,2.80%,HOXD9;FOXE1
prerank,regulation of store-operated calcium entry (GO:2001256),0.3831010391881978,0.7953947101789384,0.7290322580645161,0.9217357362793859,1.0,3/10,18.49%,CD84;SARAF;HOMER2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.307760005129668,0.7952185708728661,0.7290836653386454,0.9215998874927863,1.0,5/29,11.20%,LTBR;BID;AGT;PYCARD;DEDD2
prerank,activation of protein kinase A activity (GO:0034199),0.35361208285920015,0.7952001815458565,0.7535410764872521,0.9212479381982766,1.0,7/16,18.51%,ADCY5;PRKAR2A;ADCY8;ADCY3;PRRC1;ADCY7;ADCY9
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3629653656380534,0.7949201387706067,0.7181818181818181,0.9213083298232148,1.0,4/13,18.68%,ALG11;ALG12;ALG9;ALG8
prerank,protein acetylation (GO:0006473),0.3118771928707979,0.7942420876809291,0.7550505050505051,0.9219544996242329,1.0,7/30,15.24%,KAT5;NAA60;SIRT1;CREBBP;NAA50;NAT9;ING4
prerank,positive regulation of cellular component movement (GO:0051272),0.31859938148882916,0.7942186934367165,0.7333333333333333,0.9216067015692543,1.0,2/24,5.29%,ADAM17;TGFBR1
prerank,negative regulation of complement activation (GO:0045916),-0.32845589404475806,-0.7941377235322334,0.739247311827957,0.9825422216259397,1.0,2/10,6.40%,CR1L;CD46
prerank,lung development (GO:0030324),0.3038129047438791,0.7938448767944752,0.7480314960629921,0.9218033386930176,1.0,1/33,0.41%,BAG6
prerank,positive regulation of cellular catabolic process (GO:0031331),0.2581045708448215,0.793810904791985,0.837696335078534,0.9214739039076241,1.0,37/132,19.99%,ADAM8;HMGB1;NPRL2;PFKFB3;ADAM9;KAT5;PTTG1IP;APOE;SNX33;CNOT8;FURIN;MSN;RC3H1;UFL1;BAD;CNOT7;VPS35;IGF1;APP;ENTPD5;OPTN;FOXO3;MTDH;VGLL4;ATF6;TNFRSF1B;DAPK1;FLCN;PFKFB2;ZC3H12A;TRIM5;UPF1;PRKAA1;CNOT1;TRIM8;ITCH;SNCA
prerank,histone H3 deacetylation (GO:0070932),0.3481868112333177,0.7930284003153222,0.7284671532846715,0.9222720256933499,1.0,5/15,16.90%,SIRT1;HDAC1;SFPQ;SIRT2;PER1
prerank,negative regulation of secretion (GO:0051048),-0.33540867458498635,-0.7928276756703558,0.7438692098092643,0.9833915727821475,1.0,6/10,40.25%,CD74;ERBB3;VAMP3;NR1H3;EGF;PTGER3
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.32683777702943057,-0.7926781339996797,0.710594315245478,0.9821122135821336,1.0,5/11,22.26%,PAPOLA;ZC3H3;PAF1;ZFP36L1;LEO1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.35884993466066273,0.7923445227873476,0.7369230769230769,0.9229490538794216,1.0,3/13,10.13%,NUP153;APOD;RANGAP1
prerank,eye development (GO:0001654),-0.20690729491594195,-0.7921998633689518,0.896551724137931,0.98147819463246,1.0,5/54,4.59%,PBX3;PBX1;NIPBL;HIPK1;CACNA1C
prerank,negative regulation of cell projection organization (GO:0031345),-0.20985081405539507,-0.7918273438222402,0.8444444444444444,0.9806144949753532,1.0,20/48,29.13%,GRIN2B;STMN2;YWHAH;HDAC2;PTPN9;SPOCK1;PTEN;PRAG1;KANK1;MINAR1;DCC;PAQR3;TRPV4;EPHA4;CRMP1;STX1B;ADCY6;EFNB2;RAB29;MT3
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.2469644875679467,-0.7917413916849555,0.8017241379310345,0.979208478450664,1.0,10/28,22.78%,PTK2;AXIN1;PTEN;DDRGK1;PSMC3;RNF139;FBXW7;CDK5RAP3;ECSCR;PSMC5
prerank,striated muscle cell development (GO:0055002),0.35561458399320567,0.7915452473549641,0.7190839694656489,0.923781479865127,1.0,1/14,3.02%,FLII
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.37489965651246904,0.7907915279692431,0.7033492822966507,0.9245442748138061,1.0,2/11,11.07%,LARP7;EXOSC10
prerank,positive regulation of T cell differentiation (GO:0045582),0.2941584940267091,0.7906731264582008,0.7732342007434945,0.9243535217461206,1.0,3/36,4.91%,ADAM8;ZMIZ1;PNP
prerank,vasodilation (GO:0042311),0.35672594958993364,0.7897941949332885,0.725705329153605,0.9252660853466621,1.0,3/13,16.84%,KCNMA1;ADRB2;SOD2
prerank,response to estrogen (GO:0043627),0.3079087330667637,0.7895034290743437,0.7425997425997426,0.9253134437788454,1.0,2/31,4.76%,NCOA4;ARID5A
prerank,calcium-ion regulated exocytosis (GO:0017156),0.3157610194094648,0.7894802815006243,0.7582128777923784,0.9249622737972419,1.0,7/27,17.60%,RIMS1;RIMS3;ARL8B;SYT1;ARHGAP17;SDF4;SYT4
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.2790434228704093,-0.7894594984002473,0.7792642140468228,0.9818481341691051,1.0,4/17,22.29%,AKAP13;ADRA1A;ADRA1B;ADRB1
prerank,mucosal immune response (GO:0002385),0.34482185628715256,0.7892695433257201,0.7245508982035929,0.9248951771081353,1.0,2/15,15.77%,OTUD7B;RNASE3
prerank,cardiolipin metabolic process (GO:0032048),0.35728949386525133,0.7891969021896019,0.7210031347962382,0.92461879961766,1.0,5/13,19.21%,PLA2G4A;HADHA;PNPLA8;CRLS1;PLA2G6
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.37056796841833795,0.789138677351334,0.7457337883959044,0.9243366688886547,1.0,3/10,11.39%,SH3BP1;MSN;MYO9A
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.3168464492661018,-0.7889699022425731,0.7338501291989664,0.9812171179783488,1.0,4/11,31.73%,SOX6;FRS2;EFNB2;FZD7
prerank,regulation of biomineral tissue development (GO:0070167),0.3128975823388618,0.7886650411380736,0.7421981004070556,0.9246673225091694,1.0,4/26,9.86%,SOX9;BMP2K;ANKH;DDR2
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.34320185433456124,0.7884148642296844,0.7350689127105666,0.9246691529087147,1.0,3/15,15.17%,PRKCH;NCOA3;MED1
prerank,defense response to virus (GO:0051607),0.26211154423519933,0.7881263631440436,0.8143322475570033,0.9247110746578341,1.0,24/100,20.16%,BCL2L1;ACOD1;EIF2AK2;RELA;IFITM3;NCBP3;TRIM56;TLR7;PTPRC;PYCARD;CNOT7;MLKL;NT5C3A;FLNA;IL6;RNASE1;IFNAR2;NLRC5;TTC4;TRIM5;CGAS;TLR2;MAP3K14;AGBL5
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.3664704445986092,0.787694651199854,0.7226753670473083,0.9249729568094242,1.0,2/12,10.68%,CARD9;IL18
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.3149439711779887,0.7874125013778158,0.7524204702627939,0.9250194087479097,1.0,5/22,11.13%,PDGFA;PDGFB;TOM1L1;NBN;TAOK2
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.3446492152043909,0.7873469146933655,0.7488789237668162,0.9247514354819979,1.0,3/16,12.75%,ADSS2;GART;AMPD2
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.33889353036540876,0.7873017925266088,0.7398843930635838,0.9244432266059642,1.0,5/17,11.47%,MAML3;DLGAP5;CREBBP;RBPJ;MAML1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.26862615798011924,-0.7868819703858585,0.7961165048543689,0.9833771486981909,1.0,10/18,29.50%,CCT4;TCP1;CCT2;NAF1;CCT5;DKC1;DCP2;SHQ1;RUVBL1;CCT3
prerank,regulation of cell projection organization (GO:0031344),-0.3032110185218462,-0.7868546366631964,0.7391304347826086,0.9818989194480992,1.0,2/13,7.90%,MOV10;ERMN
prerank,cellular response to fluid shear stress (GO:0071498),0.35801142590838275,0.7867662492476392,0.7282780410742496,0.9248639861718998,1.0,1/12,1.39%,NFE2L2
prerank,negative regulation of transposition (GO:0010529),0.34503714877077485,0.7865233337704883,0.7458646616541353,0.9248346714381507,1.0,4/16,16.93%,TUT7;TEX15;SMYD5;UBR2
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.36118128723130094,0.7863905868120246,0.7398496240601504,0.9246399359374647,1.0,2/12,7.04%,JUP;TRPM4
prerank,acylglycerol catabolic process (GO:0046464),0.30825913913355335,0.7863645598703681,0.7572944297082228,0.9243037886222295,1.0,1/30,1.49%,LPL
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.27678189855782687,-0.7862611895319036,0.8193979933110368,0.9813802170869838,1.0,11/17,34.82%,IK;BUB3;RB1;MTBP;ZW10;ZWILCH;KNL1;CENPA;BOD1;HASPIN;SPDL1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.37343862511135534,0.7858882032118661,0.7366720516962844,0.9246070573476807,1.0,3/11,17.55%,RC3H1;RC3H2;ZC3H12A
prerank,double-strand break repair (GO:0006302),0.25314299963649145,0.7857718788465384,0.8703319502074689,0.9244228460118245,1.0,26/158,14.84%,RAD51AP2;HPF1;HMGB1;KAT5;SEM1;APTX;XRCC5;RAD52;XRCC1;BAZ1B;POLB;TDP1;MAPK8;NBN;SUMO1;SFPQ;PARP2;RFWD3;UBXN1;KPNA2;NABP1;MORF4L1;HERC2;SETX;MDC1;NSMCE1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.28918319645494944,0.785478575501014,0.7675276752767528,0.9244982254836182,1.0,8/40,11.94%,UBE3A;TAF1;GLMN;SMURF1;PTK2B;LATS1;UFL1;CLU
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.37617697521718974,0.7853731336108096,0.7278382581648523,0.9239058977743838,1.0,1/10,3.46%,NFATC3
prerank,calcineurin-mediated signaling (GO:0097720),0.37617697521718974,0.7853731336108096,0.7278382581648523,0.9239058977743838,1.0,1/10,3.46%,NFATC3
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.2523087919493509,-0.7853498613374716,0.8131868131868132,0.9814346884098097,1.0,3/23,6.08%,NMT1;CALM1;FNTB
prerank,negative regulation of locomotion (GO:0040013),-0.3129368807324823,-0.7853188332614389,0.7688311688311689,0.9799793899111954,1.0,1/12,0.01%,SPOCK3
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.3479830050688711,0.7851517258205801,0.71875,0.9238643428155014,1.0,4/15,18.77%,PTK2B;DYRK1A;TEC;AATK
prerank,anion transport (GO:0006820),0.3001972826666127,0.7845912372662394,0.7636594663278272,0.9242755791838022,1.0,3/33,7.11%,LRRC8D;SLC4A2;VDAC2
prerank,response to glucagon (GO:0033762),0.33506153878051553,0.7845003781301212,0.7466307277628033,0.9240283852162487,1.0,7/19,18.51%,ADCY5;PRKAR2A;ADCY8;ADCY3;CREB1;ADCY7;ADCY9
prerank,Golgi to plasma membrane transport (GO:0006893),0.2786434967289886,0.7840678814184284,0.7775147928994083,0.9243028274703855,1.0,10/47,13.99%,LLGL1;ARFGEF2;GGA1;RAB31;EXOC5;ARL3;GOLGA4;NSF;OPTN;PREPL
prerank,regulation of autophagosome maturation (GO:1901096),0.3508012226537187,0.7840372704779772,0.7193798449612403,0.9239715624664859,1.0,2/13,5.18%,FYCO1;RUBCN
prerank,positive regulation of transmembrane transport (GO:0034764),-0.3037469394845217,-0.7837695137893901,0.7804154302670623,0.9812345823216748,1.0,3/13,6.10%,C2CD5;ACSL1;BRAF
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.28496366964623937,0.7833597521064286,0.8096385542168675,0.9245894810785081,1.0,9/46,15.91%,PIN1;SIRPA;SEMA6A;PTPRC;PTPRR;TNIP1;SYNJ2BP;CNKSR3;FLCN
prerank,mitochondrial fission (GO:0000266),0.3380812926938431,0.7828369564665995,0.7360703812316716,0.9249657481873731,1.0,6/16,20.32%,DNM2;MTFP1;GDAP1;MTFR1L;MFF;MIEF1
prerank,melanosome organization (GO:0032438),0.3067074665588768,0.7823484059751141,0.7727272727272727,0.9253091479146308,1.0,4/26,13.98%,BLOC1S6;AP1M1;RAB32;AP1G1
prerank,mesenchymal cell development (GO:0014031),0.33089178271405983,0.7823410113350994,0.7361702127659574,0.9249454611066746,1.0,3/18,10.36%,KLHL12;TAPT1;PEF1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.27601171578609496,-0.7822048658857519,0.7840531561461794,0.9823928578078656,1.0,7/19,19.48%,TGFBR3;ERBB4;NOTCH1;FGFR2;ZFPM2;BMPR1A;FGF2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.3039310198976694,0.7819129173021304,0.7608695652173914,0.9251914026288628,1.0,6/29,14.89%,MID1IP1;APOE;CTDNEP1;CNEP1R1;CREB1;MTOR
prerank,regulation of nuclear division (GO:0051783),0.3230909933844753,0.7816628369334485,0.765034965034965,0.9251815986710608,1.0,2/20,10.61%,PIN1;RCC1
prerank,nucleus organization (GO:0006997),0.28405313942628435,0.7815313695859485,0.7945205479452054,0.9249902472784647,1.0,9/47,15.64%,VPS4A;LEMD2;NDC1;PDCD6IP;SUN2;CTDNEP1;LEMD3;NUP98;NUP54
prerank,establishment of endothelial barrier (GO:0061028),0.3041475615777914,0.7811361422387229,0.761528326745718,0.9251881816549724,1.0,8/29,21.66%,MARVELD2;MSN;PPP1R16B;ICAM1;RAP1B;RAP2B;TJP1;RAPGEF1
prerank,cGMP-mediated signaling (GO:0019934),0.3480716286685799,0.7810777440186467,0.7432432432432432,0.9249012146111651,1.0,2/13,8.17%,APOE;HTR2C
prerank,regulation of mast cell degranulation (GO:0043304),0.34929931636851974,0.7809509154922171,0.7557959814528593,0.9246941821474194,1.0,1/14,2.60%,CD84
prerank,magnesium ion transport (GO:0015693),-0.3100461840691796,-0.7808584420028617,0.744807121661721,0.9831352735053627,1.0,6/12,23.78%,NIPA2;MRS2;NIPAL3;CNNM4;SLC41A1;NIPAL4
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.35634437882830583,0.7805808742536218,0.7554858934169278,0.9248898889994244,1.0,4/13,20.86%,CACNA1G;SYT1;SYT4;SYT10
prerank,cellular response to cAMP (GO:0071320),0.30350257447302065,0.7805778736694348,0.7526315789473684,0.9245245915835968,1.0,3/30,9.42%,INPP5K;AKAP6;AKAP9
prerank,regulation of cholesterol efflux (GO:0010874),0.2971259603991973,0.780537296786353,0.7693282636248415,0.9242122383192006,1.0,6/30,16.45%,APOE;ZDHHC8;LRP1;SIRT1;GPS2;RXRA
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.3304000166424122,-0.7801613027591773,0.7348484848484849,0.9828363871687231,1.0,6/10,22.98%,CCT4;TCP1;CCT2;CCT5;DKC1;WRAP53
prerank,steroid biosynthetic process (GO:0006694),-0.20264455346126814,-0.7801602649828682,0.9285714285714286,0.9813430513288696,1.0,18/56,30.10%,OSBPL6;INSIG2;FDFT1;LBR;PRLR;CH25H;ACOT8;CYP51A1;OSBPL9;INSIG1;PMVK;FDXR;SQLE;LSS;CYP39A1;EBP;AMACR;DHCR7
prerank,protein localization to membrane (GO:0072657),0.24670695720126753,0.7801201348400439,0.8837920489296636,0.9244331649252112,1.0,25/187,9.67%,EPHA2;PDZD11;TM9SF4;INPP5K;BID;WDR19;NDC1;FGF13;IKBKB;FLOT2;RAB8B;LIN7C;JUP;ITGAL;TSPAN14;MRAP2;SMURF1;EFR3B;ARL3;ZDHHC3;SLMAP;P2RY1;ANK1;EHD4;ATP1B1
prerank,heart looping (GO:0001947),0.2908888166645201,0.780113021591585,0.7691358024691358,0.924070595623772,1.0,4/40,9.23%,TGFBR2;BBS4;ENG;MICAL2
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.34733971473856784,0.7800320332530241,0.7537764350453172,0.9238092844899548,1.0,3/15,10.87%,PRKD2;SMOC2;TMSB4X
prerank,regulation of lamellipodium organization (GO:1902743),0.356739884322242,0.7799158688814685,0.7237048665620094,0.9236062158487363,1.0,1/14,1.25%,EPHA2
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.3737411510420865,0.7798285802252762,0.7416798732171157,0.9233545486586445,1.0,3/11,12.70%,UQCRC1;UQCRB;UQCRFS1
prerank,postsynaptic membrane organization (GO:0001941),0.3293414869990632,0.7796490093514296,0.7540983606557377,0.9232501496441489,1.0,5/17,16.78%,APOE;DNAJA3;LRP4;LRRC4;CEL
prerank,protein palmitoylation (GO:0018345),0.3023524760018682,0.7795452497355245,0.7684210526315789,0.9230286485238803,1.0,6/30,11.08%,CLIP3;ZDHHC9;ZDHHC7;ZDHHC8;ZDHHC3;ZDHHC21
prerank,cellular response to interleukin-2 (GO:0071352),0.37391648551168966,0.7791232146511942,0.7471451876019576,0.9228963254550322,1.0,3/11,20.40%,PTK2B;JAK1;STAT5A
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.37391648551168966,0.7791232146511942,0.7471451876019576,0.9228963254550322,1.0,3/11,20.40%,PTK2B;JAK1;STAT5A
prerank,cellular component maintenance (GO:0043954),-0.31271838004428376,-0.7787105303097679,0.7915567282321899,0.9823429734514185,1.0,2/12,4.24%,MTMR2;INSR
prerank,negative regulation of receptor internalization (GO:0002091),-0.30802777263426095,-0.7786394381970223,0.7862796833773087,0.9809876222018942,1.0,5/12,25.63%,RIN3;MTMR2;ANKRD13D;UBQLN2;ANKRD13B
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.33088114442745725,0.778541928558801,0.7514367816091954,0.9233758242939943,1.0,2/17,9.77%,AKAP6;SUMO1
prerank,modulation by symbiont of entry into host (GO:0052372),-0.2721712282208939,-0.7781992439077611,0.7896440129449838,0.9802053601141768,1.0,3/16,11.17%,TRIM14;EXOC2;TRIM27
prerank,regulation of transferase activity (GO:0051338),0.3378597053755782,0.7781969247254207,0.7633477633477633,0.9234854933657021,1.0,7/17,22.66%,PARP4;HMBOX1;LDB2;LDB1;NLRC5;ATM;SMG6
prerank,clathrin-dependent endocytosis (GO:0072583),0.31306796708902257,0.7778471133661896,0.7642384105960265,0.923624417302289,1.0,12/26,22.52%,PICALM;AP2A1;CLTC;INPP5F;AP2M1;LMBRD1;ITSN1;SGIP1;GAK;PIP5K1C;ITSN2;CLTB
prerank,fatty acid elongation (GO:0030497),0.3501911527093836,0.7777210982989666,0.7598736176935229,0.9234393331811369,1.0,5/13,23.95%,ELOVL1;ELOVL7;ELOVL6;HACD1;HACD2
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.35593426753042234,0.7773153288743243,0.7362637362637363,0.9236782685047726,1.0,1/12,2.87%,UCKL1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.2823217937772484,0.7772309785063187,0.801452784503632,0.923424647635503,1.0,13/49,19.48%,RAB7B;EIF6;HDAC1;CNOT4;KMT2B;KMT2D;KMT2A;RUNX1;SIN3A;AGO3;TNRC6C;MEF2C;PRMT1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.3172264233740861,-0.7766317651921569,0.782051282051282,0.9812997462144577,1.0,6/11,29.92%,NOVA1;PCBP1;NOVA2;IGF2BP2;IGF2BP3;PCBP4
prerank,Ras protein signal transduction (GO:0007265),0.252485280722214,0.7763585527062533,0.8651211801896733,0.9243175300039553,1.0,35/137,19.49%,ARHGDIA;JUN;COL1A2;ABI2;RHOB;RHOG;ADGRG1;NCKAP1;TRIM28;CDC42EP3;RALB;NRAS;CYFIP1;KSR2;RASGRP3;GNB1;SETDB1;LIMK1;IGF1;ARHGAP5;USP8;SOS1;DBNL;RAC1;MYO9B;ARHGAP1;RASGRP2;ARHGEF3;KRAS;TIAM1;RAP1B;CDH13;RGL2;ELMO1;RAP2B
prerank,androgen metabolic process (GO:0008209),0.3269301224735567,0.7762965143456242,0.7643758765778401,0.9240341540239368,1.0,2/18,15.17%,SPP1;MED1
prerank,regulation of synapse assembly (GO:0051963),0.2796587844353449,0.7762104739293495,0.7938271604938272,0.9237848765869511,1.0,13/46,19.99%,DLG5;SLITRK3;CLSTN1;PTPRD;BDNF;VPS35;APP;SYNDIG1;MEF2C;LRFN5;TLR2;GPC6;SNCA
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.3240370162932489,0.7758136488334884,0.7763347763347763,0.9239847404136907,1.0,3/20,10.92%,TGFBR1;ENG;RBPJ
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.29384225903468336,0.7757171986867253,0.7779204107830552,0.9237532309526802,1.0,6/36,11.40%,FZD5;FZD6;TCF7L2;CTNNB1;GNB1;GNAO1
prerank,cellular response to gamma radiation (GO:0071480),-0.2704859221329246,-0.7754826501705118,0.7993311036789298,0.9816810996294463,1.0,11/17,36.84%,TLK2;HSF1;RPL26;WRN;ATR;CRYAB;TMEM109;HRAS;YAP1;MDM2;TP53
prerank,aortic valve morphogenesis (GO:0003180),-0.23598418095459628,-0.7749085063587965,0.8252032520325203,0.9811793622780977,1.0,6/30,18.64%,ROBO1;ROCK2;NOTCH1;ROBO2;RB1;SLIT2
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.3265340549719321,0.774053916010709,0.763235294117647,0.925739349411231,1.0,5/18,17.45%,COLGALT1;DDR2;IL6;RUNX1;SMAD3
prerank,nuclear transport (GO:0051169),-0.27425566365029785,-0.7740009998805204,0.7893175074183977,0.9811801296095407,1.0,9/16,43.27%,ANP32A;NUTF2;RGS14;AAAS;NXT2;RSRC1;NXT1;RBM15B;BANF1
prerank,protein localization to plasma membrane (GO:0072659),0.2518937025284671,0.7739938121335851,0.868421052631579,0.925454301423313,1.0,18/129,9.67%,EPHA2;INPP5K;NECTIN3;FGF13;IKBKB;FLOT2;RAB8B;JUP;TSPAN14;MRAP2;SMURF1;EFR3B;ZDHHC3;SLMAP;P2RY1;ANK1;EHD4;ATP1B1
prerank,regulation of JUN kinase activity (GO:0043506),0.2955067663267964,0.7737987542672329,0.7827191867852605,0.9253581198080392,1.0,3/33,8.75%,DVL2;DUSP19;DNAJA1
prerank,termination of RNA polymerase II transcription (GO:0006369),0.2935143633429306,0.7737908569378654,0.7859007832898173,0.92500294772787,1.0,7/33,15.02%,SLBP;TTF2;NCBP1;FIP1L1;SETX;SNRPG;SYMPK
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.21359682691385706,-0.7737715112590623,0.8497109826589595,0.9800721151362158,1.0,15/42,25.76%,KLHL15;PARP1;SPIDR;WDR48;FBH1;ERCC6;UBQLN4;HELB;RIF1;SMCHD1;PPP4C;WRAP53;MRNIP;RTEL1;MMS19
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.34351278993255907,0.7736550072429563,0.7685185185185185,0.9248156969214311,1.0,6/15,21.33%,AGT;IGF1;MEF2A;SLC9A1;IL6ST;CAMK2D
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.35085759430605096,0.77355841122001,0.7571428571428571,0.9245723210338346,1.0,5/13,23.95%,ELOVL1;ELOVL7;ELOVL6;HACD1;HACD2
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.3270631688385266,-0.7735579501087779,0.754054054054054,0.978948117894212,1.0,5/10,21.70%,DSE;B3GAT3;CSGALNACT2;XYLT2;B3GAT2
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.30543779119778186,0.7730245150581879,0.7578659370725034,0.9249604080938506,1.0,5/26,12.57%,SHANK1;RIMS1;PTK2B;PRKCZ;APP
prerank,cell-matrix adhesion (GO:0007160),0.257718681136439,0.7729181856606289,0.834941050375134,0.9247384104076826,1.0,6/95,6.48%,ADAMTS12;BCAM;ZYX;ADAM9;ITGB3;ITGAL
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.31417518764344504,0.77252665908778,0.7540983606557377,0.924920446946975,1.0,5/22,20.62%,DGKZ;PRNP;GPS2;DUSP3;THY1
prerank,plasma membrane tubulation (GO:0097320),0.3532566718912523,0.7719422693887004,0.7715582450832073,0.9253890887817873,1.0,6/13,21.99%,SNX33;PACSIN2;WHAMM;MICALL1;BIN3;PACSIN1
prerank,regulation of filopodium assembly (GO:0051489),0.28219597744606784,0.7718552973605438,0.7776381909547738,0.9251355680115942,1.0,9/38,15.12%,FXR2;PIK3R1;TENM2;RHOQ;TRPM2;FMR1;MYO10;PPP1R16B;GPM6A
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.33819888898574557,0.7717287865893105,0.7343976777939042,0.924955438542437,1.0,4/16,16.23%,VPS28;STAM;TMEM50B;VTA1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.2531318085428563,-0.7712298558088707,0.8181818181818182,0.9811939865120478,1.0,7/23,22.33%,OCIAD1;ERBB4;NOTCH1;CENPJ;IL10RA;IL7R;KIT
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.30676232790707236,0.7712278218419477,0.7547945205479452,0.9253254063742483,1.0,3/25,5.90%,HSP90AB1;PSME3IP1;TAF1
prerank,negative regulation of DNA recombination (GO:0045910),0.2821398813220386,0.7707849150266708,0.81375,0.9255687618746647,1.0,10/43,19.34%,POLR2J;ACD;RADX;MSH3;POLR2E;POLR2B;POLR2G;CGAS;POLR2K;TERF2IP
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.26970265203349963,0.7705415748055829,0.8190148911798396,0.9255386190330993,1.0,17/65,21.20%,RHBDF2;PLAUR;RNF115;PTPN12;AGT;DGKD;STAM;EPS15L1;DOK1;CCDC88A;EPN1;CDH13;DUSP3;BCAR3;EPS15;CDC42;DAB2IP
prerank,cilium assembly (GO:0060271),0.241668841406726,0.7702436138553279,0.9433771486349848,0.9255836500289668,1.0,41/297,14.24%,CCDC13;SFI1;CFAP70;SSNA1;CEP126;ATP6V1D;ATP6V0D1;WDR19;HDAC6;ATAT1;ARL6;RAB8B;DYNLT2B;ASAP1;RSPH9;TRAPPC14;CFAP46;TRIP11;CSNK1E;BBS4;EXOC5;ARL3;LZTFL1;TUBB;EHD4;HAUS8;AKAP9;TRAF3IP1;EXOC7;DCTN3;SSX2IP;IFT43;PAFAH1B1;TTC8;IFT172;OCRL;RP2;GBF1;DYNC2H1;CEP250;ARF4
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.3348135345390184,0.7701368609315009,0.7566371681415929,0.9253763079798434,1.0,2/16,4.79%,SSBP1;MCM2
prerank,organic substance transport (GO:0071702),0.2525481817673892,0.7699873423004924,0.8636847710330139,0.9252230625066679,1.0,23/121,19.29%,MYH9;ARL6IP5;ARRDC2;SLC23A1;SLC22A4;NDC1;CLN8;PEX3;PPT1;TCN2;CMTM6;TOM1;SLC6A2;SLC18A1;SPNS2;MFSD12;PICK1;TAP2;RAB7A;HSP90B1;ATP8A1;ARRDC4;SNX4
prerank,leukotriene biosynthetic process (GO:0019370),-0.28542654465624656,-0.7693431649456375,0.7774647887323943,0.9828786640215385,1.0,5/14,21.06%,LTC4S;ALOX5;GGT5;LTA4H;GGT7
prerank,synaptic vesicle cycle (GO:0099504),0.29788225356889003,0.7688269025586689,0.7846153846153846,0.9264674772055392,1.0,3/30,6.19%,BRSK1;RIMS1;SLC32A1
prerank,alcohol catabolic process (GO:0046164),0.36612244803754684,0.7687909867336227,0.7416798732171157,0.9261534958429473,1.0,3/10,21.94%,APOE;CEL;CYP27A1
prerank,myelination in peripheral nervous system (GO:0022011),0.35131285254836225,0.7683590785301209,0.7472527472527473,0.9263714019879098,1.0,3/13,15.51%,CNTNAP1;SIRT2;ARHGEF10
prerank,artery development (GO:0060840),-0.2503173573756806,-0.7683184400799533,0.8153310104529616,0.9831203838166063,1.0,7/23,20.92%,ROBO1;BMPR2;ROBO2;PKD2;NRP1;VEGFA;ACVRL1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.3691660050689831,0.7679079238392772,0.7587939698492462,0.926603633087577,1.0,2/10,13.93%,KMT5A;SETD7
prerank,regulation of mitochondrial fission (GO:0090140),-0.243291090730301,-0.7675941187143472,0.8226950354609929,0.982797053321434,1.0,7/24,19.11%,STAT2;RALA;LRRK2;BNIP3;FIS1;DCN;DNM1L
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.37492081150080603,0.7670951067354123,0.7549668874172185,0.927363173043161,1.0,3/10,12.12%,FURIN;RIC1;ANXA2
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3190864312091732,0.7667058776163094,0.7741046831955923,0.9275575795200326,1.0,5/21,17.06%,G6PC3;DERA;PGM2L1;TKT;PGD
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.3210062681353856,0.7663925665047915,0.7744154057771664,0.9276467482556623,1.0,3/19,12.75%,GMPR2;PNP;AMPD2
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.2599000131295182,0.7660152935281777,0.8409343715239155,0.9277953983500735,1.0,25/73,22.51%,HDAC6;GLMN;MYO1C;TBP;BAZ1B;DDX21;SPI1;HDAC5;DNMT3A;AEBP2;POLR2E;TDG;CTCF;ACTB;SMYD5;KAT2A;EZH2;RBBP4;POLR2K;POLR1A;POLR1G;SMARCA5;PHF1;PHF2;MYBBP1A
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.21387423065949718,-0.7659176088480171,0.8953488372093024,0.9840182084499143,1.0,5/38,6.61%,JAK2;HSP90AA1;ROCK2;INSR;CD34
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.2868033610929305,-0.765486801091218,0.8181818181818182,0.9832135093145677,1.0,7/15,33.86%,BMPER;FGF2;VEGFA;PDPK1;S100A1;KLF4;JMJD8
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.323865457392901,0.7653265990805962,0.7685459940652819,0.9284135429751416,1.0,3/18,9.32%,PCID2;NXF1;IWS1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.2746047277096936,-0.7650380104198654,0.7931034482758621,0.9823857225037705,1.0,9/17,27.90%,COX7B;COX8A;NDUFA4;COX4I1;COX6A1;COX15;COX7C;CYCS;COX5B
prerank,lipid modification (GO:0030258),0.28990310890367277,0.7650296887948772,0.7972465581977471,0.9284592928524681,1.0,6/37,15.11%,SGPP2;PLPPR4;DGKZ;DGKD;DGKQ;PLPP1
prerank,telomere maintenance via telomerase (GO:0007004),0.29698363783744264,0.7647800410728126,0.7792732166890982,0.9284294158094196,1.0,4/28,8.65%,ACD;HSP90AB1;PTGES3;PPP6R3
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.32208774464135087,-0.7647756041786918,0.7513089005235603,0.9813276045778446,1.0,5/10,28.23%,FCGR2B;ARRB2;CX3CR1;LILRB1;CEACAM1
prerank,cardiac conduction system development (GO:0003161),0.3070811390362276,0.7642664644698337,0.7919463087248322,0.9287637417805956,1.0,5/24,23.58%,CACNA1G;MAML1;GJA1;SMAD5;NOTCH2
prerank,ventricular septum development (GO:0003281),0.2852518149084407,0.7636416155982498,0.7916666666666666,0.9292538197114364,1.0,4/37,5.39%,MATR3;MDM4;TGFBR1;TGFBR2
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.34277221285946036,0.7633072080528066,0.7769461077844312,0.9293400116523705,1.0,2/14,8.49%,ADSS2;GART
prerank,regulation of intracellular signal transduction (GO:1902531),0.23839041039434256,0.7630829250891286,0.96996996996997,0.9292978749081817,1.0,93/420,19.14%,CASTOR1;ARHGDIA;SQSTM1;RRAGC;PRKD2;AKAP5;ARHGAP30;USP2;RICTOR;PIN1;KMT5A;ITFG2;KALRN;KAT5;RELA;NOP2;RHOB;MDM4;TMEM127;RHOG;ARHGEF26;TAF15;PPP2R5B;TAF1;CMKLR1;TAF12;RHOU;CHD4;ARHGEF4;IER3;AKAP6;ARHGEF6;SGMS1;TBP;TP53RK;GMIP;PYCARD;PHLPP1;ARHGAP22;NBN;FGD1;RHOQ;HDAC1;TAGAP;TMSB4X;PRKAG1;TAOK2;UFL1;MYO9A;TAF6;WWC2;TNIK;PRKAR2A;TRIO;SRGAP2;SRGAP3;ANKRD54;OCRL;ENTPD5;OPTN;ARHGAP5;CRK;TRAF3;ATP6AP2;PRKAB1;PPP1R16B;TMBIM4;MTOR;SOS1;RALBP1;ARHGAP17;RAC1;FLCN;MYO9B;RNF34;PRDM11;ARHGAP1;ARHGAP32;ARHGEF3;ARHGEF2;SLC15A4;TIAM1;TOPBP1;ITSN1;RBBP4;PLK3;SGK1;ARAF;PRKAA1;TTC5;ARHGAP25;NTRK2;ARHGAP24
prerank,vascular process in circulatory system (GO:0003018),-0.2927191622101167,-0.7626082433179164,0.7716763005780347,0.9817535536104303,1.0,5/13,27.76%,ROCK2;GCLM;ITGB1BP1;ADCY6;ROCK1
prerank,regulation of tube diameter (GO:0035296),-0.2927191622101167,-0.7626082433179164,0.7716763005780347,0.9817535536104303,1.0,5/13,27.76%,ROCK2;GCLM;ITGB1BP1;ADCY6;ROCK1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.3484187783678404,0.7619343053630969,0.7522935779816514,0.9304550121069551,1.0,4/12,21.27%,GCNT2;FLOT1;THY1;CD44
prerank,cellular response to radiation (GO:0071478),-0.20980034469708833,-0.7617371168617936,0.8857142857142857,0.9816534104369328,1.0,18/40,35.10%,GRB2;SPIDR;CLOCK;BLM;MAPK14;RAD9B;RHNO1;EEF1D;RAD9A;KDM4D;TNKS1BP1;HUS1;GADD45A;CDKN1A;RAD1;NET1;ECT2;RAD51AP1
prerank,retina homeostasis (GO:0001895),0.3073339002493375,0.7616575751256407,0.7793103448275862,0.9304623327406184,1.0,4/23,15.46%,BBS4;ACTG1;POTEF;ACTB
prerank,long-term synaptic potentiation (GO:0060291),-0.2598961611294943,-0.7616022555242581,0.8362989323843416,0.9803825821426942,1.0,5/21,14.36%,GRIN2B;TSHZ3;SLC8A3;VAMP2;SHANK2
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.313107600882492,0.7610759027045702,0.7726027397260274,0.9308708651725244,1.0,4/21,11.10%,PCID2;DELE1;PYCARD;SOX2
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.2158615066301694,-0.760849059491873,0.8870056497175142,0.9801041875999688,1.0,8/39,14.66%,FGF12;YWHAH;UTRN;WNK2;PRKCE;WNK3;GPD1L;FXYD5
prerank,nucleoside salvage (GO:0043174),0.36744355438937765,0.7608324320918152,0.7528830313014827,0.9308253105702022,1.0,1/10,2.87%,UCKL1
prerank,dendritic spine morphogenesis (GO:0060997),0.3340614959219357,0.7607187273305821,0.7518796992481203,0.9306032136683292,1.0,5/15,21.09%,SHANK1;DOCK10;WASL;CDC42;DIP2A
prerank,protein lipidation (GO:0006497),0.26484364099189484,0.760040108201985,0.8283062645011601,0.9311297047649278,1.0,16/59,15.73%,PIGQ;ZDHHC9;PIK3C3;ZDHHC7;ZDHHC8;ZDHHC3;DPM1;ZDHHC21;PIGN;PIGM;PGAP4;WIPI1;ZDHHC5;PIGP;DPM2;PIGF
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.2867687172719623,0.759599361440254,0.8066914498141264,0.931388861232172,1.0,8/38,13.95%,IL34;PDGFB;AGT;PTPRC;PRNP;SH3BP5L;APP;FCGR1A
prerank,sulfur compound transport (GO:0072348),-0.2308341705608684,-0.7594977801491951,0.8677685950413223,0.9807621540453081,1.0,15/27,35.57%,ABCG2;SLC26A11;SLC25A26;SLC35F3;SLC25A30;SLC25A19;SLC25A11;SLC19A2;RACGAP1;SLC35B2;MGST1;SLC27A1;SLC26A8;SLC26A6;SLC25A10
prerank,lipid oxidation (GO:0034440),-0.30809680032037723,-0.7584335993519932,0.7690140845070422,0.9808780826852845,1.0,4/12,21.87%,PLA2G7;PPARGC1A;ALOX5;ACOX1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.34638980699492056,0.7582680068009222,0.7769347496206374,0.932836771411078,1.0,1/13,0.61%,STAT3
prerank,purine ribonucleotide transport (GO:0015868),0.325146673223812,0.7580996962347545,0.7723342939481268,0.9327157405547484,1.0,2/16,4.44%,LRRC8D;ABCC5
prerank,activation of phospholipase C activity (GO:0007202),-0.23592358824379595,-0.7573626857048198,0.8405172413793104,0.981082928372745,1.0,12/29,33.69%,P2RY12;PLCG1;HTR2B;C5AR1;ADRA1A;PHB2;ANG;EDNRA;HTR2A;RASGRP4;ARHGAP6;TXK
prerank,autophagy of mitochondrion (GO:0000422),0.28064695874554,0.7573440635479608,0.8007518796992481,0.9334102364580282,1.0,6/38,11.61%,SQSTM1;GABARAP;GABARAPL1;MAP1LC3A;MAP1LC3B;FUNDC2
prerank,monoacylglycerol metabolic process (GO:0046462),-0.2909707393939128,-0.7570901531293472,0.814404432132964,0.9800431714949145,1.0,4/13,19.15%,MGLL;MOGAT3;ABHD12;DGAT1
prerank,diacylglycerol metabolic process (GO:0046339),0.30820338173263495,0.7569781484852435,0.8043775649794802,0.9335502400973559,1.0,7/23,20.95%,DGKZ;DGKD;DGKQ;DAGLA;DGKH;DGKG;MOGAT1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.36480060677507065,0.7563129637570434,0.7612179487179487,0.9340690023969225,1.0,4/10,23.16%,SIRT2;APC;CDC42;RCC2
prerank,Golgi to lysosome transport (GO:0090160),0.35469014412863736,0.7554960906524714,0.7467741935483871,0.9347781543916632,1.0,5/11,21.02%,AP1G1;SORT1;GAK;LAMP1;CCDC91
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.2800649458867128,0.7545912673927959,0.8272383354350568,0.9356073361933775,1.0,8/36,13.99%,NECTIN3;GGA1;RAB31;GOLGA4;NSF;OPTN;GORASP2;PREPL
prerank,mitotic recombination (GO:0006312),0.3355792136564192,0.7543773094426891,0.765990639625585,0.9355314244028474,1.0,3/15,10.15%,RAD52;TPRKB;MSH3
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.289171445184352,0.7540056695340318,0.7956577266922095,0.9356752422748814,1.0,5/31,11.89%,UBE2S;PIN1;DCUN1D1;UBE2L3;MAGEC2
prerank,negative regulation of wound healing (GO:0061045),-0.23041348047683652,-0.7527941122913805,0.8949416342412452,0.984892727391214,1.0,9/28,19.48%,CD34;CLASP2;CASK;PTEN;TFPI;ALOX5;PHLDB2;AJAP1;FGF2
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.24670064173348982,-0.7523774354938553,0.8287937743190662,0.9840857519891761,1.0,3/22,5.49%,SH3GL2;STMN2;MAGI2
prerank,cell differentiation in spinal cord (GO:0021515),-0.31904936439926435,-0.7523412835997021,0.7737226277372263,0.9826862193556476,1.0,4/10,29.48%,SOX6;MDGA2;SOX4;SOX13
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.2803328572513765,0.7519501543555869,0.8124207858048162,0.9380156105449363,1.0,8/40,13.60%,HNRNPK;SERPINE1;PPT1;DGKD;ARRB1;CLU;ANXA2;FMR1
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.2107304313168465,-0.7517579124334697,0.8956043956043956,0.9821156834651718,1.0,12/40,26.29%,BMPR2;TMEM119;ATRAID;SLC8A1;ALOX5;NELL1;BMPR1A;ATP2B1;PKDCC;ADGRV1;ACVR2A;P2RX7
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.2698948278387827,0.7513290776463523,0.827503015681544,0.9384748977189984,1.0,12/52,17.17%,MAGOH;HNRNPU;FXR2;ZBTB7A;SRSF12;HNRNPL;DDX5;FMR1;PTBP1;RBM8A;HNRNPA1;NSRP1
prerank,establishment of epithelial cell polarity (GO:0090162),-0.26309304461295246,-0.7513095750118745,0.8323699421965318,0.9813586332908599,1.0,8/19,27.95%,RHOA;GOLPH3;PARD3;CYTH3;CYTH1;RAP2A;CLASP1;OPHN1
prerank,establishment of apical/basal cell polarity (GO:0035089),0.3291205467000978,0.7508935381768943,0.7924528301886793,0.9386841211407859,1.0,4/14,13.41%,SH3BP1;MSN;MYO9A;SCRIB
prerank,regulation of nervous system process (GO:0031644),-0.2625756763176934,-0.7501095687404183,0.8217821782178217,0.9817274457930817,1.0,6/18,18.70%,ROCK2;SLC8A3;DLGAP2;CHRNA7;DLGAP4;DLGAP1
prerank,glucan catabolic process (GO:0009251),-0.2745111567055604,-0.7500118384410039,0.8018018018018018,0.980448789990953,1.0,4/15,17.06%,CALM1;PYGL;PYGB;PHKA1
prerank,regulation of chromatin binding (GO:0035561),0.36697985792300336,0.7496613964049007,0.7868852459016393,0.9399358028783913,1.0,4/10,15.92%,BTAF1;HMBOX1;MED25;WAPL
prerank,neural crest cell differentiation (GO:0014033),0.31949904563027753,0.7493684186360684,0.7720797720797721,0.9399692265807386,1.0,6/18,18.17%,KLHL12;TAPT1;PEF1;FBXL17;PDCD6;MEF2C
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.32432914006642644,0.7492331745167227,0.7675438596491229,0.9397879659784502,1.0,4/16,13.08%,HNRNPM;DHX9;SFPQ;DDX5
prerank,positive regulation of vascular permeability (GO:0043117),-0.2898527236911824,-0.7491389527223987,0.7869318181818182,0.9803265078796943,1.0,4/12,21.53%,TJP2;ANGPT1;VEGFA;TRPV4
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.30336177205396625,0.7489994508574465,0.7903871829105474,0.9397253736648435,1.0,9/23,20.70%,PFKFB3;PDGFB;IGF1;APP;ENTPD5;NFKB1;PFKFB2;PRKAA1;MLXIPL
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.3338301511098727,0.7486662966077998,0.7834586466165413,0.9397853963309943,1.0,2/16,3.98%,ETF1;HDAC6
prerank,organic cation transport (GO:0015695),0.30690055332553445,0.7476527014103512,0.7804195804195804,0.9407601760380451,1.0,3/20,16.10%,SLC22A4;RALBP1;SEC14L1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.33980845867848775,0.7474932037665473,0.7701674277016742,0.9405927697551689,1.0,5/13,21.90%,PLXNA1;NRP2;SEMA3A;PLXND1;PLXNA2
prerank,telomere maintenance via recombination (GO:0000722),-0.29648233822242887,-0.7469615109080745,0.8025974025974026,0.9821287062208903,1.0,6/11,32.69%,TEP1;RAD51D;NSMCE2;SMC5;RAD50;ERCC1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.34471603468800444,0.7466520081154344,0.7767145135566188,0.9413061227389042,1.0,2/12,10.77%,CHAC2;HAGH
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.29375843611212327,0.7458773967251943,0.8141361256544503,0.9419528375206765,1.0,8/28,20.63%,ZBTB7A;TCIM;ARRB1;LFNG;YTHDF2;MMP14;ARRDC1;METTL3
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.2702897874968474,0.7456025564006755,0.8373493975903614,0.9419466349203017,1.0,7/46,13.71%,TIMM8B;DNAJC19;TOMM20;GDAP1;TIMM44;DNAJC15;TIMM9
prerank,telomere capping (GO:0016233),0.32129990018818577,0.7449694914348653,0.7703488372093024,0.9424185519825601,1.0,3/16,9.60%,ACD;STN1;NBN
prerank,regulation of cellular component size (GO:0032535),0.2906489354982764,0.7445164677728541,0.8155467720685112,0.9426521561051795,1.0,9/30,18.46%,ATP13A2;PICALM;RAP1GAP2;LARS1;MSN;MTOR;RAC1;AP2M1;RPTOR
prerank,cellular glucose homeostasis (GO:0001678),0.28040818102089765,0.7442186336664083,0.835633626097867,0.9426583146181957,1.0,10/41,18.47%,SLC39A14;LRRC8D;PIK3R1;SIRT1;PDK3;ADCY8;FOXK2;PAX2;UNC13B;PRKAA1
prerank,electron transport chain (GO:0022900),-0.2765874330499821,-0.743966172183549,0.8432601880877743,0.9849092666202628,1.0,6/15,25.26%,ENOX2;PPARGC1A;SDHA;PDIA5;ETFDH;ETFRF1
prerank,ceramide transport (GO:0035627),-0.2922086305377056,-0.7436858026201559,0.8,0.9838656517382522,1.0,2/12,7.49%,ABCB4;GLTP
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.22474709606015164,-0.7435761898637564,0.8760330578512396,0.9811813466216543,1.0,11/29,30.13%,CROT;ACBD6;ACSF2;ACSL6;ACOT11;ACOT8;THEM4;ACOT9;MLYCD;OXSM;ACOT6
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.22474709606015164,-0.7435761898637564,0.8760330578512396,0.9811813466216543,1.0,11/29,30.13%,CROT;ACBD6;ACSF2;ACSL6;ACOT11;ACOT8;THEM4;ACOT9;MLYCD;OXSM;ACOT6
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.23528424976371526,-0.7433266911686666,0.8846153846153846,0.9801106695572496,1.0,7/25,24.94%,ANK2;PLCG1;CAPN3;CACNB2;CX3CL1;CEMIP;PDPK1
prerank,regulation of microtubule nucleation (GO:0010968),-0.31633185595789204,-0.7430775471910236,0.8098958333333334,0.9790835950293487,1.0,1/10,2.86%,CKAP5
prerank,regulation of neuron projection development (GO:0010975),0.2397058865962253,0.7427688351618678,0.9123711340206185,0.9442066570392259,1.0,26/163,13.88%,BRSK1;NDEL1;KIDINS220;ABI2;EFHC2;RUFY3;ABL2;APOE;RETREG3;BRSK2;PTK2B;CAMK2G;ITM2C;SCN1B;BDNF;CDKL5;PTPRO;EPHA3;SCARB2;TOX;MYLIP;LPAR1;ROR1;NPTN;SETX;DENND5A
prerank,cholesterol metabolic process (GO:0008203),0.2531216798118281,0.7419186409362968,0.8602029312288614,0.9449158521277293,1.0,10/68,16.78%,FDX1;APOE;STARD3;ACLY;CLN8;OSBPL1A;MSMO1;HMGCS1;RXRA;CEL
prerank,negative regulation of viral release from host cell (GO:1902187),-0.28438261505372187,-0.7413168146717412,0.8267045454545454,0.9801164117200399,1.0,3/13,10.07%,TRIM35;PML;CHMP3
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.23357769040060175,0.7412849641694951,0.9475277497477296,0.9453560027262095,1.0,47/260,16.67%,CFAP70;CEP126;INPP5K;ATP6V1D;ATP6V0D1;WDR19;HDAC6;ATAT1;ARL6;RAB8B;DYNLT2B;ASAP1;SDCBP;TRAPPC14;ARHGEF4;BBS4;ARHGEF6;EXOC5;ARL3;CD2AP;CYFIP1;LZTFL1;EHD4;TRAF3IP1;FGD1;EXOC7;SSX2IP;IFT43;TTC8;PTPRO;IFT172;TNIK;SRGAP2;OCRL;RP2;GBF1;DYNC2H1;CEP250;ARF4;WHAMM;FLNA;S1PR1;KIF3B;RAC1;PMP22;CFAP43;CCDC88A
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.2873406841234956,0.7410810007490308,0.8061911170928667,0.9452472398640012,1.0,4/29,8.65%,ACD;HSP90AB1;PTGES3;PPP6R3
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.2783791801907062,-0.7408025610339574,0.8213333333333334,0.979393567869619,1.0,3/14,13.93%,ATP1B3;ANK2;ATP1B2
prerank,lipoprotein biosynthetic process (GO:0042158),0.3464419909449947,0.7406948889987716,0.7953488372093023,0.9453979038514775,1.0,4/11,19.04%,APOE;PIK3C3;WIPI1;WIPI2
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.3083973164834788,0.7398783527665165,0.7902298850574713,0.9461014731261917,1.0,2/21,3.30%,MID1IP1;FGF13
prerank,response to muramyl dipeptide (GO:0032495),0.3402172997229642,0.7393970941576937,0.7851500789889415,0.9463625755379101,1.0,3/12,17.01%,ERBIN;RIPK2;ARHGEF2
prerank,regulation of developmental growth (GO:0048638),0.285909581795875,0.7385660043871052,0.8145780051150895,0.9470660375467023,1.0,7/29,17.48%,DNM2;APOE;LATS1;IGF1;APP;SIN3A;NRCAM
prerank,chromatin remodeling at centromere (GO:0031055),0.28142259247528273,0.7377515151493563,0.8172323759791122,0.9477421674976947,1.0,4/31,11.50%,CENPP;NASP;HJURP;CENPC
prerank,regulation of cell aging (GO:0090342),-0.30073065118497094,-0.7376537526221952,0.78,0.9822686042667106,1.0,5/11,21.20%,ING2;NEK4;PNPT1;VASH1;LMNA
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.31200009227038306,0.7376466760755871,0.8055152394775036,0.9475158899855526,1.0,4/18,13.30%,PRKD2;CRTC1;CD200;ADCY8
prerank,Golgi ribbon formation (GO:0090161),0.3329711958197789,0.7376401597692537,0.826645264847512,0.9471567677321653,1.0,3/13,12.70%,TMED5;TRIP11;OPTN
prerank,cell part morphogenesis (GO:0032990),-0.2831958583588142,-0.7374476763336123,0.7845303867403315,0.9811197328780864,1.0,5/13,19.86%,PID1;FIS1;PNPT1;DNM1L;SUPV3L1
prerank,regulation of cell size (GO:0008361),0.30624530764794766,0.7373443123111673,0.8045325779036827,0.9471668298579184,1.0,7/23,18.46%,PLEK;RAP1GAP2;LARS1;MSN;MTOR;RAC1;RPTOR
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.3027973913032213,0.7372154590691362,0.7638888888888888,0.9469612992603171,1.0,6/19,20.62%,COL16A1;PPM1F;LIMS1;RAC1;MAP4K4;THY1
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.2432554815319254,-0.7367918295459117,0.8740740740740741,0.9806083156044716,1.0,11/22,29.09%,NFS1;HSCB;CIAO2A;CIAPIN1;ISCU;CIAO1;MMS19;LYRM4;NUBP1;FXN;ISCA2
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.258267932323833,-0.7365014560958073,0.85,0.9795649305613308,1.0,2/18,2.44%,NGLY1;MANBA
prerank,dendritic cell differentiation (GO:0097028),0.3080111082703366,0.7363854628092302,0.8050139275766016,0.9476985444582466,1.0,3/22,11.95%,TGFBR2;IRF8;TRPM2
prerank,postreplication repair (GO:0006301),0.26704711693269356,0.7360669704128908,0.8481481481481481,0.9477731729424897,1.0,12/45,22.47%,RPS27A;UBC;PCNA;PARP10;POLD4;NSMCE1;POLD3;ZBTB1;VCP;POLI;RPA1;UBE2A
prerank,positive regulation of interferon-alpha production (GO:0032727),0.31119360125012174,0.7360284352241289,0.8045649072753209,0.9474526930166389,1.0,4/19,10.11%,TBK1;DHX9;TLR7;RIPK2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.34482170893428815,0.7357917283651673,0.7990506329113924,0.9474092130526893,1.0,1/11,1.93%,PLAUR
prerank,ovarian follicle development (GO:0001541),0.3372567182196544,0.7353965410552685,0.8037974683544303,0.9475522192848763,1.0,1/13,2.55%,EIF2B2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.3622382608829537,0.7352338153137061,0.7797147385103012,0.94738421116715,1.0,1/10,3.29%,SOX9
prerank,regulation of macrophage activation (GO:0043030),0.28120895558252756,0.7350935917152563,0.8482849604221636,0.9471937008194292,1.0,8/30,19.03%,KARS1;CD200;IL6;HSPD1;GPR137B;ZC3H12A;CEBPA;LRFN5
prerank,synaptic vesicle exocytosis (GO:0016079),0.2709214599022818,0.7348152237409701,0.83125,0.9471754348550568,1.0,4/40,4.55%,BLOC1S6;RIMS1;RIMS3;SNAP47
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.2954660128680915,-0.7346436904688838,0.8036175710594315,0.980638135822539,1.0,4/11,22.44%,BIN1;SESTD1;CACNB2;NOS1AP
prerank,cellular modified amino acid catabolic process (GO:0042219),0.322951475394133,0.7343571789579859,0.7941605839416058,0.9474091721862687,1.0,3/15,13.11%,CHAC2;GOT2;DPEP1
prerank,positive regulation of lipid storage (GO:0010884),0.3071799549841037,0.7341750000246801,0.809052333804809,0.947275790390785,1.0,5/21,17.55%,LPL;PLIN2;IKBKE;NFKB1;ZC3H12A
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.290176294676861,0.7338951617769488,0.8192457737321196,0.9472752686944265,1.0,2/26,3.59%,ADAM17;SNX6
prerank,glutathione biosynthetic process (GO:0006750),0.3447227933361282,0.7330064008922517,0.7888707037643208,0.947986278622787,1.0,2/11,10.77%,CHAC2;HAGH
prerank,protein O-linked mannosylation (GO:0035269),0.31430522570290537,0.7322283143110248,0.8192090395480226,0.9485943265928226,1.0,4/18,16.03%,FKRP;DPM1;DPM2;RXYLT1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.29431535097366135,0.7313504387429252,0.8282290279627164,0.9493167764660352,1.0,4/25,9.67%,TCAF1;STAC;AKAP9;ATP1B1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.267481372198189,0.7312978154256295,0.8489461358313818,0.9490165210383926,1.0,5/47,11.71%,PLEK;SIRPA;APOC1;WDTC1;PRMT3
prerank,retrograde axonal transport (GO:0008090),0.31933756203031366,0.731165708578908,0.798581560283688,0.9488107381279212,1.0,4/16,16.44%,FBXW11;KIF5A;PAFAH1B1;MAP1A
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.24711860569435182,-0.7311609832536756,0.8532423208191127,0.9837521450828581,1.0,13/20,39.86%,PAXIP1;RPS6KA5;PPARGC1A;MAPK3;BRD7;SOX4;BRCA1;RPS6KA4;DIP2B;RUVBL2;GLYR1;IL1B;NOS1
prerank,TOR signaling (GO:0031929),0.2927378923109825,0.7311427397605008,0.8130841121495327,0.9484766880509872,1.0,10/26,23.34%,RICTOR;NPRL3;MTOR;SYAP1;FLCN;CCDC88A;RPTOR;EIF4EBP1;EIF4EBP2;PINK1
prerank,nucleoside catabolic process (GO:0009164),-0.29658859056719067,-0.7310089817571597,0.8247422680412371,0.9825753450531283,1.0,1/11,0.65%,DPYD
prerank,regulation of pseudopodium assembly (GO:0031272),0.343060305837934,0.7296070175527448,0.7733333333333333,0.9496908121023251,1.0,3/10,20.99%,CDC42EP3;APC;CDC42
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.343060305837934,0.7296070175527448,0.7733333333333333,0.9496908121023251,1.0,3/10,20.99%,CDC42EP3;APC;CDC42
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.24795892873344622,0.7288511922644951,0.8696629213483146,0.9502849102452826,1.0,10/72,11.80%,SESN2;KAT5;MDM4;PCNA;CNOT8;CNOT6;NBN;BTG2;CNOT4;CNOT7
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.2585443180038143,-0.7287248765239516,0.8480243161094225,0.9840260518130884,1.0,9/16,36.89%,SCARB1;LDLR;SREBF1;NR1H2;GPLD1;SLC27A1;ABHD5;NR1H3;PNPLA2
prerank,negative regulation of cilium assembly (GO:1902018),0.333558272827091,0.7282801567702049,0.7848484848484848,0.9506570673401236,1.0,4/12,14.40%,MAP4;TBC1D30;EVI5L;TBC1D7
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.32296026654247706,0.7280303333427426,0.8220588235294117,0.9505961840197568,1.0,3/15,15.03%,LRP1;DDR2;IL6
prerank,DNA replication (GO:0006260),0.24063574902761578,0.7273809333345244,0.8890086206896551,0.9510470635959809,1.0,11/105,9.60%,TBRG1;WRNIP1;KAT5;MCM2;RPAIN;BAZ1A;SET;ORC5;POLG2;POLB;NBN
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.24914949614586523,0.7270746075251473,0.8781038374717833,0.9510687879331461,1.0,8/76,13.47%,CALCA;CMKLR1;AGT;HTR2C;P2RY1;GNA15;C5AR2;LPAR1
prerank,translesion synthesis (GO:0019985),0.2614983951649809,0.7269998085003151,0.858560794044665,0.9507991131371806,1.0,11/42,21.22%,RPS27A;UBC;PCNA;PARP10;POLDIP2;POLD4;POLD3;ZBTB1;VCP;POLI;RPA1
prerank,histone deubiquitination (GO:0016578),0.3066637343441263,0.7269615771681247,0.7967836257309941,0.950489123752816,1.0,7/18,21.82%,USP3;TRRAP;USP21;KAT2A;ENY2;USP16;USP36
prerank,microglial cell activation (GO:0001774),0.30111663360149526,0.7266187632722968,0.8258503401360544,0.9505599643535249,1.0,7/21,22.84%,TYROBP;CLU;APP;ITGB2;SNCA;C1QA;ITGAM
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.29750051992405435,0.7264945267153685,0.8321775312066574,0.9503465179566567,1.0,2/23,4.09%,DERL2;SEL1L
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.3175967478614251,0.7263847997271797,0.7958041958041958,0.9501144001309887,1.0,3/16,12.31%,NAA60;CREBBP;NAA50
prerank,mitotic chromosome condensation (GO:0007076),-0.22917814725755237,-0.7263378714967175,0.8970588235294118,0.9857894942245325,1.0,8/26,18.52%,NCAPD3;CSNK2A1;CSNK2A2;PHF8;NCAPG2;SMC2;RB1;CHMP1A
prerank,cellular response to interferon-beta (GO:0035458),-0.2746632440751018,-0.7258471087674704,0.8353658536585366,0.9850555578162,1.0,5/14,17.01%,STAT1;UBE2K;IRGM;IRF1;PNPT1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.2600742177515275,0.7253039830642357,0.8456937799043063,0.9510782086874149,1.0,16/48,22.51%,ZMIZ1;MYO1C;TBP;ATAD2B;BAZ1B;DDX21;POLR2E;ACTB;CDCA4;KAT2A;POLR2K;POLR1A;POLR1G;SMARCA5;PHF2;MYBBP1A
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.26380505139962573,-0.7249097573940393,0.8523076923076923,0.9848192965441739,1.0,6/16,23.73%,AKIRIN1;MAPK14;RIPOR2;HIF1AN;BTG1;LRRC8A
prerank,cellular response to ATP (GO:0071318),0.3240209592934927,0.7241175100638444,0.8200899550224887,0.952147395066325,1.0,2/14,8.37%,TAF1;P2RY1
prerank,regulation of cardiac conduction (GO:1903779),0.2585753783750798,0.7239626720511992,0.8597122302158273,0.9519885066555451,1.0,6/54,10.26%,NPPC;FKBP1B;AGT;ATP1B1;TRPC1;ASPH
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.250146693583304,0.7235371928738648,0.8802736602052451,0.9521306350131581,1.0,9/70,11.28%,BCL2L1;GABARAP;BID;BCL2L2;DELE1;ACVR1B;CASP9;DEDD2;BAD
prerank,cellular response to glucagon stimulus (GO:0071377),0.3161598670422086,0.7231719131284118,0.8282967032967034,0.9522290576612472,1.0,6/17,18.51%,ADCY5;PRKAR2A;ADCY8;ADCY3;ADCY7;ADCY9
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.23412088266104672,0.7231466600174749,0.9213836477987422,0.9518999960967689,1.0,36/158,20.41%,LITAF;LTBR;LGALS1;IKBKB;RELA;NEK6;TBK1;TMED4;RBCK1;CARD9;DDX21;RIPK2;CARD16;RNF31;CFLAR;MIER1;LPAR1;ROR1;SLC20A1;IKBKE;GOLT1B;MTDH;BRD4;FLNA;PRKCB;TRIM5;PPP5C;GJA1;ALPK1;IRAK4;TERF2IP;TRIM8;MAP3K14;NDFIP2;ANKRD17;TMEM106A
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.19636357155464848,-0.7228575206980737,0.9415204678362573,0.9859733129752832,1.0,16/44,30.10%,OSBPL6;INSIG2;LBR;PSAT1;CH25H;ACOT8;PARK7;PER2;OSBPL9;INSIG1;PMVK;SQLE;CYP39A1;EBP;AMACR;DHCR7
prerank,Rap protein signal transduction (GO:0032486),-0.3007687623017727,-0.722460683347899,0.825136612021858,0.9850678468510585,1.0,5/10,33.26%,SGSM3;RAP2C;RAP2A;RAPGEF3;PLK2
prerank,lymphocyte proliferation (GO:0046651),0.300119643189987,0.7222460416072491,0.8202247191011236,0.9526095253229727,1.0,5/22,18.17%,PTPRC;MSN;HSPD1;PIK3CG;MEF2C
prerank,regulation of histone acetylation (GO:0035065),0.27503761483355454,0.7221941858439475,0.8558786346396966,0.9523185237138334,1.0,8/33,15.91%,SET;TADA2A;SPI1;IWS1;ARRB1;HDAC5;KMT2A;FLCN
prerank,regulation of hemopoiesis (GO:1903706),0.346409354587588,0.7220630720922505,0.7929447852760736,0.952115204730829,1.0,5/10,20.19%,CREBBP;MYSM1;RUNX1;PRKCB;PTN
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.2786291037721358,0.7210802896122407,0.8267515923566879,0.9529436043179919,1.0,10/29,21.19%,TARBP2;TUT7;DGCR8;PUM2;DROSHA;AGO3;SMAD3;AGO2;METTL3;HNRNPA2B1
prerank,regulation of B cell activation (GO:0050864),0.289906978026372,0.720646260756983,0.8390501319261213,0.953112125888997,1.0,1/25,1.37%,SAMSN1
prerank,N-terminal protein amino acid modification (GO:0031365),-0.26781528627147844,-0.7205610927800226,0.8386075949367089,0.986005741283242,1.0,5/14,19.19%,METAP1D;NAA15;NTMT1;NAA16;NAA40
prerank,cellular response to virus (GO:0098586),0.28176905484448456,0.7204941667928031,0.8420348058902276,0.952937458339506,1.0,8/30,17.55%,RRP1B;GSDME;GBF1;FMR1;POU2F2;IL6;RIOK3;ZC3H12A
prerank,neuromuscular synaptic transmission (GO:0007274),-0.2441013263434413,-0.7199978650541022,0.8625429553264605,0.9853006172369123,1.0,1/18,0.18%,FCHSD2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.29166089118769556,0.7194488512677938,0.8297297297297297,0.9538642879103721,1.0,5/23,18.89%,AKAP6;MAML1;IGF1;MEF2C;MMP14
prerank,positive regulation of interferon-beta production (GO:0032728),0.2781188001304665,0.7180085539000516,0.847457627118644,0.9552535903182873,1.0,7/33,11.13%,TBK1;TRIM56;POLR3B;DHX9;TLR7;RIPK2;POLR3F
prerank,regulation of DNA replication (GO:0006275),0.25860965012562537,0.7179378278261287,0.8604091456077015,0.9549707253085818,1.0,13/49,20.22%,PCNA;PDS5A;TSPYL2;DHX9;ORC5;STN1;GTPBP4;ATAD5;WAPL;CCDC88A;BRPF3;BCAR3;ANKRD17
prerank,sulfation (GO:0051923),0.33603264281230383,0.7176339306248172,0.8015873015873016,0.9549577252977294,1.0,11/11,66.42%,HS3ST5;UST;CHST4;SULT1C4;SULT1C2;SULT2A1;CHST5;SULT2B1;SULT6B1;SULT4A1;SULT1A1
prerank,histone mRNA catabolic process (GO:0071044),0.3204539614422079,0.7175864205479818,0.7988252569750367,0.9546536876779197,1.0,7/15,23.30%,TUT7;EXOSC10;TUT1;UPF1;XRN1;ATM;SSB
prerank,embryonic heart tube morphogenesis (GO:0003143),0.26426856283674555,0.7174741522378875,0.8595848595848596,0.9544310727857692,1.0,7/44,18.17%,TGFBR2;BBS4;ENG;MICAL2;SMO;ACVR1;MEF2C
prerank,regulation of blood coagulation (GO:0030193),0.2846621410560684,0.7173597253944307,0.8247282608695652,0.9542086269896249,1.0,2/27,5.51%,SERPINE1;APOE
prerank,positive regulation of mitochondrion organization (GO:0010822),0.2520778002327565,0.7169958748370518,0.8895486935866983,0.9542659306022089,1.0,14/57,20.80%,PLAUR;BID;ADCK1;PYCARD;BAD;VPS35;CAMKK2;RALBP1;HTRA2;BMF;MFF;FBXO7;MIEF1;FAM162A
prerank,mammary gland development (GO:0030879),-0.23927399022053408,-0.7166610522153383,0.8885017421602788,0.9879730585824983,1.0,3/21,13.17%,JAK2;ERBB4;PRLR
prerank,regulation of axon regeneration (GO:0048679),0.3336384849619455,0.716178414099948,0.7993827160493827,0.9548714058006211,1.0,5/12,20.77%,INPP5F;PTPRS;CERS2;PTN;RTN4RL1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.21482530206581385,-0.7160901419499438,0.9294117647058824,0.9872683533659952,1.0,14/32,45.94%,DEFA6;RNASE7;GAPDH;RPL39;ANG;PF4;ROMO1;HMGN2;RPS19;S100A9;RNASE6;CAMP;CXCL14;PGLYRP1
prerank,regulation of B cell proliferation (GO:0030888),0.2611094318679,0.7160534587710188,0.8763769889840881,0.9546709028226393,1.0,5/44,10.61%,TYROBP;TNFSF13B;GPR183;PTPRC;RC3H1
prerank,negative regulation of response to stimulus (GO:0048585),0.24852425617883794,0.7150128794358378,0.8827751196172249,0.9555613835734338,1.0,10/60,14.27%,PDCD1;CDK6;SIRT1;PIM3;HHIP;KLF7;YBX1;CLU;COL3A1;WFS1
prerank,amino sugar metabolic process (GO:0006040),0.3455446603944913,0.7144756040775236,0.8172920065252854,0.9558329149658851,1.0,2/10,12.89%,GFPT1;CSGALNACT1
prerank,protein localization to condensed chromosome (GO:1903083),-0.28467184282263847,-0.7143265582237132,0.88,0.9879579420977245,1.0,6/12,26.67%,IK;BUB3;MTBP;ZW10;ZWILCH;KNL1
prerank,positive regulation of wound healing (GO:0090303),-0.20768322691337096,-0.7142040837237662,0.9459459459459459,0.9867245787327891,1.0,10/36,20.85%,PTK2;FERMT2;ARFGEF1;PRKCE;KANK1;ST3GAL4;XBP1;ITGB1;DMTN;ENPP4
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.3007794009692527,0.7138414444044664,0.8301886792452831,0.9562046671059709,1.0,2/17,11.28%,SOX9;BAD
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.3356275382201229,0.71380088603388,0.8084112149532711,0.9555273477008287,1.0,4/11,16.64%,LARP7;CCT8;CCT7;CCT6A
prerank,regulation of protein localization to Cajal body (GO:1904869),0.3356275382201229,0.71380088603388,0.8084112149532711,0.9555273477008287,1.0,4/11,16.64%,LARP7;CCT8;CCT7;CCT6A
prerank,hippo signaling (GO:0035329),0.2778611094841909,0.7134962578880233,0.8348993288590604,0.9555177644827249,1.0,5/26,15.56%,DVL2;MOB1B;LATS1;WWTR1;DCHS1
prerank,negative regulation of cell death (GO:0060548),0.23625435379708878,0.7134509104142114,0.9112097669256382,0.9552105356254548,1.0,16/88,17.57%,CSF1;NCK1;ATP13A2;CD200R1;SORL1;CD200;CLU;VPS35;SRGAP2;WFS1;TNFRSF1B;PAX2;BTBD10;HTRA2;GPNMB;INPP5A
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.3136940696055605,0.7131905592124692,0.8222222222222222,0.9551448201922991,1.0,1/15,3.01%,MID1IP1
prerank,negative regulation of double-strand break repair (GO:2000780),-0.21804974676490368,-0.7131140438394898,0.9363636363636364,0.9866592358886133,1.0,12/30,29.54%,KLHL15;FBH1;HSF1;ERCC6;UBQLN4;HELB;RIF1;SMCHD1;TRIP12;HMGA2;OGG1;POLQ
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.21463379497534504,-0.7130600657126488,0.9233870967741935,0.985351422634697,1.0,5/32,12.53%,LPCAT3;CSNK2A1;CSNK2A2;LPIN2;SLC44A5
prerank,atrioventricular valve morphogenesis (GO:0003181),0.29649474955318045,0.7124023247117792,0.8291666666666667,0.9557203470523474,1.0,2/19,5.39%,MDM4;TGFBR2
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.2687621424535203,0.7123208787026593,0.8584298584298584,0.9554553545912584,1.0,4/34,15.46%,SLC7A5;PTPRC;IL6;CD86
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.23538205537320367,-0.7117171245678017,0.9038461538461539,0.9855529736890016,1.0,6/23,16.15%,GNG2;MAPK1;PRKACA;LRRK2;MAPK3;TGM2
prerank,regulation of neuron differentiation (GO:0045664),0.2425477610639699,0.7114731833259857,0.9023569023569024,0.9560687163676156,1.0,15/76,18.17%,DISP3;CASZ1;BDNF;SOX2;ZC4H2;NEPRO;TCF3;MED1;CNTN4;SIN3A;ARHGEF2;NRCAM;TIAM1;CALR;MEF2C
prerank,regulation of muscle cell differentiation (GO:0051147),0.2755993210208135,0.7113586360535077,0.8565789473684211,0.9558259457388482,1.0,10/31,21.95%,CTNNB1;SPAG9;TCF3;PTBP1;MEF2A;CTNNA2;MEF2C;CDK9;CDC42;CDH2
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.2727900713804026,-0.711332876111142,0.8452380952380952,0.9845977625859784,1.0,2/13,6.15%,IL33;GOLGA2
prerank,inorganic anion transmembrane transport (GO:0098661),0.24655720544828474,0.7113215221716834,0.8805104408352669,0.955509410309261,1.0,11/63,15.07%,GABRB2;SLC37A1;SLC25A3;SLC20A2;SLC1A3;SLC12A6;SLC1A1;SLC37A3;ANO4;SLC20A1;GABRA4
prerank,positive regulation of histone acetylation (GO:0035066),-0.22800738485079075,-0.7104114219279912,0.8929889298892989,0.9843296652860526,1.0,6/23,16.02%,PAXIP1;RPS6KA5;PPARGC1A;MAPK3;BRD7;KAT7
prerank,regulation of ossification (GO:0030278),0.2660523546465767,0.7099874349559212,0.8644918444165621,0.9567280447402914,1.0,11/36,20.86%,SOX9;BMP2K;LRP4;ANKH;DDR2;RBPJ;S1PR1;ACVR1;MEF2C;PTN;NBR1
prerank,organophosphate ester transport (GO:0015748),0.29095570363494255,0.7098939769656224,0.8351498637602179,0.95647265546083,1.0,1/24,0.55%,PRELID1
prerank,protein oxidation (GO:0018158),0.3353699666685954,0.7097039218002439,0.8375,0.9563264779581978,1.0,2/11,17.69%,SUMF1;TMX3
prerank,tRNA export from nucleus (GO:0006409),0.2681124422322158,0.7091089899269093,0.8490322580645161,0.9562910080003589,1.0,7/32,15.64%,NUP153;NDC1;NUP88;NUP210;NUP37;NUP98;NUP54
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.2681124422322158,0.7091089899269093,0.8490322580645161,0.9562910080003589,1.0,7/32,15.64%,NUP153;NDC1;NUP88;NUP210;NUP37;NUP98;NUP54
prerank,selective autophagy (GO:0061912),0.2497705527153854,0.7084138249013993,0.8786808009422851,0.9566919113415682,1.0,7/56,11.19%,SQSTM1;HDAC6;RPS27A;UBC;WDFY3;MAP1LC3B;UFL1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.2275619789643407,0.7083535240029982,0.941908713692946,0.956398365035047,1.0,24/146,15.65%,SFI1;SSNA1;PSMD2;PSMC4;PSMD4;PSMD1;PSME3;CSNK1E;PSMB6;PSMD10;TUBB;HAUS8;AKAP9;DCTN3;PSMB1;PSMD11;PAFAH1B1;PSMA2;PSMD13;PSMB10;CEP250;BRD4;PSMB3;SKP1
prerank,heterochromatin organization (GO:0070828),0.3181010372072141,0.7083375896704074,0.8138461538461539,0.9560545752157669,1.0,3/14,13.93%,SIRT1;SETDB1;SETD7
prerank,heart morphogenesis (GO:0003007),0.25135406291684614,0.707981350721792,0.8753056234718827,0.9561106669265719,1.0,4/50,8.66%,SOX9;MDM4;TGFBR1;ENG
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.29343207976665675,0.7076236544836803,0.8351648351648352,0.9561580493898617,1.0,5/23,19.37%,VPS4A;CHFR;NABP1;PLK3;INTS3
prerank,mitochondrial protein processing (GO:0034982),-0.2841764316119686,-0.706553103570897,0.8402203856749312,0.9873534265243208,1.0,5/11,25.04%,IMMP1L;SPG7;STOML2;ATP23;PMPCA
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.3002817808708601,0.706478464251729,0.8301886792452831,0.9570926480213215,1.0,3/18,11.94%,PICALM;RELA;CLU
prerank,positive regulation of neuron migration (GO:2001224),0.3301129562280562,0.7055775938579278,0.8267477203647416,0.9577486195034033,1.0,6/11,22.85%,SEMA6A;SEMA3A;ARHGEF2;DAB2IP;PLAA;SHTN1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.3305935030400412,0.7052450172860413,0.7941176470588235,0.9577642457179526,1.0,2/12,9.79%,AP2A1;CLTC
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.29677167612857136,0.7050517032467105,0.8555708390646493,0.9576248742264364,1.0,1/20,2.79%,BCKDK
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.2542667582473998,-0.7049418291048247,0.884180790960452,0.9877459663853027,1.0,5/16,23.68%,PDCD10;HMOX1;FGF2;VEGFA;THBS1
prerank,calcium import into the mitochondrion (GO:0036444),-0.2964488329020603,-0.7044138923591168,0.8702290076335878,0.9869639967260497,1.0,7/10,44.17%,MCUB;MICU3;MAIP1;SMDT1;MICU2;MCU;MCUR1
prerank,phospholipid biosynthetic process (GO:0008654),0.2719561640178534,0.7044054406260976,0.8764478764478765,0.9580003293991055,1.0,8/36,17.67%,AGPAT4;FADS1;SGMS1;LPCAT1;FAR1;DHDDS;CPNE3;CRLS1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.3148889153849519,0.7037414933001136,0.8125915080527086,0.958408127630742,1.0,6/15,21.18%,BDNF;SOS1;ZFYVE27;SORT1;NTRK2;BCAR1
prerank,regulation of blood circulation (GO:1903522),-0.19901219699709025,-0.7033996608794585,0.9395348837209302,0.9867011884044404,1.0,4/34,13.00%,CELF2;TPM1;SRI;ECE1
prerank,regulation of embryonic development (GO:0045995),0.2676611431757939,0.7030705359591451,0.8593350383631714,0.9588116907096231,1.0,6/34,17.93%,BAG6;PHLDB1;B4GALT5;TDG;DAG1;ZBED3
prerank,diol metabolic process (GO:0034311),0.2923375998576268,0.7022308067305708,0.8526912181303116,0.9593865940179869,1.0,3/19,15.11%,SGPP2;GCH1;PLPP1
prerank,positive regulation of vasoconstriction (GO:0045907),0.31950202806890826,0.7016569106333155,0.85,0.9596901528958418,1.0,1/13,7.04%,TRPM4
prerank,muscle cell migration (GO:0014812),0.338521653949253,0.7013228942634481,0.8441558441558441,0.9597018708400579,1.0,1/10,5.62%,ITGB3
prerank,actin filament polymerization (GO:0030041),0.2765873298092906,0.7011516355133524,0.8638743455497382,0.9595405606635288,1.0,5/29,12.36%,CATIP;FAM107A;WASHC3;TTC17;DIAPH1
prerank,cellular response to superoxide (GO:0071451),-0.29847880767841556,-0.7010942548348582,0.7969151670951157,0.9878821645036547,1.0,5/10,29.13%,CCS;SOD1;PRDX2;PRDX1;MT3
prerank,histone exchange (GO:0043486),0.25769108759116693,0.700605460106291,0.8468244084682441,0.9597676366261999,1.0,4/37,11.50%,CENPP;NASP;HJURP;CENPC
prerank,fatty acid metabolic process (GO:0006631),0.23062794563677674,0.7005385516235899,0.9238095238095239,0.959480969634376,1.0,15/115,17.60%,ALOXE3;LPL;ACSF3;ADIPOR1;ACLY;GPX4;CRAT;ACACA;MSMO1;PON2;NUDT19;PNPLA8;ADIPOR2;CEL;SGPL1
prerank,regulation of phosphatase activity (GO:0010921),0.28107623859448083,0.7004283469748325,0.8528198074277854,0.9592540849881847,1.0,3/24,12.65%,PPP6R1;PPP6R3;GPATCH2
prerank,fatty acid transport (GO:0015908),-0.2509208735845005,-0.6997743878217749,0.8852941176470588,0.9879453238017262,1.0,3/17,9.05%,ACSL1;SLC25A17;PPARG
prerank,positive regulation of synapse assembly (GO:0051965),0.2734627680740751,0.6995327192510766,0.8485254691689008,0.9599123270188892,1.0,4/27,10.45%,DLG5;CLSTN1;PTPRD;BDNF
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.23606780685023726,0.699410542221767,0.9016759776536313,0.9596885835571963,1.0,21/80,21.54%,HNRNPD;PICALM;RELA;FXR2;LARP6;LARP4B;EIF6;SMPD3;NSUN5;CLU;FMR1;MTOR;IL6;ELAVL1;PLA2G6;LRRTM3;GSAP;LARP4;METTL3;EIF4A3;CPEB3
prerank,adenine nucleotide transport (GO:0051503),0.2964418928606314,0.6988270813359619,0.849645390070922,0.9599750724515799,1.0,2/17,4.44%,LRRC8D;ABCC5
prerank,glycerolipid catabolic process (GO:0046503),0.2942840700572085,0.6988002546932987,0.8577464788732394,0.9596403411793798,1.0,4/19,15.53%,PLA2G4A;ENPP6;SMPD4;GPCPD1
prerank,inorganic ion transmembrane transport (GO:0098660),0.32387844290195966,0.6978220785990022,0.8315301391035549,0.9603412659466221,1.0,1/12,7.04%,TRPM4
prerank,tRNA modification (GO:0006400),0.24072709915839297,0.6977302759964669,0.8888888888888888,0.9600817229641085,1.0,14/62,17.88%,CTU2;METTL6;THUMPD3;TPRKB;THUMPD2;QTRT1;TRMT10A;TRMT44;PUS7;MTO1;OSGEP;CDKAL1;TYW5;NSUN6
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.2902430482426261,-0.6970481141055923,0.8555858310626703,0.989518970773232,1.0,4/11,21.68%,ZFPM2;BMPR1A;SOX4;TGFB2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.27789523683165207,-0.6969694682898162,0.8772378516624041,0.9882468153119115,1.0,5/11,23.45%,SCARB1;LDLR;SREBF1;NR1H2;GPLD1
prerank,regulation of protein polymerization (GO:0032271),-0.20281636718505497,-0.6968702304798641,0.957345971563981,0.987012051455644,1.0,13/35,30.66%,FCHSD2;HSP90AA1;TPPP;CAMSAP1;PRUNE1;PFN2;ARL2;ABL1;CTTN;HAX1;GBA2;TPPP3;HCLS1
prerank,determination of heart left/right asymmetry (GO:0061371),0.258039104002675,0.6961679331779965,0.8779284833538841,0.9614640284198571,1.0,4/43,9.23%,TGFBR2;BBS4;ENG;MICAL2
prerank,purine nucleotide metabolic process (GO:0006163),-0.21726377368720662,-0.6961250807523308,0.8977272727272727,0.9864277680003712,1.0,8/24,26.65%,PRPSAP2;HPRT1;MTHFD1;GDA;PPAT;GPX1;ITPA;NT5C
prerank,RNA methylation (GO:0001510),0.24223913465030567,0.6960827879867337,0.8976744186046511,0.9611983994031468,1.0,10/60,14.25%,TGS1;NOP2;METTL6;NSUN4;THUMPD3;THUMPD2;TRMT10A;NSUN5;TRMT44;TFB2M
prerank,arachidonate transport (GO:1903963),0.3348816772330678,0.6960675600491901,0.8321917808219178,0.9605002395853572,1.0,10/10,66.53%,PNPLA8;PLA2G1B;DRD4;ACE;DRD3;PLA2G5;BDKRB2;NMUR2;DRD2;ANXA1
prerank,arachidonic acid secretion (GO:0050482),0.3348816772330678,0.6960675600491901,0.8321917808219178,0.9605002395853572,1.0,10/10,66.53%,PNPLA8;PLA2G1B;DRD4;ACE;DRD3;PLA2G5;BDKRB2;NMUR2;DRD2;ANXA1
prerank,alpha-amino acid catabolic process (GO:1901606),-0.208656137629886,-0.6958925674948517,0.9442231075697212,0.9853341517867545,1.0,13/29,39.65%,KYNU;MTRR;HOGA1;KYAT1;HAAO;SARDH;KMO;FAH;PRODH;IL4I1;ALDH4A1;DDO;HSD17B10
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.318282073438898,0.6958439381338106,0.8474320241691843,0.960389430183694,1.0,3/13,15.88%,ZMIZ1;SPI1;CDCA4
prerank,neuron apoptotic process (GO:0051402),0.2890067911970044,0.695533673627026,0.8561253561253561,0.9603750684699739,1.0,6/19,20.80%,BID;APP;NAE1;CIT;TRPC5;FAM162A
prerank,ncRNA export from nucleus (GO:0097064),0.25895308633525976,0.6953537588046074,0.8659003831417624,0.9602129085677864,1.0,7/36,15.64%,NUP153;NDC1;NUP88;NUP210;NUP37;NUP98;NUP54
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.29180213262992716,0.69529120745025,0.8653576437587658,0.9599284558659114,1.0,2/20,3.33%,PIN1;FKBP1B
prerank,ether lipid biosynthetic process (GO:0008611),0.3328973198393334,0.6932331061559636,0.8390092879256966,0.9617848746711555,1.0,2/10,10.99%,PLA2G4A;FAR1
prerank,spindle assembly (GO:0051225),0.2384953675008887,0.6930491546633675,0.9079254079254079,0.9616247087689587,1.0,19/67,19.79%,NEK7;NEK6;CCDC61;TUBGCP5;HAUS8;TUBGCP6;RCC1;WRAP73;GOLGA8B;NCOR1;FLNA;TUBGCP4;ABRAXAS2;ARHGEF10;KIF3B;CSNK1D;MZT1;MAPRE3;HAUS3
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.3387876303955442,0.6917424947057135,0.8444816053511706,0.9626749703875618,1.0,1/10,2.84%,ACD
prerank,cellular lipid catabolic process (GO:0044242),-0.2113231823427415,-0.6912952188895186,0.9510204081632653,0.9886701469369158,1.0,11/27,36.21%,LPIN2;PLBD2;ABHD12;ACOT8;ACOX1;PLBD1;MT3;SMPDL3B;FAAH;ACADL;ANGPTL3
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.3209567345464578,0.691260902133566,0.836038961038961,0.9628119968836771,1.0,4/12,16.64%,GNL3L;CCT8;CCT7;CCT6A
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.2669698107098484,0.6906156314592276,0.8542199488491049,0.9631329790335859,1.0,7/29,17.08%,HSP90AB1;PTPN6;CNOT7;CDC37;YTHDF2;IFNAR2;NLRC5
prerank,genitalia development (GO:0048806),-0.27390401829541045,-0.6905577523458984,0.8370165745856354,0.9881185651373732,1.0,2/12,13.27%,PKD1;PTPN11
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.3222969650744056,0.6901250359969779,0.8417818740399385,0.9633047421897095,1.0,1/11,1.89%,ARL6IP5
prerank,early endosome to Golgi transport (GO:0034498),-0.27914554641506184,-0.6901179790729146,0.8434343434343434,0.9872641001036533,1.0,3/11,12.53%,TMED9;LMAN1;RBSN
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.2845159570790968,0.6900228957829767,0.861878453038674,0.9630544875911209,1.0,7/22,21.33%,AGT;GLRX3;IGF1;MEF2A;SLC9A1;IL6ST;CAMK2D
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.3025571866299763,0.6895451918764806,0.8496350364963504,0.9631942794428718,1.0,1/16,1.33%,BCL2L1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.26094767610746816,-0.6883358138947138,0.9098591549295775,0.9877426696312439,1.0,12/14,60.89%,ECE1;ENPEP;RASL10B;AVPR2;ACE;ACE2;OXTR;EDN3;EDN2;AVPR1A;AGTR1;EDN1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.2314457916508258,0.6879666013354582,0.9210233592880979,0.9645007846652568,1.0,15/78,19.63%,IPO5;ADAM17;INCA1;PDGFB;PSMD10;LATS1;CCNK;GTPBP4;CDC37;CCNT1;ACTB;APC;CEBPA;MAPRE3;CCND1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.33240144689763657,0.6878189897326826,0.8499184339314845,0.9642868751674002,1.0,3/10,13.81%,SYP;APP;NPTN
prerank,sodium ion transmembrane transport (GO:0035725),0.2313678278899337,0.6875347888860607,0.9162946428571429,0.9642389123027538,1.0,7/84,9.70%,SLC6A8;SLC6A11;SCN8A;TRPM4;SLC6A6;ATP1B1;SCN1B
prerank,insulin secretion (GO:0030073),-0.23681109600616312,-0.6872432057691087,0.8852459016393442,0.9874738019385731,1.0,8/19,29.68%,RAB11FIP2;RIMS2;RAB11B;PTPRN;PARK7;ADCYAP1;SELENOT;RAB11FIP5
prerank,regulation of cellular catabolic process (GO:0031329),0.24142098310353344,0.6870358162020934,0.9119638826185101,0.964400180900092,1.0,9/62,12.88%,RRAGC;RAB39B;NUPR1;HDAC6;ABL2;MTMR3;VPS29;SCARB2;PSAP
prerank,engulfment of apoptotic cell (GO:0043652),0.3017109658902277,0.686999953803126,0.85,0.9640814051574422,1.0,2/15,6.15%,RHOG;XKR8
prerank,glycerolipid metabolic process (GO:0046486),0.3314513146941115,0.6867080064933809,0.8670120898100173,0.9640203853760776,1.0,2/11,12.62%,DGKZ;DGKQ
prerank,mitotic cytokinetic process (GO:1902410),0.2863393552604815,0.6863880344201966,0.8660968660968661,0.9640055455935554,1.0,2/20,4.74%,VPS4A;PDCD6IP
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.23657408511247546,0.686069288928514,0.8976377952755905,0.963963976238768,1.0,17/72,17.38%,CLIP3;HSP90AB1;IKBKB;RBCK1;PTPRC;PYCARD;SUMO1;PTPN6;RNF31;IRAK2;CFLAR;SPPL2A;CDC37;RUNX1;TNFAIP3;IFNAR2;OTULIN
prerank,DNA double-strand break processing (GO:0000729),0.2911297661567648,0.685994550610212,0.8640226628895185,0.963682249062311,1.0,3/18,9.60%,KAT5;RAD52;NBN
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.3155175060330525,0.685588018482721,0.8317757009345794,0.9637589435593172,1.0,3/12,14.53%,FYCO1;SETX;ADRB2
prerank,axonal fasciculation (GO:0007413),-0.2752659531855101,-0.6852266478780114,0.8885542168674698,0.9880641871719265,1.0,3/12,9.55%,SEMA5A;MEGF8;EPHB2
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.32929165308686636,0.685019791486363,0.8330757341576507,0.9639958468114581,1.0,3/10,15.68%,HMGB1;ZBTB7B;RUNX1
prerank,maintenance of blood-brain barrier (GO:0035633),0.26387476334866133,0.6847504403121557,0.8821954484605087,0.9639202889650995,1.0,10/30,21.52%,LSR;ACTG1;SLC1A1;IL6;ACTB;DMD;GJA1;TJP1;VCL;MBP
prerank,response to cAMP (GO:0051591),0.25643919709853813,0.6845608359482611,0.8735777496839444,0.9637585241254789,1.0,4/37,12.62%,INPP5K;AKAP6;AKAP9;DGKQ
prerank,double-strand break repair via break-induced replication (GO:0000727),0.31792170337394243,0.68427929022284,0.8515151515151516,0.9636834963531171,1.0,1/12,4.79%,MCM2
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.22113559099081265,-0.6842229180710264,0.9277566539923955,0.9876338429171283,1.0,7/23,21.86%,FBH1;EXOG;CASP3;CECR2;DFFA;HMGB2;KPNB1
prerank,cilium movement (GO:0003341),0.24555665446779207,0.6839472404037882,0.8824242424242424,0.9636831267898487,1.0,3/48,10.34%,CFAP70;RSPH9;DNAH9
prerank,respiratory electron transport chain (GO:0022904),-0.2555472072606578,-0.6838489617159424,0.8769230769230769,0.9866692334122795,1.0,7/14,29.06%,GPD2;PPARGC1A;SDHA;SLC25A12;ETFDH;ETFRF1;SLC25A22
prerank,regulation of protein processing (GO:0070613),0.28625509292539336,0.6837875645065322,0.8652777777777778,0.963510809223745,1.0,4/21,19.23%,ADAM8;PRNP;RUNX1;SERPINE2
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.3200595009156384,0.6837186933790134,0.8536209553158706,0.9632331702630151,1.0,1/12,2.74%,UBE2S
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.22050758977038945,0.6835097732965646,0.9539748953974896,0.9631009155040314,1.0,19/148,11.88%,USP2;RICTOR;RPS15;PIN1;KMT5A;CHD5;KAT5;NOP2;MDM4;TAF15;TAF1;TAF12;CHD4;TBP;TP53RK;NBN;HDAC1;PRKAG1;TAF6
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.2533491002855508,0.6826207634539209,0.89,0.9636920725446521,1.0,8/37,15.73%,WDR19;TRIP11;TRAF3IP1;SSX2IP;IFT43;IFT172;DYNC2H1;KIF3B
prerank,B cell mediated immunity (GO:0019724),-0.2856907203545149,-0.6825992522904905,0.8591160220994475,0.9865161872059659,1.0,3/10,16.61%,FCGR2B;CD74;TLR8
prerank,cellular response to heat (GO:0034605),0.2543610387616911,0.6822633898218335,0.8929032258064517,0.9636901571778155,1.0,9/35,19.93%,HSP90AB1;IL1A;TCIM;SUMO1;IER5;STUB1;HTRA2;PDCD6;VCP
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.284809997396655,-0.6822332735080072,0.8605263157894737,0.9855499133034777,1.0,6/10,42.75%,PCGF5;KDM1B;PRMT7;PCGF3;IGF2;ZFP57
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.3251629978182623,0.6817336817755264,0.8461538461538461,0.9638880302672593,1.0,2/10,10.92%,SIRT1;KDM1A
prerank,regulation of viral entry into host cell (GO:0046596),0.2693504881386078,0.6815961199390683,0.8721399730820996,0.9636882584104991,1.0,8/30,22.26%,LGALS1;IFITM3;P4HB;HS3ST5;TRIM5;TRIM26;NECTIN2;TMPRSS4
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.30524501387366015,0.6814730646987338,0.8486238532110092,0.963452020032871,1.0,5/14,20.76%,MYO1C;VEGFC;PGF;VEGFB;PIK3CD
prerank,muscle organ development (GO:0007517),0.24186189913510744,0.680991870233129,0.9168618266978923,0.9635896612406203,1.0,9/54,18.24%,EGR3;CHD2;IGF1;SGCE;MEF2A;MEF2B;TCF12;MEF2C;DMD
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.3234515345870453,0.6809488384152111,0.8373205741626795,0.9632800744979124,1.0,1/10,3.33%,FKBP1B
prerank,prostanoid metabolic process (GO:0006692),-0.2610555850085693,-0.6809153696355097,0.8698224852071006,0.9854861238627778,1.0,2/13,5.90%,PTGS1;PTGR2
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.3193373534803862,0.6807788175715671,0.8401206636500754,0.9631000687738636,1.0,3/11,17.01%,NUPR1;YBX3;ARHGEF2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.26459168256020893,0.6803852165284009,0.8888888888888888,0.9631468655500085,1.0,5/29,12.04%,PIN1;DCUN1D1;UBE2L3;MAGEC2;LIMK1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.2739839011199393,0.6802726702449767,0.8596256684491979,0.9629081821955617,1.0,2/25,3.30%,PIN1;FGF13
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.3255321779699989,0.6794163044300403,0.846875,0.963412637366025,1.0,1/11,2.99%,HMGB1
prerank,regulation of centrosome cycle (GO:0046605),0.2807286026003828,0.6783093522958126,0.8753541076487252,0.9642011897209106,1.0,3/21,10.33%,PDCD6IP;SIRT1;FBXW5
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.3132207508278487,0.6776807397954937,0.8530734632683659,0.9644450309505258,1.0,1/12,3.14%,HNRNPU
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.31869959908668855,0.6776187735099521,0.8440944881889764,0.9641451444305412,1.0,2/11,10.92%,SIRT1;KDM1A
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.2752301357390771,0.6775086286448242,0.8821138211382114,0.9639023086879094,1.0,3/24,9.29%,TCAF1;MYO1C;PRNP
prerank,glucose transmembrane transport (GO:1904659),0.28883674652704794,0.6773736530051526,0.8712574850299402,0.9636830658834445,1.0,3/18,17.80%,SLC2A1;SLC5A3;SORT1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.2735138178813025,0.6769858542680445,0.9,0.9637061055797027,1.0,7/27,21.59%,RPP30;LACTB2;POP1;RNASE1;ZC3H12A;RNASEH1;XRN1
prerank,apoptotic DNA fragmentation (GO:0006309),0.2986843506274295,0.6767408910304972,0.8741058655221745,0.9635971800198989,1.0,1/16,2.99%,HMGB1
prerank,positive regulation of cartilage development (GO:0061036),0.29724224590301807,0.6759368860006217,0.8607038123167156,0.9640301214724171,1.0,2/17,8.68%,SOX9;TAPT1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.2844595322959642,0.6752612020126985,0.8831710709318498,0.9643569580085437,1.0,2/20,6.86%,PLEK;MRAP2
prerank,erythrocyte development (GO:0048821),-0.2880504802156889,-0.6748125860270627,0.883419689119171,0.9896278658330837,1.0,1/10,0.06%,NCKAP1L
prerank,macrophage activation (GO:0042116),0.2558911967458861,0.6741263435591252,0.9125475285171103,0.9651180475452716,1.0,10/34,22.84%,SBNO2;FOXP1;CLU;APP;SLC11A1;ITGB2;SNCA;TMEM106A;C1QA;ITGAM
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.27159552376791896,0.6733815025329809,0.8959459459459459,0.9654867613982314,1.0,6/26,15.62%,FLOT2;GPS2;LGR4;GPR108;OTUD4;FLOT1
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.28447465873154476,0.673241377319534,0.8678977272727273,0.9652709462383663,1.0,6/20,21.96%,LYPD1;GNB1;GRK2;AGRN;CDK5R1;LY6H
prerank,regulation of centrosome duplication (GO:0010824),0.2626353354279063,0.6727447983858353,0.8932806324110671,0.9653936221225193,1.0,4/30,10.33%,PDCD6IP;CENATAC;SIRT1;FBXW5
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.27471349611082074,0.6718487330308122,0.88268156424581,0.9659294058564615,1.0,2/22,4.14%,PICALM;RELA
prerank,icosanoid secretion (GO:0032309),-0.2682870738949907,-0.6718467652989384,0.9012987012987013,0.990985835103551,1.0,1/12,4.14%,ABCC4
prerank,lipoprotein localization (GO:0044872),0.3229197310064682,0.6713423961123391,0.8644859813084113,0.9660823478066504,1.0,2/11,7.87%,ZDHHC3;LRP1
prerank,regulation of cell junction assembly (GO:1901888),0.263381896341892,0.6709961674076043,0.8958904109589041,0.9660623735585685,1.0,8/27,21.66%,PRKCH;MYO1C;FLOT1;RUNX1;RAP1B;MEF2C;TJP1;RAPGEF1
prerank,heterochromatin assembly (GO:0031507),0.27873544144899864,0.670623070744235,0.8645980253878702,0.9660695480613262,1.0,4/20,11.25%,BAZ2A;SIRT1;HDAC1;SIRT2
prerank,positive regulation of filopodium assembly (GO:0051491),0.2704465300822793,0.670195130546676,0.8630527817403709,0.9661359323099336,1.0,8/24,21.35%,PIK3R1;TENM2;RHOQ;FMR1;GPM6A;WASL;CDC42;AGRN
prerank,cardiac atrium morphogenesis (GO:0003209),-0.2444892593624655,-0.6696672091872357,0.8878504672897196,0.9914931102739453,1.0,2/16,7.85%,BMPR2;NOTCH1
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.30507140905568964,0.6692896992070843,0.8526148969889065,0.9666704687858164,1.0,3/12,11.94%,APOE;PFDN1;CLU
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.31062318384863963,0.6689857744143467,0.8636363636363636,0.9666125157113018,1.0,1/11,6.66%,AGT
prerank,regulation of AMPA receptor activity (GO:2000311),0.2662159199214301,0.6682656506226157,0.8875,0.9669285871696894,1.0,3/25,9.07%,SHANK1;CACNG8;CACNG2
prerank,lipoprotein transport (GO:0042953),-0.2767258765693753,-0.6679887895357612,0.8617021276595744,0.9915954971399719,1.0,4/10,26.15%,ZDHHC17;PPARG;CD36;UNC119B
prerank,negative regulation of microtubule polymerization (GO:0031115),0.3092823251000686,0.6676721026054517,0.877488514548239,0.9671681332972093,1.0,4/12,19.99%,CLIP3;DYRK1A;TUBB4A;SNCA
prerank,regulation of steroid metabolic process (GO:0019218),0.2719484208421072,0.6675226814902253,0.8867403314917127,0.9669487568974741,1.0,7/23,22.34%,APOE;DGKQ;STUB1;RORA;TTC39B;NR5A1;PANK2
prerank,lysine metabolic process (GO:0006553),0.3060683179761526,0.6672877651579255,0.8469055374592834,0.966481141343684,1.0,2/12,12.98%,SLC25A21;OGDH
prerank,lysine catabolic process (GO:0006554),0.3060683179761526,0.6672877651579255,0.8469055374592834,0.966481141343684,1.0,2/12,12.98%,SLC25A21;OGDH
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.26639602013856484,0.6670737473338255,0.8907330567081605,0.9663460566451723,1.0,8/23,22.90%,KIF5A;TUBB;HOOK2;MYO10;CCDC88A;CCDC88B;DYNC1I1;HOOK3
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.3148118854631864,0.6670407455871058,0.8580750407830342,0.9660210597919381,1.0,3/11,17.90%,ARRB1;ADRB2;GRK2
prerank,regulation of insulin secretion (GO:0050796),0.22259627514757913,0.6670034805916674,0.9551282051282052,0.965705815226372,1.0,13/101,15.95%,MYRIP;TFAP2B;CACNA1A;MIDN;ADCY5;BRSK2;TCF7L2;GLUD1;BAD;SLC2A1;IL6;LRP5;MTNR1B
prerank,immunoglobulin mediated immune response (GO:0016064),-0.27981408990836276,-0.6668296174949525,0.8818897637795275,0.9912158400713161,1.0,6/10,37.71%,FCGR2B;CD74;TLR8;CD27;CD81;FCER1G
prerank,B cell receptor signaling pathway (GO:0050853),0.25751349535754425,0.6661700537909054,0.8986842105263158,0.9661856760006384,1.0,9/32,21.18%,SH2B2;PTPRC;BLNK;TEC;PRKCB;MEF2C;RFTN1;PIK3CD;BCAR1
prerank,protein localization to chromatin (GO:0071168),0.28761132704331405,0.6660934573441653,0.8678977272727273,0.9659044533043116,1.0,5/18,21.10%,LEMD2;WAPL;RAD21;PIH1D1;ESR1
prerank,negative regulation of cell cycle process (GO:0010948),0.23140695652657017,0.6658826349536079,0.9155092592592593,0.9657553743744239,1.0,11/61,18.34%,VPS4A;PPP1R10;RYBP;UXT;TOM1L1;PCGF2;CBX5;NME6;WAPL;EZH2;RBBP4
prerank,mitochondrial genome maintenance (GO:0000002),0.3159402395830516,0.6657974150268862,0.8635658914728682,0.9654859146350512,1.0,3/11,9.41%,LONP1;SLC25A33;SLC25A36
prerank,in utero embryonic development (GO:0001701),-0.20711137865247553,-0.6650458976992865,0.9541984732824428,0.9912658778251323,1.0,4/25,10.71%,PKD1;ZNF568;MBNL1;FGFR2
prerank,regulation of neuron projection arborization (GO:0150011),0.2922276269655854,0.6650169368710128,0.880057803468208,0.9658868885211707,1.0,1/15,1.43%,DVL2
prerank,negative regulation of blood pressure (GO:0045776),0.30243579725767883,0.6648561220339018,0.8573643410852713,0.9656855635342766,1.0,1/13,6.22%,SCPEP1
prerank,regulation of endocytic recycling (GO:2001135),0.3119507889003915,0.6640137554256518,0.8874388254486134,0.9661245218869526,1.0,3/11,16.62%,SORL1;INPP5F;ARHGAP1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.24517173381403362,0.6639982187254526,0.9009009009009009,0.9657873811510007,1.0,5/39,14.64%,CORO1C;JAG1;PTPRO;GCNT2;NEXMIF
prerank,axoneme assembly (GO:0035082),-0.2022871128440914,-0.6635128141354113,0.9725490196078431,0.9912383574798858,1.0,25/31,53.02%,DCX;DNAI4;TTC12;CFAP74;SPAG1;TTLL3;CCDC39;SPAG16;SPEF1;DNAAF3;CCDC40;FOXJ1;LRGUK;JHY;DNAJB13;CFAP206;DRC1;SPAG17;GAS8;DNAAF2;RSPH1;RP1;RSPH4A;DNAAF1;CCDC65
prerank,regulation of response to biotic stimulus (GO:0002831),0.26238468342845955,0.6634335241430406,0.9006535947712418,0.9659531937961175,1.0,3/28,7.48%,TKFC;CD55;FOXP1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.254077609636178,0.6631789835971457,0.908150064683053,0.9658571929874794,1.0,4/32,13.08%,BAG6;SIRT1;PYCARD;DDX5
prerank,protein localization to Golgi apparatus (GO:0034067),0.26234882415527755,0.6628691837121784,0.8901251738525731,0.9657912128215477,1.0,9/27,19.43%,TMED10;SORL1;OPTN;GBF1;ARL1;CSNK1D;ARL5B;GAK;ARL5C
prerank,positive regulation of sodium ion transport (GO:0010765),0.30624555536821274,0.6628479911925581,0.8517940717628705,0.9654630183872349,1.0,4/12,18.81%,SCN1B;PRSS8;CNKSR3;AHCYL1
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.2755484337794615,-0.6625719440080253,0.8726790450928382,0.9906878460897625,1.0,7/10,50.06%,CTNS;ZEB2;ATP7A;OPN3;GIPC1;RAPGEF2;CDH3
prerank,cellular response to hexose stimulus (GO:0071331),0.2689653857554152,0.6625708847238883,0.8926174496644296,0.9653790434998482,1.0,6/23,18.47%,SLC39A14;PDK3;ADCY8;PAX2;UNC13B;PRKAA1
prerank,recombinational repair (GO:0000725),0.22534551407063516,0.661415955673473,0.9401993355481728,0.9661222479359014,1.0,10/77,14.84%,RAD51AP2;SEM1;RAD52;XRCC1;NBN;SFPQ;RFWD3;NABP1;MORF4L1;NSMCE1
prerank,carbohydrate derivative transport (GO:1901264),0.2819914912110755,0.661171657913861,0.8888888888888888,0.9660006160353167,1.0,4/18,17.64%,SLC29A1;SLC15A3;VLDLR;SLC15A4
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.3032810083159855,0.6610646093741549,0.8789712556732224,0.9657602407067104,1.0,1/14,2.18%,FUS
prerank,ketone body metabolic process (GO:1902224),0.32348418697303694,0.6608121979127599,0.848780487804878,0.9656535813673683,1.0,2/10,12.91%,HMGCL;ACAT1
prerank,mitotic nuclear division (GO:0140014),0.2262782821876657,0.6607726403442862,0.9375,0.9653348454297558,1.0,12/71,15.73%,NDEL1;UBE2S;MIS12;PPP2R2D;CCDC61;CTDP1;NDC80;WRAP73;FLNA;ABRAXAS2;ARHGEF10;KIF3B
prerank,regulation of isotype switching (GO:0045191),0.29627903707638414,0.6606218356879002,0.8660578386605784,0.9651184087101142,1.0,3/14,17.64%,KMT5B;HMCES;SLC15A4
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.26390601344127557,0.6603536170010524,0.9110512129380054,0.965014741627108,1.0,4/25,16.05%,DOT1L;ZBTB7A;IGF1;SIN3A
prerank,positive regulation of tissue remodeling (GO:0034105),-0.28450621735843695,-0.6599666729341054,0.8703241895261845,0.9913243486118233,1.0,4/10,34.00%,ROCK2;IL15;ROCK1;TMBIM1
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.23037650463625708,-0.6599542758570723,0.9456869009584664,0.9900221457188707,1.0,9/18,35.33%,RALA;BNIP3;FIS1;DCN;DNM1L;DDHD1;KDR;MIEF2;MUL1
prerank,secondary palate development (GO:0062009),0.29643514288221395,0.6598981566482787,0.8863636363636364,0.9650947413036354,1.0,1/14,5.39%,TGFBR2
prerank,regulation of myoblast fusion (GO:1901739),-0.2716331234174791,-0.6579134108000922,0.8773841961852861,0.9903848919383504,1.0,4/11,23.05%,MAPK14;RIPOR2;EHD1;CD53
prerank,regulation of nervous system development (GO:0051960),-0.18840495361580425,-0.6575741211264889,0.9601990049751243,0.9893305498024377,1.0,10/37,23.77%,PTPRZ1;DOCK7;BHLHE41;PRUNE1;NPHP3;CX3CR1;HMGB2;BHLHE40;CX3CL1;PER2
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.31266979036726267,0.6574826889926175,0.8594507269789984,0.9669684026139957,1.0,1/10,4.22%,SSBP1
prerank,hyaluronan catabolic process (GO:0030214),0.2790207090837418,0.6574218648405858,0.8791848617176128,0.9666754364204412,1.0,2/18,8.58%,GUSB;CEMIP2
prerank,protein localization to kinetochore (GO:0034501),-0.24735932228923307,-0.6568249575783784,0.9058823529411765,0.9886167378006684,1.0,8/14,34.82%,IK;BUB3;MTBP;ZW10;ZWILCH;KNL1;CENPT;SPDL1
prerank,regulation of sister chromatid cohesion (GO:0007063),0.3056429485243724,0.6567923203242703,0.8669724770642202,0.9669053152775854,1.0,4/12,17.19%,CTNNB1;CTCF;WAPL;RAD21
prerank,DNA alkylation (GO:0006305),0.2755138842853544,0.6556497515496544,0.8885672937771346,0.9671997919294797,1.0,4/19,16.17%,BAZ2A;TEX15;DNMT3A;GATAD2A
prerank,DNA methylation or demethylation (GO:0044728),0.2755138842853544,0.6556497515496544,0.8885672937771346,0.9671997919294797,1.0,4/19,16.17%,BAZ2A;TEX15;DNMT3A;GATAD2A
prerank,protein deneddylation (GO:0000338),-0.27548585543799753,-0.6541249361309954,0.8821989528795812,0.9893566929853301,1.0,3/10,15.53%,COPS4;COPS7A;COPS8
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.28610507316811806,0.6540983395982437,0.8875562218890555,0.9682649225409821,1.0,1/15,1.71%,CUL3
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.2543850257253162,-0.6539039592955884,0.8958333333333334,0.988235753652366,1.0,3/13,17.67%,NR3C2;PGR;CALCOCO1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.25354784439303885,-0.652386798785643,0.9211956521739131,0.9880887675408601,1.0,6/12,35.32%,CHEK2;HUS1;CLSPN;STK33;ORC1;SETMAR
prerank,regulation of cellular senescence (GO:2000772),0.25062100572176116,0.6521210490217608,0.9132124352331606,0.9696929086180497,1.0,8/28,21.63%,NEK6;CDK6;SIRT1;YBX1;YPEL3;CGAS;ZKSCAN3;TERF2
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.2605548162328724,0.6518044350294498,0.8952380952380953,0.9696214561552526,1.0,4/24,11.95%,ANXA6;HTR2C;PTPRC;TRPM2
prerank,response to interferon-beta (GO:0035456),0.27123151134351065,0.6506232048416296,0.890295358649789,0.9703166888887917,1.0,7/22,19.66%,ACOD1;IFITM3;NDUFA13;IKBKE;IFNAR2;HTRA2;AIM2
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.2460545227528816,0.650431424451527,0.9229813664596274,0.9701280020200747,1.0,6/35,13.86%,SOX9;APOE;AKAP6;HTR2C;DGKQ;CAP1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.23184129593469474,-0.6497022687042968,0.9274924471299094,0.988807402688083,1.0,7/16,35.02%,DPYD;DPYSL5;CRMP1;NT5C;DPYSL2;NT5E;UPP2
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.22097135123313463,0.649535042437447,0.9493243243243243,0.9705538974995943,1.0,13/72,16.77%,POLR2J;HNRNPM;FIBP;NCBP1;GTF2F2;POLR2E;HNRNPH1;SETX;PTBP1;POLR2B;POLR2G;FGF9;HNRNPA1
prerank,positive regulation of DNA recombination (GO:0045911),0.26481603883060095,0.6480507062343438,0.9162234042553191,0.9714947901626759,1.0,3/27,10.23%,FUS;KMT5B;ERCC2
prerank,catecholamine biosynthetic process (GO:0042423),0.30489062119621857,0.6479557190852272,0.8916797488226059,0.9712363238700029,1.0,2/11,19.99%,GCH1;SNCA
prerank,determination of bilateral symmetry (GO:0009855),-0.20748497459427628,-0.647288811251129,0.952,0.9892514590040756,1.0,13/25,42.70%,NOTCH1;BBS7;PKD2;NPHP3;GALNT11;CITED2;DNAH11;DNAH5;MKKS;ODAD2;STIL;CFAP53;FOXJ1
prerank,synaptic vesicle endocytosis (GO:0048488),0.24498240046618933,0.6469475177649374,0.9217731421121251,0.9717666050594677,1.0,13/33,23.57%,PICALM;DNM2;STON1;SYT1;CEL;ITSN1;GAK;SNCA;PIP5K1C;ITSN2;PACSIN1;DNM3;SYNJ1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.30088771091428446,0.646378745338227,0.8895800933125972,0.971886209924754,1.0,3/12,19.21%,TRPM4;ADCY8;PLA2G6
prerank,epiboly involved in wound healing (GO:0090505),0.28560478640203313,0.6458910939719883,0.884272997032641,0.9719403756393258,1.0,1/16,1.49%,LCP1
prerank,positive regulation of cellular senescence (GO:2000774),0.30655646817839294,0.6452445139893521,0.8814102564102564,0.972152570985979,1.0,3/10,18.71%,SIRT1;YPEL3;CGAS
prerank,negative regulation by host of viral process (GO:0044793),-0.2761014788389584,-0.6440533271201334,0.9005102040816326,0.9901527392365133,1.0,3/10,16.32%,EIF2AK4;VAPA;PSMC3
prerank,endodermal cell differentiation (GO:0035987),-0.19339486093517472,-0.6438961450875323,0.9534883720930233,0.9889653241697428,1.0,14/31,32.14%,ITGAV;COL11A1;COL8A1;ITGA4;PAF1;ITGB5;LEO1;RTF1;COL12A1;COL4A2;HMGA2;SETD2;VTN;FN1
prerank,I-kappaB phosphorylation (GO:0007252),0.30454364602866846,0.6431036566422523,0.8883572567783095,0.9735915517045596,1.0,4/10,21.20%,TLR7;ERC1;TLR2;DAB2IP
prerank,filopodium assembly (GO:0046847),-0.23030355108274908,-0.6430930514268998,0.9516129032258065,0.9882639048699506,1.0,3/16,13.05%,FGD4;FGD2;FGD6
prerank,microtubule anchoring at centrosome (GO:0034454),0.3065925581497986,0.6422406528284189,0.8813838550247117,0.9739560814069292,1.0,4/10,22.90%,BBS4;DCTN1;NIN;HOOK3
prerank,polyamine metabolic process (GO:0006595),0.2944353178397681,0.6401326922388243,0.8821705426356589,0.9753686322690752,1.0,3/13,14.77%,HDAC6;PAOX;SMOX
prerank,sphingosine metabolic process (GO:0006670),0.2811154176948173,0.6399410663389996,0.9047619047619048,0.9751908776260844,1.0,1/17,1.79%,SGPP2
prerank,type I interferon signaling pathway (GO:0060337),0.23863582874223604,0.6398050349569293,0.9267990074441688,0.974604588381443,1.0,5/41,10.50%,EGR1;IFITM3;IFNAR1;IP6K2;IRF8
prerank,cellular response to type I interferon (GO:0071357),0.23863582874223604,0.6398050349569293,0.9267990074441688,0.974604588381443,1.0,5/41,10.50%,EGR1;IFITM3;IFNAR1;IP6K2;IRF8
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.27358391563651513,0.6393949708670642,0.9015151515151515,0.974613433935341,1.0,5/17,23.58%,JAG1;RBPJ;ACVR1;TGFB1;NOTCH2
prerank,female gonad development (GO:0008585),0.2723563718064733,0.6393011505158571,0.92524682651622,0.9743328727745921,1.0,1/19,2.55%,EIF2B2
prerank,regulation of viral life cycle (GO:1903900),0.2641916056630883,0.6393002882095621,0.9166666666666666,0.973986269436092,1.0,5/21,20.39%,VPS4A;KPNA2;HS3ST5;TRIM5;NECTIN2
prerank,negative regulation of lipid storage (GO:0010888),-0.2186208595038658,-0.6391748552796565,0.9591836734693877,0.9896932248873506,1.0,3/19,9.05%,ABCA1;ITGAV;PPARG
prerank,purine nucleotide catabolic process (GO:0006195),0.2916794020580905,0.6385310193510547,0.9054878048780488,0.9742471081581808,1.0,1/13,4.91%,PNP
prerank,response to iron ion (GO:0010039),-0.24893610498791144,-0.6384578849444169,0.9176136363636364,0.9888499740573221,1.0,5/12,30.31%,ACO1;HIF1A;SLC11A2;FXN;HFE
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.23429413063836885,0.6382846562823038,0.9381953028430161,0.9741094665729643,1.0,6/39,15.31%,JAG1;BMP6;PPM1F;GTPBP4;NEXMIF;AKNA
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.24577719191669817,0.6381127365543753,0.9116883116883117,0.9738997698814208,1.0,3/30,11.19%,PLEK;PTPRC;UFL1
prerank,skeletal system morphogenesis (GO:0048705),0.2329968300334701,0.6381085595208381,0.9280397022332506,0.9735564317019628,1.0,7/42,17.77%,HOXD9;TGFBR1;HHIP;LRP5;ANKRD11;HOXB3;SPEF2
prerank,amyloid precursor protein catabolic process (GO:0042987),0.2877146628261469,0.6378790544378286,0.8868778280542986,0.9733896704901527,1.0,2/14,7.65%,ADAM17;ADAM19
prerank,visual system development (GO:0150063),0.24196129268807162,0.6378583524892277,0.9285714285714286,0.973060576682404,1.0,4/37,11.10%,FREM2;RAB18;PBX4;SOX2
prerank,positive regulation of leukocyte activation (GO:0002696),0.2756609502016974,0.636301656848162,0.9027355623100304,0.9739539626365047,1.0,4/18,20.39%,KARS1;HSPD1;CEBPA;NECTIN2
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.2806020828967698,0.6354662153294736,0.8885542168674698,0.974288426338755,1.0,2/15,8.21%,BMP2K;DGKD
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.297647578476394,0.6354040936722573,0.8794992175273866,0.9739951771197117,1.0,2/11,11.74%,TRIM28;SETDB1
prerank,relaxation of muscle (GO:0090075),0.29229048839773986,0.6344325360697214,0.8951367781155015,0.9744297034731394,1.0,2/13,9.67%,KCNJ2;ATP1B1
prerank,chromatin assembly (GO:0031497),0.2356438977353771,0.6343953633607134,0.9323308270676691,0.9741112631651224,1.0,8/38,18.97%,SOX9;NAA60;SIRT1;SART3;CTCF;BRD2;RBBP4;KAT6B
prerank,mesenchyme development (GO:0060485),-0.2324170182037651,-0.6334684302127965,0.9184952978056427,0.9907213210071252,1.0,3/15,15.05%,BMPR2;FGFR2;PKD2
prerank,protein methylation (GO:0006479),0.2389547414775675,0.6333815967267497,0.9389027431421446,0.9745517741882682,1.0,9/40,21.05%,PRMT2;ETF1;FAM98B;PRMT3;LCMT1;EEF1AKMT1;EZH2;PRMT1;CAMKMT
prerank,negative regulation of viral life cycle (GO:1903901),-0.23676268483154284,-0.6322490508564467,0.9404761904761905,0.9902714684695423,1.0,5/15,23.85%,GSN;BST2;LY6E;PPIA;CIITA
prerank,cellular response to interleukin-4 (GO:0071353),0.30653218003071414,0.6315564586192296,0.8917609046849758,0.975639042749765,1.0,1/10,7.63%,STAT6
prerank,intracellular sterol transport (GO:0032366),0.29118129615263444,0.6314241116437366,0.8895800933125972,0.975390521393883,1.0,1/13,1.71%,VPS4A
prerank,negative regulation of innate immune response (GO:0045824),0.24108838992641246,0.6299121829018041,0.9375,0.9761789132862562,1.0,9/34,20.63%,ACOD1;NLRC3;CNOT7;TNFAIP3;YTHDF2;NLRC5;TRAFD1;FAM3A;METTL3
prerank,cardiac ventricle morphogenesis (GO:0003208),0.2292468366133261,0.629894452862738,0.948019801980198,0.9758470207000547,1.0,4/41,10.92%,TGFBR2;JAG1;ENG;RBPJ
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.28831830409334325,0.6279873610803236,0.8919382504288165,0.9769951516906936,1.0,2/11,9.52%,SORL1;MSN
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.22637664568967308,0.627578752232732,0.9544910179640719,0.9769632967097112,1.0,10/48,17.08%,PTPRC;PELI3;CARD16;PYDC1;CNOT7;GPS2;IL6;OTUD4;YTHDF2;NLRC5
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.25934597982246316,-0.6274103483994659,0.9252873563218391,0.9919228940912853,1.0,4/11,23.08%,NOTCH1;GSK3A;LMNA;MLIP
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.22731595030277776,0.6261245835775279,0.9528415961305925,0.9777459223864186,1.0,10/48,21.33%,FKBP1B;AKAP6;PTK2B;TRPC1;DIAPH1;SELENON;DMD;SNCA;THY1;CAMK2D
prerank,regulation of cartilage development (GO:0061035),0.2669386576758759,0.6259533913657861,0.902046783625731,0.9775261671712249,1.0,2/18,8.68%,SOX9;TAPT1
prerank,positive regulation of catabolic process (GO:0009896),0.2160068789314902,0.6255850280089461,0.9621301775147929,0.9774480960809381,1.0,18/65,21.91%,VPS28;EGLN2;SMURF1;SORL1;NSF;DDB1;IDE;NDUFA13;STX5;TNFAIP3;APC;RAB7A;ITCH;VCP;FOXO1;DAB2IP;AREL1;GPC3
prerank,C-terminal protein amino acid modification (GO:0018410),0.30404790965551776,0.6252165768150078,0.8881789137380192,0.9773711943413832,1.0,3/11,15.86%,TTL;FOLH1;LCMT1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.24554665681268512,-0.6249251242097669,0.9271137026239067,0.9920948821875393,1.0,6/11,39.23%,CTPS2;SLC25A19;DCK;SLC19A2;ENPP3;TPK1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.20816577293774932,0.6247890231937246,0.9710610932475884,0.9773429745670048,1.0,11/95,14.84%,RAD51AP2;SEM1;MCM2;RAD52;XRCC1;NBN;SFPQ;RFWD3;NABP1;MORF4L1;NSMCE1
prerank,histone methylation (GO:0016571),0.251691449839116,0.6239859961681685,0.9197860962566845,0.9776082915667782,1.0,3/26,10.23%,PRMT2;SMYD3;CREBBP
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.26880608625285013,0.6231675122905763,0.9155354449472096,0.9778485677438744,1.0,3/17,12.62%,INPP5K;SIRT2;DGKQ
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.21732516412546446,0.6211854793807512,0.9594438006952491,0.9789430150204018,1.0,12/62,17.87%,ALS2;ADGRG1;RASGRF1;ERBIN;ARRB1;IGF1;COL3A1;LPAR1;RAC1;ARHGEF3;GPR65;PIK3CG
prerank,regulation of fatty acid oxidation (GO:0046320),0.2648094435712241,0.6187552807889692,0.910355486862442,0.9802831876817389,1.0,1/16,3.29%,SOX9
prerank,negative regulation of telomere maintenance (GO:0032205),-0.23104122471987731,-0.618687094836779,0.9491017964071856,0.9944740987299976,1.0,7/15,32.69%,PARP1;TNKS;SLX4;RTEL1;RAD50;PINX1;ERCC1
prerank,histone ubiquitination (GO:0016574),0.2539017569711363,0.6172051521247358,0.9261363636363636,0.9810191641744572,1.0,6/21,22.47%,RNF20;UBE2E1;UBR2;CTR9;RNF40;UBE2A
prerank,pentose-phosphate shunt (GO:0006098),-0.25454100260477447,-0.6169479050008891,0.9112903225806451,0.9941854557677825,1.0,4/11,19.93%,RBKS;PGLS;RPIA;H6PD
prerank,regulation of tissue remodeling (GO:0034103),0.2599257592991289,0.6166884565761541,0.9172821270310192,0.9810256445275192,1.0,6/18,22.98%,DDR2;IL18;RUNX1;GPNMB;CST3;TGFB1
prerank,peptidyl-proline modification (GO:0018208),0.24722147609679113,0.616577328320484,0.9309878213802436,0.9807551482262072,1.0,2/25,3.33%,PIN1;FKBP1B
prerank,response to organophosphorus (GO:0046683),-0.2197620168652615,-0.6165298307279963,0.934375,0.9931329946518928,1.0,5/16,28.28%,STAT1;TYMS;RFC3;P2RX7;VGF
prerank,cranial nerve development (GO:0021545),0.29492180018089265,0.6157968616390721,0.9080996884735203,0.9809523459204468,1.0,4/11,23.10%,TMEM126A;PAX2;TIFAB;CHD7
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.2432043699997916,0.6150124566191025,0.9246031746031746,0.9811664253102745,1.0,7/27,19.55%,RPS27A;UBC;IRAK2;TNIP1;HSPD1;IRAK4;TLR2
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.2537923853778691,0.6144063348969266,0.9127988748241913,0.9812586592860773,1.0,2/21,10.29%,PLA2G4A;OSBPL8
prerank,monocarboxylic acid catabolic process (GO:0072329),0.2549768206926276,0.6136849434126054,0.9407806191117093,0.9814033341680425,1.0,4/21,20.93%,AGXT;NUDT19;CEL;LDHD
prerank,tRNA methylation (GO:0030488),0.233046388188097,0.6136504232086876,0.9285714285714286,0.981075889143985,1.0,7/34,17.88%,METTL6;THUMPD3;THUMPD2;TRMT10A;TRMT44;MTO1;NSUN6
prerank,regulation of cell motility (GO:2000145),0.19944334473862801,0.6127591448345918,0.9852164730728616,0.9813177048926004,1.0,24/121,19.36%,PLXNA1;PIN1;ABL2;RHOB;MEMO1;CDK6;CYRIB;TMSB4X;DOCK10;DIAPH1;INPP5F;CRK;FLNA;LDB2;LDB1;RAF1;RAC1;FGF9;TBCCD1;TTBK2;SGK1;SERPINE2;CSF1R;PLXND1
prerank,toxin transport (GO:1901998),0.29578474234033225,0.6124878620443571,0.905448717948718,0.9811715120679992,1.0,1/10,7.06%,ANTXR1
prerank,cell differentiation in hindbrain (GO:0021533),0.29023623260652764,0.6117735381871005,0.8998357963875205,0.9812997671530832,1.0,1/11,6.77%,FAIM2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.2775358903973333,0.6115996221939112,0.9007633587786259,0.9810673121075809,1.0,1/14,3.60%,KMT5B
prerank,RNA biosynthetic process (GO:0032774),0.23847882143292243,0.6111239161785147,0.9458762886597938,0.9810246761527099,1.0,5/31,13.84%,TTF2;TAF12;TBP;TAF6;SETX
prerank,relaxation of cardiac muscle (GO:0055119),0.2823808565418831,0.6094294448823708,0.9134466769706336,0.9818307925161218,1.0,2/13,9.67%,KCNJ2;ATP1B1
prerank,neuron projection fasciculation (GO:0106030),-0.25508733834796815,-0.6092808675110769,0.9357541899441341,0.9957080316112062,1.0,2/10,9.55%,SEMA5A;EPHB2
prerank,response to acidic pH (GO:0010447),-0.23918168885792157,-0.6092246484623389,0.9283489096573209,0.9944480375647446,1.0,5/13,33.18%,LGMN;RAB11B;PKD2L1;RAB11FIP5;CHP1
prerank,negative regulation of immune effector process (GO:0002698),0.280027520224273,0.6084111438169804,0.8993808049535603,0.9821234525776863,1.0,2/13,10.61%,CD55;RC3H1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.22399870476626688,-0.6082297031885053,0.9520958083832335,0.993664537960962,1.0,1/15,2.84%,GRM5
prerank,positive regulation of TORC1 signaling (GO:1904263),0.262377233090312,0.6079646801226952,0.9166666666666666,0.9820664835997408,1.0,6/16,21.07%,LARS1;GPR137C;FLCN;GPR137B;PIH1D1;CLEC16A
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.18727998826137815,-0.6056512875140404,0.9824561403508771,0.9936403910005206,1.0,7/26,31.05%,SPTLC2;ASAH1;ACER3;CYB5R3;SPHK2;SPTLC1;ACER2
prerank,DNA recombination (GO:0006310),0.22905985711377122,0.6054356254169027,0.954954954954955,0.9833691724855429,1.0,5/37,13.78%,HMGB1;RPAIN;RAD52;MSH3;TSN
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.2578154665903239,-0.605106733174255,0.928395061728395,0.9926239081117121,1.0,5/10,35.57%,IRAK3;TLE5;MAPK7;KLF4;MAP2K5
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.29066466472018215,0.6043335235667452,0.92,0.9837199158003996,1.0,2/10,10.12%,CPEB1;NCBP1
prerank,inositol phosphate-mediated signaling (GO:0048016),0.25793478453823737,0.6042440426403707,0.9269662921348315,0.9834267970557201,1.0,1/19,3.46%,NFATC3
prerank,negative regulation of phosphatase activity (GO:0010923),0.24030415489721949,0.6040546055914263,0.9481582537517054,0.9832056582803818,1.0,3/25,12.65%,FKBP1B;CRY2;GPATCH2
prerank,positive regulation of isotype switching (GO:0045830),0.2694261729917598,0.6029647989223761,0.9117199391171994,0.9835568253214123,1.0,1/15,3.60%,KMT5B
prerank,cell junction maintenance (GO:0034331),-0.22492239135931766,-0.6013817929721808,0.9494047619047619,0.9931690791608098,1.0,6/14,37.05%,MYADM;NLGN2;CHCHD10;F2R;CBLN1;CBLN2
prerank,regulation of cell morphogenesis (GO:0022604),0.22989371408685672,0.5997331660954172,0.958994708994709,0.9851811151576535,1.0,9/30,21.73%,SPARC;ZRANB1;ZMYM4;MYO9A;LARP4;PHIP;CD44;NTNG2;NTNG1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.22753671111609622,-0.5987875409003748,0.9478260869565217,0.9931204729222779,1.0,5/13,30.74%,GAS6;CD74;TRIM44;AGPAT1;AGPAT2
prerank,regulation of gastrulation (GO:0010470),-0.21818723822782093,-0.5987169152100276,0.9512195121951219,0.9918909194957742,1.0,5/14,27.41%,CLASP2;POGLUT1;PHLDB2;TENM4;CLASP1
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.20390597665129523,-0.5986757996904803,0.9620689655172414,0.9906426548629059,1.0,13/21,42.84%,HPRT1;HINT1;NUDT7;PDE4D;MLYCD;PDE9A;NT5E;AMPD3;NUDT16;FITM2;PDE2A;NUDT18;NUDT11
prerank,negative regulation of nervous system development (GO:0051961),0.25735392614477587,0.5980968977951333,0.9308270676691729,0.9858335786456298,1.0,6/17,24.21%,SORL1;IL6;TLR2;REST;HOOK3;SLIT1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.2859302354102594,0.5978684823382905,0.9264705882352942,0.9856236675194194,1.0,1/10,7.23%,SEMA6A
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.27383292957441346,0.5972223205179978,0.9375975039001561,0.9856670602950522,1.0,1/13,8.46%,CYRIB
prerank,rRNA methylation (GO:0031167),0.24015062739632181,0.5956149098516319,0.9286713286713286,0.9862852430134911,1.0,4/22,14.25%,NOP2;NSUN4;NSUN5;TFB2M
prerank,DNA methylation (GO:0006306),0.23842104137293021,0.5925328921000884,0.9495798319327731,0.987712232018291,1.0,5/23,17.26%,BAZ2A;TEX15;DNMT3A;GATAD2A;PICK1
prerank,microtubule-based transport (GO:0099111),0.27078101456554493,0.5921773931662857,0.9179566563467493,0.987554443554421,1.0,13/13,72.94%,SPEF2;DYNC1I1;HTT;CCDC103;ROPN1L;DNAAF4;SPA17;DNAAF2;SPAG17;ADCY10;CABYR;CCDC40;DYNC1I2
prerank,positive regulation of viral genome replication (GO:0045070),0.22564925460775642,0.590720013802053,0.9638069705093834,0.9880487672026167,1.0,5/29,15.28%,TARBP2;CNOT7;DDB1;SRPK2;ADARB1
prerank,sister chromatid segregation (GO:0000819),0.22788456302793733,0.5903198351164806,0.9546632124352331,0.9879228815162501,1.0,4/31,13.79%,MIS12;LATS1;NDC80;WRAP73
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.21098699822539416,0.5900461354551912,0.9758162031438936,0.9877318194425707,1.0,8/44,15.78%,SIAH2;PCID2;CARD16;DPEP1;CST7;HGF;PAX2;RAF1
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.20860564612189864,-0.5899099539318113,0.9727891156462585,0.9933746297350527,1.0,11/18,37.52%,SETD1A;ASH1L;SETD4;EHMT2;SMYD2;SUV39H1;EHMT1;SETD2;SUV39H2;SETMAR;SETD1B
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.26978072807318043,0.5873500043967729,0.9328,0.9889494515259226,1.0,2/14,8.98%,AK8;CMPK1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.28345091184261584,0.586759112189731,0.9222222222222223,0.9889131504257411,1.0,2/10,15.24%,KAT5;ING4
prerank,camera-type eye development (GO:0043010),-0.18869901594513483,-0.5864716632696767,0.979253112033195,0.9934273250241926,1.0,5/25,21.78%,CACNA1C;FBN1;TENM3;VEGFA;CEP290
prerank,homologous chromosome segregation (GO:0045143),0.24344140853911683,0.5863325839032502,0.9445214979195562,0.9887940977005664,1.0,3/20,14.33%,CENPC;TERB1;MEI4
prerank,negative regulation of protein polymerization (GO:0032272),0.2344408543286828,0.5854907768139972,0.9652406417112299,0.9889134866001312,1.0,3/27,8.46%,CLIP3;PFN1;CYRIB
prerank,endodermal cell fate commitment (GO:0001711),0.2755926173417483,0.5847511599989798,0.943801652892562,0.9889603212965902,1.0,2/10,17.70%,SOX2;CTR9
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.28200047653061167,0.5842688042181602,0.9357495881383855,0.9888797948918902,1.0,1/10,9.77%,SUMO1
prerank,RNA modification (GO:0009451),0.20736050764792835,0.5841899293207626,0.970344009489917,0.9885820642268338,1.0,10/54,17.88%,CTU2;NOP2;NSUN4;QTRT1;NSUN5;ADARB1;PUS7;CDKAL1;TYW5;NSUN6
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.1928629604413993,-0.5835263715752489,0.9806949806949807,0.9933699952117898,1.0,2/23,4.25%,LPCAT3;PLAAT3
prerank,negative regulation of viral entry into host cell (GO:0046597),0.2749000760274986,0.5833389460309134,0.9403225806451613,0.9887024573407477,1.0,3/12,19.69%,IFITM3;TRIM5;TRIM26
prerank,megakaryocyte differentiation (GO:0030219),-0.23537663806840745,-0.5831739234961053,0.9614325068870524,0.9922554961501728,1.0,1/11,5.70%,UBA5
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.269721623609515,0.582021474463534,0.9440993788819876,0.9890632675241834,1.0,2/12,10.92%,SIRT1;KDM1A
prerank,regulation of catecholamine secretion (GO:0050433),-0.1751080136621281,-0.5792669901323374,0.9959349593495935,0.992526463700335,1.0,15/29,43.59%,SYT2;SYT7;STX1A;KCNB1;SYT6;SYT8;SYT3;SYT12;SYT11;CHRNA4;CHGA;SYT13;DRD2;SYT5;SYT17
prerank,cellular biogenic amine catabolic process (GO:0042402),0.28278316982108787,0.5786816922579376,0.925984251968504,0.9904541854300639,1.0,2/10,14.77%,COMT;SMOX
prerank,cellular polysaccharide catabolic process (GO:0044247),0.25758759678178056,0.5773422652657378,0.9394856278366112,0.9907827218662248,1.0,8/16,25.50%,PHKG1;PGM2L1;PHKA2;AOAH;PHKG2;AGL;PHKB;PGM2
prerank,modulation of chemical synaptic transmission (GO:0050804),0.1895430775015606,0.5768689887417106,0.9935553168635876,0.9906538978162164,1.0,16/107,16.78%,RIMS1;RIMS3;DGKZ;CACNA1A;CLSTN1;AKAP9;GRID1;BDNF;SYN3;SNCAIP;APP;FMR1;GRIK5;SYT1;LRRC4;CEL
prerank,UV protection (GO:0009650),0.2747191994379142,0.5743213430628428,0.9262820512820513,0.9915759805610971,1.0,3/10,21.13%,ERCC2;SDF4;CAT
prerank,acylglycerol biosynthetic process (GO:0046463),0.2348345876831976,0.5733574565956594,0.9621109607577808,0.9917031063224173,1.0,2/23,10.06%,PLA2G4A;GPAT4
prerank,regulation of synapse organization (GO:0050807),0.22426509622984442,0.5731595592487203,0.9589403973509933,0.9914468022558318,1.0,6/26,18.17%,ARHGAP22;CDKL5;GRIPAP1;YWHAZ;CTNNA2;MEF2C
prerank,hydrogen peroxide catabolic process (GO:0042744),0.2665692437875224,0.5717239975719174,0.9354838709677419,0.9917977566363019,1.0,1/11,5.83%,PRDX5
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.23850691389258705,-0.5708175219695208,0.9609375,0.9942903695439197,1.0,5/10,33.64%,DLGAP2;DLGAP4;DLGAP1;NPTX1;BEGAIN
prerank,angiogenesis involved in wound healing (GO:0060055),0.26660540500132907,0.5697229134165201,0.9397781299524565,0.9923955881358676,1.0,2/11,15.58%,ITGB3;ADIPOR2
prerank,defense response to tumor cell (GO:0002357),0.27596696255182596,0.5688590239200487,0.940032414910859,0.9924508375848561,1.0,2/10,15.84%,SPI1;DAPK1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.2192126376182565,0.5673496770260806,0.9668789808917198,0.9927784943689002,1.0,3/32,11.65%,AKAP6;TRPC1;TRPC3
prerank,negative regulation of developmental process (GO:0051093),0.19525366636863703,0.5667812602725895,0.9873417721518988,0.9926740940245634,1.0,7/69,10.61%,SOX9;BCL11A;CDK6;SPI1;ADCK1;KLF7;RC3H1
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.2430258014461938,-0.5666080208656622,0.968,0.9944736455745047,1.0,6/10,42.45%,NOTCH1;TNFRSF1A;DPP4;FAP;EMILIN1;CHADL
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.2374005623767207,0.5665279114006445,0.9636363636363636,0.9924441934139646,1.0,1/19,5.51%,APOE
prerank,cell proliferation in forebrain (GO:0021846),-0.23935754805541543,-0.564628794630035,0.9581151832460733,0.9938834206723487,1.0,3/10,24.83%,DOCK7;CEP120;NUMBL
prerank,hexose transmembrane transport (GO:0008645),0.23109296482412084,0.5644929398318516,0.9557142857142857,0.9929905504359091,1.0,21/21,76.92%,SLC2A1;SLC5A3;PPARD;SLC2A7;PPBP;SLC5A9;SLC2A10;SLC5A2;SLC2A9;SLC5A10;SLC5A1;SLC2A4;SLC2A2;SLC2A12;SLC2A3;SLC45A1;SLC45A3;SLC2A6;SLC2A8;SLC50A1;SLC2A5
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.2674867033955897,0.5640950893498514,0.9368088467614534,0.9928210781828786,1.0,1/11,4.03%,KAT5
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.26532888668643595,0.5628569129321958,0.939117199391172,0.9930360489535198,1.0,2/12,12.79%,APOC1;P4HB
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.24889333448978573,0.5618085143211252,0.9602941176470589,0.9931301971733232,1.0,2/15,14.77%,PAOX;SMOX
prerank,positive regulation of transporter activity (GO:0032411),0.2581573749585135,0.5617247434424125,0.9525267993874426,0.9928227806193192,1.0,3/13,18.43%,KMT2A;RXRA;SGK1
prerank,positive regulation of cell aging (GO:0090343),0.2590624014448342,0.5613482922961369,0.9427244582043344,0.9926477900395123,1.0,3/11,18.71%,SIRT1;YPEL3;CGAS
prerank,cell cycle checkpoint signaling (GO:0000075),-0.22122722531540226,-0.5608394709563218,0.9786096256684492,0.9938313487115685,1.0,7/12,33.26%,NABP2;ZW10;WEE1;ZWILCH;BUB1B;BUB1;PLK2
prerank,T cell differentiation (GO:0030217),0.2099623734961169,0.560772287082812,0.988833746898263,0.9925429983062424,1.0,3/40,9.03%,ADAM17;SPI1;PTPRC
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.24571145554627022,0.5603327158602849,0.9431988041853513,0.9923932708854345,1.0,1/16,10.21%,CLDN11
prerank,DNA catabolic process (GO:0006308),-0.22463448278320064,-0.5602755375381823,0.9617486338797814,0.9927667403145748,1.0,5/11,42.15%,FBH1;SETMAR;DNASE1L2;DFFB;MUS81
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.22857968916347926,0.5573284352619404,0.9728571428571429,0.9932719485095011,1.0,5/22,21.10%,PSMC4;MED1;MED13;MED4;ESR1
prerank,DNA strand elongation (GO:0022616),0.23452544081538862,0.5552753606890327,0.9586305278174037,0.9937379690019472,1.0,2/18,9.60%,GINS3;NBN
prerank,regulation of cilium movement (GO:0003352),0.2645784947586467,0.5543392192334257,0.9403453689167975,0.9937638411898307,1.0,10/10,73.56%,CFAP43;CCDC65;DNAAF1;DRC1;CFAP206;CCDC40;ODAD2;CFAP298;DNAH11;CCDC39
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.21309018254027182,0.5535995848473753,0.9762532981530343,0.9937157520322696,1.0,3/31,10.92%,TGFBR1;ENG;RBPJ
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.21207945374354442,0.5535290787180999,0.9795134443021767,0.9934031861404313,1.0,5/31,16.07%,DNAJC19;TOMM20;TIMM44;DNAJC15;HSPD1
prerank,mitochondrion localization (GO:0051646),0.23289391300529164,0.5515083718135989,0.9753761969904241,0.9938768476834301,1.0,5/19,20.39%,MTM1;TRAK1;MEF2A;ZBED3;NECTIN2
prerank,sulfur amino acid metabolic process (GO:0000096),-0.17489782075871715,-0.5507230376232489,0.9841897233201581,0.9943210784179043,1.0,6/24,23.00%,SMS;MTHFD1;MSRA;MTRR;NOX4;MTR
prerank,positive regulation of hormone secretion (GO:0046887),0.23995013474315804,0.5497740963815401,0.95355587808418,0.9941843436492023,1.0,1/17,5.63%,SPP1
prerank,aspartate family amino acid metabolic process (GO:0009066),0.2382564178374745,0.5472965831320163,0.9575402635431918,0.994796403200994,1.0,4/18,14.48%,SLC25A13;GOT2;FOLH1;GOT1
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.19993345366143267,0.5471641462012349,0.9827160493827161,0.9945001787792488,1.0,6/43,13.61%,BRSK1;NBN;CHFR;TAOK2;NABP1;NAE1
prerank,regulation of leukocyte activation (GO:0002694),0.24107881738934267,0.5458601851082429,0.9497716894977168,0.9946411129208146,1.0,6/14,24.53%,CD33;CD200;GPR137B;LYN;MYO18A;MFHAS1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.254677202449118,0.5448067634026496,0.9533762057877814,0.9946731105681342,1.0,1/11,5.47%,ADIPOR1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.2180588265818204,0.5444347538296871,0.9686684073107049,0.9944563966677936,1.0,3/25,12.02%,HSP90AB1;CLU;DDAH2
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.18300385788719892,0.5426381857002448,0.9977924944812362,0.9947417370911737,1.0,17/83,20.59%,SFI1;SSNA1;CSNK1E;TUBB;HAUS8;AKAP9;DCTN3;PAFAH1B1;ATAD5;CEP250;CSNK1D;DCTN1;ODF2;TUBB4A;HAUS3;ACTR1A;SDCCAG8
prerank,carnitine metabolic process (GO:0009437),0.25436911853001876,0.5411036807642685,0.9558359621451105,0.9949102073276173,1.0,4/12,18.51%,CRAT;BBOX1;TMLHE;ALDH9A1
prerank,smooth muscle tissue development (GO:0048745),0.2607562979447498,0.5384061804603496,0.964041095890411,0.9954891246624676,1.0,2/10,17.14%,ENG;SMO
prerank,regulation of pH (GO:0006885),0.24898868926956225,0.5369116575476921,0.9658536585365853,0.9956312314813796,1.0,3/11,20.27%,ATP6AP1;SLC9A1;SLC9A7
prerank,peptidyl-lysine methylation (GO:0018022),0.21229887658896945,0.532297812295137,0.9808743169398907,0.99675149029838,1.0,4/26,16.36%,KMT5A;SMYD3;SETD7;EEF1AKMT1
prerank,regulation of coagulation (GO:0050818),0.2520762944742135,0.5305342667433768,0.9630818619582665,0.9969843268130629,1.0,2/11,16.70%,HS3ST5;PROC
prerank,regulation of B cell apoptotic process (GO:0002902),0.24819261099859344,0.5299876890359428,0.9581993569131833,0.9968059233132143,1.0,2/12,13.61%,FOXP1;BCL6
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.25826119016206606,0.5299840834927851,0.9568690095846646,0.9964636277663604,1.0,2/10,10.92%,CTNNB1;KDM1A
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.24639045825486494,0.5299667664535921,0.9563812600969306,0.9961251711984804,1.0,11/11,75.38%,PTPRC;XCL1;SMAD7;KLRC1;FOXP3;KLRD1;IL4I1;AHR;HFE;CEACAM1;LILRB1
prerank,aminoglycan metabolic process (GO:0006022),0.26008595162504944,0.528755139942064,0.9509803921568627,0.9961525750063025,1.0,3/10,17.67%,XYLT1;B4GALT7;B3GAT1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.2312747076966801,0.5273954333785099,0.9710806697108066,0.996230013929717,1.0,2/16,9.43%,APOE;GCH1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.22443895555004517,0.5261192853998516,0.9624819624819625,0.9962487234350565,1.0,2/17,10.78%,BAIAP2L1;BAIAP2
prerank,regulation of lipid catabolic process (GO:0050994),0.2226170295142253,0.5252452374384028,0.9743589743589743,0.9961598240395363,1.0,3/19,18.47%,APOC1;PDE3B;PRKAA1
prerank,defense response to Gram-positive bacterium (GO:0050830),0.19400347630108838,0.524632469411907,0.9913258983890955,0.9959940036048847,1.0,4/40,15.77%,ADAM17;DROSHA;IL6;RNASE3
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.20790014557716147,0.5225929764965679,0.9804432855280313,0.9962084004883112,1.0,3/26,12.02%,HSP90AB1;CLU;DDAH2
prerank,sulfur amino acid catabolic process (GO:0000098),-0.22418732903891575,-0.5222621281326797,0.9768637532133676,0.9998022948236288,1.0,7/10,49.34%,MTRR;ADO;TST;MPST;CBS;GADL1;CTH
prerank,odontogenesis (GO:0042476),0.1971576923994825,0.5215104102670031,0.9845559845559846,0.9961724503847037,1.0,4/35,16.01%,COL1A2;HDAC1;TUFT1;ANKRD11
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.22977951638867986,0.5200101621621488,0.9749631811487481,0.9962400203973013,1.0,2/15,11.39%,ZDHHC3;SYN3
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.22258334207923205,0.5185597399737113,0.9705882352941176,0.9962730574128019,1.0,2/16,12.61%,ADIPOR1;INPP5F
prerank,negative regulation of ATPase activity (GO:0032780),-0.18600152181646112,-0.5179218576674882,0.9879518072289156,0.9993809943651492,1.0,10/16,49.29%,OXA1L;PAM16;IFIT1;ATP5IF1;VCPKMT;TP53;PPIF;TLR9;PLN;LTF
prerank,regulation of membrane depolarization (GO:0003254),-0.1781763083597394,-0.5178730221189692,0.9839743589743589,0.998137716013437,1.0,4/18,27.82%,LRRK2;GPD1L;PTPN3;SCN3B
prerank,apoptotic nuclear changes (GO:0030262),0.20797311271277458,0.5154814545956147,0.9865951742627346,0.9967082781285388,1.0,3/24,16.17%,HMGB1;DEDD2;ACIN1
prerank,epithelial cell-cell adhesion (GO:0090136),0.24405800752164275,0.5150101018551095,0.9752704791344667,0.996489480216485,1.0,1/11,6.08%,JUP
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.19844446919994246,0.5103473766955814,0.9895968790637191,0.997308674893014,1.0,8/31,22.57%,CACNA1G;STXBP3;SYT1;SYT4;RAB3GAP1;SYT10;REST;SYT9
prerank,iron-sulfur cluster assembly (GO:0016226),0.205193204370342,0.5059868422632087,0.9945578231292517,0.9979723311287384,1.0,4/24,14.43%,GLRX5;GLRX3;ISCA1;ABCB7
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.1762106315877205,-0.5047765889937051,0.9904458598726115,0.9990699075827266,1.0,9/18,42.63%,VPS4B;CDC25A;CDK4;CDC7;RAD51C;CDC25B;DTL;CDK1;STOX1
prerank,regulation of receptor binding (GO:1900120),-0.2074999196291915,-0.5046707218954131,0.9777227722772277,0.9978451071663206,1.0,2/10,17.55%,ATP2A2;GREM2
prerank,bile acid biosynthetic process (GO:0006699),-0.16176046724471319,-0.503625137666773,1.0,0.9967591292128498,1.0,6/24,29.18%,OSBPL6;CH25H;ACOT8;OSBPL9;CYP39A1;AMACR
prerank,pancreas development (GO:0031016),0.22998128053209085,0.5032176985482176,0.9714285714285714,0.9982686636299529,1.0,1/12,8.35%,TCF7L2
prerank,regulation of regulated secretory pathway (GO:1903305),0.19092104473766996,0.4998967282847244,0.9923566878980892,0.9986243040230167,1.0,9/34,22.57%,RIMS1;RIMS3;PREPL;SYT1;VPS18;SYT4;SYT10;SNAPIN;SYT9
prerank,bile acid metabolic process (GO:0008206),-0.15286453988271714,-0.4972360770722959,1.0,0.9964520803824409,1.0,7/27,29.18%,OSBPL6;CH25H;ACOT8;OSBPL9;CYP39A1;GBA2;AMACR
prerank,regulation of phospholipase activity (GO:0010517),0.2424240048842245,0.4962580137463279,0.98,0.9990406249403754,1.0,1/10,7.87%,LRP1
prerank,extracellular matrix assembly (GO:0085029),-0.16193833825517145,-0.4952856979189713,0.9934426229508196,0.9954782409515179,1.0,17/23,48.45%,GAS6;QSOX1;PXDN;NTN4;EFEMP2;ATP7A;LAMB2;LAMB1;TNXB;EMILIN1;HAS1;HAS2;RAMP2;LAMB3;MYH11;HAS3;FBLN5
prerank,negative regulation of hydrolase activity (GO:0051346),0.1779343761347305,0.49474024326906135,0.9952380952380953,0.9990006048941823,1.0,5/49,14.16%,SLC39A14;RRP1B;GMIP;GPATCH2;CST7
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.23435619722331663,0.492470765242458,0.9740061162079511,0.99912248725464,1.0,1/11,4.71%,ZMIZ1
prerank,"phototransduction, visible light (GO:0007603)",0.22456481622506858,0.4914411388238016,0.9880239520958084,0.9989772121663342,1.0,1/14,11.35%,GNB1
prerank,axonal transport of mitochondrion (GO:0019896),0.23277328005784612,0.4894519985582078,0.9820359281437125,0.9990217158794086,1.0,1/11,6.74%,TRAK1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.21257593946200454,0.48856940610713884,0.9823529411764705,0.9988379359608781,1.0,5/17,20.92%,ALG12;DHDDS;ALG9;ALG8;DOLPP1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.2042273891264332,0.4883836878923159,0.9889196675900277,0.9985283917092304,1.0,5/22,20.34%,STAC;STAC2;FMR1;DMD;CACNB4
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.2250645932238291,0.4880521524947762,0.9829721362229102,0.9982515930233239,1.0,3/12,19.63%,RFWD3;PLK3;CCND1
prerank,positive regulation of interleukin-12 production (GO:0032735),0.19153656597919516,0.4870840493872422,0.993573264781491,0.9980711231420634,1.0,2/31,10.11%,HMGB1;RIPK2
prerank,negative regulation of biosynthetic process (GO:0009890),-0.18118906275406832,-0.4870773070067485,0.9849397590361446,0.9952640759127617,1.0,5/16,28.23%,ABCD2;TRAP1;PARK7;CIITA;CEACAM1
prerank,neurotransmitter biosynthetic process (GO:0042136),0.21265610425654727,0.4839922467260187,0.9819548872180451,0.9982634148219757,1.0,13/14,60.49%,DAGLA;ALDH9A1;DAGLB;SLC6A4;SLC6A3;SLC44A4;DBH;PAH;SLC22A2;ACHE;MOXD1;NOS1;CHAT
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.21063208727536056,0.4837379096821983,0.9845070422535211,0.9979680604500136,1.0,1/18,5.49%,MIDN
prerank,copper ion transport (GO:0006825),0.22540791432385113,0.479479670827713,0.9860031104199067,0.9983362729867429,1.0,2/11,12.67%,SLC31A1;CUTC
prerank,neuron projection regeneration (GO:0031102),0.22999183980917726,0.47779617300061544,0.9839486356340289,0.9982498876493108,1.0,10/10,77.02%,PTN;RTN4RL1;MAPK8IP3;NREP;RTN4RL2;FOLR1;GAP43;DHFR;OMG;MTR
prerank,protein localization to microtubule organizing center (GO:1905508),0.2069980598945648,0.47056099578808913,0.9879154078549849,0.9990198544094377,1.0,7/15,26.34%,BBS4;CSNK1D;HOOK3;NEDD1;PIBF1;CEP192;C2CD3
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.21682360326428127,0.46216639417097877,0.9885433715220949,0.9997586234534434,1.0,11/11,78.33%,MEF2C;TGFB1;DHX36;WNT3A;GATA4;TBX5;MYOCD;GPER1;GREM1;EFNB2;TGFB2
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.17945376611484185,0.45583922669717825,0.9945429740791268,1.0,1.0,5/27,19.58%,AK8;CMPK1;TXNRD1;RRM2B;DCTD
prerank,regulation of response to cytokine stimulus (GO:0060759),0.1880514036918075,0.4515489051673318,0.9899280575539569,1.0,1.0,3/19,15.68%,DHX9;IRAK2;RUNX1
prerank,homocysteine metabolic process (GO:0050667),0.21003025144224585,0.4442819254401964,0.9902120717781403,1.0,1.0,3/11,21.76%,DPEP1;BLMH;MTHFR
prerank,response to steroid hormone (GO:0048545),0.1702562298444501,0.4399582827013334,1.0,1.0,1.0,4/31,16.47%,UBE3A;UBE2L3;MED1;ATP1A3
prerank,regulation of centriole replication (GO:0046599),0.18632424911845527,0.4347653055327025,0.9985734664764622,1.0,1.0,3/18,17.68%,MDM1;KAT2A;RBM14
prerank,protein localization to centrosome (GO:0071539),0.18425019508030152,0.4290125289165022,0.9926144756277696,1.0,1.0,6/17,24.31%,BBS4;CSNK1D;GOLGB1;HOOK3;NEDD1;PIBF1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.1748587558442617,0.4279844217868034,0.9944211994421199,1.0,1.0,9/21,25.37%,ATAD5;BRD4;CCND1;RCC2;RAB11A;MECP2;FBXO5;RAD51B;NPM1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.18707260918257798,0.4229893176308418,0.9941520467836257,1.0,1.0,4/15,20.63%,CNOT7;YTHDF2;NLRC5;METTL3
prerank,muscle tissue development (GO:0060537),0.18978304881903382,0.41712976379806804,0.993660855784469,1.0,1.0,5/13,25.31%,ENG;SMO;CSRP3;CSRP1;NF1
prerank,detection of visible light (GO:0009584),0.17998687891345622,0.4148362572441668,0.9985074626865672,1.0,1.0,1/16,13.91%,CEP250
prerank,regulation of response to stress (GO:0080134),0.20171330532601445,0.414743385436487,0.9937106918238994,1.0,1.0,3/10,22.39%,ADCY8;CORO2B;EIF4G1
prerank,regulation of lymphocyte activation (GO:0051249),0.18687664313655997,0.4085896744296451,0.9940564635958395,1.0,1.0,2/12,16.99%,PAG1;KAT2A
prerank,negative regulation of cell development (GO:0010721),0.15815659465477538,0.3952777498318279,1.0,1.0,1.0,3/25,15.03%,SORL1;IGF1;IL6
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.18651850242557572,0.3951863498923836,1.0,1.0,1.0,1/11,8.28%,ITM2C
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.17888859504726334,0.3918946658581413,0.9969088098918083,0.9998548196165122,1.0,3/13,19.33%,SYP;RAB3GAP1;SHISA9
prerank,positive regulation of embryonic development (GO:0040019),-0.13582147649090984,-0.39138326354056785,1.0,0.9996798158462435,1.0,1/19,4.64%,NIBAN2
prerank,gastrulation (GO:0007369),0.16988479213447077,0.38958523831601327,1.0,0.9995964001888333,1.0,3/15,21.91%,LRP5;LMBRD1;GPC3
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.17395928881626904,0.388748121664746,0.9968944099378882,0.999283899661251,1.0,3/14,19.39%,ATP1B1;DMD;SLC9A1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.17060451584895578,0.3581382679040972,1.0,0.9996529496092759,1.0,4/10,24.50%,INPP5F;SH2B3;PIBF1;PPP2CA
